data_1fd6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1fd6 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.465 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 70.4 m . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.07 0.462 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.0 m -78.67 99.57 6.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.639 -0.663 . . . . 0.0 110.76 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.465 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 73.2 m-85 -87.45 167.4 14.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.555 -0.716 . . . . 0.0 109.907 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -138.75 129.87 26.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.464 -0.772 . . . . 0.0 110.435 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.423 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 44.3 tp -106.5 123.06 47.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.509 -0.744 . . . . 0.0 110.209 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.6 tp -75.42 165.98 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.6 mt -127.89 72.66 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.225 -0.922 . . . . 0.0 110.676 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -95.38 49.19 1.18 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.274 -0.892 . . . . 0.0 109.029 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.69 166.5 14.96 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -84.89 6.35 25.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.724 -0.868 . . . . 0.0 110.608 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 m -116.84 -30.76 5.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 110.482 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.5 mt -135.71 173.11 12.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 110.783 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.38 139.38 3.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.66 -0.65 . . . . 0.0 110.294 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.37 -136.1 7.68 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -153.99 154.36 33.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.617 -0.931 . . . . 0.0 110.287 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.9 m -143.82 155.23 44.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.59 -0.694 . . . . 0.0 110.211 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.0 p -133.25 173.9 10.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.563 -0.711 . . . . 0.0 110.329 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.445 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 7.6 t -164.11 -170.32 2.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.64 -0.663 . . . . 0.0 110.167 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.56 100.11 6.09 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.639 -0.663 . . . . 0.0 110.4 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.84 142.69 50.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.465 -0.772 . . . . 0.0 110.01 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.81 -30.39 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.576 -0.702 . . . . 0.0 110.048 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.1 p30 -170.06 176.08 4.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.611 -0.681 . . . . 0.0 110.323 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.78 -25.15 26.15 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.515 -0.741 . . . . 0.0 110.969 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.06 -27.0 66.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.492 -0.755 . . . . 0.0 110.431 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.2 m -112.1 -27.99 8.16 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.499 -0.751 . . . . 0.0 110.364 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.428 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -59.69 -49.6 77.11 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.487 -0.758 . . . . 0.0 110.375 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -59.14 -40.19 84.72 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.541 -0.724 . . . . 0.0 110.309 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -56.94 -35.5 69.16 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.35 -0.844 . . . . 0.0 110.363 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 93.8 t -84.39 -48.19 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.601 -0.687 . . . . 0.0 110.056 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 9.7 m-85 -65.87 -36.82 84.5 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 110.206 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.1 tptt -63.44 -44.89 93.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.518 -0.739 . . . . 0.0 109.43 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -60.72 -31.57 70.87 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.609 0.718 . . . . 0.0 109.708 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -70.7 -57.14 4.99 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.33 -47.22 85.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.751 -0.593 . . . . 0.0 110.022 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -54.94 -32.95 61.81 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.474 -0.766 . . . . 0.0 110.591 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.42 -49.99 43.13 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.615 -0.678 . . . . 0.0 109.985 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -71.35 -46.34 60.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.569 -0.707 . . . . 0.0 109.886 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.47 43.26 0.29 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.459 HD12 HG21 ' A' ' 40' ' ' ILE . 81.1 mt -105.59 71.32 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.447 -1.031 . . . . 0.0 110.245 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -95.4 46.05 1.1 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.2 -135.85 0.1 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -115.47 102.19 9.58 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.423 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 38.3 m95 -72.56 142.42 48.44 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.177 0.989 . . . . 0.0 112.456 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -150.9 133.05 15.32 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.415 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 63.2 t80 -102.83 109.24 20.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.664 -0.648 . . . . 0.0 110.206 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.34 109.33 16.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.655 -0.653 . . . . 0.0 110.096 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -67.6 -20.61 65.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.693 -0.629 . . . . 0.0 110.767 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.39 -42.56 67.08 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.251 -0.906 . . . . 0.0 110.859 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.7 p -141.31 18.7 2.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.585 -0.697 . . . . 0.0 110.685 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER 50.31 90.35 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.151 -0.968 . . . . 0.0 111.152 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 57.6 m -156.59 108.46 2.48 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.789 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.415 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 93.1 m-85 -60.37 123.29 16.84 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.4 m -115.5 94.53 4.75 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.242 -0.983 . . . . 0.0 112.846 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.406 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.0 p -95.55 166.84 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.128 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.4 m -160.26 108.1 1.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.677 -0.639 . . . . 0.0 109.86 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.214 -179.922 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.426 HG23 ' CZ ' ' A' ' 4' ' ' PHE . 22.4 m . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.001 0.429 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.8 m -118.22 91.24 3.51 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.593 -0.692 . . . . 0.0 110.524 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.434 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 98.6 m-85 -80.34 168.69 18.72 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.594 -0.691 . . . . 0.0 109.967 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -145.88 115.79 7.34 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.463 -0.773 . . . . 0.0 110.372 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.435 ' CB ' ' CD1' ' A' ' 31' ' ' PHE . 30.1 tp -94.11 127.18 39.78 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.422 -0.799 . . . . 0.0 110.2 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 tp -76.47 170.12 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.8 mt -129.99 71.13 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.22 -0.925 . . . . 0.0 110.715 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -96.15 47.25 1.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.506 -0.746 . . . . 0.0 109.22 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.43 167.0 24.47 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -82.32 3.12 29.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.76 -0.847 . . . . 0.0 110.754 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 m -116.88 -30.63 5.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.104 -0.997 . . . . 0.0 110.455 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.9 mt -128.7 172.48 11.2 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.455 -0.778 . . . . 0.0 110.694 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -154.99 131.76 10.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.696 -0.627 . . . . 0.0 109.932 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.71 -140.22 11.55 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -147.82 178.04 8.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.565 -0.962 . . . . 0.0 110.42 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.7 m -152.27 128.94 10.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.542 -0.724 . . . . 0.0 110.162 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.3 p -114.53 155.77 25.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.574 -0.704 . . . . 0.0 110.256 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.431 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 8.1 t -160.55 153.51 21.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.597 -0.689 . . . . 0.0 110.309 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -86.71 112.41 21.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.524 -0.735 . . . . 0.0 110.326 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.6 147.32 52.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.642 -0.661 . . . . 0.0 110.048 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 p -64.25 -33.58 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.531 -0.73 . . . . 0.0 110.227 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.2 p30 -170.86 -177.85 2.38 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.486 -0.759 . . . . 0.0 110.362 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.434 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.36 -25.24 23.18 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.477 -0.764 . . . . 0.0 111.003 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.24 -46.01 89.64 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.443 -0.785 . . . . 0.0 110.315 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.5 m -90.2 -26.48 20.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.605 -0.684 . . . . 0.0 110.168 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.75 -62.32 1.96 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.55 -0.719 . . . . 0.0 110.217 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -60.36 -37.06 79.54 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.505 -0.747 . . . . 0.0 109.972 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.4 ttpt -58.42 -37.16 74.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.446 -0.783 . . . . 0.0 110.073 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.1 t -84.55 -45.84 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.689 -0.632 . . . . 0.0 109.786 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.435 ' CD1' ' CB ' ' A' ' 6' ' ' LEU . 14.0 m-85 -66.41 -34.01 77.0 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.636 -0.665 . . . . 0.0 110.207 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -66.15 -46.21 78.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.442 -0.786 . . . . 0.0 109.015 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -61.11 -30.91 70.65 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.634 0.73 . . . . 0.0 109.381 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -69.26 -55.74 9.62 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.07 -38.86 92.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.712 -0.617 . . . . 0.0 109.797 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -59.02 -34.05 71.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.528 -0.733 . . . . 0.0 110.357 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -78.03 -47.67 17.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.657 -0.652 . . . . 0.0 110.141 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -69.76 -41.91 74.57 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.593 -0.692 . . . . 0.0 110.087 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.34 62.54 0.4 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.446 HD13 HG22 ' A' ' 40' ' ' ILE . 87.0 mt -127.65 81.47 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.552 -0.97 . . . . 0.0 110.421 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -98.76 37.67 1.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.04 -140.24 0.02 OUTLIER Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -114.56 110.7 20.22 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.424 ' CZ3' ' CD1' ' A' ' 6' ' ' LEU . 29.9 m95 -77.88 143.03 38.09 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 122.205 1.003 . . . . 0.0 112.364 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.0 p -153.94 132.12 11.86 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -105.65 143.77 33.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.63 -0.669 . . . . 0.0 110.06 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.69 108.73 18.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.765 -0.584 . . . . 0.0 109.804 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.6 -23.03 65.33 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.638 -0.664 . . . . 0.0 110.62 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.23 -37.55 64.74 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.309 -0.87 . . . . 0.0 110.788 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.5 p -147.79 19.04 1.15 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.518 -0.739 . . . . 0.0 110.766 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.419 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.6 94.56 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.204 -0.935 . . . . 0.0 110.886 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.9 m -159.1 100.72 1.56 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.559 -0.713 . . . . 0.0 110.791 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -61.95 140.1 58.35 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.445 -0.785 . . . . 0.0 109.006 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.8 m -131.87 100.03 4.95 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.272 -0.971 . . . . 0.0 112.69 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.414 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.3 p -101.61 166.25 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.22 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.4 m -160.79 112.26 1.86 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.661 -0.649 . . . . 0.0 109.931 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 118.016 -0.993 . . . . 0.0 110.13 179.943 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.441 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 62.0 m . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.072 0.463 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.6 m -84.81 95.44 8.98 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.633 -0.667 . . . . 0.0 110.696 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.441 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 95.8 m-85 -79.77 173.99 12.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.48 -0.763 . . . . 0.0 109.778 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -142.67 123.26 14.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.486 -0.759 . . . . 0.0 110.658 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.42 HD13 ' CH2' ' A' ' 44' ' ' TRP . 47.4 tp -101.16 127.61 47.64 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.425 -0.797 . . . . 0.0 109.897 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 tt -77.39 174.06 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 86.2 mt -133.14 73.33 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.32 -0.862 . . . . 0.0 110.444 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -95.82 47.79 1.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.414 -0.804 . . . . 0.0 109.004 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.72 154.78 16.45 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -71.81 -9.1 57.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.704 -0.88 . . . . 0.0 110.396 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -90.31 -34.57 15.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 110.281 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.82 167.39 22.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.474 -0.766 . . . . 0.0 110.769 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -147.62 137.29 22.69 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.569 -0.707 . . . . 0.0 110.195 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.8 -136.81 8.7 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -146.97 168.64 20.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.53 -0.983 . . . . 0.0 110.326 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.2 m -143.45 149.87 38.22 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.638 -0.664 . . . . 0.0 110.125 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.8 p -131.41 157.66 42.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.534 -0.729 . . . . 0.0 110.297 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.439 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 8.6 t -160.98 168.12 25.17 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.566 -0.708 . . . . 0.0 110.235 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.26 124.22 44.16 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.602 -0.686 . . . . 0.0 110.145 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.03 138.15 20.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.6 -0.688 . . . . 0.0 110.181 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.08 -34.3 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.537 -0.727 . . . . 0.0 110.064 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.2 p30 -169.65 -173.91 1.75 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.61 -0.681 . . . . 0.0 110.306 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.85 -23.83 47.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.594 -0.691 . . . . 0.0 110.932 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.09 -31.49 68.95 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.395 -0.816 . . . . 0.0 110.36 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.2 m -110.66 -24.3 10.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.57 -0.706 . . . . 0.0 110.447 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.425 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -58.27 -62.11 2.08 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.425 -0.797 . . . . 0.0 110.23 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -60.2 -39.8 87.82 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.555 -0.716 . . . . 0.0 109.903 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -57.64 -37.22 72.96 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.469 -0.769 . . . . 0.0 110.236 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.4 t -83.42 -48.64 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.699 -0.626 . . . . 0.0 109.871 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.439 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 5.4 m-85 -64.39 -34.11 77.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.551 -0.718 . . . . 0.0 110.11 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -64.61 -44.03 91.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.482 -0.761 . . . . 0.0 109.166 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -60.99 -35.36 76.62 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.84 0.829 . . . . 0.0 109.474 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -65.24 -53.54 42.84 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.97 97.73 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.715 -0.615 . . . . 0.0 110.048 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -57.32 -39.83 76.66 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.56 -0.712 . . . . 0.0 110.451 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.71 -56.63 11.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.581 -0.699 . . . . 0.0 110.01 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -64.34 -51.35 63.81 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.588 -0.695 . . . . 0.0 109.903 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.92 55.84 0.16 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.497 HG22 HD13 ' A' ' 40' ' ' ILE . 82.0 mt -118.72 73.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.53 -0.982 . . . . 0.0 110.278 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -95.64 43.2 1.09 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.57 -137.08 0.07 OUTLIER Glycine 0 N--CA 1.488 2.127 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -114.6 107.63 15.75 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.42 ' CH2' HD13 ' A' ' 6' ' ' LEU . 35.0 m95 -77.26 143.51 38.85 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.055 0.931 . . . . 0.0 112.359 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.6 p -152.65 132.01 12.87 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -102.36 124.91 48.77 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.717 -0.615 . . . . 0.0 110.083 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -95.05 113.57 25.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.689 -0.632 . . . . 0.0 109.975 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.51 -15.09 63.18 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.672 -0.643 . . . . 0.0 110.928 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.46 -44.34 80.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.222 -0.924 . . . . 0.0 110.719 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.6 p -147.59 25.11 1.08 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.494 -0.754 . . . . 0.0 110.628 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.431 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.44 89.87 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.357 -0.839 . . . . 0.0 110.841 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 83.2 m -150.46 101.76 2.99 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.478 -0.764 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.401 ' CZ ' ' HB1' ' A' ' 27' ' ' ALA . 85.6 m-85 -61.98 127.84 33.31 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.448 -0.783 . . . . 0.0 108.939 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.6 m -121.06 101.5 7.71 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.338 -0.945 . . . . 0.0 113.027 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.3 p -101.07 167.85 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 108.981 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 98.5 m -159.82 109.14 1.81 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.521 -0.737 . . . . 0.0 109.977 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.185 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.429 HG21 ' CE2' ' A' ' 4' ' ' PHE . 33.7 m . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.121 0.486 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.7 m -97.77 97.48 9.02 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.607 -0.683 . . . . 0.0 110.552 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.45 ' CD2' ' CB ' ' A' ' 27' ' ' ALA . 95.2 m-85 -78.65 175.88 9.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.544 -0.723 . . . . 0.0 109.753 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -144.51 119.6 10.08 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.401 -0.812 . . . . 0.0 110.621 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.431 ' CD1' ' CZ3' ' A' ' 44' ' ' TRP . 42.6 tp -100.04 130.67 46.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.298 -0.876 . . . . 0.0 110.48 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.6 tp -80.36 168.24 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.7 mt -129.41 74.76 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 111.007 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -97.65 47.8 1.02 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.322 -0.861 . . . . 0.0 108.924 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.03 165.94 15.39 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -85.6 6.83 25.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.702 -0.881 . . . . 0.0 110.444 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -113.46 -31.96 6.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.921 . . . . 0.0 109.989 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 tp -140.43 167.44 22.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.558 -0.714 . . . . 0.0 110.375 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -155.26 140.62 17.69 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.592 -0.692 . . . . 0.0 110.323 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.69 -134.64 7.58 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.54 161.7 42.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.621 -0.929 . . . . 0.0 110.386 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.3 m -145.81 151.1 37.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.634 -0.666 . . . . 0.0 110.068 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 p -130.76 157.1 43.75 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.568 -0.708 . . . . 0.0 110.282 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.411 HG22 ' CE2' ' A' ' 31' ' ' PHE . 8.3 t -149.29 -172.05 4.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.562 -0.711 . . . . 0.0 110.252 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -123.85 103.94 8.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.486 -0.759 . . . . 0.0 110.249 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.02 153.47 47.56 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.56 -0.712 . . . . 0.0 110.116 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.54 -22.2 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.573 -0.705 . . . . 0.0 110.46 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 44.2 p30 -172.35 -177.92 1.9 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.316 -0.865 . . . . 0.0 110.203 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.406 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.45 -24.57 20.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.523 -0.736 . . . . 0.0 111.064 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.49 -52.13 66.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.463 -0.773 . . . . 0.0 110.479 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.1 m -80.6 -26.52 37.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.571 -0.705 . . . . 0.0 110.509 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.45 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -59.93 -64.03 1.09 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.498 -0.751 . . . . 0.0 110.495 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -60.13 -40.02 88.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.532 -0.73 . . . . 0.0 110.115 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -57.1 -38.39 73.31 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.456 -0.778 . . . . 0.0 110.313 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 87.7 t -83.06 -48.61 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.614 -0.679 . . . . 0.0 109.922 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.411 ' CE2' HG22 ' A' ' 19' ' ' THR . 9.1 m-85 -63.63 -34.09 77.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.614 -0.679 . . . . 0.0 110.112 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -64.31 -45.84 86.17 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.461 -0.774 . . . . 0.0 109.095 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -62.15 -29.2 70.18 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.601 0.715 . . . . 0.0 109.618 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -72.15 -54.2 10.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.52 -38.6 84.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.672 -0.642 . . . . 0.0 110.293 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -58.21 -38.52 76.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.483 -0.76 . . . . 0.0 110.667 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -68.33 -38.88 81.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.573 -0.704 . . . . 0.0 110.26 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -81.94 -32.7 30.69 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.603 -0.686 . . . . 0.0 110.109 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.75 48.3 1.28 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.435 HD13 HG23 ' A' ' 40' ' ' ILE . 81.7 mt -104.53 62.84 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.584 -0.95 . . . . 0.0 110.225 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -83.01 59.73 5.08 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.11 -141.53 10.23 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -113.54 109.55 18.81 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.894 -0.768 . . . . 0.0 109.029 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.431 ' CZ3' ' CD1' ' A' ' 6' ' ' LEU . 32.9 m95 -78.44 143.38 36.77 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.064 0.935 . . . . 0.0 112.178 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.6 p -155.1 132.78 11.31 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -103.0 158.76 16.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.652 -0.655 . . . . 0.0 110.167 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.03 111.99 12.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.834 -0.541 . . . . 0.0 109.66 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.98 -20.18 65.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.692 -0.63 . . . . 0.0 110.814 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.77 -41.08 70.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.296 -0.878 . . . . 0.0 110.746 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.6 p -147.7 20.72 1.16 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.563 -0.71 . . . . 0.0 110.757 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.414 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.65 89.6 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.217 -0.927 . . . . 0.0 110.72 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.0 m -151.1 102.96 2.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.349 -0.844 . . . . 0.0 111.516 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.421 ' CZ ' ' HB1' ' A' ' 27' ' ' ALA . 73.3 m-85 -64.13 133.77 53.6 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.1 m -125.94 100.43 6.37 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.766 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.407 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.5 p -103.26 166.97 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.371 -0.831 . . . . 0.0 109.171 177.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.3 m -160.3 110.75 1.84 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.655 -0.653 . . . . 0.0 109.782 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.182 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.445 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 62.0 m . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.121 0.486 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.4 m -85.7 95.01 9.24 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.642 -0.661 . . . . 0.0 110.596 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.445 ' CD2' ' CB ' ' A' ' 27' ' ' ALA . 96.4 m-85 -77.81 176.08 9.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.44 -0.788 . . . . 0.0 109.735 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -142.79 124.94 15.36 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.499 -0.751 . . . . 0.0 110.383 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.431 ' CB ' ' CD1' ' A' ' 31' ' ' PHE . 54.4 tp -104.02 118.82 37.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.454 -0.779 . . . . 0.0 110.204 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 tp -68.84 171.16 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.1 mt -131.48 74.98 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.228 -0.92 . . . . 0.0 110.597 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -98.01 45.99 1.02 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.76 164.63 15.32 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -81.94 1.48 35.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.777 -0.837 . . . . 0.0 110.491 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.4 m -108.43 -31.41 7.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.206 -0.934 . . . . 0.0 110.152 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.1 mt -137.53 168.58 19.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.466 -0.771 . . . . 0.0 110.608 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -154.76 134.02 12.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.655 -0.653 . . . . 0.0 110.015 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.72 -143.7 15.13 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -135.71 160.58 38.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.539 -0.977 . . . . 0.0 110.3 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.5 m -135.53 158.62 43.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.541 -0.724 . . . . 0.0 110.116 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.9 p -142.99 154.53 44.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.58 -0.7 . . . . 0.0 110.431 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.451 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 8.7 t -159.77 159.55 32.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.608 -0.683 . . . . 0.0 110.228 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -93.19 121.07 34.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.552 -0.718 . . . . 0.0 110.183 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.27 138.39 23.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.582 -0.699 . . . . 0.0 110.174 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.8 m -59.31 -32.59 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.508 -0.745 . . . . 0.0 110.445 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -171.01 -178.24 2.42 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.586 -0.696 . . . . 0.0 110.319 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.4 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.79 -25.25 26.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.474 -0.766 . . . . 0.0 110.962 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.19 -26.53 64.89 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.488 -0.758 . . . . 0.0 110.374 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.4 m -113.82 -25.75 8.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.518 -0.739 . . . . 0.0 110.556 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.445 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -58.11 -60.76 3.25 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.417 -0.802 . . . . 0.0 110.408 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -59.88 -35.76 75.51 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.601 -0.687 . . . . 0.0 110.266 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -57.65 -38.99 76.0 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.401 -0.812 . . . . 0.0 110.189 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.0 t -83.79 -47.44 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.667 -0.646 . . . . 0.0 109.816 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.451 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 8.0 m-85 -62.68 -34.98 78.22 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.577 -0.702 . . . . 0.0 109.906 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -64.03 -46.94 82.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.409 -0.807 . . . . 0.0 109.084 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -62.15 -31.92 72.47 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.698 0.761 . . . . 0.0 109.472 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.417 ' CD2' HD23 ' A' ' 6' ' ' LEU . 10.1 t80 -68.16 -50.35 55.11 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.13 -37.25 80.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.764 -0.585 . . . . 0.0 109.929 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -58.06 -46.75 84.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.577 -0.702 . . . . 0.0 110.533 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -60.59 -56.95 15.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.579 -0.701 . . . . 0.0 110.324 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -63.71 -45.93 87.73 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.58 -0.7 . . . . 0.0 110.136 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.97 63.07 0.39 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.426 HD13 HG21 ' A' ' 40' ' ' ILE . 85.5 mt -118.04 63.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.528 -0.984 . . . . 0.0 110.133 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -83.31 59.54 5.08 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.82 -138.77 7.2 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -115.97 106.27 13.59 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.421 ' CZ3' HD12 ' A' ' 6' ' ' LEU . 37.3 m95 -76.5 142.36 40.95 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.212 1.005 . . . . 0.0 112.419 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -150.3 132.18 15.12 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.406 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 18.9 t80 -105.75 133.7 50.05 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.625 -0.672 . . . . 0.0 110.072 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -103.6 112.9 26.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.712 -0.618 . . . . 0.0 109.922 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -69.29 -23.05 63.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.647 -0.658 . . . . 0.0 110.561 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.98 -40.87 67.27 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.317 -0.864 . . . . 0.0 110.721 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.5 p -145.06 18.43 1.59 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.576 -0.702 . . . . 0.0 110.863 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.406 ' HG3' ' CE2' ' A' ' 46' ' ' TYR . 5.0 mptt 51.24 92.71 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.177 -0.952 . . . . 0.0 111.084 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.6 m -154.42 101.58 2.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.483 -0.761 . . . . 0.0 110.707 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -62.0 129.22 39.89 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.557 -0.714 . . . . 0.0 109.095 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.7 m -121.34 100.81 7.25 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.649 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.401 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.6 p -101.24 167.25 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.526 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.4 m -160.8 109.05 1.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.698 -0.626 . . . . 0.0 109.784 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.19 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.449 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 32.1 m . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.033 0.444 . . . . 0.0 110.362 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.0 m -93.79 97.61 10.53 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.61 -0.681 . . . . 0.0 110.874 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.449 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 92.9 m-85 -81.85 171.26 14.7 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.466 -0.771 . . . . 0.0 109.839 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -144.04 122.33 12.29 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.506 -0.746 . . . . 0.0 110.41 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.427 HD22 ' CD2' ' A' ' 34' ' ' TYR . 49.4 tp -99.49 123.94 44.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.558 -0.714 . . . . 0.0 110.141 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 tp -76.38 166.39 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.0 mt -128.58 74.76 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.213 -0.93 . . . . 0.0 110.488 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -95.57 47.95 1.13 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.414 -0.804 . . . . 0.0 108.901 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.94 151.85 17.61 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -71.14 -9.41 58.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.656 -0.908 . . . . 0.0 110.4 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 m -89.03 -36.13 15.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.43 174.58 10.81 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.455 -0.778 . . . . 0.0 110.59 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.3 tttt -156.24 144.42 19.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.697 . . . . 0.0 110.403 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.65 -123.05 3.23 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -164.77 166.88 19.46 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.566 -0.961 . . . . 0.0 110.101 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 m -135.63 148.31 48.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.541 -0.725 . . . . 0.0 110.231 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.7 p -137.78 146.44 43.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.541 -0.724 . . . . 0.0 110.245 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.445 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 7.2 t -163.76 134.26 4.38 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.596 -0.69 . . . . 0.0 110.141 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.05 112.1 2.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.561 -0.712 . . . . 0.0 110.29 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.88 137.58 50.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.495 -0.753 . . . . 0.0 110.176 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 p -60.02 -32.4 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.53 -0.731 . . . . 0.0 110.25 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -171.68 174.86 4.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.454 -0.779 . . . . 0.0 110.294 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.436 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.87 -24.82 17.17 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.54 -0.725 . . . . 0.0 110.928 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.24 -38.87 92.85 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.49 -0.757 . . . . 0.0 110.097 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.9 m -93.35 -27.6 16.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.525 -0.734 . . . . 0.0 110.358 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.419 ' HB3' ' CE1' ' A' ' 53' ' ' PHE . . . -66.41 -52.35 47.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.526 -0.734 . . . . 0.0 110.448 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.48 -37.47 70.39 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.499 -0.751 . . . . 0.0 110.549 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -60.31 -33.48 72.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.41 -0.806 . . . . 0.0 109.787 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.6 t -87.32 -44.19 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.651 . . . . 0.0 109.564 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.445 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 30.1 m-85 -66.28 -39.02 89.13 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.627 -0.671 . . . . 0.0 109.767 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -62.81 -50.9 69.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.608 -0.683 . . . . 0.0 109.551 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -61.26 -31.17 70.98 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.607 0.718 . . . . 0.0 109.63 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.427 ' CD2' HD22 ' A' ' 6' ' ' LEU . 17.7 t80 -68.55 -46.45 69.47 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.78 -38.67 67.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.739 -0.6 . . . . 0.0 109.91 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -58.76 -49.24 78.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.538 -0.726 . . . . 0.0 110.393 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -61.54 -56.05 24.28 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.683 -0.635 . . . . 0.0 110.123 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -60.91 -48.38 82.08 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.602 -0.686 . . . . 0.0 110.108 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.36 49.61 0.27 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.431 HG23 HD12 ' A' ' 40' ' ' ILE . 84.7 mt -117.65 75.47 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.515 -0.991 . . . . 0.0 110.398 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -98.36 39.95 1.21 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.88 -137.83 0.02 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -113.27 112.6 24.01 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.421 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 29.9 m95 -81.89 142.88 32.09 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.213 1.006 . . . . 0.0 112.686 -177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 p -152.68 131.28 12.27 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -100.59 108.41 20.32 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.742 -0.599 . . . . 0.0 109.997 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -78.53 100.4 6.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.698 -0.626 . . . . 0.0 109.967 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -62.34 -24.59 67.42 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.714 -0.616 . . . . 0.0 110.439 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.07 -34.03 54.73 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.371 -0.831 . . . . 0.0 111.043 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.8 p -147.15 17.67 1.21 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.523 -0.736 . . . . 0.0 110.905 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 50.55 87.0 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.117 -0.989 . . . . 0.0 111.066 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.6 m -155.17 108.56 2.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.536 -0.727 . . . . 0.0 110.755 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.419 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 83.5 m-85 -61.14 126.16 26.35 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.7 m -118.83 96.6 5.32 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.223 -0.991 . . . . 0.0 113.079 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.417 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.0 p -100.01 167.12 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 109.19 177.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 84.9 m -160.64 109.38 1.65 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.588 -0.695 . . . . 0.0 109.814 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.062 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.454 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 47.5 m . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.029 0.442 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 59.4 m -104.27 98.74 8.49 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.641 -0.662 . . . . 0.0 110.731 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.454 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 86.4 m-85 -78.57 172.35 13.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.546 -0.721 . . . . 0.0 109.831 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -142.22 121.23 12.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.488 -0.757 . . . . 0.0 110.335 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.418 HD11 ' CZ3' ' A' ' 44' ' ' TRP . 53.8 tp -100.87 118.24 36.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.434 -0.791 . . . . 0.0 110.338 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.1 tp -66.91 168.19 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.7 mt -130.63 74.37 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.181 -0.949 . . . . 0.0 110.711 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -96.11 48.91 1.12 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.81 157.35 15.01 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -74.54 -6.29 47.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.71 -0.876 . . . . 0.0 110.632 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -97.18 -33.83 11.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.247 -0.908 . . . . 0.0 110.275 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.5 mt -137.34 170.73 15.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.539 -0.725 . . . . 0.0 110.454 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -157.21 134.33 10.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.539 -0.726 . . . . 0.0 110.273 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.13 -144.42 16.36 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -136.18 153.34 51.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.598 -0.942 . . . . 0.0 110.244 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.2 m -130.93 147.83 52.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.704 . . . . 0.0 110.052 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.0 p -129.35 165.64 21.1 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.555 -0.716 . . . . 0.0 110.303 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.4 t -156.42 -176.24 5.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.695 . . . . 0.0 110.119 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.81 92.95 3.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.556 -0.715 . . . . 0.0 110.421 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.65 179.54 4.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.421 -0.799 . . . . 0.0 110.088 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -100.43 -25.55 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.615 -0.678 . . . . 0.0 110.02 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -167.81 176.25 6.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.507 -0.746 . . . . 0.0 110.014 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.97 -25.42 60.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.471 -0.768 . . . . 0.0 110.789 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.0 -25.43 65.26 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.467 -0.771 . . . . 0.0 110.752 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.6 m -111.95 -27.46 8.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.376 -0.827 . . . . 0.0 110.66 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.444 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -60.74 -54.48 44.71 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.516 -0.74 . . . . 0.0 110.461 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -57.44 -39.3 75.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.525 -0.735 . . . . 0.0 110.697 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -56.41 -36.74 69.28 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.274 -0.891 . . . . 0.0 110.588 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.5 t -84.88 -47.59 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.606 -0.684 . . . . 0.0 109.975 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.414 ' CD1' HD21 ' A' ' 6' ' ' LEU . 8.8 m-85 -65.08 -37.22 86.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.584 -0.698 . . . . 0.0 110.135 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -63.65 -45.01 92.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.465 -0.772 . . . . 0.0 109.177 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -62.88 -29.0 70.42 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.537 0.684 . . . . 0.0 109.616 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -73.0 -47.39 45.58 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.61 -35.78 65.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.691 -0.63 . . . . 0.0 109.766 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -56.05 -49.6 73.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.528 -0.733 . . . . 0.0 110.599 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -69.45 -46.9 65.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.642 -0.661 . . . . 0.0 109.986 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -61.53 -42.05 98.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.571 -0.706 . . . . 0.0 110.023 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.54 50.18 0.82 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.407 ' CG2' ' CG1' ' A' ' 55' ' ' VAL . 86.1 mt -110.64 61.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.538 -0.978 . . . . 0.0 110.173 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -81.45 60.6 4.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.533 -0.729 . . . . 0.0 109.166 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.6 -139.04 7.77 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -116.38 107.1 14.38 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.418 ' CZ3' HD11 ' A' ' 6' ' ' LEU . 37.2 m95 -77.3 143.46 38.83 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.19 0.995 . . . . 0.0 112.374 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 p -154.43 131.01 10.64 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -104.62 138.51 40.85 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.643 -0.661 . . . . 0.0 109.959 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -114.28 116.62 29.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.689 -0.632 . . . . 0.0 109.937 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -70.31 -25.19 63.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.725 -0.609 . . . . 0.0 110.566 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.05 -38.32 56.68 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.41 -0.806 . . . . 0.0 110.757 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.7 p -142.75 13.34 1.9 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.625 -0.672 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.08 90.74 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.079 -1.013 . . . . 0.0 111.013 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.2 m -157.35 110.0 2.46 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.325 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.428 ' CZ ' ' HB1' ' A' ' 27' ' ' ALA . 87.3 m-85 -64.24 129.05 38.42 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.6 m -119.96 99.03 6.38 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.193 -1.003 . . . . 0.0 112.904 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.407 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 9.3 p -102.85 165.74 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.469 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.9 m -162.31 114.49 1.67 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.767 -0.583 . . . . 0.0 109.909 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.089 179.715 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.427 HG23 ' CZ ' ' A' ' 4' ' ' PHE . 21.1 m . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.111 0.482 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.6 m -90.89 88.48 7.06 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.701 -0.625 . . . . 0.0 110.637 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.437 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 96.6 m-85 -71.15 167.94 18.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.457 -0.777 . . . . 0.0 109.909 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -136.19 132.89 36.52 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.496 -0.753 . . . . 0.0 110.254 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.422 HD12 ' CH2' ' A' ' 44' ' ' TRP . 58.1 tp -109.41 117.57 34.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.355 -0.841 . . . . 0.0 110.316 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 tp -66.57 171.1 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.2 mt -133.84 74.93 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 110.717 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -96.58 47.58 1.07 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.348 -0.845 . . . . 0.0 108.912 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.21 153.99 16.91 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.85 -9.45 57.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.929 . . . . 0.0 110.631 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.6 m -92.14 -32.6 15.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.182 -0.949 . . . . 0.0 110.432 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 34.0 mt -142.21 170.23 16.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.374 -0.828 . . . . 0.0 110.768 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -153.97 136.51 15.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.68 -0.637 . . . . 0.0 110.294 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.14 -147.24 18.04 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -139.08 162.73 34.23 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.597 -0.943 . . . . 0.0 110.264 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.4 m -140.11 168.54 19.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.585 -0.697 . . . . 0.0 110.221 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.2 p -137.65 168.32 19.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.512 -0.742 . . . . 0.0 110.175 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.428 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 8.2 t -158.9 -173.2 4.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.599 -0.688 . . . . 0.0 110.36 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -126.95 96.91 4.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.538 -0.726 . . . . 0.0 110.079 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -130.28 140.17 50.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.57 -0.706 . . . . 0.0 110.134 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.86 -29.68 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.624 -0.672 . . . . 0.0 110.002 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -167.42 -178.24 3.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.678 . . . . 0.0 110.286 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.437 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.88 -24.82 39.49 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.508 -0.745 . . . . 0.0 110.968 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.88 -29.6 68.44 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.486 -0.759 . . . . 0.0 110.32 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.5 m -107.5 -26.53 10.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.575 -0.703 . . . . 0.0 110.394 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.431 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -59.3 -63.45 1.3 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.434 -0.791 . . . . 0.0 110.413 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -58.26 -36.81 73.81 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.481 -0.762 . . . . 0.0 110.126 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -57.6 -38.42 74.88 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.437 -0.789 . . . . 0.0 110.07 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.0 t -83.93 -48.09 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.662 -0.649 . . . . 0.0 109.726 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.428 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 7.1 m-85 -61.97 -35.12 77.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.648 -0.658 . . . . 0.0 109.91 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -63.97 -46.02 86.51 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.563 -0.711 . . . . 0.0 109.086 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -62.31 -31.91 72.59 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.628 0.727 . . . . 0.0 109.403 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -69.31 -54.3 15.27 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.25 95.73 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.698 -0.626 . . . . 0.0 109.827 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.59 -42.25 87.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.573 -0.705 . . . . 0.0 110.451 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.42 -52.22 28.97 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.605 -0.685 . . . . 0.0 110.017 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -63.75 -50.37 69.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.596 -0.69 . . . . 0.0 109.922 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.24 58.53 0.18 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.443 HG23 HD12 ' A' ' 40' ' ' ILE . 84.9 mt -125.56 67.18 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.472 -1.017 . . . . 0.0 110.401 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -89.81 53.56 2.6 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.83 -138.33 3.08 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.63 110.92 21.36 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.982 -0.716 . . . . 0.0 109.384 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.422 ' CH2' HD12 ' A' ' 6' ' ' LEU . 32.9 m95 -81.47 143.56 31.99 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 122.131 0.967 . . . . 0.0 112.228 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.1 p -154.0 132.05 11.75 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.409 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 25.3 t80 -105.35 129.0 53.78 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.657 -0.652 . . . . 0.0 110.166 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -102.16 120.34 40.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.716 -0.615 . . . . 0.0 109.981 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -73.04 -20.14 61.04 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.665 -0.647 . . . . 0.0 110.678 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.87 -41.18 67.25 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.314 -0.866 . . . . 0.0 110.861 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.6 p -144.9 18.21 1.61 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.57 -0.706 . . . . 0.0 110.744 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.409 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 0.7 OUTLIER 51.31 93.19 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.16 -0.962 . . . . 0.0 110.78 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.7 m -157.19 106.42 2.18 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.175 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 27' ' ' ALA . 92.2 m-85 -63.94 127.33 30.91 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.9 m -117.17 104.2 10.96 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.344 -0.848 . . . . 0.0 112.597 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.402 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.4 p -105.21 167.11 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.846 . . . . 0.0 109.207 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.8 m -160.8 108.04 1.52 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.724 -0.61 . . . . 0.0 109.714 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.182 -179.862 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.451 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 57.9 m . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 121.113 0.482 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.0 m -104.76 104.43 14.22 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.567 -0.708 . . . . 0.0 110.617 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.451 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 77.3 m-85 -84.82 178.52 7.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.54 -0.725 . . . . 0.0 109.742 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -149.56 109.67 4.13 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.445 -0.785 . . . . 0.0 110.644 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.42 HD23 ' CD1' ' A' ' 31' ' ' PHE . 58.1 tp -90.6 121.37 32.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.414 -0.804 . . . . 0.0 110.324 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 tp -72.0 168.23 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 75.4 mt -130.05 72.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.208 -0.933 . . . . 0.0 110.796 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 -96.93 49.18 1.07 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.472 -0.768 . . . . 0.0 109.174 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.14 165.42 13.2 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.01 2.66 29.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.593 -0.946 . . . . 0.0 110.732 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -111.98 -29.27 7.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.119 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.1 mt -135.6 166.26 23.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.477 -0.764 . . . . 0.0 110.609 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -154.05 132.29 11.89 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.696 -0.627 . . . . 0.0 110.161 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.09 -129.82 5.07 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -159.25 152.44 22.3 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.581 -0.953 . . . . 0.0 110.592 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.4 m -125.5 154.12 42.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.616 -0.677 . . . . 0.0 110.068 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 p -139.5 150.87 45.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.457 -0.777 . . . . 0.0 110.391 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.432 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 8.4 t -153.12 147.66 26.07 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.616 -0.677 . . . . 0.0 110.202 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -85.04 112.65 20.82 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.506 -0.746 . . . . 0.0 110.381 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.86 -171.15 2.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.498 -0.751 . . . . 0.0 110.032 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -109.46 -27.2 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.618 -0.676 . . . . 0.0 110.067 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -170.13 173.8 5.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.464 -0.772 . . . . 0.0 110.185 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.2 -26.25 64.67 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.571 -0.705 . . . . 0.0 110.715 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.37 -26.56 65.19 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.463 -0.773 . . . . 0.0 110.621 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.4 m -109.45 -32.54 7.11 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.5 -0.75 . . . . 0.0 110.31 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.445 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -59.15 -52.61 64.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.5 -0.75 . . . . 0.0 110.427 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -59.15 -43.17 92.03 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.518 -0.739 . . . . 0.0 110.302 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -57.52 -34.75 69.44 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.369 -0.832 . . . . 0.0 110.319 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 83.6 t -84.99 -48.44 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.585 -0.697 . . . . 0.0 109.84 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.432 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 3.9 m-85 -65.39 -36.09 82.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.594 -0.691 . . . . 0.0 110.183 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -63.87 -46.59 84.26 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.477 -0.764 . . . . 0.0 109.341 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -59.9 -30.71 69.2 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.541 0.686 . . . . 0.0 109.822 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -70.33 -52.69 20.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.18 -38.49 91.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.701 -0.624 . . . . 0.0 110.042 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -57.14 -45.89 83.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.45 -0.781 . . . . 0.0 110.563 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.83 -49.89 54.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.612 -0.68 . . . . 0.0 110.02 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -62.5 -42.88 99.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.613 -0.679 . . . . 0.0 110.032 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.51 47.83 0.53 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.416 ' CG2' ' CG1' ' A' ' 55' ' ' VAL . 83.6 mt -119.07 74.58 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.53 -0.983 . . . . 0.0 110.409 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -97.78 39.69 1.2 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.67 -138.01 0.03 OUTLIER Glycine 0 N--CA 1.488 2.159 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -112.24 112.49 24.12 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.407 ' CZ3' HD11 ' A' ' 6' ' ' LEU . 29.6 m95 -82.38 143.86 30.93 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.24 1.019 . . . . 0.0 112.499 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 p -155.24 131.89 10.55 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -102.09 128.65 48.47 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.644 -0.66 . . . . 0.0 110.263 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -99.78 104.57 16.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.673 -0.642 . . . . 0.0 109.866 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -64.52 -21.45 66.68 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.594 -0.691 . . . . 0.0 110.881 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.29 -38.41 63.1 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.286 -0.884 . . . . 0.0 110.788 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.3 p -147.65 21.12 1.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.607 -0.683 . . . . 0.0 110.617 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER 50.27 90.83 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.211 -0.931 . . . . 0.0 111.129 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.4 m -155.29 103.59 2.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.523 -0.735 . . . . 0.0 110.717 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 27' ' ' ALA . 86.8 m-85 -60.92 132.21 53.13 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.7 m -122.66 98.84 6.1 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.133 -1.027 . . . . 0.0 113.119 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.416 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.2 p -102.87 166.7 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.333 -0.854 . . . . 0.0 109.144 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.6 m -160.84 109.99 1.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.659 -0.65 . . . . 0.0 109.762 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.263 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.45 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 90.5 m . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.036 0.446 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.5 m -139.92 107.44 5.58 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.582 -0.699 . . . . 0.0 110.436 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.45 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 97.4 m-85 -96.06 169.68 9.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.654 -0.654 . . . . 0.0 109.996 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -139.3 119.46 13.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.48 -0.763 . . . . 0.0 110.423 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.422 HD13 ' CH2' ' A' ' 44' ' ' TRP . 50.2 tp -98.75 121.99 41.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.486 -0.759 . . . . 0.0 110.243 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.0 tp -70.26 171.78 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 82.8 mt -132.09 71.74 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.175 -0.953 . . . . 0.0 110.523 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -96.17 46.81 1.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.478 -0.764 . . . . 0.0 109.085 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.54 158.27 17.3 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -73.39 -7.86 53.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.759 -0.847 . . . . 0.0 110.525 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.2 m -96.81 -32.77 11.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.208 -0.932 . . . . 0.0 110.273 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.9 mt -136.5 173.85 11.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.498 -0.751 . . . . 0.0 110.6 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -153.22 128.47 9.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.655 -0.653 . . . . 0.0 110.179 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.02 -142.6 14.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.01 -178.9 6.54 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.997 . . . . 0.0 110.347 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 t -162.74 159.77 24.61 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.588 -0.695 . . . . 0.0 110.278 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.4 p -134.52 156.46 48.6 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.57 -0.706 . . . . 0.0 110.177 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.407 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 7.5 t -142.62 -173.17 3.8 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.538 -0.727 . . . . 0.0 110.305 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -122.45 101.93 7.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.611 -0.681 . . . . 0.0 110.2 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.36 170.31 12.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.592 -0.692 . . . . 0.0 110.087 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -87.01 -26.93 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.64 -0.662 . . . . 0.0 109.902 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -175.24 -179.03 1.25 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.41 -0.806 . . . . 0.0 109.772 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.435 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.39 -25.88 38.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.392 -0.817 . . . . 0.0 110.936 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.24 -25.66 65.82 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.573 -0.705 . . . . 0.0 110.552 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.3 m -112.74 -26.17 8.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.476 -0.765 . . . . 0.0 110.359 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.429 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -58.6 -58.74 7.22 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.441 -0.787 . . . . 0.0 110.422 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -60.08 -41.3 92.17 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.604 -0.685 . . . . 0.0 110.143 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -56.74 -38.44 72.41 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.362 -0.836 . . . . 0.0 110.346 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.0 t -82.63 -48.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.622 -0.674 . . . . 0.0 109.975 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.418 ' CD1' HD23 ' A' ' 6' ' ' LEU . 7.3 m-85 -64.33 -32.81 74.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.531 -0.731 . . . . 0.0 110.19 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -64.75 -45.77 85.01 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.415 -0.803 . . . . 0.0 108.934 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -62.53 -33.12 74.28 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.659 0.743 . . . . 0.0 109.391 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -66.13 -51.48 57.52 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.61 -42.52 82.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.77 -0.581 . . . . 0.0 110.095 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -56.94 -36.14 69.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.47 -0.768 . . . . 0.0 110.537 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -62.98 -59.19 5.16 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.562 -0.711 . . . . 0.0 110.094 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -67.87 -47.25 69.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.656 -0.652 . . . . 0.0 110.017 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.33 60.0 0.19 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 85.2 mt -115.8 62.91 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.475 -1.015 . . . . 0.0 110.145 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -86.2 56.53 4.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.443 -0.786 . . . . 0.0 109.037 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.68 -136.53 3.01 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -117.43 99.42 6.98 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.842 -0.799 . . . . 0.0 109.298 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.422 ' CH2' HD13 ' A' ' 6' ' ' LEU . 30.8 m95 -69.16 143.38 54.09 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.225 1.012 . . . . 0.0 112.541 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 p -153.41 131.41 11.78 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -101.79 138.14 39.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.641 -0.662 . . . . 0.0 110.166 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -105.92 103.5 13.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.725 -0.61 . . . . 0.0 109.784 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.12 -21.96 66.54 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.672 -0.643 . . . . 0.0 110.657 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.95 -39.41 65.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.295 -0.878 . . . . 0.0 110.84 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.8 p -148.14 22.75 1.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.483 -0.76 . . . . 0.0 110.7 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.3 91.32 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.21 -0.931 . . . . 0.0 110.816 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.4 m -153.99 102.71 2.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.484 -0.76 . . . . 0.0 111.119 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 27' ' ' ALA . 75.3 m-85 -63.26 133.73 54.69 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.6 m -126.3 101.84 6.91 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.347 -0.941 . . . . 0.0 112.883 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.6 p -104.26 165.81 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.374 -0.829 . . . . 0.0 109.322 177.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.0 m -162.24 119.37 2.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.753 -0.592 . . . . 0.0 110.074 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.173 179.588 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.448 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 47.9 m . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 121.103 0.478 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.2 m -88.87 93.97 9.77 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.591 -0.693 . . . . 0.0 110.76 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.461 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 94.0 m-85 -76.92 167.9 21.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.5 -0.75 . . . . 0.0 109.963 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -138.92 123.84 18.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.525 -0.735 . . . . 0.0 110.352 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.427 HD11 ' CZ3' ' A' ' 44' ' ' TRP . 44.8 tp -100.0 124.26 45.16 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.476 -0.765 . . . . 0.0 110.317 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.5 tp -74.6 168.2 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 72.6 mt -127.84 73.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.41 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -95.13 47.58 1.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.37 -0.831 . . . . 0.0 108.985 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.74 159.33 14.21 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -79.19 -1.53 36.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.759 -0.848 . . . . 0.0 110.364 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.8 m -99.87 -32.4 11.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 110.035 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.36 172.0 14.16 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.513 -0.742 . . . . 0.0 110.379 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.59 145.18 19.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.573 -0.705 . . . . 0.0 110.267 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.89 -132.11 6.01 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -154.23 163.19 40.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.59 -0.947 . . . . 0.0 110.349 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.1 m -149.58 145.48 26.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.566 -0.709 . . . . 0.0 110.141 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.3 p -132.68 167.2 20.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.585 -0.697 . . . . 0.0 110.24 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.411 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 8.1 t -162.94 170.15 18.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.617 -0.677 . . . . 0.0 110.305 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -101.68 123.38 45.58 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.626 -0.671 . . . . 0.0 110.143 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -151.89 146.41 25.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.568 -0.707 . . . . 0.0 110.264 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.4 p -61.39 -34.25 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.595 -0.691 . . . . 0.0 110.056 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 39.3 p30 -170.19 177.03 4.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.592 -0.692 . . . . 0.0 110.281 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.461 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.45 -26.86 21.93 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.518 -0.739 . . . . 0.0 111.021 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.48 -23.33 57.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.539 -0.725 . . . . 0.0 110.554 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.6 m -118.0 -14.14 10.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.499 -0.751 . . . . 0.0 111.088 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.417 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . . . -72.14 -50.07 30.85 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.228 -0.92 . . . . 0.0 110.406 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.52 -30.68 68.76 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.482 -0.761 . . . . 0.0 110.412 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -58.9 -40.46 84.54 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.376 -0.827 . . . . 0.0 110.341 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.0 t -82.99 -42.21 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.517 -0.739 . . . . 0.0 109.867 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.411 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 13.1 m-85 -68.27 -35.37 77.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.573 -0.704 . . . . 0.0 110.119 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -63.77 -46.66 84.23 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.473 -0.767 . . . . 0.0 109.128 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -62.64 -30.95 71.75 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.611 0.72 . . . . 0.0 109.467 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -69.7 -47.84 61.76 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.61 -33.76 64.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.68 -0.637 . . . . 0.0 110.001 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -60.68 -52.23 66.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.623 -0.673 . . . . 0.0 110.417 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.6 -35.54 78.14 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 110.52 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -79.29 -42.42 25.84 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.562 -0.711 . . . . 0.0 110.312 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.3 41.0 1.19 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.408 HD11 HG23 ' A' ' 40' ' ' ILE . 79.8 mt -99.64 59.52 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.549 -0.971 . . . . 0.0 110.166 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -80.84 61.48 4.49 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.36 -138.32 7.84 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -117.39 102.1 8.95 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.981 -0.717 . . . . 0.0 109.332 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.427 ' CZ3' HD11 ' A' ' 6' ' ' LEU . 37.0 m95 -71.91 142.68 49.49 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.191 0.996 . . . . 0.0 112.516 -178.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -151.93 132.52 13.92 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -108.39 138.04 45.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.645 -0.659 . . . . 0.0 110.285 -178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.06 123.4 49.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.69 -0.631 . . . . 0.0 109.602 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -78.01 -24.25 48.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.624 -0.672 . . . . 0.0 110.619 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.06 -39.43 66.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.382 -0.824 . . . . 0.0 110.834 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.5 p -141.77 12.86 2.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.599 -0.688 . . . . 0.0 111.102 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.435 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.95 94.41 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.133 -0.98 . . . . 0.0 111.205 179.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.2 m -157.9 105.33 1.97 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.549 -0.719 . . . . 0.0 110.761 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 27' ' ' ALA . 73.6 m-85 -60.67 132.96 55.53 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.461 -0.774 . . . . 0.0 109.169 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.7 m -125.82 99.9 6.16 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.207 -0.997 . . . . 0.0 112.666 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.406 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.2 p -102.17 167.47 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.88 . . . . 0.0 109.271 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 98.9 m -160.28 109.2 1.71 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.593 -0.692 . . . . 0.0 109.894 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.274 -179.992 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.434 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 63.0 m . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.111 0.481 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.5 t -87.82 95.15 9.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.66 -0.65 . . . . 0.0 110.819 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.451 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 96.5 m-85 -77.1 171.48 14.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.42 -0.8 . . . . 0.0 109.819 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -139.31 128.89 24.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.49 -0.756 . . . . 0.0 110.331 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.438 ' CD1' ' CZ3' ' A' ' 44' ' ' TRP . 41.1 tp -103.41 122.62 45.25 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.385 -0.822 . . . . 0.0 110.432 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.0 tp -70.74 171.13 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.9 mt -133.8 74.4 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.644 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -95.86 47.73 1.11 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.545 -0.722 . . . . 0.0 109.138 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.42 163.66 13.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -82.3 2.65 31.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.651 -0.911 . . . . 0.0 110.791 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 m -111.5 -28.87 7.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.19 -0.943 . . . . 0.0 110.138 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 mt -136.93 167.3 21.76 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.558 -0.714 . . . . 0.0 110.393 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -155.75 138.04 14.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.538 -0.726 . . . . 0.0 110.213 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.07 -133.23 7.32 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -163.75 163.02 24.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.533 -0.98 . . . . 0.0 110.262 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.9 m -144.56 150.32 37.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.551 -0.718 . . . . 0.0 110.281 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.2 p -126.91 161.27 28.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.592 -0.693 . . . . 0.0 110.247 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.4 t -153.08 -171.59 3.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.506 -0.746 . . . . 0.0 110.382 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -115.97 109.25 17.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.54 -0.725 . . . . 0.0 110.152 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.36 138.55 38.39 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.601 -0.687 . . . . 0.0 110.155 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.8 m -57.4 -30.51 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.571 -0.705 . . . . 0.0 110.515 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.2 p30 -172.47 -179.56 2.25 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.407 -0.808 . . . . 0.0 110.283 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.451 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.18 -25.2 31.09 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.502 -0.749 . . . . 0.0 110.876 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.27 -25.88 66.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.49 -0.756 . . . . 0.0 110.605 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.9 m -113.3 -25.86 8.65 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.435 -0.791 . . . . 0.0 110.64 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.431 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -58.14 -49.09 78.19 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.458 -0.776 . . . . 0.0 110.569 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -61.6 -36.47 80.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.607 -0.683 . . . . 0.0 110.447 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -56.72 -40.06 75.02 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.327 -0.858 . . . . 0.0 110.744 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.4 -45.52 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.483 -0.761 . . . . 0.0 110.065 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.405 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 12.7 m-85 -66.91 -35.87 80.99 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.622 -0.674 . . . . 0.0 110.3 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.5 tttm -63.61 -44.06 95.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.488 -0.758 . . . . 0.0 109.35 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.33 -30.68 71.72 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.61 0.719 . . . . 0.0 109.565 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -70.02 -44.24 69.7 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.47 -41.54 46.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.716 -0.615 . . . . 0.0 109.802 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -58.95 -37.77 77.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.624 -0.672 . . . . 0.0 110.4 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -69.68 -50.75 40.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.602 -0.686 . . . . 0.0 110.058 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -69.87 -50.0 46.76 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.531 -0.731 . . . . 0.0 110.018 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.92 50.99 0.17 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.418 ' CG2' ' CG1' ' A' ' 55' ' ' VAL . 77.9 mt -115.79 74.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.52 -0.988 . . . . 0.0 110.298 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.25 39.54 1.23 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.85 -137.25 0.02 OUTLIER Glycine 0 N--CA 1.488 2.127 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -111.89 109.61 19.5 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.888 -0.772 . . . . 0.0 108.973 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.438 ' CZ3' ' CD1' ' A' ' 6' ' ' LEU . 35.1 m95 -79.81 143.78 34.11 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.042 0.925 . . . . 0.0 112.062 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 p -155.29 132.8 11.14 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -101.92 137.41 40.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.726 -0.609 . . . . 0.0 110.109 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -108.28 114.32 28.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.766 -0.584 . . . . 0.0 109.829 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -69.8 -18.04 63.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.666 -0.646 . . . . 0.0 110.896 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.8 -42.58 72.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.234 -0.916 . . . . 0.0 110.788 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.9 p -147.14 22.92 1.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.549 -0.719 . . . . 0.0 110.559 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.418 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER 51.67 94.69 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.322 -0.862 . . . . 0.0 110.859 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.4 m -156.94 107.5 2.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.456 -0.778 . . . . 0.0 111.269 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.422 ' CE1' ' HB2' ' A' ' 27' ' ' ALA . 69.0 m-85 -63.65 132.57 51.54 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.0 m -124.08 99.52 6.28 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.254 -0.979 . . . . 0.0 113.08 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.418 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.9 p -102.03 167.67 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 108.917 177.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.8 m -160.19 109.42 1.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.573 -0.705 . . . . 0.0 110.034 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.184 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.435 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 46.1 m . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.13 0.49 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.5 m -85.34 95.94 9.39 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.656 -0.652 . . . . 0.0 110.697 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.435 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 89.8 m-85 -80.55 165.67 21.89 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.52 -0.738 . . . . 0.0 109.717 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.7 ttpp -139.62 118.61 12.57 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.426 -0.796 . . . . 0.0 110.521 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.424 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 46.9 tp -95.95 125.24 40.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.424 -0.797 . . . . 0.0 110.241 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 tp -73.48 168.55 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.465 HD12 HG21 ' A' ' 8' ' ' ILE . 79.6 mt -128.93 73.18 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.195 -0.94 . . . . 0.0 110.45 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -96.64 47.2 1.06 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.451 -0.781 . . . . 0.0 109.147 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.29 166.92 20.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -85.84 7.24 24.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.691 -0.888 . . . . 0.0 110.456 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.3 m -115.43 -33.35 5.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.973 . . . . 0.0 110.086 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 mt -137.45 167.64 21.22 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.486 -0.759 . . . . 0.0 110.571 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -153.23 139.14 18.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.596 -0.69 . . . . 0.0 110.369 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.08 -144.6 16.23 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -142.68 168.14 20.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.573 -0.957 . . . . 0.0 110.255 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.6 m -157.67 133.38 9.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.564 -0.71 . . . . 0.0 110.181 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.2 p -112.86 167.5 10.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.54 -0.725 . . . . 0.0 110.25 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.42 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 7.7 t -159.35 167.68 28.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.499 -0.751 . . . . 0.0 110.29 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -98.51 112.19 24.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.618 -0.676 . . . . 0.0 110.219 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.88 137.9 31.71 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.586 -0.696 . . . . 0.0 110.052 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.9 m -60.46 -30.33 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.506 -0.746 . . . . 0.0 110.254 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -170.67 -179.65 2.97 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.574 -0.703 . . . . 0.0 110.326 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.429 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.51 -24.39 31.43 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.584 -0.698 . . . . 0.0 110.87 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.67 -28.11 65.43 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.46 -0.775 . . . . 0.0 110.512 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 46.5 m -109.43 -27.29 9.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.585 -0.697 . . . . 0.0 110.291 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.425 ' HB1' ' CD2' ' A' ' 4' ' ' PHE . . . -61.6 -61.32 2.61 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.537 -0.727 . . . . 0.0 110.062 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -58.85 -38.36 78.54 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.562 -0.711 . . . . 0.0 109.921 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -58.69 -40.13 82.69 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.575 -0.703 . . . . 0.0 109.735 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.9 t -82.6 -47.89 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.692 -0.63 . . . . 0.0 109.509 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.42 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 7.1 m-85 -61.18 -32.71 72.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.629 -0.669 . . . . 0.0 109.998 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -65.5 -46.21 80.57 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -61.93 -30.94 71.24 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.65 0.738 . . . . 0.0 109.471 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -69.14 -54.29 15.73 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.3 -37.77 86.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.689 -0.632 . . . . 0.0 109.956 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -59.6 -33.34 71.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.512 -0.743 . . . . 0.0 110.428 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -70.68 -36.64 73.41 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.648 -0.657 . . . . 0.0 110.287 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -88.47 -27.9 21.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.581 -0.699 . . . . 0.0 110.161 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.82 39.73 3.3 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.457 HG23 HD11 ' A' ' 40' ' ' ILE . 80.8 mt -95.77 65.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.551 -0.97 . . . . 0.0 110.199 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -87.83 54.66 3.18 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.62 -137.01 2.64 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.71 105.29 11.84 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.939 -0.742 . . . . 0.0 109.202 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.424 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 31.7 m95 -74.13 143.38 45.34 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.138 0.97 . . . . 0.0 112.413 -177.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.6 p -153.83 131.49 11.48 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -102.27 129.69 48.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.681 -0.637 . . . . 0.0 110.198 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.27 117.66 35.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.675 -0.64 . . . . 0.0 109.879 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.13 -13.16 61.13 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.648 -0.657 . . . . 0.0 111.005 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.66 -43.19 80.14 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.174 -0.954 . . . . 0.0 110.549 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.7 p -147.49 24.33 1.11 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.609 -0.682 . . . . 0.0 110.435 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.69 93.45 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.305 -0.872 . . . . 0.0 110.853 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.4 m -156.48 105.11 2.24 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.903 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' ' 27' ' ' ALA . 91.6 m-85 -62.7 132.84 53.63 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.5 m -124.22 101.43 7.19 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.866 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.407 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.2 p -102.51 166.59 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.349 -0.844 . . . . 0.0 109.167 177.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 98.9 m -160.52 110.12 1.74 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.653 -0.654 . . . . 0.0 109.865 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.23 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.465 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 60.4 m . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.055 0.455 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.0 m -115.01 102.24 9.76 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.564 -0.71 . . . . 0.0 110.77 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.465 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 94.9 m-85 -82.77 -177.22 6.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.586 -0.696 . . . . 0.0 109.746 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -152.2 114.85 4.57 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.43 -0.794 . . . . 0.0 110.396 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.431 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 14.1 tp -93.51 140.03 30.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.269 -0.894 . . . . 0.0 110.277 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 tp -89.96 165.2 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.462 HD11 HG23 ' A' ' 8' ' ' ILE . 48.7 mm -126.44 77.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -0.903 . . . . 0.0 110.514 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -98.83 48.93 0.97 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.58 161.63 12.64 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -76.96 -12.47 59.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.767 -0.843 . . . . 0.0 110.435 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.8 m -91.1 -29.97 17.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 110.158 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.6 mt -141.14 167.64 21.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 110.49 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -153.82 131.48 11.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.645 -0.659 . . . . 0.0 110.057 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.95 -124.67 3.33 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -165.91 172.54 11.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.521 -0.987 . . . . 0.0 110.43 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.1 m -152.87 161.37 42.63 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.55 -0.719 . . . . 0.0 110.241 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 p -137.96 171.26 14.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.614 -0.679 . . . . 0.0 110.207 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.452 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 7.7 t -161.77 164.03 29.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.588 -0.695 . . . . 0.0 110.341 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -102.34 93.69 5.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.574 -0.704 . . . . 0.0 110.159 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -117.36 -172.45 2.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.553 -0.717 . . . . 0.0 110.214 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -112.14 -25.82 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.656 -0.653 . . . . 0.0 110.154 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -166.84 177.96 6.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.521 -0.737 . . . . 0.0 110.023 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.25 -25.84 59.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.723 . . . . 0.0 110.812 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.13 -45.33 93.36 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.451 -0.78 . . . . 0.0 110.458 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.7 m -87.61 -28.04 22.14 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.495 -0.753 . . . . 0.0 110.433 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.462 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -64.57 -63.47 1.12 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.533 -0.729 . . . . 0.0 110.402 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -57.9 -42.67 85.2 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.518 -0.739 . . . . 0.0 110.311 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -55.61 -39.3 70.59 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.382 -0.824 . . . . 0.0 110.248 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 88.3 t -82.31 -49.03 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.701 -0.624 . . . . 0.0 109.893 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.452 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 5.6 m-85 -62.95 -33.62 75.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.65 -0.656 . . . . 0.0 110.337 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -65.21 -45.87 82.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.414 -0.804 . . . . 0.0 109.094 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -61.71 -31.72 71.88 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.625 0.726 . . . . 0.0 109.552 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -68.43 -53.4 23.92 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.14 -47.25 80.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.733 -0.605 . . . . 0.0 109.784 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -58.03 -28.11 64.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.603 -0.686 . . . . 0.0 110.43 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.88 -47.19 19.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.608 -0.683 . . . . 0.0 110.194 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -76.22 -43.12 43.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.562 -0.711 . . . . 0.0 110.063 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.23 51.09 0.18 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.468 HG22 HD13 ' A' ' 40' ' ' ILE . 83.9 mt -122.57 73.52 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.463 -1.022 . . . . 0.0 110.231 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.97 39.7 1.26 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.56 -137.79 0.02 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -111.94 111.91 23.18 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.431 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 28.4 m95 -80.59 142.82 33.69 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.233 1.016 . . . . 0.0 112.467 -177.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 p -153.93 132.95 12.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -103.16 140.5 37.27 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.649 -0.657 . . . . 0.0 110.156 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.6 116.63 30.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.643 -0.661 . . . . 0.0 110.004 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -71.2 -15.14 62.45 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.646 -0.659 . . . . 0.0 111.147 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.99 -43.48 77.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.206 -0.934 . . . . 0.0 110.681 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.8 p -147.47 23.02 1.15 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.566 -0.709 . . . . 0.0 110.569 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.51 88.99 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.246 -0.909 . . . . 0.0 110.764 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.2 m -151.95 106.16 3.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.448 -0.782 . . . . 0.0 110.872 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 27' ' ' ALA . 86.0 m-85 -62.98 137.11 58.17 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.419 -0.801 . . . . 0.0 108.842 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.8 m -126.81 95.09 4.22 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.124 -1.03 . . . . 0.0 113.231 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.409 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.5 p -97.4 167.34 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 109.145 177.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.9 m -160.58 111.62 1.85 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.549 -0.719 . . . . 0.0 110.126 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.05 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.448 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 8.7 m . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.136 0.493 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.8 t -95.13 79.97 3.58 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.533 -0.729 . . . . 0.0 110.892 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.448 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 98.1 m-85 -62.13 179.62 0.28 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.335 -0.853 . . . . 0.0 109.779 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -153.9 126.46 8.1 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.524 -0.735 . . . . 0.0 110.353 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.426 HD22 ' CD2' ' A' ' 34' ' ' TYR . 46.3 tp -103.87 135.43 45.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.459 -0.776 . . . . 0.0 110.189 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 tp -86.78 168.69 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.8 mt -128.43 72.64 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.203 -0.936 . . . . 0.0 110.634 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -95.6 48.47 1.14 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 0.0 108.969 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.95 154.56 16.53 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -72.42 -6.99 47.43 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.665 -0.903 . . . . 0.0 110.942 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -96.99 -30.75 12.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.202 -0.936 . . . . 0.0 110.283 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 tp -145.21 157.58 44.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.497 -0.752 . . . . 0.0 110.433 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -140.13 136.01 33.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.591 -0.693 . . . . 0.0 110.497 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.72 -140.57 10.87 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -151.72 168.55 24.69 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.541 -0.976 . . . . 0.0 110.434 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.2 m -150.54 148.49 28.75 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.588 -0.695 . . . . 0.0 110.265 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.1 p -131.13 168.38 17.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.578 -0.701 . . . . 0.0 110.155 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.447 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 8.6 t -164.32 179.09 7.02 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.588 -0.695 . . . . 0.0 110.378 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.96 128.25 54.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.714 . . . . 0.0 110.111 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.25 138.3 16.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.598 -0.689 . . . . 0.0 110.189 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.9 m -59.35 -26.7 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.505 -0.747 . . . . 0.0 110.45 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.3 p30 -173.12 -178.24 1.73 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.452 -0.78 . . . . 0.0 110.304 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.91 -25.29 56.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.54 -0.725 . . . . 0.0 110.869 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.04 -27.17 65.23 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.456 -0.778 . . . . 0.0 110.397 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.9 m -109.71 -27.84 9.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.518 -0.739 . . . . 0.0 110.305 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.447 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -59.02 -62.98 1.47 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.536 -0.727 . . . . 0.0 110.233 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -58.47 -32.48 68.8 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.521 -0.737 . . . . 0.0 110.166 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -56.61 -45.56 81.4 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.414 -0.804 . . . . 0.0 110.156 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.8 t -80.18 -45.05 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.653 -0.654 . . . . 0.0 109.697 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.447 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 12.6 m-85 -61.88 -33.56 74.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.597 -0.689 . . . . 0.0 110.04 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -64.52 -46.65 82.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.457 -0.777 . . . . 0.0 109.058 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -63.15 -33.5 75.6 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.608 0.718 . . . . 0.0 109.329 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.426 ' CD2' HD22 ' A' ' 6' ' ' LEU . 18.8 t80 -65.2 -46.67 79.76 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.99 -38.2 66.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.718 -0.614 . . . . 0.0 109.651 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -60.27 -45.3 93.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.539 -0.726 . . . . 0.0 110.316 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -60.28 -53.35 58.73 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.585 -0.697 . . . . 0.0 110.358 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -69.18 -48.24 62.74 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.525 -0.735 . . . . 0.0 110.033 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.44 46.11 0.3 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.45 HD12 HG21 ' A' ' 40' ' ' ILE . 80.1 mt -108.79 77.03 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.501 -0.999 . . . . 0.0 110.454 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -98.99 39.28 1.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.74 -138.35 0.02 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -112.45 111.05 21.62 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.842 -0.799 . . . . 0.0 108.956 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.423 ' CH2' HD11 ' A' ' 6' ' ' LEU . 29.3 m95 -80.31 143.56 33.51 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.182 0.991 . . . . 0.0 112.483 -178.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 p -152.91 132.28 12.86 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -104.81 120.87 42.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.678 -0.638 . . . . 0.0 110.111 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -90.77 111.39 22.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.649 -0.657 . . . . 0.0 110.087 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -66.72 -15.76 63.76 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.601 -0.687 . . . . 0.0 110.849 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.09 -42.69 73.18 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.168 -0.957 . . . . 0.0 110.812 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 81.0 p -147.07 24.12 1.17 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.53 -0.731 . . . . 0.0 110.527 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 4.3 mptt 51.79 87.35 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.247 -0.908 . . . . 0.0 110.78 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.4 m -150.88 103.65 3.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.513 -0.742 . . . . 0.0 110.728 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 27' ' ' ALA . 95.4 m-85 -62.5 134.84 56.98 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.489 -0.757 . . . . 0.0 109.112 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.7 m -125.72 104.05 8.15 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 119.354 -0.938 . . . . 0.0 112.71 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.414 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.1 p -104.73 167.24 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.279 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.2 m -159.79 109.59 1.85 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.586 -0.696 . . . . 0.0 109.801 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.098 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.433 HG23 ' CE2' ' A' ' 4' ' ' PHE . 40.2 m . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.253 0.549 . . . . 0.0 110.011 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 58.8 m -89.87 96.73 10.81 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.588 -0.695 . . . . 0.0 110.662 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.454 ' CD2' ' CB ' ' A' ' 27' ' ' ALA . 87.6 m-85 -79.34 170.03 17.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.528 -0.732 . . . . 0.0 109.77 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -140.09 124.57 18.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.456 -0.778 . . . . 0.0 110.474 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.427 HD12 ' CZ3' ' A' ' 44' ' ' TRP . 53.3 tp -101.94 120.42 40.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.426 -0.796 . . . . 0.0 109.817 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 tt -69.36 172.75 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 76.8 mt -135.39 75.39 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 119.414 -0.915 . . . . 0.0 110.676 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -96.68 47.59 1.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.89 154.46 16.63 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.0 tttp -71.25 -9.78 58.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.688 -0.889 . . . . 0.0 110.611 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.0 m -91.44 -33.44 15.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.215 -0.928 . . . . 0.0 110.273 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.8 mt -142.13 167.5 21.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.465 -0.772 . . . . 0.0 110.638 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -147.52 136.78 22.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.634 -0.666 . . . . 0.0 110.198 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.26 -137.41 9.87 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -155.96 152.2 27.9 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.591 -0.947 . . . . 0.0 110.356 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.8 m -122.94 160.67 25.72 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.626 -0.671 . . . . 0.0 110.223 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.4 p -128.67 174.87 9.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.538 -0.726 . . . . 0.0 110.296 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.46 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 7.5 t -167.14 -173.26 2.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.526 -0.734 . . . . 0.0 110.328 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -128.56 101.97 6.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 0.0 110.177 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.0 155.07 47.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.605 -0.684 . . . . 0.0 110.135 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.8 p -74.42 -23.84 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.59 -0.694 . . . . 0.0 110.287 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -171.62 176.04 3.84 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.311 -0.868 . . . . 0.0 110.385 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.451 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -57.12 -29.61 63.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.553 -0.717 . . . . 0.0 110.992 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.89 -24.4 57.52 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.458 -0.776 . . . . 0.0 110.614 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.9 m -110.94 -27.98 8.56 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.466 -0.771 . . . . 0.0 110.355 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.454 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -60.81 -52.75 63.73 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.506 -0.746 . . . . 0.0 110.278 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -57.66 -39.87 78.03 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.554 -0.716 . . . . 0.0 110.415 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -56.9 -39.11 73.8 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.332 -0.855 . . . . 0.0 110.288 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.3 t -80.91 -49.19 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.665 -0.647 . . . . 0.0 110.105 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.46 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 6.2 m-85 -65.01 -33.08 75.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.594 -0.691 . . . . 0.0 110.409 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -64.1 -46.85 82.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.439 -0.788 . . . . 0.0 109.232 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -61.5 -31.97 71.98 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.619 0.724 . . . . 0.0 109.675 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.423 ' CD2' HD23 ' A' ' 6' ' ' LEU . 15.8 t80 -67.88 -42.96 80.44 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.45 -38.89 40.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.614 -0.678 . . . . 0.0 110.017 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -58.29 -52.19 66.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.467 -0.77 . . . . 0.0 110.28 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.6 -47.22 86.45 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.647 -0.658 . . . . 0.0 110.108 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -65.37 -45.9 82.24 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.555 -0.716 . . . . 0.0 110.037 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.44 36.93 0.88 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.48 HG23 HD11 ' A' ' 40' ' ' ILE . 80.1 mt -104.21 69.05 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.43 -1.041 . . . . 0.0 110.29 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -92.23 49.35 1.5 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.54 -0.725 . . . . 0.0 109.324 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.1 -137.09 0.84 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.17 112.24 22.21 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.893 -0.769 . . . . 0.0 109.11 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.427 ' CZ3' HD12 ' A' ' 6' ' ' LEU . 25.2 m95 -81.09 143.11 32.67 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.247 1.023 . . . . 0.0 112.445 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 p -150.98 131.82 14.13 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.405 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 31.1 t80 -105.05 128.81 53.5 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.669 -0.645 . . . . 0.0 110.031 -178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -102.47 111.26 23.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.676 -0.64 . . . . 0.0 109.953 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -66.69 -23.9 66.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.719 -0.613 . . . . 0.0 110.588 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.65 -38.78 64.46 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.404 -0.81 . . . . 0.0 110.851 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.2 p -143.26 14.71 1.84 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.541 -0.724 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.405 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 4.4 mptt 50.92 87.12 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.074 -1.016 . . . . 0.0 110.712 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.5 m -149.64 105.59 3.46 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.118 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.417 ' CE2' ' HB3' ' A' ' 27' ' ' ALA . 82.4 m-85 -62.25 123.72 18.94 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.3 m -117.39 104.15 10.83 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.175 -0.953 . . . . 0.0 112.854 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.417 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.4 p -106.38 164.67 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.353 -0.842 . . . . 0.0 109.377 177.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.0 m -163.91 116.11 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.384 179.96 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.438 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 86.3 m . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.111 0.481 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.7 t -88.04 104.29 16.52 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.701 -0.624 . . . . 0.0 110.756 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.455 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 83.9 m-85 -86.79 176.45 7.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.387 -0.821 . . . . 0.0 109.87 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -146.75 115.82 6.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.47 -0.769 . . . . 0.0 110.245 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.425 HD12 ' CH2' ' A' ' 44' ' ' TRP . 48.3 tp -93.66 122.39 36.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.545 -0.722 . . . . 0.0 110.157 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.0 tp -70.44 171.64 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.9 mt -132.26 71.73 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.216 -0.928 . . . . 0.0 110.564 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -95.43 48.07 1.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.499 -0.751 . . . . 0.0 109.062 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.5 159.79 14.05 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -75.66 -6.16 49.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.707 -0.878 . . . . 0.0 110.564 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.9 t -100.17 -27.09 13.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.666 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.4 mt -143.78 163.59 32.9 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.425 -0.797 . . . . 0.0 110.577 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -147.9 131.95 17.25 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.588 -0.695 . . . . 0.0 110.2 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.71 -132.63 6.25 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -162.54 159.04 24.31 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.51 -0.994 . . . . 0.0 110.326 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 48.7 m -138.84 165.1 27.92 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.501 -0.749 . . . . 0.0 110.275 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.6 p -135.27 168.84 18.44 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.584 -0.697 . . . . 0.0 110.262 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.433 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 8.1 t -164.62 168.9 17.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.55 -0.719 . . . . 0.0 110.194 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -101.54 116.32 32.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.488 -0.757 . . . . 0.0 110.262 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -144.88 142.78 30.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.567 -0.708 . . . . 0.0 110.095 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.7 m -57.35 -37.32 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.449 -0.782 . . . . 0.0 110.095 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -172.34 -172.49 0.94 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.699 -0.626 . . . . 0.0 109.773 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.455 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.98 -23.14 12.22 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.461 -0.774 . . . . 0.0 111.174 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.28 -35.9 74.58 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.471 -0.768 . . . . 0.0 110.718 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.5 m -106.64 -25.39 11.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.445 -0.784 . . . . 0.0 110.811 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.425 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -57.83 -60.61 3.43 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.407 -0.808 . . . . 0.0 110.733 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -57.01 -40.09 75.98 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.521 -0.737 . . . . 0.0 110.568 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -57.65 -37.89 74.12 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.366 -0.834 . . . . 0.0 110.144 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 99.5 t -82.46 -48.7 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.64 -0.663 . . . . 0.0 109.851 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.433 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 7.1 m-85 -63.85 -33.17 75.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.551 -0.718 . . . . 0.0 110.212 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -64.76 -44.98 88.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.5 -0.75 . . . . 0.0 109.086 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -61.85 -27.63 68.92 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.505 0.669 . . . . 0.0 109.779 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -74.4 -53.08 10.31 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.94 -40.14 92.1 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.581 -0.7 . . . . 0.0 110.18 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -57.72 -49.73 75.55 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.537 -0.727 . . . . 0.0 110.693 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.88 -55.94 27.07 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.522 -0.736 . . . . 0.0 110.2 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -60.96 -47.68 85.34 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.563 -0.711 . . . . 0.0 110.082 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.71 64.58 0.3 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.408 ' CG2' ' CG1' ' A' ' 55' ' ' VAL . 82.4 mt -126.01 79.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.545 -0.974 . . . . 0.0 110.148 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -95.39 43.95 1.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.52 -140.48 0.64 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -118.78 111.33 18.32 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.425 ' CH2' HD12 ' A' ' 6' ' ' LEU . 26.0 m95 -77.13 143.9 38.81 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.178 0.99 . . . . 0.0 112.416 -177.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.6 p -151.27 132.77 14.72 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -104.41 113.71 27.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.621 -0.674 . . . . 0.0 110.122 -178.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -88.66 116.27 26.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.674 -0.641 . . . . 0.0 109.957 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.15 -15.78 61.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.625 -0.672 . . . . 0.0 110.845 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.97 -39.43 65.96 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.189 -0.944 . . . . 0.0 110.766 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.1 p -148.47 20.11 1.06 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.561 -0.712 . . . . 0.0 110.702 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.409 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.52 85.89 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.194 -0.941 . . . . 0.0 110.837 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.5 m -150.39 105.51 3.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.559 -0.713 . . . . 0.0 110.494 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.421 ' CZ ' ' HB1' ' A' ' 27' ' ' ALA . 90.0 m-85 -60.02 126.98 29.62 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.7 m -119.96 100.03 6.97 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.984 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.408 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.6 p -100.83 166.93 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.44 -0.788 . . . . 0.0 109.021 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.1 m -158.68 109.81 2.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.515 -0.74 . . . . 0.0 110.295 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.288 179.917 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.429 HG22 ' CE1' ' A' ' 4' ' ' PHE . 55.6 m . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.066 0.46 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 65.6 m -122.75 96.65 5.11 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.617 -0.677 . . . . 0.0 110.44 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.459 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 97.4 m-85 -81.41 175.34 10.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.585 -0.697 . . . . 0.0 110.081 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -151.33 127.78 10.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.523 -0.736 . . . . 0.0 110.185 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.429 HD12 ' CZ3' ' A' ' 44' ' ' TRP . 48.0 tp -104.73 125.21 50.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.494 -0.754 . . . . 0.0 110.442 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 tp -75.17 171.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.0 mt -130.8 74.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.179 -0.951 . . . . 0.0 110.674 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -97.3 46.91 1.03 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.31 -0.869 . . . . 0.0 108.796 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.93 165.17 17.36 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.94 4.58 29.0 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.726 -0.867 . . . . 0.0 110.643 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -114.87 -26.86 7.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 110.484 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 tp -143.39 166.8 23.77 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.831 . . . . 0.0 110.769 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -153.53 143.23 21.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.559 -0.713 . . . . 0.0 110.27 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.05 -142.62 14.13 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -142.5 172.07 13.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.568 -0.96 . . . . 0.0 110.341 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.9 m -155.9 132.72 10.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.628 -0.67 . . . . 0.0 110.02 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.0 p -119.81 167.24 12.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.514 -0.741 . . . . 0.0 110.357 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.438 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 8.0 t -167.17 166.06 15.15 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.618 -0.677 . . . . 0.0 110.265 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -100.29 111.06 23.31 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.564 -0.71 . . . . 0.0 110.218 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.01 139.67 45.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.583 -0.698 . . . . 0.0 110.199 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.73 -28.8 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.543 -0.723 . . . . 0.0 110.408 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 p30 -173.87 -176.45 1.21 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.431 -0.793 . . . . 0.0 110.34 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.459 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -57.99 -23.94 56.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.613 -0.679 . . . . 0.0 110.809 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.65 -29.38 67.99 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.453 -0.779 . . . . 0.0 110.281 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.2 m -106.29 -28.17 10.57 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.55 -0.719 . . . . 0.0 110.154 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.402 ' HB3' ' CE2' ' A' ' 53' ' ' PHE . . . -61.3 -59.89 4.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.562 -0.711 . . . . 0.0 110.097 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -59.77 -43.79 94.17 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.601 -0.687 . . . . 0.0 110.215 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -54.64 -40.22 68.78 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.284 -0.885 . . . . 0.0 110.229 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.8 t -82.17 -48.52 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.697 -0.627 . . . . 0.0 109.918 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.438 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 13.5 m-85 -62.16 -32.73 73.38 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.653 -0.654 . . . . 0.0 110.304 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -66.31 -42.86 87.68 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.046 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -62.42 -30.11 70.99 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.505 0.669 . . . . 0.0 109.678 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -70.22 -50.68 37.47 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.47 83.59 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.629 -0.67 . . . . 0.0 110.075 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -57.0 -36.47 70.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.479 -0.763 . . . . 0.0 110.65 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -69.83 -41.29 75.14 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.519 -0.738 . . . . 0.0 110.174 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -80.84 -27.98 36.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.596 -0.69 . . . . 0.0 110.269 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.82 38.35 4.68 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.409 ' CG2' ' CG1' ' A' ' 55' ' ' VAL . 76.8 mt -89.5 66.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.548 -0.972 . . . . 0.0 110.226 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -85.63 56.97 4.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.569 -0.707 . . . . 0.0 109.15 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.33 -138.21 4.98 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.47 102.19 8.72 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.868 -0.784 . . . . 0.0 109.161 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.429 ' CZ3' HD12 ' A' ' 6' ' ' LEU . 32.6 m95 -69.88 143.13 52.88 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.153 0.977 . . . . 0.0 112.457 -177.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.4 p -152.0 131.83 13.28 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -107.26 152.72 23.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.635 -0.666 . . . . 0.0 110.059 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -126.98 113.72 16.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.687 -0.633 . . . . 0.0 109.911 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -67.61 -23.05 65.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.703 -0.623 . . . . 0.0 110.833 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.75 -40.15 62.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.275 -0.891 . . . . 0.0 110.718 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.2 p -144.98 16.46 1.57 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.667 -0.645 . . . . 0.0 110.744 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.434 ' HG2' ' CE2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.81 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.121 -0.987 . . . . 0.0 110.876 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.6 m -152.78 102.46 2.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.494 -0.754 . . . . 0.0 110.949 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 27' ' ' ALA . 96.1 m-85 -63.0 136.75 58.0 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.4 m -129.37 103.04 6.69 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.37 -0.932 . . . . 0.0 112.322 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.409 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.7 p -102.54 167.04 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 0.0 109.265 177.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 92.0 m -160.71 112.65 1.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.595 -0.69 . . . . 0.0 110.273 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.086 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.441 HG21 ' CE2' ' A' ' 4' ' ' PHE . 93.9 m . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.126 0.489 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.2 m -88.58 104.27 16.68 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.606 -0.684 . . . . 0.0 110.707 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.444 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 88.8 m-85 -85.57 179.6 7.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.548 -0.72 . . . . 0.0 109.821 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.3 mtmm -144.44 117.24 8.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.438 -0.789 . . . . 0.0 110.575 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.442 ' CD1' ' CZ3' ' A' ' 44' ' ' TRP . 34.7 tp -99.47 121.66 41.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.464 -0.772 . . . . 0.0 110.164 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.8 tp -70.69 169.3 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.2 mt -131.33 77.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 110.856 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -97.24 46.93 1.03 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.225 -0.922 . . . . 0.0 108.633 178.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.12 153.04 16.97 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.59 -8.09 53.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.756 -0.849 . . . . 0.0 110.716 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -94.14 -30.88 14.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.215 -0.928 . . . . 0.0 110.4 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -145.63 174.78 10.89 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.423 -0.798 . . . . 0.0 110.498 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -165.72 142.58 5.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.608 -0.682 . . . . 0.0 110.48 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.5 -121.74 2.75 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -157.07 153.05 27.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.973 . . . . 0.0 110.304 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.4 m -138.9 142.67 38.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.553 -0.717 . . . . 0.0 110.244 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -124.61 153.09 42.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.617 -0.677 . . . . 0.0 110.184 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.452 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 8.9 t -151.35 142.24 22.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.554 -0.716 . . . . 0.0 110.285 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.49 114.66 16.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.594 -0.691 . . . . 0.0 110.34 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -142.4 139.87 31.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.463 -0.773 . . . . 0.0 110.054 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.2 m -56.46 -36.45 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.481 -0.762 . . . . 0.0 110.23 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -172.66 -173.27 0.99 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.595 -0.691 . . . . 0.0 109.934 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.5 -22.36 12.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.403 -0.811 . . . . 0.0 111.269 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.71 66.77 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.355 -0.841 . . . . 0.0 110.505 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.5 m -116.44 -21.69 9.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.466 -0.771 . . . . 0.0 110.954 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.431 ' HB1' ' CZ ' ' A' ' 53' ' ' PHE . . . -57.3 -62.97 1.39 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.318 -0.864 . . . . 0.0 110.667 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -59.98 -36.41 77.09 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.45 -0.781 . . . . 0.0 110.086 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -57.6 -43.68 84.86 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.486 -0.759 . . . . 0.0 109.962 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.6 t -78.77 -48.23 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.713 -0.617 . . . . 0.0 109.667 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.452 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 4.9 m-85 -61.33 -32.81 72.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.621 -0.675 . . . . 0.0 110.262 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -64.07 -42.94 96.8 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.433 -0.792 . . . . 0.0 108.9 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -64.56 -32.31 73.9 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.643 0.735 . . . . 0.0 109.341 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -68.04 -56.02 10.42 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.38 91.5 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.716 -0.615 . . . . 0.0 110.287 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -56.77 -37.92 71.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.483 -0.76 . . . . 0.0 110.643 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.14 -37.87 84.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.596 -0.69 . . . . 0.0 110.284 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -91.21 -30.72 16.49 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.511 -0.743 . . . . 0.0 110.178 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.06 44.3 1.77 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.409 ' CG2' ' CG1' ' A' ' 55' ' ' VAL . 79.8 mt -95.08 62.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.486 -1.008 . . . . 0.0 110.159 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.85 59.16 5.05 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.66 -138.47 6.4 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -115.13 103.15 10.58 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.845 -0.797 . . . . 0.0 109.015 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.442 ' CZ3' ' CD1' ' A' ' 6' ' ' LEU . 38.5 m95 -73.18 143.34 47.26 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 122.161 0.981 . . . . 0.0 112.195 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.0 p -155.91 131.43 9.61 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -105.71 133.07 51.03 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.655 -0.653 . . . . 0.0 109.955 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -104.3 109.97 22.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.77 -0.581 . . . . 0.0 109.888 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.6 -20.99 66.59 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.656 -0.653 . . . . 0.0 110.588 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.87 -37.84 60.86 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.263 -0.898 . . . . 0.0 110.958 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -147.68 19.89 1.16 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.573 -0.704 . . . . 0.0 110.826 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.418 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 50.63 85.38 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.154 -0.966 . . . . 0.0 110.875 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.3 m -151.43 105.81 3.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.467 -0.771 . . . . 0.0 111.035 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.431 ' CZ ' ' HB1' ' A' ' 27' ' ' ALA . 84.1 m-85 -62.83 137.6 58.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.485 -0.76 . . . . 0.0 109.071 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.3 m -128.79 98.76 5.08 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.316 -0.954 . . . . 0.0 112.764 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.409 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.0 p -101.86 166.46 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 109.254 177.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.8 m -161.67 111.06 1.55 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.725 -0.609 . . . . 0.0 109.657 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.24 -179.999 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.44 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 87.1 m . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.112 0.482 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.6 m -110.58 92.23 3.97 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.603 -0.686 . . . . 0.0 110.506 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.44 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 96.9 m-85 -67.35 169.38 9.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.568 -0.707 . . . . 0.0 109.961 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -140.41 120.16 13.41 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.576 -0.703 . . . . 0.0 110.491 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.427 HD12 ' CZ3' ' A' ' 44' ' ' TRP . 28.7 tp -98.95 130.41 45.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.512 -0.743 . . . . 0.0 109.919 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 tp -78.95 171.81 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.2 mt -132.63 72.12 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.258 -0.901 . . . . 0.0 110.431 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -93.94 50.55 1.43 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.43 156.07 15.9 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -71.64 -13.43 61.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.716 -0.873 . . . . 0.0 110.492 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.5 m -88.57 -33.44 17.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.272 -0.893 . . . . 0.0 110.38 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.4 mt -144.1 162.81 35.32 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.406 -0.809 . . . . 0.0 110.832 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -143.35 136.71 28.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.67 -0.644 . . . . 0.0 110.146 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.23 -145.41 17.44 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -144.57 166.8 24.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.537 -0.978 . . . . 0.0 110.275 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.0 m -139.33 168.84 18.93 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.73 . . . . 0.0 110.211 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 p -137.55 165.43 26.32 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.526 -0.734 . . . . 0.0 110.354 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.451 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 7.9 t -146.78 163.03 37.32 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.507 -0.745 . . . . 0.0 110.262 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -111.97 87.63 2.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.499 -0.75 . . . . 0.0 110.24 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -126.29 -171.76 2.47 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.529 -0.732 . . . . 0.0 110.206 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.7 p -112.41 -25.84 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.563 -0.711 . . . . 0.0 110.224 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -164.91 174.4 10.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.469 -0.77 . . . . 0.0 110.0 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.08 -23.5 14.04 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.422 -0.799 . . . . 0.0 110.781 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.56 -42.84 79.26 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.392 -0.817 . . . . 0.0 109.996 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 85.6 m -87.93 -34.03 18.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.649 -0.657 . . . . 0.0 109.413 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.411 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . . . -63.25 -178.8 0.27 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.673 -0.642 . . . . 0.0 109.595 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 66.36 -63.01 0.26 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.546 -0.721 . . . . 0.0 110.528 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.83 -34.72 60.13 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.999 -1.063 . . . . 0.0 110.246 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.3 t -82.17 -50.23 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.698 -0.626 . . . . 0.0 109.666 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.451 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 4.6 m-85 -62.86 -33.65 75.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.586 -0.696 . . . . 0.0 109.856 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -63.7 -41.32 98.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.593 -0.692 . . . . 0.0 109.28 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -60.97 -31.78 71.35 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.642 0.734 . . . . 0.0 109.714 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -71.53 -55.73 7.28 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.51 -47.18 76.84 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.68 -0.638 . . . . 0.0 110.31 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -56.18 -28.36 57.91 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.491 -0.756 . . . . 0.0 110.519 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.41 -39.64 24.65 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.69 -0.631 . . . . 0.0 110.048 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -79.13 -46.89 17.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.65 -0.656 . . . . 0.0 110.003 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.79 60.06 0.18 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.416 HG23 HD11 ' A' ' 40' ' ' ILE . 86.4 mt -124.04 67.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.549 -0.971 . . . . 0.0 110.173 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.26 53.29 2.6 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.93 -138.47 2.71 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -115.56 101.11 8.57 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.857 -0.79 . . . . 0.0 109.337 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.427 ' CZ3' HD12 ' A' ' 6' ' ' LEU . 34.3 m95 -70.02 143.52 52.52 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 122.002 0.906 . . . . 0.0 112.098 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.2 p -155.01 130.51 9.81 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -103.08 146.14 28.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.665 -0.647 . . . . 0.0 109.783 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -118.31 116.89 27.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.72 -0.612 . . . . 0.0 109.857 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -71.42 -21.2 62.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.666 -0.646 . . . . 0.0 110.584 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.83 -40.52 66.5 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.269 -0.895 . . . . 0.0 110.806 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.8 p -144.83 17.19 1.61 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.605 -0.684 . . . . 0.0 110.789 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.43 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.27 91.61 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.187 -0.945 . . . . 0.0 111.043 179.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.8 m -158.59 104.8 1.81 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.45 -0.781 . . . . 0.0 110.715 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -62.16 139.49 58.47 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.2 m -131.51 102.7 6.04 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.954 -178.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.414 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.3 p -102.97 166.95 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.347 -0.846 . . . . 0.0 109.17 177.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.8 m -160.92 115.09 2.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.666 -0.646 . . . . 0.0 109.964 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.127 179.807 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.452 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 62.8 m . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.081 0.467 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.6 m -92.26 103.01 15.51 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.604 -0.685 . . . . 0.0 110.503 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.452 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 79.5 m-85 -84.68 170.05 13.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.586 -0.696 . . . . 0.0 110.068 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.66 145.29 38.26 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.571 -0.705 . . . . 0.0 109.889 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.432 HD12 ' CZ3' ' A' ' 44' ' ' TRP . 18.3 tp -123.12 135.2 54.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.484 -0.76 . . . . 0.0 110.436 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 tp -85.56 156.0 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.5 mm -120.51 74.78 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.368 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -95.7 47.35 1.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 178.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.74 153.28 17.59 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -69.28 -10.91 60.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.627 -0.925 . . . . 0.0 110.452 179.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.2 m -87.66 -37.76 16.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 110.256 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.1 mt -138.62 172.44 12.88 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.45 -0.781 . . . . 0.0 110.778 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -151.9 135.93 16.53 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.602 -0.686 . . . . 0.0 110.094 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.12 -145.46 15.73 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -146.18 178.2 8.41 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.585 -0.95 . . . . 0.0 110.406 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.4 m -159.71 152.87 22.01 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 110.16 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.0 p -124.51 163.4 21.94 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.561 -0.712 . . . . 0.0 110.349 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.425 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.2 t -150.5 -171.54 3.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.633 -0.667 . . . . 0.0 110.211 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.35 98.35 5.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.549 -0.719 . . . . 0.0 110.33 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.3 148.54 50.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.456 -0.777 . . . . 0.0 109.844 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.8 p -63.35 -36.43 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.041 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -169.75 -174.9 1.96 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.606 -0.683 . . . . 0.0 110.081 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.43 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.54 -26.02 29.4 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.504 -0.747 . . . . 0.0 111.074 -179.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.87 -28.64 69.02 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.506 -0.747 . . . . 0.0 110.3 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.5 m -113.03 -25.81 8.78 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.596 -0.69 . . . . 0.0 110.464 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.437 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -58.58 -61.74 2.37 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.471 -0.768 . . . . 0.0 110.496 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -57.7 -34.42 69.43 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.55 -0.719 . . . . 0.0 110.166 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -58.01 -36.86 73.28 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.37 -0.831 . . . . 0.0 109.996 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.2 t -84.59 -48.6 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.67 -0.644 . . . . 0.0 109.674 179.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.425 ' CZ ' HG22 ' A' ' 19' ' ' THR . 8.6 m-85 -62.31 -37.01 83.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.623 -0.673 . . . . 0.0 110.008 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -62.76 -47.28 84.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.572 -0.705 . . . . 0.0 109.169 179.413 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -63.21 -34.19 77.1 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.708 0.766 . . . . 0.0 109.286 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -65.81 -53.31 41.83 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.89 -45.72 84.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.735 -0.603 . . . . 0.0 109.895 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -58.82 -37.03 75.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 110.349 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -65.46 -54.17 32.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.659 -0.651 . . . . 0.0 109.949 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -69.61 -49.24 55.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.566 -0.709 . . . . 0.0 109.852 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.69 54.17 0.11 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.416 HD11 HG23 ' A' ' 40' ' ' ILE . 80.1 mt -119.97 70.32 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.427 -1.043 . . . . 0.0 110.236 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -94.55 48.82 1.23 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.16 -138.24 0.6 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -110.31 111.7 23.18 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.432 ' CZ3' HD12 ' A' ' 6' ' ' LEU . 35.9 m95 -83.83 143.27 30.04 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.213 1.006 . . . . 0.0 112.738 -177.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 p -154.7 131.72 10.91 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -101.03 143.94 30.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.65 -0.656 . . . . 0.0 110.306 -178.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -115.75 109.58 17.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.726 -0.609 . . . . 0.0 109.775 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -67.13 -21.8 65.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.646 -0.659 . . . . 0.0 110.593 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.4 -40.26 64.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.318 -0.864 . . . . 0.0 110.805 -179.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.1 p -148.82 21.04 1.01 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.549 -0.719 . . . . 0.0 110.676 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.54 92.74 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.168 -0.957 . . . . 0.0 110.744 179.874 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.1 m -152.57 101.64 2.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.355 -0.841 . . . . 0.0 111.515 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -63.49 124.21 20.74 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.0 m -115.23 96.66 5.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.263 -0.898 . . . . 0.0 113.14 -177.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.401 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.4 p -99.24 166.89 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 177.339 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 92.5 m -157.5 105.77 2.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.606 -0.684 . . . . 0.0 109.749 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.254 -179.723 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.445 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 44.1 m . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 121.21 0.529 . . . . 0.0 110.362 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.2 m -85.53 90.83 8.08 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.589 -0.694 . . . . 0.0 110.623 -179.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.445 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 96.5 m-85 -73.28 170.34 15.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.478 -0.764 . . . . 0.0 109.81 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -141.44 139.71 33.45 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.467 -0.77 . . . . 0.0 110.583 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.421 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 38.9 tp -114.3 121.39 43.5 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.636 -0.665 . . . . 0.0 109.95 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 tp -71.47 166.26 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 71.5 mt -127.7 72.51 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.335 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -93.62 49.17 1.34 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.456 -0.777 . . . . 0.0 109.107 179.117 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.4 149.7 18.81 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -66.71 -13.63 61.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.649 -0.913 . . . . 0.0 110.41 179.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.6 m -85.05 -37.59 20.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.243 -0.911 . . . . 0.0 110.446 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.0 mt -141.38 170.06 16.43 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.444 -0.785 . . . . 0.0 110.769 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -151.22 141.49 22.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.611 -0.681 . . . . 0.0 110.177 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.95 -149.73 18.89 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -144.4 160.3 41.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.535 -0.98 . . . . 0.0 110.351 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.7 m -147.89 147.84 30.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.585 -0.697 . . . . 0.0 110.207 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -119.27 171.23 8.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.529 -0.732 . . . . 0.0 110.225 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.449 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 7.9 t -142.97 -170.43 3.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.548 -0.72 . . . . 0.0 110.369 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -126.86 88.59 2.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.622 -0.674 . . . . 0.0 110.123 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -130.64 137.89 49.82 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.608 -0.682 . . . . 0.0 110.3 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.1 m -59.39 -25.45 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.527 -0.733 . . . . 0.0 110.574 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 p30 -170.87 179.95 3.0 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.401 -0.812 . . . . 0.0 110.404 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.435 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.18 -22.84 18.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.478 -0.764 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.04 -45.14 79.28 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.307 -0.87 . . . . 0.0 110.173 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.7 m -85.83 -31.63 22.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.649 -0.657 . . . . 0.0 109.541 179.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.26 -176.93 0.11 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.698 -0.626 . . . . 0.0 109.611 179.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 66.63 -61.73 0.3 Allowed 'General case' 0 N--CA 1.508 2.455 0 O-C-N 121.508 -0.745 . . . . 0.0 110.75 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -55.63 -34.22 64.73 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.064 -1.022 . . . . 0.0 110.268 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.0 t -83.49 -49.81 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.599 -0.688 . . . . 0.0 109.768 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.449 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 7.7 m-85 -63.17 -34.19 77.09 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.578 -0.701 . . . . 0.0 109.668 179.837 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -63.56 -41.23 98.42 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -62.8 -33.83 76.01 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.701 0.763 . . . . 0.0 109.544 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.401 ' CD2' HD23 ' A' ' 6' ' ' LEU . 7.8 t80 -68.02 -51.47 46.58 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.015 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.53 -49.07 62.34 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.792 -0.567 . . . . 0.0 110.078 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -55.94 -29.78 60.67 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.468 -0.77 . . . . 0.0 110.356 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.36 -40.16 89.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.681 -0.637 . . . . 0.0 109.822 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.26 -44.15 10.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.624 -0.672 . . . . 0.0 109.983 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.52 38.62 0.51 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.432 HG22 HD12 ' A' ' 40' ' ' ILE . 84.9 mt -93.32 64.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.379 -1.071 . . . . 0.0 109.908 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.3 54.77 3.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.503 -0.748 . . . . 0.0 108.999 178.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.76 -136.55 1.8 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.038 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -114.08 102.09 9.84 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.932 -0.746 . . . . 0.0 109.035 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.421 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 40.4 m95 -74.44 142.41 44.94 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.154 0.978 . . . . 0.0 112.226 -178.133 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.5 p -153.22 131.3 11.85 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.424 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 13.7 t80 -107.5 113.56 26.97 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.877 -178.529 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.37 118.62 26.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.699 -0.626 . . . . 0.0 109.929 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -69.76 -23.41 63.36 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.72 -0.612 . . . . 0.0 110.36 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.38 -37.12 55.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.416 -0.803 . . . . 0.0 111.015 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.3 p -144.34 14.51 1.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.482 -0.761 . . . . 0.0 111.12 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HG3' ' CE2' ' A' ' 46' ' ' TYR . 1.0 OUTLIER 50.97 86.72 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.043 -1.036 . . . . 0.0 110.82 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.1 m -153.14 107.48 3.12 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.515 -0.741 . . . . 0.0 110.934 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -64.06 124.15 20.86 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.7 m -116.14 98.32 6.55 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.283 -0.886 . . . . 0.0 112.888 -177.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.3 p -98.13 166.75 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.887 . . . . 0.0 109.395 177.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.7 m -160.78 108.84 1.58 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.648 -0.657 . . . . 0.0 109.751 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.13 -179.961 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.444 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 5.7 m . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.137 0.494 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.9 t -96.35 79.24 3.1 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.68 -0.637 . . . . 0.0 110.99 -179.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.454 ' CD2' ' CB ' ' A' ' 27' ' ' ALA . 97.4 m-85 -62.14 166.38 4.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.321 -0.862 . . . . 0.0 109.6 179.445 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -137.4 122.21 18.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.403 -0.811 . . . . 0.0 110.658 -179.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.422 HD13 ' CH2' ' A' ' 44' ' ' TRP . 47.0 tp -99.88 130.59 46.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.546 -0.721 . . . . 0.0 110.049 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 tp -81.75 165.52 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 70.1 mt -124.11 73.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.251 -0.906 . . . . 0.0 110.279 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.17 46.79 1.12 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 0.0 108.967 178.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.22 158.1 15.66 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -76.31 -5.07 45.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.767 -0.843 . . . . 0.0 110.604 179.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.2 m -99.15 -36.84 9.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.191 -0.943 . . . . 0.0 110.273 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.33 164.29 28.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.444 -0.785 . . . . 0.0 110.53 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.16 138.4 19.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.602 -0.686 . . . . 0.0 110.326 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.21 -141.94 12.34 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -145.71 157.94 43.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.546 -0.973 . . . . 0.0 110.396 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.9 m -146.39 137.91 24.63 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.613 -0.679 . . . . 0.0 110.123 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.3 p -119.48 164.16 16.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.538 -0.727 . . . . 0.0 110.264 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.454 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 8.5 t -152.8 -166.26 2.41 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.589 -0.694 . . . . 0.0 110.285 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -131.12 122.66 27.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.712 -0.617 . . . . 0.0 110.204 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -151.08 158.71 44.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.575 -0.703 . . . . 0.0 110.197 -179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -77.3 -25.44 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.583 -0.698 . . . . 0.0 110.156 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.8 p30 -172.41 179.61 2.47 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.406 -0.809 . . . . 0.0 110.277 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.61 -25.66 53.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.541 -0.725 . . . . 0.0 110.807 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.99 -27.32 65.31 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.484 -0.76 . . . . 0.0 110.489 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.5 m -109.27 -27.87 9.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.505 -0.747 . . . . 0.0 110.313 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.454 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -59.64 -55.64 31.95 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.522 -0.736 . . . . 0.0 110.324 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -59.22 -42.11 90.22 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.573 -0.704 . . . . 0.0 110.333 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -57.59 -35.77 70.85 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.336 -0.853 . . . . 0.0 110.177 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.42 -49.04 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.692 -0.63 . . . . 0.0 110.004 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.454 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 7.2 m-85 -65.44 -35.45 80.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.56 -0.713 . . . . 0.0 110.329 -179.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -64.06 -41.98 97.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.435 -0.791 . . . . 0.0 109.377 179.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -60.6 -29.63 69.33 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.561 0.696 . . . . 0.0 109.957 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -73.22 -54.11 9.23 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.41 -44.14 92.18 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.665 -0.647 . . . . 0.0 110.073 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -56.38 -37.33 69.96 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.494 -0.754 . . . . 0.0 110.581 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -75.1 -50.38 16.56 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.652 -0.655 . . . . 0.0 110.146 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -65.8 -48.5 71.51 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.528 -0.732 . . . . 0.0 110.067 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.3 62.05 0.2 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.409 HD11 HG21 ' A' ' 40' ' ' ILE . 85.5 mt -129.56 77.22 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.472 -1.016 . . . . 0.0 110.458 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.76 40.7 1.15 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.15 -136.14 0.02 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -120.22 100.79 7.39 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.82 -0.812 . . . . 0.0 109.011 179.284 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.422 ' CH2' HD13 ' A' ' 6' ' ' LEU . 27.8 m95 -67.38 142.97 56.56 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.218 1.008 . . . . 0.0 112.478 -177.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.5 p -151.72 131.6 13.31 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -103.13 128.55 50.02 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.696 -0.628 . . . . 0.0 109.967 -178.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -97.59 108.2 20.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.686 -0.634 . . . . 0.0 110.019 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -65.97 -20.08 66.08 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.645 -0.659 . . . . 0.0 110.633 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.71 -38.6 64.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.282 -0.886 . . . . 0.0 110.812 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.6 p -148.61 22.18 1.02 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.522 -0.736 . . . . 0.0 110.752 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.88 90.75 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.128 -0.982 . . . . 0.0 110.928 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.1 m -156.67 106.37 2.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.477 -0.764 . . . . 0.0 110.857 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -62.27 136.58 57.99 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.535 -0.728 . . . . 0.0 109.095 178.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.4 m -129.77 101.57 5.94 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.558 -178.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.404 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.2 p -102.81 165.4 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.612 177.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.4 m -163.49 115.34 1.45 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.875 -0.516 . . . . 0.0 109.751 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.34 179.521 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.453 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 9.9 t . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 120.806 0.336 . . . . 0.0 110.234 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.7 m -129.49 96.11 4.18 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.539 -0.725 . . . . 0.0 110.739 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.453 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 84.9 m-85 -77.6 169.34 18.46 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.533 -0.729 . . . . 0.0 109.644 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -140.14 113.61 8.57 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.503 -0.748 . . . . 0.0 110.418 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.444 HD11 ' CH2' ' A' ' 44' ' ' TRP . 42.8 tp -94.03 122.31 36.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.565 -0.709 . . . . 0.0 109.966 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 tp -72.92 166.83 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.8 mt -128.67 73.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.527 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -94.37 49.55 1.3 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.416 -0.802 . . . . 0.0 109.124 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.31 151.79 18.32 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.6 -10.1 56.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.678 -0.895 . . . . 0.0 110.613 179.426 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.1 m -90.38 -32.49 16.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 110.373 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.3 mt -143.34 173.12 11.89 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.451 -0.781 . . . . 0.0 110.917 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -156.69 140.68 16.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.618 -0.676 . . . . 0.0 110.129 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.11 -134.48 8.19 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -162.1 164.98 27.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.518 -0.99 . . . . 0.0 110.286 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 76.2 m -138.69 164.06 30.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.542 -0.724 . . . . 0.0 110.339 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.6 p -136.98 161.06 37.09 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.57 -0.706 . . . . 0.0 110.204 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.449 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 7.6 t -169.78 148.43 3.58 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.543 -0.723 . . . . 0.0 110.192 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.36 132.43 35.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.495 -0.753 . . . . 0.0 110.13 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -155.36 140.98 17.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.358 -0.839 . . . . 0.0 110.473 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.6 m -58.8 -32.59 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.571 -0.706 . . . . 0.0 110.405 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -170.14 179.11 3.62 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.546 -0.721 . . . . 0.0 110.294 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.98 -24.67 40.01 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.492 -0.755 . . . . 0.0 110.847 -179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.67 -35.13 72.09 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.438 -0.789 . . . . 0.0 110.508 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.5 m -97.4 -25.58 15.16 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.52 -0.737 . . . . 0.0 110.506 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.437 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -66.62 -58.51 5.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.436 -0.79 . . . . 0.0 110.467 -179.742 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -57.23 -42.12 80.79 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.573 -0.704 . . . . 0.0 110.597 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -55.99 -40.65 73.63 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.298 -0.876 . . . . 0.0 110.196 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.4 t -80.18 -49.41 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.626 -0.671 . . . . 0.0 109.733 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.449 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 7.7 m-85 -61.77 -30.51 70.84 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.098 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -65.11 -43.76 90.97 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.168 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -62.57 -30.86 71.63 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.606 0.717 . . . . 0.0 109.439 178.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -70.95 -50.28 36.36 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.171 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.93 -42.92 72.65 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.638 -0.664 . . . . 0.0 109.989 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -58.7 -38.29 77.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.563 -0.711 . . . . 0.0 110.517 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -71.3 -51.96 21.54 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.551 -0.718 . . . . 0.0 110.037 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -66.66 -48.85 68.07 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.544 -0.722 . . . . 0.0 109.931 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.14 61.45 0.19 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.497 HD12 HG21 ' A' ' 40' ' ' ILE . 83.1 mt -126.18 68.23 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.519 -0.989 . . . . 0.0 110.331 179.657 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.76 52.92 2.42 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.49 -140.28 4.08 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.2 110.52 21.06 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.904 -0.762 . . . . 0.0 109.471 179.53 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.444 ' CH2' HD11 ' A' ' 6' ' ' LEU . 31.6 m95 -80.23 143.9 33.35 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.125 0.964 . . . . 0.0 112.318 -178.134 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 p -157.48 131.65 8.29 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -107.43 146.03 32.23 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.704 -0.623 . . . . 0.0 109.894 -178.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -118.36 114.99 23.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.716 -0.615 . . . . 0.0 109.929 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -69.31 -24.05 63.88 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.666 -0.646 . . . . 0.0 110.542 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.48 -36.82 55.78 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.37 -0.831 . . . . 0.0 110.832 -179.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.1 p -147.81 17.71 1.13 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.574 -0.703 . . . . 0.0 110.88 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.26 93.06 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.221 -0.924 . . . . 0.0 111.01 179.793 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.4 m -157.72 105.27 2.01 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.233 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 73.8 m-85 -64.67 136.56 57.09 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.813 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.1 m -127.59 100.02 5.82 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.887 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.408 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.4 p -104.88 166.65 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 108.974 177.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -161.12 112.33 1.79 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.719 -0.613 . . . . 0.0 109.778 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.158 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.426 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 63.3 m . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.095 0.474 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.0 m -96.19 94.39 7.48 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.654 -0.654 . . . . 0.0 110.417 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.435 ' CD2' ' CB ' ' A' ' 27' ' ' ALA . 96.4 m-85 -72.14 167.49 20.17 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.528 -0.732 . . . . 0.0 109.966 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -132.77 115.82 15.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.544 -0.722 . . . . 0.0 110.317 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.421 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -94.09 111.84 23.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.518 -0.738 . . . . 0.0 110.263 -179.977 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 tp -63.74 171.32 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.074 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.416 HG22 HD12 ' A' ' 8' ' ' ILE . 74.0 mt -133.23 74.53 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.928 . . . . 0.0 110.678 -179.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -95.56 48.0 1.13 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.18 156.81 15.36 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -74.47 -6.57 49.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.766 -0.844 . . . . 0.0 110.346 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.9 m -92.64 -37.1 12.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 110.133 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.3 mt -139.78 176.06 9.06 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.536 -0.728 . . . . 0.0 110.527 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.15 138.9 11.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.574 -0.704 . . . . 0.0 110.225 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.26 -136.54 9.04 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -144.46 162.91 35.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.56 -0.965 . . . . 0.0 110.332 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.6 m -146.67 130.23 16.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.598 -0.689 . . . . 0.0 110.107 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.8 p -112.4 174.88 5.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.628 -0.67 . . . . 0.0 110.323 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.433 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 7.4 t -166.54 -170.55 1.66 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.573 -0.705 . . . . 0.0 110.246 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -120.95 105.72 10.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.545 -0.722 . . . . 0.0 110.222 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.43 140.81 43.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.557 -0.714 . . . . 0.0 110.138 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 p -61.85 -30.67 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.552 -0.718 . . . . 0.0 109.909 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -168.89 179.11 4.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.67 -0.644 . . . . 0.0 110.142 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.421 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.56 -23.01 14.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.489 -0.757 . . . . 0.0 111.137 -179.575 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.86 -32.1 70.39 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.391 -0.818 . . . . 0.0 110.441 -179.859 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.4 m -104.05 -26.99 12.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.529 -0.732 . . . . 0.0 110.47 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.435 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -60.67 -58.17 9.59 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.526 -0.734 . . . . 0.0 110.495 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -58.43 -45.09 89.19 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.483 -0.76 . . . . 0.0 110.521 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -54.4 -41.0 68.75 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.254 -0.903 . . . . 0.0 110.507 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.2 t -81.39 -47.89 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.649 -0.657 . . . . 0.0 110.091 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.433 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 4.5 m-85 -63.84 -32.72 74.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.694 . . . . 0.0 110.212 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -64.93 -42.97 94.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -63.64 -33.54 75.84 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.712 0.767 . . . . 0.0 109.099 178.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -66.06 -57.01 8.68 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.65 -46.18 91.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.753 -0.592 . . . . 0.0 110.085 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -57.48 -34.85 69.45 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.578 -0.701 . . . . 0.0 110.566 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.19 -48.47 67.83 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.537 -0.727 . . . . 0.0 110.135 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -76.49 -47.26 23.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.58 -0.7 . . . . 0.0 110.041 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.22 69.17 0.19 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.443 HG23 HD12 ' A' ' 40' ' ' ILE . 81.7 mt -127.44 60.82 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.997 . . . . 0.0 110.343 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -82.46 60.72 5.26 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.8 -140.8 10.05 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -178.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -114.04 105.5 13.3 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.922 -0.752 . . . . 0.0 109.039 179.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -75.78 143.27 42.05 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.04 0.924 . . . . 0.0 112.209 -178.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.1 p -153.16 132.08 12.49 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.403 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 48.7 t80 -99.82 131.62 45.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.744 -0.597 . . . . 0.0 110.18 -178.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.16 119.15 38.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.754 -0.591 . . . . 0.0 109.951 179.746 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.24 -21.32 56.51 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.591 -0.693 . . . . 0.0 110.719 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.07 -40.39 67.16 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.311 -0.868 . . . . 0.0 110.829 -179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.0 p -147.55 19.51 1.18 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.585 -0.697 . . . . 0.0 110.84 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.403 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 0.6 OUTLIER 51.68 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.195 -0.941 . . . . 0.0 111.004 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 57.1 m -158.54 108.33 2.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.513 -0.742 . . . . 0.0 110.684 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 27' ' ' ALA . 64.9 m-85 -62.22 127.44 31.36 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.576 -0.703 . . . . 0.0 109.177 179.146 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.1 m -120.3 105.39 10.88 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.398 -0.921 . . . . 0.0 112.47 -178.465 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.417 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.9 p -109.57 168.14 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.468 -0.77 . . . . 0.0 108.954 177.478 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.5 m -160.04 109.7 1.81 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.471 -0.768 . . . . 0.0 110.013 -179.511 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.242 -179.941 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.415 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 71.4 m . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.157 0.503 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.5 m -93.54 91.4 7.08 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.623 -0.673 . . . . 0.0 110.576 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.416 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 96.8 m-85 -69.15 173.49 5.55 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.542 -0.724 . . . . 0.0 109.934 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -139.56 110.54 6.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.454 -0.778 . . . . 0.0 110.416 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.437 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -91.28 109.63 20.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.535 -0.728 . . . . 0.0 110.068 179.872 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 tt -63.06 171.75 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.341 -0.849 . . . . 0.0 108.854 179.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 80.1 mt -133.64 71.94 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.438 -179.53 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -95.12 47.7 1.15 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.423 -0.798 . . . . 0.0 109.175 179.125 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.96 160.24 13.52 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.524 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -76.43 -7.36 54.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.653 -0.91 . . . . 0.0 110.461 179.202 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.2 t -98.34 -23.51 15.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.458 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.8 mt -147.21 163.62 35.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.321 -0.862 . . . . 0.0 110.495 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.47 132.68 17.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.64 -0.663 . . . . 0.0 110.146 179.864 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.06 -142.07 13.54 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -145.84 171.59 14.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.537 -0.978 . . . . 0.0 110.239 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 m -147.53 156.6 42.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.632 -0.667 . . . . 0.0 110.158 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.5 p -138.59 155.56 48.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.563 -0.711 . . . . 0.0 110.256 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.441 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 8.3 t -154.8 160.38 41.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.584 -0.698 . . . . 0.0 110.283 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -90.02 106.72 18.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.599 -0.688 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.05 139.28 45.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.622 -0.674 . . . . 0.0 110.216 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -59.21 -34.59 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.547 -0.721 . . . . 0.0 110.1 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -169.3 -178.77 3.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.586 -0.696 . . . . 0.0 110.271 179.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.416 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.98 -23.0 17.1 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.531 -0.73 . . . . 0.0 111.053 -179.828 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.06 -26.32 62.35 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.49 -0.756 . . . . 0.0 110.701 -179.672 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.1 m -114.76 -24.85 8.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.422 -0.799 . . . . 0.0 110.691 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . . . -59.1 -60.03 4.52 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.402 -0.811 . . . . 0.0 110.415 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -59.42 -37.2 77.43 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.542 -0.724 . . . . 0.0 110.401 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -56.72 -44.73 81.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.423 -0.798 . . . . 0.0 110.578 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.0 t -80.13 -43.34 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.52 -0.737 . . . . 0.0 109.96 179.732 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.441 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 10.3 m-85 -65.52 -35.2 80.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.554 -0.717 . . . . 0.0 110.329 -179.727 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -63.64 -45.48 90.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 108.991 179.286 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -63.43 -32.84 74.39 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.69 0.757 . . . . 0.0 109.136 178.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -66.48 -56.58 10.22 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.56 -45.87 90.58 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.695 -0.628 . . . . 0.0 110.15 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -58.51 -32.49 68.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.57 -0.706 . . . . 0.0 110.328 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -60.94 -59.93 4.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.599 -0.688 . . . . 0.0 109.968 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -72.5 -45.98 56.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.624 -0.673 . . . . 0.0 109.828 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.36 72.89 0.23 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.725 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.453 HD12 HG22 ' A' ' 40' ' ' ILE . 80.4 mt -122.9 62.06 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.482 -1.011 . . . . 0.0 110.004 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.78 61.12 5.0 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.72 -140.76 9.98 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -178.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -116.62 104.53 11.48 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.877 -0.778 . . . . 0.0 109.038 179.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -73.98 143.94 45.41 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 122.084 0.945 . . . . 0.0 112.248 -178.112 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -153.84 132.13 11.95 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.75 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -103.74 139.08 39.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.618 -0.676 . . . . 0.0 110.186 -178.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -113.34 122.05 46.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.718 -0.613 . . . . 0.0 109.843 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -75.89 -19.5 58.78 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.732 -0.605 . . . . 0.0 110.778 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.37 -39.18 66.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.24 -0.913 . . . . 0.0 110.774 -179.718 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.4 p -148.18 18.56 1.09 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.561 -0.712 . . . . 0.0 110.752 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.3 94.97 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.23 -0.919 . . . . 0.0 110.927 179.977 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.2 m -156.22 108.78 2.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.472 -0.767 . . . . 0.0 111.015 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 27' ' ' ALA . 77.1 m-85 -65.17 127.58 32.28 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.59 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 45.7 m -120.23 102.87 8.79 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.753 -178.214 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.406 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.6 p -105.72 167.33 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.374 -0.829 . . . . 0.0 108.99 177.372 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.4 m -160.35 111.07 1.85 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.555 -0.716 . . . . 0.0 110.097 -179.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.169 179.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.45 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 92.6 m . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.14 0.495 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.5 m -92.95 108.53 20.07 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.618 -0.676 . . . . 0.0 110.437 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.457 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 73.7 m-85 -88.47 174.12 8.3 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.587 -0.696 . . . . 0.0 110.098 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -142.68 112.97 7.18 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 110.406 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.421 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -96.09 112.62 24.3 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.496 -0.753 . . . . 0.0 109.941 179.731 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 tt -65.37 172.58 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.977 179.338 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 77.6 mt -133.98 72.33 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.384 -0.822 . . . . 0.0 110.383 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -95.23 47.17 1.13 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.439 -0.788 . . . . 0.0 109.272 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.32 160.7 13.38 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -77.64 -2.72 37.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.734 -0.862 . . . . 0.0 110.495 179.309 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -101.45 -30.44 11.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.969 . . . . 0.0 109.951 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 60.4 mt -140.01 165.9 26.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.482 -0.761 . . . . 0.0 110.508 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -151.11 132.41 14.54 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.643 -0.661 . . . . 0.0 110.218 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 131.84 -133.44 7.17 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -162.52 160.36 25.97 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.547 -0.972 . . . . 0.0 110.428 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.2 m -140.79 143.13 34.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.572 -0.705 . . . . 0.0 110.069 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.5 p -122.84 150.16 43.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.505 -0.747 . . . . 0.0 110.403 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.42 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.8 t -143.54 -172.09 3.65 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.647 -0.658 . . . . 0.0 110.247 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -114.34 107.73 15.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.59 -0.694 . . . . 0.0 110.146 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.63 147.8 52.35 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.586 -0.696 . . . . 0.0 110.096 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.6 p -65.7 -31.69 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.542 -0.724 . . . . 0.0 109.57 179.482 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -173.07 -174.94 1.12 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.587 -0.696 . . . . 0.0 109.952 179.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.457 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.27 -24.77 12.33 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.456 -0.777 . . . . 0.0 111.162 -179.458 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.59 78.14 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.497 -0.752 . . . . 0.0 110.377 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.1 m -100.78 -28.18 12.95 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.56 -0.712 . . . . 0.0 110.431 -179.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.448 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -61.42 -61.89 2.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.476 -0.765 . . . . 0.0 110.294 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -60.52 -37.28 80.66 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.596 -0.69 . . . . 0.0 110.25 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -57.6 -43.62 84.84 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.424 -0.798 . . . . 0.0 110.391 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.26 -45.81 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.585 -0.697 . . . . 0.0 109.819 179.691 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.421 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 11.5 m-85 -64.01 -33.21 75.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.573 -0.704 . . . . 0.0 110.283 -179.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -64.57 -45.09 88.51 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.132 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -63.02 -33.61 75.8 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.697 0.761 . . . . 0.0 109.18 178.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -64.5 -54.98 23.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.751 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.27 96.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.784 -0.573 . . . . 0.0 110.023 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -57.92 -35.79 71.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.556 -0.715 . . . . 0.0 110.484 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.47 -43.35 99.02 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.624 -0.672 . . . . 0.0 110.023 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -84.31 -42.46 15.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.625 -0.672 . . . . 0.0 109.922 179.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.51 47.47 0.41 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.722 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.413 HG21 HD12 ' A' ' 40' ' ' ILE . 79.6 mt -96.91 63.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.463 -1.022 . . . . 0.0 110.168 179.798 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.4 59.56 4.64 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.89 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.53 -139.71 8.1 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.046 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -118.59 103.09 9.39 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.307 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -71.62 142.73 49.95 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.065 0.936 . . . . 0.0 112.266 -177.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p -150.26 131.62 14.64 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -108.97 123.56 49.3 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.719 -0.613 . . . . 0.0 110.099 -178.606 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -100.93 119.05 38.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.708 -0.62 . . . . 0.0 109.834 179.599 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.36 -19.41 62.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.672 -0.643 . . . . 0.0 110.812 -179.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.12 -37.69 55.02 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.214 -0.929 . . . . 0.0 110.877 -179.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.7 p -147.06 17.37 1.22 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.628 -0.67 . . . . 0.0 110.754 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.87 86.67 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.18 -0.95 . . . . 0.0 110.948 179.817 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.6 m -151.51 105.7 3.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.483 -0.761 . . . . 0.0 110.766 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -62.06 129.14 39.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.462 -0.774 . . . . 0.0 108.971 178.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.5 m -121.92 102.13 7.99 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.451 -178.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.409 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.2 p -103.16 167.46 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.381 -0.824 . . . . 0.0 109.319 177.744 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.7 m -159.99 110.33 1.87 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.598 -0.689 . . . . 0.0 110.159 -179.474 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.068 179.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.458 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 67.5 m . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.115 0.483 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.5 m -80.87 101.97 9.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.611 -0.681 . . . . 0.0 110.573 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.458 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 74.9 m-85 -88.2 166.95 14.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.545 -0.722 . . . . 0.0 109.813 179.652 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -134.02 118.56 17.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.416 -0.803 . . . . 0.0 110.414 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.422 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -99.21 112.87 24.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.51 -0.744 . . . . 0.0 110.384 -179.926 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 tp -66.08 167.31 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.07 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.6 mt -129.0 72.8 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.33 -0.856 . . . . 0.0 110.459 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -95.87 47.82 1.11 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.264 -0.898 . . . . 0.0 108.999 179.014 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.67 166.43 16.92 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -86.04 6.89 26.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.75 -0.853 . . . . 0.0 110.375 179.066 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -113.95 -30.85 6.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.915 . . . . 0.0 110.067 179.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.3 169.67 17.15 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.435 -0.791 . . . . 0.0 110.507 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -153.1 143.41 22.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.608 -0.682 . . . . 0.0 110.258 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 132.64 -140.73 12.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -153.67 155.91 36.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.631 -0.923 . . . . 0.0 110.209 -179.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.9 m -134.94 169.5 17.31 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.6 -0.687 . . . . 0.0 110.281 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.5 p -151.66 150.17 29.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.613 -0.679 . . . . 0.0 110.133 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.445 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 7.3 t -156.36 142.86 18.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.593 -0.692 . . . . 0.0 110.236 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -67.07 124.18 22.33 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.585 -0.697 . . . . 0.0 110.24 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.01 140.58 25.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.524 -0.735 . . . . 0.0 110.208 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -58.54 -35.24 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.548 -0.72 . . . . 0.0 110.14 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -171.24 -170.79 0.87 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.564 -0.71 . . . . 0.0 110.159 179.546 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.68 -25.54 54.18 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.507 -0.746 . . . . 0.0 110.844 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.64 -51.88 67.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.464 -0.773 . . . . 0.0 110.429 -179.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.8 m -84.56 -27.6 27.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.477 -0.764 . . . . 0.0 110.338 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.418 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . . . -61.39 -59.34 5.42 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.592 -0.692 . . . . 0.0 110.245 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -61.81 -32.63 72.95 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.569 -0.707 . . . . 0.0 110.268 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -57.87 -45.84 85.76 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.42 -0.8 . . . . 0.0 110.445 -179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.0 t -79.54 -42.57 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.61 -0.681 . . . . 0.0 109.879 179.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.445 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 12.5 m-85 -65.9 -33.85 76.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.631 -0.668 . . . . 0.0 110.182 -179.808 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -64.04 -47.39 80.38 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.305 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -63.64 -33.28 75.28 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.672 0.748 . . . . 0.0 109.081 178.789 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -64.32 -54.51 31.93 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.12 -40.17 95.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.825 -0.547 . . . . 0.0 110.014 179.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -58.95 -37.29 76.41 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.532 -0.73 . . . . 0.0 110.488 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -64.19 -40.03 95.23 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.55 -0.719 . . . . 0.0 110.265 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -86.38 -29.03 23.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.543 -0.723 . . . . 0.0 110.15 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.74 49.68 1.36 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.425 HG22 HD13 ' A' ' 40' ' ' ILE . 84.8 mt -103.4 62.7 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.603 -0.939 . . . . 0.0 110.286 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -85.12 58.57 5.11 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.99 -138.97 6.22 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 -178.848 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -116.74 102.94 9.85 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.497 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -72.79 141.39 48.07 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.101 0.953 . . . . 0.0 112.401 -177.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.4 132.45 19.27 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.299 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.405 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 53.9 t80 -105.53 113.24 26.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.635 -0.666 . . . . 0.0 110.128 -178.485 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.87 104.12 14.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.702 -0.624 . . . . 0.0 109.826 179.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -65.04 -24.83 67.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.676 -0.64 . . . . 0.0 110.553 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.95 -34.81 60.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.414 -0.804 . . . . 0.0 110.787 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.1 p -144.9 15.66 1.56 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.621 -0.674 . . . . 0.0 110.982 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 50.3 90.34 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.129 -0.982 . . . . 0.0 111.097 179.81 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.7 m -154.89 107.15 2.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.538 -0.726 . . . . 0.0 110.853 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 27' ' ' ALA . 82.6 m-85 -62.08 125.4 23.75 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.483 -0.761 . . . . 0.0 109.041 178.858 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.5 m -120.27 100.01 6.92 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.251 -0.98 . . . . 0.0 112.54 -178.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.417 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.8 p -103.7 167.28 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.39 -0.819 . . . . 0.0 109.212 177.597 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.2 m -160.65 109.89 1.69 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.667 -0.646 . . . . 0.0 109.762 -179.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.249 -179.922 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.459 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 89.2 m . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.1 0.476 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.1 t -80.99 105.86 12.55 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.634 -0.666 . . . . 0.0 110.503 -179.854 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.459 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 60.4 m-85 -90.37 164.42 14.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.447 -0.783 . . . . 0.0 109.966 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -130.38 122.29 27.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.461 -0.775 . . . . 0.0 110.569 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.424 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -105.5 110.55 22.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.527 -0.733 . . . . 0.0 109.939 179.81 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 tp -62.74 166.9 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.353 -0.842 . . . . 0.0 109.007 179.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.8 mt -130.8 72.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.303 -0.873 . . . . 0.0 110.489 -179.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -97.12 49.58 1.06 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.449 -0.782 . . . . 0.0 109.257 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.71 163.25 12.49 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -78.18 -2.05 35.7 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.646 -0.914 . . . . 0.0 110.874 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.5 m -107.34 -28.03 10.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.232 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mp -135.13 164.8 26.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.521 -0.737 . . . . 0.0 110.303 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -154.71 126.78 7.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.571 -0.706 . . . . 0.0 110.313 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.07 -140.01 11.33 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -144.85 171.77 13.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.637 -0.92 . . . . 0.0 110.376 -179.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 t -154.98 157.79 38.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.628 -0.67 . . . . 0.0 109.976 179.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.9 p -140.42 149.43 42.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.546 -0.721 . . . . 0.0 110.513 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.448 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 8.5 t -146.35 162.15 38.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.626 -0.671 . . . . 0.0 109.994 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -88.22 107.16 18.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.567 -0.708 . . . . 0.0 110.281 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.96 138.56 50.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.611 -0.681 . . . . 0.0 110.1 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.68 -31.81 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.614 -0.679 . . . . 0.0 110.248 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -171.32 179.99 2.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.504 -0.747 . . . . 0.0 110.377 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.45 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.79 -31.47 64.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.489 -0.757 . . . . 0.0 110.78 -179.573 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.27 -28.47 68.09 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.536 -0.727 . . . . 0.0 110.266 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.3 m -108.14 -27.99 9.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.58 -0.7 . . . . 0.0 110.304 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.456 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -60.2 -54.95 39.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.508 -0.745 . . . . 0.0 110.236 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -60.06 -31.82 70.36 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.573 -0.705 . . . . 0.0 110.239 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -58.26 -40.62 82.29 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.342 -0.849 . . . . 0.0 110.35 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.0 t -82.19 -44.93 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.585 -0.697 . . . . 0.0 109.851 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.448 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 9.1 m-85 -65.85 -37.84 87.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.65 -0.656 . . . . 0.0 110.229 -179.808 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -62.07 -46.05 90.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.465 -0.772 . . . . 0.0 109.387 179.665 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -62.47 -34.24 76.44 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.782 0.801 . . . . 0.0 109.339 179.083 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.64 -49.36 68.96 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.25 -45.15 57.53 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.769 -0.582 . . . . 0.0 110.444 -179.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -56.26 -39.84 73.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.423 -0.798 . . . . 0.0 110.617 -179.715 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -75.13 -31.54 61.11 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.606 -0.684 . . . . 0.0 110.11 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -80.14 -40.89 26.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.546 -0.721 . . . . 0.0 110.006 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.43 37.15 0.94 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.41 ' CG2' ' CG1' ' A' ' 55' ' ' VAL . 84.7 mt -103.64 62.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.528 -0.984 . . . . 0.0 110.174 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -85.67 57.35 4.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.51 -0.744 . . . . 0.0 109.008 178.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.47 -138.69 5.23 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -178.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -116.3 105.14 12.21 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.43 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -74.63 142.22 44.59 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.182 0.992 . . . . 0.0 112.459 -177.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.05 132.59 17.72 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.452 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -106.48 111.74 24.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.646 -0.659 . . . . 0.0 110.262 -178.357 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.16 112.02 20.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.694 -0.629 . . . . 0.0 109.778 179.662 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -70.32 -21.78 62.88 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.639 -0.663 . . . . 0.0 110.663 -179.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.94 -35.24 58.41 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.311 -0.868 . . . . 0.0 110.955 -179.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.9 p -148.16 18.41 1.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.537 -0.727 . . . . 0.0 110.932 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.409 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.72 93.14 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.182 -0.949 . . . . 0.0 110.989 179.713 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.4 m -158.66 104.68 1.79 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.454 -0.779 . . . . 0.0 110.886 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -61.05 128.52 36.82 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.423 -0.798 . . . . 0.0 109.149 179.014 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 85.0 m -120.7 101.21 7.58 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.522 -178.404 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 9.5 p -103.9 166.87 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.863 . . . . 0.0 109.309 177.599 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.0 m -160.72 110.02 1.68 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.62 -0.675 . . . . 0.0 109.835 -179.736 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.19 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.458 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 55.0 m . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.127 0.489 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.6 m -106.66 96.1 6.21 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.585 -0.697 . . . . 0.0 110.624 -179.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.458 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 92.1 m-85 -73.59 -178.85 3.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.538 -0.726 . . . . 0.0 109.838 179.606 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -146.74 110.75 5.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.49 -0.756 . . . . 0.0 110.289 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.415 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -92.27 110.67 22.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.502 -0.749 . . . . 0.0 110.364 -179.771 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 tp -64.22 170.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.286 -0.884 . . . . 0.0 108.653 178.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.0 mt -131.53 74.2 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.245 -0.909 . . . . 0.0 110.722 -179.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -96.07 47.13 1.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.458 -0.776 . . . . 0.0 109.052 179.022 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.1 161.9 13.29 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.602 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -79.74 -0.53 34.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.771 -0.84 . . . . 0.0 110.587 179.315 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -104.79 -30.82 9.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.981 . . . . 0.0 109.928 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.8 mt -138.54 166.02 25.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.635 -0.666 . . . . 0.0 110.363 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -154.63 132.81 11.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.573 -0.704 . . . . 0.0 110.202 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.89 -147.29 19.12 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -144.88 122.25 11.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.555 -0.967 . . . . 0.0 110.368 179.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.5 m -109.67 149.81 29.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.631 -0.668 . . . . 0.0 110.253 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.8 p -131.94 162.41 30.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.56 -0.712 . . . . 0.0 110.164 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.441 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 7.6 t -142.93 -172.55 3.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.561 -0.712 . . . . 0.0 110.328 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -123.53 89.36 3.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.614 -0.679 . . . . 0.0 110.153 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -116.19 -177.25 3.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.585 -0.697 . . . . 0.0 109.982 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.17 -24.88 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.728 . . . . 0.0 110.326 179.822 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -168.11 175.56 6.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.452 -0.78 . . . . 0.0 110.156 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.88 -25.14 60.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.516 -0.74 . . . . 0.0 110.744 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.7 -27.96 66.89 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.472 -0.767 . . . . 0.0 110.502 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.4 m -109.27 -27.23 9.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.551 -0.718 . . . . 0.0 110.417 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . . . -62.0 -62.96 1.42 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.505 -0.747 . . . . 0.0 110.407 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -58.17 -41.65 84.33 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.519 -0.738 . . . . 0.0 110.528 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.6 tttm -55.68 -42.49 75.24 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.362 -0.836 . . . . 0.0 110.314 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.2 t -80.27 -48.13 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.674 . . . . 0.0 109.934 179.545 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.441 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 5.4 m-85 -62.05 -33.75 74.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.585 -0.697 . . . . 0.0 110.22 -179.676 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -63.7 -43.84 95.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.425 -0.797 . . . . 0.0 108.924 179.19 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -62.71 -33.5 75.23 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.728 0.775 . . . . 0.0 109.298 178.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -67.26 -56.48 9.63 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.56 -41.44 94.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.736 -0.602 . . . . 0.0 110.302 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -58.11 -36.93 73.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.51 -0.744 . . . . 0.0 110.605 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.38 -42.4 68.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.545 -0.722 . . . . 0.0 110.18 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -77.77 -28.93 50.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.573 -0.705 . . . . 0.0 110.215 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.88 55.06 0.95 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.422 HG22 HD12 ' A' ' 40' ' ' ILE . 84.0 mt -115.44 59.7 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.485 -1.009 . . . . 0.0 110.353 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.15 60.77 5.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.658 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.05 -138.93 7.97 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -178.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -115.4 103.57 10.91 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.948 -0.736 . . . . 0.0 109.28 179.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -73.92 143.38 45.77 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.146 0.974 . . . . 0.0 112.497 -177.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -151.22 133.31 15.21 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 178.656 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -104.0 139.17 39.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.593 -0.692 . . . . 0.0 110.313 -178.41 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -112.74 113.57 25.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.687 -0.633 . . . . 0.0 109.976 179.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -69.68 -21.37 63.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.701 -0.624 . . . . 0.0 110.847 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.6 -40.48 65.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.293 -0.879 . . . . 0.0 110.814 -179.592 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.5 p -148.84 20.28 1.01 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.555 -0.716 . . . . 0.0 110.597 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER 52.1 93.46 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.174 -0.954 . . . . 0.0 110.63 179.948 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.6 m -151.41 103.17 2.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.497 -0.752 . . . . 0.0 111.112 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 27' ' ' ALA . 78.2 m-85 -63.44 123.41 18.68 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.451 -0.781 . . . . 0.0 109.018 178.786 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.9 m -116.92 103.78 10.63 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.323 -0.951 . . . . 0.0 112.619 -178.349 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.42 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.4 p -106.02 168.27 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.409 -0.807 . . . . 0.0 109.002 177.396 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.7 m -160.2 108.9 1.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.543 -0.723 . . . . 0.0 110.028 -179.558 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.168 179.884 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.444 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 79.1 m . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.086 0.47 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.1 t -89.44 99.39 12.4 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.65 -0.656 . . . . 0.0 110.585 -179.844 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.444 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 90.6 m-85 -80.68 176.56 9.69 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.364 -0.835 . . . . 0.0 110.005 179.885 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -141.95 110.46 6.07 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.428 -0.795 . . . . 0.0 110.272 -179.972 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -93.62 111.54 23.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.489 -0.757 . . . . 0.0 110.467 -179.92 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 tp -64.18 170.29 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.948 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 77.8 mt -132.43 74.72 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.772 -179.788 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -95.72 49.33 1.16 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.811 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.43 160.75 13.17 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.327 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -80.6 -0.16 36.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.769 -0.842 . . . . 0.0 110.47 179.015 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -102.14 -31.81 10.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.134 -0.979 . . . . 0.0 109.951 179.855 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.9 170.49 16.04 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.508 -0.745 . . . . 0.0 110.401 -179.978 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -154.12 142.77 20.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.618 -0.676 . . . . 0.0 110.374 -179.793 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.55 -164.34 21.02 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -119.88 145.31 46.8 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.551 -0.97 . . . . 0.0 110.315 -179.955 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 m -121.75 146.2 47.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.586 -0.696 . . . . 0.0 110.225 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.9 p -130.08 166.94 19.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.57 -0.706 . . . . 0.0 110.179 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.452 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 7.4 t -167.01 -179.5 4.69 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.568 -0.708 . . . . 0.0 110.3 -179.921 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -112.55 101.18 9.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.546 -0.721 . . . . 0.0 110.209 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.48 146.21 50.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.589 -0.694 . . . . 0.0 110.219 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.1 p -70.17 -26.28 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.546 -0.721 . . . . 0.0 110.186 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -170.37 177.94 3.92 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.412 -0.805 . . . . 0.0 110.465 179.734 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.42 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.13 -25.84 47.71 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.578 -0.701 . . . . 0.0 111.139 -179.425 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.11 -39.26 81.72 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.372 -0.83 . . . . 0.0 110.334 -179.776 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.6 m -94.41 -29.63 14.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.594 -0.691 . . . . 0.0 110.087 179.914 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.419 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -61.02 -55.91 27.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.595 -0.69 . . . . 0.0 110.226 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -61.97 -37.32 84.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.568 -0.708 . . . . 0.0 110.3 -179.949 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -58.36 -41.9 85.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.379 -0.825 . . . . 0.0 110.387 -179.958 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.8 t -81.37 -44.21 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.558 -0.714 . . . . 0.0 109.813 179.666 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.452 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 11.2 m-85 -65.75 -36.46 83.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.602 -0.686 . . . . 0.0 110.192 -179.861 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -63.13 -45.17 93.23 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.469 -0.769 . . . . 0.0 109.15 179.366 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -63.25 -31.06 72.12 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.657 0.742 . . . . 0.0 109.27 178.713 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -69.67 -51.06 38.06 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.866 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.31 -41.27 76.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.627 -0.671 . . . . 0.0 110.002 179.9 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -58.49 -44.53 89.43 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.746 . . . . 0.0 110.423 -179.977 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.74 -46.21 83.18 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.59 -0.694 . . . . 0.0 110.204 -179.952 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -70.84 -50.19 38.01 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.535 -0.728 . . . . 0.0 110.07 179.941 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.61 58.08 0.19 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.463 HG23 HD13 ' A' ' 40' ' ' ILE . 82.2 mt -116.05 59.82 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.548 -0.971 . . . . 0.0 110.234 179.826 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.97 62.89 3.51 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.872 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.18 -141.99 12.84 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -178.813 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -114.73 111.47 21.31 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.944 -0.739 . . . . 0.0 109.039 179.152 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -80.39 143.22 33.66 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.038 0.923 . . . . 0.0 112.264 -177.887 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 p -152.17 133.62 14.54 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 178.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -104.09 139.98 38.41 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.194 -178.636 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -109.54 108.9 19.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.65 -0.656 . . . . 0.0 109.938 179.724 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -67.62 -21.08 65.41 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.707 -0.621 . . . . 0.0 110.759 -179.866 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.15 -41.79 72.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.29 -0.881 . . . . 0.0 110.747 -179.726 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 67.2 p -146.84 21.75 1.26 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.6 -0.688 . . . . 0.0 110.617 -179.932 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.31 95.32 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.235 -0.916 . . . . 0.0 110.753 179.804 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.8 m -154.81 102.75 2.38 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.213 -179.841 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 27' ' ' ALA . 71.4 m-85 -63.81 128.9 37.86 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.708 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.1 m -122.65 106.76 11.24 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.588 -178.583 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.412 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.0 p -110.69 167.35 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.436 -0.79 . . . . 0.0 109.143 177.481 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 78.7 m -161.39 111.42 1.65 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.642 -0.661 . . . . 0.0 109.83 -179.791 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.137 179.903 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.455 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 68.5 m . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.091 0.472 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.4 m -84.43 94.31 8.49 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.606 -0.684 . . . . 0.0 110.698 -179.679 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.455 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 96.7 m-85 -77.47 177.86 7.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.521 -0.737 . . . . 0.0 109.736 179.518 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -142.93 112.11 6.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.417 -0.802 . . . . 0.0 110.608 -179.897 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.432 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -94.14 116.84 29.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.523 -0.736 . . . . 0.0 110.378 179.95 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 tt -70.79 173.38 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.457 -0.777 . . . . 0.0 109.023 179.287 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.402 ' HB ' ' N ' ' A' ' 15' ' ' GLY . 83.0 mt -132.63 75.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.835 . . . . 0.0 110.161 179.903 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.01 45.2 1.04 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.526 -0.734 . . . . 0.0 109.204 179.379 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.04 158.92 15.89 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.74 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -76.7 -3.61 38.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.705 -0.879 . . . . 0.0 110.598 179.358 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 m -101.84 -33.1 9.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 110.217 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.0 mt -132.7 175.29 9.46 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.497 -0.752 . . . . 0.0 110.483 179.932 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -159.69 133.46 7.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.651 -0.656 . . . . 0.0 110.125 -179.866 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.402 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 132.46 -145.9 17.71 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.826 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -135.97 175.52 9.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.529 -0.983 . . . . 0.0 110.321 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.9 m -150.73 134.42 16.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.527 -0.733 . . . . 0.0 110.262 179.899 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.3 p -121.56 161.82 21.69 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.537 -0.727 . . . . 0.0 110.335 -179.968 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.447 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 9.1 t -165.66 -179.52 5.43 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.56 -0.712 . . . . 0.0 110.272 179.921 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.42 119.58 39.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.607 -0.683 . . . . 0.0 110.061 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.07 139.03 24.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.585 -0.697 . . . . 0.0 110.142 -179.892 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.0 m -57.98 -33.71 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.474 -0.766 . . . . 0.0 110.598 -179.932 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.4 p30 -170.35 -174.21 1.64 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.519 -0.738 . . . . 0.0 110.33 179.84 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.405 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.46 -27.15 56.12 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.523 -0.735 . . . . 0.0 110.739 -179.755 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.74 -26.46 65.67 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.474 -0.766 . . . . 0.0 110.32 179.861 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.2 m -110.0 -27.38 9.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.539 -0.725 . . . . 0.0 110.249 179.908 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.451 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -59.55 -60.68 3.45 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.624 -0.672 . . . . 0.0 110.361 -179.917 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -59.93 -36.15 76.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.555 -0.716 . . . . 0.0 110.158 -179.985 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -57.66 -45.23 85.81 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.461 -0.774 . . . . 0.0 110.49 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.03 -43.91 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.561 -0.712 . . . . 0.0 110.134 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.447 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 8.0 m-85 -66.77 -34.06 76.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.583 -0.698 . . . . 0.0 110.291 -179.679 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -63.95 -40.57 96.73 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.393 -0.817 . . . . 0.0 108.897 179.212 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -63.35 -33.92 76.58 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.733 0.777 . . . . 0.0 109.239 179.003 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.68 -59.31 3.7 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.735 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.85 -46.78 88.2 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.752 -0.592 . . . . 0.0 110.275 179.894 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -55.95 -27.96 54.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.524 -0.735 . . . . 0.0 110.712 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.89 -52.56 49.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.577 -0.702 . . . . 0.0 109.973 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -78.13 -45.0 24.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.596 -0.69 . . . . 0.0 109.994 179.856 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.47 53.16 0.18 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.769 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.423 HG21 HD11 ' A' ' 40' ' ' ILE . 84.1 mt -103.13 63.03 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.514 -0.992 . . . . 0.0 110.052 179.63 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.92 56.35 3.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.414 -0.804 . . . . 0.0 108.907 178.879 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.56 -137.31 3.66 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.123 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -116.03 101.16 8.5 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.403 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -71.77 142.52 49.71 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.998 0.904 . . . . 0.0 111.846 -178.197 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 p -151.24 132.19 14.24 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.939 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -103.17 139.35 38.77 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.679 -0.638 . . . . 0.0 110.108 -178.701 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.25 104.76 13.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.775 -0.578 . . . . 0.0 109.511 179.432 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -63.2 -20.87 65.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.676 -0.64 . . . . 0.0 110.798 -179.568 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.26 -40.05 67.44 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.287 -0.883 . . . . 0.0 110.703 -179.765 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.0 p -148.14 21.84 1.09 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.621 -0.674 . . . . 0.0 110.516 179.998 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.56 91.36 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.198 -0.939 . . . . 0.0 110.743 179.976 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.4 m -150.23 98.54 2.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.462 -0.774 . . . . 0.0 111.23 -179.807 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 27' ' ' ALA . 66.3 m-85 -61.81 127.8 33.17 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.391 -0.818 . . . . 0.0 108.959 178.656 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.7 m -123.67 107.63 11.69 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.451 -178.499 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.403 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.6 p -107.96 167.4 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.358 -0.839 . . . . 0.0 108.917 177.401 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.2 m -160.7 111.01 1.77 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.636 -0.665 . . . . 0.0 109.984 -179.703 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.102 179.811 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.452 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 86.6 m . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.173 0.511 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 t -82.36 99.94 9.68 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.628 -0.67 . . . . 0.0 110.503 -179.95 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.452 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 89.6 m-85 -84.76 170.52 13.15 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.351 -0.843 . . . . 0.0 109.771 179.696 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -139.96 115.31 9.89 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.417 -0.802 . . . . 0.0 110.466 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.429 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -96.95 113.16 24.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.5 -0.75 . . . . 0.0 110.479 -179.915 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 tp -65.42 170.01 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.133 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.8 mt -131.17 73.17 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.237 179.734 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.18 48.15 1.23 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.475 -0.766 . . . . 0.0 109.092 179.094 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.97 156.0 15.81 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.464 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -74.18 -6.35 47.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.746 -0.855 . . . . 0.0 110.408 179.185 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.8 m -94.94 -31.52 13.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.167 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.47 164.51 33.13 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.489 -0.757 . . . . 0.0 110.604 -179.869 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -144.73 140.27 28.45 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.62 -0.675 . . . . 0.0 110.311 -179.877 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 132.6 -144.47 16.33 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -144.26 162.34 36.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.505 -0.997 . . . . 0.0 110.281 -179.979 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.4 m -137.8 143.44 41.06 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.598 -0.689 . . . . 0.0 109.951 179.788 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.2 p -127.21 153.67 45.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.592 -0.692 . . . . 0.0 110.297 -179.874 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.441 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 9.0 t -159.04 156.14 28.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.605 -0.685 . . . . 0.0 110.236 179.848 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -86.23 123.76 31.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.579 -0.701 . . . . 0.0 110.148 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.14 144.9 29.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.595 -0.691 . . . . 0.0 110.271 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.18 -36.06 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.565 -0.709 . . . . 0.0 110.195 -179.998 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -170.81 -168.38 0.67 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.561 -0.712 . . . . 0.0 110.389 179.787 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.88 -33.52 66.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.593 -0.692 . . . . 0.0 111.214 -179.287 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.02 -48.05 73.89 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.349 -0.845 . . . . 0.0 110.826 -179.51 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.9 m -85.87 -27.54 24.99 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.543 -0.723 . . . . 0.0 110.306 179.998 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . . . -60.42 -61.21 2.76 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.537 -0.727 . . . . 0.0 110.303 -179.922 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -59.81 -38.79 82.95 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.554 -0.716 . . . . 0.0 110.382 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -55.95 -40.44 73.22 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.326 -0.859 . . . . 0.0 110.617 -179.893 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.5 t -82.05 -47.36 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.588 -0.695 . . . . 0.0 110.148 179.863 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.441 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 8.1 m-85 -64.68 -35.25 80.42 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.529 -0.732 . . . . 0.0 110.292 -179.771 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.59 -43.81 95.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.498 -0.751 . . . . 0.0 109.17 179.441 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -60.77 -32.39 71.71 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.677 0.751 . . . . 0.0 109.539 179.07 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -68.86 -55.44 11.08 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.881 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.55 -44.18 87.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.746 -0.596 . . . . 0.0 110.209 -179.948 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -56.24 -32.13 64.19 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.491 -0.756 . . . . 0.0 110.439 -179.839 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -70.48 -52.77 19.65 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.649 -0.657 . . . . 0.0 109.883 179.692 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -68.54 -41.68 79.52 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.596 -0.69 . . . . 0.0 109.759 179.652 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.44 44.05 0.62 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.685 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.415 ' CG2' ' CG1' ' A' ' 55' ' ' VAL . 81.2 mt -96.51 63.1 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.522 -0.987 . . . . 0.0 110.204 179.762 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -83.73 58.52 4.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.578 -0.701 . . . . 0.0 109.292 179.163 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.47 -137.69 5.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.33 100.95 7.63 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.183 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -69.73 142.68 53.25 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.131 0.967 . . . . 0.0 112.489 -177.775 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -149.88 131.81 15.19 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.567 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -106.29 134.84 48.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.638 -0.663 . . . . 0.0 110.159 -178.454 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.61 110.5 22.71 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.661 -0.649 . . . . 0.0 109.848 179.57 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -67.3 -24.64 65.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.637 -0.664 . . . . 0.0 110.623 -179.672 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.42 -37.44 56.74 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.325 -0.859 . . . . 0.0 110.899 -179.655 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.1 p -145.93 16.83 1.41 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.623 -0.673 . . . . 0.0 110.839 179.837 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.417 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.13 93.06 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.084 -1.01 . . . . 0.0 110.729 179.939 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.9 m -155.49 104.06 2.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.523 -0.736 . . . . 0.0 111.051 -179.697 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 27' ' ' ALA . 86.1 m-85 -62.44 132.17 51.64 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.498 -0.751 . . . . 0.0 109.037 178.88 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.1 m -126.9 105.17 8.45 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.396 -0.922 . . . . 0.0 112.426 -178.686 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.415 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 9.2 p -107.2 166.43 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.341 -0.85 . . . . 0.0 109.443 177.694 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.9 m -162.33 117.02 1.85 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.673 -0.642 . . . . 0.0 110.107 -179.525 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.124 179.456 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.417 HG22 ' CE2' ' A' ' 4' ' ' PHE . 62.2 m . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.125 0.488 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.7 m -94.26 93.43 7.74 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.508 -0.745 . . . . 0.0 110.481 -179.835 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.452 ' CD2' ' CB ' ' A' ' 27' ' ' ALA . 97.5 m-85 -71.77 169.72 15.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.579 -0.701 . . . . 0.0 109.978 179.824 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -136.22 114.15 11.28 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.532 -0.73 . . . . 0.0 110.413 -179.825 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.447 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -93.98 111.98 23.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.485 -0.759 . . . . 0.0 110.554 -179.969 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.6 tp -63.51 171.06 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.061 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 82.8 mt -133.05 74.03 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.559 -179.91 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -96.16 46.46 1.08 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.854 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.05 156.83 16.72 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.692 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -75.48 -5.83 47.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.766 -0.844 . . . . 0.0 110.383 179.117 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -93.88 -34.74 13.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.136 179.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.52 -176.34 4.51 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.536 -179.994 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -163.47 134.56 4.7 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.644 -0.66 . . . . 0.0 110.167 -179.953 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.89 -141.93 12.97 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.932 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -138.88 161.81 36.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.573 -0.957 . . . . 0.0 110.306 -179.796 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.1 m -136.87 140.34 42.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.581 -0.699 . . . . 0.0 110.175 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.7 p -129.55 159.44 36.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.492 -0.755 . . . . 0.0 110.398 -179.794 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.45 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 8.9 t -162.14 171.31 17.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.566 -0.709 . . . . 0.0 110.231 179.657 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.13 105.45 16.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.552 -0.718 . . . . 0.0 110.155 179.982 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.17 139.03 49.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.542 -0.724 . . . . 0.0 110.232 179.89 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 p -59.4 -33.36 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.566 -0.709 . . . . 0.0 110.179 179.953 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.3 p30 -170.04 -179.36 3.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.554 -0.716 . . . . 0.0 110.344 179.887 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.2 -24.83 44.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.49 -0.756 . . . . 0.0 110.862 -179.831 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.68 -30.48 67.41 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.447 -0.783 . . . . 0.0 110.472 -179.776 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.2 m -109.48 -27.13 9.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.525 -0.735 . . . . 0.0 110.313 179.936 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.452 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -60.35 -42.77 96.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.501 -0.749 . . . . 0.0 110.127 179.916 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.87 -45.76 63.84 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.66 -0.65 . . . . 0.0 110.251 179.84 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -56.04 -31.9 63.56 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.243 -0.911 . . . . 0.0 110.551 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.0 t -87.01 -48.44 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.652 -0.655 . . . . 0.0 110.104 -179.937 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.45 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 6.3 m-85 -67.56 -38.79 84.63 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.981 -179.731 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -62.63 -43.87 97.71 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.515 -0.741 . . . . 0.0 109.093 179.226 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.6 tp60 -64.04 -34.12 77.29 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.761 0.791 . . . . 0.0 109.123 178.792 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -64.91 -57.71 8.07 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.676 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.96 -40.76 85.7 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.777 -0.577 . . . . 0.0 110.292 -179.895 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -58.01 -36.74 73.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.539 -0.726 . . . . 0.0 110.467 -179.879 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.96 -44.47 89.29 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.556 -0.715 . . . . 0.0 109.825 179.773 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -77.57 -40.37 42.58 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.673 -0.642 . . . . 0.0 109.971 179.729 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.87 40.83 0.88 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.82 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.425 HD13 HG22 ' A' ' 40' ' ' ILE . 75.8 mt -97.52 63.73 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.52 -0.988 . . . . 0.0 110.239 179.799 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -85.64 57.38 4.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.492 -0.755 . . . . 0.0 109.09 178.895 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.64 -139.32 6.17 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -178.839 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.55 108.72 17.92 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.859 -0.789 . . . . 0.0 109.008 179.455 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -79.59 142.49 35.63 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.118 0.961 . . . . 0.0 112.349 -177.794 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.2 p -153.7 131.9 11.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.786 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.4 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 21.8 t80 -97.04 125.48 41.51 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.701 -0.625 . . . . 0.0 110.202 -178.506 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -87.72 98.46 11.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.751 -0.593 . . . . 0.0 109.746 179.584 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -63.4 -19.19 64.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.589 -0.694 . . . . 0.0 110.767 -179.767 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.6 -42.54 74.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.269 -0.895 . . . . 0.0 110.661 -179.77 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.2 p -148.45 27.82 0.9 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.627 -0.671 . . . . 0.0 110.356 -179.871 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.417 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 5.6 mptt 52.52 96.8 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.336 -0.853 . . . . 0.0 110.809 -179.964 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.0 m -158.19 104.25 1.86 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.45 -0.781 . . . . 0.0 110.829 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -63.05 131.86 50.02 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.522 -0.736 . . . . 0.0 109.026 178.969 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 80.7 m -125.77 110.11 13.33 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.432 -0.907 . . . . 0.0 112.421 -178.528 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.423 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.3 p -114.35 167.4 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.37 -0.831 . . . . 0.0 109.35 177.726 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.3 m -161.65 112.34 1.66 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.623 -0.673 . . . . 0.0 110.084 -179.649 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.172 179.764 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.458 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 40.2 m . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.105 0.479 . . . . 0.0 110.371 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 m -89.23 91.91 8.96 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.604 -0.685 . . . . 0.0 110.615 -179.791 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.458 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 97.3 m-85 -74.08 170.07 16.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.45 -0.781 . . . . 0.0 109.834 179.661 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -134.23 114.55 13.16 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.419 -0.801 . . . . 0.0 110.323 179.901 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.427 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -94.87 110.69 22.54 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.687 . . . . 0.0 110.399 -179.948 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 tt -65.46 162.64 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.044 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 8' ' ' ILE . 49.0 mm -125.37 76.97 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.397 -179.741 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -96.13 47.33 1.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.991 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.23 159.58 13.82 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.217 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.0 tptt -77.83 -3.24 40.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.787 -0.831 . . . . 0.0 110.394 179.163 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.5 m -99.79 -32.01 11.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 110.14 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.9 mt -140.49 173.98 10.97 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.508 -0.745 . . . . 0.0 110.559 -179.916 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -160.73 135.98 7.84 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.63 -0.669 . . . . 0.0 109.994 179.795 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.07 -144.49 16.46 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -137.47 151.65 48.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.564 -0.963 . . . . 0.0 110.446 -179.851 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 m -130.84 144.87 51.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.613 -0.679 . . . . 0.0 110.08 179.857 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.8 p -131.8 139.8 48.99 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.549 -0.719 . . . . 0.0 110.355 -179.837 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.451 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 7.9 t -146.04 134.01 21.4 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 110.353 179.942 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.91 129.1 39.36 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.592 -0.692 . . . . 0.0 110.455 -179.919 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.53 140.67 19.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.561 -0.712 . . . . 0.0 109.989 179.887 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -58.58 -36.36 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.479 -0.763 . . . . 0.0 110.225 -179.949 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 39.4 p30 -169.92 -176.01 2.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.578 -0.701 . . . . 0.0 110.209 179.621 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.453 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.57 -26.36 54.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.535 -0.728 . . . . 0.0 110.786 -179.667 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.48 -29.6 67.94 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.467 -0.771 . . . . 0.0 110.319 -179.895 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.7 m -106.26 -27.39 11.06 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.583 -0.698 . . . . 0.0 110.382 179.952 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.426 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . . . -59.73 -50.04 75.4 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.481 -0.762 . . . . 0.0 110.32 -179.981 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -62.19 -46.22 89.89 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.591 -0.693 . . . . 0.0 110.078 179.862 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -55.73 -34.68 65.37 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.445 -0.784 . . . . 0.0 110.873 -179.801 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.2 t -84.66 -47.65 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.502 -0.749 . . . . 0.0 110.274 -179.829 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.451 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 7.5 m-85 -68.11 -37.88 81.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.547 -0.721 . . . . 0.0 110.188 -179.76 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -62.26 -45.78 91.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.73 . . . . 0.0 109.367 179.661 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -60.95 -29.91 69.92 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.608 0.718 . . . . 0.0 109.619 179.004 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -72.53 -59.16 2.86 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.832 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.68 -49.42 77.57 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.728 -0.608 . . . . 0.0 110.194 179.986 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -56.1 -33.0 64.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.547 -0.721 . . . . 0.0 110.666 -179.816 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.16 -31.23 49.57 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.58 -0.7 . . . . 0.0 110.025 179.886 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -83.47 -47.26 11.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.602 -0.686 . . . . 0.0 110.028 179.908 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.93 48.88 0.15 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.93 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.414 ' CG2' ' CG1' ' A' ' 55' ' ' VAL . 79.1 mt -116.26 58.52 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.505 -0.997 . . . . 0.0 110.391 179.935 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -81.35 60.55 4.46 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.433 -0.792 . . . . 0.0 109.013 178.918 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.96 -139.68 8.88 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -178.87 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -114.43 110.25 19.57 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.397 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -80.31 142.93 34.04 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.131 0.967 . . . . 0.0 112.456 -177.852 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.0 p -153.04 130.95 11.73 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.853 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.403 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 14.3 t80 -102.07 128.76 48.38 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.693 -0.629 . . . . 0.0 109.848 -178.742 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.6 110.67 22.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.712 -0.617 . . . . 0.0 109.887 179.726 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -69.69 -22.9 63.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.706 -0.621 . . . . 0.0 110.686 -179.913 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.92 -39.56 68.95 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.424 -0.798 . . . . 0.0 110.939 -179.769 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.8 p -145.77 19.22 1.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.53 -0.731 . . . . 0.0 110.974 -179.873 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.403 ' HG3' ' CE2' ' A' ' 46' ' ' TYR . 0.3 OUTLIER 51.88 95.65 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.23 -0.918 . . . . 0.0 110.957 179.7 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.1 m -158.7 106.46 1.87 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.499 -0.75 . . . . 0.0 110.683 179.83 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 27' ' ' ALA . 69.3 m-85 -63.65 129.38 39.92 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.948 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 56.7 m -123.25 107.2 11.42 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.36 -178.472 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.414 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.6 p -110.82 167.16 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.845 . . . . 0.0 109.436 177.791 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 83.7 m -161.61 116.37 2.0 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.652 -0.655 . . . . 0.0 110.06 -179.782 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 . . . . . 0 N--CA 1.498 1.951 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.387 179.746 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.425 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 32.7 m . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.092 0.472 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 51.3 m -95.08 91.31 6.28 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.622 -0.674 . . . . 0.0 110.492 -179.767 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.444 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 96.8 m-85 -69.89 172.43 7.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.548 -0.72 . . . . 0.0 109.836 179.713 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -140.59 116.31 10.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.476 -0.765 . . . . 0.0 110.555 -179.659 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.431 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -96.27 112.77 24.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.536 -0.727 . . . . 0.0 110.423 -179.9 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.2 tp -63.01 172.67 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.005 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 74.2 mt -135.61 70.24 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.209 -0.932 . . . . 0.0 110.974 -179.724 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -93.59 50.12 1.44 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.316 -0.865 . . . . 0.0 109.033 178.539 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.04 155.31 16.18 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.303 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -11.82 61.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.639 -0.918 . . . . 0.0 110.247 179.138 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -86.75 -36.11 18.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 110.332 -179.849 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.8 mt -138.67 -173.26 3.51 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 110.655 -179.912 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.15 127.08 2.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.603 -0.685 . . . . 0.0 110.345 179.94 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.99 -137.85 9.45 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.858 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -143.92 173.38 11.76 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.553 -0.969 . . . . 0.0 110.396 -179.858 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.4 m -153.26 146.8 25.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.622 -0.674 . . . . 0.0 110.175 179.864 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.3 p -132.5 170.19 15.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.628 -0.67 . . . . 0.0 110.226 179.965 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.446 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 8.3 t -165.58 179.43 6.07 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.573 -0.705 . . . . 0.0 110.166 -179.938 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -104.58 102.04 11.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.564 -0.71 . . . . 0.0 110.255 179.988 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.42 135.4 49.45 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.58 -0.7 . . . . 0.0 110.187 179.972 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.8 m -60.48 -27.23 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.497 -0.752 . . . . 0.0 110.345 179.955 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.1 p30 -172.79 178.43 2.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.422 -0.798 . . . . 0.0 110.221 179.67 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.02 -27.54 45.17 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.504 -0.747 . . . . 0.0 110.763 -179.606 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.37 -24.09 67.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.6 -0.688 . . . . 0.0 110.49 179.934 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 m -108.11 -26.11 10.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.449 -0.782 . . . . 0.0 110.628 -179.738 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.38 -48.24 61.78 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.495 -0.753 . . . . 0.0 110.35 -179.813 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -60.18 -41.53 93.07 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.564 -0.71 . . . . 0.0 110.488 -179.867 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -58.55 -36.36 73.78 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.379 -0.826 . . . . 0.0 110.591 -179.874 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.88 -41.56 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.516 -0.74 . . . . 0.0 110.222 -179.922 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.446 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 11.0 m-85 -72.5 -39.04 67.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.519 -0.738 . . . . 0.0 110.32 -179.851 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.4 tttt -62.03 -45.49 93.37 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.387 -0.821 . . . . 0.0 109.173 179.335 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -62.43 -33.06 74.05 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.721 0.772 . . . . 0.0 109.339 179.023 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -67.5 -56.71 8.45 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.847 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.07 -38.69 87.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.749 -0.595 . . . . 0.0 110.148 179.997 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -58.11 -39.96 79.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.503 -0.748 . . . . 0.0 110.557 -179.843 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -69.66 -43.04 73.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.567 -0.708 . . . . 0.0 110.134 -179.946 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -75.34 -28.9 59.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.589 -0.695 . . . . 0.0 110.102 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.06 52.25 1.39 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.886 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.45 HG23 HD12 ' A' ' 40' ' ' ILE . 83.9 mt -109.22 61.24 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.501 -0.999 . . . . 0.0 110.256 179.94 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -84.05 57.89 4.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.439 -0.788 . . . . 0.0 108.993 178.791 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.46 -138.04 5.56 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -178.916 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -116.79 101.22 8.36 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.874 -0.78 . . . . 0.0 109.365 179.484 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -71.74 143.06 49.73 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 122.02 0.914 . . . . 0.0 112.176 -178.2 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.66 131.74 14.37 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.464 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -105.02 131.73 52.17 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.713 -0.617 . . . . 0.0 110.294 -178.365 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -106.74 119.22 38.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.662 -0.649 . . . . 0.0 109.819 179.546 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -73.22 -21.46 60.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.655 -0.653 . . . . 0.0 110.707 -179.762 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.67 -38.23 60.14 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.257 -0.902 . . . . 0.0 110.804 -179.781 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.0 p -146.88 17.15 1.25 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.594 -0.691 . . . . 0.0 110.86 179.889 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.405 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 50.88 93.33 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.122 -0.986 . . . . 0.0 110.697 179.953 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.0 m -154.86 106.87 2.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.464 -0.772 . . . . 0.0 110.94 -179.662 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -61.93 130.12 44.15 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.698 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 85.0 m -123.39 107.23 11.39 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.539 -178.598 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.409 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.1 p -111.64 166.94 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.452 -0.78 . . . . 0.0 109.15 177.536 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.8 m -161.88 111.89 1.57 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.766 -0.584 . . . . 0.0 109.796 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.163 179.86 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.454 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 12.0 m . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.081 0.467 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.0 t -87.81 84.29 7.05 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.684 -0.635 . . . . 0.0 110.8 -179.616 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.454 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 92.9 m-85 -68.6 167.82 14.28 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.357 -0.84 . . . . 0.0 109.938 179.72 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -131.21 114.75 15.46 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.524 -0.735 . . . . 0.0 110.308 179.974 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.418 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -95.12 109.63 21.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.498 -0.752 . . . . 0.0 110.256 179.916 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 tp -63.24 169.56 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.166 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.2 mt -130.84 71.52 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.589 -179.575 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -94.68 48.3 1.2 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.383 -0.823 . . . . 0.0 108.978 178.947 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.8 160.29 17.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.504 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -1.62 35.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.776 -0.837 . . . . 0.0 110.583 179.205 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.1 m -103.0 -37.58 7.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.318 -179.928 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.65 176.54 8.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.486 -0.759 . . . . 0.0 110.589 -179.981 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -157.14 137.85 13.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.528 -0.732 . . . . 0.0 110.274 -179.962 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.02 -153.5 20.95 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.946 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -143.04 157.74 44.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.558 -0.966 . . . . 0.0 110.248 -179.961 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.7 t -144.16 164.49 30.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.556 -0.715 . . . . 0.0 110.304 179.993 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.9 p -135.84 174.21 10.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.573 -0.704 . . . . 0.0 110.189 179.941 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.429 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 7.6 t -161.98 -168.59 1.96 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.583 -0.698 . . . . 0.0 110.369 -179.951 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.26 103.23 8.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.637 -0.664 . . . . 0.0 110.387 179.9 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -133.56 143.18 48.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.485 -0.76 . . . . 0.0 110.238 -179.888 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.72 -31.6 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.584 -0.698 . . . . 0.0 109.927 179.789 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 50.9 p-10 -170.18 179.1 3.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.635 -0.666 . . . . 0.0 110.148 179.723 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.446 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.04 -25.56 45.4 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.508 -0.745 . . . . 0.0 110.855 -179.647 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.23 -26.51 64.95 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.52 -0.737 . . . . 0.0 110.533 -179.855 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.3 m -111.36 -26.98 8.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.521 -0.737 . . . . 0.0 110.46 -179.896 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.408 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -59.96 -53.51 56.99 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.498 -0.751 . . . . 0.0 110.317 -179.868 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -59.78 -37.72 79.84 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.578 -0.701 . . . . 0.0 110.315 179.94 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -56.32 -43.31 78.85 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.415 -0.803 . . . . 0.0 110.371 179.93 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.7 t -80.29 -46.09 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.611 -0.68 . . . . 0.0 109.852 179.633 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.429 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 9.2 m-85 -63.22 -35.52 80.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.607 -0.683 . . . . 0.0 110.355 -179.749 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -63.54 -42.71 98.4 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.411 -0.806 . . . . 0.0 109.138 179.438 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -63.25 -33.97 76.65 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.735 0.779 . . . . 0.0 109.205 178.898 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -66.63 -58.67 4.67 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.745 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.6 -34.11 73.72 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.712 -0.618 . . . . 0.0 110.061 179.799 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -55.16 -54.13 47.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.613 -0.68 . . . . 0.0 110.741 -179.924 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.18 -44.35 96.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.573 -0.705 . . . . 0.0 110.13 179.923 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -67.5 -29.64 69.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.597 -0.689 . . . . 0.0 110.072 179.87 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.6 50.96 2.42 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.987 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.418 HD13 HG23 ' A' ' 40' ' ' ILE . 83.1 mt -107.52 61.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.569 -0.96 . . . . 0.0 110.208 179.936 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.07 61.62 4.71 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 178.612 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.23 -140.73 10.23 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -178.685 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -116.02 103.54 10.68 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.572 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -73.73 142.13 46.33 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.044 0.926 . . . . 0.0 112.129 -178.211 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 p -149.71 131.96 15.49 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.722 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.419 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 45.9 t80 -103.7 127.8 51.12 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.718 -0.614 . . . . 0.0 110.014 -178.452 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -98.02 120.61 38.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.706 -0.621 . . . . 0.0 110.075 179.902 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.48 -23.03 53.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.677 -0.639 . . . . 0.0 110.489 179.961 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.4 -40.66 68.46 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.39 -0.819 . . . . 0.0 110.894 -179.733 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.8 p -145.76 18.0 1.46 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.564 -0.71 . . . . 0.0 111.011 -179.899 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.419 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 0.2 OUTLIER 52.15 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.115 -0.99 . . . . 0.0 110.962 179.715 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.0 m -156.2 104.68 2.26 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.431 -0.793 . . . . 0.0 110.996 -179.949 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 27' ' ' ALA . 63.7 m-85 -61.48 123.9 19.14 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.522 -0.736 . . . . 0.0 109.129 178.839 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.4 m -119.49 104.89 10.72 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.667 -178.453 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.412 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.6 p -107.32 167.02 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.241 177.554 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.5 m -159.09 109.17 1.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.647 -0.658 . . . . 0.0 109.902 -179.766 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.122 -179.929 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.426 HG23 ' CE2' ' A' ' 4' ' ' PHE . 33.1 m . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 121.146 0.498 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.0 m -143.3 91.16 2.24 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.643 -0.661 . . . . 0.0 109.902 179.88 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.444 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 83.6 m-85 -80.95 175.88 10.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.555 -0.716 . . . . 0.0 110.253 -179.608 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -137.49 142.16 41.49 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.673 -0.642 . . . . 0.0 109.96 179.728 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.453 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 3.4 tm? -115.62 99.8 7.59 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.527 -0.733 . . . . 0.0 110.191 -179.614 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 tp -63.16 124.68 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.465 -0.772 . . . . 0.0 108.96 179.625 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.0 mt -92.65 68.27 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.524 -0.735 . . . . 0.0 110.605 -178.907 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -89.19 53.0 2.52 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.199 -0.938 . . . . 0.0 109.221 178.966 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.3 169.0 17.0 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.483 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -83.72 5.48 24.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.749 -0.853 . . . . 0.0 110.499 179.088 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.5 m -114.29 -30.45 6.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 110.245 -179.931 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.2 mt -137.1 179.24 6.5 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.373 -0.829 . . . . 0.0 110.741 -179.903 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.03 134.45 4.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.625 -0.672 . . . . 0.0 110.084 -179.938 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.11 -150.1 21.54 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.921 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -139.06 155.32 48.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.624 -0.927 . . . . 0.0 110.298 -179.883 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 76.8 m -126.04 156.08 40.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 110.089 -179.99 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.5 p -145.38 144.98 30.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.587 -0.695 . . . . 0.0 110.323 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.7 t -156.17 144.78 20.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.57 -0.706 . . . . 0.0 110.202 179.775 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.23 112.6 12.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.567 -0.708 . . . . 0.0 109.778 179.712 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.91 144.42 50.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.605 -0.685 . . . . 0.0 110.027 -179.864 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.8 m -60.6 -33.48 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.522 -0.736 . . . . 0.0 110.239 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.0 p30 -175.26 -175.35 0.82 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.462 -0.774 . . . . 0.0 110.254 179.422 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.8 -25.19 55.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.545 -0.722 . . . . 0.0 110.876 -179.725 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.24 -26.52 63.0 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.462 -0.774 . . . . 0.0 110.543 -179.83 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.5 m -111.49 -25.91 9.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.529 -0.732 . . . . 0.0 110.559 -179.882 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.426 ' HB1' ' CE1' ' A' ' 53' ' ' PHE . . . -59.66 -57.41 13.03 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.457 -0.777 . . . . 0.0 110.45 -179.825 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -59.18 -36.28 75.06 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.465 -0.772 . . . . 0.0 110.416 -179.986 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -61.06 -41.54 96.81 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.351 -0.843 . . . . 0.0 109.864 179.764 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.9 t -83.51 -39.34 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.578 -0.701 . . . . 0.0 109.337 179.278 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.453 ' CD2' ' HB2' ' A' ' 6' ' ' LEU . 5.0 m-30 -66.45 -35.41 80.23 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.703 -0.623 . . . . 0.0 109.644 179.558 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -69.43 -45.45 69.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.663 -0.648 . . . . 0.0 109.624 179.712 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -61.94 -32.18 72.58 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.625 0.726 . . . . 0.0 109.671 179.397 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -67.65 -48.48 66.55 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.063 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.19 -33.09 61.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.781 -0.574 . . . . 0.0 110.391 -179.679 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -58.69 -45.24 89.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.497 -0.752 . . . . 0.0 110.399 -179.814 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.03 -36.98 72.57 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.599 -0.688 . . . . 0.0 110.156 179.941 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -74.43 -34.8 63.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.617 -0.677 . . . . 0.0 110.049 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.59 35.5 3.53 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.965 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.479 HG23 HD11 ' A' ' 40' ' ' ILE . 81.6 mt -100.09 69.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.537 -0.978 . . . . 0.0 110.204 179.991 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.08 51.5 1.81 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.692 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.71 -136.81 0.75 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -178.711 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -113.95 102.95 10.68 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.641 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.444 ' CH2' HD23 ' A' ' 6' ' ' LEU . 35.2 m95 -74.02 142.0 45.78 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.113 0.959 . . . . 0.0 112.161 -178.101 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 p -152.58 132.17 13.06 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.022 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.42 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 53.8 t80 -103.8 103.75 13.67 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.71 -0.618 . . . . 0.0 109.951 -178.846 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.78 109.32 15.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.686 -0.634 . . . . 0.0 109.839 179.781 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -64.62 -22.12 66.89 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.706 -0.621 . . . . 0.0 110.437 -179.965 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.79 -35.54 44.33 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.331 -0.855 . . . . 0.0 110.791 -179.855 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.0 p -145.4 15.48 1.46 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.545 -0.722 . . . . 0.0 110.95 179.862 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER 51.01 82.24 0.06 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.092 -1.005 . . . . 0.0 110.716 179.818 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.6 m -150.11 110.71 4.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.38 -0.825 . . . . 0.0 111.429 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.426 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 88.7 m-85 -65.53 112.76 3.75 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.439 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.4 m -104.85 99.41 9.05 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.918 -177.545 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.7 p -100.38 164.92 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 0.0 108.972 177.044 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.0 m -160.62 110.53 1.75 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.722 -0.611 . . . . 0.0 110.135 -179.677 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.038 179.824 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.455 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 4.1 m . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.169 0.509 . . . . 0.0 110.048 . . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 m -89.08 86.68 6.95 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.585 -0.697 . . . . 0.0 110.627 -179.576 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.455 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 66.0 m-85 -76.05 169.73 17.62 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.458 -0.776 . . . . 0.0 109.788 179.684 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.0 mtmm -141.45 105.3 4.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.482 -0.761 . . . . 0.0 110.392 -179.928 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.419 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -90.61 107.34 19.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.495 -0.753 . . . . 0.0 110.041 179.817 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 tp -64.2 160.2 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 119.616 -0.834 . . . . 0.0 108.921 179.231 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.441 HD13 HG23 ' A' ' 8' ' ' ILE . 49.0 mm -123.31 76.84 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.456 -179.735 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.9 48.3 1.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.784 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.9 153.16 17.76 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.234 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -12.61 61.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.686 -0.89 . . . . 0.0 110.283 179.178 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.6 m -85.98 -35.75 20.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.898 . . . . 0.0 110.336 -179.999 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 38.9 mt -143.72 171.43 14.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.521 -0.737 . . . . 0.0 110.545 -179.902 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.96 137.54 13.13 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.611 -0.681 . . . . 0.0 110.105 179.89 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.28 -138.05 9.43 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.962 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -141.08 165.53 27.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.971 . . . . 0.0 110.298 -179.917 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.1 m -151.75 128.47 10.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.582 -0.699 . . . . 0.0 110.1 179.977 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.4 p -126.32 149.4 49.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.735 . . . . 0.0 110.374 -179.915 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.437 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 9.0 t -150.56 129.14 12.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.621 -0.675 . . . . 0.0 110.179 179.807 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -60.91 118.48 6.75 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.513 -0.742 . . . . 0.0 110.101 179.868 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.84 156.89 45.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.58 -0.7 . . . . 0.0 110.319 -179.786 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 p -65.0 -37.0 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.621 -0.674 . . . . 0.0 110.063 179.963 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -174.73 -173.67 0.74 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.517 -0.739 . . . . 0.0 109.964 179.8 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.442 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.77 -24.15 21.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.43 -0.794 . . . . 0.0 111.018 -179.643 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.66 -43.79 85.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.402 -0.811 . . . . 0.0 110.504 -179.892 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.3 m -94.7 -29.97 14.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.572 -0.705 . . . . 0.0 110.254 179.907 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.452 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -58.76 -62.21 2.04 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.488 -0.758 . . . . 0.0 110.419 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.17 -35.26 74.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.652 -0.655 . . . . 0.0 110.308 179.988 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -60.35 -41.94 94.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.29 -0.881 . . . . 0.0 110.114 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.7 t -81.45 -41.28 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.605 -0.684 . . . . 0.0 109.648 179.562 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 14.7 m-85 -67.66 -38.37 83.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 0.0 110.155 -179.934 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -63.34 -47.89 80.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.535 -0.728 . . . . 0.0 109.654 179.723 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -59.82 -32.92 71.11 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.732 0.777 . . . . 0.0 109.452 179.241 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -66.99 -59.2 3.68 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.717 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.96 -44.66 96.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.729 -0.607 . . . . 0.0 109.995 179.703 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -56.0 -42.4 76.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.537 -0.727 . . . . 0.0 110.61 -179.777 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.22 -41.65 85.38 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.596 -0.69 . . . . 0.0 109.9 179.862 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -72.86 -51.66 17.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.577 -0.702 . . . . 0.0 109.856 179.779 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.8 43.72 0.23 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.686 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.469 HG23 HD11 ' A' ' 40' ' ' ILE . 80.3 mt -104.5 59.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.515 -0.991 . . . . 0.0 110.256 179.755 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -80.74 60.95 4.22 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.47 -0.769 . . . . 0.0 109.058 178.961 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.7 -138.34 7.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -178.906 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.79 102.78 9.39 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.891 -0.77 . . . . 0.0 109.07 179.281 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 53.3 m95 -73.03 142.62 47.68 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.207 1.004 . . . . 0.0 112.574 -177.705 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.3 p -150.46 131.49 14.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.411 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -106.58 128.86 54.47 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.637 -0.664 . . . . 0.0 110.329 -178.288 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -100.73 111.28 23.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.697 -0.627 . . . . 0.0 109.911 179.707 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -68.91 -24.69 64.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.689 -0.632 . . . . 0.0 110.525 -179.881 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.31 -36.33 52.93 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.353 -0.842 . . . . 0.0 110.969 -179.695 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.3 p -147.2 16.86 1.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.514 -0.741 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.431 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.36 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.149 -0.969 . . . . 0.0 110.809 179.798 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.9 m -159.64 104.27 1.58 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.423 -0.798 . . . . 0.0 111.209 -179.943 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CZ ' ' HB1' ' A' ' 27' ' ' ALA . 96.7 m-85 -65.0 128.12 34.43 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.557 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.8 m -120.39 103.11 8.93 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.34 -178.52 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.416 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 8.5 p -106.13 165.74 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 0.0 109.56 177.935 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 84.4 m -162.54 117.08 1.79 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.785 -0.572 . . . . 0.0 109.88 -179.744 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.991 179.691 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.436 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 77.7 m . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.203 0.525 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.4 m -93.47 103.8 15.98 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.631 -0.668 . . . . 0.0 110.446 -179.87 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.436 ' CZ ' HG21 ' A' ' 2' ' ' THR . 84.7 m-85 -84.11 179.54 7.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.515 -0.74 . . . . 0.0 110.178 179.938 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -145.69 111.94 5.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.527 -0.733 . . . . 0.0 110.502 179.966 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.416 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -92.72 111.45 23.06 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.435 -0.79 . . . . 0.0 110.321 -179.959 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.6 tt -65.03 174.01 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.357 -0.84 . . . . 0.0 108.801 179.205 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 76.1 mt -135.0 74.51 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.658 -179.888 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -96.28 49.73 1.14 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.953 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.71 160.95 13.19 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.327 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm -78.15 -7.44 57.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.724 -0.868 . . . . 0.0 110.463 179.201 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 t -98.23 -25.56 14.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.164 -0.96 . . . . 0.0 110.701 -179.77 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 tp -150.09 164.67 34.97 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.416 -0.802 . . . . 0.0 110.744 -179.875 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.16 140.11 23.99 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.61 -0.681 . . . . 0.0 110.412 -179.773 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 132.79 -144.69 16.63 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.978 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -142.7 170.56 15.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.485 -1.009 . . . . 0.0 110.277 -179.942 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.7 m -144.06 161.39 38.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.64 -0.663 . . . . 0.0 110.188 179.991 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.8 p -144.54 151.09 38.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.543 -0.723 . . . . 0.0 110.41 -179.838 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.451 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 8.6 t -155.99 164.56 38.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.584 -0.698 . . . . 0.0 110.064 179.795 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -94.87 109.72 21.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.526 -0.733 . . . . 0.0 110.292 -179.959 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.47 143.15 47.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.612 -0.68 . . . . 0.0 109.95 179.9 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.5 m -57.4 -38.84 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.451 -0.781 . . . . 0.0 110.232 179.808 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -172.93 -170.2 0.63 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.623 -0.673 . . . . 0.0 109.771 179.58 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.419 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.48 -22.57 21.44 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.474 -0.766 . . . . 0.0 111.096 -179.673 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.64 -27.9 69.54 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.461 -0.774 . . . . 0.0 110.55 -179.738 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.7 m -114.37 -25.65 8.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.468 -0.77 . . . . 0.0 110.684 -179.63 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . . . -58.77 -62.28 1.99 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.453 -0.779 . . . . 0.0 110.628 -179.708 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.86 -45.04 86.87 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.446 -0.784 . . . . 0.0 110.446 179.934 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -53.29 -44.03 67.96 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.391 -0.818 . . . . 0.0 110.727 -179.956 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.1 t -78.25 -48.88 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.54 -0.725 . . . . 0.0 109.983 179.74 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.451 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 3.9 m-85 -62.11 -31.16 71.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 110.238 -179.55 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -64.88 -39.38 93.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.393 -0.817 . . . . 0.0 108.92 179.262 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -61.88 -30.04 70.6 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.56 0.695 . . . . 0.0 109.704 179.083 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -73.18 -54.86 7.41 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.196 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.65 -48.78 75.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.738 -0.601 . . . . 0.0 110.149 179.974 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -55.95 -28.71 58.22 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.516 -0.74 . . . . 0.0 110.515 -179.897 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.62 -38.39 29.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.658 -0.651 . . . . 0.0 110.056 179.909 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -80.59 -34.41 35.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.56 -0.713 . . . . 0.0 110.058 179.927 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.54 49.13 0.61 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.906 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.415 ' CG2' ' CG1' ' A' ' 55' ' ' VAL . 85.1 mt -115.15 67.92 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.52 -0.988 . . . . 0.0 110.329 179.852 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -90.83 51.88 2.06 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.771 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.49 -139.14 2.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -178.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -114.83 108.53 16.87 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.356 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -77.14 142.08 39.87 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.1 0.953 . . . . 0.0 112.321 -177.985 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.1 p -147.49 133.1 18.79 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.752 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.401 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 71.7 t80 -100.49 131.97 46.13 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.712 -0.618 . . . . 0.0 110.454 -178.357 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -100.79 125.29 47.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.678 -0.639 . . . . 0.0 109.946 179.81 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -82.04 -18.49 43.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.69 -0.631 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.01 -44.74 83.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.271 -0.893 . . . . 0.0 110.725 -179.7 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.2 p -147.37 23.81 1.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.519 -0.738 . . . . 0.0 110.65 -179.588 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.41 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 1.3 mppt? 52.42 95.38 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.239 -0.913 . . . . 0.0 110.727 179.953 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.7 m -151.76 101.79 2.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.53 -0.731 . . . . 0.0 110.749 -179.964 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 27' ' ' ALA . 81.4 m-85 -61.08 124.16 19.73 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.811 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.3 m -117.98 105.47 11.93 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.387 -0.925 . . . . 0.0 112.611 -178.197 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.415 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.8 p -105.87 168.04 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.42 -0.8 . . . . 0.0 109.128 177.538 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.1 m -158.28 108.14 2.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.564 -0.71 . . . . 0.0 109.948 -179.676 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.17 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 mtm . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.079 0.466 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.465 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 70.4 m -102.18 111.99 24.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.573 -0.705 . . . . 0.0 110.184 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.0 m -78.67 99.57 6.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.639 -0.663 . . . . 0.0 110.76 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.465 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 73.2 m-85 -87.45 167.4 14.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.555 -0.716 . . . . 0.0 109.907 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.6 mtpt -138.75 129.87 26.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.464 -0.772 . . . . 0.0 110.435 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.423 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 44.3 tp -106.5 123.06 47.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.509 -0.744 . . . . 0.0 110.209 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.6 tp -75.42 165.98 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.6 mt -127.89 72.66 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.225 -0.922 . . . . 0.0 110.676 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -95.38 49.19 1.18 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.274 -0.892 . . . . 0.0 109.029 178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.69 166.5 14.96 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -84.89 6.35 25.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.724 -0.868 . . . . 0.0 110.608 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 m -116.84 -30.76 5.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 110.482 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.5 mt -135.71 173.11 12.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 110.783 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.38 139.38 3.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.66 -0.65 . . . . 0.0 110.294 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.37 -136.1 7.68 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -153.99 154.36 33.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.617 -0.931 . . . . 0.0 110.287 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.9 m -143.82 155.23 44.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.59 -0.694 . . . . 0.0 110.211 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.0 p -133.25 173.9 10.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.563 -0.711 . . . . 0.0 110.329 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.445 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 7.6 t -164.11 -170.32 2.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.64 -0.663 . . . . 0.0 110.167 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.56 100.11 6.09 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.639 -0.663 . . . . 0.0 110.4 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.84 142.69 50.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.465 -0.772 . . . . 0.0 110.01 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.81 -30.39 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.576 -0.702 . . . . 0.0 110.048 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.1 p30 -170.06 176.08 4.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.611 -0.681 . . . . 0.0 110.323 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.78 -25.15 26.15 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.515 -0.741 . . . . 0.0 110.969 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.06 -27.0 66.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.492 -0.755 . . . . 0.0 110.431 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.2 m -112.1 -27.99 8.16 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.499 -0.751 . . . . 0.0 110.364 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.428 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -59.69 -49.6 77.11 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.487 -0.758 . . . . 0.0 110.375 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -59.14 -40.19 84.72 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.541 -0.724 . . . . 0.0 110.309 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -56.94 -35.5 69.16 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.35 -0.844 . . . . 0.0 110.363 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 93.8 t -84.39 -48.19 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.601 -0.687 . . . . 0.0 110.056 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.445 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 9.7 m-85 -65.87 -36.82 84.5 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 110.206 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.1 tptt -63.44 -44.89 93.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.518 -0.739 . . . . 0.0 109.43 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -60.72 -31.57 70.87 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.609 0.718 . . . . 0.0 109.708 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -70.7 -57.14 4.99 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.33 -47.22 85.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.751 -0.593 . . . . 0.0 110.022 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -54.94 -32.95 61.81 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.474 -0.766 . . . . 0.0 110.591 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.42 -49.99 43.13 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.615 -0.678 . . . . 0.0 109.985 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -71.35 -46.34 60.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.569 -0.707 . . . . 0.0 109.886 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.47 43.26 0.29 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.459 HD12 HG21 ' A' ' 40' ' ' ILE . 81.1 mt -105.59 71.32 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.447 -1.031 . . . . 0.0 110.245 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -95.4 46.05 1.1 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.2 -135.85 0.1 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -115.47 102.19 9.58 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.423 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 38.3 m95 -72.56 142.42 48.44 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.177 0.989 . . . . 0.0 112.456 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -150.9 133.05 15.32 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.415 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 63.2 t80 -102.83 109.24 20.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.664 -0.648 . . . . 0.0 110.206 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.34 109.33 16.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.655 -0.653 . . . . 0.0 110.096 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -67.6 -20.61 65.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.693 -0.629 . . . . 0.0 110.767 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.39 -42.56 67.08 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.251 -0.906 . . . . 0.0 110.859 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.7 p -141.31 18.7 2.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.585 -0.697 . . . . 0.0 110.685 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER 50.31 90.35 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.151 -0.968 . . . . 0.0 111.152 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 57.6 m -156.59 108.46 2.48 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.789 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.415 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 93.1 m-85 -60.37 123.29 16.84 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.4 m -115.5 94.53 4.75 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.242 -0.983 . . . . 0.0 112.846 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.406 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.0 p -95.55 166.84 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.128 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.4 m -160.26 108.1 1.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.677 -0.639 . . . . 0.0 109.86 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.214 -179.922 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 mtm . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.122 0.487 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.426 HG23 ' CZ ' ' A' ' 4' ' ' PHE . 22.4 m -79.63 145.53 32.99 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.556 -0.715 . . . . 0.0 110.091 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.8 m -118.22 91.24 3.51 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.593 -0.692 . . . . 0.0 110.524 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.434 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 98.6 m-85 -80.34 168.69 18.72 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.594 -0.691 . . . . 0.0 109.967 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -145.88 115.79 7.34 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.463 -0.773 . . . . 0.0 110.372 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.435 ' CB ' ' CD1' ' A' ' 31' ' ' PHE . 30.1 tp -94.11 127.18 39.78 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.422 -0.799 . . . . 0.0 110.2 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 tp -76.47 170.12 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.8 mt -129.99 71.13 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.22 -0.925 . . . . 0.0 110.715 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -96.15 47.25 1.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.506 -0.746 . . . . 0.0 109.22 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.43 167.0 24.47 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -82.32 3.12 29.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.76 -0.847 . . . . 0.0 110.754 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 m -116.88 -30.63 5.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.104 -0.997 . . . . 0.0 110.455 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.9 mt -128.7 172.48 11.2 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.455 -0.778 . . . . 0.0 110.694 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -154.99 131.76 10.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.696 -0.627 . . . . 0.0 109.932 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.71 -140.22 11.55 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -147.82 178.04 8.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.565 -0.962 . . . . 0.0 110.42 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.7 m -152.27 128.94 10.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.542 -0.724 . . . . 0.0 110.162 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.3 p -114.53 155.77 25.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.574 -0.704 . . . . 0.0 110.256 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.431 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 8.1 t -160.55 153.51 21.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.597 -0.689 . . . . 0.0 110.309 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -86.71 112.41 21.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.524 -0.735 . . . . 0.0 110.326 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.6 147.32 52.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.642 -0.661 . . . . 0.0 110.048 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 p -64.25 -33.58 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.531 -0.73 . . . . 0.0 110.227 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.2 p30 -170.86 -177.85 2.38 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.486 -0.759 . . . . 0.0 110.362 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.434 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.36 -25.24 23.18 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.477 -0.764 . . . . 0.0 111.003 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.24 -46.01 89.64 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.443 -0.785 . . . . 0.0 110.315 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.5 m -90.2 -26.48 20.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.605 -0.684 . . . . 0.0 110.168 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.75 -62.32 1.96 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.55 -0.719 . . . . 0.0 110.217 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -60.36 -37.06 79.54 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.505 -0.747 . . . . 0.0 109.972 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.4 ttpt -58.42 -37.16 74.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.446 -0.783 . . . . 0.0 110.073 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.1 t -84.55 -45.84 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.689 -0.632 . . . . 0.0 109.786 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.435 ' CD1' ' CB ' ' A' ' 6' ' ' LEU . 14.0 m-85 -66.41 -34.01 77.0 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.636 -0.665 . . . . 0.0 110.207 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -66.15 -46.21 78.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.442 -0.786 . . . . 0.0 109.015 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -61.11 -30.91 70.65 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.634 0.73 . . . . 0.0 109.381 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -69.26 -55.74 9.62 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.07 -38.86 92.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.712 -0.617 . . . . 0.0 109.797 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -59.02 -34.05 71.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.528 -0.733 . . . . 0.0 110.357 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -78.03 -47.67 17.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.657 -0.652 . . . . 0.0 110.141 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -69.76 -41.91 74.57 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.593 -0.692 . . . . 0.0 110.087 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.34 62.54 0.4 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.446 HD13 HG22 ' A' ' 40' ' ' ILE . 87.0 mt -127.65 81.47 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.552 -0.97 . . . . 0.0 110.421 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -98.76 37.67 1.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.04 -140.24 0.02 OUTLIER Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -114.56 110.7 20.22 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.424 ' CZ3' ' CD1' ' A' ' 6' ' ' LEU . 29.9 m95 -77.88 143.03 38.09 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 122.205 1.003 . . . . 0.0 112.364 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.0 p -153.94 132.12 11.86 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -105.65 143.77 33.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.63 -0.669 . . . . 0.0 110.06 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.69 108.73 18.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.765 -0.584 . . . . 0.0 109.804 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.6 -23.03 65.33 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.638 -0.664 . . . . 0.0 110.62 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.23 -37.55 64.74 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.309 -0.87 . . . . 0.0 110.788 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.5 p -147.79 19.04 1.15 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.518 -0.739 . . . . 0.0 110.766 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.419 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.6 94.56 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.204 -0.935 . . . . 0.0 110.886 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.9 m -159.1 100.72 1.56 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.559 -0.713 . . . . 0.0 110.791 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -61.95 140.1 58.35 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.445 -0.785 . . . . 0.0 109.006 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.8 m -131.87 100.03 4.95 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.272 -0.971 . . . . 0.0 112.69 -178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.414 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.3 p -101.61 166.25 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.22 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.4 m -160.79 112.26 1.86 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.661 -0.649 . . . . 0.0 109.931 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 118.016 -0.993 . . . . 0.0 110.13 179.943 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.108 0.48 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.441 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 62.0 m -87.43 112.78 22.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.606 -0.684 . . . . 0.0 110.222 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.6 m -84.81 95.44 8.98 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.633 -0.667 . . . . 0.0 110.696 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.441 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 95.8 m-85 -79.77 173.99 12.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.48 -0.763 . . . . 0.0 109.778 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.8 mtmt -142.67 123.26 14.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.486 -0.759 . . . . 0.0 110.658 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.42 HD13 ' CH2' ' A' ' 44' ' ' TRP . 47.4 tp -101.16 127.61 47.64 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.425 -0.797 . . . . 0.0 109.897 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 tt -77.39 174.06 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 86.2 mt -133.14 73.33 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.32 -0.862 . . . . 0.0 110.444 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -95.82 47.79 1.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.414 -0.804 . . . . 0.0 109.004 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.72 154.78 16.45 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -71.81 -9.1 57.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.704 -0.88 . . . . 0.0 110.396 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -90.31 -34.57 15.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 110.281 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.82 167.39 22.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.474 -0.766 . . . . 0.0 110.769 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -147.62 137.29 22.69 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.569 -0.707 . . . . 0.0 110.195 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.8 -136.81 8.7 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -146.97 168.64 20.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.53 -0.983 . . . . 0.0 110.326 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.2 m -143.45 149.87 38.22 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.638 -0.664 . . . . 0.0 110.125 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.8 p -131.41 157.66 42.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.534 -0.729 . . . . 0.0 110.297 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.439 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 8.6 t -160.98 168.12 25.17 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.566 -0.708 . . . . 0.0 110.235 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.26 124.22 44.16 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.602 -0.686 . . . . 0.0 110.145 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.03 138.15 20.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.6 -0.688 . . . . 0.0 110.181 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.08 -34.3 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.537 -0.727 . . . . 0.0 110.064 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.2 p30 -169.65 -173.91 1.75 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.61 -0.681 . . . . 0.0 110.306 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.85 -23.83 47.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.594 -0.691 . . . . 0.0 110.932 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.09 -31.49 68.95 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.395 -0.816 . . . . 0.0 110.36 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 52.2 m -110.66 -24.3 10.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.57 -0.706 . . . . 0.0 110.447 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.425 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -58.27 -62.11 2.08 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.425 -0.797 . . . . 0.0 110.23 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -60.2 -39.8 87.82 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.555 -0.716 . . . . 0.0 109.903 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -57.64 -37.22 72.96 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.469 -0.769 . . . . 0.0 110.236 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.4 t -83.42 -48.64 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.699 -0.626 . . . . 0.0 109.871 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.439 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 5.4 m-85 -64.39 -34.11 77.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.551 -0.718 . . . . 0.0 110.11 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -64.61 -44.03 91.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.482 -0.761 . . . . 0.0 109.166 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -60.99 -35.36 76.62 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.84 0.829 . . . . 0.0 109.474 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -65.24 -53.54 42.84 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.97 97.73 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.715 -0.615 . . . . 0.0 110.048 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -57.32 -39.83 76.66 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.56 -0.712 . . . . 0.0 110.451 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.71 -56.63 11.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.581 -0.699 . . . . 0.0 110.01 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -64.34 -51.35 63.81 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.588 -0.695 . . . . 0.0 109.903 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.92 55.84 0.16 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.497 HG22 HD13 ' A' ' 40' ' ' ILE . 82.0 mt -118.72 73.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.53 -0.982 . . . . 0.0 110.278 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -95.64 43.2 1.09 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.57 -137.08 0.07 OUTLIER Glycine 0 N--CA 1.488 2.127 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -114.6 107.63 15.75 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.42 ' CH2' HD13 ' A' ' 6' ' ' LEU . 35.0 m95 -77.26 143.51 38.85 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.055 0.931 . . . . 0.0 112.359 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.6 p -152.65 132.01 12.87 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -102.36 124.91 48.77 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.717 -0.615 . . . . 0.0 110.083 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -95.05 113.57 25.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.689 -0.632 . . . . 0.0 109.975 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.51 -15.09 63.18 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.672 -0.643 . . . . 0.0 110.928 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.46 -44.34 80.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.222 -0.924 . . . . 0.0 110.719 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.6 p -147.59 25.11 1.08 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.494 -0.754 . . . . 0.0 110.628 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.431 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.44 89.87 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.357 -0.839 . . . . 0.0 110.841 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 83.2 m -150.46 101.76 2.99 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.478 -0.764 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.401 ' CZ ' ' HB1' ' A' ' 27' ' ' ALA . 85.6 m-85 -61.98 127.84 33.31 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.448 -0.783 . . . . 0.0 108.939 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.6 m -121.06 101.5 7.71 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.338 -0.945 . . . . 0.0 113.027 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.3 p -101.07 167.85 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 108.981 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 98.5 m -159.82 109.14 1.81 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.521 -0.737 . . . . 0.0 109.977 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.185 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.047 0.451 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.429 HG21 ' CE2' ' A' ' 4' ' ' PHE . 33.7 m -92.27 116.01 28.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.53 -0.731 . . . . 0.0 110.424 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.7 m -97.77 97.48 9.02 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.607 -0.683 . . . . 0.0 110.552 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.45 ' CD2' ' CB ' ' A' ' 27' ' ' ALA . 95.2 m-85 -78.65 175.88 9.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.544 -0.723 . . . . 0.0 109.753 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -144.51 119.6 10.08 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.401 -0.812 . . . . 0.0 110.621 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.431 ' CD1' ' CZ3' ' A' ' 44' ' ' TRP . 42.6 tp -100.04 130.67 46.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.298 -0.876 . . . . 0.0 110.48 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.6 tp -80.36 168.24 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.7 mt -129.41 74.76 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 111.007 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -97.65 47.8 1.02 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.322 -0.861 . . . . 0.0 108.924 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.03 165.94 15.39 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -85.6 6.83 25.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.702 -0.881 . . . . 0.0 110.444 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -113.46 -31.96 6.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.921 . . . . 0.0 109.989 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 tp -140.43 167.44 22.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.558 -0.714 . . . . 0.0 110.375 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -155.26 140.62 17.69 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.592 -0.692 . . . . 0.0 110.323 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.69 -134.64 7.58 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.54 161.7 42.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.621 -0.929 . . . . 0.0 110.386 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.3 m -145.81 151.1 37.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.634 -0.666 . . . . 0.0 110.068 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 p -130.76 157.1 43.75 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.568 -0.708 . . . . 0.0 110.282 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.411 HG22 ' CE2' ' A' ' 31' ' ' PHE . 8.3 t -149.29 -172.05 4.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.562 -0.711 . . . . 0.0 110.252 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -123.85 103.94 8.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.486 -0.759 . . . . 0.0 110.249 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.02 153.47 47.56 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.56 -0.712 . . . . 0.0 110.116 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.54 -22.2 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.573 -0.705 . . . . 0.0 110.46 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 44.2 p30 -172.35 -177.92 1.9 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.316 -0.865 . . . . 0.0 110.203 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.406 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.45 -24.57 20.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.523 -0.736 . . . . 0.0 111.064 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.49 -52.13 66.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.463 -0.773 . . . . 0.0 110.479 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 31.1 m -80.6 -26.52 37.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.571 -0.705 . . . . 0.0 110.509 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.45 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -59.93 -64.03 1.09 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.498 -0.751 . . . . 0.0 110.495 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -60.13 -40.02 88.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.532 -0.73 . . . . 0.0 110.115 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -57.1 -38.39 73.31 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.456 -0.778 . . . . 0.0 110.313 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 87.7 t -83.06 -48.61 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.614 -0.679 . . . . 0.0 109.922 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.411 ' CE2' HG22 ' A' ' 19' ' ' THR . 9.1 m-85 -63.63 -34.09 77.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.614 -0.679 . . . . 0.0 110.112 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -64.31 -45.84 86.17 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.461 -0.774 . . . . 0.0 109.095 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -62.15 -29.2 70.18 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.601 0.715 . . . . 0.0 109.618 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -72.15 -54.2 10.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.52 -38.6 84.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.672 -0.642 . . . . 0.0 110.293 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -58.21 -38.52 76.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.483 -0.76 . . . . 0.0 110.667 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -68.33 -38.88 81.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.573 -0.704 . . . . 0.0 110.26 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -81.94 -32.7 30.69 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.603 -0.686 . . . . 0.0 110.109 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.75 48.3 1.28 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.435 HD13 HG23 ' A' ' 40' ' ' ILE . 81.7 mt -104.53 62.84 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.584 -0.95 . . . . 0.0 110.225 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -83.01 59.73 5.08 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.11 -141.53 10.23 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -113.54 109.55 18.81 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.894 -0.768 . . . . 0.0 109.029 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.431 ' CZ3' ' CD1' ' A' ' 6' ' ' LEU . 32.9 m95 -78.44 143.38 36.77 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.064 0.935 . . . . 0.0 112.178 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.6 p -155.1 132.78 11.31 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -103.0 158.76 16.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.652 -0.655 . . . . 0.0 110.167 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.03 111.99 12.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.834 -0.541 . . . . 0.0 109.66 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.98 -20.18 65.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.692 -0.63 . . . . 0.0 110.814 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.77 -41.08 70.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.296 -0.878 . . . . 0.0 110.746 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.6 p -147.7 20.72 1.16 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.563 -0.71 . . . . 0.0 110.757 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.414 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.65 89.6 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.217 -0.927 . . . . 0.0 110.72 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.0 m -151.1 102.96 2.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.349 -0.844 . . . . 0.0 111.516 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.421 ' CZ ' ' HB1' ' A' ' 27' ' ' ALA . 73.3 m-85 -64.13 133.77 53.6 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.1 m -125.94 100.43 6.37 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.766 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.407 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.5 p -103.26 166.97 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.371 -0.831 . . . . 0.0 109.171 177.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.3 m -160.3 110.75 1.84 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.655 -0.653 . . . . 0.0 109.782 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.182 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtm . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.067 0.461 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.445 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 62.0 m -74.02 111.77 9.5 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.57 -0.706 . . . . 0.0 110.211 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.4 m -85.7 95.01 9.24 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.642 -0.661 . . . . 0.0 110.596 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.445 ' CD2' ' CB ' ' A' ' 27' ' ' ALA . 96.4 m-85 -77.81 176.08 9.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.44 -0.788 . . . . 0.0 109.735 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -142.79 124.94 15.36 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.499 -0.751 . . . . 0.0 110.383 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.431 ' CB ' ' CD1' ' A' ' 31' ' ' PHE . 54.4 tp -104.02 118.82 37.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.454 -0.779 . . . . 0.0 110.204 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 tp -68.84 171.16 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.1 mt -131.48 74.98 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.228 -0.92 . . . . 0.0 110.597 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -98.01 45.99 1.02 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.76 164.63 15.32 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -81.94 1.48 35.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.777 -0.837 . . . . 0.0 110.491 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.4 m -108.43 -31.41 7.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.206 -0.934 . . . . 0.0 110.152 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.1 mt -137.53 168.58 19.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.466 -0.771 . . . . 0.0 110.608 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -154.76 134.02 12.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.655 -0.653 . . . . 0.0 110.015 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.72 -143.7 15.13 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -135.71 160.58 38.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.539 -0.977 . . . . 0.0 110.3 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.5 m -135.53 158.62 43.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.541 -0.724 . . . . 0.0 110.116 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.9 p -142.99 154.53 44.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.58 -0.7 . . . . 0.0 110.431 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.451 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 8.7 t -159.77 159.55 32.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.608 -0.683 . . . . 0.0 110.228 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -93.19 121.07 34.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.552 -0.718 . . . . 0.0 110.183 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.27 138.39 23.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.582 -0.699 . . . . 0.0 110.174 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.8 m -59.31 -32.59 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.508 -0.745 . . . . 0.0 110.445 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -171.01 -178.24 2.42 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.586 -0.696 . . . . 0.0 110.319 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.4 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.79 -25.25 26.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.474 -0.766 . . . . 0.0 110.962 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.19 -26.53 64.89 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.488 -0.758 . . . . 0.0 110.374 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.4 m -113.82 -25.75 8.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.518 -0.739 . . . . 0.0 110.556 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.445 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -58.11 -60.76 3.25 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.417 -0.802 . . . . 0.0 110.408 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -59.88 -35.76 75.51 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.601 -0.687 . . . . 0.0 110.266 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -57.65 -38.99 76.0 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.401 -0.812 . . . . 0.0 110.189 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.0 t -83.79 -47.44 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.667 -0.646 . . . . 0.0 109.816 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.451 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 8.0 m-85 -62.68 -34.98 78.22 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.577 -0.702 . . . . 0.0 109.906 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -64.03 -46.94 82.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.409 -0.807 . . . . 0.0 109.084 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -62.15 -31.92 72.47 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.698 0.761 . . . . 0.0 109.472 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.417 ' CD2' HD23 ' A' ' 6' ' ' LEU . 10.1 t80 -68.16 -50.35 55.11 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.13 -37.25 80.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.764 -0.585 . . . . 0.0 109.929 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -58.06 -46.75 84.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.577 -0.702 . . . . 0.0 110.533 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -60.59 -56.95 15.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.579 -0.701 . . . . 0.0 110.324 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 -63.71 -45.93 87.73 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.58 -0.7 . . . . 0.0 110.136 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.97 63.07 0.39 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.426 HD13 HG21 ' A' ' 40' ' ' ILE . 85.5 mt -118.04 63.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.528 -0.984 . . . . 0.0 110.133 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -83.31 59.54 5.08 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.82 -138.77 7.2 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -115.97 106.27 13.59 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.421 ' CZ3' HD12 ' A' ' 6' ' ' LEU . 37.3 m95 -76.5 142.36 40.95 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.212 1.005 . . . . 0.0 112.419 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -150.3 132.18 15.12 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.406 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 18.9 t80 -105.75 133.7 50.05 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.625 -0.672 . . . . 0.0 110.072 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -103.6 112.9 26.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.712 -0.618 . . . . 0.0 109.922 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -69.29 -23.05 63.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.647 -0.658 . . . . 0.0 110.561 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.98 -40.87 67.27 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.317 -0.864 . . . . 0.0 110.721 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.5 p -145.06 18.43 1.59 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.576 -0.702 . . . . 0.0 110.863 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.406 ' HG3' ' CE2' ' A' ' 46' ' ' TYR . 5.0 mptt 51.24 92.71 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.177 -0.952 . . . . 0.0 111.084 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.6 m -154.42 101.58 2.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.483 -0.761 . . . . 0.0 110.707 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -62.0 129.22 39.89 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.557 -0.714 . . . . 0.0 109.095 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.7 m -121.34 100.81 7.25 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.649 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.401 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.6 p -101.24 167.25 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.526 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.4 m -160.8 109.05 1.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.698 -0.626 . . . . 0.0 109.784 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.19 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.0 mtm . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.146 0.498 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.449 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 32.1 m -85.39 115.7 23.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.585 -0.697 . . . . 0.0 110.362 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.0 m -93.79 97.61 10.53 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.61 -0.681 . . . . 0.0 110.874 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.449 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 92.9 m-85 -81.85 171.26 14.7 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.466 -0.771 . . . . 0.0 109.839 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.5 mttt -144.04 122.33 12.29 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.506 -0.746 . . . . 0.0 110.41 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.427 HD22 ' CD2' ' A' ' 34' ' ' TYR . 49.4 tp -99.49 123.94 44.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.558 -0.714 . . . . 0.0 110.141 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 tp -76.38 166.39 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.0 mt -128.58 74.76 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.213 -0.93 . . . . 0.0 110.488 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -95.57 47.95 1.13 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.414 -0.804 . . . . 0.0 108.901 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.94 151.85 17.61 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -71.14 -9.41 58.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.656 -0.908 . . . . 0.0 110.4 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 m -89.03 -36.13 15.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.43 174.58 10.81 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.455 -0.778 . . . . 0.0 110.59 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.3 tttt -156.24 144.42 19.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.697 . . . . 0.0 110.403 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.65 -123.05 3.23 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -164.77 166.88 19.46 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.566 -0.961 . . . . 0.0 110.101 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 m -135.63 148.31 48.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.541 -0.725 . . . . 0.0 110.231 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.7 p -137.78 146.44 43.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.541 -0.724 . . . . 0.0 110.245 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.445 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 7.2 t -163.76 134.26 4.38 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.596 -0.69 . . . . 0.0 110.141 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.05 112.1 2.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.561 -0.712 . . . . 0.0 110.29 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.88 137.58 50.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.495 -0.753 . . . . 0.0 110.176 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 p -60.02 -32.4 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.53 -0.731 . . . . 0.0 110.25 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -171.68 174.86 4.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.454 -0.779 . . . . 0.0 110.294 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.436 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.87 -24.82 17.17 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.54 -0.725 . . . . 0.0 110.928 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.24 -38.87 92.85 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.49 -0.757 . . . . 0.0 110.097 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.9 m -93.35 -27.6 16.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.525 -0.734 . . . . 0.0 110.358 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.419 ' HB3' ' CE1' ' A' ' 53' ' ' PHE . . . -66.41 -52.35 47.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.526 -0.734 . . . . 0.0 110.448 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.48 -37.47 70.39 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.499 -0.751 . . . . 0.0 110.549 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -60.31 -33.48 72.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.41 -0.806 . . . . 0.0 109.787 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.6 t -87.32 -44.19 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.651 . . . . 0.0 109.564 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.445 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 30.1 m-85 -66.28 -39.02 89.13 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.627 -0.671 . . . . 0.0 109.767 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -62.81 -50.9 69.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.608 -0.683 . . . . 0.0 109.551 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -61.26 -31.17 70.98 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.607 0.718 . . . . 0.0 109.63 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.427 ' CD2' HD22 ' A' ' 6' ' ' LEU . 17.7 t80 -68.55 -46.45 69.47 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.78 -38.67 67.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.739 -0.6 . . . . 0.0 109.91 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -58.76 -49.24 78.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.538 -0.726 . . . . 0.0 110.393 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -61.54 -56.05 24.28 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.683 -0.635 . . . . 0.0 110.123 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -60.91 -48.38 82.08 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.602 -0.686 . . . . 0.0 110.108 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.36 49.61 0.27 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.431 HG23 HD12 ' A' ' 40' ' ' ILE . 84.7 mt -117.65 75.47 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.515 -0.991 . . . . 0.0 110.398 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -98.36 39.95 1.21 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.88 -137.83 0.02 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -113.27 112.6 24.01 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.421 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 29.9 m95 -81.89 142.88 32.09 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.213 1.006 . . . . 0.0 112.686 -177.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 p -152.68 131.28 12.27 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -100.59 108.41 20.32 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.742 -0.599 . . . . 0.0 109.997 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -78.53 100.4 6.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.698 -0.626 . . . . 0.0 109.967 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -62.34 -24.59 67.42 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.714 -0.616 . . . . 0.0 110.439 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.07 -34.03 54.73 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.371 -0.831 . . . . 0.0 111.043 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.8 p -147.15 17.67 1.21 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.523 -0.736 . . . . 0.0 110.905 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 50.55 87.0 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.117 -0.989 . . . . 0.0 111.066 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.6 m -155.17 108.56 2.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.536 -0.727 . . . . 0.0 110.755 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.419 ' CE1' ' HB3' ' A' ' 27' ' ' ALA . 83.5 m-85 -61.14 126.16 26.35 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.7 m -118.83 96.6 5.32 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.223 -0.991 . . . . 0.0 113.079 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.417 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.0 p -100.01 167.12 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 109.19 177.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 84.9 m -160.64 109.38 1.65 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.588 -0.695 . . . . 0.0 109.814 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.062 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 mtp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.116 0.484 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.454 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 47.5 m -104.65 112.66 25.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.603 -0.685 . . . . 0.0 110.069 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 59.4 m -104.27 98.74 8.49 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.641 -0.662 . . . . 0.0 110.731 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.454 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 86.4 m-85 -78.57 172.35 13.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.546 -0.721 . . . . 0.0 109.831 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -142.22 121.23 12.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.488 -0.757 . . . . 0.0 110.335 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.418 HD11 ' CZ3' ' A' ' 44' ' ' TRP . 53.8 tp -100.87 118.24 36.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.434 -0.791 . . . . 0.0 110.338 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.1 tp -66.91 168.19 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.7 mt -130.63 74.37 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.181 -0.949 . . . . 0.0 110.711 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -96.11 48.91 1.12 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.81 157.35 15.01 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -74.54 -6.29 47.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.71 -0.876 . . . . 0.0 110.632 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -97.18 -33.83 11.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.247 -0.908 . . . . 0.0 110.275 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.5 mt -137.34 170.73 15.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.539 -0.725 . . . . 0.0 110.454 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -157.21 134.33 10.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.539 -0.726 . . . . 0.0 110.273 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.13 -144.42 16.36 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -136.18 153.34 51.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.598 -0.942 . . . . 0.0 110.244 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.2 m -130.93 147.83 52.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.704 . . . . 0.0 110.052 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.0 p -129.35 165.64 21.1 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.555 -0.716 . . . . 0.0 110.303 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.4 t -156.42 -176.24 5.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.695 . . . . 0.0 110.119 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.81 92.95 3.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.556 -0.715 . . . . 0.0 110.421 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.65 179.54 4.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.421 -0.799 . . . . 0.0 110.088 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -100.43 -25.55 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.615 -0.678 . . . . 0.0 110.02 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -167.81 176.25 6.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.507 -0.746 . . . . 0.0 110.014 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.97 -25.42 60.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.471 -0.768 . . . . 0.0 110.789 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.0 -25.43 65.26 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.467 -0.771 . . . . 0.0 110.752 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.6 m -111.95 -27.46 8.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.376 -0.827 . . . . 0.0 110.66 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.444 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -60.74 -54.48 44.71 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.516 -0.74 . . . . 0.0 110.461 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -57.44 -39.3 75.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.525 -0.735 . . . . 0.0 110.697 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -56.41 -36.74 69.28 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.274 -0.891 . . . . 0.0 110.588 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.5 t -84.88 -47.59 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.606 -0.684 . . . . 0.0 109.975 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.414 ' CD1' HD21 ' A' ' 6' ' ' LEU . 8.8 m-85 -65.08 -37.22 86.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.584 -0.698 . . . . 0.0 110.135 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -63.65 -45.01 92.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.465 -0.772 . . . . 0.0 109.177 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -62.88 -29.0 70.42 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.537 0.684 . . . . 0.0 109.616 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -73.0 -47.39 45.58 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.61 -35.78 65.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.691 -0.63 . . . . 0.0 109.766 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -56.05 -49.6 73.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.528 -0.733 . . . . 0.0 110.599 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -69.45 -46.9 65.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.642 -0.661 . . . . 0.0 109.986 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -61.53 -42.05 98.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.571 -0.706 . . . . 0.0 110.023 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.54 50.18 0.82 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.407 ' CG2' ' CG1' ' A' ' 55' ' ' VAL . 86.1 mt -110.64 61.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.538 -0.978 . . . . 0.0 110.173 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -81.45 60.6 4.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.533 -0.729 . . . . 0.0 109.166 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.6 -139.04 7.77 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -116.38 107.1 14.38 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.418 ' CZ3' HD11 ' A' ' 6' ' ' LEU . 37.2 m95 -77.3 143.46 38.83 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.19 0.995 . . . . 0.0 112.374 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 p -154.43 131.01 10.64 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -104.62 138.51 40.85 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.643 -0.661 . . . . 0.0 109.959 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -114.28 116.62 29.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.689 -0.632 . . . . 0.0 109.937 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -70.31 -25.19 63.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.725 -0.609 . . . . 0.0 110.566 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.05 -38.32 56.68 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.41 -0.806 . . . . 0.0 110.757 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.7 p -142.75 13.34 1.9 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.625 -0.672 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.08 90.74 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.079 -1.013 . . . . 0.0 111.013 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.2 m -157.35 110.0 2.46 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.325 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.428 ' CZ ' ' HB1' ' A' ' 27' ' ' ALA . 87.3 m-85 -64.24 129.05 38.42 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 47.6 m -119.96 99.03 6.38 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.193 -1.003 . . . . 0.0 112.904 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.407 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 9.3 p -102.85 165.74 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.469 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.9 m -162.31 114.49 1.67 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.767 -0.583 . . . . 0.0 109.909 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.089 179.715 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.052 0.453 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.427 HG23 ' CZ ' ' A' ' 4' ' ' PHE . 21.1 m -87.0 112.91 22.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.529 -0.732 . . . . 0.0 110.256 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.6 m -90.89 88.48 7.06 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.701 -0.625 . . . . 0.0 110.637 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.437 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 96.6 m-85 -71.15 167.94 18.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.457 -0.777 . . . . 0.0 109.909 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -136.19 132.89 36.52 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.496 -0.753 . . . . 0.0 110.254 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.422 HD12 ' CH2' ' A' ' 44' ' ' TRP . 58.1 tp -109.41 117.57 34.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.355 -0.841 . . . . 0.0 110.316 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 tp -66.57 171.1 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.2 mt -133.84 74.93 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 110.717 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -96.58 47.58 1.07 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.348 -0.845 . . . . 0.0 108.912 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.21 153.99 16.91 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.85 -9.45 57.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.929 . . . . 0.0 110.631 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.6 m -92.14 -32.6 15.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.182 -0.949 . . . . 0.0 110.432 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 34.0 mt -142.21 170.23 16.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.374 -0.828 . . . . 0.0 110.768 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -153.97 136.51 15.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.68 -0.637 . . . . 0.0 110.294 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.14 -147.24 18.04 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -139.08 162.73 34.23 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.597 -0.943 . . . . 0.0 110.264 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.4 m -140.11 168.54 19.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.585 -0.697 . . . . 0.0 110.221 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.2 p -137.65 168.32 19.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.512 -0.742 . . . . 0.0 110.175 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.428 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 8.2 t -158.9 -173.2 4.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.599 -0.688 . . . . 0.0 110.36 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -126.95 96.91 4.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.538 -0.726 . . . . 0.0 110.079 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -130.28 140.17 50.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.57 -0.706 . . . . 0.0 110.134 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.86 -29.68 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.624 -0.672 . . . . 0.0 110.002 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -167.42 -178.24 3.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.678 . . . . 0.0 110.286 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.437 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.88 -24.82 39.49 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.508 -0.745 . . . . 0.0 110.968 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.88 -29.6 68.44 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.486 -0.759 . . . . 0.0 110.32 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.5 m -107.5 -26.53 10.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.575 -0.703 . . . . 0.0 110.394 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.431 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -59.3 -63.45 1.3 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.434 -0.791 . . . . 0.0 110.413 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -58.26 -36.81 73.81 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.481 -0.762 . . . . 0.0 110.126 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -57.6 -38.42 74.88 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.437 -0.789 . . . . 0.0 110.07 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.0 t -83.93 -48.09 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.662 -0.649 . . . . 0.0 109.726 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.428 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 7.1 m-85 -61.97 -35.12 77.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.648 -0.658 . . . . 0.0 109.91 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -63.97 -46.02 86.51 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.563 -0.711 . . . . 0.0 109.086 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -62.31 -31.91 72.59 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.628 0.727 . . . . 0.0 109.403 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -69.31 -54.3 15.27 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.17 -40.25 95.73 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.698 -0.626 . . . . 0.0 109.827 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.59 -42.25 87.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.573 -0.705 . . . . 0.0 110.451 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.42 -52.22 28.97 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.605 -0.685 . . . . 0.0 110.017 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -63.75 -50.37 69.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.596 -0.69 . . . . 0.0 109.922 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.24 58.53 0.18 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.443 HG23 HD12 ' A' ' 40' ' ' ILE . 84.9 mt -125.56 67.18 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.472 -1.017 . . . . 0.0 110.401 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -89.81 53.56 2.6 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.83 -138.33 3.08 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.63 110.92 21.36 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.982 -0.716 . . . . 0.0 109.384 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.422 ' CH2' HD12 ' A' ' 6' ' ' LEU . 32.9 m95 -81.47 143.56 31.99 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 122.131 0.967 . . . . 0.0 112.228 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.1 p -154.0 132.05 11.75 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.409 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 25.3 t80 -105.35 129.0 53.78 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.657 -0.652 . . . . 0.0 110.166 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -102.16 120.34 40.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.716 -0.615 . . . . 0.0 109.981 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -73.04 -20.14 61.04 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.665 -0.647 . . . . 0.0 110.678 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.87 -41.18 67.25 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.314 -0.866 . . . . 0.0 110.861 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.6 p -144.9 18.21 1.61 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.57 -0.706 . . . . 0.0 110.744 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.409 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 0.7 OUTLIER 51.31 93.19 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.16 -0.962 . . . . 0.0 110.78 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.7 m -157.19 106.42 2.18 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.175 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 27' ' ' ALA . 92.2 m-85 -63.94 127.33 30.91 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.9 m -117.17 104.2 10.96 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.344 -0.848 . . . . 0.0 112.597 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.402 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.4 p -105.21 167.11 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.846 . . . . 0.0 109.207 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.8 m -160.8 108.04 1.52 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.724 -0.61 . . . . 0.0 109.714 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.182 -179.862 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tpp . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.0 0.429 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.451 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 57.9 m -91.09 112.54 24.49 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.579 -0.701 . . . . 0.0 110.167 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.0 m -104.76 104.43 14.22 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.567 -0.708 . . . . 0.0 110.617 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.451 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 77.3 m-85 -84.82 178.52 7.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.54 -0.725 . . . . 0.0 109.742 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -149.56 109.67 4.13 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.445 -0.785 . . . . 0.0 110.644 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.42 HD23 ' CD1' ' A' ' 31' ' ' PHE . 58.1 tp -90.6 121.37 32.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.414 -0.804 . . . . 0.0 110.324 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 tp -72.0 168.23 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 75.4 mt -130.05 72.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.208 -0.933 . . . . 0.0 110.796 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 -96.93 49.18 1.07 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.472 -0.768 . . . . 0.0 109.174 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.14 165.42 13.2 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.01 2.66 29.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.593 -0.946 . . . . 0.0 110.732 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -111.98 -29.27 7.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.119 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.1 mt -135.6 166.26 23.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.477 -0.764 . . . . 0.0 110.609 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -154.05 132.29 11.89 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.696 -0.627 . . . . 0.0 110.161 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.09 -129.82 5.07 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -159.25 152.44 22.3 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.581 -0.953 . . . . 0.0 110.592 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.4 m -125.5 154.12 42.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.616 -0.677 . . . . 0.0 110.068 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 p -139.5 150.87 45.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.457 -0.777 . . . . 0.0 110.391 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.432 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 8.4 t -153.12 147.66 26.07 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.616 -0.677 . . . . 0.0 110.202 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -85.04 112.65 20.82 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.506 -0.746 . . . . 0.0 110.381 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.86 -171.15 2.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.498 -0.751 . . . . 0.0 110.032 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -109.46 -27.2 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.618 -0.676 . . . . 0.0 110.067 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -170.13 173.8 5.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.464 -0.772 . . . . 0.0 110.185 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.2 -26.25 64.67 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.571 -0.705 . . . . 0.0 110.715 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.37 -26.56 65.19 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.463 -0.773 . . . . 0.0 110.621 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.4 m -109.45 -32.54 7.11 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.5 -0.75 . . . . 0.0 110.31 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.445 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -59.15 -52.61 64.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.5 -0.75 . . . . 0.0 110.427 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -59.15 -43.17 92.03 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.518 -0.739 . . . . 0.0 110.302 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -57.52 -34.75 69.44 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.369 -0.832 . . . . 0.0 110.319 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 83.6 t -84.99 -48.44 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.585 -0.697 . . . . 0.0 109.84 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.432 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 3.9 m-85 -65.39 -36.09 82.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.594 -0.691 . . . . 0.0 110.183 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -63.87 -46.59 84.26 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.477 -0.764 . . . . 0.0 109.341 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -59.9 -30.71 69.2 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.541 0.686 . . . . 0.0 109.822 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -70.33 -52.69 20.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.18 -38.49 91.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.701 -0.624 . . . . 0.0 110.042 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -57.14 -45.89 83.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.45 -0.781 . . . . 0.0 110.563 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.83 -49.89 54.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.612 -0.68 . . . . 0.0 110.02 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -62.5 -42.88 99.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.613 -0.679 . . . . 0.0 110.032 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.51 47.83 0.53 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.416 ' CG2' ' CG1' ' A' ' 55' ' ' VAL . 83.6 mt -119.07 74.58 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.53 -0.983 . . . . 0.0 110.409 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -97.78 39.69 1.2 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.67 -138.01 0.03 OUTLIER Glycine 0 N--CA 1.488 2.159 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -112.24 112.49 24.12 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.407 ' CZ3' HD11 ' A' ' 6' ' ' LEU . 29.6 m95 -82.38 143.86 30.93 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.24 1.019 . . . . 0.0 112.499 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 p -155.24 131.89 10.55 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -102.09 128.65 48.47 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.644 -0.66 . . . . 0.0 110.263 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -99.78 104.57 16.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.673 -0.642 . . . . 0.0 109.866 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -64.52 -21.45 66.68 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.594 -0.691 . . . . 0.0 110.881 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.29 -38.41 63.1 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.286 -0.884 . . . . 0.0 110.788 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.3 p -147.65 21.12 1.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.607 -0.683 . . . . 0.0 110.617 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER 50.27 90.83 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.211 -0.931 . . . . 0.0 111.129 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.4 m -155.29 103.59 2.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.523 -0.735 . . . . 0.0 110.717 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 27' ' ' ALA . 86.8 m-85 -60.92 132.21 53.13 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.7 m -122.66 98.84 6.1 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.133 -1.027 . . . . 0.0 113.119 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.416 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.2 p -102.87 166.7 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.333 -0.854 . . . . 0.0 109.144 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 91.6 m -160.84 109.99 1.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.659 -0.65 . . . . 0.0 109.762 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.263 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 mmt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.125 0.488 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.45 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 90.5 m -61.38 159.32 12.79 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.534 -0.729 . . . . 0.0 110.007 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.5 m -139.92 107.44 5.58 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.582 -0.699 . . . . 0.0 110.436 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.45 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 97.4 m-85 -96.06 169.68 9.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.654 -0.654 . . . . 0.0 109.996 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -139.3 119.46 13.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.48 -0.763 . . . . 0.0 110.423 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.422 HD13 ' CH2' ' A' ' 44' ' ' TRP . 50.2 tp -98.75 121.99 41.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.486 -0.759 . . . . 0.0 110.243 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.0 tp -70.26 171.78 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 82.8 mt -132.09 71.74 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.175 -0.953 . . . . 0.0 110.523 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -96.17 46.81 1.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.478 -0.764 . . . . 0.0 109.085 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.54 158.27 17.3 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -73.39 -7.86 53.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.759 -0.847 . . . . 0.0 110.525 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.2 m -96.81 -32.77 11.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.208 -0.932 . . . . 0.0 110.273 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.9 mt -136.5 173.85 11.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.498 -0.751 . . . . 0.0 110.6 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -153.22 128.47 9.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.655 -0.653 . . . . 0.0 110.179 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.02 -142.6 14.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.01 -178.9 6.54 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.997 . . . . 0.0 110.347 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 t -162.74 159.77 24.61 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.588 -0.695 . . . . 0.0 110.278 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.4 p -134.52 156.46 48.6 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.57 -0.706 . . . . 0.0 110.177 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.407 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 7.5 t -142.62 -173.17 3.8 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.538 -0.727 . . . . 0.0 110.305 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -122.45 101.93 7.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.611 -0.681 . . . . 0.0 110.2 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.36 170.31 12.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.592 -0.692 . . . . 0.0 110.087 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -87.01 -26.93 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.64 -0.662 . . . . 0.0 109.902 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -175.24 -179.03 1.25 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.41 -0.806 . . . . 0.0 109.772 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.435 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.39 -25.88 38.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.392 -0.817 . . . . 0.0 110.936 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.24 -25.66 65.82 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.573 -0.705 . . . . 0.0 110.552 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.3 m -112.74 -26.17 8.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.476 -0.765 . . . . 0.0 110.359 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.429 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -58.6 -58.74 7.22 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.441 -0.787 . . . . 0.0 110.422 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -60.08 -41.3 92.17 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.604 -0.685 . . . . 0.0 110.143 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -56.74 -38.44 72.41 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.362 -0.836 . . . . 0.0 110.346 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.0 t -82.63 -48.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.622 -0.674 . . . . 0.0 109.975 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.418 ' CD1' HD23 ' A' ' 6' ' ' LEU . 7.3 m-85 -64.33 -32.81 74.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.531 -0.731 . . . . 0.0 110.19 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -64.75 -45.77 85.01 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.415 -0.803 . . . . 0.0 108.934 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -62.53 -33.12 74.28 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.659 0.743 . . . . 0.0 109.391 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -66.13 -51.48 57.52 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.61 -42.52 82.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.77 -0.581 . . . . 0.0 110.095 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -56.94 -36.14 69.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.47 -0.768 . . . . 0.0 110.537 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -62.98 -59.19 5.16 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.562 -0.711 . . . . 0.0 110.094 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -67.87 -47.25 69.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.656 -0.652 . . . . 0.0 110.017 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.33 60.0 0.19 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 85.2 mt -115.8 62.91 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.475 -1.015 . . . . 0.0 110.145 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -86.2 56.53 4.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.443 -0.786 . . . . 0.0 109.037 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.68 -136.53 3.01 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -117.43 99.42 6.98 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.842 -0.799 . . . . 0.0 109.298 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.422 ' CH2' HD13 ' A' ' 6' ' ' LEU . 30.8 m95 -69.16 143.38 54.09 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.225 1.012 . . . . 0.0 112.541 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 p -153.41 131.41 11.78 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -101.79 138.14 39.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.641 -0.662 . . . . 0.0 110.166 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -105.92 103.5 13.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.725 -0.61 . . . . 0.0 109.784 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.12 -21.96 66.54 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.672 -0.643 . . . . 0.0 110.657 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.95 -39.41 65.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.295 -0.878 . . . . 0.0 110.84 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.8 p -148.14 22.75 1.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.483 -0.76 . . . . 0.0 110.7 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.3 91.32 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.21 -0.931 . . . . 0.0 110.816 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.4 m -153.99 102.71 2.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.484 -0.76 . . . . 0.0 111.119 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 27' ' ' ALA . 75.3 m-85 -63.26 133.73 54.69 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.6 m -126.3 101.84 6.91 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.347 -0.941 . . . . 0.0 112.883 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.6 p -104.26 165.81 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.374 -0.829 . . . . 0.0 109.322 177.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.0 m -162.24 119.37 2.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.753 -0.592 . . . . 0.0 110.074 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.173 179.588 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mtt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.071 0.463 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.448 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 47.9 m -89.41 112.23 23.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.545 -0.722 . . . . 0.0 110.271 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.2 m -88.87 93.97 9.77 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.591 -0.693 . . . . 0.0 110.76 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.461 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 94.0 m-85 -76.92 167.9 21.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.5 -0.75 . . . . 0.0 109.963 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -138.92 123.84 18.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.525 -0.735 . . . . 0.0 110.352 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.427 HD11 ' CZ3' ' A' ' 44' ' ' TRP . 44.8 tp -100.0 124.26 45.16 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.476 -0.765 . . . . 0.0 110.317 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.5 tp -74.6 168.2 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 72.6 mt -127.84 73.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.41 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -95.13 47.58 1.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.37 -0.831 . . . . 0.0 108.985 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.74 159.33 14.21 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -79.19 -1.53 36.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.759 -0.848 . . . . 0.0 110.364 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.8 m -99.87 -32.4 11.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 110.035 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.36 172.0 14.16 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.513 -0.742 . . . . 0.0 110.379 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.59 145.18 19.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.573 -0.705 . . . . 0.0 110.267 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.89 -132.11 6.01 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -154.23 163.19 40.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.59 -0.947 . . . . 0.0 110.349 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.1 m -149.58 145.48 26.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.566 -0.709 . . . . 0.0 110.141 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.3 p -132.68 167.2 20.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.585 -0.697 . . . . 0.0 110.24 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.411 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 8.1 t -162.94 170.15 18.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.617 -0.677 . . . . 0.0 110.305 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -101.68 123.38 45.58 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.626 -0.671 . . . . 0.0 110.143 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -151.89 146.41 25.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.568 -0.707 . . . . 0.0 110.264 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.4 p -61.39 -34.25 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.595 -0.691 . . . . 0.0 110.056 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 39.3 p30 -170.19 177.03 4.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.592 -0.692 . . . . 0.0 110.281 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.461 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.45 -26.86 21.93 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.518 -0.739 . . . . 0.0 111.021 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.48 -23.33 57.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.539 -0.725 . . . . 0.0 110.554 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.6 m -118.0 -14.14 10.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.499 -0.751 . . . . 0.0 111.088 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.417 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . . . -72.14 -50.07 30.85 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.228 -0.92 . . . . 0.0 110.406 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.52 -30.68 68.76 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.482 -0.761 . . . . 0.0 110.412 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -58.9 -40.46 84.54 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.376 -0.827 . . . . 0.0 110.341 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.0 t -82.99 -42.21 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.517 -0.739 . . . . 0.0 109.867 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.411 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 13.1 m-85 -68.27 -35.37 77.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.573 -0.704 . . . . 0.0 110.119 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -63.77 -46.66 84.23 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.473 -0.767 . . . . 0.0 109.128 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -62.64 -30.95 71.75 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.611 0.72 . . . . 0.0 109.467 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -69.7 -47.84 61.76 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.61 -33.76 64.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.68 -0.637 . . . . 0.0 110.001 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -60.68 -52.23 66.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.623 -0.673 . . . . 0.0 110.417 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.6 -35.54 78.14 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 110.52 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -79.29 -42.42 25.84 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.562 -0.711 . . . . 0.0 110.312 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.3 41.0 1.19 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.408 HD11 HG23 ' A' ' 40' ' ' ILE . 79.8 mt -99.64 59.52 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.549 -0.971 . . . . 0.0 110.166 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -80.84 61.48 4.49 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.36 -138.32 7.84 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -117.39 102.1 8.95 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.981 -0.717 . . . . 0.0 109.332 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.427 ' CZ3' HD11 ' A' ' 6' ' ' LEU . 37.0 m95 -71.91 142.68 49.49 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.191 0.996 . . . . 0.0 112.516 -178.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -151.93 132.52 13.92 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -108.39 138.04 45.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.645 -0.659 . . . . 0.0 110.285 -178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.06 123.4 49.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.69 -0.631 . . . . 0.0 109.602 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -78.01 -24.25 48.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.624 -0.672 . . . . 0.0 110.619 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.06 -39.43 66.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.382 -0.824 . . . . 0.0 110.834 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.5 p -141.77 12.86 2.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.599 -0.688 . . . . 0.0 111.102 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.435 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.95 94.41 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.133 -0.98 . . . . 0.0 111.205 179.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.2 m -157.9 105.33 1.97 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.549 -0.719 . . . . 0.0 110.761 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.416 ' CE1' ' HB2' ' A' ' 27' ' ' ALA . 73.6 m-85 -60.67 132.96 55.53 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.461 -0.774 . . . . 0.0 109.169 178.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.7 m -125.82 99.9 6.16 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.207 -0.997 . . . . 0.0 112.666 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.406 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.2 p -102.17 167.47 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.88 . . . . 0.0 109.271 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 98.9 m -160.28 109.2 1.71 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.593 -0.692 . . . . 0.0 109.894 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.274 -179.992 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.067 0.46 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.434 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 63.0 m -145.32 111.86 5.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.517 -0.739 . . . . 0.0 110.201 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.5 t -87.82 95.15 9.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.66 -0.65 . . . . 0.0 110.819 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.451 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 96.5 m-85 -77.1 171.48 14.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.42 -0.8 . . . . 0.0 109.819 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -139.31 128.89 24.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.49 -0.756 . . . . 0.0 110.331 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.438 ' CD1' ' CZ3' ' A' ' 44' ' ' TRP . 41.1 tp -103.41 122.62 45.25 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.385 -0.822 . . . . 0.0 110.432 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.0 tp -70.74 171.13 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.9 mt -133.8 74.4 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.644 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -95.86 47.73 1.11 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.545 -0.722 . . . . 0.0 109.138 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.42 163.66 13.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -82.3 2.65 31.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.651 -0.911 . . . . 0.0 110.791 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 m -111.5 -28.87 7.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.19 -0.943 . . . . 0.0 110.138 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 mt -136.93 167.3 21.76 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.558 -0.714 . . . . 0.0 110.393 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -155.75 138.04 14.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.538 -0.726 . . . . 0.0 110.213 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.07 -133.23 7.32 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -163.75 163.02 24.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.533 -0.98 . . . . 0.0 110.262 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.9 m -144.56 150.32 37.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.551 -0.718 . . . . 0.0 110.281 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.2 p -126.91 161.27 28.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.592 -0.693 . . . . 0.0 110.247 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.4 t -153.08 -171.59 3.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.506 -0.746 . . . . 0.0 110.382 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -115.97 109.25 17.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.54 -0.725 . . . . 0.0 110.152 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.36 138.55 38.39 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.601 -0.687 . . . . 0.0 110.155 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.8 m -57.4 -30.51 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.571 -0.705 . . . . 0.0 110.515 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.2 p30 -172.47 -179.56 2.25 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.407 -0.808 . . . . 0.0 110.283 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.451 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.18 -25.2 31.09 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.502 -0.749 . . . . 0.0 110.876 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.27 -25.88 66.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.49 -0.756 . . . . 0.0 110.605 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.9 m -113.3 -25.86 8.65 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.435 -0.791 . . . . 0.0 110.64 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.431 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -58.14 -49.09 78.19 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.458 -0.776 . . . . 0.0 110.569 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -61.6 -36.47 80.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.607 -0.683 . . . . 0.0 110.447 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -56.72 -40.06 75.02 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.327 -0.858 . . . . 0.0 110.744 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.4 -45.52 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.483 -0.761 . . . . 0.0 110.065 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.405 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 12.7 m-85 -66.91 -35.87 80.99 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.622 -0.674 . . . . 0.0 110.3 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.5 tttm -63.61 -44.06 95.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.488 -0.758 . . . . 0.0 109.35 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.33 -30.68 71.72 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.61 0.719 . . . . 0.0 109.565 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -70.02 -44.24 69.7 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.47 -41.54 46.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.716 -0.615 . . . . 0.0 109.802 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -58.95 -37.77 77.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.624 -0.672 . . . . 0.0 110.4 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -69.68 -50.75 40.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.602 -0.686 . . . . 0.0 110.058 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -69.87 -50.0 46.76 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.531 -0.731 . . . . 0.0 110.018 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.92 50.99 0.17 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.418 ' CG2' ' CG1' ' A' ' 55' ' ' VAL . 77.9 mt -115.79 74.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.52 -0.988 . . . . 0.0 110.298 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.25 39.54 1.23 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.85 -137.25 0.02 OUTLIER Glycine 0 N--CA 1.488 2.127 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -111.89 109.61 19.5 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.888 -0.772 . . . . 0.0 108.973 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.438 ' CZ3' ' CD1' ' A' ' 6' ' ' LEU . 35.1 m95 -79.81 143.78 34.11 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.042 0.925 . . . . 0.0 112.062 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.8 p -155.29 132.8 11.14 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -101.92 137.41 40.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.726 -0.609 . . . . 0.0 110.109 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -108.28 114.32 28.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.766 -0.584 . . . . 0.0 109.829 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -69.8 -18.04 63.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.666 -0.646 . . . . 0.0 110.896 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.8 -42.58 72.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.234 -0.916 . . . . 0.0 110.788 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.9 p -147.14 22.92 1.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.549 -0.719 . . . . 0.0 110.559 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.418 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER 51.67 94.69 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.322 -0.862 . . . . 0.0 110.859 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.4 m -156.94 107.5 2.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.456 -0.778 . . . . 0.0 111.269 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.422 ' CE1' ' HB2' ' A' ' 27' ' ' ALA . 69.0 m-85 -63.65 132.57 51.54 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.0 m -124.08 99.52 6.28 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.254 -0.979 . . . . 0.0 113.08 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.418 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.9 p -102.03 167.67 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 108.917 177.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.8 m -160.19 109.42 1.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.573 -0.705 . . . . 0.0 110.034 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.184 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.064 0.459 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.435 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 46.1 m -151.59 112.66 4.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.552 -0.718 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.5 m -85.34 95.94 9.39 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.656 -0.652 . . . . 0.0 110.697 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.435 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 89.8 m-85 -80.55 165.67 21.89 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.52 -0.738 . . . . 0.0 109.717 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.7 ttpp -139.62 118.61 12.57 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.426 -0.796 . . . . 0.0 110.521 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.424 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 46.9 tp -95.95 125.24 40.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.424 -0.797 . . . . 0.0 110.241 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.3 tp -73.48 168.55 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.465 HD12 HG21 ' A' ' 8' ' ' ILE . 79.6 mt -128.93 73.18 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.195 -0.94 . . . . 0.0 110.45 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -96.64 47.2 1.06 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.451 -0.781 . . . . 0.0 109.147 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.29 166.92 20.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -85.84 7.24 24.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.691 -0.888 . . . . 0.0 110.456 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.3 m -115.43 -33.35 5.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.973 . . . . 0.0 110.086 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 mt -137.45 167.64 21.22 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.486 -0.759 . . . . 0.0 110.571 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -153.23 139.14 18.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.596 -0.69 . . . . 0.0 110.369 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.08 -144.6 16.23 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -142.68 168.14 20.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.573 -0.957 . . . . 0.0 110.255 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.6 m -157.67 133.38 9.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.564 -0.71 . . . . 0.0 110.181 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.2 p -112.86 167.5 10.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.54 -0.725 . . . . 0.0 110.25 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.42 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 7.7 t -159.35 167.68 28.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.499 -0.751 . . . . 0.0 110.29 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -98.51 112.19 24.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.618 -0.676 . . . . 0.0 110.219 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.88 137.9 31.71 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.586 -0.696 . . . . 0.0 110.052 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.9 m -60.46 -30.33 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.506 -0.746 . . . . 0.0 110.254 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -170.67 -179.65 2.97 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.574 -0.703 . . . . 0.0 110.326 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.429 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.51 -24.39 31.43 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.584 -0.698 . . . . 0.0 110.87 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.67 -28.11 65.43 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.46 -0.775 . . . . 0.0 110.512 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 46.5 m -109.43 -27.29 9.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.585 -0.697 . . . . 0.0 110.291 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.425 ' HB1' ' CD2' ' A' ' 4' ' ' PHE . . . -61.6 -61.32 2.61 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.537 -0.727 . . . . 0.0 110.062 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -58.85 -38.36 78.54 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.562 -0.711 . . . . 0.0 109.921 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -58.69 -40.13 82.69 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.575 -0.703 . . . . 0.0 109.735 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.9 t -82.6 -47.89 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.692 -0.63 . . . . 0.0 109.509 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.42 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 7.1 m-85 -61.18 -32.71 72.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.629 -0.669 . . . . 0.0 109.998 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -65.5 -46.21 80.57 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -61.93 -30.94 71.24 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.65 0.738 . . . . 0.0 109.471 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -69.14 -54.29 15.73 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.3 -37.77 86.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.689 -0.632 . . . . 0.0 109.956 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -59.6 -33.34 71.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.512 -0.743 . . . . 0.0 110.428 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -70.68 -36.64 73.41 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.648 -0.657 . . . . 0.0 110.287 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -88.47 -27.9 21.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.581 -0.699 . . . . 0.0 110.161 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.82 39.73 3.3 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.457 HG23 HD11 ' A' ' 40' ' ' ILE . 80.8 mt -95.77 65.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.551 -0.97 . . . . 0.0 110.199 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -87.83 54.66 3.18 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.62 -137.01 2.64 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.71 105.29 11.84 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.939 -0.742 . . . . 0.0 109.202 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.424 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 31.7 m95 -74.13 143.38 45.34 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.138 0.97 . . . . 0.0 112.413 -177.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.6 p -153.83 131.49 11.48 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -102.27 129.69 48.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.681 -0.637 . . . . 0.0 110.198 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.27 117.66 35.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.675 -0.64 . . . . 0.0 109.879 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.13 -13.16 61.13 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.648 -0.657 . . . . 0.0 111.005 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.66 -43.19 80.14 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.174 -0.954 . . . . 0.0 110.549 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.7 p -147.49 24.33 1.11 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.609 -0.682 . . . . 0.0 110.435 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.69 93.45 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.305 -0.872 . . . . 0.0 110.853 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.4 m -156.48 105.11 2.24 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.903 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.421 ' CE2' ' HB3' ' A' ' 27' ' ' ALA . 91.6 m-85 -62.7 132.84 53.63 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.5 m -124.22 101.43 7.19 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.866 -178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.407 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.2 p -102.51 166.59 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.349 -0.844 . . . . 0.0 109.167 177.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 98.9 m -160.52 110.12 1.74 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.653 -0.654 . . . . 0.0 109.865 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.23 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 mtp . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.132 0.492 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.465 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 60.4 m -83.47 123.05 29.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.588 -0.695 . . . . 0.0 110.041 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.0 m -115.01 102.24 9.76 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.564 -0.71 . . . . 0.0 110.77 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.465 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 94.9 m-85 -82.77 -177.22 6.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.586 -0.696 . . . . 0.0 109.746 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -152.2 114.85 4.57 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.43 -0.794 . . . . 0.0 110.396 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.431 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 14.1 tp -93.51 140.03 30.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.269 -0.894 . . . . 0.0 110.277 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 tp -89.96 165.2 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.462 HD11 HG23 ' A' ' 8' ' ' ILE . 48.7 mm -126.44 77.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -0.903 . . . . 0.0 110.514 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -98.83 48.93 0.97 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.58 161.63 12.64 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -76.96 -12.47 59.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.767 -0.843 . . . . 0.0 110.435 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.8 m -91.1 -29.97 17.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 110.158 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 24.6 mt -141.14 167.64 21.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 110.49 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -153.82 131.48 11.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.645 -0.659 . . . . 0.0 110.057 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.95 -124.67 3.33 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -165.91 172.54 11.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.521 -0.987 . . . . 0.0 110.43 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.1 m -152.87 161.37 42.63 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.55 -0.719 . . . . 0.0 110.241 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 p -137.96 171.26 14.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.614 -0.679 . . . . 0.0 110.207 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.452 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 7.7 t -161.77 164.03 29.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.588 -0.695 . . . . 0.0 110.341 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -102.34 93.69 5.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.574 -0.704 . . . . 0.0 110.159 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -117.36 -172.45 2.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.553 -0.717 . . . . 0.0 110.214 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -112.14 -25.82 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.656 -0.653 . . . . 0.0 110.154 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -166.84 177.96 6.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.521 -0.737 . . . . 0.0 110.023 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.25 -25.84 59.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.723 . . . . 0.0 110.812 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.13 -45.33 93.36 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.451 -0.78 . . . . 0.0 110.458 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.7 m -87.61 -28.04 22.14 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.495 -0.753 . . . . 0.0 110.433 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.462 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -64.57 -63.47 1.12 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.533 -0.729 . . . . 0.0 110.402 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -57.9 -42.67 85.2 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.518 -0.739 . . . . 0.0 110.311 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -55.61 -39.3 70.59 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.382 -0.824 . . . . 0.0 110.248 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 88.3 t -82.31 -49.03 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.701 -0.624 . . . . 0.0 109.893 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.452 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 5.6 m-85 -62.95 -33.62 75.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.65 -0.656 . . . . 0.0 110.337 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -65.21 -45.87 82.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.414 -0.804 . . . . 0.0 109.094 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -61.71 -31.72 71.88 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.625 0.726 . . . . 0.0 109.552 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -68.43 -53.4 23.92 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.14 -47.25 80.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.733 -0.605 . . . . 0.0 109.784 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -58.03 -28.11 64.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.603 -0.686 . . . . 0.0 110.43 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.88 -47.19 19.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.608 -0.683 . . . . 0.0 110.194 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -76.22 -43.12 43.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.562 -0.711 . . . . 0.0 110.063 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.23 51.09 0.18 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.468 HG22 HD13 ' A' ' 40' ' ' ILE . 83.9 mt -122.57 73.52 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.463 -1.022 . . . . 0.0 110.231 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.97 39.7 1.26 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.56 -137.79 0.02 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -111.94 111.91 23.18 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.431 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 28.4 m95 -80.59 142.82 33.69 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.233 1.016 . . . . 0.0 112.467 -177.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 p -153.93 132.95 12.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -103.16 140.5 37.27 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.649 -0.657 . . . . 0.0 110.156 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.6 116.63 30.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.643 -0.661 . . . . 0.0 110.004 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -71.2 -15.14 62.45 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.646 -0.659 . . . . 0.0 111.147 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.99 -43.48 77.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.206 -0.934 . . . . 0.0 110.681 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.8 p -147.47 23.02 1.15 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.566 -0.709 . . . . 0.0 110.569 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.51 88.99 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.246 -0.909 . . . . 0.0 110.764 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.2 m -151.95 106.16 3.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.448 -0.782 . . . . 0.0 110.872 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 27' ' ' ALA . 86.0 m-85 -62.98 137.11 58.17 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.419 -0.801 . . . . 0.0 108.842 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.8 m -126.81 95.09 4.22 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.124 -1.03 . . . . 0.0 113.231 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.409 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.5 p -97.4 167.34 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 109.145 177.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.9 m -160.58 111.62 1.85 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.549 -0.719 . . . . 0.0 110.126 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.05 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.2 mtt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.107 0.479 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.448 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 8.7 m -87.32 114.24 23.76 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.546 -0.721 . . . . 0.0 110.194 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.8 t -95.13 79.97 3.58 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.533 -0.729 . . . . 0.0 110.892 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.448 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 98.1 m-85 -62.13 179.62 0.28 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.335 -0.853 . . . . 0.0 109.779 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -153.9 126.46 8.1 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.524 -0.735 . . . . 0.0 110.353 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.426 HD22 ' CD2' ' A' ' 34' ' ' TYR . 46.3 tp -103.87 135.43 45.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.459 -0.776 . . . . 0.0 110.189 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 tp -86.78 168.69 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.8 mt -128.43 72.64 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.203 -0.936 . . . . 0.0 110.634 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -95.6 48.47 1.14 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 0.0 108.969 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.95 154.56 16.53 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -72.42 -6.99 47.43 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.665 -0.903 . . . . 0.0 110.942 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -96.99 -30.75 12.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.202 -0.936 . . . . 0.0 110.283 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 tp -145.21 157.58 44.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.497 -0.752 . . . . 0.0 110.433 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -140.13 136.01 33.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.591 -0.693 . . . . 0.0 110.497 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.72 -140.57 10.87 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -151.72 168.55 24.69 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.541 -0.976 . . . . 0.0 110.434 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.2 m -150.54 148.49 28.75 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.588 -0.695 . . . . 0.0 110.265 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.1 p -131.13 168.38 17.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.578 -0.701 . . . . 0.0 110.155 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.447 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 8.6 t -164.32 179.09 7.02 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.588 -0.695 . . . . 0.0 110.378 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.96 128.25 54.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.714 . . . . 0.0 110.111 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.25 138.3 16.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.598 -0.689 . . . . 0.0 110.189 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.9 m -59.35 -26.7 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.505 -0.747 . . . . 0.0 110.45 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.3 p30 -173.12 -178.24 1.73 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.452 -0.78 . . . . 0.0 110.304 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.91 -25.29 56.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.54 -0.725 . . . . 0.0 110.869 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.04 -27.17 65.23 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.456 -0.778 . . . . 0.0 110.397 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.9 m -109.71 -27.84 9.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.518 -0.739 . . . . 0.0 110.305 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.447 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -59.02 -62.98 1.47 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.536 -0.727 . . . . 0.0 110.233 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -58.47 -32.48 68.8 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.521 -0.737 . . . . 0.0 110.166 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -56.61 -45.56 81.4 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.414 -0.804 . . . . 0.0 110.156 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.8 t -80.18 -45.05 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.653 -0.654 . . . . 0.0 109.697 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.447 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 12.6 m-85 -61.88 -33.56 74.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.597 -0.689 . . . . 0.0 110.04 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -64.52 -46.65 82.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.457 -0.777 . . . . 0.0 109.058 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -63.15 -33.5 75.6 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.608 0.718 . . . . 0.0 109.329 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.426 ' CD2' HD22 ' A' ' 6' ' ' LEU . 18.8 t80 -65.2 -46.67 79.76 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.99 -38.2 66.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.718 -0.614 . . . . 0.0 109.651 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -60.27 -45.3 93.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.539 -0.726 . . . . 0.0 110.316 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -60.28 -53.35 58.73 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.585 -0.697 . . . . 0.0 110.358 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -69.18 -48.24 62.74 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.525 -0.735 . . . . 0.0 110.033 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.44 46.11 0.3 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.45 HD12 HG21 ' A' ' 40' ' ' ILE . 80.1 mt -108.79 77.03 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.501 -0.999 . . . . 0.0 110.454 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -98.99 39.28 1.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.74 -138.35 0.02 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -112.45 111.05 21.62 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.842 -0.799 . . . . 0.0 108.956 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.423 ' CH2' HD11 ' A' ' 6' ' ' LEU . 29.3 m95 -80.31 143.56 33.51 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.182 0.991 . . . . 0.0 112.483 -178.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.6 p -152.91 132.28 12.86 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -104.81 120.87 42.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.678 -0.638 . . . . 0.0 110.111 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -90.77 111.39 22.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.649 -0.657 . . . . 0.0 110.087 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -66.72 -15.76 63.76 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.601 -0.687 . . . . 0.0 110.849 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.09 -42.69 73.18 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.168 -0.957 . . . . 0.0 110.812 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 81.0 p -147.07 24.12 1.17 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.53 -0.731 . . . . 0.0 110.527 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 4.3 mptt 51.79 87.35 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.247 -0.908 . . . . 0.0 110.78 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.4 m -150.88 103.65 3.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.513 -0.742 . . . . 0.0 110.728 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 27' ' ' ALA . 95.4 m-85 -62.5 134.84 56.98 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.489 -0.757 . . . . 0.0 109.112 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.7 m -125.72 104.05 8.15 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 119.354 -0.938 . . . . 0.0 112.71 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.414 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.1 p -104.73 167.24 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.279 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.2 m -159.79 109.59 1.85 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.586 -0.696 . . . . 0.0 109.801 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.098 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mtt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.047 0.451 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.433 HG23 ' CE2' ' A' ' 4' ' ' PHE . 40.2 m -72.01 111.64 7.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.576 -0.702 . . . . 0.0 110.011 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 58.8 m -89.87 96.73 10.81 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.588 -0.695 . . . . 0.0 110.662 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.454 ' CD2' ' CB ' ' A' ' 27' ' ' ALA . 87.6 m-85 -79.34 170.03 17.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.528 -0.732 . . . . 0.0 109.77 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -140.09 124.57 18.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.456 -0.778 . . . . 0.0 110.474 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.427 HD12 ' CZ3' ' A' ' 44' ' ' TRP . 53.3 tp -101.94 120.42 40.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.426 -0.796 . . . . 0.0 109.817 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.5 tt -69.36 172.75 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 76.8 mt -135.39 75.39 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 119.414 -0.915 . . . . 0.0 110.676 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -96.68 47.59 1.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.89 154.46 16.63 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.0 tttp -71.25 -9.78 58.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.688 -0.889 . . . . 0.0 110.611 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.0 m -91.44 -33.44 15.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.215 -0.928 . . . . 0.0 110.273 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 23.8 mt -142.13 167.5 21.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.465 -0.772 . . . . 0.0 110.638 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -147.52 136.78 22.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.634 -0.666 . . . . 0.0 110.198 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.26 -137.41 9.87 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -155.96 152.2 27.9 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.591 -0.947 . . . . 0.0 110.356 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.8 m -122.94 160.67 25.72 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.626 -0.671 . . . . 0.0 110.223 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.4 p -128.67 174.87 9.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.538 -0.726 . . . . 0.0 110.296 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.46 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 7.5 t -167.14 -173.26 2.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.526 -0.734 . . . . 0.0 110.328 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -128.56 101.97 6.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 0.0 110.177 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.0 155.07 47.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.605 -0.684 . . . . 0.0 110.135 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.8 p -74.42 -23.84 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.59 -0.694 . . . . 0.0 110.287 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -171.62 176.04 3.84 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.311 -0.868 . . . . 0.0 110.385 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.451 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -57.12 -29.61 63.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.553 -0.717 . . . . 0.0 110.992 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.89 -24.4 57.52 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.458 -0.776 . . . . 0.0 110.614 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.9 m -110.94 -27.98 8.56 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.466 -0.771 . . . . 0.0 110.355 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.454 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -60.81 -52.75 63.73 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.506 -0.746 . . . . 0.0 110.278 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -57.66 -39.87 78.03 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.554 -0.716 . . . . 0.0 110.415 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -56.9 -39.11 73.8 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.332 -0.855 . . . . 0.0 110.288 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.3 t -80.91 -49.19 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.665 -0.647 . . . . 0.0 110.105 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.46 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 6.2 m-85 -65.01 -33.08 75.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.594 -0.691 . . . . 0.0 110.409 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -64.1 -46.85 82.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.439 -0.788 . . . . 0.0 109.232 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -61.5 -31.97 71.98 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.619 0.724 . . . . 0.0 109.675 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.423 ' CD2' HD23 ' A' ' 6' ' ' LEU . 15.8 t80 -67.88 -42.96 80.44 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.45 -38.89 40.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.614 -0.678 . . . . 0.0 110.017 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -58.29 -52.19 66.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.467 -0.77 . . . . 0.0 110.28 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.6 -47.22 86.45 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.647 -0.658 . . . . 0.0 110.108 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -65.37 -45.9 82.24 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.555 -0.716 . . . . 0.0 110.037 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.44 36.93 0.88 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.48 HG23 HD11 ' A' ' 40' ' ' ILE . 80.1 mt -104.21 69.05 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.43 -1.041 . . . . 0.0 110.29 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -92.23 49.35 1.5 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.54 -0.725 . . . . 0.0 109.324 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.1 -137.09 0.84 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.17 112.24 22.21 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.893 -0.769 . . . . 0.0 109.11 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.427 ' CZ3' HD12 ' A' ' 6' ' ' LEU . 25.2 m95 -81.09 143.11 32.67 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.247 1.023 . . . . 0.0 112.445 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 p -150.98 131.82 14.13 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.405 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 31.1 t80 -105.05 128.81 53.5 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.669 -0.645 . . . . 0.0 110.031 -178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -102.47 111.26 23.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.676 -0.64 . . . . 0.0 109.953 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -66.69 -23.9 66.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.719 -0.613 . . . . 0.0 110.588 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.65 -38.78 64.46 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.404 -0.81 . . . . 0.0 110.851 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.2 p -143.26 14.71 1.84 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.541 -0.724 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.405 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 4.4 mptt 50.92 87.12 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.074 -1.016 . . . . 0.0 110.712 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.5 m -149.64 105.59 3.46 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.118 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.417 ' CE2' ' HB3' ' A' ' 27' ' ' ALA . 82.4 m-85 -62.25 123.72 18.94 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.3 m -117.39 104.15 10.83 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.175 -0.953 . . . . 0.0 112.854 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.417 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.4 p -106.38 164.67 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.353 -0.842 . . . . 0.0 109.377 177.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.0 m -163.91 116.11 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.384 179.96 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mtp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.106 0.479 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.438 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 86.3 m -99.91 112.08 24.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.584 -0.698 . . . . 0.0 110.237 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.7 t -88.04 104.29 16.52 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.701 -0.624 . . . . 0.0 110.756 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.455 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 83.9 m-85 -86.79 176.45 7.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.387 -0.821 . . . . 0.0 109.87 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.0 ttmt -146.75 115.82 6.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.47 -0.769 . . . . 0.0 110.245 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.425 HD12 ' CH2' ' A' ' 44' ' ' TRP . 48.3 tp -93.66 122.39 36.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.545 -0.722 . . . . 0.0 110.157 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.0 tp -70.44 171.64 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 84.9 mt -132.26 71.73 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.216 -0.928 . . . . 0.0 110.564 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -95.43 48.07 1.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.499 -0.751 . . . . 0.0 109.062 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.5 159.79 14.05 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -75.66 -6.16 49.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.707 -0.878 . . . . 0.0 110.564 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.9 t -100.17 -27.09 13.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.666 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.4 mt -143.78 163.59 32.9 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.425 -0.797 . . . . 0.0 110.577 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -147.9 131.95 17.25 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.588 -0.695 . . . . 0.0 110.2 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.71 -132.63 6.25 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -162.54 159.04 24.31 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.51 -0.994 . . . . 0.0 110.326 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 48.7 m -138.84 165.1 27.92 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.501 -0.749 . . . . 0.0 110.275 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.6 p -135.27 168.84 18.44 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.584 -0.697 . . . . 0.0 110.262 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.433 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 8.1 t -164.62 168.9 17.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.55 -0.719 . . . . 0.0 110.194 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -101.54 116.32 32.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.488 -0.757 . . . . 0.0 110.262 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -144.88 142.78 30.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.567 -0.708 . . . . 0.0 110.095 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.7 m -57.35 -37.32 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.449 -0.782 . . . . 0.0 110.095 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -172.34 -172.49 0.94 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.699 -0.626 . . . . 0.0 109.773 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.455 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.98 -23.14 12.22 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.461 -0.774 . . . . 0.0 111.174 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.28 -35.9 74.58 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.471 -0.768 . . . . 0.0 110.718 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.5 m -106.64 -25.39 11.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.445 -0.784 . . . . 0.0 110.811 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.425 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -57.83 -60.61 3.43 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.407 -0.808 . . . . 0.0 110.733 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -57.01 -40.09 75.98 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.521 -0.737 . . . . 0.0 110.568 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -57.65 -37.89 74.12 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.366 -0.834 . . . . 0.0 110.144 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 99.5 t -82.46 -48.7 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.64 -0.663 . . . . 0.0 109.851 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.433 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 7.1 m-85 -63.85 -33.17 75.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.551 -0.718 . . . . 0.0 110.212 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -64.76 -44.98 88.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.5 -0.75 . . . . 0.0 109.086 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -61.85 -27.63 68.92 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.505 0.669 . . . . 0.0 109.779 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -74.4 -53.08 10.31 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.94 -40.14 92.1 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.581 -0.7 . . . . 0.0 110.18 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -57.72 -49.73 75.55 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.537 -0.727 . . . . 0.0 110.693 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.88 -55.94 27.07 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.522 -0.736 . . . . 0.0 110.2 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -60.96 -47.68 85.34 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.563 -0.711 . . . . 0.0 110.082 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.71 64.58 0.3 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.408 ' CG2' ' CG1' ' A' ' 55' ' ' VAL . 82.4 mt -126.01 79.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.545 -0.974 . . . . 0.0 110.148 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -95.39 43.95 1.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.52 -140.48 0.64 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -118.78 111.33 18.32 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.425 ' CH2' HD12 ' A' ' 6' ' ' LEU . 26.0 m95 -77.13 143.9 38.81 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.178 0.99 . . . . 0.0 112.416 -177.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.6 p -151.27 132.77 14.72 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -104.41 113.71 27.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.621 -0.674 . . . . 0.0 110.122 -178.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -88.66 116.27 26.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.674 -0.641 . . . . 0.0 109.957 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.15 -15.78 61.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.625 -0.672 . . . . 0.0 110.845 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.97 -39.43 65.96 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.189 -0.944 . . . . 0.0 110.766 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 69.1 p -148.47 20.11 1.06 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.561 -0.712 . . . . 0.0 110.702 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.409 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.52 85.89 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.194 -0.941 . . . . 0.0 110.837 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 89.5 m -150.39 105.51 3.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.559 -0.713 . . . . 0.0 110.494 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.421 ' CZ ' ' HB1' ' A' ' 27' ' ' ALA . 90.0 m-85 -60.02 126.98 29.62 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.7 m -119.96 100.03 6.97 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.984 -177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.408 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.6 p -100.83 166.93 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.44 -0.788 . . . . 0.0 109.021 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.1 m -158.68 109.81 2.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.515 -0.74 . . . . 0.0 110.295 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.288 179.917 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.101 0.477 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.429 HG22 ' CE1' ' A' ' 4' ' ' PHE . 55.6 m -77.75 145.53 36.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.597 -0.689 . . . . 0.0 110.177 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 65.6 m -122.75 96.65 5.11 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.617 -0.677 . . . . 0.0 110.44 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.459 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 97.4 m-85 -81.41 175.34 10.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.585 -0.697 . . . . 0.0 110.081 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.0 ttpt -151.33 127.78 10.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.523 -0.736 . . . . 0.0 110.185 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.429 HD12 ' CZ3' ' A' ' 44' ' ' TRP . 48.0 tp -104.73 125.21 50.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.494 -0.754 . . . . 0.0 110.442 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 tp -75.17 171.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.0 mt -130.8 74.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.179 -0.951 . . . . 0.0 110.674 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -97.3 46.91 1.03 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.31 -0.869 . . . . 0.0 108.796 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.93 165.17 17.36 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.94 4.58 29.0 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.726 -0.867 . . . . 0.0 110.643 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -114.87 -26.86 7.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 110.484 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 tp -143.39 166.8 23.77 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.831 . . . . 0.0 110.769 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -153.53 143.23 21.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.559 -0.713 . . . . 0.0 110.27 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.05 -142.62 14.13 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -142.5 172.07 13.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.568 -0.96 . . . . 0.0 110.341 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.9 m -155.9 132.72 10.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.628 -0.67 . . . . 0.0 110.02 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.0 p -119.81 167.24 12.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.514 -0.741 . . . . 0.0 110.357 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.438 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 8.0 t -167.17 166.06 15.15 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.618 -0.677 . . . . 0.0 110.265 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -100.29 111.06 23.31 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.564 -0.71 . . . . 0.0 110.218 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -135.01 139.67 45.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.583 -0.698 . . . . 0.0 110.199 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.73 -28.8 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.543 -0.723 . . . . 0.0 110.408 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.5 p30 -173.87 -176.45 1.21 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.431 -0.793 . . . . 0.0 110.34 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.459 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -57.99 -23.94 56.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.613 -0.679 . . . . 0.0 110.809 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.65 -29.38 67.99 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.453 -0.779 . . . . 0.0 110.281 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.2 m -106.29 -28.17 10.57 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.55 -0.719 . . . . 0.0 110.154 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.402 ' HB3' ' CE2' ' A' ' 53' ' ' PHE . . . -61.3 -59.89 4.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.562 -0.711 . . . . 0.0 110.097 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -59.77 -43.79 94.17 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.601 -0.687 . . . . 0.0 110.215 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -54.64 -40.22 68.78 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.284 -0.885 . . . . 0.0 110.229 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.8 t -82.17 -48.52 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.697 -0.627 . . . . 0.0 109.918 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.438 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 13.5 m-85 -62.16 -32.73 73.38 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.653 -0.654 . . . . 0.0 110.304 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -66.31 -42.86 87.68 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.046 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -62.42 -30.11 70.99 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.505 0.669 . . . . 0.0 109.678 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -70.22 -50.68 37.47 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.24 -37.47 83.59 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.629 -0.67 . . . . 0.0 110.075 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -57.0 -36.47 70.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.479 -0.763 . . . . 0.0 110.65 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -69.83 -41.29 75.14 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.519 -0.738 . . . . 0.0 110.174 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -80.84 -27.98 36.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.596 -0.69 . . . . 0.0 110.269 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.82 38.35 4.68 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.409 ' CG2' ' CG1' ' A' ' 55' ' ' VAL . 76.8 mt -89.5 66.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.548 -0.972 . . . . 0.0 110.226 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -85.63 56.97 4.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.569 -0.707 . . . . 0.0 109.15 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.33 -138.21 4.98 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.47 102.19 8.72 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.868 -0.784 . . . . 0.0 109.161 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.429 ' CZ3' HD12 ' A' ' 6' ' ' LEU . 32.6 m95 -69.88 143.13 52.88 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.153 0.977 . . . . 0.0 112.457 -177.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.4 p -152.0 131.83 13.28 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -107.26 152.72 23.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.635 -0.666 . . . . 0.0 110.059 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -126.98 113.72 16.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.687 -0.633 . . . . 0.0 109.911 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -67.61 -23.05 65.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.703 -0.623 . . . . 0.0 110.833 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.75 -40.15 62.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.275 -0.891 . . . . 0.0 110.718 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.2 p -144.98 16.46 1.57 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.667 -0.645 . . . . 0.0 110.744 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.434 ' HG2' ' CE2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.81 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.121 -0.987 . . . . 0.0 110.876 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.6 m -152.78 102.46 2.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.494 -0.754 . . . . 0.0 110.949 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 27' ' ' ALA . 96.1 m-85 -63.0 136.75 58.0 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 86.4 m -129.37 103.04 6.69 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.37 -0.932 . . . . 0.0 112.322 -178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.409 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.7 p -102.54 167.04 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 0.0 109.265 177.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 92.0 m -160.71 112.65 1.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.595 -0.69 . . . . 0.0 110.273 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.086 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 tpp . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.06 0.457 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.441 HG21 ' CE2' ' A' ' 4' ' ' PHE . 93.9 m -134.93 112.97 11.07 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.63 -0.669 . . . . 0.0 110.124 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.2 m -88.58 104.27 16.68 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.606 -0.684 . . . . 0.0 110.707 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.444 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 88.8 m-85 -85.57 179.6 7.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.548 -0.72 . . . . 0.0 109.821 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.3 mtmm -144.44 117.24 8.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.438 -0.789 . . . . 0.0 110.575 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.442 ' CD1' ' CZ3' ' A' ' 44' ' ' TRP . 34.7 tp -99.47 121.66 41.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.464 -0.772 . . . . 0.0 110.164 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.8 tp -70.69 169.3 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.2 mt -131.33 77.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 110.856 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -97.24 46.93 1.03 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.225 -0.922 . . . . 0.0 108.633 178.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.12 153.04 16.97 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.59 -8.09 53.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.756 -0.849 . . . . 0.0 110.716 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -94.14 -30.88 14.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.215 -0.928 . . . . 0.0 110.4 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -145.63 174.78 10.89 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.423 -0.798 . . . . 0.0 110.498 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -165.72 142.58 5.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.608 -0.682 . . . . 0.0 110.48 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.5 -121.74 2.75 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -157.07 153.05 27.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.973 . . . . 0.0 110.304 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.4 m -138.9 142.67 38.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.553 -0.717 . . . . 0.0 110.244 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -124.61 153.09 42.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.617 -0.677 . . . . 0.0 110.184 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.452 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 8.9 t -151.35 142.24 22.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.554 -0.716 . . . . 0.0 110.285 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.49 114.66 16.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.594 -0.691 . . . . 0.0 110.34 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -142.4 139.87 31.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.463 -0.773 . . . . 0.0 110.054 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.2 m -56.46 -36.45 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.481 -0.762 . . . . 0.0 110.23 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -172.66 -173.27 0.99 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.595 -0.691 . . . . 0.0 109.934 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.5 -22.36 12.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.403 -0.811 . . . . 0.0 111.269 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.71 66.77 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.355 -0.841 . . . . 0.0 110.505 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.5 m -116.44 -21.69 9.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.466 -0.771 . . . . 0.0 110.954 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.431 ' HB1' ' CZ ' ' A' ' 53' ' ' PHE . . . -57.3 -62.97 1.39 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.318 -0.864 . . . . 0.0 110.667 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -59.98 -36.41 77.09 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.45 -0.781 . . . . 0.0 110.086 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -57.6 -43.68 84.86 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.486 -0.759 . . . . 0.0 109.962 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.6 t -78.77 -48.23 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.713 -0.617 . . . . 0.0 109.667 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.452 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 4.9 m-85 -61.33 -32.81 72.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.621 -0.675 . . . . 0.0 110.262 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -64.07 -42.94 96.8 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.433 -0.792 . . . . 0.0 108.9 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -64.56 -32.31 73.9 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.643 0.735 . . . . 0.0 109.341 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -68.04 -56.02 10.42 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.38 91.5 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.716 -0.615 . . . . 0.0 110.287 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -56.77 -37.92 71.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.483 -0.76 . . . . 0.0 110.643 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.14 -37.87 84.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.596 -0.69 . . . . 0.0 110.284 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -91.21 -30.72 16.49 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.511 -0.743 . . . . 0.0 110.178 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.06 44.3 1.77 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.409 ' CG2' ' CG1' ' A' ' 55' ' ' VAL . 79.8 mt -95.08 62.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.486 -1.008 . . . . 0.0 110.159 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.85 59.16 5.05 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.66 -138.47 6.4 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -115.13 103.15 10.58 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.845 -0.797 . . . . 0.0 109.015 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.442 ' CZ3' ' CD1' ' A' ' 6' ' ' LEU . 38.5 m95 -73.18 143.34 47.26 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 122.161 0.981 . . . . 0.0 112.195 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.0 p -155.91 131.43 9.61 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -105.71 133.07 51.03 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.655 -0.653 . . . . 0.0 109.955 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -104.3 109.97 22.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.77 -0.581 . . . . 0.0 109.888 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.6 -20.99 66.59 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.656 -0.653 . . . . 0.0 110.588 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.87 -37.84 60.86 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.263 -0.898 . . . . 0.0 110.958 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 p -147.68 19.89 1.16 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.573 -0.704 . . . . 0.0 110.826 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.418 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 50.63 85.38 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.154 -0.966 . . . . 0.0 110.875 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.3 m -151.43 105.81 3.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.467 -0.771 . . . . 0.0 111.035 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.431 ' CZ ' ' HB1' ' A' ' 27' ' ' ALA . 84.1 m-85 -62.83 137.6 58.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.485 -0.76 . . . . 0.0 109.071 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.3 m -128.79 98.76 5.08 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.316 -0.954 . . . . 0.0 112.764 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.409 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.0 p -101.86 166.46 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 109.254 177.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.8 m -161.67 111.06 1.55 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.725 -0.609 . . . . 0.0 109.657 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.24 -179.999 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.034 0.445 . . . . 0.0 110.038 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.44 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 87.1 m -82.56 112.41 19.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.538 -0.726 . . . . 0.0 110.16 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.6 m -110.58 92.23 3.97 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.603 -0.686 . . . . 0.0 110.506 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.44 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 96.9 m-85 -67.35 169.38 9.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.568 -0.707 . . . . 0.0 109.961 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -140.41 120.16 13.41 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.576 -0.703 . . . . 0.0 110.491 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.427 HD12 ' CZ3' ' A' ' 44' ' ' TRP . 28.7 tp -98.95 130.41 45.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.512 -0.743 . . . . 0.0 109.919 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 tp -78.95 171.81 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.2 mt -132.63 72.12 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.258 -0.901 . . . . 0.0 110.431 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -93.94 50.55 1.43 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.43 156.07 15.9 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -71.64 -13.43 61.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.716 -0.873 . . . . 0.0 110.492 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.5 m -88.57 -33.44 17.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.272 -0.893 . . . . 0.0 110.38 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.4 mt -144.1 162.81 35.32 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.406 -0.809 . . . . 0.0 110.832 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -143.35 136.71 28.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.67 -0.644 . . . . 0.0 110.146 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.23 -145.41 17.44 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -144.57 166.8 24.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.537 -0.978 . . . . 0.0 110.275 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.0 m -139.33 168.84 18.93 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.73 . . . . 0.0 110.211 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 p -137.55 165.43 26.32 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.526 -0.734 . . . . 0.0 110.354 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.451 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 7.9 t -146.78 163.03 37.32 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.507 -0.745 . . . . 0.0 110.262 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -111.97 87.63 2.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.499 -0.75 . . . . 0.0 110.24 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -126.29 -171.76 2.47 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.529 -0.732 . . . . 0.0 110.206 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.7 p -112.41 -25.84 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.563 -0.711 . . . . 0.0 110.224 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -164.91 174.4 10.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.469 -0.77 . . . . 0.0 110.0 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.08 -23.5 14.04 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.422 -0.799 . . . . 0.0 110.781 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.56 -42.84 79.26 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.392 -0.817 . . . . 0.0 109.996 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 85.6 m -87.93 -34.03 18.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.649 -0.657 . . . . 0.0 109.413 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.411 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . . . -63.25 -178.8 0.27 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.673 -0.642 . . . . 0.0 109.595 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 66.36 -63.01 0.26 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.546 -0.721 . . . . 0.0 110.528 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.83 -34.72 60.13 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.999 -1.063 . . . . 0.0 110.246 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.3 t -82.17 -50.23 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.698 -0.626 . . . . 0.0 109.666 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.451 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 4.6 m-85 -62.86 -33.65 75.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.586 -0.696 . . . . 0.0 109.856 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -63.7 -41.32 98.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.593 -0.692 . . . . 0.0 109.28 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -60.97 -31.78 71.35 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.642 0.734 . . . . 0.0 109.714 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -71.53 -55.73 7.28 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.51 -47.18 76.84 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.68 -0.638 . . . . 0.0 110.31 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -56.18 -28.36 57.91 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.491 -0.756 . . . . 0.0 110.519 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.41 -39.64 24.65 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.69 -0.631 . . . . 0.0 110.048 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -79.13 -46.89 17.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.65 -0.656 . . . . 0.0 110.003 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.79 60.06 0.18 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.416 HG23 HD11 ' A' ' 40' ' ' ILE . 86.4 mt -124.04 67.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.549 -0.971 . . . . 0.0 110.173 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.26 53.29 2.6 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.93 -138.47 2.71 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -115.56 101.11 8.57 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.857 -0.79 . . . . 0.0 109.337 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.427 ' CZ3' HD12 ' A' ' 6' ' ' LEU . 34.3 m95 -70.02 143.52 52.52 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 122.002 0.906 . . . . 0.0 112.098 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.2 p -155.01 130.51 9.81 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -103.08 146.14 28.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.665 -0.647 . . . . 0.0 109.783 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -118.31 116.89 27.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.72 -0.612 . . . . 0.0 109.857 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -71.42 -21.2 62.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.666 -0.646 . . . . 0.0 110.584 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.83 -40.52 66.5 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.269 -0.895 . . . . 0.0 110.806 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.8 p -144.83 17.19 1.61 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.605 -0.684 . . . . 0.0 110.789 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.43 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.27 91.61 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.187 -0.945 . . . . 0.0 111.043 179.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.8 m -158.59 104.8 1.81 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.45 -0.781 . . . . 0.0 110.715 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -62.16 139.49 58.47 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.2 m -131.51 102.7 6.04 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.954 -178.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.414 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.3 p -102.97 166.95 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.347 -0.846 . . . . 0.0 109.17 177.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.8 m -160.92 115.09 2.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.666 -0.646 . . . . 0.0 109.964 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.127 179.807 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 mmt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.058 0.456 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.452 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 62.8 m -116.03 112.09 21.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.572 -0.705 . . . . 0.0 110.198 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.6 m -92.26 103.01 15.51 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.604 -0.685 . . . . 0.0 110.503 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.452 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 79.5 m-85 -84.68 170.05 13.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.586 -0.696 . . . . 0.0 110.068 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.66 145.29 38.26 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.571 -0.705 . . . . 0.0 109.889 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.432 HD12 ' CZ3' ' A' ' 44' ' ' TRP . 18.3 tp -123.12 135.2 54.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.484 -0.76 . . . . 0.0 110.436 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 tp -85.56 156.0 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.5 mm -120.51 74.78 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.368 -179.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -95.7 47.35 1.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 178.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.74 153.28 17.59 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -69.28 -10.91 60.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.627 -0.925 . . . . 0.0 110.452 179.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.2 m -87.66 -37.76 16.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 110.256 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.1 mt -138.62 172.44 12.88 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.45 -0.781 . . . . 0.0 110.778 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -151.9 135.93 16.53 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.602 -0.686 . . . . 0.0 110.094 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.12 -145.46 15.73 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -146.18 178.2 8.41 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.585 -0.95 . . . . 0.0 110.406 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.4 m -159.71 152.87 22.01 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 110.16 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.0 p -124.51 163.4 21.94 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.561 -0.712 . . . . 0.0 110.349 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.425 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.2 t -150.5 -171.54 3.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.633 -0.667 . . . . 0.0 110.211 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.35 98.35 5.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.549 -0.719 . . . . 0.0 110.33 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.3 148.54 50.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.456 -0.777 . . . . 0.0 109.844 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.8 p -63.35 -36.43 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.041 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -169.75 -174.9 1.96 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.606 -0.683 . . . . 0.0 110.081 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.43 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.54 -26.02 29.4 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.504 -0.747 . . . . 0.0 111.074 -179.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.87 -28.64 69.02 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.506 -0.747 . . . . 0.0 110.3 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.5 m -113.03 -25.81 8.78 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.596 -0.69 . . . . 0.0 110.464 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.437 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -58.58 -61.74 2.37 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.471 -0.768 . . . . 0.0 110.496 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -57.7 -34.42 69.43 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.55 -0.719 . . . . 0.0 110.166 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -58.01 -36.86 73.28 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.37 -0.831 . . . . 0.0 109.996 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.2 t -84.59 -48.6 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.67 -0.644 . . . . 0.0 109.674 179.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.425 ' CZ ' HG22 ' A' ' 19' ' ' THR . 8.6 m-85 -62.31 -37.01 83.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.623 -0.673 . . . . 0.0 110.008 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -62.76 -47.28 84.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.572 -0.705 . . . . 0.0 109.169 179.413 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -63.21 -34.19 77.1 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.708 0.766 . . . . 0.0 109.286 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -65.81 -53.31 41.83 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.89 -45.72 84.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.735 -0.603 . . . . 0.0 109.895 179.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -58.82 -37.03 75.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 110.349 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -65.46 -54.17 32.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.659 -0.651 . . . . 0.0 109.949 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -69.61 -49.24 55.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.566 -0.709 . . . . 0.0 109.852 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.69 54.17 0.11 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.416 HD11 HG23 ' A' ' 40' ' ' ILE . 80.1 mt -119.97 70.32 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.427 -1.043 . . . . 0.0 110.236 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -94.55 48.82 1.23 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.16 -138.24 0.6 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -110.31 111.7 23.18 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.432 ' CZ3' HD12 ' A' ' 6' ' ' LEU . 35.9 m95 -83.83 143.27 30.04 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.213 1.006 . . . . 0.0 112.738 -177.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 p -154.7 131.72 10.91 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -101.03 143.94 30.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.65 -0.656 . . . . 0.0 110.306 -178.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -115.75 109.58 17.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.726 -0.609 . . . . 0.0 109.775 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -67.13 -21.8 65.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.646 -0.659 . . . . 0.0 110.593 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.4 -40.26 64.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.318 -0.864 . . . . 0.0 110.805 -179.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 80.1 p -148.82 21.04 1.01 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.549 -0.719 . . . . 0.0 110.676 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.415 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.54 92.74 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.168 -0.957 . . . . 0.0 110.744 179.874 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.1 m -152.57 101.64 2.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.355 -0.841 . . . . 0.0 111.515 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -63.49 124.21 20.74 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.0 m -115.23 96.66 5.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.263 -0.898 . . . . 0.0 113.14 -177.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.401 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.4 p -99.24 166.89 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 177.339 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 92.5 m -157.5 105.77 2.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.606 -0.684 . . . . 0.0 109.749 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.254 -179.723 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 121.092 0.472 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.445 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 44.1 m -99.14 111.31 23.73 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.546 -0.721 . . . . 0.0 110.362 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.2 m -85.53 90.83 8.08 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.589 -0.694 . . . . 0.0 110.623 -179.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.445 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 96.5 m-85 -73.28 170.34 15.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.478 -0.764 . . . . 0.0 109.81 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -141.44 139.71 33.45 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.467 -0.77 . . . . 0.0 110.583 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.421 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 38.9 tp -114.3 121.39 43.5 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.636 -0.665 . . . . 0.0 109.95 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 tp -71.47 166.26 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 71.5 mt -127.7 72.51 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.335 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -93.62 49.17 1.34 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.456 -0.777 . . . . 0.0 109.107 179.117 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.4 149.7 18.81 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -66.71 -13.63 61.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.649 -0.913 . . . . 0.0 110.41 179.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.6 m -85.05 -37.59 20.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.243 -0.911 . . . . 0.0 110.446 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.0 mt -141.38 170.06 16.43 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.444 -0.785 . . . . 0.0 110.769 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -151.22 141.49 22.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.611 -0.681 . . . . 0.0 110.177 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.95 -149.73 18.89 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -144.4 160.3 41.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.535 -0.98 . . . . 0.0 110.351 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.7 m -147.89 147.84 30.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.585 -0.697 . . . . 0.0 110.207 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -119.27 171.23 8.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.529 -0.732 . . . . 0.0 110.225 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.449 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 7.9 t -142.97 -170.43 3.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.548 -0.72 . . . . 0.0 110.369 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -126.86 88.59 2.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.622 -0.674 . . . . 0.0 110.123 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -130.64 137.89 49.82 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.608 -0.682 . . . . 0.0 110.3 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.1 m -59.39 -25.45 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.527 -0.733 . . . . 0.0 110.574 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 p30 -170.87 179.95 3.0 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.401 -0.812 . . . . 0.0 110.404 179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.435 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.18 -22.84 18.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.478 -0.764 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.04 -45.14 79.28 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.307 -0.87 . . . . 0.0 110.173 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.7 m -85.83 -31.63 22.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.649 -0.657 . . . . 0.0 109.541 179.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.26 -176.93 0.11 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.698 -0.626 . . . . 0.0 109.611 179.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 66.63 -61.73 0.3 Allowed 'General case' 0 N--CA 1.508 2.455 0 O-C-N 121.508 -0.745 . . . . 0.0 110.75 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -55.63 -34.22 64.73 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.064 -1.022 . . . . 0.0 110.268 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.0 t -83.49 -49.81 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.599 -0.688 . . . . 0.0 109.768 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.449 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 7.7 m-85 -63.17 -34.19 77.09 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.578 -0.701 . . . . 0.0 109.668 179.837 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -63.56 -41.23 98.42 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -62.8 -33.83 76.01 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.701 0.763 . . . . 0.0 109.544 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.401 ' CD2' HD23 ' A' ' 6' ' ' LEU . 7.8 t80 -68.02 -51.47 46.58 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.015 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.53 -49.07 62.34 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.792 -0.567 . . . . 0.0 110.078 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -55.94 -29.78 60.67 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.468 -0.77 . . . . 0.0 110.356 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.36 -40.16 89.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.681 -0.637 . . . . 0.0 109.822 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.26 -44.15 10.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.624 -0.672 . . . . 0.0 109.983 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.52 38.62 0.51 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.432 HG22 HD12 ' A' ' 40' ' ' ILE . 84.9 mt -93.32 64.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.379 -1.071 . . . . 0.0 109.908 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.3 54.77 3.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.503 -0.748 . . . . 0.0 108.999 178.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.76 -136.55 1.8 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.038 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -114.08 102.09 9.84 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.932 -0.746 . . . . 0.0 109.035 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.421 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 40.4 m95 -74.44 142.41 44.94 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.154 0.978 . . . . 0.0 112.226 -178.133 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.5 p -153.22 131.3 11.85 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.657 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.424 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 13.7 t80 -107.5 113.56 26.97 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.877 -178.529 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.37 118.62 26.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.699 -0.626 . . . . 0.0 109.929 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -69.76 -23.41 63.36 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.72 -0.612 . . . . 0.0 110.36 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.38 -37.12 55.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.416 -0.803 . . . . 0.0 111.015 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.3 p -144.34 14.51 1.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.482 -0.761 . . . . 0.0 111.12 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HG3' ' CE2' ' A' ' 46' ' ' TYR . 1.0 OUTLIER 50.97 86.72 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.043 -1.036 . . . . 0.0 110.82 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.1 m -153.14 107.48 3.12 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.515 -0.741 . . . . 0.0 110.934 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -64.06 124.15 20.86 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.7 m -116.14 98.32 6.55 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.283 -0.886 . . . . 0.0 112.888 -177.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.3 p -98.13 166.75 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.887 . . . . 0.0 109.395 177.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.7 m -160.78 108.84 1.58 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.648 -0.657 . . . . 0.0 109.751 -179.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.13 -179.961 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 mtm . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.082 0.468 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.444 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 5.7 m -102.7 113.85 27.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.534 -0.729 . . . . 0.0 110.118 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.9 t -96.35 79.24 3.1 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.68 -0.637 . . . . 0.0 110.99 -179.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.454 ' CD2' ' CB ' ' A' ' 27' ' ' ALA . 97.4 m-85 -62.14 166.38 4.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.321 -0.862 . . . . 0.0 109.6 179.445 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -137.4 122.21 18.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.403 -0.811 . . . . 0.0 110.658 -179.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.422 HD13 ' CH2' ' A' ' 44' ' ' TRP . 47.0 tp -99.88 130.59 46.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.546 -0.721 . . . . 0.0 110.049 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 tp -81.75 165.52 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 70.1 mt -124.11 73.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.251 -0.906 . . . . 0.0 110.279 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.17 46.79 1.12 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 0.0 108.967 178.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.22 158.1 15.66 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -76.31 -5.07 45.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.767 -0.843 . . . . 0.0 110.604 179.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.2 m -99.15 -36.84 9.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.191 -0.943 . . . . 0.0 110.273 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.33 164.29 28.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.444 -0.785 . . . . 0.0 110.53 -179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.16 138.4 19.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.602 -0.686 . . . . 0.0 110.326 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.21 -141.94 12.34 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -145.71 157.94 43.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.546 -0.973 . . . . 0.0 110.396 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.9 m -146.39 137.91 24.63 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.613 -0.679 . . . . 0.0 110.123 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.3 p -119.48 164.16 16.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.538 -0.727 . . . . 0.0 110.264 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.454 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 8.5 t -152.8 -166.26 2.41 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.589 -0.694 . . . . 0.0 110.285 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -131.12 122.66 27.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.712 -0.617 . . . . 0.0 110.204 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -151.08 158.71 44.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.575 -0.703 . . . . 0.0 110.197 -179.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -77.3 -25.44 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.583 -0.698 . . . . 0.0 110.156 179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.8 p30 -172.41 179.61 2.47 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.406 -0.809 . . . . 0.0 110.277 179.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.61 -25.66 53.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.541 -0.725 . . . . 0.0 110.807 -179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.99 -27.32 65.31 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.484 -0.76 . . . . 0.0 110.489 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 62.5 m -109.27 -27.87 9.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.505 -0.747 . . . . 0.0 110.313 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.454 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -59.64 -55.64 31.95 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.522 -0.736 . . . . 0.0 110.324 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -59.22 -42.11 90.22 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.573 -0.704 . . . . 0.0 110.333 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -57.59 -35.77 70.85 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.336 -0.853 . . . . 0.0 110.177 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.42 -49.04 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.692 -0.63 . . . . 0.0 110.004 179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.454 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 7.2 m-85 -65.44 -35.45 80.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.56 -0.713 . . . . 0.0 110.329 -179.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -64.06 -41.98 97.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.435 -0.791 . . . . 0.0 109.377 179.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -60.6 -29.63 69.33 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.561 0.696 . . . . 0.0 109.957 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -73.22 -54.11 9.23 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.41 -44.14 92.18 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.665 -0.647 . . . . 0.0 110.073 179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -56.38 -37.33 69.96 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.494 -0.754 . . . . 0.0 110.581 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -75.1 -50.38 16.56 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.652 -0.655 . . . . 0.0 110.146 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -65.8 -48.5 71.51 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.528 -0.732 . . . . 0.0 110.067 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.3 62.05 0.2 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.409 HD11 HG21 ' A' ' 40' ' ' ILE . 85.5 mt -129.56 77.22 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.472 -1.016 . . . . 0.0 110.458 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.76 40.7 1.15 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.15 -136.14 0.02 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -120.22 100.79 7.39 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.82 -0.812 . . . . 0.0 109.011 179.284 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.422 ' CH2' HD13 ' A' ' 6' ' ' LEU . 27.8 m95 -67.38 142.97 56.56 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.218 1.008 . . . . 0.0 112.478 -177.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.5 p -151.72 131.6 13.31 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -103.13 128.55 50.02 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.696 -0.628 . . . . 0.0 109.967 -178.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -97.59 108.2 20.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.686 -0.634 . . . . 0.0 110.019 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -65.97 -20.08 66.08 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.645 -0.659 . . . . 0.0 110.633 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.71 -38.6 64.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.282 -0.886 . . . . 0.0 110.812 -179.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 71.6 p -148.61 22.18 1.02 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.522 -0.736 . . . . 0.0 110.752 -179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.88 90.75 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.128 -0.982 . . . . 0.0 110.928 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.1 m -156.67 106.37 2.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.477 -0.764 . . . . 0.0 110.857 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -62.27 136.58 57.99 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.535 -0.728 . . . . 0.0 109.095 178.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.4 m -129.77 101.57 5.94 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.558 -178.559 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.404 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.2 p -102.81 165.4 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.612 177.706 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.4 m -163.49 115.34 1.45 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.875 -0.516 . . . . 0.0 109.751 -179.706 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.34 179.521 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ptp . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.108 0.48 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.453 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 9.9 t -109.8 -171.39 1.83 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.533 -0.729 . . . . 0.0 110.234 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.7 m -129.49 96.11 4.18 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.539 -0.725 . . . . 0.0 110.739 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.453 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 84.9 m-85 -77.6 169.34 18.46 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.533 -0.729 . . . . 0.0 109.644 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -140.14 113.61 8.57 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.503 -0.748 . . . . 0.0 110.418 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.444 HD11 ' CH2' ' A' ' 44' ' ' TRP . 42.8 tp -94.03 122.31 36.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.565 -0.709 . . . . 0.0 109.966 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.9 tp -72.92 166.83 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.8 mt -128.67 73.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.527 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -94.37 49.55 1.3 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.416 -0.802 . . . . 0.0 109.124 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.31 151.79 18.32 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.6 -10.1 56.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.678 -0.895 . . . . 0.0 110.613 179.426 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.1 m -90.38 -32.49 16.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 110.373 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.3 mt -143.34 173.12 11.89 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.451 -0.781 . . . . 0.0 110.917 -179.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -156.69 140.68 16.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.618 -0.676 . . . . 0.0 110.129 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 128.11 -134.48 8.19 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -162.1 164.98 27.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.518 -0.99 . . . . 0.0 110.286 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 76.2 m -138.69 164.06 30.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.542 -0.724 . . . . 0.0 110.339 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.6 p -136.98 161.06 37.09 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.57 -0.706 . . . . 0.0 110.204 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.449 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 7.6 t -169.78 148.43 3.58 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.543 -0.723 . . . . 0.0 110.192 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -82.36 132.43 35.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.495 -0.753 . . . . 0.0 110.13 179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -155.36 140.98 17.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.358 -0.839 . . . . 0.0 110.473 -179.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.6 m -58.8 -32.59 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.571 -0.706 . . . . 0.0 110.405 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.0 p30 -170.14 179.11 3.62 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.546 -0.721 . . . . 0.0 110.294 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.98 -24.67 40.01 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.492 -0.755 . . . . 0.0 110.847 -179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.67 -35.13 72.09 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.438 -0.789 . . . . 0.0 110.508 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.5 m -97.4 -25.58 15.16 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.52 -0.737 . . . . 0.0 110.506 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.437 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -66.62 -58.51 5.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.436 -0.79 . . . . 0.0 110.467 -179.742 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -57.23 -42.12 80.79 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.573 -0.704 . . . . 0.0 110.597 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -55.99 -40.65 73.63 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.298 -0.876 . . . . 0.0 110.196 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.4 t -80.18 -49.41 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.626 -0.671 . . . . 0.0 109.733 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.449 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 7.7 m-85 -61.77 -30.51 70.84 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.098 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -65.11 -43.76 90.97 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.168 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -62.57 -30.86 71.63 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.606 0.717 . . . . 0.0 109.439 178.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -70.95 -50.28 36.36 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.171 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.93 -42.92 72.65 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.638 -0.664 . . . . 0.0 109.989 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -58.7 -38.29 77.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.563 -0.711 . . . . 0.0 110.517 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -71.3 -51.96 21.54 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.551 -0.718 . . . . 0.0 110.037 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -66.66 -48.85 68.07 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.544 -0.722 . . . . 0.0 109.931 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.14 61.45 0.19 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.497 HD12 HG21 ' A' ' 40' ' ' ILE . 83.1 mt -126.18 68.23 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.519 -0.989 . . . . 0.0 110.331 179.657 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.76 52.92 2.42 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.49 -140.28 4.08 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.2 110.52 21.06 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.904 -0.762 . . . . 0.0 109.471 179.53 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.444 ' CH2' HD11 ' A' ' 6' ' ' LEU . 31.6 m95 -80.23 143.9 33.35 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.125 0.964 . . . . 0.0 112.318 -178.134 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 p -157.48 131.65 8.29 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -107.43 146.03 32.23 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.704 -0.623 . . . . 0.0 109.894 -178.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -118.36 114.99 23.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.716 -0.615 . . . . 0.0 109.929 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -69.31 -24.05 63.88 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.666 -0.646 . . . . 0.0 110.542 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.48 -36.82 55.78 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.37 -0.831 . . . . 0.0 110.832 -179.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.1 p -147.81 17.71 1.13 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.574 -0.703 . . . . 0.0 110.88 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.26 93.06 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.221 -0.924 . . . . 0.0 111.01 179.793 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.4 m -157.72 105.27 2.01 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.233 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 73.8 m-85 -64.67 136.56 57.09 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.813 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 51.1 m -127.59 100.02 5.82 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.887 -178.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.408 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.4 p -104.88 166.65 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 108.974 177.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -161.12 112.33 1.79 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.719 -0.613 . . . . 0.0 109.778 -179.701 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.158 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptt? . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.106 0.479 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.426 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 63.3 m -112.61 112.12 23.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.565 -0.71 . . . . 0.0 110.32 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.0 m -96.19 94.39 7.48 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.654 -0.654 . . . . 0.0 110.417 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.435 ' CD2' ' CB ' ' A' ' 27' ' ' ALA . 96.4 m-85 -72.14 167.49 20.17 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.528 -0.732 . . . . 0.0 109.966 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 12.1 mtmt -132.77 115.82 15.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.544 -0.722 . . . . 0.0 110.317 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.421 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -94.09 111.84 23.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.518 -0.738 . . . . 0.0 110.263 -179.977 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.8 tp -63.74 171.32 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.074 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.416 HG22 HD12 ' A' ' 8' ' ' ILE . 74.0 mt -133.23 74.53 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.928 . . . . 0.0 110.678 -179.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -95.56 48.0 1.13 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.18 156.81 15.36 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -74.47 -6.57 49.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.766 -0.844 . . . . 0.0 110.346 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.9 m -92.64 -37.1 12.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 110.133 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.3 mt -139.78 176.06 9.06 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.536 -0.728 . . . . 0.0 110.527 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.15 138.9 11.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.574 -0.704 . . . . 0.0 110.225 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.26 -136.54 9.04 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -144.46 162.91 35.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.56 -0.965 . . . . 0.0 110.332 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.6 m -146.67 130.23 16.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.598 -0.689 . . . . 0.0 110.107 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.8 p -112.4 174.88 5.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.628 -0.67 . . . . 0.0 110.323 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.433 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 7.4 t -166.54 -170.55 1.66 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.573 -0.705 . . . . 0.0 110.246 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -120.95 105.72 10.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.545 -0.722 . . . . 0.0 110.222 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -136.43 140.81 43.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.557 -0.714 . . . . 0.0 110.138 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 p -61.85 -30.67 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.552 -0.718 . . . . 0.0 109.909 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -168.89 179.11 4.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.67 -0.644 . . . . 0.0 110.142 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.421 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.56 -23.01 14.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.489 -0.757 . . . . 0.0 111.137 -179.575 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.86 -32.1 70.39 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.391 -0.818 . . . . 0.0 110.441 -179.859 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.4 m -104.05 -26.99 12.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.529 -0.732 . . . . 0.0 110.47 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -60.67 -58.17 9.59 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.526 -0.734 . . . . 0.0 110.495 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -58.43 -45.09 89.19 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.483 -0.76 . . . . 0.0 110.521 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -54.4 -41.0 68.75 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.254 -0.903 . . . . 0.0 110.507 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.2 t -81.39 -47.89 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.649 -0.657 . . . . 0.0 110.091 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.433 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 4.5 m-85 -63.84 -32.72 74.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.694 . . . . 0.0 110.212 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -64.93 -42.97 94.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -63.64 -33.54 75.84 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.712 0.767 . . . . 0.0 109.099 178.748 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -66.06 -57.01 8.68 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.65 -46.18 91.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.753 -0.592 . . . . 0.0 110.085 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -57.48 -34.85 69.45 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.578 -0.701 . . . . 0.0 110.566 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.19 -48.47 67.83 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.537 -0.727 . . . . 0.0 110.135 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -76.49 -47.26 23.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.58 -0.7 . . . . 0.0 110.041 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.22 69.17 0.19 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.443 HG23 HD12 ' A' ' 40' ' ' ILE . 81.7 mt -127.44 60.82 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.997 . . . . 0.0 110.343 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -82.46 60.72 5.26 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.8 -140.8 10.05 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -178.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -114.04 105.5 13.3 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.922 -0.752 . . . . 0.0 109.039 179.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 55.9 m95 -75.78 143.27 42.05 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.04 0.924 . . . . 0.0 112.209 -178.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.1 p -153.16 132.08 12.49 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.403 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 48.7 t80 -99.82 131.62 45.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.744 -0.597 . . . . 0.0 110.18 -178.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.16 119.15 38.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.754 -0.591 . . . . 0.0 109.951 179.746 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.24 -21.32 56.51 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.591 -0.693 . . . . 0.0 110.719 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.07 -40.39 67.16 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.311 -0.868 . . . . 0.0 110.829 -179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.0 p -147.55 19.51 1.18 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.585 -0.697 . . . . 0.0 110.84 -179.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.403 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 0.6 OUTLIER 51.68 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.195 -0.941 . . . . 0.0 111.004 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 57.1 m -158.54 108.33 2.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.513 -0.742 . . . . 0.0 110.684 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 27' ' ' ALA . 64.9 m-85 -62.22 127.44 31.36 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.576 -0.703 . . . . 0.0 109.177 179.146 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.1 m -120.3 105.39 10.88 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.398 -0.921 . . . . 0.0 112.47 -178.465 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.417 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.9 p -109.57 168.14 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.468 -0.77 . . . . 0.0 108.954 177.478 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 96.5 m -160.04 109.7 1.81 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.471 -0.768 . . . . 0.0 110.013 -179.511 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.242 -179.941 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.055 0.455 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.415 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 71.4 m -97.66 111.96 24.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.619 -0.676 . . . . 0.0 110.136 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.5 m -93.54 91.4 7.08 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.623 -0.673 . . . . 0.0 110.576 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.416 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 96.8 m-85 -69.15 173.49 5.55 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.542 -0.724 . . . . 0.0 109.934 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.3 mtpm? -139.56 110.54 6.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.454 -0.778 . . . . 0.0 110.416 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.437 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -91.28 109.63 20.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.535 -0.728 . . . . 0.0 110.068 179.872 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 tt -63.06 171.75 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.341 -0.849 . . . . 0.0 108.854 179.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 80.1 mt -133.64 71.94 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.438 -179.53 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -95.12 47.7 1.15 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.423 -0.798 . . . . 0.0 109.175 179.125 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.96 160.24 13.52 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.524 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -76.43 -7.36 54.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.653 -0.91 . . . . 0.0 110.461 179.202 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.2 t -98.34 -23.51 15.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.458 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 35.8 mt -147.21 163.62 35.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.321 -0.862 . . . . 0.0 110.495 179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.47 132.68 17.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.64 -0.663 . . . . 0.0 110.146 179.864 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.06 -142.07 13.54 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -145.84 171.59 14.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.537 -0.978 . . . . 0.0 110.239 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 m -147.53 156.6 42.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.632 -0.667 . . . . 0.0 110.158 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.5 p -138.59 155.56 48.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.563 -0.711 . . . . 0.0 110.256 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.441 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 8.3 t -154.8 160.38 41.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.584 -0.698 . . . . 0.0 110.283 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -90.02 106.72 18.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.599 -0.688 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.05 139.28 45.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.622 -0.674 . . . . 0.0 110.216 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -59.21 -34.59 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.547 -0.721 . . . . 0.0 110.1 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.3 p30 -169.3 -178.77 3.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.586 -0.696 . . . . 0.0 110.271 179.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.416 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.98 -23.0 17.1 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.531 -0.73 . . . . 0.0 111.053 -179.828 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.06 -26.32 62.35 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.49 -0.756 . . . . 0.0 110.701 -179.672 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.1 m -114.76 -24.85 8.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.422 -0.799 . . . . 0.0 110.691 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 53' ' ' PHE . . . -59.1 -60.03 4.52 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.402 -0.811 . . . . 0.0 110.415 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -59.42 -37.2 77.43 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.542 -0.724 . . . . 0.0 110.401 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -56.72 -44.73 81.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.423 -0.798 . . . . 0.0 110.578 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.0 t -80.13 -43.34 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.52 -0.737 . . . . 0.0 109.96 179.732 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.441 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 10.3 m-85 -65.52 -35.2 80.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.554 -0.717 . . . . 0.0 110.329 -179.727 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -63.64 -45.48 90.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 108.991 179.286 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -63.43 -32.84 74.39 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.69 0.757 . . . . 0.0 109.136 178.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -66.48 -56.58 10.22 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.56 -45.87 90.58 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.695 -0.628 . . . . 0.0 110.15 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -58.51 -32.49 68.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.57 -0.706 . . . . 0.0 110.328 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -60.94 -59.93 4.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.599 -0.688 . . . . 0.0 109.968 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 -72.5 -45.98 56.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.624 -0.673 . . . . 0.0 109.828 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.36 72.89 0.23 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.725 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.453 HD12 HG22 ' A' ' 40' ' ' ILE . 80.4 mt -122.9 62.06 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.482 -1.011 . . . . 0.0 110.004 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.78 61.12 5.0 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.72 -140.76 9.98 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -178.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -116.62 104.53 11.48 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.877 -0.778 . . . . 0.0 109.038 179.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -73.98 143.94 45.41 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 122.084 0.945 . . . . 0.0 112.248 -178.112 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -153.84 132.13 11.95 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.75 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 26.4 t80 -103.74 139.08 39.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.618 -0.676 . . . . 0.0 110.186 -178.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -113.34 122.05 46.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.718 -0.613 . . . . 0.0 109.843 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -75.89 -19.5 58.78 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.732 -0.605 . . . . 0.0 110.778 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.37 -39.18 66.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.24 -0.913 . . . . 0.0 110.774 -179.718 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.4 p -148.18 18.56 1.09 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.561 -0.712 . . . . 0.0 110.752 -179.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.3 94.97 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.23 -0.919 . . . . 0.0 110.927 179.977 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.2 m -156.22 108.78 2.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.472 -0.767 . . . . 0.0 111.015 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.4 ' CZ ' ' HB2' ' A' ' 27' ' ' ALA . 77.1 m-85 -65.17 127.58 32.28 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.59 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 45.7 m -120.23 102.87 8.79 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.753 -178.214 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.406 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.6 p -105.72 167.33 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.374 -0.829 . . . . 0.0 108.99 177.372 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.4 m -160.35 111.07 1.85 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.555 -0.716 . . . . 0.0 110.097 -179.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.169 179.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.5 mmm . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.096 0.474 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.45 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 92.6 m -103.07 112.12 24.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.633 -0.667 . . . . 0.0 110.153 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.5 m -92.95 108.53 20.07 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.618 -0.676 . . . . 0.0 110.437 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.457 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 73.7 m-85 -88.47 174.12 8.3 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.587 -0.696 . . . . 0.0 110.098 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -142.68 112.97 7.18 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 110.406 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.421 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -96.09 112.62 24.3 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.496 -0.753 . . . . 0.0 109.941 179.731 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 tt -65.37 172.58 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.977 179.338 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 77.6 mt -133.98 72.33 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.384 -0.822 . . . . 0.0 110.383 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -95.23 47.17 1.13 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.439 -0.788 . . . . 0.0 109.272 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.32 160.7 13.38 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -77.64 -2.72 37.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.734 -0.862 . . . . 0.0 110.495 179.309 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -101.45 -30.44 11.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.969 . . . . 0.0 109.951 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 60.4 mt -140.01 165.9 26.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.482 -0.761 . . . . 0.0 110.508 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -151.11 132.41 14.54 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.643 -0.661 . . . . 0.0 110.218 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 131.84 -133.44 7.17 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -162.52 160.36 25.97 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.547 -0.972 . . . . 0.0 110.428 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.2 m -140.79 143.13 34.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.572 -0.705 . . . . 0.0 110.069 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.5 p -122.84 150.16 43.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.505 -0.747 . . . . 0.0 110.403 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.42 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.8 t -143.54 -172.09 3.65 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.647 -0.658 . . . . 0.0 110.247 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -114.34 107.73 15.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.59 -0.694 . . . . 0.0 110.146 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.63 147.8 52.35 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.586 -0.696 . . . . 0.0 110.096 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.6 p -65.7 -31.69 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.542 -0.724 . . . . 0.0 109.57 179.482 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -173.07 -174.94 1.12 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.587 -0.696 . . . . 0.0 109.952 179.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.457 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.27 -24.77 12.33 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.456 -0.777 . . . . 0.0 111.162 -179.458 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.59 78.14 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.497 -0.752 . . . . 0.0 110.377 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.1 m -100.78 -28.18 12.95 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.56 -0.712 . . . . 0.0 110.431 -179.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.448 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -61.42 -61.89 2.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.476 -0.765 . . . . 0.0 110.294 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -60.52 -37.28 80.66 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.596 -0.69 . . . . 0.0 110.25 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -57.6 -43.62 84.84 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.424 -0.798 . . . . 0.0 110.391 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.26 -45.81 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.585 -0.697 . . . . 0.0 109.819 179.691 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.421 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 11.5 m-85 -64.01 -33.21 75.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.573 -0.704 . . . . 0.0 110.283 -179.782 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -64.57 -45.09 88.51 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.132 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -63.02 -33.61 75.8 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.697 0.761 . . . . 0.0 109.18 178.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -64.5 -54.98 23.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.751 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.27 -44.27 96.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.784 -0.573 . . . . 0.0 110.023 179.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -57.92 -35.79 71.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.556 -0.715 . . . . 0.0 110.484 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.47 -43.35 99.02 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.624 -0.672 . . . . 0.0 110.023 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -84.31 -42.46 15.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.625 -0.672 . . . . 0.0 109.922 179.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.51 47.47 0.41 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.722 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.413 HG21 HD12 ' A' ' 40' ' ' ILE . 79.6 mt -96.91 63.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.463 -1.022 . . . . 0.0 110.168 179.798 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.4 59.56 4.64 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.89 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.53 -139.71 8.1 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.046 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -118.59 103.09 9.39 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.307 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -71.62 142.73 49.95 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.065 0.936 . . . . 0.0 112.266 -177.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p -150.26 131.62 14.64 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -108.97 123.56 49.3 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.719 -0.613 . . . . 0.0 110.099 -178.606 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -100.93 119.05 38.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.708 -0.62 . . . . 0.0 109.834 179.599 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.36 -19.41 62.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.672 -0.643 . . . . 0.0 110.812 -179.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.12 -37.69 55.02 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.214 -0.929 . . . . 0.0 110.877 -179.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.7 p -147.06 17.37 1.22 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.628 -0.67 . . . . 0.0 110.754 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.87 86.67 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.18 -0.95 . . . . 0.0 110.948 179.817 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.6 m -151.51 105.7 3.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.483 -0.761 . . . . 0.0 110.766 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -62.06 129.14 39.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.462 -0.774 . . . . 0.0 108.971 178.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.5 m -121.92 102.13 7.99 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.451 -178.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.409 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.2 p -103.16 167.46 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.381 -0.824 . . . . 0.0 109.319 177.744 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.7 m -159.99 110.33 1.87 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.598 -0.689 . . . . 0.0 110.159 -179.474 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.068 179.721 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.006 0.432 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.458 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 67.5 m -91.27 111.16 22.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.619 -0.676 . . . . 0.0 110.259 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.5 m -80.87 101.97 9.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.611 -0.681 . . . . 0.0 110.573 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.458 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 74.9 m-85 -88.2 166.95 14.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.545 -0.722 . . . . 0.0 109.813 179.652 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -134.02 118.56 17.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.416 -0.803 . . . . 0.0 110.414 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.422 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -99.21 112.87 24.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.51 -0.744 . . . . 0.0 110.384 -179.926 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 tp -66.08 167.31 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.07 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.6 mt -129.0 72.8 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.33 -0.856 . . . . 0.0 110.459 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -95.87 47.82 1.11 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.264 -0.898 . . . . 0.0 108.999 179.014 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.67 166.43 16.92 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -86.04 6.89 26.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.75 -0.853 . . . . 0.0 110.375 179.066 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -113.95 -30.85 6.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.915 . . . . 0.0 110.067 179.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.3 169.67 17.15 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.435 -0.791 . . . . 0.0 110.507 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -153.1 143.41 22.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.608 -0.682 . . . . 0.0 110.258 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 132.64 -140.73 12.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -153.67 155.91 36.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.631 -0.923 . . . . 0.0 110.209 -179.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.9 m -134.94 169.5 17.31 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.6 -0.687 . . . . 0.0 110.281 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.5 p -151.66 150.17 29.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.613 -0.679 . . . . 0.0 110.133 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.445 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 7.3 t -156.36 142.86 18.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.593 -0.692 . . . . 0.0 110.236 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -67.07 124.18 22.33 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.585 -0.697 . . . . 0.0 110.24 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.01 140.58 25.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.524 -0.735 . . . . 0.0 110.208 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -58.54 -35.24 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.548 -0.72 . . . . 0.0 110.14 -179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -171.24 -170.79 0.87 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.564 -0.71 . . . . 0.0 110.159 179.546 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.68 -25.54 54.18 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.507 -0.746 . . . . 0.0 110.844 -179.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.64 -51.88 67.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.464 -0.773 . . . . 0.0 110.429 -179.778 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.8 m -84.56 -27.6 27.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.477 -0.764 . . . . 0.0 110.338 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.418 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . . . -61.39 -59.34 5.42 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.592 -0.692 . . . . 0.0 110.245 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -61.81 -32.63 72.95 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.569 -0.707 . . . . 0.0 110.268 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -57.87 -45.84 85.76 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.42 -0.8 . . . . 0.0 110.445 -179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.0 t -79.54 -42.57 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.61 -0.681 . . . . 0.0 109.879 179.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.445 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 12.5 m-85 -65.9 -33.85 76.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.631 -0.668 . . . . 0.0 110.182 -179.808 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -64.04 -47.39 80.38 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.305 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -63.64 -33.28 75.28 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.672 0.748 . . . . 0.0 109.081 178.789 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -64.32 -54.51 31.93 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.12 -40.17 95.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.825 -0.547 . . . . 0.0 110.014 179.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -58.95 -37.29 76.41 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.532 -0.73 . . . . 0.0 110.488 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -64.19 -40.03 95.23 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.55 -0.719 . . . . 0.0 110.265 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -86.38 -29.03 23.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.543 -0.723 . . . . 0.0 110.15 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.74 49.68 1.36 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.425 HG22 HD13 ' A' ' 40' ' ' ILE . 84.8 mt -103.4 62.7 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.603 -0.939 . . . . 0.0 110.286 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -85.12 58.57 5.11 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.99 -138.97 6.22 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 -178.848 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -116.74 102.94 9.85 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.497 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -72.79 141.39 48.07 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.101 0.953 . . . . 0.0 112.401 -177.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.4 132.45 19.27 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.299 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.405 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 53.9 t80 -105.53 113.24 26.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.635 -0.666 . . . . 0.0 110.128 -178.485 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.87 104.12 14.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.702 -0.624 . . . . 0.0 109.826 179.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -65.04 -24.83 67.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.676 -0.64 . . . . 0.0 110.553 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.95 -34.81 60.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.414 -0.804 . . . . 0.0 110.787 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.1 p -144.9 15.66 1.56 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.621 -0.674 . . . . 0.0 110.982 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 50.3 90.34 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.129 -0.982 . . . . 0.0 111.097 179.81 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.7 m -154.89 107.15 2.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.538 -0.726 . . . . 0.0 110.853 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CZ ' ' HB2' ' A' ' 27' ' ' ALA . 82.6 m-85 -62.08 125.4 23.75 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.483 -0.761 . . . . 0.0 109.041 178.858 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.5 m -120.27 100.01 6.92 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.251 -0.98 . . . . 0.0 112.54 -178.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.417 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.8 p -103.7 167.28 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.39 -0.819 . . . . 0.0 109.212 177.597 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.2 m -160.65 109.89 1.69 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.667 -0.646 . . . . 0.0 109.762 -179.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.249 -179.922 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.007 0.432 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.459 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 89.2 m -83.72 111.56 19.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.594 -0.691 . . . . 0.0 110.222 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.1 t -80.99 105.86 12.55 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.634 -0.666 . . . . 0.0 110.503 -179.854 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.459 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 60.4 m-85 -90.37 164.42 14.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.447 -0.783 . . . . 0.0 109.966 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.1 mttm -130.38 122.29 27.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.461 -0.775 . . . . 0.0 110.569 179.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.424 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -105.5 110.55 22.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.527 -0.733 . . . . 0.0 109.939 179.81 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 tp -62.74 166.9 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.353 -0.842 . . . . 0.0 109.007 179.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.8 mt -130.8 72.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.303 -0.873 . . . . 0.0 110.489 -179.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 -97.12 49.58 1.06 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.449 -0.782 . . . . 0.0 109.257 179.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.71 163.25 12.49 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -78.18 -2.05 35.7 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.646 -0.914 . . . . 0.0 110.874 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.5 m -107.34 -28.03 10.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.232 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mp -135.13 164.8 26.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.521 -0.737 . . . . 0.0 110.303 179.749 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -154.71 126.78 7.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.571 -0.706 . . . . 0.0 110.313 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.07 -140.01 11.33 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -144.85 171.77 13.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.637 -0.92 . . . . 0.0 110.376 -179.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 t -154.98 157.79 38.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.628 -0.67 . . . . 0.0 109.976 179.822 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.9 p -140.42 149.43 42.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.546 -0.721 . . . . 0.0 110.513 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.448 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 8.5 t -146.35 162.15 38.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.626 -0.671 . . . . 0.0 109.994 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -88.22 107.16 18.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.567 -0.708 . . . . 0.0 110.281 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.96 138.56 50.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.611 -0.681 . . . . 0.0 110.1 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.68 -31.81 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.614 -0.679 . . . . 0.0 110.248 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 p30 -171.32 179.99 2.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.504 -0.747 . . . . 0.0 110.377 179.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.45 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.79 -31.47 64.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.489 -0.757 . . . . 0.0 110.78 -179.573 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.27 -28.47 68.09 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.536 -0.727 . . . . 0.0 110.266 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.3 m -108.14 -27.99 9.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.58 -0.7 . . . . 0.0 110.304 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.456 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -60.2 -54.95 39.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.508 -0.745 . . . . 0.0 110.236 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -60.06 -31.82 70.36 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.573 -0.705 . . . . 0.0 110.239 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -58.26 -40.62 82.29 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.342 -0.849 . . . . 0.0 110.35 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.0 t -82.19 -44.93 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.585 -0.697 . . . . 0.0 109.851 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.448 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 9.1 m-85 -65.85 -37.84 87.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.65 -0.656 . . . . 0.0 110.229 -179.808 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -62.07 -46.05 90.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.465 -0.772 . . . . 0.0 109.387 179.665 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -62.47 -34.24 76.44 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.782 0.801 . . . . 0.0 109.339 179.083 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.64 -49.36 68.96 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.25 -45.15 57.53 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.769 -0.582 . . . . 0.0 110.444 -179.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -56.26 -39.84 73.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.423 -0.798 . . . . 0.0 110.617 -179.715 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -75.13 -31.54 61.11 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.606 -0.684 . . . . 0.0 110.11 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -80.14 -40.89 26.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.546 -0.721 . . . . 0.0 110.006 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.43 37.15 0.94 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.41 ' CG2' ' CG1' ' A' ' 55' ' ' VAL . 84.7 mt -103.64 62.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.528 -0.984 . . . . 0.0 110.174 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -85.67 57.35 4.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.51 -0.744 . . . . 0.0 109.008 178.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.47 -138.69 5.23 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -178.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -116.3 105.14 12.21 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.43 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -74.63 142.22 44.59 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.182 0.992 . . . . 0.0 112.459 -177.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.05 132.59 17.72 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.452 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -106.48 111.74 24.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.646 -0.659 . . . . 0.0 110.262 -178.357 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.16 112.02 20.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.694 -0.629 . . . . 0.0 109.778 179.662 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -70.32 -21.78 62.88 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.639 -0.663 . . . . 0.0 110.663 -179.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.94 -35.24 58.41 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.311 -0.868 . . . . 0.0 110.955 -179.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.9 p -148.16 18.41 1.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.537 -0.727 . . . . 0.0 110.932 -179.944 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.409 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.72 93.14 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.182 -0.949 . . . . 0.0 110.989 179.713 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.4 m -158.66 104.68 1.79 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.454 -0.779 . . . . 0.0 110.886 -179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -61.05 128.52 36.82 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.423 -0.798 . . . . 0.0 109.149 179.014 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 85.0 m -120.7 101.21 7.58 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.522 -178.404 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.41 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 9.5 p -103.9 166.87 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.863 . . . . 0.0 109.309 177.599 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.0 m -160.72 110.02 1.68 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.62 -0.675 . . . . 0.0 109.835 -179.736 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.19 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.042 0.449 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.458 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 55.0 m -92.71 111.89 23.65 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.551 -0.718 . . . . 0.0 110.149 179.877 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.6 m -106.66 96.1 6.21 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.585 -0.697 . . . . 0.0 110.624 -179.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.458 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 92.1 m-85 -73.59 -178.85 3.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.538 -0.726 . . . . 0.0 109.838 179.606 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -146.74 110.75 5.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.49 -0.756 . . . . 0.0 110.289 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.415 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -92.27 110.67 22.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.502 -0.749 . . . . 0.0 110.364 -179.771 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 tp -64.22 170.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.286 -0.884 . . . . 0.0 108.653 178.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 78.0 mt -131.53 74.2 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.245 -0.909 . . . . 0.0 110.722 -179.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -96.07 47.13 1.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.458 -0.776 . . . . 0.0 109.052 179.022 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.1 161.9 13.29 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.602 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -79.74 -0.53 34.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.771 -0.84 . . . . 0.0 110.587 179.315 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -104.79 -30.82 9.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.981 . . . . 0.0 109.928 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.8 mt -138.54 166.02 25.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.635 -0.666 . . . . 0.0 110.363 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -154.63 132.81 11.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.573 -0.704 . . . . 0.0 110.202 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.89 -147.29 19.12 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -144.88 122.25 11.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.555 -0.967 . . . . 0.0 110.368 179.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.5 m -109.67 149.81 29.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.631 -0.668 . . . . 0.0 110.253 179.967 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.8 p -131.94 162.41 30.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.56 -0.712 . . . . 0.0 110.164 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.441 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 7.6 t -142.93 -172.55 3.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.561 -0.712 . . . . 0.0 110.328 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -123.53 89.36 3.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.614 -0.679 . . . . 0.0 110.153 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -116.19 -177.25 3.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.585 -0.697 . . . . 0.0 109.982 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.17 -24.88 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.728 . . . . 0.0 110.326 179.822 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -168.11 175.56 6.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.452 -0.78 . . . . 0.0 110.156 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.88 -25.14 60.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.516 -0.74 . . . . 0.0 110.744 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.7 -27.96 66.89 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.472 -0.767 . . . . 0.0 110.502 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.4 m -109.27 -27.23 9.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.551 -0.718 . . . . 0.0 110.417 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . . . -62.0 -62.96 1.42 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.505 -0.747 . . . . 0.0 110.407 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -58.17 -41.65 84.33 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.519 -0.738 . . . . 0.0 110.528 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.6 tttm -55.68 -42.49 75.24 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.362 -0.836 . . . . 0.0 110.314 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.2 t -80.27 -48.13 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.674 . . . . 0.0 109.934 179.545 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.441 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 5.4 m-85 -62.05 -33.75 74.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.585 -0.697 . . . . 0.0 110.22 -179.676 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -63.7 -43.84 95.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.425 -0.797 . . . . 0.0 108.924 179.19 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -62.71 -33.5 75.23 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.728 0.775 . . . . 0.0 109.298 178.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -67.26 -56.48 9.63 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.56 -41.44 94.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.736 -0.602 . . . . 0.0 110.302 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -58.11 -36.93 73.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.51 -0.744 . . . . 0.0 110.605 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.38 -42.4 68.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.545 -0.722 . . . . 0.0 110.18 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -77.77 -28.93 50.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.573 -0.705 . . . . 0.0 110.215 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.88 55.06 0.95 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.422 HG22 HD12 ' A' ' 40' ' ' ILE . 84.0 mt -115.44 59.7 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.485 -1.009 . . . . 0.0 110.353 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.15 60.77 5.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.658 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.05 -138.93 7.97 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -178.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -115.4 103.57 10.91 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.948 -0.736 . . . . 0.0 109.28 179.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -73.92 143.38 45.77 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.146 0.974 . . . . 0.0 112.497 -177.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -151.22 133.31 15.21 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 178.656 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -104.0 139.17 39.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.593 -0.692 . . . . 0.0 110.313 -178.41 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -112.74 113.57 25.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.687 -0.633 . . . . 0.0 109.976 179.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -69.68 -21.37 63.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.701 -0.624 . . . . 0.0 110.847 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.6 -40.48 65.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.293 -0.879 . . . . 0.0 110.814 -179.592 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 66.5 p -148.84 20.28 1.01 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.555 -0.716 . . . . 0.0 110.597 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.426 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER 52.1 93.46 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.174 -0.954 . . . . 0.0 110.63 179.948 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.6 m -151.41 103.17 2.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.497 -0.752 . . . . 0.0 111.112 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 27' ' ' ALA . 78.2 m-85 -63.44 123.41 18.68 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.451 -0.781 . . . . 0.0 109.018 178.786 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.9 m -116.92 103.78 10.63 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.323 -0.951 . . . . 0.0 112.619 -178.349 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.42 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.4 p -106.02 168.27 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.409 -0.807 . . . . 0.0 109.002 177.396 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.7 m -160.2 108.9 1.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.543 -0.723 . . . . 0.0 110.028 -179.558 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.168 179.884 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.157 0.503 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.444 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 79.1 m -102.84 112.19 24.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.567 -0.708 . . . . 0.0 110.278 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.1 t -89.44 99.39 12.4 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.65 -0.656 . . . . 0.0 110.585 -179.844 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.444 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 90.6 m-85 -80.68 176.56 9.69 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.364 -0.835 . . . . 0.0 110.005 179.885 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -141.95 110.46 6.07 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.428 -0.795 . . . . 0.0 110.272 -179.972 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -93.62 111.54 23.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.489 -0.757 . . . . 0.0 110.467 -179.92 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.5 tp -64.18 170.29 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.948 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 77.8 mt -132.43 74.72 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.772 -179.788 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -95.72 49.33 1.16 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.811 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.43 160.75 13.17 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.327 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -80.6 -0.16 36.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.769 -0.842 . . . . 0.0 110.47 179.015 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -102.14 -31.81 10.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.134 -0.979 . . . . 0.0 109.951 179.855 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -144.9 170.49 16.04 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.508 -0.745 . . . . 0.0 110.401 -179.978 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -154.12 142.77 20.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.618 -0.676 . . . . 0.0 110.374 -179.793 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.55 -164.34 21.02 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -119.88 145.31 46.8 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.551 -0.97 . . . . 0.0 110.315 -179.955 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 m -121.75 146.2 47.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.586 -0.696 . . . . 0.0 110.225 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.9 p -130.08 166.94 19.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.57 -0.706 . . . . 0.0 110.179 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.452 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 7.4 t -167.01 -179.5 4.69 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.568 -0.708 . . . . 0.0 110.3 -179.921 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -112.55 101.18 9.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.546 -0.721 . . . . 0.0 110.209 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.48 146.21 50.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.589 -0.694 . . . . 0.0 110.219 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.1 p -70.17 -26.28 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.546 -0.721 . . . . 0.0 110.186 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -170.37 177.94 3.92 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.412 -0.805 . . . . 0.0 110.465 179.734 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.42 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.13 -25.84 47.71 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.578 -0.701 . . . . 0.0 111.139 -179.425 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.11 -39.26 81.72 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.372 -0.83 . . . . 0.0 110.334 -179.776 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.6 m -94.41 -29.63 14.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.594 -0.691 . . . . 0.0 110.087 179.914 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.419 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -61.02 -55.91 27.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.595 -0.69 . . . . 0.0 110.226 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -61.97 -37.32 84.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.568 -0.708 . . . . 0.0 110.3 -179.949 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -58.36 -41.9 85.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.379 -0.825 . . . . 0.0 110.387 -179.958 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.8 t -81.37 -44.21 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.558 -0.714 . . . . 0.0 109.813 179.666 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.452 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 11.2 m-85 -65.75 -36.46 83.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.602 -0.686 . . . . 0.0 110.192 -179.861 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -63.13 -45.17 93.23 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.469 -0.769 . . . . 0.0 109.15 179.366 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -63.25 -31.06 72.12 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.657 0.742 . . . . 0.0 109.27 178.713 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -69.67 -51.06 38.06 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.866 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.31 -41.27 76.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.627 -0.671 . . . . 0.0 110.002 179.9 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -58.49 -44.53 89.43 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.746 . . . . 0.0 110.423 -179.977 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.74 -46.21 83.18 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.59 -0.694 . . . . 0.0 110.204 -179.952 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -70.84 -50.19 38.01 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.535 -0.728 . . . . 0.0 110.07 179.941 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.61 58.08 0.19 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.463 HG23 HD13 ' A' ' 40' ' ' ILE . 82.2 mt -116.05 59.82 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.548 -0.971 . . . . 0.0 110.234 179.826 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.97 62.89 3.51 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.872 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.18 -141.99 12.84 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -178.813 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -114.73 111.47 21.31 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.944 -0.739 . . . . 0.0 109.039 179.152 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -80.39 143.22 33.66 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.038 0.923 . . . . 0.0 112.264 -177.887 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 p -152.17 133.62 14.54 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 178.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -104.09 139.98 38.41 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.194 -178.636 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -109.54 108.9 19.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.65 -0.656 . . . . 0.0 109.938 179.724 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -67.62 -21.08 65.41 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.707 -0.621 . . . . 0.0 110.759 -179.866 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.15 -41.79 72.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.29 -0.881 . . . . 0.0 110.747 -179.726 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 67.2 p -146.84 21.75 1.26 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.6 -0.688 . . . . 0.0 110.617 -179.932 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.31 95.32 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.235 -0.916 . . . . 0.0 110.753 179.804 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.8 m -154.81 102.75 2.38 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.213 -179.841 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 27' ' ' ALA . 71.4 m-85 -63.81 128.9 37.86 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.708 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.1 m -122.65 106.76 11.24 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.588 -178.583 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.412 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.0 p -110.69 167.35 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.436 -0.79 . . . . 0.0 109.143 177.481 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 78.7 m -161.39 111.42 1.65 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.642 -0.661 . . . . 0.0 109.83 -179.791 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.137 179.903 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.08 0.467 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.455 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 68.5 m -143.29 112.27 6.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.638 -0.664 . . . . 0.0 110.137 179.971 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.4 m -84.43 94.31 8.49 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.606 -0.684 . . . . 0.0 110.698 -179.679 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.455 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 96.7 m-85 -77.47 177.86 7.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.521 -0.737 . . . . 0.0 109.736 179.518 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm -142.93 112.11 6.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.417 -0.802 . . . . 0.0 110.608 -179.897 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.432 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -94.14 116.84 29.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.523 -0.736 . . . . 0.0 110.378 179.95 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 tt -70.79 173.38 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.457 -0.777 . . . . 0.0 109.023 179.287 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.402 ' HB ' ' N ' ' A' ' 15' ' ' GLY . 83.0 mt -132.63 75.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.835 . . . . 0.0 110.161 179.903 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.01 45.2 1.04 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.526 -0.734 . . . . 0.0 109.204 179.379 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.04 158.92 15.89 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.74 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -76.7 -3.61 38.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.705 -0.879 . . . . 0.0 110.598 179.358 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 m -101.84 -33.1 9.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 110.217 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.0 mt -132.7 175.29 9.46 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.497 -0.752 . . . . 0.0 110.483 179.932 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -159.69 133.46 7.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.651 -0.656 . . . . 0.0 110.125 -179.866 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.402 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 132.46 -145.9 17.71 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.826 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -135.97 175.52 9.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.529 -0.983 . . . . 0.0 110.321 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.9 m -150.73 134.42 16.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.527 -0.733 . . . . 0.0 110.262 179.899 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.3 p -121.56 161.82 21.69 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.537 -0.727 . . . . 0.0 110.335 -179.968 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.447 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 9.1 t -165.66 -179.52 5.43 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.56 -0.712 . . . . 0.0 110.272 179.921 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.42 119.58 39.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.607 -0.683 . . . . 0.0 110.061 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.07 139.03 24.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.585 -0.697 . . . . 0.0 110.142 -179.892 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.0 m -57.98 -33.71 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.474 -0.766 . . . . 0.0 110.598 -179.932 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.4 p30 -170.35 -174.21 1.64 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.519 -0.738 . . . . 0.0 110.33 179.84 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.405 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.46 -27.15 56.12 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.523 -0.735 . . . . 0.0 110.739 -179.755 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.74 -26.46 65.67 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.474 -0.766 . . . . 0.0 110.32 179.861 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.2 m -110.0 -27.38 9.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.539 -0.725 . . . . 0.0 110.249 179.908 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.451 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -59.55 -60.68 3.45 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.624 -0.672 . . . . 0.0 110.361 -179.917 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -59.93 -36.15 76.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.555 -0.716 . . . . 0.0 110.158 -179.985 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -57.66 -45.23 85.81 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.461 -0.774 . . . . 0.0 110.49 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.03 -43.91 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.561 -0.712 . . . . 0.0 110.134 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.447 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 8.0 m-85 -66.77 -34.06 76.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.583 -0.698 . . . . 0.0 110.291 -179.679 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -63.95 -40.57 96.73 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.393 -0.817 . . . . 0.0 108.897 179.212 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -63.35 -33.92 76.58 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.733 0.777 . . . . 0.0 109.239 179.003 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.68 -59.31 3.7 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.735 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.85 -46.78 88.2 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.752 -0.592 . . . . 0.0 110.275 179.894 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -55.95 -27.96 54.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.524 -0.735 . . . . 0.0 110.712 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.89 -52.56 49.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.577 -0.702 . . . . 0.0 109.973 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -78.13 -45.0 24.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.596 -0.69 . . . . 0.0 109.994 179.856 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.47 53.16 0.18 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.769 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.423 HG21 HD11 ' A' ' 40' ' ' ILE . 84.1 mt -103.13 63.03 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.514 -0.992 . . . . 0.0 110.052 179.63 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.92 56.35 3.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.414 -0.804 . . . . 0.0 108.907 178.879 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.56 -137.31 3.66 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.123 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -116.03 101.16 8.5 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.403 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -71.77 142.52 49.71 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.998 0.904 . . . . 0.0 111.846 -178.197 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 p -151.24 132.19 14.24 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.939 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -103.17 139.35 38.77 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.679 -0.638 . . . . 0.0 110.108 -178.701 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.25 104.76 13.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.775 -0.578 . . . . 0.0 109.511 179.432 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -63.2 -20.87 65.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.676 -0.64 . . . . 0.0 110.798 -179.568 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.26 -40.05 67.44 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.287 -0.883 . . . . 0.0 110.703 -179.765 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.0 p -148.14 21.84 1.09 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.621 -0.674 . . . . 0.0 110.516 179.998 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.56 91.36 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.198 -0.939 . . . . 0.0 110.743 179.976 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 20.4 m -150.23 98.54 2.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.462 -0.774 . . . . 0.0 111.23 -179.807 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 27' ' ' ALA . 66.3 m-85 -61.81 127.8 33.17 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.391 -0.818 . . . . 0.0 108.959 178.656 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 91.7 m -123.67 107.63 11.69 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.451 -178.499 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.403 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.6 p -107.96 167.4 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.358 -0.839 . . . . 0.0 108.917 177.401 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.2 m -160.7 111.01 1.77 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.636 -0.665 . . . . 0.0 109.984 -179.703 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.102 179.811 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 mtt . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.099 0.476 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.452 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 86.6 m -97.62 112.72 24.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.547 -0.72 . . . . 0.0 110.155 -179.99 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 t -82.36 99.94 9.68 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.628 -0.67 . . . . 0.0 110.503 -179.95 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.452 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 89.6 m-85 -84.76 170.52 13.15 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.351 -0.843 . . . . 0.0 109.771 179.696 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.5 tttt -139.96 115.31 9.89 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.417 -0.802 . . . . 0.0 110.466 -179.946 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.429 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -96.95 113.16 24.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.5 -0.75 . . . . 0.0 110.479 -179.915 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.7 tp -65.42 170.01 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.133 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 83.8 mt -131.17 73.17 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.237 179.734 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.18 48.15 1.23 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.475 -0.766 . . . . 0.0 109.092 179.094 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.97 156.0 15.81 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.464 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -74.18 -6.35 47.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.746 -0.855 . . . . 0.0 110.408 179.185 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.8 m -94.94 -31.52 13.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.167 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.47 164.51 33.13 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.489 -0.757 . . . . 0.0 110.604 -179.869 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -144.73 140.27 28.45 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.62 -0.675 . . . . 0.0 110.311 -179.877 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 132.6 -144.47 16.33 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -144.26 162.34 36.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.505 -0.997 . . . . 0.0 110.281 -179.979 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.4 m -137.8 143.44 41.06 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.598 -0.689 . . . . 0.0 109.951 179.788 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.2 p -127.21 153.67 45.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.592 -0.692 . . . . 0.0 110.297 -179.874 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.441 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 9.0 t -159.04 156.14 28.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.605 -0.685 . . . . 0.0 110.236 179.848 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -86.23 123.76 31.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.579 -0.701 . . . . 0.0 110.148 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.14 144.9 29.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.595 -0.691 . . . . 0.0 110.271 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.18 -36.06 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.565 -0.709 . . . . 0.0 110.195 -179.998 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -170.81 -168.38 0.67 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.561 -0.712 . . . . 0.0 110.389 179.787 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.88 -33.52 66.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.593 -0.692 . . . . 0.0 111.214 -179.287 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -55.02 -48.05 73.89 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.349 -0.845 . . . . 0.0 110.826 -179.51 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.9 m -85.87 -27.54 24.99 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.543 -0.723 . . . . 0.0 110.306 179.998 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . . . -60.42 -61.21 2.76 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.537 -0.727 . . . . 0.0 110.303 -179.922 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -59.81 -38.79 82.95 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.554 -0.716 . . . . 0.0 110.382 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -55.95 -40.44 73.22 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.326 -0.859 . . . . 0.0 110.617 -179.893 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.5 t -82.05 -47.36 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.588 -0.695 . . . . 0.0 110.148 179.863 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.441 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 8.1 m-85 -64.68 -35.25 80.42 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.529 -0.732 . . . . 0.0 110.292 -179.771 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.59 -43.81 95.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.498 -0.751 . . . . 0.0 109.17 179.441 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -60.77 -32.39 71.71 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.677 0.751 . . . . 0.0 109.539 179.07 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -68.86 -55.44 11.08 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.881 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.55 -44.18 87.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.746 -0.596 . . . . 0.0 110.209 -179.948 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -56.24 -32.13 64.19 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.491 -0.756 . . . . 0.0 110.439 -179.839 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -70.48 -52.77 19.65 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.649 -0.657 . . . . 0.0 109.883 179.692 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -68.54 -41.68 79.52 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.596 -0.69 . . . . 0.0 109.759 179.652 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.44 44.05 0.62 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.685 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.415 ' CG2' ' CG1' ' A' ' 55' ' ' VAL . 81.2 mt -96.51 63.1 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.522 -0.987 . . . . 0.0 110.204 179.762 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -83.73 58.52 4.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.578 -0.701 . . . . 0.0 109.292 179.163 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.47 -137.69 5.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.33 100.95 7.63 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.183 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -69.73 142.68 53.25 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.131 0.967 . . . . 0.0 112.489 -177.775 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -149.88 131.81 15.19 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.567 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.8 t80 -106.29 134.84 48.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.638 -0.663 . . . . 0.0 110.159 -178.454 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.61 110.5 22.71 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.661 -0.649 . . . . 0.0 109.848 179.57 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -67.3 -24.64 65.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.637 -0.664 . . . . 0.0 110.623 -179.672 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.42 -37.44 56.74 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.325 -0.859 . . . . 0.0 110.899 -179.655 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.1 p -145.93 16.83 1.41 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.623 -0.673 . . . . 0.0 110.839 179.837 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.417 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.13 93.06 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.084 -1.01 . . . . 0.0 110.729 179.939 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.9 m -155.49 104.06 2.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.523 -0.736 . . . . 0.0 111.051 -179.697 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 27' ' ' ALA . 86.1 m-85 -62.44 132.17 51.64 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.498 -0.751 . . . . 0.0 109.037 178.88 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 77.1 m -126.9 105.17 8.45 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.396 -0.922 . . . . 0.0 112.426 -178.686 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.415 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 9.2 p -107.2 166.43 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.341 -0.85 . . . . 0.0 109.443 177.694 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.9 m -162.33 117.02 1.85 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.673 -0.642 . . . . 0.0 110.107 -179.525 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.124 179.456 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.6 mtt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.108 0.48 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.417 HG22 ' CE2' ' A' ' 4' ' ' PHE . 62.2 m -120.65 112.57 19.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.558 -0.714 . . . . 0.0 110.383 -179.962 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.7 m -94.26 93.43 7.74 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.508 -0.745 . . . . 0.0 110.481 -179.835 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.452 ' CD2' ' CB ' ' A' ' 27' ' ' ALA . 97.5 m-85 -71.77 169.72 15.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.579 -0.701 . . . . 0.0 109.978 179.824 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -136.22 114.15 11.28 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.532 -0.73 . . . . 0.0 110.413 -179.825 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.447 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -93.98 111.98 23.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.485 -0.759 . . . . 0.0 110.554 -179.969 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.6 tp -63.51 171.06 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.061 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 82.8 mt -133.05 74.03 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.559 -179.91 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -96.16 46.46 1.08 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.854 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.05 156.83 16.72 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.692 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -75.48 -5.83 47.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.766 -0.844 . . . . 0.0 110.383 179.117 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -93.88 -34.74 13.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.136 179.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.52 -176.34 4.51 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.536 -179.994 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -163.47 134.56 4.7 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.644 -0.66 . . . . 0.0 110.167 -179.953 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.89 -141.93 12.97 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.932 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -138.88 161.81 36.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.573 -0.957 . . . . 0.0 110.306 -179.796 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.1 m -136.87 140.34 42.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.581 -0.699 . . . . 0.0 110.175 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.7 p -129.55 159.44 36.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.492 -0.755 . . . . 0.0 110.398 -179.794 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.45 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 8.9 t -162.14 171.31 17.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.566 -0.709 . . . . 0.0 110.231 179.657 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.13 105.45 16.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.552 -0.718 . . . . 0.0 110.155 179.982 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.17 139.03 49.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.542 -0.724 . . . . 0.0 110.232 179.89 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 p -59.4 -33.36 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.566 -0.709 . . . . 0.0 110.179 179.953 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.3 p30 -170.04 -179.36 3.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.554 -0.716 . . . . 0.0 110.344 179.887 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.2 -24.83 44.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.49 -0.756 . . . . 0.0 110.862 -179.831 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.68 -30.48 67.41 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.447 -0.783 . . . . 0.0 110.472 -179.776 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.2 m -109.48 -27.13 9.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.525 -0.735 . . . . 0.0 110.313 179.936 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.452 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -60.35 -42.77 96.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.501 -0.749 . . . . 0.0 110.127 179.916 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.87 -45.76 63.84 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.66 -0.65 . . . . 0.0 110.251 179.84 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -56.04 -31.9 63.56 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.243 -0.911 . . . . 0.0 110.551 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.0 t -87.01 -48.44 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.652 -0.655 . . . . 0.0 110.104 -179.937 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.45 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 6.3 m-85 -67.56 -38.79 84.63 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.981 -179.731 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -62.63 -43.87 97.71 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.515 -0.741 . . . . 0.0 109.093 179.226 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.6 tp60 -64.04 -34.12 77.29 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.761 0.791 . . . . 0.0 109.123 178.792 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -64.91 -57.71 8.07 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.676 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.96 -40.76 85.7 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.777 -0.577 . . . . 0.0 110.292 -179.895 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -58.01 -36.74 73.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.539 -0.726 . . . . 0.0 110.467 -179.879 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.96 -44.47 89.29 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.556 -0.715 . . . . 0.0 109.825 179.773 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -77.57 -40.37 42.58 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.673 -0.642 . . . . 0.0 109.971 179.729 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.87 40.83 0.88 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.82 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.425 HD13 HG22 ' A' ' 40' ' ' ILE . 75.8 mt -97.52 63.73 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.52 -0.988 . . . . 0.0 110.239 179.799 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -85.64 57.38 4.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.492 -0.755 . . . . 0.0 109.09 178.895 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.64 -139.32 6.17 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -178.839 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.55 108.72 17.92 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.859 -0.789 . . . . 0.0 109.008 179.455 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -79.59 142.49 35.63 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.118 0.961 . . . . 0.0 112.349 -177.794 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.2 p -153.7 131.9 11.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.786 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.4 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 21.8 t80 -97.04 125.48 41.51 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.701 -0.625 . . . . 0.0 110.202 -178.506 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -87.72 98.46 11.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.751 -0.593 . . . . 0.0 109.746 179.584 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -63.4 -19.19 64.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.589 -0.694 . . . . 0.0 110.767 -179.767 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -55.6 -42.54 74.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.269 -0.895 . . . . 0.0 110.661 -179.77 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 75.2 p -148.45 27.82 0.9 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.627 -0.671 . . . . 0.0 110.356 -179.871 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.417 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 5.6 mptt 52.52 96.8 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.336 -0.853 . . . . 0.0 110.809 -179.964 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.0 m -158.19 104.25 1.86 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.45 -0.781 . . . . 0.0 110.829 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -63.05 131.86 50.02 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.522 -0.736 . . . . 0.0 109.026 178.969 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 80.7 m -125.77 110.11 13.33 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.432 -0.907 . . . . 0.0 112.421 -178.528 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.423 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.3 p -114.35 167.4 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.37 -0.831 . . . . 0.0 109.35 177.726 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 85.3 m -161.65 112.34 1.66 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.623 -0.673 . . . . 0.0 110.084 -179.649 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.172 179.764 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtm . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.1 0.476 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.458 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 40.2 m -101.27 112.94 25.59 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.581 -0.7 . . . . 0.0 110.371 -179.861 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 m -89.23 91.91 8.96 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.604 -0.685 . . . . 0.0 110.615 -179.791 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.458 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 97.3 m-85 -74.08 170.07 16.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.45 -0.781 . . . . 0.0 109.834 179.661 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -134.23 114.55 13.16 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.419 -0.801 . . . . 0.0 110.323 179.901 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.427 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -94.87 110.69 22.54 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.687 . . . . 0.0 110.399 -179.948 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 tt -65.46 162.64 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.044 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 8' ' ' ILE . 49.0 mm -125.37 76.97 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.397 -179.741 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -96.13 47.33 1.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.991 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.23 159.58 13.82 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.217 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.0 tptt -77.83 -3.24 40.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.787 -0.831 . . . . 0.0 110.394 179.163 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.5 m -99.79 -32.01 11.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 110.14 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.9 mt -140.49 173.98 10.97 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.508 -0.745 . . . . 0.0 110.559 -179.916 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -160.73 135.98 7.84 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.63 -0.669 . . . . 0.0 109.994 179.795 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.07 -144.49 16.46 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -137.47 151.65 48.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.564 -0.963 . . . . 0.0 110.446 -179.851 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 m -130.84 144.87 51.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.613 -0.679 . . . . 0.0 110.08 179.857 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.8 p -131.8 139.8 48.99 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.549 -0.719 . . . . 0.0 110.355 -179.837 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.451 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 7.9 t -146.04 134.01 21.4 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 110.353 179.942 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.91 129.1 39.36 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.592 -0.692 . . . . 0.0 110.455 -179.919 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.53 140.67 19.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.561 -0.712 . . . . 0.0 109.989 179.887 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -58.58 -36.36 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.479 -0.763 . . . . 0.0 110.225 -179.949 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 39.4 p30 -169.92 -176.01 2.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.578 -0.701 . . . . 0.0 110.209 179.621 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.453 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.57 -26.36 54.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.535 -0.728 . . . . 0.0 110.786 -179.667 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.48 -29.6 67.94 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.467 -0.771 . . . . 0.0 110.319 -179.895 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.7 m -106.26 -27.39 11.06 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.583 -0.698 . . . . 0.0 110.382 179.952 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.426 ' HB3' ' CD2' ' A' ' 4' ' ' PHE . . . -59.73 -50.04 75.4 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.481 -0.762 . . . . 0.0 110.32 -179.981 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -62.19 -46.22 89.89 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.591 -0.693 . . . . 0.0 110.078 179.862 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -55.73 -34.68 65.37 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.445 -0.784 . . . . 0.0 110.873 -179.801 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.2 t -84.66 -47.65 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.502 -0.749 . . . . 0.0 110.274 -179.829 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.451 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 7.5 m-85 -68.11 -37.88 81.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.547 -0.721 . . . . 0.0 110.188 -179.76 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -62.26 -45.78 91.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.73 . . . . 0.0 109.367 179.661 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -60.95 -29.91 69.92 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.608 0.718 . . . . 0.0 109.619 179.004 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -72.53 -59.16 2.86 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.832 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.68 -49.42 77.57 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.728 -0.608 . . . . 0.0 110.194 179.986 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -56.1 -33.0 64.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.547 -0.721 . . . . 0.0 110.666 -179.816 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.16 -31.23 49.57 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.58 -0.7 . . . . 0.0 110.025 179.886 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -83.47 -47.26 11.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.602 -0.686 . . . . 0.0 110.028 179.908 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.93 48.88 0.15 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.93 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.414 ' CG2' ' CG1' ' A' ' 55' ' ' VAL . 79.1 mt -116.26 58.52 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.505 -0.997 . . . . 0.0 110.391 179.935 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -81.35 60.55 4.46 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.433 -0.792 . . . . 0.0 109.013 178.918 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.96 -139.68 8.88 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -178.87 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -114.43 110.25 19.57 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.397 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -80.31 142.93 34.04 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.131 0.967 . . . . 0.0 112.456 -177.852 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.0 p -153.04 130.95 11.73 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.853 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.403 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 14.3 t80 -102.07 128.76 48.38 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.693 -0.629 . . . . 0.0 109.848 -178.742 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.6 110.67 22.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.712 -0.617 . . . . 0.0 109.887 179.726 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -69.69 -22.9 63.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.706 -0.621 . . . . 0.0 110.686 -179.913 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.92 -39.56 68.95 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.424 -0.798 . . . . 0.0 110.939 -179.769 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.8 p -145.77 19.22 1.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.53 -0.731 . . . . 0.0 110.974 -179.873 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.403 ' HG3' ' CE2' ' A' ' 46' ' ' TYR . 0.3 OUTLIER 51.88 95.65 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.23 -0.918 . . . . 0.0 110.957 179.7 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.1 m -158.7 106.46 1.87 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.499 -0.75 . . . . 0.0 110.683 179.83 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 27' ' ' ALA . 69.3 m-85 -63.65 129.38 39.92 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.948 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 56.7 m -123.25 107.2 11.42 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.36 -178.472 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.414 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.6 p -110.82 167.16 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.845 . . . . 0.0 109.436 177.791 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 83.7 m -161.61 116.37 2.0 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.652 -0.655 . . . . 0.0 110.06 -179.782 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 . . . . . 0 N--CA 1.498 1.951 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.387 179.746 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mmt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.175 0.512 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.425 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 32.7 m -119.1 112.39 19.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.58 -0.7 . . . . 0.0 110.222 179.922 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 51.3 m -95.08 91.31 6.28 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.622 -0.674 . . . . 0.0 110.492 -179.767 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.444 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 96.8 m-85 -69.89 172.43 7.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.548 -0.72 . . . . 0.0 109.836 179.713 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -140.59 116.31 10.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.476 -0.765 . . . . 0.0 110.555 -179.659 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.431 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -96.27 112.77 24.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.536 -0.727 . . . . 0.0 110.423 -179.9 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.2 tp -63.01 172.67 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.005 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 74.2 mt -135.61 70.24 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.209 -0.932 . . . . 0.0 110.974 -179.724 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -93.59 50.12 1.44 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.316 -0.865 . . . . 0.0 109.033 178.539 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.04 155.31 16.18 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.303 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -11.82 61.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.639 -0.918 . . . . 0.0 110.247 179.138 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -86.75 -36.11 18.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 110.332 -179.849 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.8 mt -138.67 -173.26 3.51 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 110.655 -179.912 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.15 127.08 2.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.603 -0.685 . . . . 0.0 110.345 179.94 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.99 -137.85 9.45 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.858 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -143.92 173.38 11.76 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.553 -0.969 . . . . 0.0 110.396 -179.858 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.4 m -153.26 146.8 25.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.622 -0.674 . . . . 0.0 110.175 179.864 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.3 p -132.5 170.19 15.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.628 -0.67 . . . . 0.0 110.226 179.965 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.446 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 8.3 t -165.58 179.43 6.07 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.573 -0.705 . . . . 0.0 110.166 -179.938 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -104.58 102.04 11.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.564 -0.71 . . . . 0.0 110.255 179.988 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.42 135.4 49.45 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.58 -0.7 . . . . 0.0 110.187 179.972 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.8 m -60.48 -27.23 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.497 -0.752 . . . . 0.0 110.345 179.955 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.1 p30 -172.79 178.43 2.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.422 -0.798 . . . . 0.0 110.221 179.67 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.02 -27.54 45.17 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.504 -0.747 . . . . 0.0 110.763 -179.606 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.37 -24.09 67.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.6 -0.688 . . . . 0.0 110.49 179.934 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 m -108.11 -26.11 10.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.449 -0.782 . . . . 0.0 110.628 -179.738 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -69.38 -48.24 61.78 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.495 -0.753 . . . . 0.0 110.35 -179.813 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -60.18 -41.53 93.07 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.564 -0.71 . . . . 0.0 110.488 -179.867 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -58.55 -36.36 73.78 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.379 -0.826 . . . . 0.0 110.591 -179.874 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.88 -41.56 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.516 -0.74 . . . . 0.0 110.222 -179.922 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.446 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 11.0 m-85 -72.5 -39.04 67.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.519 -0.738 . . . . 0.0 110.32 -179.851 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.4 tttt -62.03 -45.49 93.37 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.387 -0.821 . . . . 0.0 109.173 179.335 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -62.43 -33.06 74.05 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.721 0.772 . . . . 0.0 109.339 179.023 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -67.5 -56.71 8.45 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.847 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.07 -38.69 87.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.749 -0.595 . . . . 0.0 110.148 179.997 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -58.11 -39.96 79.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.503 -0.748 . . . . 0.0 110.557 -179.843 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -69.66 -43.04 73.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.567 -0.708 . . . . 0.0 110.134 -179.946 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -75.34 -28.9 59.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.589 -0.695 . . . . 0.0 110.102 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.06 52.25 1.39 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.886 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.45 HG23 HD12 ' A' ' 40' ' ' ILE . 83.9 mt -109.22 61.24 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.501 -0.999 . . . . 0.0 110.256 179.94 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -84.05 57.89 4.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.439 -0.788 . . . . 0.0 108.993 178.791 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.46 -138.04 5.56 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -178.916 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -116.79 101.22 8.36 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.874 -0.78 . . . . 0.0 109.365 179.484 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -71.74 143.06 49.73 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 122.02 0.914 . . . . 0.0 112.176 -178.2 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.66 131.74 14.37 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.464 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -105.02 131.73 52.17 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.713 -0.617 . . . . 0.0 110.294 -178.365 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -106.74 119.22 38.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.662 -0.649 . . . . 0.0 109.819 179.546 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -73.22 -21.46 60.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.655 -0.653 . . . . 0.0 110.707 -179.762 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.67 -38.23 60.14 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.257 -0.902 . . . . 0.0 110.804 -179.781 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 76.0 p -146.88 17.15 1.25 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.594 -0.691 . . . . 0.0 110.86 179.889 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.405 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 50.88 93.33 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.122 -0.986 . . . . 0.0 110.697 179.953 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.0 m -154.86 106.87 2.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.464 -0.772 . . . . 0.0 110.94 -179.662 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -61.93 130.12 44.15 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.698 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 85.0 m -123.39 107.23 11.39 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.539 -178.598 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.409 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 11.1 p -111.64 166.94 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.452 -0.78 . . . . 0.0 109.15 177.536 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.8 m -161.88 111.89 1.57 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.766 -0.584 . . . . 0.0 109.796 -179.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.163 179.86 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mtt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.1 0.476 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.454 ' CG2' ' CZ ' ' A' ' 4' ' ' PHE . 12.0 m -151.16 112.14 4.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.578 -0.702 . . . . 0.0 110.23 -179.969 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.0 t -87.81 84.29 7.05 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.684 -0.635 . . . . 0.0 110.8 -179.616 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.454 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 92.9 m-85 -68.6 167.82 14.28 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.357 -0.84 . . . . 0.0 109.938 179.72 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -131.21 114.75 15.46 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.524 -0.735 . . . . 0.0 110.308 179.974 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.418 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -95.12 109.63 21.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.498 -0.752 . . . . 0.0 110.256 179.916 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 tp -63.24 169.56 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.166 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 81.2 mt -130.84 71.52 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.589 -179.575 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -94.68 48.3 1.2 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.383 -0.823 . . . . 0.0 108.978 178.947 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.8 160.29 17.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.504 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -1.62 35.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.776 -0.837 . . . . 0.0 110.583 179.205 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.1 m -103.0 -37.58 7.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.318 -179.928 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -134.65 176.54 8.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.486 -0.759 . . . . 0.0 110.589 -179.981 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -157.14 137.85 13.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.528 -0.732 . . . . 0.0 110.274 -179.962 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.02 -153.5 20.95 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.946 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -143.04 157.74 44.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.558 -0.966 . . . . 0.0 110.248 -179.961 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.7 t -144.16 164.49 30.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.556 -0.715 . . . . 0.0 110.304 179.993 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.9 p -135.84 174.21 10.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.573 -0.704 . . . . 0.0 110.189 179.941 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.429 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 7.6 t -161.98 -168.59 1.96 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.583 -0.698 . . . . 0.0 110.369 -179.951 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.26 103.23 8.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.637 -0.664 . . . . 0.0 110.387 179.9 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -133.56 143.18 48.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.485 -0.76 . . . . 0.0 110.238 -179.888 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.72 -31.6 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.584 -0.698 . . . . 0.0 109.927 179.789 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 50.9 p-10 -170.18 179.1 3.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.635 -0.666 . . . . 0.0 110.148 179.723 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.446 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.04 -25.56 45.4 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.508 -0.745 . . . . 0.0 110.855 -179.647 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.23 -26.51 64.95 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.52 -0.737 . . . . 0.0 110.533 -179.855 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.3 m -111.36 -26.98 8.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.521 -0.737 . . . . 0.0 110.46 -179.896 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.408 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -59.96 -53.51 56.99 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.498 -0.751 . . . . 0.0 110.317 -179.868 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -59.78 -37.72 79.84 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.578 -0.701 . . . . 0.0 110.315 179.94 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -56.32 -43.31 78.85 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.415 -0.803 . . . . 0.0 110.371 179.93 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.7 t -80.29 -46.09 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.611 -0.68 . . . . 0.0 109.852 179.633 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.429 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 9.2 m-85 -63.22 -35.52 80.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.607 -0.683 . . . . 0.0 110.355 -179.749 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -63.54 -42.71 98.4 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.411 -0.806 . . . . 0.0 109.138 179.438 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -63.25 -33.97 76.65 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.735 0.779 . . . . 0.0 109.205 178.898 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -66.63 -58.67 4.67 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.745 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.6 -34.11 73.72 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.712 -0.618 . . . . 0.0 110.061 179.799 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -55.16 -54.13 47.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.613 -0.68 . . . . 0.0 110.741 -179.924 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.18 -44.35 96.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.573 -0.705 . . . . 0.0 110.13 179.923 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -67.5 -29.64 69.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.597 -0.689 . . . . 0.0 110.072 179.87 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.6 50.96 2.42 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.987 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.418 HD13 HG23 ' A' ' 40' ' ' ILE . 83.1 mt -107.52 61.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.569 -0.96 . . . . 0.0 110.208 179.936 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.07 61.62 4.71 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 178.612 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.23 -140.73 10.23 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -178.685 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -116.02 103.54 10.68 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.572 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 52.0 m95 -73.73 142.13 46.33 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.044 0.926 . . . . 0.0 112.129 -178.211 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 p -149.71 131.96 15.49 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.722 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.419 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 45.9 t80 -103.7 127.8 51.12 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.718 -0.614 . . . . 0.0 110.014 -178.452 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -98.02 120.61 38.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.706 -0.621 . . . . 0.0 110.075 179.902 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.48 -23.03 53.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.677 -0.639 . . . . 0.0 110.489 179.961 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.4 -40.66 68.46 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.39 -0.819 . . . . 0.0 110.894 -179.733 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.8 p -145.76 18.0 1.46 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.564 -0.71 . . . . 0.0 111.011 -179.899 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.419 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 0.2 OUTLIER 52.15 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.115 -0.99 . . . . 0.0 110.962 179.715 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.0 m -156.2 104.68 2.26 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.431 -0.793 . . . . 0.0 110.996 -179.949 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 27' ' ' ALA . 63.7 m-85 -61.48 123.9 19.14 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.522 -0.736 . . . . 0.0 109.129 178.839 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.4 m -119.49 104.89 10.72 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.667 -178.453 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.412 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.6 p -107.32 167.02 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.241 177.554 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 99.5 m -159.09 109.17 1.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.647 -0.658 . . . . 0.0 109.902 -179.766 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.122 -179.929 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mtm . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.103 0.478 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.426 HG23 ' CE2' ' A' ' 4' ' ' PHE . 33.1 m -77.79 165.22 24.44 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.565 -0.709 . . . . 0.0 110.217 -179.921 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 90.0 m -143.3 91.16 2.24 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.643 -0.661 . . . . 0.0 109.902 179.88 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.444 ' CZ ' ' N ' ' A' ' 24' ' ' ALA . 83.6 m-85 -80.95 175.88 10.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.555 -0.716 . . . . 0.0 110.253 -179.608 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -137.49 142.16 41.49 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.673 -0.642 . . . . 0.0 109.96 179.728 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.453 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 3.4 tm? -115.62 99.8 7.59 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.527 -0.733 . . . . 0.0 110.191 -179.614 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 tp -63.16 124.68 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.465 -0.772 . . . . 0.0 108.96 179.625 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.0 mt -92.65 68.27 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.524 -0.735 . . . . 0.0 110.605 -178.907 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.1 m-20 -89.19 53.0 2.52 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.199 -0.938 . . . . 0.0 109.221 178.966 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.3 169.0 17.0 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.483 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -83.72 5.48 24.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.749 -0.853 . . . . 0.0 110.499 179.088 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.5 m -114.29 -30.45 6.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 110.245 -179.931 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.2 mt -137.1 179.24 6.5 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.373 -0.829 . . . . 0.0 110.741 -179.903 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.03 134.45 4.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.625 -0.672 . . . . 0.0 110.084 -179.938 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.11 -150.1 21.54 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.921 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -139.06 155.32 48.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.624 -0.927 . . . . 0.0 110.298 -179.883 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 76.8 m -126.04 156.08 40.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 110.089 -179.99 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.5 p -145.38 144.98 30.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.587 -0.695 . . . . 0.0 110.323 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.7 t -156.17 144.78 20.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.57 -0.706 . . . . 0.0 110.202 179.775 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.23 112.6 12.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.567 -0.708 . . . . 0.0 109.778 179.712 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.91 144.42 50.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.605 -0.685 . . . . 0.0 110.027 -179.864 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.8 m -60.6 -33.48 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.522 -0.736 . . . . 0.0 110.239 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.0 p30 -175.26 -175.35 0.82 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.462 -0.774 . . . . 0.0 110.254 179.422 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.8 -25.19 55.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.545 -0.722 . . . . 0.0 110.876 -179.725 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.24 -26.52 63.0 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.462 -0.774 . . . . 0.0 110.543 -179.83 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.5 m -111.49 -25.91 9.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.529 -0.732 . . . . 0.0 110.559 -179.882 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.426 ' HB1' ' CE1' ' A' ' 53' ' ' PHE . . . -59.66 -57.41 13.03 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.457 -0.777 . . . . 0.0 110.45 -179.825 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -59.18 -36.28 75.06 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.465 -0.772 . . . . 0.0 110.416 -179.986 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -61.06 -41.54 96.81 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.351 -0.843 . . . . 0.0 109.864 179.764 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.9 t -83.51 -39.34 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.578 -0.701 . . . . 0.0 109.337 179.278 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.453 ' CD2' ' HB2' ' A' ' 6' ' ' LEU . 5.0 m-30 -66.45 -35.41 80.23 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.703 -0.623 . . . . 0.0 109.644 179.558 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -69.43 -45.45 69.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.663 -0.648 . . . . 0.0 109.624 179.712 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -61.94 -32.18 72.58 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.625 0.726 . . . . 0.0 109.671 179.397 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -67.65 -48.48 66.55 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.063 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.19 -33.09 61.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.781 -0.574 . . . . 0.0 110.391 -179.679 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -58.69 -45.24 89.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.497 -0.752 . . . . 0.0 110.399 -179.814 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.03 -36.98 72.57 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.599 -0.688 . . . . 0.0 110.156 179.941 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -74.43 -34.8 63.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.617 -0.677 . . . . 0.0 110.049 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.59 35.5 3.53 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.965 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.479 HG23 HD11 ' A' ' 40' ' ' ILE . 81.6 mt -100.09 69.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.537 -0.978 . . . . 0.0 110.204 179.991 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.08 51.5 1.81 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.692 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.71 -136.81 0.75 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -178.711 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -113.95 102.95 10.68 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.641 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.444 ' CH2' HD23 ' A' ' 6' ' ' LEU . 35.2 m95 -74.02 142.0 45.78 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.113 0.959 . . . . 0.0 112.161 -178.101 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 p -152.58 132.17 13.06 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.022 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.42 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 53.8 t80 -103.8 103.75 13.67 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.71 -0.618 . . . . 0.0 109.951 -178.846 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.78 109.32 15.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.686 -0.634 . . . . 0.0 109.839 179.781 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -64.62 -22.12 66.89 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.706 -0.621 . . . . 0.0 110.437 -179.965 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.79 -35.54 44.33 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.331 -0.855 . . . . 0.0 110.791 -179.855 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.0 p -145.4 15.48 1.46 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.545 -0.722 . . . . 0.0 110.95 179.862 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 0.0 OUTLIER 51.01 82.24 0.06 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.092 -1.005 . . . . 0.0 110.716 179.818 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.6 m -150.11 110.71 4.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.38 -0.825 . . . . 0.0 111.429 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.426 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 88.7 m-85 -65.53 112.76 3.75 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.439 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 88.4 m -104.85 99.41 9.05 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.918 -177.545 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.7 p -100.38 164.92 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 0.0 108.972 177.044 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 90.0 m -160.62 110.53 1.75 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.722 -0.611 . . . . 0.0 110.135 -179.677 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.038 179.824 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 ptt? . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.128 0.489 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.455 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 4.1 m -103.85 114.75 29.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.624 -0.672 . . . . 0.0 110.048 179.991 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 m -89.08 86.68 6.95 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.585 -0.697 . . . . 0.0 110.627 -179.576 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.455 ' CE2' ' CG2' ' A' ' 2' ' ' THR . 66.0 m-85 -76.05 169.73 17.62 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.458 -0.776 . . . . 0.0 109.788 179.684 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.0 mtmm -141.45 105.3 4.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.482 -0.761 . . . . 0.0 110.392 -179.928 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.419 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -90.61 107.34 19.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.495 -0.753 . . . . 0.0 110.041 179.817 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.8 tp -64.2 160.2 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 119.616 -0.834 . . . . 0.0 108.921 179.231 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.441 HD13 HG23 ' A' ' 8' ' ' ILE . 49.0 mm -123.31 76.84 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.456 -179.735 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.9 48.3 1.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.784 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.9 153.16 17.76 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.234 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -12.61 61.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.686 -0.89 . . . . 0.0 110.283 179.178 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.6 m -85.98 -35.75 20.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.898 . . . . 0.0 110.336 -179.999 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 38.9 mt -143.72 171.43 14.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.521 -0.737 . . . . 0.0 110.545 -179.902 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.96 137.54 13.13 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.611 -0.681 . . . . 0.0 110.105 179.89 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.28 -138.05 9.43 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.962 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -141.08 165.53 27.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.971 . . . . 0.0 110.298 -179.917 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.1 m -151.75 128.47 10.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.582 -0.699 . . . . 0.0 110.1 179.977 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.4 p -126.32 149.4 49.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.735 . . . . 0.0 110.374 -179.915 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.437 ' CG2' ' CZ ' ' A' ' 31' ' ' PHE . 9.0 t -150.56 129.14 12.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.621 -0.675 . . . . 0.0 110.179 179.807 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -60.91 118.48 6.75 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.513 -0.742 . . . . 0.0 110.101 179.868 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.84 156.89 45.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.58 -0.7 . . . . 0.0 110.319 -179.786 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 p -65.0 -37.0 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.621 -0.674 . . . . 0.0 110.063 179.963 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -174.73 -173.67 0.74 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.517 -0.739 . . . . 0.0 109.964 179.8 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.442 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.77 -24.15 21.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.43 -0.794 . . . . 0.0 111.018 -179.643 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.66 -43.79 85.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.402 -0.811 . . . . 0.0 110.504 -179.892 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.3 m -94.7 -29.97 14.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.572 -0.705 . . . . 0.0 110.254 179.907 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.452 ' CB ' ' CD2' ' A' ' 4' ' ' PHE . . . -58.76 -62.21 2.04 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.488 -0.758 . . . . 0.0 110.419 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.17 -35.26 74.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.652 -0.655 . . . . 0.0 110.308 179.988 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -60.35 -41.94 94.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.29 -0.881 . . . . 0.0 110.114 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.7 t -81.45 -41.28 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.605 -0.684 . . . . 0.0 109.648 179.562 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CZ ' ' CG2' ' A' ' 19' ' ' THR . 14.7 m-85 -67.66 -38.37 83.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 0.0 110.155 -179.934 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -63.34 -47.89 80.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.535 -0.728 . . . . 0.0 109.654 179.723 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -59.82 -32.92 71.11 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.732 0.777 . . . . 0.0 109.452 179.241 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -66.99 -59.2 3.68 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.717 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.96 -44.66 96.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.729 -0.607 . . . . 0.0 109.995 179.703 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -56.0 -42.4 76.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.537 -0.727 . . . . 0.0 110.61 -179.777 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.22 -41.65 85.38 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.596 -0.69 . . . . 0.0 109.9 179.862 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -72.86 -51.66 17.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.577 -0.702 . . . . 0.0 109.856 179.779 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.8 43.72 0.23 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.686 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.469 HG23 HD11 ' A' ' 40' ' ' ILE . 80.3 mt -104.5 59.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.515 -0.991 . . . . 0.0 110.256 179.755 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -80.74 60.95 4.22 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.47 -0.769 . . . . 0.0 109.058 178.961 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.7 -138.34 7.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -178.906 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.79 102.78 9.39 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.891 -0.77 . . . . 0.0 109.07 179.281 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 53.3 m95 -73.03 142.62 47.68 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.207 1.004 . . . . 0.0 112.574 -177.705 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.3 p -150.46 131.49 14.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.411 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -106.58 128.86 54.47 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.637 -0.664 . . . . 0.0 110.329 -178.288 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -100.73 111.28 23.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.697 -0.627 . . . . 0.0 109.911 179.707 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -68.91 -24.69 64.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.689 -0.632 . . . . 0.0 110.525 -179.881 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.31 -36.33 52.93 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.353 -0.842 . . . . 0.0 110.969 -179.695 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.3 p -147.2 16.86 1.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.514 -0.741 . . . . 0.0 110.94 179.99 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.431 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.36 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.149 -0.969 . . . . 0.0 110.809 179.798 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.9 m -159.64 104.27 1.58 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.423 -0.798 . . . . 0.0 111.209 -179.943 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CZ ' ' HB1' ' A' ' 27' ' ' ALA . 96.7 m-85 -65.0 128.12 34.43 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.557 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.8 m -120.39 103.11 8.93 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.34 -178.52 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.416 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 8.5 p -106.13 165.74 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 0.0 109.56 177.935 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 84.4 m -162.54 117.08 1.79 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.785 -0.572 . . . . 0.0 109.88 -179.744 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.991 179.691 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmt . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.104 0.478 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.436 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 77.7 m -84.1 112.35 20.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.619 -0.675 . . . . 0.0 110.246 -179.929 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.4 m -93.47 103.8 15.98 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.631 -0.668 . . . . 0.0 110.446 -179.87 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.436 ' CZ ' HG21 ' A' ' 2' ' ' THR . 84.7 m-85 -84.11 179.54 7.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.515 -0.74 . . . . 0.0 110.178 179.938 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.7 ttmt -145.69 111.94 5.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.527 -0.733 . . . . 0.0 110.502 179.966 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.416 ' HB2' ' CD1' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -92.72 111.45 23.06 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.435 -0.79 . . . . 0.0 110.321 -179.959 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.6 tt -65.03 174.01 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.357 -0.84 . . . . 0.0 108.801 179.205 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 76.1 mt -135.0 74.51 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.658 -179.888 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -96.28 49.73 1.14 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.953 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.71 160.95 13.19 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.327 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm -78.15 -7.44 57.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.724 -0.868 . . . . 0.0 110.463 179.201 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 t -98.23 -25.56 14.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.164 -0.96 . . . . 0.0 110.701 -179.77 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 tp -150.09 164.67 34.97 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.416 -0.802 . . . . 0.0 110.744 -179.875 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.16 140.11 23.99 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.61 -0.681 . . . . 0.0 110.412 -179.773 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 132.79 -144.69 16.63 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.978 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -142.7 170.56 15.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.485 -1.009 . . . . 0.0 110.277 -179.942 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.7 m -144.06 161.39 38.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.64 -0.663 . . . . 0.0 110.188 179.991 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.8 p -144.54 151.09 38.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.543 -0.723 . . . . 0.0 110.41 -179.838 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.451 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 8.6 t -155.99 164.56 38.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.584 -0.698 . . . . 0.0 110.064 179.795 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -94.87 109.72 21.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.526 -0.733 . . . . 0.0 110.292 -179.959 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.47 143.15 47.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.612 -0.68 . . . . 0.0 109.95 179.9 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.5 m -57.4 -38.84 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.451 -0.781 . . . . 0.0 110.232 179.808 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -172.93 -170.2 0.63 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.623 -0.673 . . . . 0.0 109.771 179.58 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.419 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.48 -22.57 21.44 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.474 -0.766 . . . . 0.0 111.096 -179.673 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.64 -27.9 69.54 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.461 -0.774 . . . . 0.0 110.55 -179.738 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.7 m -114.37 -25.65 8.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.468 -0.77 . . . . 0.0 110.684 -179.63 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 53' ' ' PHE . . . -58.77 -62.28 1.99 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.453 -0.779 . . . . 0.0 110.628 -179.708 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.86 -45.04 86.87 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.446 -0.784 . . . . 0.0 110.446 179.934 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -53.29 -44.03 67.96 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.391 -0.818 . . . . 0.0 110.727 -179.956 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.1 t -78.25 -48.88 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.54 -0.725 . . . . 0.0 109.983 179.74 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.451 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 3.9 m-85 -62.11 -31.16 71.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 110.238 -179.55 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -64.88 -39.38 93.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.393 -0.817 . . . . 0.0 108.92 179.262 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -61.88 -30.04 70.6 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.56 0.695 . . . . 0.0 109.704 179.083 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -73.18 -54.86 7.41 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.196 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.65 -48.78 75.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.738 -0.601 . . . . 0.0 110.149 179.974 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -55.95 -28.71 58.22 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.516 -0.74 . . . . 0.0 110.515 -179.897 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.62 -38.39 29.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.658 -0.651 . . . . 0.0 110.056 179.909 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -80.59 -34.41 35.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.56 -0.713 . . . . 0.0 110.058 179.927 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.54 49.13 0.61 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.906 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.415 ' CG2' ' CG1' ' A' ' 55' ' ' VAL . 85.1 mt -115.15 67.92 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.52 -0.988 . . . . 0.0 110.329 179.852 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -90.83 51.88 2.06 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.771 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.49 -139.14 2.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -178.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -114.83 108.53 16.87 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.356 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.0 m95 -77.14 142.08 39.87 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.1 0.953 . . . . 0.0 112.321 -177.985 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.1 p -147.49 133.1 18.79 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.752 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.401 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 71.7 t80 -100.49 131.97 46.13 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.712 -0.618 . . . . 0.0 110.454 -178.357 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -100.79 125.29 47.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.678 -0.639 . . . . 0.0 109.946 179.81 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -82.04 -18.49 43.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.69 -0.631 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -57.01 -44.74 83.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.271 -0.893 . . . . 0.0 110.725 -179.7 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.2 p -147.37 23.81 1.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.519 -0.738 . . . . 0.0 110.65 -179.588 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.41 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 1.3 mppt? 52.42 95.38 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.239 -0.913 . . . . 0.0 110.727 179.953 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 90.7 m -151.76 101.79 2.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.53 -0.731 . . . . 0.0 110.749 -179.964 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.436 ' CZ ' ' HB3' ' A' ' 27' ' ' ALA . 81.4 m-85 -61.08 124.16 19.73 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.811 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 62.3 m -117.98 105.47 11.93 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.387 -0.925 . . . . 0.0 112.611 -178.197 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.415 ' CG1' ' CG2' ' A' ' 40' ' ' ILE . 10.8 p -105.87 168.04 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.42 -0.8 . . . . 0.0 109.128 177.538 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.1 m -158.28 108.14 2.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.564 -0.71 . . . . 0.0 109.948 -179.676 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.17 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.581 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 70.4 m . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.07 0.462 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.0 m -78.67 99.57 6.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.639 -0.663 . . . . 0.0 110.76 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.71 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 73.2 m-85 -87.45 167.4 14.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.555 -0.716 . . . . 0.0 109.907 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.571 ' CG ' HG22 ' A' ' 18' ' ' THR . 3.6 mtpt -138.75 129.87 26.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.464 -0.772 . . . . 0.0 110.435 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.536 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 44.3 tp -106.5 123.06 47.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.509 -0.744 . . . . 0.0 110.209 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.616 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.6 tp -75.42 165.98 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.6 mt -127.89 72.66 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.225 -0.922 . . . . 0.0 110.676 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.522 ' HB3' HG23 ' A' ' 56' ' ' THR . 71.5 m-20 -95.38 49.19 1.18 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.274 -0.892 . . . . 0.0 109.029 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.69 166.5 14.96 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -84.89 6.35 25.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.724 -0.868 . . . . 0.0 110.608 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 m -116.84 -30.76 5.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 110.482 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.5 mt -135.71 173.11 12.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 110.783 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.38 139.38 3.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.66 -0.65 . . . . 0.0 110.294 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.37 -136.1 7.68 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -153.99 154.36 33.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.617 -0.931 . . . . 0.0 110.287 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.9 m -143.82 155.23 44.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.59 -0.694 . . . . 0.0 110.211 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.571 HG22 ' CG ' ' A' ' 5' ' ' LYS . 74.0 p -133.25 173.9 10.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.563 -0.711 . . . . 0.0 110.329 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.554 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.6 t -164.11 -170.32 2.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.64 -0.663 . . . . 0.0 110.167 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.56 100.11 6.09 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.639 -0.663 . . . . 0.0 110.4 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.84 142.69 50.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.465 -0.772 . . . . 0.0 110.01 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.81 -30.39 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.576 -0.702 . . . . 0.0 110.048 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.556 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 24.1 p30 -170.06 176.08 4.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.611 -0.681 . . . . 0.0 110.323 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.78 -25.15 26.15 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.515 -0.741 . . . . 0.0 110.969 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.556 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -60.06 -27.0 66.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.492 -0.755 . . . . 0.0 110.431 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.2 m -112.1 -27.99 8.16 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.499 -0.751 . . . . 0.0 110.364 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.71 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.69 -49.6 77.11 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.487 -0.758 . . . . 0.0 110.375 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -59.14 -40.19 84.72 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.541 -0.724 . . . . 0.0 110.309 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -56.94 -35.5 69.16 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.35 -0.844 . . . . 0.0 110.363 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 93.8 t -84.39 -48.19 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.601 -0.687 . . . . 0.0 110.056 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.554 ' CZ ' HG22 ' A' ' 19' ' ' THR . 9.7 m-85 -65.87 -36.82 84.5 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 110.206 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.1 tptt -63.44 -44.89 93.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.518 -0.739 . . . . 0.0 109.43 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -60.72 -31.57 70.87 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.609 0.718 . . . . 0.0 109.708 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -70.7 -57.14 4.99 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.735 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.33 -47.22 85.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.751 -0.593 . . . . 0.0 110.022 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -54.94 -32.95 61.81 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.474 -0.766 . . . . 0.0 110.591 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.42 -49.99 43.13 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.615 -0.678 . . . . 0.0 109.985 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -71.35 -46.34 60.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.569 -0.707 . . . . 0.0 109.886 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.47 43.26 0.29 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.735 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 81.1 mt -105.59 71.32 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.447 -1.031 . . . . 0.0 110.245 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -95.4 46.05 1.1 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.2 -135.85 0.1 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -115.47 102.19 9.58 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.536 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 38.3 m95 -72.56 142.42 48.44 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.177 0.989 . . . . 0.0 112.456 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -150.9 133.05 15.32 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.425 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 63.2 t80 -102.83 109.24 20.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.664 -0.648 . . . . 0.0 110.206 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.34 109.33 16.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.655 -0.653 . . . . 0.0 110.096 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -67.6 -20.61 65.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.693 -0.629 . . . . 0.0 110.767 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.39 -42.56 67.08 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.251 -0.906 . . . . 0.0 110.859 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.7 p -141.31 18.7 2.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.585 -0.697 . . . . 0.0 110.685 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.435 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER 50.31 90.35 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.151 -0.968 . . . . 0.0 111.152 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 57.6 m -156.59 108.46 2.48 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.789 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 93.1 m-85 -60.37 123.29 16.84 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.616 ' HA ' HG22 ' A' ' 7' ' ' ILE . 48.4 m -115.5 94.53 4.75 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.242 -0.983 . . . . 0.0 112.846 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.549 HG21 HG22 ' A' ' 40' ' ' ILE . 11.0 p -95.55 166.84 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.128 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.522 HG23 ' HB3' ' A' ' 9' ' ' ASN . 95.4 m -160.26 108.1 1.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.677 -0.639 . . . . 0.0 109.86 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.214 -179.922 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.684 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 22.4 m . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.001 0.429 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.8 m -118.22 91.24 3.51 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.593 -0.692 . . . . 0.0 110.524 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.71 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 98.6 m-85 -80.34 168.69 18.72 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.594 -0.691 . . . . 0.0 109.967 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -145.88 115.79 7.34 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.463 -0.773 . . . . 0.0 110.372 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.62 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 30.1 tp -94.11 127.18 39.78 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.422 -0.799 . . . . 0.0 110.2 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.655 HG21 HG23 ' A' ' 54' ' ' THR . 2.4 tp -76.47 170.12 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 16' ' ' GLU . 78.8 mt -129.99 71.13 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.22 -0.925 . . . . 0.0 110.715 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.538 ' HB3' HG23 ' A' ' 56' ' ' THR . 5.8 m-20 -96.15 47.25 1.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.506 -0.746 . . . . 0.0 109.22 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.43 167.0 24.47 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -82.32 3.12 29.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.76 -0.847 . . . . 0.0 110.754 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 m -116.88 -30.63 5.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.104 -0.997 . . . . 0.0 110.455 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.415 ' HB3' HG21 ' A' ' 8' ' ' ILE . 54.9 mt -128.7 172.48 11.2 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.455 -0.778 . . . . 0.0 110.694 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -154.99 131.76 10.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.696 -0.627 . . . . 0.0 109.932 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.71 -140.22 11.55 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.457 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.1 pt-20 -147.82 178.04 8.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.565 -0.962 . . . . 0.0 110.42 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.413 ' OG1' HD11 ' A' ' 8' ' ' ILE . 19.7 m -152.27 128.94 10.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.542 -0.724 . . . . 0.0 110.162 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.3 p -114.53 155.77 25.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.574 -0.704 . . . . 0.0 110.256 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.791 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.1 t -160.55 153.51 21.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.597 -0.689 . . . . 0.0 110.309 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -86.71 112.41 21.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.524 -0.735 . . . . 0.0 110.326 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.6 147.32 52.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.642 -0.661 . . . . 0.0 110.048 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 p -64.25 -33.58 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.531 -0.73 . . . . 0.0 110.227 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.617 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 27.2 p30 -170.86 -177.85 2.38 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.486 -0.759 . . . . 0.0 110.362 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -54.36 -25.24 23.18 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.477 -0.764 . . . . 0.0 111.003 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.617 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.24 -46.01 89.64 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.443 -0.785 . . . . 0.0 110.315 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.525 ' O ' HG23 ' A' ' 30' ' ' VAL . 34.5 m -90.2 -26.48 20.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.605 -0.684 . . . . 0.0 110.168 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.71 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.75 -62.32 1.96 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.55 -0.719 . . . . 0.0 110.217 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -60.36 -37.06 79.54 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.505 -0.747 . . . . 0.0 109.972 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.4 ttpt -58.42 -37.16 74.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.446 -0.783 . . . . 0.0 110.073 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 26' ' ' THR . 90.1 t -84.55 -45.84 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.689 -0.632 . . . . 0.0 109.786 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.791 ' CZ ' HG22 ' A' ' 19' ' ' THR . 14.0 m-85 -66.41 -34.01 77.0 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.636 -0.665 . . . . 0.0 110.207 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -66.15 -46.21 78.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.442 -0.786 . . . . 0.0 109.015 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -61.11 -30.91 70.65 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.634 0.73 . . . . 0.0 109.381 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -69.26 -55.74 9.62 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.708 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -63.07 -38.86 92.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.712 -0.617 . . . . 0.0 109.797 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -59.02 -34.05 71.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.528 -0.733 . . . . 0.0 110.357 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -78.03 -47.67 17.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.657 -0.652 . . . . 0.0 110.141 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -69.76 -41.91 74.57 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.593 -0.692 . . . . 0.0 110.087 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.34 62.54 0.4 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.708 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 87.0 mt -127.65 81.47 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.552 -0.97 . . . . 0.0 110.421 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -98.76 37.67 1.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.04 -140.24 0.02 OUTLIER Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -114.56 110.7 20.22 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.62 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 29.9 m95 -77.88 143.03 38.09 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 122.205 1.003 . . . . 0.0 112.364 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 44' ' ' TRP . 6.0 p -153.94 132.12 11.86 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -105.65 143.77 33.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.63 -0.669 . . . . 0.0 110.06 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.69 108.73 18.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.765 -0.584 . . . . 0.0 109.804 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.6 -23.03 65.33 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.638 -0.664 . . . . 0.0 110.62 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.442 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.23 -37.55 64.74 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.309 -0.87 . . . . 0.0 110.788 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.442 HG23 ' C ' ' A' ' 49' ' ' ALA . 72.5 p -147.79 19.04 1.15 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.518 -0.739 . . . . 0.0 110.766 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.443 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.6 94.56 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.204 -0.935 . . . . 0.0 110.886 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.9 m -159.1 100.72 1.56 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.559 -0.713 . . . . 0.0 110.791 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 91.0 m-85 -61.95 140.1 58.35 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.445 -0.785 . . . . 0.0 109.006 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.655 HG23 HG21 ' A' ' 7' ' ' ILE . 55.8 m -131.87 100.03 4.95 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.272 -0.971 . . . . 0.0 112.69 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.557 HG21 HG22 ' A' ' 40' ' ' ILE . 10.3 p -101.61 166.25 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.22 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.538 HG23 ' HB3' ' A' ' 9' ' ' ASN . 93.4 m -160.79 112.26 1.86 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.661 -0.649 . . . . 0.0 109.931 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 118.016 -0.993 . . . . 0.0 110.13 179.943 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.572 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 62.0 m . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.072 0.463 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.6 m -84.81 95.44 8.98 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.633 -0.667 . . . . 0.0 110.696 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.742 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 95.8 m-85 -79.77 173.99 12.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.48 -0.763 . . . . 0.0 109.778 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.529 ' CG ' HG22 ' A' ' 18' ' ' THR . 8.8 mtmt -142.67 123.26 14.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.486 -0.759 . . . . 0.0 110.658 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.607 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 47.4 tp -101.16 127.61 47.64 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.425 -0.797 . . . . 0.0 109.897 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.687 HG21 HG23 ' A' ' 54' ' ' THR . 2.8 tt -77.39 174.06 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.493 HG21 ' HB3' ' A' ' 13' ' ' LEU . 86.2 mt -133.14 73.33 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.32 -0.862 . . . . 0.0 110.444 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.543 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.5 m-20 -95.82 47.79 1.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.414 -0.804 . . . . 0.0 109.004 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.72 154.78 16.45 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -71.81 -9.1 57.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.704 -0.88 . . . . 0.0 110.396 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -90.31 -34.57 15.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 110.281 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.493 ' HB3' HG21 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -144.82 167.39 22.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.474 -0.766 . . . . 0.0 110.769 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -147.62 137.29 22.69 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.569 -0.707 . . . . 0.0 110.195 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.8 -136.81 8.7 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -146.97 168.64 20.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.53 -0.983 . . . . 0.0 110.326 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.2 m -143.45 149.87 38.22 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.638 -0.664 . . . . 0.0 110.125 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.529 HG22 ' CG ' ' A' ' 5' ' ' LYS . 20.8 p -131.41 157.66 42.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.534 -0.729 . . . . 0.0 110.297 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.79 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.6 t -160.98 168.12 25.17 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.566 -0.708 . . . . 0.0 110.235 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.26 124.22 44.16 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.602 -0.686 . . . . 0.0 110.145 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.03 138.15 20.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.6 -0.688 . . . . 0.0 110.181 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.49 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.8 p -60.08 -34.3 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.537 -0.727 . . . . 0.0 110.064 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.57 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 51.2 p30 -169.65 -173.91 1.75 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.61 -0.681 . . . . 0.0 110.306 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.85 -23.83 47.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.594 -0.691 . . . . 0.0 110.932 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.57 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.09 -31.49 68.95 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.395 -0.816 . . . . 0.0 110.36 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.548 ' O ' HG23 ' A' ' 30' ' ' VAL . 52.2 m -110.66 -24.3 10.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.57 -0.706 . . . . 0.0 110.447 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.742 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.27 -62.11 2.08 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.425 -0.797 . . . . 0.0 110.23 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -60.2 -39.8 87.82 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.555 -0.716 . . . . 0.0 109.903 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -57.64 -37.22 72.96 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.469 -0.769 . . . . 0.0 110.236 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 26' ' ' THR . 98.4 t -83.42 -48.64 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.699 -0.626 . . . . 0.0 109.871 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.79 ' CZ ' HG22 ' A' ' 19' ' ' THR . 5.4 m-85 -64.39 -34.11 77.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.551 -0.718 . . . . 0.0 110.11 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -64.61 -44.03 91.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.482 -0.761 . . . . 0.0 109.166 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -60.99 -35.36 76.62 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.84 0.829 . . . . 0.0 109.474 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -65.24 -53.54 42.84 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.702 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -63.91 -40.97 97.73 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.715 -0.615 . . . . 0.0 110.048 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -57.32 -39.83 76.66 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.56 -0.712 . . . . 0.0 110.451 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.71 -56.63 11.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.581 -0.699 . . . . 0.0 110.01 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -64.34 -51.35 63.81 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.588 -0.695 . . . . 0.0 109.903 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.92 55.84 0.16 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.702 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 82.0 mt -118.72 73.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.53 -0.982 . . . . 0.0 110.278 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -95.64 43.2 1.09 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.57 -137.08 0.07 OUTLIER Glycine 0 N--CA 1.488 2.127 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -114.6 107.63 15.75 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.607 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 35.0 m95 -77.26 143.51 38.85 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.055 0.931 . . . . 0.0 112.359 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 44' ' ' TRP . 3.6 p -152.65 132.01 12.87 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.412 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 31.0 t80 -102.36 124.91 48.77 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.717 -0.615 . . . . 0.0 110.083 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -95.05 113.57 25.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.689 -0.632 . . . . 0.0 109.975 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.51 -15.09 63.18 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.672 -0.643 . . . . 0.0 110.928 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.437 ' C ' HG23 ' A' ' 50' ' ' THR . . . -56.46 -44.34 80.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.222 -0.924 . . . . 0.0 110.719 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.437 HG23 ' C ' ' A' ' 49' ' ' ALA . 68.6 p -147.59 25.11 1.08 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.494 -0.754 . . . . 0.0 110.628 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.456 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.44 89.87 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.357 -0.839 . . . . 0.0 110.841 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 83.2 m -150.46 101.76 2.99 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.478 -0.764 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.471 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 85.6 m-85 -61.98 127.84 33.31 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.448 -0.783 . . . . 0.0 108.939 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.687 HG23 HG21 ' A' ' 7' ' ' ILE . 55.6 m -121.06 101.5 7.71 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.338 -0.945 . . . . 0.0 113.027 -178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.531 HG21 HG22 ' A' ' 40' ' ' ILE . 11.3 p -101.07 167.85 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 108.981 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.543 HG23 ' HB3' ' A' ' 9' ' ' ASN . 98.5 m -159.82 109.14 1.81 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.521 -0.737 . . . . 0.0 109.977 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.185 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.53 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 33.7 m . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.121 0.486 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.7 m -97.77 97.48 9.02 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.607 -0.683 . . . . 0.0 110.552 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.817 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 95.2 m-85 -78.65 175.88 9.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.544 -0.723 . . . . 0.0 109.753 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.431 ' HB3' HG23 ' A' ' 52' ' ' THR . 23.8 tttt -144.51 119.6 10.08 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.401 -0.812 . . . . 0.0 110.621 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.632 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 42.6 tp -100.04 130.67 46.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.298 -0.876 . . . . 0.0 110.48 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.612 HG22 ' HA ' ' A' ' 54' ' ' THR . 3.6 tp -80.36 168.24 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 13' ' ' LEU . 79.7 mt -129.41 74.76 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 111.007 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.436 ' HB3' HG23 ' A' ' 56' ' ' THR . 97.2 m-20 -97.65 47.8 1.02 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.322 -0.861 . . . . 0.0 108.924 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.03 165.94 15.39 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -85.6 6.83 25.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.702 -0.881 . . . . 0.0 110.444 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -113.46 -31.96 6.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.921 . . . . 0.0 109.989 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.467 ' O ' HG22 ' A' ' 8' ' ' ILE . 2.1 tp -140.43 167.44 22.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.558 -0.714 . . . . 0.0 110.375 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -155.26 140.62 17.69 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.592 -0.692 . . . . 0.0 110.323 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.69 -134.64 7.58 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.54 161.7 42.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.621 -0.929 . . . . 0.0 110.386 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.3 m -145.81 151.1 37.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.634 -0.666 . . . . 0.0 110.068 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 p -130.76 157.1 43.75 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.568 -0.708 . . . . 0.0 110.282 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.41 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.3 t -149.29 -172.05 4.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.562 -0.711 . . . . 0.0 110.252 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -123.85 103.94 8.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.486 -0.759 . . . . 0.0 110.249 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.761 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -129.02 153.47 47.56 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.56 -0.712 . . . . 0.0 110.116 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.54 -22.2 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.573 -0.705 . . . . 0.0 110.46 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.566 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 44.2 p30 -172.35 -177.92 1.9 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.316 -0.865 . . . . 0.0 110.203 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.406 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.45 -24.57 20.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.523 -0.736 . . . . 0.0 111.064 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.566 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.49 -52.13 66.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.463 -0.773 . . . . 0.0 110.479 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.761 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 31.1 m -80.6 -26.52 37.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.571 -0.705 . . . . 0.0 110.509 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.817 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.93 -64.03 1.09 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.498 -0.751 . . . . 0.0 110.495 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -60.13 -40.02 88.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.532 -0.73 . . . . 0.0 110.115 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -57.1 -38.39 73.31 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.456 -0.778 . . . . 0.0 110.313 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 26' ' ' THR . 87.7 t -83.06 -48.61 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.614 -0.679 . . . . 0.0 109.922 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.502 ' HB3' HD22 ' A' ' 6' ' ' LEU . 9.1 m-85 -63.63 -34.09 77.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.614 -0.679 . . . . 0.0 110.112 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -64.31 -45.84 86.17 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.461 -0.774 . . . . 0.0 109.095 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -62.15 -29.2 70.18 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.601 0.715 . . . . 0.0 109.618 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -72.15 -54.2 10.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.755 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.52 -38.6 84.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.672 -0.642 . . . . 0.0 110.293 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -58.21 -38.52 76.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.483 -0.76 . . . . 0.0 110.667 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -68.33 -38.88 81.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.573 -0.704 . . . . 0.0 110.26 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -81.94 -32.7 30.69 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.603 -0.686 . . . . 0.0 110.109 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.75 48.3 1.28 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.755 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 81.7 mt -104.53 62.84 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.584 -0.95 . . . . 0.0 110.225 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -83.01 59.73 5.08 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.11 -141.53 10.23 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -113.54 109.55 18.81 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.894 -0.768 . . . . 0.0 109.029 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.632 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 32.9 m95 -78.44 143.38 36.77 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.064 0.935 . . . . 0.0 112.178 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 44' ' ' TRP . 7.6 p -155.1 132.78 11.31 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -103.0 158.76 16.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.652 -0.655 . . . . 0.0 110.167 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.03 111.99 12.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.834 -0.541 . . . . 0.0 109.66 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.98 -20.18 65.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.692 -0.63 . . . . 0.0 110.814 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.435 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.77 -41.08 70.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.296 -0.878 . . . . 0.0 110.746 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.435 HG23 ' C ' ' A' ' 49' ' ' ALA . 69.6 p -147.7 20.72 1.16 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.563 -0.71 . . . . 0.0 110.757 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.439 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.65 89.6 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.217 -0.927 . . . . 0.0 110.72 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.431 HG23 ' HB3' ' A' ' 5' ' ' LYS . 7.0 m -151.1 102.96 2.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.349 -0.844 . . . . 0.0 111.516 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.541 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 73.3 m-85 -64.13 133.77 53.6 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.612 ' HA ' HG22 ' A' ' 7' ' ' ILE . 71.1 m -125.94 100.43 6.37 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.766 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.562 HG11 HG21 ' A' ' 40' ' ' ILE . 11.5 p -103.26 166.97 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.371 -0.831 . . . . 0.0 109.171 177.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.474 ' N ' HG22 ' A' ' 55' ' ' VAL . 97.3 m -160.3 110.75 1.84 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.655 -0.653 . . . . 0.0 109.782 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.182 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.579 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 62.0 m . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.121 0.486 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.4 m -85.7 95.01 9.24 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.642 -0.661 . . . . 0.0 110.596 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.796 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.4 m-85 -77.81 176.08 9.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.44 -0.788 . . . . 0.0 109.735 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -142.79 124.94 15.36 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.499 -0.751 . . . . 0.0 110.383 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.583 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 54.4 tp -104.02 118.82 37.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.454 -0.779 . . . . 0.0 110.204 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.698 HG21 HG23 ' A' ' 54' ' ' THR . 2.7 tp -68.84 171.16 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.426 HD11 ' OG1' ' A' ' 17' ' ' THR . 81.1 mt -131.48 74.98 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.228 -0.92 . . . . 0.0 110.597 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.512 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.3 m-20 -98.01 45.99 1.02 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.76 164.63 15.32 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -81.94 1.48 35.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.777 -0.837 . . . . 0.0 110.491 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.4 m -108.43 -31.41 7.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.206 -0.934 . . . . 0.0 110.152 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.568 HD11 ' OD1' ' A' ' 38' ' ' ASN . 50.1 mt -137.53 168.58 19.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.466 -0.771 . . . . 0.0 110.608 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -154.76 134.02 12.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.655 -0.653 . . . . 0.0 110.015 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.72 -143.7 15.13 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -135.71 160.58 38.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.539 -0.977 . . . . 0.0 110.3 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.426 ' OG1' HD11 ' A' ' 8' ' ' ILE . 17.5 m -135.53 158.62 43.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.541 -0.724 . . . . 0.0 110.116 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.9 p -142.99 154.53 44.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.58 -0.7 . . . . 0.0 110.431 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.767 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.7 t -159.77 159.55 32.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.608 -0.683 . . . . 0.0 110.228 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -93.19 121.07 34.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.552 -0.718 . . . . 0.0 110.183 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.27 138.39 23.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.582 -0.699 . . . . 0.0 110.174 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.8 m -59.31 -32.59 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.508 -0.745 . . . . 0.0 110.445 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.669 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 24.8 p30 -171.01 -178.24 2.42 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.586 -0.696 . . . . 0.0 110.319 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -54.79 -25.25 26.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.474 -0.766 . . . . 0.0 110.962 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.669 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.19 -26.53 64.89 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.488 -0.758 . . . . 0.0 110.374 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.4 m -113.82 -25.75 8.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.518 -0.739 . . . . 0.0 110.556 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.796 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.11 -60.76 3.25 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.417 -0.802 . . . . 0.0 110.408 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -59.88 -35.76 75.51 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.601 -0.687 . . . . 0.0 110.266 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -57.65 -38.99 76.0 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.401 -0.812 . . . . 0.0 110.189 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.0 t -83.79 -47.44 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.667 -0.646 . . . . 0.0 109.816 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.767 ' CZ ' HG22 ' A' ' 19' ' ' THR . 8.0 m-85 -62.68 -34.98 78.22 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.577 -0.702 . . . . 0.0 109.906 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -64.03 -46.94 82.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.409 -0.807 . . . . 0.0 109.084 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -62.15 -31.92 72.47 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.698 0.761 . . . . 0.0 109.472 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -68.16 -50.35 55.11 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.743 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -68.13 -37.25 80.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.764 -0.585 . . . . 0.0 109.929 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -58.06 -46.75 84.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.577 -0.702 . . . . 0.0 110.533 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -60.59 -56.95 15.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.579 -0.701 . . . . 0.0 110.324 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.568 ' OD1' HD11 ' A' ' 13' ' ' LEU . 53.7 m-80 -63.71 -45.93 87.73 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.58 -0.7 . . . . 0.0 110.136 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.97 63.07 0.39 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.743 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 85.5 mt -118.04 63.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.528 -0.984 . . . . 0.0 110.133 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -83.31 59.54 5.08 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.82 -138.77 7.2 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -115.97 106.27 13.59 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.583 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 37.3 m95 -76.5 142.36 40.95 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.212 1.005 . . . . 0.0 112.419 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -150.3 132.18 15.12 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.413 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 18.9 t80 -105.75 133.7 50.05 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.625 -0.672 . . . . 0.0 110.072 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -103.6 112.9 26.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.712 -0.618 . . . . 0.0 109.922 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -69.29 -23.05 63.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.647 -0.658 . . . . 0.0 110.561 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.98 -40.87 67.27 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.317 -0.864 . . . . 0.0 110.721 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.5 p -145.06 18.43 1.59 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.576 -0.702 . . . . 0.0 110.863 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HG3' ' CE2' ' A' ' 46' ' ' TYR . 5.0 mptt 51.24 92.71 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.177 -0.952 . . . . 0.0 111.084 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.6 m -154.42 101.58 2.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.483 -0.761 . . . . 0.0 110.707 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -62.0 129.22 39.89 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.557 -0.714 . . . . 0.0 109.095 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.698 HG23 HG21 ' A' ' 7' ' ' ILE . 75.7 m -121.34 100.81 7.25 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.649 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.599 HG11 HG21 ' A' ' 40' ' ' ILE . 10.6 p -101.24 167.25 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.526 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.512 HG23 ' HB3' ' A' ' 9' ' ' ASN . 89.4 m -160.8 109.05 1.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.698 -0.626 . . . . 0.0 109.784 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.19 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.595 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 32.1 m . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.033 0.444 . . . . 0.0 110.362 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.0 m -93.79 97.61 10.53 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.61 -0.681 . . . . 0.0 110.874 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.595 ' CZ ' HG21 ' A' ' 2' ' ' THR . 92.9 m-85 -81.85 171.26 14.7 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.466 -0.771 . . . . 0.0 109.839 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.44 ' O ' HG23 ' A' ' 52' ' ' THR . 10.5 mttt -144.04 122.33 12.29 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.506 -0.746 . . . . 0.0 110.41 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.545 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 49.4 tp -99.49 123.94 44.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.558 -0.714 . . . . 0.0 110.141 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.606 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.9 tp -76.38 166.39 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.526 HD12 ' N ' ' A' ' 16' ' ' GLU . 81.0 mt -128.58 74.76 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.213 -0.93 . . . . 0.0 110.488 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.651 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.9 m-20 -95.57 47.95 1.13 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.414 -0.804 . . . . 0.0 108.901 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.94 151.85 17.61 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -71.14 -9.41 58.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.656 -0.908 . . . . 0.0 110.4 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 m -89.03 -36.13 15.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.43 174.58 10.81 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.455 -0.778 . . . . 0.0 110.59 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.3 tttt -156.24 144.42 19.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.697 . . . . 0.0 110.403 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.65 -123.05 3.23 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.526 ' N ' HD12 ' A' ' 8' ' ' ILE . 12.3 tt0 -164.77 166.88 19.46 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.566 -0.961 . . . . 0.0 110.101 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 m -135.63 148.31 48.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.541 -0.725 . . . . 0.0 110.231 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.7 p -137.78 146.44 43.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.541 -0.724 . . . . 0.0 110.245 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.671 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.2 t -163.76 134.26 4.38 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.596 -0.69 . . . . 0.0 110.141 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.05 112.1 2.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.561 -0.712 . . . . 0.0 110.29 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.472 ' HB3' ' HD2' ' A' ' 4' ' ' PHE . . . -129.88 137.58 50.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.495 -0.753 . . . . 0.0 110.176 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.594 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.3 p -60.02 -32.4 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.53 -0.731 . . . . 0.0 110.25 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.594 ' OD1' HG13 ' A' ' 22' ' ' VAL . 51.8 p-10 -171.68 174.86 4.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.454 -0.779 . . . . 0.0 110.294 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.436 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.87 -24.82 17.17 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.54 -0.725 . . . . 0.0 110.928 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.24 -38.87 92.85 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.49 -0.757 . . . . 0.0 110.097 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.9 m -93.35 -27.6 16.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.525 -0.734 . . . . 0.0 110.358 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.697 ' HB1' ' HE2' ' A' ' 31' ' ' PHE . . . -66.41 -52.35 47.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.526 -0.734 . . . . 0.0 110.448 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.48 -37.47 70.39 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.499 -0.751 . . . . 0.0 110.549 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -60.31 -33.48 72.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.41 -0.806 . . . . 0.0 109.787 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.6 t -87.32 -44.19 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.651 . . . . 0.0 109.564 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.697 ' HE2' ' HB1' ' A' ' 27' ' ' ALA . 30.1 m-85 -66.28 -39.02 89.13 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.627 -0.671 . . . . 0.0 109.767 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -62.81 -50.9 69.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.608 -0.683 . . . . 0.0 109.551 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -61.26 -31.17 70.98 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.607 0.718 . . . . 0.0 109.63 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -68.55 -46.45 69.47 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.601 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -72.78 -38.67 67.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.739 -0.6 . . . . 0.0 109.91 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -58.76 -49.24 78.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.538 -0.726 . . . . 0.0 110.393 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -61.54 -56.05 24.28 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.683 -0.635 . . . . 0.0 110.123 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -60.91 -48.38 82.08 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.602 -0.686 . . . . 0.0 110.108 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.36 49.61 0.27 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.601 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.7 mt -117.65 75.47 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.515 -0.991 . . . . 0.0 110.398 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -98.36 39.95 1.21 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.88 -137.83 0.02 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -113.27 112.6 24.01 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.545 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 29.9 m95 -81.89 142.88 32.09 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.213 1.006 . . . . 0.0 112.686 -177.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 44' ' ' TRP . 2.4 p -152.68 131.28 12.27 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -100.59 108.41 20.32 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.742 -0.599 . . . . 0.0 109.997 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -78.53 100.4 6.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.698 -0.626 . . . . 0.0 109.967 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -62.34 -24.59 67.42 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.714 -0.616 . . . . 0.0 110.439 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.427 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.07 -34.03 54.73 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.371 -0.831 . . . . 0.0 111.043 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.427 HG23 ' C ' ' A' ' 49' ' ' ALA . 75.8 p -147.15 17.67 1.21 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.523 -0.736 . . . . 0.0 110.905 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER 50.55 87.0 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.117 -0.989 . . . . 0.0 111.066 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 5' ' ' LYS . 60.6 m -155.17 108.56 2.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.536 -0.727 . . . . 0.0 110.755 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 83.5 m-85 -61.14 126.16 26.35 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.606 ' HA ' HG22 ' A' ' 7' ' ' ILE . 44.7 m -118.83 96.6 5.32 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.223 -0.991 . . . . 0.0 113.079 -178.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.531 HG21 HG22 ' A' ' 40' ' ' ILE . 11.0 p -100.01 167.12 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 109.19 177.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.651 HG23 ' HB3' ' A' ' 9' ' ' ASN . 84.9 m -160.64 109.38 1.65 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.588 -0.695 . . . . 0.0 109.814 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.062 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.484 HG22 ' CE2' ' A' ' 4' ' ' PHE . 47.5 m . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.029 0.442 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 59.4 m -104.27 98.74 8.49 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.641 -0.662 . . . . 0.0 110.731 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.77 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 86.4 m-85 -78.57 172.35 13.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.546 -0.721 . . . . 0.0 109.831 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.582 ' HG2' HG22 ' A' ' 18' ' ' THR . 22.7 mttm -142.22 121.23 12.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.488 -0.757 . . . . 0.0 110.335 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.546 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 53.8 tp -100.87 118.24 36.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.434 -0.791 . . . . 0.0 110.338 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.601 HG22 ' HA ' ' A' ' 54' ' ' THR . 5.1 tp -66.91 168.19 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.536 HD11 ' OG1' ' A' ' 17' ' ' THR . 79.7 mt -130.63 74.37 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.181 -0.949 . . . . 0.0 110.711 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.588 ' HB3' HG23 ' A' ' 56' ' ' THR . 3.0 m-20 -96.11 48.91 1.12 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.81 157.35 15.01 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -74.54 -6.29 47.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.71 -0.876 . . . . 0.0 110.632 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -97.18 -33.83 11.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.247 -0.908 . . . . 0.0 110.275 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.421 ' HB3' HG21 ' A' ' 8' ' ' ILE . 45.5 mt -137.34 170.73 15.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.539 -0.725 . . . . 0.0 110.454 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -157.21 134.33 10.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.539 -0.726 . . . . 0.0 110.273 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.13 -144.42 16.36 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.455 ' HG2' HD12 ' A' ' 7' ' ' ILE . 11.2 mt-10 -136.18 153.34 51.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.598 -0.942 . . . . 0.0 110.244 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.536 ' OG1' HD11 ' A' ' 8' ' ' ILE . 5.2 m -130.93 147.83 52.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.704 . . . . 0.0 110.052 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.582 HG22 ' HG2' ' A' ' 5' ' ' LYS . 67.0 p -129.35 165.64 21.1 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.555 -0.716 . . . . 0.0 110.303 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.4 t -156.42 -176.24 5.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.695 . . . . 0.0 110.119 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.81 92.95 3.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.556 -0.715 . . . . 0.0 110.421 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.65 179.54 4.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.421 -0.799 . . . . 0.0 110.088 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -100.43 -25.55 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.615 -0.678 . . . . 0.0 110.02 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -167.81 176.25 6.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.507 -0.746 . . . . 0.0 110.014 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.97 -25.42 60.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.471 -0.768 . . . . 0.0 110.789 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.0 -25.43 65.26 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.467 -0.771 . . . . 0.0 110.752 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.6 m -111.95 -27.46 8.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.376 -0.827 . . . . 0.0 110.66 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.77 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.74 -54.48 44.71 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.516 -0.74 . . . . 0.0 110.461 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -57.44 -39.3 75.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.525 -0.735 . . . . 0.0 110.697 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -56.41 -36.74 69.28 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.274 -0.891 . . . . 0.0 110.588 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.5 t -84.88 -47.59 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.606 -0.684 . . . . 0.0 109.975 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.501 ' HB3' HD22 ' A' ' 6' ' ' LEU . 8.8 m-85 -65.08 -37.22 86.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.584 -0.698 . . . . 0.0 110.135 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -63.65 -45.01 92.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.465 -0.772 . . . . 0.0 109.177 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -62.88 -29.0 70.42 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.537 0.684 . . . . 0.0 109.616 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -73.0 -47.39 45.58 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -73.61 -35.78 65.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.691 -0.63 . . . . 0.0 109.766 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -56.05 -49.6 73.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.528 -0.733 . . . . 0.0 110.599 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -69.45 -46.9 65.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.642 -0.661 . . . . 0.0 109.986 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -61.53 -42.05 98.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.571 -0.706 . . . . 0.0 110.023 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.54 50.18 0.82 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.757 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 86.1 mt -110.64 61.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.538 -0.978 . . . . 0.0 110.173 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -81.45 60.6 4.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.533 -0.729 . . . . 0.0 109.166 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.6 -139.04 7.77 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -116.38 107.1 14.38 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.546 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 37.2 m95 -77.3 143.46 38.83 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.19 0.995 . . . . 0.0 112.374 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 44' ' ' TRP . 3.3 p -154.43 131.01 10.64 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -104.62 138.51 40.85 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.643 -0.661 . . . . 0.0 109.959 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -114.28 116.62 29.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.689 -0.632 . . . . 0.0 109.937 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -70.31 -25.19 63.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.725 -0.609 . . . . 0.0 110.566 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.05 -38.32 56.68 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.41 -0.806 . . . . 0.0 110.757 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.7 p -142.75 13.34 1.9 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.625 -0.672 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.08 90.74 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.079 -1.013 . . . . 0.0 111.013 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 5' ' ' LYS . 56.2 m -157.35 110.0 2.46 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.325 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 87.3 m-85 -64.24 129.05 38.42 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.601 ' HA ' HG22 ' A' ' 7' ' ' ILE . 47.6 m -119.96 99.03 6.38 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.193 -1.003 . . . . 0.0 112.904 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.567 HG11 HG21 ' A' ' 40' ' ' ILE . 9.3 p -102.85 165.74 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.469 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.588 HG23 ' HB3' ' A' ' 9' ' ' ASN . 85.9 m -162.31 114.49 1.67 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.767 -0.583 . . . . 0.0 109.909 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.089 179.715 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.601 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 21.1 m . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.111 0.482 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.6 m -90.89 88.48 7.06 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.701 -0.625 . . . . 0.0 110.637 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.798 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.6 m-85 -71.15 167.94 18.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.457 -0.777 . . . . 0.0 109.909 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -136.19 132.89 36.52 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.496 -0.753 . . . . 0.0 110.254 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.595 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 58.1 tp -109.41 117.57 34.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.355 -0.841 . . . . 0.0 110.316 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.676 HD12 ' CG ' ' A' ' 16' ' ' GLU . 4.1 tp -66.57 171.1 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.445 HG21 ' HB3' ' A' ' 13' ' ' LEU . 78.2 mt -133.84 74.93 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 110.717 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -96.58 47.58 1.07 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.348 -0.845 . . . . 0.0 108.912 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.21 153.99 16.91 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.85 -9.45 57.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.929 . . . . 0.0 110.631 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.6 m -92.14 -32.6 15.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.182 -0.949 . . . . 0.0 110.432 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.445 ' HB3' HG21 ' A' ' 8' ' ' ILE . 34.0 mt -142.21 170.23 16.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.374 -0.828 . . . . 0.0 110.768 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -153.97 136.51 15.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.68 -0.637 . . . . 0.0 110.294 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.14 -147.24 18.04 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.676 ' CG ' HD12 ' A' ' 7' ' ' ILE . 9.6 mt-10 -139.08 162.73 34.23 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.597 -0.943 . . . . 0.0 110.264 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.45 HG22 ' N ' ' A' ' 18' ' ' THR . 27.4 m -140.11 168.54 19.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.585 -0.697 . . . . 0.0 110.221 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.45 ' N ' HG22 ' A' ' 17' ' ' THR . 40.2 p -137.65 168.32 19.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.512 -0.742 . . . . 0.0 110.175 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.484 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.2 t -158.9 -173.2 4.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.599 -0.688 . . . . 0.0 110.36 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -126.95 96.91 4.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.538 -0.726 . . . . 0.0 110.079 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.717 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -130.28 140.17 50.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.57 -0.706 . . . . 0.0 110.134 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.605 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.3 p -60.86 -29.68 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.624 -0.672 . . . . 0.0 110.002 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.605 ' OD1' HG13 ' A' ' 22' ' ' VAL . 42.6 p-10 -167.42 -178.24 3.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.678 . . . . 0.0 110.286 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.437 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.88 -24.82 39.49 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.508 -0.745 . . . . 0.0 110.968 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.88 -29.6 68.44 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.486 -0.759 . . . . 0.0 110.32 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.717 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 7.5 m -107.5 -26.53 10.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.575 -0.703 . . . . 0.0 110.394 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.798 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.3 -63.45 1.3 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.434 -0.791 . . . . 0.0 110.413 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -58.26 -36.81 73.81 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.481 -0.762 . . . . 0.0 110.126 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -57.6 -38.42 74.88 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.437 -0.789 . . . . 0.0 110.07 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 26' ' ' THR . 91.0 t -83.93 -48.09 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.662 -0.649 . . . . 0.0 109.726 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.484 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.1 m-85 -61.97 -35.12 77.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.648 -0.658 . . . . 0.0 109.91 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -63.97 -46.02 86.51 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.563 -0.711 . . . . 0.0 109.086 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -62.31 -31.91 72.59 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.628 0.727 . . . . 0.0 109.403 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -69.31 -54.3 15.27 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.697 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.17 -40.25 95.73 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.698 -0.626 . . . . 0.0 109.827 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.59 -42.25 87.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.573 -0.705 . . . . 0.0 110.451 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.42 -52.22 28.97 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.605 -0.685 . . . . 0.0 110.017 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -63.75 -50.37 69.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.596 -0.69 . . . . 0.0 109.922 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.24 58.53 0.18 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.697 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.9 mt -125.56 67.18 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.472 -1.017 . . . . 0.0 110.401 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -89.81 53.56 2.6 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.83 -138.33 3.08 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.63 110.92 21.36 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.982 -0.716 . . . . 0.0 109.384 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.595 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 32.9 m95 -81.47 143.56 31.99 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 122.131 0.967 . . . . 0.0 112.228 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 44' ' ' TRP . 2.1 p -154.0 132.05 11.75 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.419 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 25.3 t80 -105.35 129.0 53.78 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.657 -0.652 . . . . 0.0 110.166 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -102.16 120.34 40.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.716 -0.615 . . . . 0.0 109.981 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -73.04 -20.14 61.04 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.665 -0.647 . . . . 0.0 110.678 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.87 -41.18 67.25 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.314 -0.866 . . . . 0.0 110.861 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.6 p -144.9 18.21 1.61 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.57 -0.706 . . . . 0.0 110.744 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.419 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 0.7 OUTLIER 51.31 93.19 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.16 -0.962 . . . . 0.0 110.78 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.7 m -157.19 106.42 2.18 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.175 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -63.94 127.33 30.91 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.642 HG23 HG21 ' A' ' 7' ' ' ILE . 88.9 m -117.17 104.2 10.96 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.344 -0.848 . . . . 0.0 112.597 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.557 HG21 HG22 ' A' ' 40' ' ' ILE . 11.4 p -105.21 167.11 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.846 . . . . 0.0 109.207 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.472 ' N ' HG22 ' A' ' 55' ' ' VAL . 97.8 m -160.8 108.04 1.52 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.724 -0.61 . . . . 0.0 109.714 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.182 -179.862 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.505 HG22 ' CE2' ' A' ' 4' ' ' PHE . 57.9 m . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 121.113 0.482 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.0 m -104.76 104.43 14.22 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.567 -0.708 . . . . 0.0 110.617 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.708 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 77.3 m-85 -84.82 178.52 7.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.54 -0.725 . . . . 0.0 109.742 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 52' ' ' THR . 23.4 ttpt -149.56 109.67 4.13 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.445 -0.785 . . . . 0.0 110.644 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.54 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 58.1 tp -90.6 121.37 32.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.414 -0.804 . . . . 0.0 110.324 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.64 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.9 tp -72.0 168.23 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.485 HD12 ' N ' ' A' ' 16' ' ' GLU . 75.4 mt -130.05 72.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.208 -0.933 . . . . 0.0 110.796 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.558 ' HB3' HG23 ' A' ' 56' ' ' THR . 37.3 m-20 -96.93 49.18 1.07 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.472 -0.768 . . . . 0.0 109.174 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.14 165.42 13.2 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.01 2.66 29.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.593 -0.946 . . . . 0.0 110.732 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -111.98 -29.27 7.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.119 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.695 HD11 ' OD1' ' A' ' 38' ' ' ASN . 80.1 mt -135.6 166.26 23.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.477 -0.764 . . . . 0.0 110.609 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -154.05 132.29 11.89 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.696 -0.627 . . . . 0.0 110.161 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.09 -129.82 5.07 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.485 ' N ' HD12 ' A' ' 8' ' ' ILE . 6.4 pt-20 -159.25 152.44 22.3 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.581 -0.953 . . . . 0.0 110.592 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.4 m -125.5 154.12 42.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.616 -0.677 . . . . 0.0 110.068 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 p -139.5 150.87 45.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.457 -0.777 . . . . 0.0 110.391 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.673 HG22 ' CE2' ' A' ' 31' ' ' PHE . 8.4 t -153.12 147.66 26.07 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.616 -0.677 . . . . 0.0 110.202 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -85.04 112.65 20.82 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.506 -0.746 . . . . 0.0 110.381 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.86 -171.15 2.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.498 -0.751 . . . . 0.0 110.032 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -109.46 -27.2 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.618 -0.676 . . . . 0.0 110.067 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -170.13 173.8 5.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.464 -0.772 . . . . 0.0 110.185 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.2 -26.25 64.67 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.571 -0.705 . . . . 0.0 110.715 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.37 -26.56 65.19 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.463 -0.773 . . . . 0.0 110.621 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.4 m -109.45 -32.54 7.11 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.5 -0.75 . . . . 0.0 110.31 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.708 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.15 -52.61 64.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.5 -0.75 . . . . 0.0 110.427 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -59.15 -43.17 92.03 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.518 -0.739 . . . . 0.0 110.302 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -57.52 -34.75 69.44 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.369 -0.832 . . . . 0.0 110.319 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 83.6 t -84.99 -48.44 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.585 -0.697 . . . . 0.0 109.84 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.673 ' CE2' HG22 ' A' ' 19' ' ' THR . 3.9 m-85 -65.39 -36.09 82.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.594 -0.691 . . . . 0.0 110.183 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -63.87 -46.59 84.26 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.477 -0.764 . . . . 0.0 109.341 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -59.9 -30.71 69.2 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.541 0.686 . . . . 0.0 109.822 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -70.33 -52.69 20.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.687 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.18 -38.49 91.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.701 -0.624 . . . . 0.0 110.042 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -57.14 -45.89 83.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.45 -0.781 . . . . 0.0 110.563 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.83 -49.89 54.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.612 -0.68 . . . . 0.0 110.02 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.695 ' OD1' HD11 ' A' ' 13' ' ' LEU . 15.8 m-80 -62.5 -42.88 99.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.613 -0.679 . . . . 0.0 110.032 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.51 47.83 0.53 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.687 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 83.6 mt -119.07 74.58 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.53 -0.983 . . . . 0.0 110.409 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -97.78 39.69 1.2 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.67 -138.01 0.03 OUTLIER Glycine 0 N--CA 1.488 2.159 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -112.24 112.49 24.12 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.54 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 29.6 m95 -82.38 143.86 30.93 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.24 1.019 . . . . 0.0 112.499 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 44' ' ' TRP . 2.4 p -155.24 131.89 10.55 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -102.09 128.65 48.47 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.644 -0.66 . . . . 0.0 110.263 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -99.78 104.57 16.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.673 -0.642 . . . . 0.0 109.866 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -64.52 -21.45 66.68 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.594 -0.691 . . . . 0.0 110.881 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.428 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.29 -38.41 63.1 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.286 -0.884 . . . . 0.0 110.788 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.428 HG23 ' C ' ' A' ' 49' ' ' ALA . 74.3 p -147.65 21.12 1.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.607 -0.683 . . . . 0.0 110.617 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER 50.27 90.83 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.211 -0.931 . . . . 0.0 111.129 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 5' ' ' LYS . 88.4 m -155.29 103.59 2.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.523 -0.735 . . . . 0.0 110.717 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 86.8 m-85 -60.92 132.21 53.13 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.64 ' HA ' HG22 ' A' ' 7' ' ' ILE . 52.7 m -122.66 98.84 6.1 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.133 -1.027 . . . . 0.0 113.119 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.541 HG21 HG22 ' A' ' 40' ' ' ILE . 11.2 p -102.87 166.7 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.333 -0.854 . . . . 0.0 109.144 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.558 HG23 ' HB3' ' A' ' 9' ' ' ASN . 91.6 m -160.84 109.99 1.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.659 -0.65 . . . . 0.0 109.762 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.263 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.516 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 90.5 m . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.036 0.446 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.5 m -139.92 107.44 5.58 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.582 -0.699 . . . . 0.0 110.436 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.797 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 97.4 m-85 -96.06 169.68 9.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.654 -0.654 . . . . 0.0 109.996 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -139.3 119.46 13.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.48 -0.763 . . . . 0.0 110.423 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.63 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 50.2 tp -98.75 121.99 41.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.486 -0.759 . . . . 0.0 110.243 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.604 HG22 ' HA ' ' A' ' 54' ' ' THR . 5.0 tp -70.26 171.78 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 82.8 mt -132.09 71.74 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.175 -0.953 . . . . 0.0 110.523 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.432 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.8 m-20 -96.17 46.81 1.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.478 -0.764 . . . . 0.0 109.085 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.54 158.27 17.3 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -73.39 -7.86 53.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.759 -0.847 . . . . 0.0 110.525 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.2 m -96.81 -32.77 11.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.208 -0.932 . . . . 0.0 110.273 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.9 mt -136.5 173.85 11.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.498 -0.751 . . . . 0.0 110.6 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -153.22 128.47 9.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.655 -0.653 . . . . 0.0 110.179 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.02 -142.6 14.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.01 -178.9 6.54 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.997 . . . . 0.0 110.347 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 6' ' ' LEU . 7.0 t -162.74 159.77 24.61 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.588 -0.695 . . . . 0.0 110.278 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.4 p -134.52 156.46 48.6 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.57 -0.706 . . . . 0.0 110.177 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.582 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.5 t -142.62 -173.17 3.8 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.538 -0.727 . . . . 0.0 110.305 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -122.45 101.93 7.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.611 -0.681 . . . . 0.0 110.2 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.446 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -127.36 170.31 12.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.592 -0.692 . . . . 0.0 110.087 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -87.01 -26.93 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.64 -0.662 . . . . 0.0 109.902 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -175.24 -179.03 1.25 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.41 -0.806 . . . . 0.0 109.772 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.435 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.39 -25.88 38.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.392 -0.817 . . . . 0.0 110.936 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.24 -25.66 65.82 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.573 -0.705 . . . . 0.0 110.552 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.446 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 7.3 m -112.74 -26.17 8.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.476 -0.765 . . . . 0.0 110.359 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.797 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.6 -58.74 7.22 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.441 -0.787 . . . . 0.0 110.422 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -60.08 -41.3 92.17 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.604 -0.685 . . . . 0.0 110.143 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -56.74 -38.44 72.41 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.362 -0.836 . . . . 0.0 110.346 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 26' ' ' THR . 84.0 t -82.63 -48.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.622 -0.674 . . . . 0.0 109.975 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.582 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.3 m-85 -64.33 -32.81 74.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.531 -0.731 . . . . 0.0 110.19 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -64.75 -45.77 85.01 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.415 -0.803 . . . . 0.0 108.934 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -62.53 -33.12 74.28 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.659 0.743 . . . . 0.0 109.391 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -66.13 -51.48 57.52 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.788 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -67.61 -42.52 82.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.77 -0.581 . . . . 0.0 110.095 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -56.94 -36.14 69.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.47 -0.768 . . . . 0.0 110.537 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -62.98 -59.19 5.16 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.562 -0.711 . . . . 0.0 110.094 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -67.87 -47.25 69.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.656 -0.652 . . . . 0.0 110.017 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.33 60.0 0.19 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.788 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 85.2 mt -115.8 62.91 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.475 -1.015 . . . . 0.0 110.145 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -86.2 56.53 4.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.443 -0.786 . . . . 0.0 109.037 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.68 -136.53 3.01 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -117.43 99.42 6.98 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.842 -0.799 . . . . 0.0 109.298 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.63 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 30.8 m95 -69.16 143.38 54.09 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.225 1.012 . . . . 0.0 112.541 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 44' ' ' TRP . 3.0 p -153.41 131.41 11.78 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -101.79 138.14 39.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.641 -0.662 . . . . 0.0 110.166 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -105.92 103.5 13.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.725 -0.61 . . . . 0.0 109.784 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.12 -21.96 66.54 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.672 -0.643 . . . . 0.0 110.657 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.434 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.95 -39.41 65.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.295 -0.878 . . . . 0.0 110.84 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.434 HG23 ' C ' ' A' ' 49' ' ' ALA . 73.8 p -148.14 22.75 1.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.483 -0.76 . . . . 0.0 110.7 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.443 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.3 91.32 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.21 -0.931 . . . . 0.0 110.816 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.4 m -153.99 102.71 2.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.484 -0.76 . . . . 0.0 111.119 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.431 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 75.3 m-85 -63.26 133.73 54.69 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.604 ' HA ' HG22 ' A' ' 7' ' ' ILE . 52.6 m -126.3 101.84 6.91 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.347 -0.941 . . . . 0.0 112.883 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.567 HG21 HG22 ' A' ' 40' ' ' ILE . 10.6 p -104.26 165.81 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.374 -0.829 . . . . 0.0 109.322 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.466 ' N ' HG22 ' A' ' 55' ' ' VAL . 76.0 m -162.24 119.37 2.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.753 -0.592 . . . . 0.0 110.074 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.173 179.588 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.599 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 47.9 m . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 121.103 0.478 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.2 m -88.87 93.97 9.77 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.591 -0.693 . . . . 0.0 110.76 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.684 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 94.0 m-85 -76.92 167.9 21.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.5 -0.75 . . . . 0.0 109.963 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -138.92 123.84 18.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.525 -0.735 . . . . 0.0 110.352 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.608 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 44.8 tp -100.0 124.26 45.16 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.476 -0.765 . . . . 0.0 110.317 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.657 HG22 ' HA ' ' A' ' 54' ' ' THR . 5.5 tp -74.6 168.2 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 13' ' ' LEU . 72.6 mt -127.84 73.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.41 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.501 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.3 m-20 -95.13 47.58 1.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.37 -0.831 . . . . 0.0 108.985 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.74 159.33 14.21 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -79.19 -1.53 36.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.759 -0.848 . . . . 0.0 110.364 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.8 m -99.87 -32.4 11.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 110.035 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.431 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -146.36 172.0 14.16 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.513 -0.742 . . . . 0.0 110.379 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.59 145.18 19.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.573 -0.705 . . . . 0.0 110.267 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.89 -132.11 6.01 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -154.23 163.19 40.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.59 -0.947 . . . . 0.0 110.349 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.1 m -149.58 145.48 26.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.566 -0.709 . . . . 0.0 110.141 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.3 p -132.68 167.2 20.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.585 -0.697 . . . . 0.0 110.24 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.692 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.1 t -162.94 170.15 18.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.617 -0.677 . . . . 0.0 110.305 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -101.68 123.38 45.58 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.626 -0.671 . . . . 0.0 110.143 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -151.89 146.41 25.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.568 -0.707 . . . . 0.0 110.264 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.446 HG13 ' OD1' ' A' ' 23' ' ' ASP . 10.4 p -61.39 -34.25 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.595 -0.691 . . . . 0.0 110.056 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.512 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 39.3 p30 -170.19 177.03 4.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.592 -0.692 . . . . 0.0 110.281 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.461 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.45 -26.86 21.93 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.518 -0.739 . . . . 0.0 111.021 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.512 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.48 -23.33 57.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.539 -0.725 . . . . 0.0 110.554 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.6 m -118.0 -14.14 10.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.499 -0.751 . . . . 0.0 111.088 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.684 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -72.14 -50.07 30.85 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.228 -0.92 . . . . 0.0 110.406 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.52 -30.68 68.76 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.482 -0.761 . . . . 0.0 110.412 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -58.9 -40.46 84.54 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.376 -0.827 . . . . 0.0 110.341 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.0 t -82.99 -42.21 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.517 -0.739 . . . . 0.0 109.867 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.692 ' CZ ' HG22 ' A' ' 19' ' ' THR . 13.1 m-85 -68.27 -35.37 77.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.573 -0.704 . . . . 0.0 110.119 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -63.77 -46.66 84.23 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.473 -0.767 . . . . 0.0 109.128 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -62.64 -30.95 71.75 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.611 0.72 . . . . 0.0 109.467 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -69.7 -47.84 61.76 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.71 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -73.61 -33.76 64.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.68 -0.637 . . . . 0.0 110.001 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -60.68 -52.23 66.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.623 -0.673 . . . . 0.0 110.417 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.6 -35.54 78.14 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 110.52 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -79.29 -42.42 25.84 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.562 -0.711 . . . . 0.0 110.312 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.3 41.0 1.19 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.71 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 79.8 mt -99.64 59.52 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.549 -0.971 . . . . 0.0 110.166 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -80.84 61.48 4.49 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.36 -138.32 7.84 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -117.39 102.1 8.95 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.981 -0.717 . . . . 0.0 109.332 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.608 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 37.0 m95 -71.91 142.68 49.49 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.191 0.996 . . . . 0.0 112.516 -178.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -151.93 132.52 13.92 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.408 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 25.0 t80 -108.39 138.04 45.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.645 -0.659 . . . . 0.0 110.285 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.06 123.4 49.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.69 -0.631 . . . . 0.0 109.602 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -78.01 -24.25 48.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.624 -0.672 . . . . 0.0 110.619 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.06 -39.43 66.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.382 -0.824 . . . . 0.0 110.834 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.5 p -141.77 12.86 2.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.599 -0.688 . . . . 0.0 111.102 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.46 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.95 94.41 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.133 -0.98 . . . . 0.0 111.205 179.517 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.2 m -157.9 105.33 1.97 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.549 -0.719 . . . . 0.0 110.761 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -60.67 132.96 55.53 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.461 -0.774 . . . . 0.0 109.169 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.657 ' HA ' HG22 ' A' ' 7' ' ' ILE . 58.7 m -125.82 99.9 6.16 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.207 -0.997 . . . . 0.0 112.666 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 40' ' ' ILE . 11.2 p -102.17 167.47 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.88 . . . . 0.0 109.271 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.501 HG23 ' HB3' ' A' ' 9' ' ' ASN . 98.9 m -160.28 109.2 1.71 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.593 -0.692 . . . . 0.0 109.894 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.274 -179.992 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.555 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 63.0 m . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.111 0.481 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.623 ' O ' HG23 ' A' ' 3' ' ' THR . 7.5 t -87.82 95.15 9.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.66 -0.65 . . . . 0.0 110.819 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.764 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.5 m-85 -77.1 171.48 14.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.42 -0.8 . . . . 0.0 109.819 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -139.31 128.89 24.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.49 -0.756 . . . . 0.0 110.331 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.611 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 41.1 tp -103.41 122.62 45.25 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.385 -0.822 . . . . 0.0 110.432 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.65 HG21 HG23 ' A' ' 54' ' ' THR . 5.0 tp -70.74 171.13 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.43 HG21 ' HB3' ' A' ' 13' ' ' LEU . 73.9 mt -133.8 74.4 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.644 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.677 ' HB3' HG23 ' A' ' 56' ' ' THR . 27.7 m-20 -95.86 47.73 1.11 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.545 -0.722 . . . . 0.0 109.138 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.42 163.66 13.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -82.3 2.65 31.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.651 -0.911 . . . . 0.0 110.791 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 m -111.5 -28.87 7.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.19 -0.943 . . . . 0.0 110.138 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.43 ' HB3' HG21 ' A' ' 8' ' ' ILE . 6.3 mt -136.93 167.3 21.76 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.558 -0.714 . . . . 0.0 110.393 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -155.75 138.04 14.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.538 -0.726 . . . . 0.0 110.213 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.07 -133.23 7.32 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -163.75 163.02 24.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.533 -0.98 . . . . 0.0 110.262 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.9 m -144.56 150.32 37.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.551 -0.718 . . . . 0.0 110.281 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.2 p -126.91 161.27 28.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.592 -0.693 . . . . 0.0 110.247 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.4 t -153.08 -171.59 3.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.506 -0.746 . . . . 0.0 110.382 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -115.97 109.25 17.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.54 -0.725 . . . . 0.0 110.152 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.36 138.55 38.39 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.601 -0.687 . . . . 0.0 110.155 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.8 m -57.4 -30.51 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.571 -0.705 . . . . 0.0 110.515 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.631 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 23.2 p30 -172.47 -179.56 2.25 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.407 -0.808 . . . . 0.0 110.283 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.451 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.18 -25.2 31.09 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.502 -0.749 . . . . 0.0 110.876 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.631 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -60.27 -25.88 66.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.49 -0.756 . . . . 0.0 110.605 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.9 m -113.3 -25.86 8.65 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.435 -0.791 . . . . 0.0 110.64 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.764 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.14 -49.09 78.19 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.458 -0.776 . . . . 0.0 110.569 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -61.6 -36.47 80.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.607 -0.683 . . . . 0.0 110.447 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -56.72 -40.06 75.02 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.327 -0.858 . . . . 0.0 110.744 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.4 -45.52 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.483 -0.761 . . . . 0.0 110.065 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 12.7 m-85 -66.91 -35.87 80.99 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.622 -0.674 . . . . 0.0 110.3 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.5 tttm -63.61 -44.06 95.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.488 -0.758 . . . . 0.0 109.35 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.33 -30.68 71.72 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.61 0.719 . . . . 0.0 109.565 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -70.02 -44.24 69.7 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.627 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -76.47 -41.54 46.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.716 -0.615 . . . . 0.0 109.802 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -58.95 -37.77 77.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.624 -0.672 . . . . 0.0 110.4 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -69.68 -50.75 40.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.602 -0.686 . . . . 0.0 110.058 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -69.87 -50.0 46.76 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.531 -0.731 . . . . 0.0 110.018 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.92 50.99 0.17 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.627 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 77.9 mt -115.79 74.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.52 -0.988 . . . . 0.0 110.298 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.25 39.54 1.23 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.85 -137.25 0.02 OUTLIER Glycine 0 N--CA 1.488 2.127 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -111.89 109.61 19.5 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.888 -0.772 . . . . 0.0 108.973 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.611 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 35.1 m95 -79.81 143.78 34.11 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.042 0.925 . . . . 0.0 112.062 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 44' ' ' TRP . 1.8 p -155.29 132.8 11.14 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -101.92 137.41 40.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.726 -0.609 . . . . 0.0 110.109 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -108.28 114.32 28.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.766 -0.584 . . . . 0.0 109.829 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -69.8 -18.04 63.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.666 -0.646 . . . . 0.0 110.896 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.419 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.8 -42.58 72.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.234 -0.916 . . . . 0.0 110.788 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.419 HG23 ' C ' ' A' ' 49' ' ' ALA . 70.9 p -147.14 22.92 1.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.549 -0.719 . . . . 0.0 110.559 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.442 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER 51.67 94.69 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.322 -0.862 . . . . 0.0 110.859 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.4 m -156.94 107.5 2.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.456 -0.778 . . . . 0.0 111.269 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -63.65 132.57 51.54 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.65 HG23 HG21 ' A' ' 7' ' ' ILE . 61.0 m -124.08 99.52 6.28 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.254 -0.979 . . . . 0.0 113.08 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.5 HG21 HG22 ' A' ' 40' ' ' ILE . 11.9 p -102.03 167.67 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 108.917 177.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.677 HG23 ' HB3' ' A' ' 9' ' ' ASN . 97.8 m -160.19 109.42 1.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.573 -0.705 . . . . 0.0 110.034 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.184 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.571 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 46.1 m . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.13 0.49 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.5 m -85.34 95.94 9.39 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.656 -0.652 . . . . 0.0 110.697 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.645 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 89.8 m-85 -80.55 165.67 21.89 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.52 -0.738 . . . . 0.0 109.717 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.7 ttpp -139.62 118.61 12.57 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.426 -0.796 . . . . 0.0 110.521 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.624 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 46.9 tp -95.95 125.24 40.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.424 -0.797 . . . . 0.0 110.241 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.669 HG21 HG23 ' A' ' 54' ' ' THR . 4.3 tp -73.48 168.55 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.6 mt -128.93 73.18 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.195 -0.94 . . . . 0.0 110.45 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.498 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.8 m-20 -96.64 47.2 1.06 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.451 -0.781 . . . . 0.0 109.147 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.29 166.92 20.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -85.84 7.24 24.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.691 -0.888 . . . . 0.0 110.456 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.3 m -115.43 -33.35 5.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.973 . . . . 0.0 110.086 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 mt -137.45 167.64 21.22 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.486 -0.759 . . . . 0.0 110.571 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -153.23 139.14 18.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.596 -0.69 . . . . 0.0 110.369 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.08 -144.6 16.23 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -142.68 168.14 20.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.573 -0.957 . . . . 0.0 110.255 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.6 m -157.67 133.38 9.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.564 -0.71 . . . . 0.0 110.181 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.2 p -112.86 167.5 10.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.54 -0.725 . . . . 0.0 110.25 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.632 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.7 t -159.35 167.68 28.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.499 -0.751 . . . . 0.0 110.29 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -98.51 112.19 24.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.618 -0.676 . . . . 0.0 110.219 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.88 137.9 31.71 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.586 -0.696 . . . . 0.0 110.052 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.64 HG23 ' OD1' ' A' ' 23' ' ' ASP . 33.9 m -60.46 -30.33 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.506 -0.746 . . . . 0.0 110.254 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.64 ' OD1' HG23 ' A' ' 22' ' ' VAL . 46.6 p-10 -170.67 -179.65 2.97 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.574 -0.703 . . . . 0.0 110.326 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.461 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -55.51 -24.39 31.43 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.584 -0.698 . . . . 0.0 110.87 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.43 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.67 -28.11 65.43 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.46 -0.775 . . . . 0.0 110.512 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 30' ' ' VAL . 46.5 m -109.43 -27.29 9.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.585 -0.697 . . . . 0.0 110.291 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.645 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -61.6 -61.32 2.61 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.537 -0.727 . . . . 0.0 110.062 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -58.85 -38.36 78.54 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.562 -0.711 . . . . 0.0 109.921 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -58.69 -40.13 82.69 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.575 -0.703 . . . . 0.0 109.735 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 26' ' ' THR . 97.9 t -82.6 -47.89 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.692 -0.63 . . . . 0.0 109.509 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.632 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.1 m-85 -61.18 -32.71 72.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.629 -0.669 . . . . 0.0 109.998 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -65.5 -46.21 80.57 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.93 -30.94 71.24 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.65 0.738 . . . . 0.0 109.471 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -69.14 -54.29 15.73 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.715 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.3 -37.77 86.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.689 -0.632 . . . . 0.0 109.956 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -59.6 -33.34 71.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.512 -0.743 . . . . 0.0 110.428 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -70.68 -36.64 73.41 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.648 -0.657 . . . . 0.0 110.287 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -88.47 -27.9 21.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.581 -0.699 . . . . 0.0 110.161 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.82 39.73 3.3 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.715 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.8 mt -95.77 65.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.551 -0.97 . . . . 0.0 110.199 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -87.83 54.66 3.18 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.62 -137.01 2.64 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.71 105.29 11.84 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.939 -0.742 . . . . 0.0 109.202 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.624 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 31.7 m95 -74.13 143.38 45.34 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.138 0.97 . . . . 0.0 112.413 -177.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 44' ' ' TRP . 8.6 p -153.83 131.49 11.48 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -102.27 129.69 48.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.681 -0.637 . . . . 0.0 110.198 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.27 117.66 35.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.675 -0.64 . . . . 0.0 109.879 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.13 -13.16 61.13 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.648 -0.657 . . . . 0.0 111.005 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.425 ' C ' HG23 ' A' ' 50' ' ' THR . . . -56.66 -43.19 80.14 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.174 -0.954 . . . . 0.0 110.549 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.425 HG23 ' C ' ' A' ' 49' ' ' ALA . 73.7 p -147.49 24.33 1.11 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.609 -0.682 . . . . 0.0 110.435 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.439 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.69 93.45 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.305 -0.872 . . . . 0.0 110.853 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.4 m -156.48 105.11 2.24 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.903 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 91.6 m-85 -62.7 132.84 53.63 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.669 HG23 HG21 ' A' ' 7' ' ' ILE . 61.5 m -124.22 101.43 7.19 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.866 -178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.551 HG11 HG21 ' A' ' 40' ' ' ILE . 11.2 p -102.51 166.59 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.349 -0.844 . . . . 0.0 109.167 177.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.498 HG23 ' HB3' ' A' ' 9' ' ' ASN . 98.9 m -160.52 110.12 1.74 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.653 -0.654 . . . . 0.0 109.865 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.23 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.501 HG22 ' CE2' ' A' ' 4' ' ' PHE . 60.4 m . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.055 0.455 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.0 m -115.01 102.24 9.76 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.564 -0.71 . . . . 0.0 110.77 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.78 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 94.9 m-85 -82.77 -177.22 6.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.586 -0.696 . . . . 0.0 109.746 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.528 ' O ' HG23 ' A' ' 52' ' ' THR . 84.9 tttt -152.2 114.85 4.57 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.43 -0.794 . . . . 0.0 110.396 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.526 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 14.1 tp -93.51 140.03 30.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.269 -0.894 . . . . 0.0 110.277 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.7 tp -89.96 165.2 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.474 HG21 ' HB3' ' A' ' 13' ' ' LEU . 48.7 mm -126.44 77.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -0.903 . . . . 0.0 110.514 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.732 ' HB3' HG23 ' A' ' 56' ' ' THR . 3.0 m-20 -98.83 48.93 0.97 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.58 161.63 12.64 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -76.96 -12.47 59.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.767 -0.843 . . . . 0.0 110.435 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.8 m -91.1 -29.97 17.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 110.158 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.474 ' HB3' HG21 ' A' ' 8' ' ' ILE . 24.6 mt -141.14 167.64 21.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 110.49 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -153.82 131.48 11.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.645 -0.659 . . . . 0.0 110.057 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.401 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 135.95 -124.67 3.33 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -165.91 172.54 11.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.521 -0.987 . . . . 0.0 110.43 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.1 m -152.87 161.37 42.63 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.55 -0.719 . . . . 0.0 110.241 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 p -137.96 171.26 14.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.614 -0.679 . . . . 0.0 110.207 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.552 HG22 ' CE2' ' A' ' 31' ' ' PHE . 7.7 t -161.77 164.03 29.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.588 -0.695 . . . . 0.0 110.341 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -102.34 93.69 5.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.574 -0.704 . . . . 0.0 110.159 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.406 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -117.36 -172.45 2.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.553 -0.717 . . . . 0.0 110.214 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -112.14 -25.82 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.656 -0.653 . . . . 0.0 110.154 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -166.84 177.96 6.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.521 -0.737 . . . . 0.0 110.023 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.25 -25.84 59.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.723 . . . . 0.0 110.812 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.13 -45.33 93.36 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.451 -0.78 . . . . 0.0 110.458 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 30' ' ' VAL . 6.7 m -87.61 -28.04 22.14 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.495 -0.753 . . . . 0.0 110.433 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.78 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -64.57 -63.47 1.12 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.533 -0.729 . . . . 0.0 110.402 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -57.9 -42.67 85.2 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.518 -0.739 . . . . 0.0 110.311 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -55.61 -39.3 70.59 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.382 -0.824 . . . . 0.0 110.248 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 26' ' ' THR . 88.3 t -82.31 -49.03 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.701 -0.624 . . . . 0.0 109.893 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.552 ' CE2' HG22 ' A' ' 19' ' ' THR . 5.6 m-85 -62.95 -33.62 75.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.65 -0.656 . . . . 0.0 110.337 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -65.21 -45.87 82.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.414 -0.804 . . . . 0.0 109.094 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -61.71 -31.72 71.88 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.625 0.726 . . . . 0.0 109.552 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -68.43 -53.4 23.92 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.616 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.14 -47.25 80.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.733 -0.605 . . . . 0.0 109.784 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -58.03 -28.11 64.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.603 -0.686 . . . . 0.0 110.43 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.88 -47.19 19.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.608 -0.683 . . . . 0.0 110.194 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -76.22 -43.12 43.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.562 -0.711 . . . . 0.0 110.063 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.23 51.09 0.18 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.616 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 83.9 mt -122.57 73.52 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.463 -1.022 . . . . 0.0 110.231 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.97 39.7 1.26 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.56 -137.79 0.02 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -111.94 111.91 23.18 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.526 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 28.4 m95 -80.59 142.82 33.69 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.233 1.016 . . . . 0.0 112.467 -177.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 44' ' ' TRP . 3.0 p -153.93 132.95 12.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -103.16 140.5 37.27 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.649 -0.657 . . . . 0.0 110.156 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.6 116.63 30.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.643 -0.661 . . . . 0.0 110.004 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -71.2 -15.14 62.45 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.646 -0.659 . . . . 0.0 111.147 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.426 ' C ' HG23 ' A' ' 50' ' ' THR . . . -55.99 -43.48 77.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.206 -0.934 . . . . 0.0 110.681 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.426 HG23 ' C ' ' A' ' 49' ' ' ALA . 68.8 p -147.47 23.02 1.15 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.566 -0.709 . . . . 0.0 110.569 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.448 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.51 88.99 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.246 -0.909 . . . . 0.0 110.764 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 5' ' ' LYS . 88.2 m -151.95 106.16 3.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.448 -0.782 . . . . 0.0 110.872 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.433 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 86.0 m-85 -62.98 137.11 58.17 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.419 -0.801 . . . . 0.0 108.842 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.628 ' HA ' HG22 ' A' ' 7' ' ' ILE . 55.8 m -126.81 95.09 4.22 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.124 -1.03 . . . . 0.0 113.231 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.514 HG11 ' CG2' ' A' ' 40' ' ' ILE . 11.5 p -97.4 167.34 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 109.145 177.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.732 HG23 ' HB3' ' A' ' 9' ' ' ASN . 97.9 m -160.58 111.62 1.85 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.549 -0.719 . . . . 0.0 110.126 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.05 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.631 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 8.7 m . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.136 0.493 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.605 ' O ' HG23 ' A' ' 3' ' ' THR . 8.8 t -95.13 79.97 3.58 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.533 -0.729 . . . . 0.0 110.892 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.803 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 98.1 m-85 -62.13 179.62 0.28 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.335 -0.853 . . . . 0.0 109.779 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.462 ' HB3' HG23 ' A' ' 52' ' ' THR . 26.6 tttt -153.9 126.46 8.1 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.524 -0.735 . . . . 0.0 110.353 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.582 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 46.3 tp -103.87 135.43 45.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.459 -0.776 . . . . 0.0 110.189 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.59 HG21 HG23 ' A' ' 54' ' ' THR . 2.6 tp -86.78 168.69 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 13' ' ' LEU . 83.8 mt -128.43 72.64 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.203 -0.936 . . . . 0.0 110.634 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.626 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.1 m-80 -95.6 48.47 1.14 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 0.0 108.969 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.95 154.56 16.53 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -72.42 -6.99 47.43 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.665 -0.903 . . . . 0.0 110.942 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -96.99 -30.75 12.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.202 -0.936 . . . . 0.0 110.283 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.563 ' O ' HG22 ' A' ' 8' ' ' ILE . 2.5 tp -145.21 157.58 44.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.497 -0.752 . . . . 0.0 110.433 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -140.13 136.01 33.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.591 -0.693 . . . . 0.0 110.497 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.72 -140.57 10.87 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -151.72 168.55 24.69 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.541 -0.976 . . . . 0.0 110.434 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.2 m -150.54 148.49 28.75 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.588 -0.695 . . . . 0.0 110.265 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.455 HG23 ' HE3' ' A' ' 5' ' ' LYS . 9.1 p -131.13 168.38 17.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.578 -0.701 . . . . 0.0 110.155 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.791 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.6 t -164.32 179.09 7.02 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.588 -0.695 . . . . 0.0 110.378 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.96 128.25 54.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.714 . . . . 0.0 110.111 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.565 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -154.25 138.3 16.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.598 -0.689 . . . . 0.0 110.189 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.9 m -59.35 -26.7 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.505 -0.747 . . . . 0.0 110.45 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.562 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 30.3 p30 -173.12 -178.24 1.73 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.452 -0.78 . . . . 0.0 110.304 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.91 -25.29 56.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.54 -0.725 . . . . 0.0 110.869 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.562 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.04 -27.17 65.23 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.456 -0.778 . . . . 0.0 110.397 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.565 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 5.9 m -109.71 -27.84 9.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.518 -0.739 . . . . 0.0 110.305 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.803 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.02 -62.98 1.47 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.536 -0.727 . . . . 0.0 110.233 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -58.47 -32.48 68.8 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.521 -0.737 . . . . 0.0 110.166 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -56.61 -45.56 81.4 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.414 -0.804 . . . . 0.0 110.156 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.8 t -80.18 -45.05 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.653 -0.654 . . . . 0.0 109.697 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.791 ' CZ ' HG22 ' A' ' 19' ' ' THR . 12.6 m-85 -61.88 -33.56 74.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.597 -0.689 . . . . 0.0 110.04 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -64.52 -46.65 82.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.457 -0.777 . . . . 0.0 109.058 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -63.15 -33.5 75.6 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.608 0.718 . . . . 0.0 109.329 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.426 ' CD2' HD23 ' A' ' 6' ' ' LEU . 18.8 t80 -65.2 -46.67 79.76 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.571 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -72.99 -38.2 66.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.718 -0.614 . . . . 0.0 109.651 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -60.27 -45.3 93.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.539 -0.726 . . . . 0.0 110.316 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -60.28 -53.35 58.73 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.585 -0.697 . . . . 0.0 110.358 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -69.18 -48.24 62.74 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.525 -0.735 . . . . 0.0 110.033 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.44 46.11 0.3 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.571 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.1 mt -108.79 77.03 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.501 -0.999 . . . . 0.0 110.454 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -98.99 39.28 1.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.74 -138.35 0.02 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -112.45 111.05 21.62 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.842 -0.799 . . . . 0.0 108.956 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.582 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 29.3 m95 -80.31 143.56 33.51 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.182 0.991 . . . . 0.0 112.483 -178.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 44' ' ' TRP . 1.6 p -152.91 132.28 12.86 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.402 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 14.5 t80 -104.81 120.87 42.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.678 -0.638 . . . . 0.0 110.111 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -90.77 111.39 22.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.649 -0.657 . . . . 0.0 110.087 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -66.72 -15.76 63.76 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.601 -0.687 . . . . 0.0 110.849 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.416 ' C ' HG23 ' A' ' 50' ' ' THR . . . -55.09 -42.69 73.18 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.168 -0.957 . . . . 0.0 110.812 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.416 HG23 ' C ' ' A' ' 49' ' ' ALA . 81.0 p -147.07 24.12 1.17 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.53 -0.731 . . . . 0.0 110.527 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.445 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 4.3 mptt 51.79 87.35 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.247 -0.908 . . . . 0.0 110.78 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.462 HG23 ' HB3' ' A' ' 5' ' ' LYS . 58.4 m -150.88 103.65 3.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.513 -0.742 . . . . 0.0 110.728 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -62.5 134.84 56.98 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.489 -0.757 . . . . 0.0 109.112 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.59 HG23 HG21 ' A' ' 7' ' ' ILE . 75.7 m -125.72 104.05 8.15 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 119.354 -0.938 . . . . 0.0 112.71 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.519 HG21 HG22 ' A' ' 40' ' ' ILE . 11.1 p -104.73 167.24 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.279 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.626 HG23 ' HB3' ' A' ' 9' ' ' ASN . 93.2 m -159.79 109.59 1.85 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.586 -0.696 . . . . 0.0 109.801 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.098 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.554 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 40.2 m . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.253 0.549 . . . . 0.0 110.011 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 58.8 m -89.87 96.73 10.81 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.588 -0.695 . . . . 0.0 110.662 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.766 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 87.6 m-85 -79.34 170.03 17.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.528 -0.732 . . . . 0.0 109.77 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.735 ' HG3' HG22 ' A' ' 18' ' ' THR . 2.2 mtpp -140.09 124.57 18.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.456 -0.778 . . . . 0.0 110.474 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.607 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 53.3 tp -101.94 120.42 40.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.426 -0.796 . . . . 0.0 109.817 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.635 HG21 HG23 ' A' ' 54' ' ' THR . 2.5 tt -69.36 172.75 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 13' ' ' LEU . 76.8 mt -135.39 75.39 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 119.414 -0.915 . . . . 0.0 110.676 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -96.68 47.59 1.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.89 154.46 16.63 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.0 tttp -71.25 -9.78 58.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.688 -0.889 . . . . 0.0 110.611 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.0 m -91.44 -33.44 15.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.215 -0.928 . . . . 0.0 110.273 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.462 ' O ' HG22 ' A' ' 8' ' ' ILE . 23.8 mt -142.13 167.5 21.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.465 -0.772 . . . . 0.0 110.638 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -147.52 136.78 22.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.634 -0.666 . . . . 0.0 110.198 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.401 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 127.26 -137.41 9.87 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -155.96 152.2 27.9 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.591 -0.947 . . . . 0.0 110.356 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.8 m -122.94 160.67 25.72 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.626 -0.671 . . . . 0.0 110.223 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.735 HG22 ' HG3' ' A' ' 5' ' ' LYS . 20.4 p -128.67 174.87 9.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.538 -0.726 . . . . 0.0 110.296 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.484 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.5 t -167.14 -173.26 2.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.526 -0.734 . . . . 0.0 110.328 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -128.56 101.97 6.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 0.0 110.177 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.0 155.07 47.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.605 -0.684 . . . . 0.0 110.135 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.42 HG13 ' OD2' ' A' ' 23' ' ' ASP . 7.8 p -74.42 -23.84 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.59 -0.694 . . . . 0.0 110.287 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.721 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 3.9 p30 -171.62 176.04 3.84 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.311 -0.868 . . . . 0.0 110.385 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.451 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -57.12 -29.61 63.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.553 -0.717 . . . . 0.0 110.992 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.721 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -57.89 -24.4 57.52 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.458 -0.776 . . . . 0.0 110.614 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.9 m -110.94 -27.98 8.56 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.466 -0.771 . . . . 0.0 110.355 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.766 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.81 -52.75 63.73 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.506 -0.746 . . . . 0.0 110.278 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -57.66 -39.87 78.03 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.554 -0.716 . . . . 0.0 110.415 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -56.9 -39.11 73.8 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.332 -0.855 . . . . 0.0 110.288 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.3 t -80.91 -49.19 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.665 -0.647 . . . . 0.0 110.105 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.484 ' CZ ' HG22 ' A' ' 19' ' ' THR . 6.2 m-85 -65.01 -33.08 75.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.594 -0.691 . . . . 0.0 110.409 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -64.1 -46.85 82.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.439 -0.788 . . . . 0.0 109.232 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -61.5 -31.97 71.98 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.619 0.724 . . . . 0.0 109.675 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.409 ' CD2' HD23 ' A' ' 6' ' ' LEU . 15.8 t80 -67.88 -42.96 80.44 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.63 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -78.45 -38.89 40.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.614 -0.678 . . . . 0.0 110.017 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -58.29 -52.19 66.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.467 -0.77 . . . . 0.0 110.28 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.6 -47.22 86.45 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.647 -0.658 . . . . 0.0 110.108 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -65.37 -45.9 82.24 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.555 -0.716 . . . . 0.0 110.037 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.44 36.93 0.88 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.63 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.1 mt -104.21 69.05 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.43 -1.041 . . . . 0.0 110.29 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -92.23 49.35 1.5 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.54 -0.725 . . . . 0.0 109.324 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.1 -137.09 0.84 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.17 112.24 22.21 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.893 -0.769 . . . . 0.0 109.11 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.607 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 25.2 m95 -81.09 143.11 32.67 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.247 1.023 . . . . 0.0 112.445 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 p -150.98 131.82 14.13 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.416 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 31.1 t80 -105.05 128.81 53.5 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.669 -0.645 . . . . 0.0 110.031 -178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -102.47 111.26 23.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.676 -0.64 . . . . 0.0 109.953 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -66.69 -23.9 66.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.719 -0.613 . . . . 0.0 110.588 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.65 -38.78 64.46 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.404 -0.81 . . . . 0.0 110.851 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.2 p -143.26 14.71 1.84 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.541 -0.724 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 4.4 mptt 50.92 87.12 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.074 -1.016 . . . . 0.0 110.712 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.5 m -149.64 105.59 3.46 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.118 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.439 ' O ' HD12 ' A' ' 6' ' ' LEU . 82.4 m-85 -62.25 123.72 18.94 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.635 HG23 HG21 ' A' ' 7' ' ' ILE . 63.3 m -117.39 104.15 10.83 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.175 -0.953 . . . . 0.0 112.854 -178.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.536 HG11 HG21 ' A' ' 40' ' ' ILE . 10.4 p -106.38 164.67 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.353 -0.842 . . . . 0.0 109.377 177.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.459 ' N ' HG22 ' A' ' 55' ' ' VAL . 64.0 m -163.91 116.11 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.384 179.96 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.463 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 86.3 m . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.111 0.481 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.618 ' O ' HG23 ' A' ' 3' ' ' THR . 8.7 t -88.04 104.29 16.52 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.701 -0.624 . . . . 0.0 110.756 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.622 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 83.9 m-85 -86.79 176.45 7.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.387 -0.821 . . . . 0.0 109.87 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.528 ' O ' HG23 ' A' ' 52' ' ' THR . 25.0 ttmt -146.75 115.82 6.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.47 -0.769 . . . . 0.0 110.245 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.606 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 48.3 tp -93.66 122.39 36.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.545 -0.722 . . . . 0.0 110.157 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.652 HG21 HG23 ' A' ' 54' ' ' THR . 5.0 tp -70.44 171.64 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.537 HG21 ' HB3' ' A' ' 13' ' ' LEU . 84.9 mt -132.26 71.73 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.216 -0.928 . . . . 0.0 110.564 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.475 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.0 m-20 -95.43 48.07 1.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.499 -0.751 . . . . 0.0 109.062 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.5 159.79 14.05 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -75.66 -6.16 49.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.707 -0.878 . . . . 0.0 110.564 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.401 ' H ' HG22 ' A' ' 12' ' ' THR . 9.9 t -100.17 -27.09 13.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.666 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.537 ' HB3' HG21 ' A' ' 8' ' ' ILE . 17.4 mt -143.78 163.59 32.9 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.425 -0.797 . . . . 0.0 110.577 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -147.9 131.95 17.25 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.588 -0.695 . . . . 0.0 110.2 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.71 -132.63 6.25 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.482 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.2 pt-20 -162.54 159.04 24.31 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.51 -0.994 . . . . 0.0 110.326 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 18' ' ' THR . 48.7 m -138.84 165.1 27.92 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.501 -0.749 . . . . 0.0 110.275 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.421 ' N ' HG22 ' A' ' 17' ' ' THR . 29.6 p -135.27 168.84 18.44 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.584 -0.697 . . . . 0.0 110.262 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.642 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.1 t -164.62 168.9 17.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.55 -0.719 . . . . 0.0 110.194 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -101.54 116.32 32.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.488 -0.757 . . . . 0.0 110.262 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -144.88 142.78 30.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.567 -0.708 . . . . 0.0 110.095 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.43 HG23 ' N ' ' A' ' 23' ' ' ASP . 33.7 m -57.35 -37.32 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.449 -0.782 . . . . 0.0 110.095 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.43 ' N ' HG23 ' A' ' 22' ' ' VAL . 1.5 t70 -172.34 -172.49 0.94 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.699 -0.626 . . . . 0.0 109.773 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.455 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.98 -23.14 12.22 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.461 -0.774 . . . . 0.0 111.174 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.28 -35.9 74.58 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.471 -0.768 . . . . 0.0 110.718 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.5 m -106.64 -25.39 11.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.445 -0.784 . . . . 0.0 110.811 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.622 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -57.83 -60.61 3.43 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.407 -0.808 . . . . 0.0 110.733 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -57.01 -40.09 75.98 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.521 -0.737 . . . . 0.0 110.568 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -57.65 -37.89 74.12 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.366 -0.834 . . . . 0.0 110.144 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 99.5 t -82.46 -48.7 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.64 -0.663 . . . . 0.0 109.851 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.642 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.1 m-85 -63.85 -33.17 75.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.551 -0.718 . . . . 0.0 110.212 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -64.76 -44.98 88.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.5 -0.75 . . . . 0.0 109.086 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -61.85 -27.63 68.92 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.505 0.669 . . . . 0.0 109.779 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -74.4 -53.08 10.31 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.728 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.94 -40.14 92.1 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.581 -0.7 . . . . 0.0 110.18 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -57.72 -49.73 75.55 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.537 -0.727 . . . . 0.0 110.693 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.88 -55.94 27.07 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.522 -0.736 . . . . 0.0 110.2 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -60.96 -47.68 85.34 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.563 -0.711 . . . . 0.0 110.082 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.71 64.58 0.3 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.728 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 82.4 mt -126.01 79.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.545 -0.974 . . . . 0.0 110.148 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -95.39 43.95 1.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.52 -140.48 0.64 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -118.78 111.33 18.32 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.606 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 26.0 m95 -77.13 143.9 38.81 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.178 0.99 . . . . 0.0 112.416 -177.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.6 p -151.27 132.77 14.72 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -104.41 113.71 27.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.621 -0.674 . . . . 0.0 110.122 -178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -88.66 116.27 26.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.674 -0.641 . . . . 0.0 109.957 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.15 -15.78 61.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.625 -0.672 . . . . 0.0 110.845 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.437 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.97 -39.43 65.96 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.189 -0.944 . . . . 0.0 110.766 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.437 HG23 ' C ' ' A' ' 49' ' ' ALA . 69.1 p -148.47 20.11 1.06 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.561 -0.712 . . . . 0.0 110.702 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.52 85.89 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.194 -0.941 . . . . 0.0 110.837 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 5' ' ' LYS . 89.5 m -150.39 105.51 3.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.559 -0.713 . . . . 0.0 110.494 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.434 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 90.0 m-85 -60.02 126.98 29.62 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.652 HG23 HG21 ' A' ' 7' ' ' ILE . 48.7 m -119.96 100.03 6.97 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.984 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.69 HG11 HG21 ' A' ' 40' ' ' ILE . 10.6 p -100.83 166.93 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.44 -0.788 . . . . 0.0 109.021 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 9' ' ' ASN . 90.1 m -158.68 109.81 2.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.515 -0.74 . . . . 0.0 110.295 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.288 179.917 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.567 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 55.6 m . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.066 0.46 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 65.6 m -122.75 96.65 5.11 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.617 -0.677 . . . . 0.0 110.44 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.652 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 97.4 m-85 -81.41 175.34 10.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.585 -0.697 . . . . 0.0 110.081 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.498 ' HB3' HG23 ' A' ' 52' ' ' THR . 16.0 ttpt -151.33 127.78 10.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.523 -0.736 . . . . 0.0 110.185 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.618 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 48.0 tp -104.73 125.21 50.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.494 -0.754 . . . . 0.0 110.442 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.728 HG21 HG23 ' A' ' 54' ' ' THR . 2.1 tp -75.17 171.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.474 HD12 ' C ' ' A' ' 15' ' ' GLY . 78.0 mt -130.8 74.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.179 -0.951 . . . . 0.0 110.674 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.54 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.7 m-20 -97.3 46.91 1.03 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.31 -0.869 . . . . 0.0 108.796 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.93 165.17 17.36 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.94 4.58 29.0 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.726 -0.867 . . . . 0.0 110.643 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -114.87 -26.86 7.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 110.484 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.3 tp -143.39 166.8 23.77 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.831 . . . . 0.0 110.769 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -153.53 143.23 21.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.559 -0.713 . . . . 0.0 110.27 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.474 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 134.05 -142.62 14.13 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -142.5 172.07 13.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.568 -0.96 . . . . 0.0 110.341 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.9 m -155.9 132.72 10.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.628 -0.67 . . . . 0.0 110.02 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.0 p -119.81 167.24 12.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.514 -0.741 . . . . 0.0 110.357 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.677 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.0 t -167.17 166.06 15.15 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.618 -0.677 . . . . 0.0 110.265 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -100.29 111.06 23.31 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.564 -0.71 . . . . 0.0 110.218 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.454 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -135.01 139.67 45.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.583 -0.698 . . . . 0.0 110.199 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.73 -28.8 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.543 -0.723 . . . . 0.0 110.408 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.598 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 27.5 p30 -173.87 -176.45 1.21 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.431 -0.793 . . . . 0.0 110.34 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -57.99 -23.94 56.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.613 -0.679 . . . . 0.0 110.809 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.598 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.65 -29.38 67.99 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.453 -0.779 . . . . 0.0 110.281 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.454 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 30.2 m -106.29 -28.17 10.57 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.55 -0.719 . . . . 0.0 110.154 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.652 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . . . -61.3 -59.89 4.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.562 -0.711 . . . . 0.0 110.097 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -59.77 -43.79 94.17 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.601 -0.687 . . . . 0.0 110.215 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -54.64 -40.22 68.78 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.284 -0.885 . . . . 0.0 110.229 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 26' ' ' THR . 97.8 t -82.17 -48.52 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.697 -0.627 . . . . 0.0 109.918 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.677 ' CZ ' HG22 ' A' ' 19' ' ' THR . 13.5 m-85 -62.16 -32.73 73.38 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.653 -0.654 . . . . 0.0 110.304 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -66.31 -42.86 87.68 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.046 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -62.42 -30.11 70.99 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.505 0.669 . . . . 0.0 109.678 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -70.22 -50.68 37.47 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.673 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -67.24 -37.47 83.59 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.629 -0.67 . . . . 0.0 110.075 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -57.0 -36.47 70.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.479 -0.763 . . . . 0.0 110.65 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -69.83 -41.29 75.14 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.519 -0.738 . . . . 0.0 110.174 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -80.84 -27.98 36.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.596 -0.69 . . . . 0.0 110.269 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.82 38.35 4.68 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.673 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 76.8 mt -89.5 66.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.548 -0.972 . . . . 0.0 110.226 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -85.63 56.97 4.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.569 -0.707 . . . . 0.0 109.15 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.33 -138.21 4.98 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.47 102.19 8.72 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.868 -0.784 . . . . 0.0 109.161 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.618 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 32.6 m95 -69.88 143.13 52.88 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.153 0.977 . . . . 0.0 112.457 -177.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 44' ' ' TRP . 3.4 p -152.0 131.83 13.28 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -107.26 152.72 23.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.635 -0.666 . . . . 0.0 110.059 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -126.98 113.72 16.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.687 -0.633 . . . . 0.0 109.911 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -67.61 -23.05 65.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.703 -0.623 . . . . 0.0 110.833 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.75 -40.15 62.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.275 -0.891 . . . . 0.0 110.718 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.2 p -144.98 16.46 1.57 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.667 -0.645 . . . . 0.0 110.744 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.461 ' HG2' ' CE2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.81 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.121 -0.987 . . . . 0.0 110.876 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.498 HG23 ' HB3' ' A' ' 5' ' ' LYS . 63.6 m -152.78 102.46 2.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.494 -0.754 . . . . 0.0 110.949 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -63.0 136.75 58.0 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.728 HG23 HG21 ' A' ' 7' ' ' ILE . 86.4 m -129.37 103.04 6.69 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.37 -0.932 . . . . 0.0 112.322 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.598 HG11 HG21 ' A' ' 40' ' ' ILE . 10.7 p -102.54 167.04 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 0.0 109.265 177.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.54 HG23 ' HB3' ' A' ' 9' ' ' ASN . 92.0 m -160.71 112.65 1.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.595 -0.69 . . . . 0.0 110.273 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.086 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.477 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 93.9 m . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.126 0.489 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.2 m -88.58 104.27 16.68 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.606 -0.684 . . . . 0.0 110.707 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.663 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 88.8 m-85 -85.57 179.6 7.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.548 -0.72 . . . . 0.0 109.821 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.3 mtmm -144.44 117.24 8.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.438 -0.789 . . . . 0.0 110.575 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.583 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 34.7 tp -99.47 121.66 41.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.464 -0.772 . . . . 0.0 110.164 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.65 HG21 HG23 ' A' ' 54' ' ' THR . 4.8 tp -70.69 169.3 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.529 HD11 ' OG1' ' A' ' 17' ' ' THR . 81.2 mt -131.33 77.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 110.856 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.532 ' HB3' HG23 ' A' ' 56' ' ' THR . 71.5 m-20 -97.24 46.93 1.03 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.225 -0.922 . . . . 0.0 108.633 178.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.12 153.04 16.97 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.59 -8.09 53.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.756 -0.849 . . . . 0.0 110.716 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -94.14 -30.88 14.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.215 -0.928 . . . . 0.0 110.4 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -145.63 174.78 10.89 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.423 -0.798 . . . . 0.0 110.498 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -165.72 142.58 5.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.608 -0.682 . . . . 0.0 110.48 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.5 -121.74 2.75 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -157.07 153.05 27.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.973 . . . . 0.0 110.304 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.529 ' OG1' HD11 ' A' ' 8' ' ' ILE . 4.4 m -138.9 142.67 38.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.553 -0.717 . . . . 0.0 110.244 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -124.61 153.09 42.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.617 -0.677 . . . . 0.0 110.184 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.734 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.9 t -151.35 142.24 22.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.554 -0.716 . . . . 0.0 110.285 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.49 114.66 16.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.594 -0.691 . . . . 0.0 110.34 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -142.4 139.87 31.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.463 -0.773 . . . . 0.0 110.054 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 23' ' ' ASP . 33.2 m -56.46 -36.45 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.481 -0.762 . . . . 0.0 110.23 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.417 ' N ' HG23 ' A' ' 22' ' ' VAL . 3.6 t70 -172.66 -173.27 0.99 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.595 -0.691 . . . . 0.0 109.934 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.5 -22.36 12.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.403 -0.811 . . . . 0.0 111.269 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.71 66.77 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.355 -0.841 . . . . 0.0 110.505 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.5 m -116.44 -21.69 9.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.466 -0.771 . . . . 0.0 110.954 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.663 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -57.3 -62.97 1.39 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.318 -0.864 . . . . 0.0 110.667 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -59.98 -36.41 77.09 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.45 -0.781 . . . . 0.0 110.086 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -57.6 -43.68 84.86 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.486 -0.759 . . . . 0.0 109.962 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.6 t -78.77 -48.23 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.713 -0.617 . . . . 0.0 109.667 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.734 ' CZ ' HG22 ' A' ' 19' ' ' THR . 4.9 m-85 -61.33 -32.81 72.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.621 -0.675 . . . . 0.0 110.262 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -64.07 -42.94 96.8 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.433 -0.792 . . . . 0.0 108.9 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -64.56 -32.31 73.9 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.643 0.735 . . . . 0.0 109.341 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -68.04 -56.02 10.42 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -59.9 -41.38 91.5 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.716 -0.615 . . . . 0.0 110.287 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -56.77 -37.92 71.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.483 -0.76 . . . . 0.0 110.643 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.14 -37.87 84.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.596 -0.69 . . . . 0.0 110.284 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -91.21 -30.72 16.49 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.511 -0.743 . . . . 0.0 110.178 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.06 44.3 1.77 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.757 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 79.8 mt -95.08 62.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.486 -1.008 . . . . 0.0 110.159 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.85 59.16 5.05 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.66 -138.47 6.4 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -115.13 103.15 10.58 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.845 -0.797 . . . . 0.0 109.015 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.583 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 38.5 m95 -73.18 143.34 47.26 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 122.161 0.981 . . . . 0.0 112.195 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 44' ' ' TRP . 7.0 p -155.91 131.43 9.61 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -105.71 133.07 51.03 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.655 -0.653 . . . . 0.0 109.955 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -104.3 109.97 22.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.77 -0.581 . . . . 0.0 109.888 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.6 -20.99 66.59 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.656 -0.653 . . . . 0.0 110.588 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.433 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.87 -37.84 60.86 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.263 -0.898 . . . . 0.0 110.958 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.433 HG23 ' C ' ' A' ' 49' ' ' ALA . 73.6 p -147.68 19.89 1.16 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.573 -0.704 . . . . 0.0 110.826 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.442 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 50.63 85.38 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.154 -0.966 . . . . 0.0 110.875 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.3 m -151.43 105.81 3.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.467 -0.771 . . . . 0.0 111.035 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.468 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 84.1 m-85 -62.83 137.6 58.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.485 -0.76 . . . . 0.0 109.071 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.65 HG23 HG21 ' A' ' 7' ' ' ILE . 68.3 m -128.79 98.76 5.08 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.316 -0.954 . . . . 0.0 112.764 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 40' ' ' ILE . 11.0 p -101.86 166.46 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 109.254 177.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.532 HG23 ' HB3' ' A' ' 9' ' ' ASN . 82.8 m -161.67 111.06 1.55 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.725 -0.609 . . . . 0.0 109.657 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.24 -179.999 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.499 HG22 ' CE2' ' A' ' 4' ' ' PHE . 87.1 m . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.112 0.482 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 19' ' ' THR . 4.6 m -110.58 92.23 3.97 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.603 -0.686 . . . . 0.0 110.506 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.9 m-85 -67.35 169.38 9.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.568 -0.707 . . . . 0.0 109.961 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.631 ' HG2' HG22 ' A' ' 18' ' ' THR . 64.0 mttt -140.41 120.16 13.41 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.576 -0.703 . . . . 0.0 110.491 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.597 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 28.7 tp -98.95 130.41 45.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.512 -0.743 . . . . 0.0 109.919 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.635 HG21 HG23 ' A' ' 54' ' ' THR . 2.4 tp -78.95 171.81 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 13' ' ' LEU . 83.2 mt -132.63 72.12 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.258 -0.901 . . . . 0.0 110.431 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.609 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.0 m-20 -93.94 50.55 1.43 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.43 156.07 15.9 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -71.64 -13.43 61.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.716 -0.873 . . . . 0.0 110.492 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.5 m -88.57 -33.44 17.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.272 -0.893 . . . . 0.0 110.38 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.521 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.4 mt -144.1 162.81 35.32 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.406 -0.809 . . . . 0.0 110.832 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -143.35 136.71 28.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.67 -0.644 . . . . 0.0 110.146 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.401 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 133.23 -145.41 17.44 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -144.57 166.8 24.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.537 -0.978 . . . . 0.0 110.275 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.0 m -139.33 168.84 18.93 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.73 . . . . 0.0 110.211 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.631 HG22 ' HG2' ' A' ' 5' ' ' LYS . 10.0 p -137.55 165.43 26.32 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.526 -0.734 . . . . 0.0 110.354 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 3' ' ' THR . 7.9 t -146.78 163.03 37.32 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.507 -0.745 . . . . 0.0 110.262 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -111.97 87.63 2.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.499 -0.75 . . . . 0.0 110.24 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.654 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -126.29 -171.76 2.47 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.529 -0.732 . . . . 0.0 110.206 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.7 p -112.41 -25.84 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.563 -0.711 . . . . 0.0 110.224 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -164.91 174.4 10.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.469 -0.77 . . . . 0.0 110.0 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.591 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -54.08 -23.5 14.04 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.422 -0.799 . . . . 0.0 110.781 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.56 -42.84 79.26 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.392 -0.817 . . . . 0.0 109.996 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.654 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 85.6 m -87.93 -34.03 18.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.649 -0.657 . . . . 0.0 109.413 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.591 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -63.25 -178.8 0.27 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.673 -0.642 . . . . 0.0 109.595 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 66.36 -63.01 0.26 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.546 -0.721 . . . . 0.0 110.528 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.83 -34.72 60.13 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.999 -1.063 . . . . 0.0 110.246 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.3 t -82.17 -50.23 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.698 -0.626 . . . . 0.0 109.666 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.539 ' HB3' HD22 ' A' ' 6' ' ' LEU . 4.6 m-85 -62.86 -33.65 75.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.586 -0.696 . . . . 0.0 109.856 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -63.7 -41.32 98.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.593 -0.692 . . . . 0.0 109.28 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -60.97 -31.78 71.35 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.642 0.734 . . . . 0.0 109.714 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -71.53 -55.73 7.28 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.776 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -65.51 -47.18 76.84 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.68 -0.638 . . . . 0.0 110.31 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -56.18 -28.36 57.91 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.491 -0.756 . . . . 0.0 110.519 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.41 -39.64 24.65 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.69 -0.631 . . . . 0.0 110.048 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -79.13 -46.89 17.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.65 -0.656 . . . . 0.0 110.003 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.79 60.06 0.18 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.776 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 86.4 mt -124.04 67.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.549 -0.971 . . . . 0.0 110.173 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.26 53.29 2.6 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.93 -138.47 2.71 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -115.56 101.11 8.57 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.857 -0.79 . . . . 0.0 109.337 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.597 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 34.3 m95 -70.02 143.52 52.52 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 122.002 0.906 . . . . 0.0 112.098 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 44' ' ' TRP . 12.2 p -155.01 130.51 9.81 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -103.08 146.14 28.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.665 -0.647 . . . . 0.0 109.783 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -118.31 116.89 27.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.72 -0.612 . . . . 0.0 109.857 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -71.42 -21.2 62.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.666 -0.646 . . . . 0.0 110.584 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.83 -40.52 66.5 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.269 -0.895 . . . . 0.0 110.806 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.8 p -144.83 17.19 1.61 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.605 -0.684 . . . . 0.0 110.789 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.456 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.27 91.61 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.187 -0.945 . . . . 0.0 111.043 179.724 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 5' ' ' LYS . 59.8 m -158.59 104.8 1.81 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.45 -0.781 . . . . 0.0 110.715 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.501 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 93.1 m-85 -62.16 139.49 58.47 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.635 HG23 HG21 ' A' ' 7' ' ' ILE . 25.2 m -131.51 102.7 6.04 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.954 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.549 HG21 HG22 ' A' ' 40' ' ' ILE . 11.3 p -102.97 166.95 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.347 -0.846 . . . . 0.0 109.17 177.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.609 HG23 ' HB3' ' A' ' 9' ' ' ASN . 99.8 m -160.92 115.09 2.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.666 -0.646 . . . . 0.0 109.964 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.127 179.807 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.452 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 62.8 m . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.081 0.467 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.6 m -92.26 103.01 15.51 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.604 -0.685 . . . . 0.0 110.503 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.756 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 79.5 m-85 -84.68 170.05 13.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.586 -0.696 . . . . 0.0 110.068 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.66 145.29 38.26 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.571 -0.705 . . . . 0.0 109.889 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 53' ' ' PHE . 18.3 tp -123.12 135.2 54.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.484 -0.76 . . . . 0.0 110.436 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.638 HG21 HG23 ' A' ' 54' ' ' THR . 3.8 tp -85.56 156.0 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.723 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.472 HG21 ' HB3' ' A' ' 13' ' ' LEU . 49.5 mm -120.51 74.78 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.368 -179.632 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.587 ' HB3' HG23 ' A' ' 56' ' ' THR . 5.9 m-20 -95.7 47.35 1.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 178.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.74 153.28 17.59 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -69.28 -10.91 60.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.627 -0.925 . . . . 0.0 110.452 179.17 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.2 m -87.66 -37.76 16.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 110.256 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.472 ' HB3' HG21 ' A' ' 8' ' ' ILE . 18.1 mt -138.62 172.44 12.88 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.45 -0.781 . . . . 0.0 110.778 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -151.9 135.93 16.53 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.602 -0.686 . . . . 0.0 110.094 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.12 -145.46 15.73 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -146.18 178.2 8.41 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.585 -0.95 . . . . 0.0 110.406 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.4 m -159.71 152.87 22.01 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 110.16 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.0 p -124.51 163.4 21.94 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.561 -0.712 . . . . 0.0 110.349 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 t -150.5 -171.54 3.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.633 -0.667 . . . . 0.0 110.211 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.35 98.35 5.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.549 -0.719 . . . . 0.0 110.33 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.403 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -128.3 148.54 50.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.456 -0.777 . . . . 0.0 109.844 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.8 p -63.35 -36.43 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.041 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -169.75 -174.9 1.96 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.606 -0.683 . . . . 0.0 110.081 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -54.54 -26.02 29.4 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.504 -0.747 . . . . 0.0 111.074 -179.523 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.87 -28.64 69.02 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.506 -0.747 . . . . 0.0 110.3 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.403 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 4.5 m -113.03 -25.81 8.78 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.596 -0.69 . . . . 0.0 110.464 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.756 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.58 -61.74 2.37 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.471 -0.768 . . . . 0.0 110.496 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -57.7 -34.42 69.43 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.55 -0.719 . . . . 0.0 110.166 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -58.01 -36.86 73.28 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.37 -0.831 . . . . 0.0 109.996 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.2 t -84.59 -48.6 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.67 -0.644 . . . . 0.0 109.674 179.477 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -62.31 -37.01 83.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.623 -0.673 . . . . 0.0 110.008 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -62.76 -47.28 84.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.572 -0.705 . . . . 0.0 109.169 179.413 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -63.21 -34.19 77.1 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.708 0.766 . . . . 0.0 109.286 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -65.81 -53.31 41.83 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.62 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.89 -45.72 84.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.735 -0.603 . . . . 0.0 109.895 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -58.82 -37.03 75.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 110.349 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -65.46 -54.17 32.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.659 -0.651 . . . . 0.0 109.949 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -69.61 -49.24 55.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.566 -0.709 . . . . 0.0 109.852 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.69 54.17 0.11 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.62 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.1 mt -119.97 70.32 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.427 -1.043 . . . . 0.0 110.236 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -94.55 48.82 1.23 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.626 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.16 -138.24 0.6 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -110.31 111.7 23.18 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.474 ' O ' HG23 ' A' ' 45' ' ' THR . 35.9 m95 -83.83 143.27 30.04 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.213 1.006 . . . . 0.0 112.738 -177.904 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 44' ' ' TRP . 1.7 p -154.7 131.72 10.91 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.606 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -101.03 143.94 30.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.65 -0.656 . . . . 0.0 110.306 -178.454 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -115.75 109.58 17.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.726 -0.609 . . . . 0.0 109.775 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -67.13 -21.8 65.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.646 -0.659 . . . . 0.0 110.593 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.449 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.4 -40.26 64.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.318 -0.864 . . . . 0.0 110.805 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.449 HG23 ' C ' ' A' ' 49' ' ' ALA . 80.1 p -148.82 21.04 1.01 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.549 -0.719 . . . . 0.0 110.676 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.439 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.54 92.74 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.168 -0.957 . . . . 0.0 110.744 179.874 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.1 m -152.57 101.64 2.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.355 -0.841 . . . . 0.0 111.515 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.403 ' O ' HD12 ' A' ' 6' ' ' LEU . 91.6 m-85 -63.49 124.21 20.74 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.272 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.638 HG23 HG21 ' A' ' 7' ' ' ILE . 63.0 m -115.23 96.66 5.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.263 -0.898 . . . . 0.0 113.14 -177.532 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.533 HG21 HG22 ' A' ' 40' ' ' ILE . 10.4 p -99.24 166.89 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 177.339 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.587 HG23 ' HB3' ' A' ' 9' ' ' ASN . 92.5 m -157.5 105.77 2.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.606 -0.684 . . . . 0.0 109.749 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.254 -179.723 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.568 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 44.1 m . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 121.21 0.529 . . . . 0.0 110.362 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.2 m -85.53 90.83 8.08 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.589 -0.694 . . . . 0.0 110.623 -179.687 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.568 ' CZ ' HG21 ' A' ' 2' ' ' THR . 96.5 m-85 -73.28 170.34 15.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.478 -0.764 . . . . 0.0 109.81 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -141.44 139.71 33.45 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.467 -0.77 . . . . 0.0 110.583 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.528 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 38.9 tp -114.3 121.39 43.5 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.636 -0.665 . . . . 0.0 109.95 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.666 HG21 HG23 ' A' ' 54' ' ' THR . 3.8 tp -71.47 166.26 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.666 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 13' ' ' LEU . 71.5 mt -127.7 72.51 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.335 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.535 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.6 m-20 -93.62 49.17 1.34 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.456 -0.777 . . . . 0.0 109.107 179.117 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.4 149.7 18.81 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -66.71 -13.63 61.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.649 -0.913 . . . . 0.0 110.41 179.406 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.6 m -85.05 -37.59 20.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.243 -0.911 . . . . 0.0 110.446 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.463 ' O ' HG22 ' A' ' 8' ' ' ILE . 10.0 mt -141.38 170.06 16.43 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.444 -0.785 . . . . 0.0 110.769 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -151.22 141.49 22.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.611 -0.681 . . . . 0.0 110.177 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.401 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 129.95 -149.73 18.89 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -144.4 160.3 41.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.535 -0.98 . . . . 0.0 110.351 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.7 m -147.89 147.84 30.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.585 -0.697 . . . . 0.0 110.207 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -119.27 171.23 8.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.529 -0.732 . . . . 0.0 110.225 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.449 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 7.9 t -142.97 -170.43 3.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.548 -0.72 . . . . 0.0 110.369 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -126.86 88.59 2.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.622 -0.674 . . . . 0.0 110.123 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.809 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -130.64 137.89 49.82 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.608 -0.682 . . . . 0.0 110.3 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.1 m -59.39 -25.45 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.527 -0.733 . . . . 0.0 110.574 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.718 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 26.1 p30 -170.87 179.95 3.0 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.401 -0.812 . . . . 0.0 110.404 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.585 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -55.18 -22.84 18.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.478 -0.764 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.718 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -56.04 -45.14 79.28 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.307 -0.87 . . . . 0.0 110.173 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.809 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 62.7 m -85.83 -31.63 22.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.649 -0.657 . . . . 0.0 109.541 179.262 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . . . -62.26 -176.93 0.11 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.698 -0.626 . . . . 0.0 109.611 179.44 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 66.63 -61.73 0.3 Allowed 'General case' 0 N--CA 1.508 2.455 0 O-C-N 121.508 -0.745 . . . . 0.0 110.75 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -55.63 -34.22 64.73 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.064 -1.022 . . . . 0.0 110.268 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.0 t -83.49 -49.81 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.599 -0.688 . . . . 0.0 109.768 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.449 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 7.7 m-85 -63.17 -34.19 77.09 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.578 -0.701 . . . . 0.0 109.668 179.837 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -63.56 -41.23 98.42 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.628 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -62.8 -33.83 76.01 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.701 0.763 . . . . 0.0 109.544 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -68.02 -51.47 46.58 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.015 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.728 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -68.53 -49.07 62.34 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.792 -0.567 . . . . 0.0 110.078 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -55.94 -29.78 60.67 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.468 -0.77 . . . . 0.0 110.356 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.36 -40.16 89.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.681 -0.637 . . . . 0.0 109.822 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.26 -44.15 10.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.624 -0.672 . . . . 0.0 109.983 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.52 38.62 0.51 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.728 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.9 mt -93.32 64.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.379 -1.071 . . . . 0.0 109.908 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.3 54.77 3.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.503 -0.748 . . . . 0.0 108.999 178.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.76 -136.55 1.8 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.038 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -114.08 102.09 9.84 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.932 -0.746 . . . . 0.0 109.035 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.528 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 40.4 m95 -74.44 142.41 44.94 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.154 0.978 . . . . 0.0 112.226 -178.133 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 44' ' ' TRP . 4.5 p -153.22 131.3 11.85 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.657 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.429 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 13.7 t80 -107.5 113.56 26.97 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.877 -178.529 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.37 118.62 26.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.699 -0.626 . . . . 0.0 109.929 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -69.76 -23.41 63.36 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.72 -0.612 . . . . 0.0 110.36 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.38 -37.12 55.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.416 -0.803 . . . . 0.0 111.015 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.3 p -144.34 14.51 1.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.482 -0.761 . . . . 0.0 111.12 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HG3' ' CE2' ' A' ' 46' ' ' TYR . 1.0 OUTLIER 50.97 86.72 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.043 -1.036 . . . . 0.0 110.82 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.1 m -153.14 107.48 3.12 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.515 -0.741 . . . . 0.0 110.934 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -64.06 124.15 20.86 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.745 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.666 HG23 HG21 ' A' ' 7' ' ' ILE . 91.7 m -116.14 98.32 6.55 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.283 -0.886 . . . . 0.0 112.888 -177.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.569 HG21 HG22 ' A' ' 40' ' ' ILE . 10.3 p -98.13 166.75 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.887 . . . . 0.0 109.395 177.478 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.535 HG23 ' HB3' ' A' ' 9' ' ' ASN . 99.7 m -160.78 108.84 1.58 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.648 -0.657 . . . . 0.0 109.751 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.13 -179.961 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.632 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 5.7 m . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.137 0.494 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.597 ' O ' HG23 ' A' ' 3' ' ' THR . 8.9 t -96.35 79.24 3.1 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.68 -0.637 . . . . 0.0 110.99 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.789 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 97.4 m-85 -62.14 166.38 4.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.321 -0.862 . . . . 0.0 109.6 179.445 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.404 ' HB3' HG23 ' A' ' 52' ' ' THR . 37.4 ttpt -137.4 122.21 18.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.403 -0.811 . . . . 0.0 110.658 -179.778 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.65 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 47.0 tp -99.88 130.59 46.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.546 -0.721 . . . . 0.0 110.049 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.662 HG21 HG23 ' A' ' 54' ' ' THR . 3.4 tp -81.75 165.52 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.721 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 13' ' ' LEU . 70.1 mt -124.11 73.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.251 -0.906 . . . . 0.0 110.279 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.17 46.79 1.12 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 0.0 108.967 178.964 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.22 158.1 15.66 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.401 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -76.31 -5.07 45.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.767 -0.843 . . . . 0.0 110.604 179.386 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.73 ' O ' HD22 ' A' ' 13' ' ' LEU . 5.2 m -99.15 -36.84 9.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.191 -0.943 . . . . 0.0 110.273 -179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.73 HD22 ' O ' ' A' ' 12' ' ' THR . 0.5 OUTLIER -137.33 164.29 28.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.444 -0.785 . . . . 0.0 110.53 -179.948 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.16 138.4 19.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.602 -0.686 . . . . 0.0 110.326 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.492 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 139.21 -141.94 12.34 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -145.71 157.94 43.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.546 -0.973 . . . . 0.0 110.396 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.9 m -146.39 137.91 24.63 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.613 -0.679 . . . . 0.0 110.123 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.3 p -119.48 164.16 16.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.538 -0.727 . . . . 0.0 110.264 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.593 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.5 t -152.8 -166.26 2.41 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.589 -0.694 . . . . 0.0 110.285 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -131.12 122.66 27.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.712 -0.617 . . . . 0.0 110.204 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.481 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -151.08 158.71 44.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.575 -0.703 . . . . 0.0 110.197 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 22' ' ' VAL . 8.4 p -77.3 -25.44 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.583 -0.698 . . . . 0.0 110.156 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.566 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 25.8 p30 -172.41 179.61 2.47 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.406 -0.809 . . . . 0.0 110.277 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.416 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.61 -25.66 53.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.541 -0.725 . . . . 0.0 110.807 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.566 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.99 -27.32 65.31 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.484 -0.76 . . . . 0.0 110.489 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.481 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 62.5 m -109.27 -27.87 9.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.505 -0.747 . . . . 0.0 110.313 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.789 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.64 -55.64 31.95 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.522 -0.736 . . . . 0.0 110.324 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -59.22 -42.11 90.22 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.573 -0.704 . . . . 0.0 110.333 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -57.59 -35.77 70.85 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.336 -0.853 . . . . 0.0 110.177 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 26' ' ' THR . 87.9 t -83.42 -49.04 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.692 -0.63 . . . . 0.0 110.004 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.593 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.2 m-85 -65.44 -35.45 80.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.56 -0.713 . . . . 0.0 110.329 -179.69 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -64.06 -41.98 97.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.435 -0.791 . . . . 0.0 109.377 179.585 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -60.6 -29.63 69.33 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.561 0.696 . . . . 0.0 109.957 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -73.22 -54.11 9.23 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.212 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.695 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.41 -44.14 92.18 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.665 -0.647 . . . . 0.0 110.073 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -56.38 -37.33 69.96 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.494 -0.754 . . . . 0.0 110.581 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -75.1 -50.38 16.56 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.652 -0.655 . . . . 0.0 110.146 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -65.8 -48.5 71.51 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.528 -0.732 . . . . 0.0 110.067 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.3 62.05 0.2 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.695 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 85.5 mt -129.56 77.22 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.472 -1.016 . . . . 0.0 110.458 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.76 40.7 1.15 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.15 -136.14 0.02 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.479 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -120.22 100.79 7.39 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.82 -0.812 . . . . 0.0 109.011 179.284 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.65 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 27.8 m95 -67.38 142.97 56.56 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.218 1.008 . . . . 0.0 112.478 -177.76 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.5 p -151.72 131.6 13.31 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.801 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -103.13 128.55 50.02 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.696 -0.628 . . . . 0.0 109.967 -178.714 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -97.59 108.2 20.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.686 -0.634 . . . . 0.0 110.019 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -65.97 -20.08 66.08 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.645 -0.659 . . . . 0.0 110.633 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.442 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.71 -38.6 64.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.282 -0.886 . . . . 0.0 110.812 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.442 HG23 ' C ' ' A' ' 49' ' ' ALA . 71.6 p -148.61 22.18 1.02 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.522 -0.736 . . . . 0.0 110.752 -179.874 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.88 90.75 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.128 -0.982 . . . . 0.0 110.928 179.828 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 5' ' ' LYS . 60.1 m -156.67 106.37 2.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.477 -0.764 . . . . 0.0 110.857 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -62.27 136.58 57.99 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.535 -0.728 . . . . 0.0 109.095 178.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.662 HG23 HG21 ' A' ' 7' ' ' ILE . 70.4 m -129.77 101.57 5.94 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.558 -178.559 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.54 HG21 HG22 ' A' ' 40' ' ' ILE . 10.2 p -102.81 165.4 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.612 177.706 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.468 ' N ' HG22 ' A' ' 55' ' ' VAL . 59.4 m -163.49 115.34 1.45 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.875 -0.516 . . . . 0.0 109.751 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.34 179.521 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.736 HG22 ' O ' ' A' ' 21' ' ' ALA . 9.9 t . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 120.806 0.336 . . . . 0.0 110.234 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.7 m -129.49 96.11 4.18 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.539 -0.725 . . . . 0.0 110.739 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.759 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 84.9 m-85 -77.6 169.34 18.46 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.533 -0.729 . . . . 0.0 109.644 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -140.14 113.61 8.57 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.503 -0.748 . . . . 0.0 110.418 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.622 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 42.8 tp -94.03 122.31 36.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.565 -0.709 . . . . 0.0 109.966 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.632 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.9 tp -72.92 166.83 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.714 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.498 HD12 ' C ' ' A' ' 15' ' ' GLY . 73.8 mt -128.67 73.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.527 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.651 ' HB3' HG23 ' A' ' 56' ' ' THR . 5.7 m-20 -94.37 49.55 1.3 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.416 -0.802 . . . . 0.0 109.124 178.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.31 151.79 18.32 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.6 -10.1 56.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.678 -0.895 . . . . 0.0 110.613 179.426 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.1 m -90.38 -32.49 16.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 110.373 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 13' ' ' LEU . 28.3 mt -143.34 173.12 11.89 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.451 -0.781 . . . . 0.0 110.917 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -156.69 140.68 16.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.618 -0.676 . . . . 0.0 110.129 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.498 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 128.11 -134.48 8.19 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.402 ' N ' HD12 ' A' ' 8' ' ' ILE . 6.8 pt-20 -162.1 164.98 27.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.518 -0.99 . . . . 0.0 110.286 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.411 HG22 ' N ' ' A' ' 18' ' ' THR . 76.2 m -138.69 164.06 30.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.542 -0.724 . . . . 0.0 110.339 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.411 ' N ' HG22 ' A' ' 17' ' ' THR . 25.6 p -136.98 161.06 37.09 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.57 -0.706 . . . . 0.0 110.204 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.598 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.6 t -169.78 148.43 3.58 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.543 -0.723 . . . . 0.0 110.192 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 2' ' ' THR . 43.5 mt-10 -82.36 132.43 35.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.495 -0.753 . . . . 0.0 110.13 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.736 ' O ' HG22 ' A' ' 2' ' ' THR . . . -155.36 140.98 17.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.358 -0.839 . . . . 0.0 110.473 -179.814 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.6 m -58.8 -32.59 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.571 -0.706 . . . . 0.0 110.405 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.598 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 30.0 p30 -170.14 179.11 3.62 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.546 -0.721 . . . . 0.0 110.294 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.98 -24.67 40.01 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.492 -0.755 . . . . 0.0 110.847 -179.788 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.598 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.67 -35.13 72.09 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.438 -0.789 . . . . 0.0 110.508 -179.889 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.5 m -97.4 -25.58 15.16 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.52 -0.737 . . . . 0.0 110.506 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.759 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -66.62 -58.51 5.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.436 -0.79 . . . . 0.0 110.467 -179.742 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -57.23 -42.12 80.79 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.573 -0.704 . . . . 0.0 110.597 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -55.99 -40.65 73.63 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.298 -0.876 . . . . 0.0 110.196 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.4 t -80.18 -49.41 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.626 -0.671 . . . . 0.0 109.733 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.598 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.7 m-85 -61.77 -30.51 70.84 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.098 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -65.11 -43.76 90.97 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.168 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -62.57 -30.86 71.63 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.606 0.717 . . . . 0.0 109.439 178.883 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -70.95 -50.28 36.36 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.171 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.686 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -69.93 -42.92 72.65 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.638 -0.664 . . . . 0.0 109.989 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -58.7 -38.29 77.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.563 -0.711 . . . . 0.0 110.517 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -71.3 -51.96 21.54 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.551 -0.718 . . . . 0.0 110.037 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -66.66 -48.85 68.07 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.544 -0.722 . . . . 0.0 109.931 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.14 61.45 0.19 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.686 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 83.1 mt -126.18 68.23 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.519 -0.989 . . . . 0.0 110.331 179.657 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.76 52.92 2.42 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.792 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.49 -140.28 4.08 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.2 110.52 21.06 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.904 -0.762 . . . . 0.0 109.471 179.53 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.622 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 31.6 m95 -80.23 143.9 33.35 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.125 0.964 . . . . 0.0 112.318 -178.134 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 44' ' ' TRP . 2.7 p -157.48 131.65 8.29 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.935 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -107.43 146.03 32.23 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.704 -0.623 . . . . 0.0 109.894 -178.647 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.487 ' OD1' ' HB3' ' A' ' 49' ' ' ALA . 23.3 t0 -118.36 114.99 23.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.716 -0.615 . . . . 0.0 109.929 179.853 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -69.31 -24.05 63.88 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.666 -0.646 . . . . 0.0 110.542 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.487 ' HB3' ' OD1' ' A' ' 47' ' ' ASP . . . -52.48 -36.82 55.78 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.37 -0.831 . . . . 0.0 110.832 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.431 HG23 ' C ' ' A' ' 49' ' ' ALA . 77.1 p -147.81 17.71 1.13 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.574 -0.703 . . . . 0.0 110.88 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.46 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.26 93.06 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.221 -0.924 . . . . 0.0 111.01 179.793 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.4 m -157.72 105.27 2.01 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.233 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -64.67 136.56 57.09 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.632 ' HA ' HG22 ' A' ' 7' ' ' ILE . 51.1 m -127.59 100.02 5.82 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.887 -178.506 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.513 HG11 HG21 ' A' ' 40' ' ' ILE . 11.4 p -104.88 166.65 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 108.974 177.093 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.651 HG23 ' HB3' ' A' ' 9' ' ' ASN . 94.1 m -161.12 112.33 1.79 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.719 -0.613 . . . . 0.0 109.778 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.158 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.562 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 63.3 m . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.095 0.474 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 19' ' ' THR . 42.0 m -96.19 94.39 7.48 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.654 -0.654 . . . . 0.0 110.417 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.77 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.4 m-85 -72.14 167.49 20.17 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.528 -0.732 . . . . 0.0 109.966 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.553 ' HG2' HG22 ' A' ' 18' ' ' THR . 12.1 mtmt -132.77 115.82 15.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.544 -0.722 . . . . 0.0 110.317 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.671 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -94.09 111.84 23.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.518 -0.738 . . . . 0.0 110.263 -179.977 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.635 HG22 ' HA ' ' A' ' 54' ' ' THR . 3.8 tp -63.74 171.32 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.074 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.478 HD11 ' OG1' ' A' ' 17' ' ' THR . 74.0 mt -133.23 74.53 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.928 . . . . 0.0 110.678 -179.872 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.484 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.4 m-80 -95.56 48.0 1.13 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.875 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.18 156.81 15.36 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.347 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -74.47 -6.57 49.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.766 -0.844 . . . . 0.0 110.346 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.9 m -92.64 -37.1 12.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 110.133 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.406 ' HB3' HG21 ' A' ' 8' ' ' ILE . 7.3 mt -139.78 176.06 9.06 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.536 -0.728 . . . . 0.0 110.527 -180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.15 138.9 11.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.574 -0.704 . . . . 0.0 110.225 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.26 -136.54 9.04 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -144.46 162.91 35.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.56 -0.965 . . . . 0.0 110.332 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.478 ' OG1' HD11 ' A' ' 8' ' ' ILE . 5.6 m -146.67 130.23 16.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.598 -0.689 . . . . 0.0 110.107 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.553 HG22 ' HG2' ' A' ' 5' ' ' LYS . 66.8 p -112.4 174.88 5.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.628 -0.67 . . . . 0.0 110.323 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.567 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.4 t -166.54 -170.55 1.66 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.573 -0.705 . . . . 0.0 110.246 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -120.95 105.72 10.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.545 -0.722 . . . . 0.0 110.222 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.519 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -136.43 140.81 43.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.557 -0.714 . . . . 0.0 110.138 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.609 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.1 p -61.85 -30.67 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.552 -0.718 . . . . 0.0 109.909 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.609 ' OD1' HG13 ' A' ' 22' ' ' VAL . 48.4 p-10 -168.89 179.11 4.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.67 -0.644 . . . . 0.0 110.142 179.812 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.421 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.56 -23.01 14.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.489 -0.757 . . . . 0.0 111.137 -179.575 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.426 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.86 -32.1 70.39 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.391 -0.818 . . . . 0.0 110.441 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.519 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 5.4 m -104.05 -26.99 12.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.529 -0.732 . . . . 0.0 110.47 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.77 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.67 -58.17 9.59 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.526 -0.734 . . . . 0.0 110.495 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -58.43 -45.09 89.19 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.483 -0.76 . . . . 0.0 110.521 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -54.4 -41.0 68.75 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.254 -0.903 . . . . 0.0 110.507 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.2 t -81.39 -47.89 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.649 -0.657 . . . . 0.0 110.091 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CZ ' HG22 ' A' ' 19' ' ' THR . 4.5 m-85 -63.84 -32.72 74.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.694 . . . . 0.0 110.212 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -64.93 -42.97 94.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -63.64 -33.54 75.84 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.712 0.767 . . . . 0.0 109.099 178.748 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -66.06 -57.01 8.68 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.745 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.805 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.65 -46.18 91.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.753 -0.592 . . . . 0.0 110.085 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -57.48 -34.85 69.45 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.578 -0.701 . . . . 0.0 110.566 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.19 -48.47 67.83 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.537 -0.727 . . . . 0.0 110.135 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -76.49 -47.26 23.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.58 -0.7 . . . . 0.0 110.041 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.22 69.17 0.19 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.805 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 81.7 mt -127.44 60.82 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.997 . . . . 0.0 110.343 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -82.46 60.72 5.26 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.697 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.8 -140.8 10.05 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -178.649 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -114.04 105.5 13.3 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.922 -0.752 . . . . 0.0 109.039 179.604 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.671 ' HH2' HD11 ' A' ' 6' ' ' LEU . 55.9 m95 -75.78 143.27 42.05 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.04 0.924 . . . . 0.0 112.209 -178.17 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 44' ' ' TRP . 4.1 p -153.16 132.08 12.49 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.783 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.412 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 48.7 t80 -99.82 131.62 45.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.744 -0.597 . . . . 0.0 110.18 -178.509 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.16 119.15 38.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.754 -0.591 . . . . 0.0 109.951 179.746 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.24 -21.32 56.51 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.591 -0.693 . . . . 0.0 110.719 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.424 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.07 -40.39 67.16 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.311 -0.868 . . . . 0.0 110.829 -179.691 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.424 HG23 ' C ' ' A' ' 49' ' ' ALA . 70.0 p -147.55 19.51 1.18 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.585 -0.697 . . . . 0.0 110.84 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.412 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 0.6 OUTLIER 51.68 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.195 -0.941 . . . . 0.0 111.004 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 5' ' ' LYS . 57.1 m -158.54 108.33 2.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.513 -0.742 . . . . 0.0 110.684 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.503 ' O ' HD23 ' A' ' 6' ' ' LEU . 64.9 m-85 -62.22 127.44 31.36 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.576 -0.703 . . . . 0.0 109.177 179.146 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.635 ' HA ' HG22 ' A' ' 7' ' ' ILE . 58.1 m -120.3 105.39 10.88 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.398 -0.921 . . . . 0.0 112.47 -178.465 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.598 HG11 HG21 ' A' ' 40' ' ' ILE . 11.9 p -109.57 168.14 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.468 -0.77 . . . . 0.0 108.954 177.478 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 9' ' ' ASN . 96.5 m -160.04 109.7 1.81 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.471 -0.768 . . . . 0.0 110.013 -179.511 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.242 -179.941 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.525 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 71.4 m . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.157 0.503 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.5 m -93.54 91.4 7.08 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.623 -0.673 . . . . 0.0 110.576 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.666 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.8 m-85 -69.15 173.49 5.55 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.542 -0.724 . . . . 0.0 109.934 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.47 ' O ' HG23 ' A' ' 52' ' ' THR . 5.3 mtpm? -139.56 110.54 6.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.454 -0.778 . . . . 0.0 110.416 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.6 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -91.28 109.63 20.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.535 -0.728 . . . . 0.0 110.068 179.872 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.661 HG21 HG23 ' A' ' 54' ' ' THR . 2.7 tt -63.06 171.75 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.341 -0.849 . . . . 0.0 108.854 179.315 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.518 HG21 ' HB3' ' A' ' 13' ' ' LEU . 80.1 mt -133.64 71.94 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.438 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.477 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.7 m-20 -95.12 47.7 1.15 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.423 -0.798 . . . . 0.0 109.175 179.125 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.96 160.24 13.52 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.524 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -76.43 -7.36 54.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.653 -0.91 . . . . 0.0 110.461 179.202 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.2 t -98.34 -23.51 15.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.458 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.518 ' HB3' HG21 ' A' ' 8' ' ' ILE . 35.8 mt -147.21 163.62 35.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.321 -0.862 . . . . 0.0 110.495 179.848 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.47 132.68 17.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.64 -0.663 . . . . 0.0 110.146 179.864 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.4 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 133.06 -142.07 13.54 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -145.84 171.59 14.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.537 -0.978 . . . . 0.0 110.239 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 m -147.53 156.6 42.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.632 -0.667 . . . . 0.0 110.158 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.5 p -138.59 155.56 48.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.563 -0.711 . . . . 0.0 110.256 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.723 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.3 t -154.8 160.38 41.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.584 -0.698 . . . . 0.0 110.283 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -90.02 106.72 18.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.599 -0.688 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.05 139.28 45.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.622 -0.674 . . . . 0.0 110.216 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.494 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.2 p -59.21 -34.59 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.547 -0.721 . . . . 0.0 110.1 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.588 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 51.3 p30 -169.3 -178.77 3.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.586 -0.696 . . . . 0.0 110.271 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.416 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.98 -23.0 17.1 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.531 -0.73 . . . . 0.0 111.053 -179.828 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.588 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.06 -26.32 62.35 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.49 -0.756 . . . . 0.0 110.701 -179.672 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.1 m -114.76 -24.85 8.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.422 -0.799 . . . . 0.0 110.691 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.666 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.1 -60.03 4.52 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.402 -0.811 . . . . 0.0 110.415 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -59.42 -37.2 77.43 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.542 -0.724 . . . . 0.0 110.401 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -56.72 -44.73 81.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.423 -0.798 . . . . 0.0 110.578 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.0 t -80.13 -43.34 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.52 -0.737 . . . . 0.0 109.96 179.732 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.723 ' CZ ' HG22 ' A' ' 19' ' ' THR . 10.3 m-85 -65.52 -35.2 80.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.554 -0.717 . . . . 0.0 110.329 -179.727 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -63.64 -45.48 90.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 108.991 179.286 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -63.43 -32.84 74.39 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.69 0.757 . . . . 0.0 109.136 178.883 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -66.48 -56.58 10.22 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.802 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.783 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -59.56 -45.87 90.58 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.695 -0.628 . . . . 0.0 110.15 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -58.51 -32.49 68.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.57 -0.706 . . . . 0.0 110.328 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -60.94 -59.93 4.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.599 -0.688 . . . . 0.0 109.968 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -72.5 -45.98 56.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.624 -0.673 . . . . 0.0 109.828 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.36 72.89 0.23 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.725 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.783 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.4 mt -122.9 62.06 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.482 -1.011 . . . . 0.0 110.004 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.78 61.12 5.0 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.919 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.72 -140.76 9.98 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -178.947 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -116.62 104.53 11.48 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.877 -0.778 . . . . 0.0 109.038 179.563 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.6 ' HH2' HD11 ' A' ' 6' ' ' LEU . 53.6 m95 -73.98 143.94 45.41 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 122.084 0.945 . . . . 0.0 112.248 -178.112 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 44' ' ' TRP . 2.0 p -153.84 132.13 11.95 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.75 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.406 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 26.4 t80 -103.74 139.08 39.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.618 -0.676 . . . . 0.0 110.186 -178.721 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -113.34 122.05 46.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.718 -0.613 . . . . 0.0 109.843 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -75.89 -19.5 58.78 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.732 -0.605 . . . . 0.0 110.778 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.444 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.37 -39.18 66.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.24 -0.913 . . . . 0.0 110.774 -179.718 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.444 HG23 ' C ' ' A' ' 49' ' ' ALA . 74.4 p -148.18 18.56 1.09 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.561 -0.712 . . . . 0.0 110.752 -179.985 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.3 94.97 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.23 -0.919 . . . . 0.0 110.927 179.977 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 5' ' ' LYS . 70.2 m -156.22 108.78 2.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.472 -0.767 . . . . 0.0 111.015 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.463 ' O ' HD23 ' A' ' 6' ' ' LEU . 77.1 m-85 -65.17 127.58 32.28 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.59 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.661 HG23 HG21 ' A' ' 7' ' ' ILE . 45.7 m -120.23 102.87 8.79 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.753 -178.214 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.587 HG11 HG21 ' A' ' 40' ' ' ILE . 10.6 p -105.72 167.33 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.374 -0.829 . . . . 0.0 108.99 177.372 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.477 HG23 ' HB3' ' A' ' 9' ' ' ASN . 99.4 m -160.35 111.07 1.85 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.555 -0.716 . . . . 0.0 110.097 -179.603 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.169 179.87 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.495 HG22 ' CE2' ' A' ' 4' ' ' PHE . 92.6 m . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.14 0.495 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.5 m -92.95 108.53 20.07 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.618 -0.676 . . . . 0.0 110.437 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.792 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 73.7 m-85 -88.47 174.12 8.3 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.587 -0.696 . . . . 0.0 110.098 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.443 ' HB3' HG23 ' A' ' 52' ' ' THR . 0.4 OUTLIER -142.68 112.97 7.18 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 110.406 179.937 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.591 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -96.09 112.62 24.3 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.496 -0.753 . . . . 0.0 109.941 179.731 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.657 HG21 HG23 ' A' ' 54' ' ' THR . 2.4 tt -65.37 172.58 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.977 179.338 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.479 HG21 ' HB3' ' A' ' 13' ' ' LEU . 77.6 mt -133.98 72.33 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.384 -0.822 . . . . 0.0 110.383 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -95.23 47.17 1.13 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.439 -0.788 . . . . 0.0 109.272 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.32 160.7 13.38 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -77.64 -2.72 37.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.734 -0.862 . . . . 0.0 110.495 179.309 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -101.45 -30.44 11.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.969 . . . . 0.0 109.951 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.479 ' HB3' HG21 ' A' ' 8' ' ' ILE . 60.4 mt -140.01 165.9 26.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.482 -0.761 . . . . 0.0 110.508 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -151.11 132.41 14.54 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.643 -0.661 . . . . 0.0 110.218 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 131.84 -133.44 7.17 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -162.52 160.36 25.97 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.547 -0.972 . . . . 0.0 110.428 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.2 m -140.79 143.13 34.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.572 -0.705 . . . . 0.0 110.069 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.5 p -122.84 150.16 43.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.505 -0.747 . . . . 0.0 110.403 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.705 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.8 t -143.54 -172.09 3.65 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.647 -0.658 . . . . 0.0 110.247 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -114.34 107.73 15.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.59 -0.694 . . . . 0.0 110.146 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -132.63 147.8 52.35 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.586 -0.696 . . . . 0.0 110.096 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.6 p -65.7 -31.69 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.542 -0.724 . . . . 0.0 109.57 179.482 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -173.07 -174.94 1.12 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.587 -0.696 . . . . 0.0 109.952 179.574 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.457 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.27 -24.77 12.33 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.456 -0.777 . . . . 0.0 111.162 -179.458 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.59 78.14 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.497 -0.752 . . . . 0.0 110.377 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.589 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 5.1 m -100.78 -28.18 12.95 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.56 -0.712 . . . . 0.0 110.431 -179.88 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.792 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -61.42 -61.89 2.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.476 -0.765 . . . . 0.0 110.294 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -60.52 -37.28 80.66 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.596 -0.69 . . . . 0.0 110.25 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -57.6 -43.62 84.84 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.424 -0.798 . . . . 0.0 110.391 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.26 -45.81 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.585 -0.697 . . . . 0.0 109.819 179.691 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.705 ' CZ ' HG22 ' A' ' 19' ' ' THR . 11.5 m-85 -64.01 -33.21 75.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.573 -0.704 . . . . 0.0 110.283 -179.782 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -64.57 -45.09 88.51 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.132 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -63.02 -33.61 75.8 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.697 0.761 . . . . 0.0 109.18 178.911 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -64.5 -54.98 23.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.751 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.806 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.27 -44.27 96.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.784 -0.573 . . . . 0.0 110.023 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -57.92 -35.79 71.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.556 -0.715 . . . . 0.0 110.484 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.47 -43.35 99.02 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.624 -0.672 . . . . 0.0 110.023 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.423 ' CG ' HD11 ' A' ' 13' ' ' LEU . 71.2 m-80 -84.31 -42.46 15.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.625 -0.672 . . . . 0.0 109.922 179.814 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.51 47.47 0.41 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.722 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.806 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 79.6 mt -96.91 63.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.463 -1.022 . . . . 0.0 110.168 179.798 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.4 59.56 4.64 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.89 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.53 -139.71 8.1 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.046 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -118.59 103.09 9.39 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.307 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.591 ' CH2' HD11 ' A' ' 6' ' ' LEU . 53.1 m95 -71.62 142.73 49.95 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.065 0.936 . . . . 0.0 112.266 -177.854 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p -150.26 131.62 14.64 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.678 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -108.97 123.56 49.3 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.719 -0.613 . . . . 0.0 110.099 -178.606 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -100.93 119.05 38.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.708 -0.62 . . . . 0.0 109.834 179.599 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.36 -19.41 62.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.672 -0.643 . . . . 0.0 110.812 -179.746 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.427 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.12 -37.69 55.02 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.214 -0.929 . . . . 0.0 110.877 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.427 HG23 ' C ' ' A' ' 49' ' ' ALA . 75.7 p -147.06 17.37 1.22 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.628 -0.67 . . . . 0.0 110.754 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.87 86.67 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.18 -0.95 . . . . 0.0 110.948 179.817 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.443 HG23 ' HB3' ' A' ' 5' ' ' LYS . 86.6 m -151.51 105.7 3.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.483 -0.761 . . . . 0.0 110.766 -179.875 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.442 ' O ' HD23 ' A' ' 6' ' ' LEU . 97.6 m-85 -62.06 129.14 39.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.462 -0.774 . . . . 0.0 108.971 178.981 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.657 HG23 HG21 ' A' ' 7' ' ' ILE . 57.5 m -121.92 102.13 7.99 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.451 -178.668 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.624 HG11 HG21 ' A' ' 40' ' ' ILE . 10.2 p -103.16 167.46 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.381 -0.824 . . . . 0.0 109.319 177.744 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.459 ' N ' HG22 ' A' ' 55' ' ' VAL . 99.7 m -159.99 110.33 1.87 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.598 -0.689 . . . . 0.0 110.159 -179.474 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.068 179.721 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.564 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 67.5 m . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.115 0.483 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.5 m -80.87 101.97 9.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.611 -0.681 . . . . 0.0 110.573 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.705 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 74.9 m-85 -88.2 166.95 14.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.545 -0.722 . . . . 0.0 109.813 179.652 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -134.02 118.56 17.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.416 -0.803 . . . . 0.0 110.414 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.586 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -99.21 112.87 24.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.51 -0.744 . . . . 0.0 110.384 -179.926 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.609 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.5 tp -66.08 167.31 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.07 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.486 HD12 ' C ' ' A' ' 15' ' ' GLY . 73.6 mt -129.0 72.8 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.33 -0.856 . . . . 0.0 110.459 -179.849 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.548 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.2 m-80 -95.87 47.82 1.11 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.264 -0.898 . . . . 0.0 108.999 179.014 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.67 166.43 16.92 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -86.04 6.89 26.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.75 -0.853 . . . . 0.0 110.375 179.066 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -113.95 -30.85 6.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.915 . . . . 0.0 110.067 179.891 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.3 169.67 17.15 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.435 -0.791 . . . . 0.0 110.507 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -153.1 143.41 22.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.608 -0.682 . . . . 0.0 110.258 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.486 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 132.64 -140.73 12.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -153.67 155.91 36.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.631 -0.923 . . . . 0.0 110.209 -179.875 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.474 ' C ' HG23 ' A' ' 18' ' ' THR . 7.9 m -134.94 169.5 17.31 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.6 -0.687 . . . . 0.0 110.281 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.474 HG23 ' C ' ' A' ' 17' ' ' THR . 41.5 p -151.66 150.17 29.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.613 -0.679 . . . . 0.0 110.133 179.929 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.893 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.3 t -156.36 142.86 18.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.593 -0.692 . . . . 0.0 110.236 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -67.07 124.18 22.33 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.585 -0.697 . . . . 0.0 110.24 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.01 140.58 25.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.524 -0.735 . . . . 0.0 110.208 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.454 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.2 p -58.54 -35.24 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.548 -0.72 . . . . 0.0 110.14 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.62 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 35.7 p30 -171.24 -170.79 0.87 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.564 -0.71 . . . . 0.0 110.159 179.546 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.436 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.68 -25.54 54.18 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.507 -0.746 . . . . 0.0 110.844 -179.812 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.62 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.64 -51.88 67.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.464 -0.773 . . . . 0.0 110.429 -179.778 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.8 m -84.56 -27.6 27.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.477 -0.764 . . . . 0.0 110.338 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.705 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -61.39 -59.34 5.42 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.592 -0.692 . . . . 0.0 110.245 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -61.81 -32.63 72.95 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.569 -0.707 . . . . 0.0 110.268 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -57.87 -45.84 85.76 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.42 -0.8 . . . . 0.0 110.445 -179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.0 t -79.54 -42.57 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.61 -0.681 . . . . 0.0 109.879 179.716 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.893 ' CZ ' HG22 ' A' ' 19' ' ' THR . 12.5 m-85 -65.9 -33.85 76.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.631 -0.668 . . . . 0.0 110.182 -179.808 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -64.04 -47.39 80.38 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.305 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -63.64 -33.28 75.28 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.672 0.748 . . . . 0.0 109.081 178.789 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -64.32 -54.51 31.93 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.599 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.772 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.12 -40.17 95.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.825 -0.547 . . . . 0.0 110.014 179.881 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -58.95 -37.29 76.41 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.532 -0.73 . . . . 0.0 110.488 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -64.19 -40.03 95.23 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.55 -0.719 . . . . 0.0 110.265 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -86.38 -29.03 23.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.543 -0.723 . . . . 0.0 110.15 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.74 49.68 1.36 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.772 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.8 mt -103.4 62.7 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.603 -0.939 . . . . 0.0 110.286 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -85.12 58.57 5.11 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.795 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.99 -138.97 6.22 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 -178.848 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -116.74 102.94 9.85 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.497 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.586 ' CH2' HD11 ' A' ' 6' ' ' LEU . 53.0 m95 -72.79 141.39 48.07 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.101 0.953 . . . . 0.0 112.401 -177.915 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.4 132.45 19.27 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.299 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.412 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 53.9 t80 -105.53 113.24 26.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.635 -0.666 . . . . 0.0 110.128 -178.485 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.87 104.12 14.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.702 -0.624 . . . . 0.0 109.826 179.647 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -65.04 -24.83 67.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.676 -0.64 . . . . 0.0 110.553 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.95 -34.81 60.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.414 -0.804 . . . . 0.0 110.787 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.1 p -144.9 15.66 1.56 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.621 -0.674 . . . . 0.0 110.982 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.438 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 50.3 90.34 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.129 -0.982 . . . . 0.0 111.097 179.81 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.7 m -154.89 107.15 2.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.538 -0.726 . . . . 0.0 110.853 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.456 ' O ' HD23 ' A' ' 6' ' ' LEU . 82.6 m-85 -62.08 125.4 23.75 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.483 -0.761 . . . . 0.0 109.041 178.858 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.609 ' HA ' HG22 ' A' ' 7' ' ' ILE . 60.5 m -120.27 100.01 6.92 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.251 -0.98 . . . . 0.0 112.54 -178.618 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.553 HG11 HG21 ' A' ' 40' ' ' ILE . 10.8 p -103.7 167.28 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.39 -0.819 . . . . 0.0 109.212 177.597 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.548 HG23 ' HB3' ' A' ' 9' ' ' ASN . 99.2 m -160.65 109.89 1.69 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.667 -0.646 . . . . 0.0 109.762 -179.785 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.249 -179.922 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.459 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 89.2 m . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.1 0.476 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.599 ' O ' HG23 ' A' ' 3' ' ' THR . 8.1 t -80.99 105.86 12.55 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.634 -0.666 . . . . 0.0 110.503 -179.854 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.708 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 60.4 m-85 -90.37 164.42 14.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.447 -0.783 . . . . 0.0 109.966 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.459 ' CB ' HG23 ' A' ' 52' ' ' THR . 18.1 mttm -130.38 122.29 27.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.461 -0.775 . . . . 0.0 110.569 179.964 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.561 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -105.5 110.55 22.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.527 -0.733 . . . . 0.0 109.939 179.81 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.606 HG22 ' HA ' ' A' ' 54' ' ' THR . 2.6 tp -62.74 166.9 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.353 -0.842 . . . . 0.0 109.007 179.482 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.46 HG21 ' HB3' ' A' ' 13' ' ' LEU . 79.8 mt -130.8 72.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.303 -0.873 . . . . 0.0 110.489 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.507 ' HB3' HG23 ' A' ' 56' ' ' THR . 34.6 m-20 -97.12 49.58 1.06 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.449 -0.782 . . . . 0.0 109.257 179.197 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.71 163.25 12.49 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -78.18 -2.05 35.7 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.646 -0.914 . . . . 0.0 110.874 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.778 ' HB ' HD12 ' A' ' 13' ' ' LEU . 19.5 m -107.34 -28.03 10.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.232 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.778 HD12 ' HB ' ' A' ' 12' ' ' THR . 4.3 mp -135.13 164.8 26.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.521 -0.737 . . . . 0.0 110.303 179.749 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -154.71 126.78 7.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.571 -0.706 . . . . 0.0 110.313 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.07 -140.01 11.33 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -144.85 171.77 13.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.637 -0.92 . . . . 0.0 110.376 -179.853 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.485 HG23 ' CE1' ' A' ' 31' ' ' PHE . 7.0 t -154.98 157.79 38.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.628 -0.67 . . . . 0.0 109.976 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.9 p -140.42 149.43 42.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.546 -0.721 . . . . 0.0 110.513 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.843 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.5 t -146.35 162.15 38.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.626 -0.671 . . . . 0.0 109.994 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -88.22 107.16 18.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.567 -0.708 . . . . 0.0 110.281 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.96 138.56 50.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.611 -0.681 . . . . 0.0 110.1 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.68 -31.81 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.614 -0.679 . . . . 0.0 110.248 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.515 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 14.7 p30 -171.32 179.99 2.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.504 -0.747 . . . . 0.0 110.377 179.856 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.45 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.79 -31.47 64.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.489 -0.757 . . . . 0.0 110.78 -179.573 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.515 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -60.27 -28.47 68.09 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.536 -0.727 . . . . 0.0 110.266 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.3 m -108.14 -27.99 9.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.58 -0.7 . . . . 0.0 110.304 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.708 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.2 -54.95 39.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.508 -0.745 . . . . 0.0 110.236 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -60.06 -31.82 70.36 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.573 -0.705 . . . . 0.0 110.239 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -58.26 -40.62 82.29 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.342 -0.849 . . . . 0.0 110.35 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.0 t -82.19 -44.93 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.585 -0.697 . . . . 0.0 109.851 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.843 ' CZ ' HG22 ' A' ' 19' ' ' THR . 9.1 m-85 -65.85 -37.84 87.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.65 -0.656 . . . . 0.0 110.229 -179.808 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -62.07 -46.05 90.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.465 -0.772 . . . . 0.0 109.387 179.665 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -62.47 -34.24 76.44 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.782 0.801 . . . . 0.0 109.339 179.083 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.64 -49.36 68.96 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.749 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -73.25 -45.15 57.53 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.769 -0.582 . . . . 0.0 110.444 -179.758 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -56.26 -39.84 73.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.423 -0.798 . . . . 0.0 110.617 -179.715 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -75.13 -31.54 61.11 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.606 -0.684 . . . . 0.0 110.11 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -80.14 -40.89 26.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.546 -0.721 . . . . 0.0 110.006 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.43 37.15 0.94 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.749 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.7 mt -103.64 62.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.528 -0.984 . . . . 0.0 110.174 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -85.67 57.35 4.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.51 -0.744 . . . . 0.0 109.008 178.917 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.47 -138.69 5.23 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -178.993 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -116.3 105.14 12.21 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.43 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.561 ' HH2' HD11 ' A' ' 6' ' ' LEU . 52.8 m95 -74.63 142.22 44.59 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.182 0.992 . . . . 0.0 112.459 -177.964 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.05 132.59 17.72 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.452 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -106.48 111.74 24.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.646 -0.659 . . . . 0.0 110.262 -178.357 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.16 112.02 20.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.694 -0.629 . . . . 0.0 109.778 179.662 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -70.32 -21.78 62.88 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.639 -0.663 . . . . 0.0 110.663 -179.766 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.454 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.94 -35.24 58.41 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.311 -0.868 . . . . 0.0 110.955 -179.784 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.454 HG23 ' C ' ' A' ' 49' ' ' ALA . 70.9 p -148.16 18.41 1.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.537 -0.727 . . . . 0.0 110.932 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.72 93.14 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.182 -0.949 . . . . 0.0 110.989 179.713 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.459 HG23 ' CB ' ' A' ' 5' ' ' LYS . 62.4 m -158.66 104.68 1.79 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.454 -0.779 . . . . 0.0 110.886 -179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.485 ' O ' HD23 ' A' ' 6' ' ' LEU . 98.7 m-85 -61.05 128.52 36.82 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.423 -0.798 . . . . 0.0 109.149 179.014 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.606 ' HA ' HG22 ' A' ' 7' ' ' ILE . 85.0 m -120.7 101.21 7.58 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.522 -178.404 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.568 HG11 HG21 ' A' ' 40' ' ' ILE . 9.5 p -103.9 166.87 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.863 . . . . 0.0 109.309 177.599 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 9' ' ' ASN . 95.0 m -160.72 110.02 1.68 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.62 -0.675 . . . . 0.0 109.835 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.19 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.513 HG22 ' CE2' ' A' ' 4' ' ' PHE . 55.0 m . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.127 0.489 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 19' ' ' THR . 6.6 m -106.66 96.1 6.21 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.585 -0.697 . . . . 0.0 110.624 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.737 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 92.1 m-85 -73.59 -178.85 3.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.538 -0.726 . . . . 0.0 109.838 179.606 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -146.74 110.75 5.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.49 -0.756 . . . . 0.0 110.289 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.66 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -92.27 110.67 22.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.502 -0.749 . . . . 0.0 110.364 -179.771 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.655 HG21 HG23 ' A' ' 54' ' ' THR . 3.4 tp -64.22 170.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.286 -0.884 . . . . 0.0 108.653 178.997 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.511 HD11 ' OG1' ' A' ' 17' ' ' THR . 78.0 mt -131.53 74.2 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.245 -0.909 . . . . 0.0 110.722 -179.655 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.429 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.5 m-20 -96.07 47.13 1.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.458 -0.776 . . . . 0.0 109.052 179.022 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.1 161.9 13.29 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.602 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -79.74 -0.53 34.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.771 -0.84 . . . . 0.0 110.587 179.315 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -104.79 -30.82 9.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.981 . . . . 0.0 109.928 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.473 ' HB3' HG21 ' A' ' 8' ' ' ILE . 54.8 mt -138.54 166.02 25.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.635 -0.666 . . . . 0.0 110.363 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -154.63 132.81 11.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.573 -0.704 . . . . 0.0 110.202 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.89 -147.29 19.12 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -144.88 122.25 11.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.555 -0.967 . . . . 0.0 110.368 179.955 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.511 ' OG1' HD11 ' A' ' 8' ' ' ILE . 62.5 m -109.67 149.81 29.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.631 -0.668 . . . . 0.0 110.253 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.8 p -131.94 162.41 30.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.56 -0.712 . . . . 0.0 110.164 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.628 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.6 t -142.93 -172.55 3.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.561 -0.712 . . . . 0.0 110.328 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -123.53 89.36 3.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.614 -0.679 . . . . 0.0 110.153 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -116.19 -177.25 3.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.585 -0.697 . . . . 0.0 109.982 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.17 -24.88 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.728 . . . . 0.0 110.326 179.822 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -168.11 175.56 6.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.452 -0.78 . . . . 0.0 110.156 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.407 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -57.88 -25.14 60.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.516 -0.74 . . . . 0.0 110.744 -179.772 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.7 -27.96 66.89 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.472 -0.767 . . . . 0.0 110.502 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.4 m -109.27 -27.23 9.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.551 -0.718 . . . . 0.0 110.417 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.737 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -62.0 -62.96 1.42 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.505 -0.747 . . . . 0.0 110.407 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -58.17 -41.65 84.33 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.519 -0.738 . . . . 0.0 110.528 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.6 tttm -55.68 -42.49 75.24 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.362 -0.836 . . . . 0.0 110.314 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.2 t -80.27 -48.13 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.674 . . . . 0.0 109.934 179.545 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.628 ' CZ ' HG22 ' A' ' 19' ' ' THR . 5.4 m-85 -62.05 -33.75 74.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.585 -0.697 . . . . 0.0 110.22 -179.676 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -63.7 -43.84 95.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.425 -0.797 . . . . 0.0 108.924 179.19 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -62.71 -33.5 75.23 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.728 0.775 . . . . 0.0 109.298 178.837 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -67.26 -56.48 9.63 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.928 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.758 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.56 -41.44 94.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.736 -0.602 . . . . 0.0 110.302 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -58.11 -36.93 73.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.51 -0.744 . . . . 0.0 110.605 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.38 -42.4 68.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.545 -0.722 . . . . 0.0 110.18 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -77.77 -28.93 50.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.573 -0.705 . . . . 0.0 110.215 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.88 55.06 0.95 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.876 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.758 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.0 mt -115.44 59.7 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.485 -1.009 . . . . 0.0 110.353 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.15 60.77 5.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.658 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.05 -138.93 7.97 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -178.553 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -115.4 103.57 10.91 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.948 -0.736 . . . . 0.0 109.28 179.629 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.66 ' HH2' HD11 ' A' ' 6' ' ' LEU . 55.6 m95 -73.92 143.38 45.77 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.146 0.974 . . . . 0.0 112.497 -177.968 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -151.22 133.31 15.21 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 178.656 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -104.0 139.17 39.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.593 -0.692 . . . . 0.0 110.313 -178.41 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -112.74 113.57 25.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.687 -0.633 . . . . 0.0 109.976 179.794 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -69.68 -21.37 63.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.701 -0.624 . . . . 0.0 110.847 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.44 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.6 -40.48 65.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.293 -0.879 . . . . 0.0 110.814 -179.592 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.44 HG23 ' C ' ' A' ' 49' ' ' ALA . 66.5 p -148.84 20.28 1.01 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.555 -0.716 . . . . 0.0 110.597 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.45 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER 52.1 93.46 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.174 -0.954 . . . . 0.0 110.63 179.948 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.6 m -151.41 103.17 2.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.497 -0.752 . . . . 0.0 111.112 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.518 ' O ' HD23 ' A' ' 6' ' ' LEU . 78.2 m-85 -63.44 123.41 18.68 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.451 -0.781 . . . . 0.0 109.018 178.786 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.655 HG23 HG21 ' A' ' 7' ' ' ILE . 62.9 m -116.92 103.78 10.63 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.323 -0.951 . . . . 0.0 112.619 -178.349 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.567 HG11 HG21 ' A' ' 40' ' ' ILE . 11.4 p -106.02 168.27 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.409 -0.807 . . . . 0.0 109.002 177.396 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.461 ' N ' HG22 ' A' ' 55' ' ' VAL . 99.7 m -160.2 108.9 1.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.543 -0.723 . . . . 0.0 110.028 -179.558 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.168 179.884 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.565 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 79.1 m . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.086 0.47 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.625 ' O ' HG23 ' A' ' 3' ' ' THR . 8.1 t -89.44 99.39 12.4 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.65 -0.656 . . . . 0.0 110.585 -179.844 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.715 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 90.6 m-85 -80.68 176.56 9.69 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.364 -0.835 . . . . 0.0 110.005 179.885 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.52 ' HB3' HG23 ' A' ' 52' ' ' THR . 16.8 mttt -141.95 110.46 6.07 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.428 -0.795 . . . . 0.0 110.272 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.607 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -93.62 111.54 23.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.489 -0.757 . . . . 0.0 110.467 -179.92 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.635 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.5 tp -64.18 170.29 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.948 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.498 HD11 ' OG1' ' A' ' 17' ' ' THR . 77.8 mt -132.43 74.72 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.772 -179.788 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.434 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.5 m-20 -95.72 49.33 1.16 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.811 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.43 160.75 13.17 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.327 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -80.6 -0.16 36.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.769 -0.842 . . . . 0.0 110.47 179.015 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -102.14 -31.81 10.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.134 -0.979 . . . . 0.0 109.951 179.855 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -144.9 170.49 16.04 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.508 -0.745 . . . . 0.0 110.401 -179.978 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -154.12 142.77 20.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.618 -0.676 . . . . 0.0 110.374 -179.793 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.432 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 127.55 -164.34 21.02 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.963 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -119.88 145.31 46.8 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.551 -0.97 . . . . 0.0 110.315 -179.955 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.498 ' OG1' HD11 ' A' ' 8' ' ' ILE . 7.0 m -121.75 146.2 47.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.586 -0.696 . . . . 0.0 110.225 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.9 p -130.08 166.94 19.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.57 -0.706 . . . . 0.0 110.179 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.629 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.4 t -167.01 -179.5 4.69 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.568 -0.708 . . . . 0.0 110.3 -179.921 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -112.55 101.18 9.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.546 -0.721 . . . . 0.0 110.209 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.48 146.21 50.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.589 -0.694 . . . . 0.0 110.219 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.1 p -70.17 -26.28 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.546 -0.721 . . . . 0.0 110.186 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.721 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 8.1 p30 -170.37 177.94 3.92 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.412 -0.805 . . . . 0.0 110.465 179.734 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.13 -25.84 47.71 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.578 -0.701 . . . . 0.0 111.139 -179.425 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.721 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.11 -39.26 81.72 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.372 -0.83 . . . . 0.0 110.334 -179.776 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.6 m -94.41 -29.63 14.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.594 -0.691 . . . . 0.0 110.087 179.914 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.715 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -61.02 -55.91 27.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.595 -0.69 . . . . 0.0 110.226 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -61.97 -37.32 84.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.568 -0.708 . . . . 0.0 110.3 -179.949 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -58.36 -41.9 85.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.379 -0.825 . . . . 0.0 110.387 -179.958 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.8 t -81.37 -44.21 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.558 -0.714 . . . . 0.0 109.813 179.666 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.629 ' CZ ' HG22 ' A' ' 19' ' ' THR . 11.2 m-85 -65.75 -36.46 83.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.602 -0.686 . . . . 0.0 110.192 -179.861 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -63.13 -45.17 93.23 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.469 -0.769 . . . . 0.0 109.15 179.366 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -63.25 -31.06 72.12 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.657 0.742 . . . . 0.0 109.27 178.713 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -69.67 -51.06 38.06 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.866 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.789 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -69.31 -41.27 76.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.627 -0.671 . . . . 0.0 110.002 179.9 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -58.49 -44.53 89.43 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.746 . . . . 0.0 110.423 -179.977 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.74 -46.21 83.18 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.59 -0.694 . . . . 0.0 110.204 -179.952 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -70.84 -50.19 38.01 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.535 -0.728 . . . . 0.0 110.07 179.941 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.61 58.08 0.19 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.789 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 82.2 mt -116.05 59.82 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.548 -0.971 . . . . 0.0 110.234 179.826 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.97 62.89 3.51 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.872 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.18 -141.99 12.84 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -178.813 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -114.73 111.47 21.31 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.944 -0.739 . . . . 0.0 109.039 179.152 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.607 ' HH2' HD11 ' A' ' 6' ' ' LEU . 52.8 m95 -80.39 143.22 33.66 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.038 0.923 . . . . 0.0 112.264 -177.887 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 p -152.17 133.62 14.54 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 178.911 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -104.09 139.98 38.41 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.194 -178.636 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -109.54 108.9 19.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.65 -0.656 . . . . 0.0 109.938 179.724 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -67.62 -21.08 65.41 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.707 -0.621 . . . . 0.0 110.759 -179.866 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.422 ' C ' HG23 ' A' ' 50' ' ' THR . . . -55.15 -41.79 72.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.29 -0.881 . . . . 0.0 110.747 -179.726 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.422 HG23 ' C ' ' A' ' 49' ' ' ALA . 67.2 p -146.84 21.75 1.26 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.6 -0.688 . . . . 0.0 110.617 -179.932 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.451 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.31 95.32 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.235 -0.916 . . . . 0.0 110.753 179.804 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.52 HG23 ' HB3' ' A' ' 5' ' ' LYS . 26.8 m -154.81 102.75 2.38 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.213 -179.841 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.436 ' O ' HD23 ' A' ' 6' ' ' LEU . 71.4 m-85 -63.81 128.9 37.86 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.708 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.635 ' HA ' HG22 ' A' ' 7' ' ' ILE . 61.1 m -122.65 106.76 11.24 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.588 -178.583 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.611 HG11 HG21 ' A' ' 40' ' ' ILE . 11.0 p -110.69 167.35 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.436 -0.79 . . . . 0.0 109.143 177.481 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.467 ' N ' HG22 ' A' ' 55' ' ' VAL . 78.7 m -161.39 111.42 1.65 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.642 -0.661 . . . . 0.0 109.83 -179.791 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.137 179.903 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.566 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 68.5 m . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.091 0.472 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.4 m -84.43 94.31 8.49 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.606 -0.684 . . . . 0.0 110.698 -179.679 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.798 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.7 m-85 -77.47 177.86 7.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.521 -0.737 . . . . 0.0 109.736 179.518 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.479 ' HB3' HG23 ' A' ' 52' ' ' THR . 8.3 ttmm -142.93 112.11 6.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.417 -0.802 . . . . 0.0 110.608 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.656 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -94.14 116.84 29.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.523 -0.736 . . . . 0.0 110.378 179.95 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.696 HG21 HG23 ' A' ' 54' ' ' THR . 2.7 tt -70.79 173.38 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.457 -0.777 . . . . 0.0 109.023 179.287 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.413 ' HB ' ' N ' ' A' ' 15' ' ' GLY . 83.0 mt -132.63 75.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.835 . . . . 0.0 110.161 179.903 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.01 45.2 1.04 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.526 -0.734 . . . . 0.0 109.204 179.379 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.04 158.92 15.89 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.74 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -76.7 -3.61 38.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.705 -0.879 . . . . 0.0 110.598 179.358 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 m -101.84 -33.1 9.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 110.217 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.609 HD11 ' CG ' ' A' ' 38' ' ' ASN . 73.0 mt -132.7 175.29 9.46 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.497 -0.752 . . . . 0.0 110.483 179.932 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -159.69 133.46 7.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.651 -0.656 . . . . 0.0 110.125 -179.866 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.413 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 132.46 -145.9 17.71 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.826 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -135.97 175.52 9.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.529 -0.983 . . . . 0.0 110.321 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.9 m -150.73 134.42 16.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.527 -0.733 . . . . 0.0 110.262 179.899 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.3 p -121.56 161.82 21.69 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.537 -0.727 . . . . 0.0 110.335 -179.968 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.752 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 9.1 t -165.66 -179.52 5.43 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.56 -0.712 . . . . 0.0 110.272 179.921 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.42 119.58 39.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.607 -0.683 . . . . 0.0 110.061 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.471 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -147.07 139.03 24.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.585 -0.697 . . . . 0.0 110.142 -179.892 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.0 m -57.98 -33.71 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.474 -0.766 . . . . 0.0 110.598 -179.932 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.708 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 15.4 p30 -170.35 -174.21 1.64 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.519 -0.738 . . . . 0.0 110.33 179.84 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.46 -27.15 56.12 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.523 -0.735 . . . . 0.0 110.739 -179.755 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.708 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.74 -26.46 65.67 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.474 -0.766 . . . . 0.0 110.32 179.861 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.471 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 50.2 m -110.0 -27.38 9.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.539 -0.725 . . . . 0.0 110.249 179.908 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.798 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.55 -60.68 3.45 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.624 -0.672 . . . . 0.0 110.361 -179.917 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -59.93 -36.15 76.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.555 -0.716 . . . . 0.0 110.158 -179.985 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -57.66 -45.23 85.81 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.461 -0.774 . . . . 0.0 110.49 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.03 -43.91 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.561 -0.712 . . . . 0.0 110.134 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.752 ' CZ ' HG22 ' A' ' 19' ' ' THR . 8.0 m-85 -66.77 -34.06 76.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.583 -0.698 . . . . 0.0 110.291 -179.679 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -63.95 -40.57 96.73 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.393 -0.817 . . . . 0.0 108.897 179.212 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -63.35 -33.92 76.58 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.733 0.777 . . . . 0.0 109.239 179.003 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.68 -59.31 3.7 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.735 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.794 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -59.85 -46.78 88.2 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.752 -0.592 . . . . 0.0 110.275 179.894 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -55.95 -27.96 54.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.524 -0.735 . . . . 0.0 110.712 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.89 -52.56 49.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.577 -0.702 . . . . 0.0 109.973 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.609 ' CG ' HD11 ' A' ' 13' ' ' LEU . 43.0 m-80 -78.13 -45.0 24.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.596 -0.69 . . . . 0.0 109.994 179.856 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.47 53.16 0.18 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.769 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.794 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.1 mt -103.13 63.03 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.514 -0.992 . . . . 0.0 110.052 179.63 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.92 56.35 3.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.414 -0.804 . . . . 0.0 108.907 178.879 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.56 -137.31 3.66 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.123 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -116.03 101.16 8.5 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.403 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.656 ' CH2' HD11 ' A' ' 6' ' ' LEU . 49.9 m95 -71.77 142.52 49.71 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.998 0.904 . . . . 0.0 111.846 -178.197 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 p -151.24 132.19 14.24 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.939 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.401 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 13.3 t80 -103.17 139.35 38.77 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.679 -0.638 . . . . 0.0 110.108 -178.701 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.25 104.76 13.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.775 -0.578 . . . . 0.0 109.511 179.432 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -63.2 -20.87 65.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.676 -0.64 . . . . 0.0 110.798 -179.568 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.445 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.26 -40.05 67.44 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.287 -0.883 . . . . 0.0 110.703 -179.765 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.445 HG23 ' C ' ' A' ' 49' ' ' ALA . 68.0 p -148.14 21.84 1.09 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.621 -0.674 . . . . 0.0 110.516 179.998 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.445 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.56 91.36 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.198 -0.939 . . . . 0.0 110.743 179.976 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.479 HG23 ' HB3' ' A' ' 5' ' ' LYS . 20.4 m -150.23 98.54 2.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.462 -0.774 . . . . 0.0 111.23 -179.807 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.456 ' O ' HD23 ' A' ' 6' ' ' LEU . 66.3 m-85 -61.81 127.8 33.17 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.391 -0.818 . . . . 0.0 108.959 178.656 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.696 HG23 HG21 ' A' ' 7' ' ' ILE . 91.7 m -123.67 107.63 11.69 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.451 -178.499 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.545 HG21 HG22 ' A' ' 40' ' ' ILE . 11.6 p -107.96 167.4 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.358 -0.839 . . . . 0.0 108.917 177.401 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.462 ' N ' HG22 ' A' ' 55' ' ' VAL . 99.2 m -160.7 111.01 1.77 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.636 -0.665 . . . . 0.0 109.984 -179.703 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.102 179.811 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.552 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 86.6 m . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.173 0.511 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.608 ' O ' HG23 ' A' ' 3' ' ' THR . 7.2 t -82.36 99.94 9.68 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.628 -0.67 . . . . 0.0 110.503 -179.95 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.647 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 89.6 m-85 -84.76 170.52 13.15 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.351 -0.843 . . . . 0.0 109.771 179.696 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.519 ' HB3' HG23 ' A' ' 52' ' ' THR . 7.5 tttt -139.96 115.31 9.89 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.417 -0.802 . . . . 0.0 110.466 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.627 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -96.95 113.16 24.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.5 -0.75 . . . . 0.0 110.479 -179.915 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.672 HG21 HG23 ' A' ' 54' ' ' THR . 2.7 tp -65.42 170.01 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.133 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 13' ' ' LEU . 83.8 mt -131.17 73.17 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.237 179.734 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.18 48.15 1.23 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.475 -0.766 . . . . 0.0 109.092 179.094 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.97 156.0 15.81 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.464 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -74.18 -6.35 47.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.746 -0.855 . . . . 0.0 110.408 179.185 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.8 m -94.94 -31.52 13.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.167 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.537 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -147.47 164.51 33.13 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.489 -0.757 . . . . 0.0 110.604 -179.869 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -144.73 140.27 28.45 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.62 -0.675 . . . . 0.0 110.311 -179.877 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 132.6 -144.47 16.33 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.605 ' HG2' HD12 ' A' ' 7' ' ' ILE . 51.3 mt-10 -144.26 162.34 36.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.505 -0.997 . . . . 0.0 110.281 -179.979 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.4 m -137.8 143.44 41.06 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.598 -0.689 . . . . 0.0 109.951 179.788 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.2 p -127.21 153.67 45.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.592 -0.692 . . . . 0.0 110.297 -179.874 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.842 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 9.0 t -159.04 156.14 28.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.605 -0.685 . . . . 0.0 110.236 179.848 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -86.23 123.76 31.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.579 -0.701 . . . . 0.0 110.148 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.14 144.9 29.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.595 -0.691 . . . . 0.0 110.271 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.18 -36.06 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.565 -0.709 . . . . 0.0 110.195 -179.998 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.589 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 4.2 p30 -170.81 -168.38 0.67 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.561 -0.712 . . . . 0.0 110.389 179.787 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.421 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.88 -33.52 66.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.593 -0.692 . . . . 0.0 111.214 -179.287 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.589 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -55.02 -48.05 73.89 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.349 -0.845 . . . . 0.0 110.826 -179.51 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.9 m -85.87 -27.54 24.99 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.543 -0.723 . . . . 0.0 110.306 179.998 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.647 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.42 -61.21 2.76 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.537 -0.727 . . . . 0.0 110.303 -179.922 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -59.81 -38.79 82.95 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.554 -0.716 . . . . 0.0 110.382 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -55.95 -40.44 73.22 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.326 -0.859 . . . . 0.0 110.617 -179.893 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.5 t -82.05 -47.36 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.588 -0.695 . . . . 0.0 110.148 179.863 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.842 ' CZ ' HG22 ' A' ' 19' ' ' THR . 8.1 m-85 -64.68 -35.25 80.42 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.529 -0.732 . . . . 0.0 110.292 -179.771 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.59 -43.81 95.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.498 -0.751 . . . . 0.0 109.17 179.441 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -60.77 -32.39 71.71 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.677 0.751 . . . . 0.0 109.539 179.07 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -68.86 -55.44 11.08 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.881 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.786 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -65.55 -44.18 87.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.746 -0.596 . . . . 0.0 110.209 -179.948 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -56.24 -32.13 64.19 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.491 -0.756 . . . . 0.0 110.439 -179.839 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -70.48 -52.77 19.65 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.649 -0.657 . . . . 0.0 109.883 179.692 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -68.54 -41.68 79.52 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.596 -0.69 . . . . 0.0 109.759 179.652 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.44 44.05 0.62 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.685 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.786 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 81.2 mt -96.51 63.1 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.522 -0.987 . . . . 0.0 110.204 179.762 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -83.73 58.52 4.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.578 -0.701 . . . . 0.0 109.292 179.163 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.47 -137.69 5.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.33 100.95 7.63 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.183 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.627 ' CH2' HD11 ' A' ' 6' ' ' LEU . 52.8 m95 -69.73 142.68 53.25 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.131 0.967 . . . . 0.0 112.489 -177.775 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -149.88 131.81 15.19 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.567 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.4 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 21.8 t80 -106.29 134.84 48.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.638 -0.663 . . . . 0.0 110.159 -178.454 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.61 110.5 22.71 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.661 -0.649 . . . . 0.0 109.848 179.57 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -67.3 -24.64 65.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.637 -0.664 . . . . 0.0 110.623 -179.672 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.405 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.42 -37.44 56.74 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.325 -0.859 . . . . 0.0 110.899 -179.655 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.405 HG23 ' C ' ' A' ' 49' ' ' ALA . 72.1 p -145.93 16.83 1.41 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.623 -0.673 . . . . 0.0 110.839 179.837 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.442 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.13 93.06 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.084 -1.01 . . . . 0.0 110.729 179.939 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.519 HG23 ' HB3' ' A' ' 5' ' ' LYS . 91.9 m -155.49 104.06 2.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.523 -0.736 . . . . 0.0 111.051 -179.697 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.437 ' O ' HD23 ' A' ' 6' ' ' LEU . 86.1 m-85 -62.44 132.17 51.64 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.498 -0.751 . . . . 0.0 109.037 178.88 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.672 HG23 HG21 ' A' ' 7' ' ' ILE . 77.1 m -126.9 105.17 8.45 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.396 -0.922 . . . . 0.0 112.426 -178.686 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.58 HG11 HG21 ' A' ' 40' ' ' ILE . 9.2 p -107.2 166.43 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.341 -0.85 . . . . 0.0 109.443 177.694 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.447 ' N ' HG22 ' A' ' 55' ' ' VAL . 86.9 m -162.33 117.02 1.85 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.673 -0.642 . . . . 0.0 110.107 -179.525 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.411 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 3.5 mt-10 . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.124 179.456 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.554 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 62.2 m . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.125 0.488 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.7 m -94.26 93.43 7.74 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.508 -0.745 . . . . 0.0 110.481 -179.835 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.707 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 97.5 m-85 -71.77 169.72 15.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.579 -0.701 . . . . 0.0 109.978 179.824 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.509 ' HG2' HG22 ' A' ' 18' ' ' THR . 2.7 mttt -136.22 114.15 11.28 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.532 -0.73 . . . . 0.0 110.413 -179.825 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.659 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -93.98 111.98 23.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.485 -0.759 . . . . 0.0 110.554 -179.969 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.637 HG21 HG23 ' A' ' 54' ' ' THR . 3.6 tp -63.51 171.06 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.061 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.479 HD11 ' OG1' ' A' ' 17' ' ' THR . 82.8 mt -133.05 74.03 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.559 -179.91 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -96.16 46.46 1.08 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.854 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.05 156.83 16.72 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.692 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -75.48 -5.83 47.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.766 -0.844 . . . . 0.0 110.383 179.117 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.47 HG22 HD12 ' A' ' 13' ' ' LEU . 7.5 m -93.88 -34.74 13.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.136 179.941 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.47 HD12 HG22 ' A' ' 12' ' ' THR . 0.6 OUTLIER -139.52 -176.34 4.51 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.536 -179.994 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -163.47 134.56 4.7 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.644 -0.66 . . . . 0.0 110.167 -179.953 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.89 -141.93 12.97 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.932 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -138.88 161.81 36.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.573 -0.957 . . . . 0.0 110.306 -179.796 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.479 ' OG1' HD11 ' A' ' 8' ' ' ILE . 6.1 m -136.87 140.34 42.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.581 -0.699 . . . . 0.0 110.175 -179.965 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.509 HG22 ' HG2' ' A' ' 5' ' ' LYS . 38.7 p -129.55 159.44 36.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.492 -0.755 . . . . 0.0 110.398 -179.794 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.746 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.9 t -162.14 171.31 17.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.566 -0.709 . . . . 0.0 110.231 179.657 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.13 105.45 16.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.552 -0.718 . . . . 0.0 110.155 179.982 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.17 139.03 49.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.542 -0.724 . . . . 0.0 110.232 179.89 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 p -59.4 -33.36 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.566 -0.709 . . . . 0.0 110.179 179.953 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.586 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 30.3 p30 -170.04 -179.36 3.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.554 -0.716 . . . . 0.0 110.344 179.887 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.2 -24.83 44.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.49 -0.756 . . . . 0.0 110.862 -179.831 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.586 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.68 -30.48 67.41 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.447 -0.783 . . . . 0.0 110.472 -179.776 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 30' ' ' VAL . 25.2 m -109.48 -27.13 9.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.525 -0.735 . . . . 0.0 110.313 179.936 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.707 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.35 -42.77 96.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.501 -0.749 . . . . 0.0 110.127 179.916 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.87 -45.76 63.84 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.66 -0.65 . . . . 0.0 110.251 179.84 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -56.04 -31.9 63.56 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.243 -0.911 . . . . 0.0 110.551 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 26' ' ' THR . 60.0 t -87.01 -48.44 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.652 -0.655 . . . . 0.0 110.104 -179.937 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.746 ' CZ ' HG22 ' A' ' 19' ' ' THR . 6.3 m-85 -67.56 -38.79 84.63 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.981 -179.731 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -62.63 -43.87 97.71 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.515 -0.741 . . . . 0.0 109.093 179.226 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.6 tp60 -64.04 -34.12 77.29 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.761 0.791 . . . . 0.0 109.123 178.792 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -64.91 -57.71 8.07 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.676 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.781 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -58.96 -40.76 85.7 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.777 -0.577 . . . . 0.0 110.292 -179.895 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -58.01 -36.74 73.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.539 -0.726 . . . . 0.0 110.467 -179.879 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.96 -44.47 89.29 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.556 -0.715 . . . . 0.0 109.825 179.773 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -77.57 -40.37 42.58 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.673 -0.642 . . . . 0.0 109.971 179.729 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.87 40.83 0.88 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.82 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.781 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 75.8 mt -97.52 63.73 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.52 -0.988 . . . . 0.0 110.239 179.799 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -85.64 57.38 4.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.492 -0.755 . . . . 0.0 109.09 178.895 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.64 -139.32 6.17 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -178.839 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.55 108.72 17.92 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.859 -0.789 . . . . 0.0 109.008 179.455 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.659 ' HH2' HD11 ' A' ' 6' ' ' LEU . 57.9 m95 -79.59 142.49 35.63 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.118 0.961 . . . . 0.0 112.349 -177.794 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 44' ' ' TRP . 6.2 p -153.7 131.9 11.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.786 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.41 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 21.8 t80 -97.04 125.48 41.51 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.701 -0.625 . . . . 0.0 110.202 -178.506 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -87.72 98.46 11.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.751 -0.593 . . . . 0.0 109.746 179.584 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -63.4 -19.19 64.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.589 -0.694 . . . . 0.0 110.767 -179.767 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.444 ' C ' HG23 ' A' ' 50' ' ' THR . . . -55.6 -42.54 74.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.269 -0.895 . . . . 0.0 110.661 -179.77 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.444 HG23 ' C ' ' A' ' 49' ' ' ALA . 75.2 p -148.45 27.82 0.9 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.627 -0.671 . . . . 0.0 110.356 -179.871 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.441 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 5.6 mptt 52.52 96.8 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.336 -0.853 . . . . 0.0 110.809 -179.964 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.0 m -158.19 104.25 1.86 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.45 -0.781 . . . . 0.0 110.829 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.451 ' O ' HD23 ' A' ' 6' ' ' LEU . 64.3 m-85 -63.05 131.86 50.02 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.522 -0.736 . . . . 0.0 109.026 178.969 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.637 HG23 HG21 ' A' ' 7' ' ' ILE . 80.7 m -125.77 110.11 13.33 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.432 -0.907 . . . . 0.0 112.421 -178.528 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.568 HG11 HG21 ' A' ' 40' ' ' ILE . 11.3 p -114.35 167.4 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.37 -0.831 . . . . 0.0 109.35 177.726 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.456 ' N ' HG22 ' A' ' 55' ' ' VAL . 85.3 m -161.65 112.34 1.66 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.623 -0.673 . . . . 0.0 110.084 -179.649 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.172 179.764 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.592 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 40.2 m . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.105 0.479 . . . . 0.0 110.371 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 m -89.23 91.91 8.96 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.604 -0.685 . . . . 0.0 110.615 -179.791 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.665 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 97.3 m-85 -74.08 170.07 16.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.45 -0.781 . . . . 0.0 109.834 179.661 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -134.23 114.55 13.16 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.419 -0.801 . . . . 0.0 110.323 179.901 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.579 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -94.87 110.69 22.54 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.687 . . . . 0.0 110.399 -179.948 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 54' ' ' THR . 2.1 tt -65.46 162.64 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.044 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.405 HG21 ' HB3' ' A' ' 13' ' ' LEU . 49.0 mm -125.37 76.97 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.397 -179.741 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -96.13 47.33 1.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.991 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.23 159.58 13.82 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.217 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.0 tptt -77.83 -3.24 40.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.787 -0.831 . . . . 0.0 110.394 179.163 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.5 m -99.79 -32.01 11.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 110.14 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.537 HD11 ' OD1' ' A' ' 38' ' ' ASN . 55.9 mt -140.49 173.98 10.97 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.508 -0.745 . . . . 0.0 110.559 -179.916 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -160.73 135.98 7.84 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.63 -0.669 . . . . 0.0 109.994 179.795 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.07 -144.49 16.46 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -137.47 151.65 48.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.564 -0.963 . . . . 0.0 110.446 -179.851 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 m -130.84 144.87 51.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.613 -0.679 . . . . 0.0 110.08 179.857 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.8 p -131.8 139.8 48.99 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.549 -0.719 . . . . 0.0 110.355 -179.837 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.895 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.9 t -146.04 134.01 21.4 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 110.353 179.942 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.91 129.1 39.36 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.592 -0.692 . . . . 0.0 110.455 -179.919 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.53 140.67 19.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.561 -0.712 . . . . 0.0 109.989 179.887 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.47 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.2 p -58.58 -36.36 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.479 -0.763 . . . . 0.0 110.225 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.549 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 39.4 p30 -169.92 -176.01 2.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.578 -0.701 . . . . 0.0 110.209 179.621 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.453 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.57 -26.36 54.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.535 -0.728 . . . . 0.0 110.786 -179.667 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.549 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.48 -29.6 67.94 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.467 -0.771 . . . . 0.0 110.319 -179.895 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 30' ' ' VAL . 11.7 m -106.26 -27.39 11.06 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.583 -0.698 . . . . 0.0 110.382 179.952 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.665 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.73 -50.04 75.4 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.481 -0.762 . . . . 0.0 110.32 -179.981 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -62.19 -46.22 89.89 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.591 -0.693 . . . . 0.0 110.078 179.862 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -55.73 -34.68 65.37 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.445 -0.784 . . . . 0.0 110.873 -179.801 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 26' ' ' THR . 65.2 t -84.66 -47.65 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.502 -0.749 . . . . 0.0 110.274 -179.829 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.895 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.5 m-85 -68.11 -37.88 81.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.547 -0.721 . . . . 0.0 110.188 -179.76 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -62.26 -45.78 91.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.73 . . . . 0.0 109.367 179.661 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -60.95 -29.91 69.92 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.608 0.718 . . . . 0.0 109.619 179.004 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -72.53 -59.16 2.86 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.832 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.805 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.68 -49.42 77.57 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.728 -0.608 . . . . 0.0 110.194 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -56.1 -33.0 64.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.547 -0.721 . . . . 0.0 110.666 -179.816 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.16 -31.23 49.57 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.58 -0.7 . . . . 0.0 110.025 179.886 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.537 ' OD1' HD11 ' A' ' 13' ' ' LEU . 3.7 m-80 -83.47 -47.26 11.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.602 -0.686 . . . . 0.0 110.028 179.908 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.93 48.88 0.15 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.93 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.805 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 79.1 mt -116.26 58.52 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.505 -0.997 . . . . 0.0 110.391 179.935 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -81.35 60.55 4.46 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.433 -0.792 . . . . 0.0 109.013 178.918 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.96 -139.68 8.88 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -178.87 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -114.43 110.25 19.57 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.397 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.579 ' HH2' HD11 ' A' ' 6' ' ' LEU . 55.5 m95 -80.31 142.93 34.04 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.131 0.967 . . . . 0.0 112.456 -177.852 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 44' ' ' TRP . 7.0 p -153.04 130.95 11.73 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.853 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.417 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 14.3 t80 -102.07 128.76 48.38 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.693 -0.629 . . . . 0.0 109.848 -178.742 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.6 110.67 22.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.712 -0.617 . . . . 0.0 109.887 179.726 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -69.69 -22.9 63.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.706 -0.621 . . . . 0.0 110.686 -179.913 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.41 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.92 -39.56 68.95 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.424 -0.798 . . . . 0.0 110.939 -179.769 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.41 HG23 ' C ' ' A' ' 49' ' ' ALA . 77.8 p -145.77 19.22 1.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.53 -0.731 . . . . 0.0 110.974 -179.873 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.417 ' HG3' ' CE2' ' A' ' 46' ' ' TYR . 0.3 OUTLIER 51.88 95.65 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.23 -0.918 . . . . 0.0 110.957 179.7 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.1 m -158.7 106.46 1.87 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.499 -0.75 . . . . 0.0 110.683 179.83 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.436 ' O ' HD23 ' A' ' 6' ' ' LEU . 69.3 m-85 -63.65 129.38 39.92 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.948 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.645 ' HA ' HG22 ' A' ' 7' ' ' ILE . 56.7 m -123.25 107.2 11.42 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.36 -178.472 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.604 HG11 HG21 ' A' ' 40' ' ' ILE . 10.6 p -110.82 167.16 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.845 . . . . 0.0 109.436 177.791 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.457 ' N ' HG22 ' A' ' 55' ' ' VAL . 83.7 m -161.61 116.37 2.0 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.652 -0.655 . . . . 0.0 110.06 -179.782 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 . . . . . 0 N--CA 1.498 1.951 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.387 179.746 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.545 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 32.7 m . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.092 0.472 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 51.3 m -95.08 91.31 6.28 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.622 -0.674 . . . . 0.0 110.492 -179.767 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.663 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.8 m-85 -69.89 172.43 7.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.548 -0.72 . . . . 0.0 109.836 179.713 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -140.59 116.31 10.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.476 -0.765 . . . . 0.0 110.555 -179.659 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.635 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -96.27 112.77 24.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.536 -0.727 . . . . 0.0 110.423 -179.9 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.614 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.2 tp -63.01 172.67 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.005 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.734 HD11 ' OG1' ' A' ' 17' ' ' THR . 74.2 mt -135.61 70.24 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.209 -0.932 . . . . 0.0 110.974 -179.724 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -93.59 50.12 1.44 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.316 -0.865 . . . . 0.0 109.033 178.539 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.04 155.31 16.18 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.303 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -11.82 61.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.639 -0.918 . . . . 0.0 110.247 179.138 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -86.75 -36.11 18.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 110.332 -179.849 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.504 ' HB3' HG21 ' A' ' 8' ' ' ILE . 17.8 mt -138.67 -173.26 3.51 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 110.655 -179.912 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.15 127.08 2.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.603 -0.685 . . . . 0.0 110.345 179.94 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.99 -137.85 9.45 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.858 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -143.92 173.38 11.76 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.553 -0.969 . . . . 0.0 110.396 -179.858 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.734 ' OG1' HD11 ' A' ' 8' ' ' ILE . 7.4 m -153.26 146.8 25.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.622 -0.674 . . . . 0.0 110.175 179.864 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.3 p -132.5 170.19 15.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.628 -0.67 . . . . 0.0 110.226 179.965 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.74 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.3 t -165.58 179.43 6.07 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.573 -0.705 . . . . 0.0 110.166 -179.938 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -104.58 102.04 11.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.564 -0.71 . . . . 0.0 110.255 179.988 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.42 135.4 49.45 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.58 -0.7 . . . . 0.0 110.187 179.972 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.8 m -60.48 -27.23 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.497 -0.752 . . . . 0.0 110.345 179.955 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.453 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 31.1 p30 -172.79 178.43 2.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.422 -0.798 . . . . 0.0 110.221 179.67 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.02 -27.54 45.17 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.504 -0.747 . . . . 0.0 110.763 -179.606 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.453 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -63.37 -24.09 67.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.6 -0.688 . . . . 0.0 110.49 179.934 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 m -108.11 -26.11 10.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.449 -0.782 . . . . 0.0 110.628 -179.738 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.663 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -69.38 -48.24 61.78 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.495 -0.753 . . . . 0.0 110.35 -179.813 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -60.18 -41.53 93.07 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.564 -0.71 . . . . 0.0 110.488 -179.867 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -58.55 -36.36 73.78 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.379 -0.826 . . . . 0.0 110.591 -179.874 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.88 -41.56 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.516 -0.74 . . . . 0.0 110.222 -179.922 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.74 ' CZ ' HG22 ' A' ' 19' ' ' THR . 11.0 m-85 -72.5 -39.04 67.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.519 -0.738 . . . . 0.0 110.32 -179.851 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.4 tttt -62.03 -45.49 93.37 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.387 -0.821 . . . . 0.0 109.173 179.335 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -62.43 -33.06 74.05 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.721 0.772 . . . . 0.0 109.339 179.023 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -67.5 -56.71 8.45 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.847 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.789 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -61.07 -38.69 87.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.749 -0.595 . . . . 0.0 110.148 179.997 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -58.11 -39.96 79.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.503 -0.748 . . . . 0.0 110.557 -179.843 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -69.66 -43.04 73.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.567 -0.708 . . . . 0.0 110.134 -179.946 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -75.34 -28.9 59.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.589 -0.695 . . . . 0.0 110.102 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.06 52.25 1.39 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.886 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.789 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 83.9 mt -109.22 61.24 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.501 -0.999 . . . . 0.0 110.256 179.94 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -84.05 57.89 4.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.439 -0.788 . . . . 0.0 108.993 178.791 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.46 -138.04 5.56 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -178.916 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -116.79 101.22 8.36 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.874 -0.78 . . . . 0.0 109.365 179.484 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.635 ' CH2' HD11 ' A' ' 6' ' ' LEU . 52.6 m95 -71.74 143.06 49.73 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 122.02 0.914 . . . . 0.0 112.176 -178.2 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.66 131.74 14.37 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.464 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.404 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 38.5 t80 -105.02 131.73 52.17 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.713 -0.617 . . . . 0.0 110.294 -178.365 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -106.74 119.22 38.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.662 -0.649 . . . . 0.0 109.819 179.546 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -73.22 -21.46 60.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.655 -0.653 . . . . 0.0 110.707 -179.762 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.429 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.67 -38.23 60.14 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.257 -0.902 . . . . 0.0 110.804 -179.781 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.429 HG23 ' C ' ' A' ' 49' ' ' ALA . 76.0 p -146.88 17.15 1.25 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.594 -0.691 . . . . 0.0 110.86 179.889 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 50.88 93.33 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.122 -0.986 . . . . 0.0 110.697 179.953 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.0 m -154.86 106.87 2.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.464 -0.772 . . . . 0.0 110.94 -179.662 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.473 ' O ' HD23 ' A' ' 6' ' ' LEU . 79.1 m-85 -61.93 130.12 44.15 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.698 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.614 ' HA ' HG22 ' A' ' 7' ' ' ILE . 85.0 m -123.39 107.23 11.39 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.539 -178.598 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.564 HG11 HG21 ' A' ' 40' ' ' ILE . 11.1 p -111.64 166.94 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.452 -0.78 . . . . 0.0 109.15 177.536 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.451 ' N ' HG22 ' A' ' 55' ' ' VAL . 90.8 m -161.88 111.89 1.57 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.766 -0.584 . . . . 0.0 109.796 -179.857 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.163 179.86 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.617 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 12.0 m . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.081 0.467 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.608 ' O ' HG23 ' A' ' 3' ' ' THR . 8.0 t -87.81 84.29 7.05 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.684 -0.635 . . . . 0.0 110.8 -179.616 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.634 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 92.9 m-85 -68.6 167.82 14.28 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.357 -0.84 . . . . 0.0 109.938 179.72 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.509 ' HG3' HG22 ' A' ' 18' ' ' THR . 22.8 mttt -131.21 114.75 15.46 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.524 -0.735 . . . . 0.0 110.308 179.974 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.628 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -95.12 109.63 21.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.498 -0.752 . . . . 0.0 110.256 179.916 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.601 HG21 HG23 ' A' ' 54' ' ' THR . 4.1 tp -63.24 169.56 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.166 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.526 HD12 ' C ' ' A' ' 15' ' ' GLY . 81.2 mt -130.84 71.52 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.589 -179.575 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -94.68 48.3 1.2 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.383 -0.823 . . . . 0.0 108.978 178.947 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.8 160.29 17.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.504 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -1.62 35.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.776 -0.837 . . . . 0.0 110.583 179.205 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.806 ' O ' HD22 ' A' ' 13' ' ' LEU . 9.1 m -103.0 -37.58 7.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.318 -179.928 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.806 HD22 ' O ' ' A' ' 12' ' ' THR . 0.9 OUTLIER -134.65 176.54 8.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.486 -0.759 . . . . 0.0 110.589 -179.981 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -157.14 137.85 13.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.528 -0.732 . . . . 0.0 110.274 -179.962 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.526 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 134.02 -153.5 20.95 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.946 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -143.04 157.74 44.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.558 -0.966 . . . . 0.0 110.248 -179.961 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.7 t -144.16 164.49 30.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.556 -0.715 . . . . 0.0 110.304 179.993 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.509 HG22 ' HG3' ' A' ' 5' ' ' LYS . 11.9 p -135.84 174.21 10.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.573 -0.704 . . . . 0.0 110.189 179.941 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.623 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.6 t -161.98 -168.59 1.96 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.583 -0.698 . . . . 0.0 110.369 -179.951 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.26 103.23 8.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.637 -0.664 . . . . 0.0 110.387 179.9 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -133.56 143.18 48.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.485 -0.76 . . . . 0.0 110.238 -179.888 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.603 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.8 p -60.72 -31.6 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.584 -0.698 . . . . 0.0 109.927 179.789 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.603 ' OD1' HG13 ' A' ' 22' ' ' VAL . 50.9 p-10 -170.18 179.1 3.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.635 -0.666 . . . . 0.0 110.148 179.723 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.446 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.04 -25.56 45.4 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.508 -0.745 . . . . 0.0 110.855 -179.647 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.23 -26.51 64.95 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.52 -0.737 . . . . 0.0 110.533 -179.855 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.3 m -111.36 -26.98 8.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.521 -0.737 . . . . 0.0 110.46 -179.896 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.634 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.96 -53.51 56.99 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.498 -0.751 . . . . 0.0 110.317 -179.868 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -59.78 -37.72 79.84 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.578 -0.701 . . . . 0.0 110.315 179.94 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -56.32 -43.31 78.85 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.415 -0.803 . . . . 0.0 110.371 179.93 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.7 t -80.29 -46.09 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.611 -0.68 . . . . 0.0 109.852 179.633 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.623 ' CZ ' HG22 ' A' ' 19' ' ' THR . 9.2 m-85 -63.22 -35.52 80.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.607 -0.683 . . . . 0.0 110.355 -179.749 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -63.54 -42.71 98.4 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.411 -0.806 . . . . 0.0 109.138 179.438 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -63.25 -33.97 76.65 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.735 0.779 . . . . 0.0 109.205 178.898 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -66.63 -58.67 4.67 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.745 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.809 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.6 -34.11 73.72 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.712 -0.618 . . . . 0.0 110.061 179.799 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -55.16 -54.13 47.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.613 -0.68 . . . . 0.0 110.741 -179.924 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.18 -44.35 96.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.573 -0.705 . . . . 0.0 110.13 179.923 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -67.5 -29.64 69.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.597 -0.689 . . . . 0.0 110.072 179.87 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.6 50.96 2.42 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.987 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.809 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 83.1 mt -107.52 61.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.569 -0.96 . . . . 0.0 110.208 179.936 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.07 61.62 4.71 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 178.612 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.23 -140.73 10.23 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -178.685 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -116.02 103.54 10.68 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.572 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.628 ' HH2' HD11 ' A' ' 6' ' ' LEU . 52.0 m95 -73.73 142.13 46.33 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.044 0.926 . . . . 0.0 112.129 -178.211 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 p -149.71 131.96 15.49 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.722 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.433 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 45.9 t80 -103.7 127.8 51.12 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.718 -0.614 . . . . 0.0 110.014 -178.452 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -98.02 120.61 38.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.706 -0.621 . . . . 0.0 110.075 179.902 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.48 -23.03 53.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.677 -0.639 . . . . 0.0 110.489 179.961 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.402 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.4 -40.66 68.46 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.39 -0.819 . . . . 0.0 110.894 -179.733 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.402 HG23 ' C ' ' A' ' 49' ' ' ALA . 73.8 p -145.76 18.0 1.46 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.564 -0.71 . . . . 0.0 111.011 -179.899 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 0.2 OUTLIER 52.15 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.115 -0.99 . . . . 0.0 110.962 179.715 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.0 m -156.2 104.68 2.26 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.431 -0.793 . . . . 0.0 110.996 -179.949 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.462 ' O ' HD23 ' A' ' 6' ' ' LEU . 63.7 m-85 -61.48 123.9 19.14 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.522 -0.736 . . . . 0.0 109.129 178.839 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.601 HG23 HG21 ' A' ' 7' ' ' ILE . 60.4 m -119.49 104.89 10.72 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.667 -178.453 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.59 HG11 HG21 ' A' ' 40' ' ' ILE . 10.6 p -107.32 167.02 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.241 177.554 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.459 ' N ' HG22 ' A' ' 55' ' ' VAL . 99.5 m -159.09 109.17 1.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.647 -0.658 . . . . 0.0 109.902 -179.766 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.122 -179.929 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.72 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 33.1 m . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 121.146 0.498 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.412 ' N ' HG22 ' A' ' 2' ' ' THR . 90.0 m -143.3 91.16 2.24 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.643 -0.661 . . . . 0.0 109.902 179.88 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.72 ' CZ ' HG21 ' A' ' 2' ' ' THR . 83.6 m-85 -80.95 175.88 10.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.555 -0.716 . . . . 0.0 110.253 -179.608 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.633 ' CB ' HG23 ' A' ' 52' ' ' THR . 26.7 mttt -137.49 142.16 41.49 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.673 -0.642 . . . . 0.0 109.96 179.728 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.536 HD13 ' C ' ' A' ' 6' ' ' LEU . 3.4 tm? -115.62 99.8 7.59 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.527 -0.733 . . . . 0.0 110.191 -179.614 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.748 HG21 HG23 ' A' ' 54' ' ' THR . 2.0 tp -63.16 124.68 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.465 -0.772 . . . . 0.0 108.96 179.625 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.589 HG21 ' HB3' ' A' ' 13' ' ' LEU . 10.0 mt -92.65 68.27 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.524 -0.735 . . . . 0.0 110.605 -178.907 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.478 ' HB3' HG23 ' A' ' 56' ' ' THR . 18.1 m-20 -89.19 53.0 2.52 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.199 -0.938 . . . . 0.0 109.221 178.966 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.3 169.0 17.0 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.483 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -83.72 5.48 24.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.749 -0.853 . . . . 0.0 110.499 179.088 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.5 m -114.29 -30.45 6.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 110.245 -179.931 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.589 ' HB3' HG21 ' A' ' 8' ' ' ILE . 13.2 mt -137.1 179.24 6.5 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.373 -0.829 . . . . 0.0 110.741 -179.903 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.03 134.45 4.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.625 -0.672 . . . . 0.0 110.084 -179.938 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.11 -150.1 21.54 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.921 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -139.06 155.32 48.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.624 -0.927 . . . . 0.0 110.298 -179.883 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.4 ' OG1' HD11 ' A' ' 8' ' ' ILE . 76.8 m -126.04 156.08 40.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 110.089 -179.99 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.5 p -145.38 144.98 30.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.587 -0.695 . . . . 0.0 110.323 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.499 HG22 ' CE1' ' A' ' 31' ' ' PHE . 9.7 t -156.17 144.78 20.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.57 -0.706 . . . . 0.0 110.202 179.775 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.23 112.6 12.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.567 -0.708 . . . . 0.0 109.778 179.712 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.91 144.42 50.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.605 -0.685 . . . . 0.0 110.027 -179.864 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.8 m -60.6 -33.48 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.522 -0.736 . . . . 0.0 110.239 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.656 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 24.0 p30 -175.26 -175.35 0.82 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.462 -0.774 . . . . 0.0 110.254 179.422 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.8 -25.19 55.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.545 -0.722 . . . . 0.0 110.876 -179.725 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.656 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.24 -26.52 63.0 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.462 -0.774 . . . . 0.0 110.543 -179.83 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.5 m -111.49 -25.91 9.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.529 -0.732 . . . . 0.0 110.559 -179.882 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.704 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.66 -57.41 13.03 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.457 -0.777 . . . . 0.0 110.45 -179.825 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -59.18 -36.28 75.06 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.465 -0.772 . . . . 0.0 110.416 -179.986 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -61.06 -41.54 96.81 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.351 -0.843 . . . . 0.0 109.864 179.764 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.9 t -83.51 -39.34 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.578 -0.701 . . . . 0.0 109.337 179.278 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.499 ' CE1' HG22 ' A' ' 19' ' ' THR . 5.0 m-30 -66.45 -35.41 80.23 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.703 -0.623 . . . . 0.0 109.644 179.558 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -69.43 -45.45 69.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.663 -0.648 . . . . 0.0 109.624 179.712 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -61.94 -32.18 72.58 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.625 0.726 . . . . 0.0 109.671 179.397 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -67.65 -48.48 66.55 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.063 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.696 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -75.19 -33.09 61.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.781 -0.574 . . . . 0.0 110.391 -179.679 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -58.69 -45.24 89.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.497 -0.752 . . . . 0.0 110.399 -179.814 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.03 -36.98 72.57 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.599 -0.688 . . . . 0.0 110.156 179.941 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -74.43 -34.8 63.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.617 -0.677 . . . . 0.0 110.049 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.59 35.5 3.53 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.965 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.696 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 81.6 mt -100.09 69.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.537 -0.978 . . . . 0.0 110.204 179.991 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.08 51.5 1.81 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.692 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.71 -136.81 0.75 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -178.711 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -113.95 102.95 10.68 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.641 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.463 ' CH2' HD21 ' A' ' 6' ' ' LEU . 35.2 m95 -74.02 142.0 45.78 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.113 0.959 . . . . 0.0 112.161 -178.101 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 44' ' ' TRP . 4.3 p -152.58 132.17 13.06 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.022 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.432 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 53.8 t80 -103.8 103.75 13.67 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.71 -0.618 . . . . 0.0 109.951 -178.846 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.78 109.32 15.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.686 -0.634 . . . . 0.0 109.839 179.781 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -64.62 -22.12 66.89 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.706 -0.621 . . . . 0.0 110.437 -179.965 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.79 -35.54 44.33 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.331 -0.855 . . . . 0.0 110.791 -179.855 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.0 p -145.4 15.48 1.46 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.545 -0.722 . . . . 0.0 110.95 179.862 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.44 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.01 82.24 0.06 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.092 -1.005 . . . . 0.0 110.716 179.818 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.633 HG23 ' CB ' ' A' ' 5' ' ' LYS . 26.6 m -150.11 110.71 4.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.38 -0.825 . . . . 0.0 111.429 -179.642 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -65.53 112.76 3.75 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.439 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.748 HG23 HG21 ' A' ' 7' ' ' ILE . 88.4 m -104.85 99.41 9.05 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.918 -177.545 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.516 HG21 HG22 ' A' ' 40' ' ' ILE . 10.7 p -100.38 164.92 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 0.0 108.972 177.044 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.478 HG23 ' HB3' ' A' ' 9' ' ' ASN . 90.0 m -160.62 110.53 1.75 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.722 -0.611 . . . . 0.0 110.135 -179.677 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.038 179.824 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.643 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 4.1 m . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.169 0.509 . . . . 0.0 110.048 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 m -89.08 86.68 6.95 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.585 -0.697 . . . . 0.0 110.627 -179.576 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.728 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 66.0 m-85 -76.05 169.73 17.62 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.458 -0.776 . . . . 0.0 109.788 179.684 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 52' ' ' THR . 11.0 mtmm -141.45 105.3 4.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.482 -0.761 . . . . 0.0 110.392 -179.928 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.524 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -90.61 107.34 19.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.495 -0.753 . . . . 0.0 110.041 179.817 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 54' ' ' THR . 2.8 tp -64.2 160.2 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 119.616 -0.834 . . . . 0.0 108.921 179.231 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 13' ' ' LEU . 49.0 mm -123.31 76.84 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.456 -179.735 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.9 48.3 1.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.784 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.9 153.16 17.76 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.234 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -12.61 61.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.686 -0.89 . . . . 0.0 110.283 179.178 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.6 m -85.98 -35.75 20.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.898 . . . . 0.0 110.336 -179.999 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.438 ' O ' HG22 ' A' ' 8' ' ' ILE . 38.9 mt -143.72 171.43 14.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.521 -0.737 . . . . 0.0 110.545 -179.902 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.96 137.54 13.13 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.611 -0.681 . . . . 0.0 110.105 179.89 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.28 -138.05 9.43 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.962 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -141.08 165.53 27.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.971 . . . . 0.0 110.298 -179.917 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.1 m -151.75 128.47 10.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.582 -0.699 . . . . 0.0 110.1 179.977 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.428 HG22 ' HG2' ' A' ' 5' ' ' LYS . 26.4 p -126.32 149.4 49.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.735 . . . . 0.0 110.374 -179.915 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.831 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 9.0 t -150.56 129.14 12.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.621 -0.675 . . . . 0.0 110.179 179.807 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -60.91 118.48 6.75 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.513 -0.742 . . . . 0.0 110.101 179.868 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.84 156.89 45.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.58 -0.7 . . . . 0.0 110.319 -179.786 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 p -65.0 -37.0 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.621 -0.674 . . . . 0.0 110.063 179.963 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -174.73 -173.67 0.74 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.517 -0.739 . . . . 0.0 109.964 179.8 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -54.77 -24.15 21.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.43 -0.794 . . . . 0.0 111.018 -179.643 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.66 -43.79 85.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.402 -0.811 . . . . 0.0 110.504 -179.892 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.3 m -94.7 -29.97 14.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.572 -0.705 . . . . 0.0 110.254 179.907 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.728 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.76 -62.21 2.04 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.488 -0.758 . . . . 0.0 110.419 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.17 -35.26 74.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.652 -0.655 . . . . 0.0 110.308 179.988 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -60.35 -41.94 94.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.29 -0.881 . . . . 0.0 110.114 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.7 t -81.45 -41.28 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.605 -0.684 . . . . 0.0 109.648 179.562 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.831 ' CZ ' HG22 ' A' ' 19' ' ' THR . 14.7 m-85 -67.66 -38.37 83.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 0.0 110.155 -179.934 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -63.34 -47.89 80.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.535 -0.728 . . . . 0.0 109.654 179.723 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -59.82 -32.92 71.11 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.732 0.777 . . . . 0.0 109.452 179.241 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.402 ' OH ' HD12 ' A' ' 8' ' ' ILE . 2.3 t80 -66.99 -59.2 3.68 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.717 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.799 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -61.96 -44.66 96.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.729 -0.607 . . . . 0.0 109.995 179.703 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -56.0 -42.4 76.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.537 -0.727 . . . . 0.0 110.61 -179.777 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.22 -41.65 85.38 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.596 -0.69 . . . . 0.0 109.9 179.862 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -72.86 -51.66 17.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.577 -0.702 . . . . 0.0 109.856 179.779 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.8 43.72 0.23 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.686 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.799 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.3 mt -104.5 59.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.515 -0.991 . . . . 0.0 110.256 179.755 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -80.74 60.95 4.22 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.47 -0.769 . . . . 0.0 109.058 178.961 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.7 -138.34 7.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -178.906 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.79 102.78 9.39 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.891 -0.77 . . . . 0.0 109.07 179.281 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.524 ' HH2' HD11 ' A' ' 6' ' ' LEU . 53.3 m95 -73.03 142.62 47.68 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.207 1.004 . . . . 0.0 112.574 -177.705 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.3 p -150.46 131.49 14.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.411 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -106.58 128.86 54.47 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.637 -0.664 . . . . 0.0 110.329 -178.288 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -100.73 111.28 23.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.697 -0.627 . . . . 0.0 109.911 179.707 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -68.91 -24.69 64.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.689 -0.632 . . . . 0.0 110.525 -179.881 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.43 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.31 -36.33 52.93 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.353 -0.842 . . . . 0.0 110.969 -179.695 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.43 HG23 ' C ' ' A' ' 49' ' ' ALA . 77.3 p -147.2 16.86 1.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.514 -0.741 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.459 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.36 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.149 -0.969 . . . . 0.0 110.809 179.798 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 5' ' ' LYS . 74.9 m -159.64 104.27 1.58 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.423 -0.798 . . . . 0.0 111.209 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.471 ' HE2' ' HB1' ' A' ' 27' ' ' ALA . 96.7 m-85 -65.0 128.12 34.43 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.557 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.672 ' HA ' HG22 ' A' ' 7' ' ' ILE . 61.8 m -120.39 103.11 8.93 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.34 -178.52 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.584 HG11 HG21 ' A' ' 40' ' ' ILE . 8.5 p -106.13 165.74 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 0.0 109.56 177.935 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.449 ' N ' HG22 ' A' ' 55' ' ' VAL . 84.4 m -162.54 117.08 1.79 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.785 -0.572 . . . . 0.0 109.88 -179.744 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.991 179.691 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.465 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 77.7 m . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.203 0.525 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.4 m -93.47 103.8 15.98 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.631 -0.668 . . . . 0.0 110.446 -179.87 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.739 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 84.7 m-85 -84.11 179.54 7.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.515 -0.74 . . . . 0.0 110.178 179.938 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.547 ' HB3' HG23 ' A' ' 52' ' ' THR . 5.7 ttmt -145.69 111.94 5.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.527 -0.733 . . . . 0.0 110.502 179.966 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.515 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -92.72 111.45 23.06 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.435 -0.79 . . . . 0.0 110.321 -179.959 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.643 HG21 HG23 ' A' ' 54' ' ' THR . 3.6 tt -65.03 174.01 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.357 -0.84 . . . . 0.0 108.801 179.205 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 13' ' ' LEU . 76.1 mt -135.0 74.51 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.658 -179.888 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -96.28 49.73 1.14 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.953 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.71 160.95 13.19 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.327 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm -78.15 -7.44 57.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.724 -0.868 . . . . 0.0 110.463 179.201 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 12' ' ' THR . 10.0 t -98.23 -25.56 14.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.164 -0.96 . . . . 0.0 110.701 -179.77 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.471 ' O ' HG22 ' A' ' 8' ' ' ILE . 3.6 tp -150.09 164.67 34.97 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.416 -0.802 . . . . 0.0 110.744 -179.875 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.16 140.11 23.99 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.61 -0.681 . . . . 0.0 110.412 -179.773 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.406 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 132.79 -144.69 16.63 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.978 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -142.7 170.56 15.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.485 -1.009 . . . . 0.0 110.277 -179.942 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.7 m -144.06 161.39 38.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.64 -0.663 . . . . 0.0 110.188 179.991 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.8 p -144.54 151.09 38.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.543 -0.723 . . . . 0.0 110.41 -179.838 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.782 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.6 t -155.99 164.56 38.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.584 -0.698 . . . . 0.0 110.064 179.795 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -94.87 109.72 21.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.526 -0.733 . . . . 0.0 110.292 -179.959 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.47 143.15 47.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.612 -0.68 . . . . 0.0 109.95 179.9 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 23' ' ' ASP . 33.5 m -57.4 -38.84 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.451 -0.781 . . . . 0.0 110.232 179.808 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.455 ' N ' HG23 ' A' ' 22' ' ' VAL . 1.3 t0 -172.93 -170.2 0.63 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.623 -0.673 . . . . 0.0 109.771 179.58 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.419 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.48 -22.57 21.44 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.474 -0.766 . . . . 0.0 111.096 -179.673 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.64 -27.9 69.54 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.461 -0.774 . . . . 0.0 110.55 -179.738 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.7 m -114.37 -25.65 8.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.468 -0.77 . . . . 0.0 110.684 -179.63 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.739 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.77 -62.28 1.99 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.453 -0.779 . . . . 0.0 110.628 -179.708 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.86 -45.04 86.87 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.446 -0.784 . . . . 0.0 110.446 179.934 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -53.29 -44.03 67.96 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.391 -0.818 . . . . 0.0 110.727 -179.956 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.1 t -78.25 -48.88 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.54 -0.725 . . . . 0.0 109.983 179.74 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.782 ' CZ ' HG22 ' A' ' 19' ' ' THR . 3.9 m-85 -62.11 -31.16 71.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 110.238 -179.55 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -64.88 -39.38 93.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.393 -0.817 . . . . 0.0 108.92 179.262 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -61.88 -30.04 70.6 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.56 0.695 . . . . 0.0 109.704 179.083 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -73.18 -54.86 7.41 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.196 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.738 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -63.65 -48.78 75.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.738 -0.601 . . . . 0.0 110.149 179.974 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -55.95 -28.71 58.22 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.516 -0.74 . . . . 0.0 110.515 -179.897 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.62 -38.39 29.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.658 -0.651 . . . . 0.0 110.056 179.909 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -80.59 -34.41 35.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.56 -0.713 . . . . 0.0 110.058 179.927 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.54 49.13 0.61 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.906 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.738 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 85.1 mt -115.15 67.92 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.52 -0.988 . . . . 0.0 110.329 179.852 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -90.83 51.88 2.06 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.771 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.49 -139.14 2.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -178.957 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -114.83 108.53 16.87 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.356 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.515 ' CH2' HD11 ' A' ' 6' ' ' LEU . 46.0 m95 -77.14 142.08 39.87 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.1 0.953 . . . . 0.0 112.321 -177.985 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.1 p -147.49 133.1 18.79 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.752 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.413 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 71.7 t80 -100.49 131.97 46.13 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.712 -0.618 . . . . 0.0 110.454 -178.357 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -100.79 125.29 47.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.678 -0.639 . . . . 0.0 109.946 179.81 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -82.04 -18.49 43.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.69 -0.631 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.43 ' C ' HG23 ' A' ' 50' ' ' THR . . . -57.01 -44.74 83.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.271 -0.893 . . . . 0.0 110.725 -179.7 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.43 HG23 ' C ' ' A' ' 49' ' ' ALA . 70.2 p -147.37 23.81 1.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.519 -0.738 . . . . 0.0 110.65 -179.588 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.43 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 1.3 mppt? 52.42 95.38 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.239 -0.913 . . . . 0.0 110.727 179.953 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.547 HG23 ' HB3' ' A' ' 5' ' ' LYS . 90.7 m -151.76 101.79 2.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.53 -0.731 . . . . 0.0 110.749 -179.964 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.469 ' O ' HD23 ' A' ' 6' ' ' LEU . 81.4 m-85 -61.08 124.16 19.73 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.811 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.643 HG23 HG21 ' A' ' 7' ' ' ILE . 62.3 m -117.98 105.47 11.93 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.387 -0.925 . . . . 0.0 112.611 -178.197 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.571 HG11 HG21 ' A' ' 40' ' ' ILE . 10.8 p -105.87 168.04 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.42 -0.8 . . . . 0.0 109.128 177.538 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.471 ' N ' HG22 ' A' ' 55' ' ' VAL . 95.1 m -158.28 108.14 2.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.564 -0.71 . . . . 0.0 109.948 -179.676 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.17 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 mtm . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.079 0.466 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.581 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 70.4 m -102.18 111.99 24.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.573 -0.705 . . . . 0.0 110.184 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.0 m -78.67 99.57 6.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.639 -0.663 . . . . 0.0 110.76 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.71 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 73.2 m-85 -87.45 167.4 14.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.555 -0.716 . . . . 0.0 109.907 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.571 ' CG ' HG22 ' A' ' 18' ' ' THR . 3.6 mtpt -138.75 129.87 26.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.464 -0.772 . . . . 0.0 110.435 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.536 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 44.3 tp -106.5 123.06 47.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.509 -0.744 . . . . 0.0 110.209 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.616 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.6 tp -75.42 165.98 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.6 mt -127.89 72.66 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.225 -0.922 . . . . 0.0 110.676 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.522 ' HB3' HG23 ' A' ' 56' ' ' THR . 71.5 m-20 -95.38 49.19 1.18 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.274 -0.892 . . . . 0.0 109.029 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.69 166.5 14.96 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -84.89 6.35 25.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.724 -0.868 . . . . 0.0 110.608 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 m -116.84 -30.76 5.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 110.482 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.5 mt -135.71 173.11 12.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 110.783 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.38 139.38 3.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.66 -0.65 . . . . 0.0 110.294 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.37 -136.1 7.68 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -153.99 154.36 33.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.617 -0.931 . . . . 0.0 110.287 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.9 m -143.82 155.23 44.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.59 -0.694 . . . . 0.0 110.211 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.571 HG22 ' CG ' ' A' ' 5' ' ' LYS . 74.0 p -133.25 173.9 10.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.563 -0.711 . . . . 0.0 110.329 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.554 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.6 t -164.11 -170.32 2.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.64 -0.663 . . . . 0.0 110.167 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.56 100.11 6.09 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.639 -0.663 . . . . 0.0 110.4 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.84 142.69 50.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.465 -0.772 . . . . 0.0 110.01 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.81 -30.39 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.576 -0.702 . . . . 0.0 110.048 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.556 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 24.1 p30 -170.06 176.08 4.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.611 -0.681 . . . . 0.0 110.323 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.78 -25.15 26.15 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.515 -0.741 . . . . 0.0 110.969 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.556 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -60.06 -27.0 66.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.492 -0.755 . . . . 0.0 110.431 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.2 m -112.1 -27.99 8.16 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.499 -0.751 . . . . 0.0 110.364 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.71 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.69 -49.6 77.11 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.487 -0.758 . . . . 0.0 110.375 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -59.14 -40.19 84.72 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.541 -0.724 . . . . 0.0 110.309 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -56.94 -35.5 69.16 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.35 -0.844 . . . . 0.0 110.363 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 93.8 t -84.39 -48.19 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.601 -0.687 . . . . 0.0 110.056 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.554 ' CZ ' HG22 ' A' ' 19' ' ' THR . 9.7 m-85 -65.87 -36.82 84.5 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 110.206 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.1 tptt -63.44 -44.89 93.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.518 -0.739 . . . . 0.0 109.43 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -60.72 -31.57 70.87 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.609 0.718 . . . . 0.0 109.708 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -70.7 -57.14 4.99 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.735 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.33 -47.22 85.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.751 -0.593 . . . . 0.0 110.022 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -54.94 -32.95 61.81 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.474 -0.766 . . . . 0.0 110.591 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.42 -49.99 43.13 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.615 -0.678 . . . . 0.0 109.985 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -71.35 -46.34 60.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.569 -0.707 . . . . 0.0 109.886 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.47 43.26 0.29 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.735 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 81.1 mt -105.59 71.32 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.447 -1.031 . . . . 0.0 110.245 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -95.4 46.05 1.1 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.2 -135.85 0.1 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -115.47 102.19 9.58 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.536 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 38.3 m95 -72.56 142.42 48.44 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.177 0.989 . . . . 0.0 112.456 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -150.9 133.05 15.32 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.425 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 63.2 t80 -102.83 109.24 20.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.664 -0.648 . . . . 0.0 110.206 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.34 109.33 16.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.655 -0.653 . . . . 0.0 110.096 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -67.6 -20.61 65.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.693 -0.629 . . . . 0.0 110.767 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.39 -42.56 67.08 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.251 -0.906 . . . . 0.0 110.859 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.7 p -141.31 18.7 2.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.585 -0.697 . . . . 0.0 110.685 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.435 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER 50.31 90.35 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.151 -0.968 . . . . 0.0 111.152 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 57.6 m -156.59 108.46 2.48 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.789 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 93.1 m-85 -60.37 123.29 16.84 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.616 ' HA ' HG22 ' A' ' 7' ' ' ILE . 48.4 m -115.5 94.53 4.75 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.242 -0.983 . . . . 0.0 112.846 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.549 HG21 HG22 ' A' ' 40' ' ' ILE . 11.0 p -95.55 166.84 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.128 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.522 HG23 ' HB3' ' A' ' 9' ' ' ASN . 95.4 m -160.26 108.1 1.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.677 -0.639 . . . . 0.0 109.86 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.214 -179.922 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 mtm . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.122 0.487 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.684 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 22.4 m -79.63 145.53 32.99 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.556 -0.715 . . . . 0.0 110.091 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.8 m -118.22 91.24 3.51 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.593 -0.692 . . . . 0.0 110.524 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.71 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 98.6 m-85 -80.34 168.69 18.72 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.594 -0.691 . . . . 0.0 109.967 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -145.88 115.79 7.34 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.463 -0.773 . . . . 0.0 110.372 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.62 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 30.1 tp -94.11 127.18 39.78 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.422 -0.799 . . . . 0.0 110.2 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.655 HG21 HG23 ' A' ' 54' ' ' THR . 2.4 tp -76.47 170.12 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 16' ' ' GLU . 78.8 mt -129.99 71.13 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.22 -0.925 . . . . 0.0 110.715 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.538 ' HB3' HG23 ' A' ' 56' ' ' THR . 5.8 m-20 -96.15 47.25 1.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.506 -0.746 . . . . 0.0 109.22 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.43 167.0 24.47 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -82.32 3.12 29.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.76 -0.847 . . . . 0.0 110.754 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 m -116.88 -30.63 5.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.104 -0.997 . . . . 0.0 110.455 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.415 ' HB3' HG21 ' A' ' 8' ' ' ILE . 54.9 mt -128.7 172.48 11.2 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.455 -0.778 . . . . 0.0 110.694 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -154.99 131.76 10.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.696 -0.627 . . . . 0.0 109.932 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.71 -140.22 11.55 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.457 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.1 pt-20 -147.82 178.04 8.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.565 -0.962 . . . . 0.0 110.42 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.413 ' OG1' HD11 ' A' ' 8' ' ' ILE . 19.7 m -152.27 128.94 10.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.542 -0.724 . . . . 0.0 110.162 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.3 p -114.53 155.77 25.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.574 -0.704 . . . . 0.0 110.256 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.791 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.1 t -160.55 153.51 21.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.597 -0.689 . . . . 0.0 110.309 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -86.71 112.41 21.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.524 -0.735 . . . . 0.0 110.326 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.6 147.32 52.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.642 -0.661 . . . . 0.0 110.048 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 p -64.25 -33.58 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.531 -0.73 . . . . 0.0 110.227 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.617 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 27.2 p30 -170.86 -177.85 2.38 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.486 -0.759 . . . . 0.0 110.362 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -54.36 -25.24 23.18 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.477 -0.764 . . . . 0.0 111.003 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.617 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.24 -46.01 89.64 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.443 -0.785 . . . . 0.0 110.315 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.525 ' O ' HG23 ' A' ' 30' ' ' VAL . 34.5 m -90.2 -26.48 20.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.605 -0.684 . . . . 0.0 110.168 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.71 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.75 -62.32 1.96 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.55 -0.719 . . . . 0.0 110.217 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -60.36 -37.06 79.54 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.505 -0.747 . . . . 0.0 109.972 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.4 ttpt -58.42 -37.16 74.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.446 -0.783 . . . . 0.0 110.073 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 26' ' ' THR . 90.1 t -84.55 -45.84 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.689 -0.632 . . . . 0.0 109.786 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.791 ' CZ ' HG22 ' A' ' 19' ' ' THR . 14.0 m-85 -66.41 -34.01 77.0 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.636 -0.665 . . . . 0.0 110.207 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -66.15 -46.21 78.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.442 -0.786 . . . . 0.0 109.015 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -61.11 -30.91 70.65 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.634 0.73 . . . . 0.0 109.381 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -69.26 -55.74 9.62 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.708 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -63.07 -38.86 92.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.712 -0.617 . . . . 0.0 109.797 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -59.02 -34.05 71.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.528 -0.733 . . . . 0.0 110.357 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -78.03 -47.67 17.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.657 -0.652 . . . . 0.0 110.141 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -69.76 -41.91 74.57 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.593 -0.692 . . . . 0.0 110.087 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.34 62.54 0.4 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.708 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 87.0 mt -127.65 81.47 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.552 -0.97 . . . . 0.0 110.421 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -98.76 37.67 1.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.04 -140.24 0.02 OUTLIER Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -114.56 110.7 20.22 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.62 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 29.9 m95 -77.88 143.03 38.09 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 122.205 1.003 . . . . 0.0 112.364 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 44' ' ' TRP . 6.0 p -153.94 132.12 11.86 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -105.65 143.77 33.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.63 -0.669 . . . . 0.0 110.06 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.69 108.73 18.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.765 -0.584 . . . . 0.0 109.804 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.6 -23.03 65.33 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.638 -0.664 . . . . 0.0 110.62 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.442 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.23 -37.55 64.74 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.309 -0.87 . . . . 0.0 110.788 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.442 HG23 ' C ' ' A' ' 49' ' ' ALA . 72.5 p -147.79 19.04 1.15 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.518 -0.739 . . . . 0.0 110.766 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.443 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.6 94.56 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.204 -0.935 . . . . 0.0 110.886 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.9 m -159.1 100.72 1.56 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.559 -0.713 . . . . 0.0 110.791 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 91.0 m-85 -61.95 140.1 58.35 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.445 -0.785 . . . . 0.0 109.006 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.655 HG23 HG21 ' A' ' 7' ' ' ILE . 55.8 m -131.87 100.03 4.95 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.272 -0.971 . . . . 0.0 112.69 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.557 HG21 HG22 ' A' ' 40' ' ' ILE . 10.3 p -101.61 166.25 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.22 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.538 HG23 ' HB3' ' A' ' 9' ' ' ASN . 93.4 m -160.79 112.26 1.86 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.661 -0.649 . . . . 0.0 109.931 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 118.016 -0.993 . . . . 0.0 110.13 179.943 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.108 0.48 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.572 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 62.0 m -87.43 112.78 22.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.606 -0.684 . . . . 0.0 110.222 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.6 m -84.81 95.44 8.98 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.633 -0.667 . . . . 0.0 110.696 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.742 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 95.8 m-85 -79.77 173.99 12.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.48 -0.763 . . . . 0.0 109.778 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.529 ' CG ' HG22 ' A' ' 18' ' ' THR . 8.8 mtmt -142.67 123.26 14.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.486 -0.759 . . . . 0.0 110.658 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.607 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 47.4 tp -101.16 127.61 47.64 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.425 -0.797 . . . . 0.0 109.897 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.687 HG21 HG23 ' A' ' 54' ' ' THR . 2.8 tt -77.39 174.06 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.493 HG21 ' HB3' ' A' ' 13' ' ' LEU . 86.2 mt -133.14 73.33 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.32 -0.862 . . . . 0.0 110.444 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.543 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.5 m-20 -95.82 47.79 1.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.414 -0.804 . . . . 0.0 109.004 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.72 154.78 16.45 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -71.81 -9.1 57.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.704 -0.88 . . . . 0.0 110.396 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -90.31 -34.57 15.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 110.281 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.493 ' HB3' HG21 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -144.82 167.39 22.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.474 -0.766 . . . . 0.0 110.769 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -147.62 137.29 22.69 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.569 -0.707 . . . . 0.0 110.195 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.8 -136.81 8.7 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -146.97 168.64 20.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.53 -0.983 . . . . 0.0 110.326 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.2 m -143.45 149.87 38.22 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.638 -0.664 . . . . 0.0 110.125 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.529 HG22 ' CG ' ' A' ' 5' ' ' LYS . 20.8 p -131.41 157.66 42.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.534 -0.729 . . . . 0.0 110.297 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.79 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.6 t -160.98 168.12 25.17 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.566 -0.708 . . . . 0.0 110.235 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.26 124.22 44.16 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.602 -0.686 . . . . 0.0 110.145 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.03 138.15 20.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.6 -0.688 . . . . 0.0 110.181 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.49 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.8 p -60.08 -34.3 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.537 -0.727 . . . . 0.0 110.064 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.57 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 51.2 p30 -169.65 -173.91 1.75 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.61 -0.681 . . . . 0.0 110.306 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.85 -23.83 47.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.594 -0.691 . . . . 0.0 110.932 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.57 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.09 -31.49 68.95 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.395 -0.816 . . . . 0.0 110.36 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.548 ' O ' HG23 ' A' ' 30' ' ' VAL . 52.2 m -110.66 -24.3 10.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.57 -0.706 . . . . 0.0 110.447 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.742 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.27 -62.11 2.08 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.425 -0.797 . . . . 0.0 110.23 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -60.2 -39.8 87.82 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.555 -0.716 . . . . 0.0 109.903 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -57.64 -37.22 72.96 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.469 -0.769 . . . . 0.0 110.236 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 26' ' ' THR . 98.4 t -83.42 -48.64 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.699 -0.626 . . . . 0.0 109.871 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.79 ' CZ ' HG22 ' A' ' 19' ' ' THR . 5.4 m-85 -64.39 -34.11 77.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.551 -0.718 . . . . 0.0 110.11 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -64.61 -44.03 91.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.482 -0.761 . . . . 0.0 109.166 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -60.99 -35.36 76.62 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.84 0.829 . . . . 0.0 109.474 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -65.24 -53.54 42.84 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.702 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -63.91 -40.97 97.73 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.715 -0.615 . . . . 0.0 110.048 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -57.32 -39.83 76.66 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.56 -0.712 . . . . 0.0 110.451 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.71 -56.63 11.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.581 -0.699 . . . . 0.0 110.01 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -64.34 -51.35 63.81 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.588 -0.695 . . . . 0.0 109.903 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.92 55.84 0.16 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.702 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 82.0 mt -118.72 73.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.53 -0.982 . . . . 0.0 110.278 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -95.64 43.2 1.09 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.57 -137.08 0.07 OUTLIER Glycine 0 N--CA 1.488 2.127 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -114.6 107.63 15.75 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.607 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 35.0 m95 -77.26 143.51 38.85 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.055 0.931 . . . . 0.0 112.359 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 44' ' ' TRP . 3.6 p -152.65 132.01 12.87 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.412 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 31.0 t80 -102.36 124.91 48.77 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.717 -0.615 . . . . 0.0 110.083 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -95.05 113.57 25.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.689 -0.632 . . . . 0.0 109.975 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.51 -15.09 63.18 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.672 -0.643 . . . . 0.0 110.928 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.437 ' C ' HG23 ' A' ' 50' ' ' THR . . . -56.46 -44.34 80.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.222 -0.924 . . . . 0.0 110.719 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.437 HG23 ' C ' ' A' ' 49' ' ' ALA . 68.6 p -147.59 25.11 1.08 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.494 -0.754 . . . . 0.0 110.628 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.456 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.44 89.87 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.357 -0.839 . . . . 0.0 110.841 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 83.2 m -150.46 101.76 2.99 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.478 -0.764 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.471 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 85.6 m-85 -61.98 127.84 33.31 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.448 -0.783 . . . . 0.0 108.939 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.687 HG23 HG21 ' A' ' 7' ' ' ILE . 55.6 m -121.06 101.5 7.71 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.338 -0.945 . . . . 0.0 113.027 -178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.531 HG21 HG22 ' A' ' 40' ' ' ILE . 11.3 p -101.07 167.85 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 108.981 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.543 HG23 ' HB3' ' A' ' 9' ' ' ASN . 98.5 m -159.82 109.14 1.81 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.521 -0.737 . . . . 0.0 109.977 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.185 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.047 0.451 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.53 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 33.7 m -92.27 116.01 28.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.53 -0.731 . . . . 0.0 110.424 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.7 m -97.77 97.48 9.02 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.607 -0.683 . . . . 0.0 110.552 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.817 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 95.2 m-85 -78.65 175.88 9.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.544 -0.723 . . . . 0.0 109.753 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.431 ' HB3' HG23 ' A' ' 52' ' ' THR . 23.8 tttt -144.51 119.6 10.08 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.401 -0.812 . . . . 0.0 110.621 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.632 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 42.6 tp -100.04 130.67 46.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.298 -0.876 . . . . 0.0 110.48 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.612 HG22 ' HA ' ' A' ' 54' ' ' THR . 3.6 tp -80.36 168.24 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 13' ' ' LEU . 79.7 mt -129.41 74.76 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 111.007 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.436 ' HB3' HG23 ' A' ' 56' ' ' THR . 97.2 m-20 -97.65 47.8 1.02 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.322 -0.861 . . . . 0.0 108.924 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.03 165.94 15.39 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -85.6 6.83 25.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.702 -0.881 . . . . 0.0 110.444 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -113.46 -31.96 6.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.921 . . . . 0.0 109.989 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.467 ' O ' HG22 ' A' ' 8' ' ' ILE . 2.1 tp -140.43 167.44 22.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.558 -0.714 . . . . 0.0 110.375 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -155.26 140.62 17.69 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.592 -0.692 . . . . 0.0 110.323 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.69 -134.64 7.58 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.54 161.7 42.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.621 -0.929 . . . . 0.0 110.386 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.3 m -145.81 151.1 37.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.634 -0.666 . . . . 0.0 110.068 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 p -130.76 157.1 43.75 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.568 -0.708 . . . . 0.0 110.282 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.41 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.3 t -149.29 -172.05 4.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.562 -0.711 . . . . 0.0 110.252 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -123.85 103.94 8.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.486 -0.759 . . . . 0.0 110.249 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.761 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -129.02 153.47 47.56 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.56 -0.712 . . . . 0.0 110.116 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.54 -22.2 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.573 -0.705 . . . . 0.0 110.46 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.566 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 44.2 p30 -172.35 -177.92 1.9 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.316 -0.865 . . . . 0.0 110.203 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.406 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.45 -24.57 20.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.523 -0.736 . . . . 0.0 111.064 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.566 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.49 -52.13 66.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.463 -0.773 . . . . 0.0 110.479 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.761 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 31.1 m -80.6 -26.52 37.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.571 -0.705 . . . . 0.0 110.509 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.817 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.93 -64.03 1.09 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.498 -0.751 . . . . 0.0 110.495 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -60.13 -40.02 88.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.532 -0.73 . . . . 0.0 110.115 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -57.1 -38.39 73.31 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.456 -0.778 . . . . 0.0 110.313 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 26' ' ' THR . 87.7 t -83.06 -48.61 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.614 -0.679 . . . . 0.0 109.922 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.502 ' HB3' HD22 ' A' ' 6' ' ' LEU . 9.1 m-85 -63.63 -34.09 77.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.614 -0.679 . . . . 0.0 110.112 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -64.31 -45.84 86.17 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.461 -0.774 . . . . 0.0 109.095 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -62.15 -29.2 70.18 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.601 0.715 . . . . 0.0 109.618 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -72.15 -54.2 10.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.755 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.52 -38.6 84.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.672 -0.642 . . . . 0.0 110.293 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -58.21 -38.52 76.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.483 -0.76 . . . . 0.0 110.667 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -68.33 -38.88 81.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.573 -0.704 . . . . 0.0 110.26 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -81.94 -32.7 30.69 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.603 -0.686 . . . . 0.0 110.109 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.75 48.3 1.28 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.755 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 81.7 mt -104.53 62.84 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.584 -0.95 . . . . 0.0 110.225 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -83.01 59.73 5.08 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.11 -141.53 10.23 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -113.54 109.55 18.81 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.894 -0.768 . . . . 0.0 109.029 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.632 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 32.9 m95 -78.44 143.38 36.77 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.064 0.935 . . . . 0.0 112.178 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 44' ' ' TRP . 7.6 p -155.1 132.78 11.31 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -103.0 158.76 16.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.652 -0.655 . . . . 0.0 110.167 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.03 111.99 12.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.834 -0.541 . . . . 0.0 109.66 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.98 -20.18 65.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.692 -0.63 . . . . 0.0 110.814 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.435 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.77 -41.08 70.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.296 -0.878 . . . . 0.0 110.746 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.435 HG23 ' C ' ' A' ' 49' ' ' ALA . 69.6 p -147.7 20.72 1.16 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.563 -0.71 . . . . 0.0 110.757 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.439 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.65 89.6 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.217 -0.927 . . . . 0.0 110.72 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.431 HG23 ' HB3' ' A' ' 5' ' ' LYS . 7.0 m -151.1 102.96 2.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.349 -0.844 . . . . 0.0 111.516 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.541 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 73.3 m-85 -64.13 133.77 53.6 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.612 ' HA ' HG22 ' A' ' 7' ' ' ILE . 71.1 m -125.94 100.43 6.37 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.766 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.562 HG11 HG21 ' A' ' 40' ' ' ILE . 11.5 p -103.26 166.97 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.371 -0.831 . . . . 0.0 109.171 177.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.474 ' N ' HG22 ' A' ' 55' ' ' VAL . 97.3 m -160.3 110.75 1.84 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.655 -0.653 . . . . 0.0 109.782 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.182 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtm . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.067 0.461 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.579 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 62.0 m -74.02 111.77 9.5 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.57 -0.706 . . . . 0.0 110.211 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.4 m -85.7 95.01 9.24 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.642 -0.661 . . . . 0.0 110.596 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.796 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.4 m-85 -77.81 176.08 9.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.44 -0.788 . . . . 0.0 109.735 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -142.79 124.94 15.36 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.499 -0.751 . . . . 0.0 110.383 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.583 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 54.4 tp -104.02 118.82 37.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.454 -0.779 . . . . 0.0 110.204 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.698 HG21 HG23 ' A' ' 54' ' ' THR . 2.7 tp -68.84 171.16 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.426 HD11 ' OG1' ' A' ' 17' ' ' THR . 81.1 mt -131.48 74.98 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.228 -0.92 . . . . 0.0 110.597 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.512 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.3 m-20 -98.01 45.99 1.02 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.76 164.63 15.32 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -81.94 1.48 35.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.777 -0.837 . . . . 0.0 110.491 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.4 m -108.43 -31.41 7.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.206 -0.934 . . . . 0.0 110.152 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.568 HD11 ' OD1' ' A' ' 38' ' ' ASN . 50.1 mt -137.53 168.58 19.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.466 -0.771 . . . . 0.0 110.608 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -154.76 134.02 12.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.655 -0.653 . . . . 0.0 110.015 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.72 -143.7 15.13 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -135.71 160.58 38.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.539 -0.977 . . . . 0.0 110.3 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.426 ' OG1' HD11 ' A' ' 8' ' ' ILE . 17.5 m -135.53 158.62 43.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.541 -0.724 . . . . 0.0 110.116 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.9 p -142.99 154.53 44.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.58 -0.7 . . . . 0.0 110.431 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.767 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.7 t -159.77 159.55 32.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.608 -0.683 . . . . 0.0 110.228 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -93.19 121.07 34.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.552 -0.718 . . . . 0.0 110.183 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.27 138.39 23.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.582 -0.699 . . . . 0.0 110.174 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.8 m -59.31 -32.59 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.508 -0.745 . . . . 0.0 110.445 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.669 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 24.8 p30 -171.01 -178.24 2.42 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.586 -0.696 . . . . 0.0 110.319 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -54.79 -25.25 26.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.474 -0.766 . . . . 0.0 110.962 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.669 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.19 -26.53 64.89 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.488 -0.758 . . . . 0.0 110.374 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.4 m -113.82 -25.75 8.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.518 -0.739 . . . . 0.0 110.556 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.796 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.11 -60.76 3.25 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.417 -0.802 . . . . 0.0 110.408 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -59.88 -35.76 75.51 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.601 -0.687 . . . . 0.0 110.266 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -57.65 -38.99 76.0 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.401 -0.812 . . . . 0.0 110.189 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.0 t -83.79 -47.44 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.667 -0.646 . . . . 0.0 109.816 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.767 ' CZ ' HG22 ' A' ' 19' ' ' THR . 8.0 m-85 -62.68 -34.98 78.22 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.577 -0.702 . . . . 0.0 109.906 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -64.03 -46.94 82.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.409 -0.807 . . . . 0.0 109.084 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -62.15 -31.92 72.47 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.698 0.761 . . . . 0.0 109.472 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -68.16 -50.35 55.11 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.743 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -68.13 -37.25 80.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.764 -0.585 . . . . 0.0 109.929 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -58.06 -46.75 84.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.577 -0.702 . . . . 0.0 110.533 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -60.59 -56.95 15.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.579 -0.701 . . . . 0.0 110.324 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.568 ' OD1' HD11 ' A' ' 13' ' ' LEU . 53.7 m-80 -63.71 -45.93 87.73 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.58 -0.7 . . . . 0.0 110.136 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.97 63.07 0.39 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.743 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 85.5 mt -118.04 63.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.528 -0.984 . . . . 0.0 110.133 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -83.31 59.54 5.08 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.82 -138.77 7.2 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -115.97 106.27 13.59 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.583 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 37.3 m95 -76.5 142.36 40.95 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.212 1.005 . . . . 0.0 112.419 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -150.3 132.18 15.12 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.413 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 18.9 t80 -105.75 133.7 50.05 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.625 -0.672 . . . . 0.0 110.072 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -103.6 112.9 26.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.712 -0.618 . . . . 0.0 109.922 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -69.29 -23.05 63.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.647 -0.658 . . . . 0.0 110.561 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.98 -40.87 67.27 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.317 -0.864 . . . . 0.0 110.721 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.5 p -145.06 18.43 1.59 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.576 -0.702 . . . . 0.0 110.863 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HG3' ' CE2' ' A' ' 46' ' ' TYR . 5.0 mptt 51.24 92.71 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.177 -0.952 . . . . 0.0 111.084 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.6 m -154.42 101.58 2.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.483 -0.761 . . . . 0.0 110.707 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -62.0 129.22 39.89 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.557 -0.714 . . . . 0.0 109.095 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.698 HG23 HG21 ' A' ' 7' ' ' ILE . 75.7 m -121.34 100.81 7.25 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.649 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.599 HG11 HG21 ' A' ' 40' ' ' ILE . 10.6 p -101.24 167.25 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.526 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.512 HG23 ' HB3' ' A' ' 9' ' ' ASN . 89.4 m -160.8 109.05 1.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.698 -0.626 . . . . 0.0 109.784 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.19 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.0 mtm . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.146 0.498 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.595 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 32.1 m -85.39 115.7 23.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.585 -0.697 . . . . 0.0 110.362 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.0 m -93.79 97.61 10.53 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.61 -0.681 . . . . 0.0 110.874 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.595 ' CZ ' HG21 ' A' ' 2' ' ' THR . 92.9 m-85 -81.85 171.26 14.7 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.466 -0.771 . . . . 0.0 109.839 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.44 ' O ' HG23 ' A' ' 52' ' ' THR . 10.5 mttt -144.04 122.33 12.29 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.506 -0.746 . . . . 0.0 110.41 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.545 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 49.4 tp -99.49 123.94 44.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.558 -0.714 . . . . 0.0 110.141 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.606 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.9 tp -76.38 166.39 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.526 HD12 ' N ' ' A' ' 16' ' ' GLU . 81.0 mt -128.58 74.76 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.213 -0.93 . . . . 0.0 110.488 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.651 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.9 m-20 -95.57 47.95 1.13 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.414 -0.804 . . . . 0.0 108.901 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.94 151.85 17.61 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -71.14 -9.41 58.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.656 -0.908 . . . . 0.0 110.4 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 m -89.03 -36.13 15.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.43 174.58 10.81 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.455 -0.778 . . . . 0.0 110.59 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.3 tttt -156.24 144.42 19.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.697 . . . . 0.0 110.403 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.65 -123.05 3.23 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.526 ' N ' HD12 ' A' ' 8' ' ' ILE . 12.3 tt0 -164.77 166.88 19.46 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.566 -0.961 . . . . 0.0 110.101 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 m -135.63 148.31 48.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.541 -0.725 . . . . 0.0 110.231 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.7 p -137.78 146.44 43.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.541 -0.724 . . . . 0.0 110.245 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.671 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.2 t -163.76 134.26 4.38 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.596 -0.69 . . . . 0.0 110.141 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.05 112.1 2.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.561 -0.712 . . . . 0.0 110.29 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.472 ' HB3' ' HD2' ' A' ' 4' ' ' PHE . . . -129.88 137.58 50.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.495 -0.753 . . . . 0.0 110.176 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.594 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.3 p -60.02 -32.4 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.53 -0.731 . . . . 0.0 110.25 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.594 ' OD1' HG13 ' A' ' 22' ' ' VAL . 51.8 p-10 -171.68 174.86 4.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.454 -0.779 . . . . 0.0 110.294 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.436 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.87 -24.82 17.17 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.54 -0.725 . . . . 0.0 110.928 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.24 -38.87 92.85 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.49 -0.757 . . . . 0.0 110.097 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.9 m -93.35 -27.6 16.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.525 -0.734 . . . . 0.0 110.358 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.697 ' HB1' ' HE2' ' A' ' 31' ' ' PHE . . . -66.41 -52.35 47.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.526 -0.734 . . . . 0.0 110.448 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.48 -37.47 70.39 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.499 -0.751 . . . . 0.0 110.549 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -60.31 -33.48 72.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.41 -0.806 . . . . 0.0 109.787 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.6 t -87.32 -44.19 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.651 . . . . 0.0 109.564 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.697 ' HE2' ' HB1' ' A' ' 27' ' ' ALA . 30.1 m-85 -66.28 -39.02 89.13 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.627 -0.671 . . . . 0.0 109.767 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -62.81 -50.9 69.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.608 -0.683 . . . . 0.0 109.551 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -61.26 -31.17 70.98 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.607 0.718 . . . . 0.0 109.63 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -68.55 -46.45 69.47 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.601 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -72.78 -38.67 67.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.739 -0.6 . . . . 0.0 109.91 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -58.76 -49.24 78.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.538 -0.726 . . . . 0.0 110.393 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -61.54 -56.05 24.28 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.683 -0.635 . . . . 0.0 110.123 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -60.91 -48.38 82.08 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.602 -0.686 . . . . 0.0 110.108 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.36 49.61 0.27 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.601 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.7 mt -117.65 75.47 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.515 -0.991 . . . . 0.0 110.398 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -98.36 39.95 1.21 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.88 -137.83 0.02 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -113.27 112.6 24.01 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.545 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 29.9 m95 -81.89 142.88 32.09 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.213 1.006 . . . . 0.0 112.686 -177.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 44' ' ' TRP . 2.4 p -152.68 131.28 12.27 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -100.59 108.41 20.32 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.742 -0.599 . . . . 0.0 109.997 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -78.53 100.4 6.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.698 -0.626 . . . . 0.0 109.967 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -62.34 -24.59 67.42 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.714 -0.616 . . . . 0.0 110.439 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.427 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.07 -34.03 54.73 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.371 -0.831 . . . . 0.0 111.043 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.427 HG23 ' C ' ' A' ' 49' ' ' ALA . 75.8 p -147.15 17.67 1.21 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.523 -0.736 . . . . 0.0 110.905 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER 50.55 87.0 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.117 -0.989 . . . . 0.0 111.066 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 5' ' ' LYS . 60.6 m -155.17 108.56 2.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.536 -0.727 . . . . 0.0 110.755 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 83.5 m-85 -61.14 126.16 26.35 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.606 ' HA ' HG22 ' A' ' 7' ' ' ILE . 44.7 m -118.83 96.6 5.32 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.223 -0.991 . . . . 0.0 113.079 -178.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.531 HG21 HG22 ' A' ' 40' ' ' ILE . 11.0 p -100.01 167.12 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 109.19 177.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.651 HG23 ' HB3' ' A' ' 9' ' ' ASN . 84.9 m -160.64 109.38 1.65 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.588 -0.695 . . . . 0.0 109.814 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.062 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 mtp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.116 0.484 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.484 HG22 ' CE2' ' A' ' 4' ' ' PHE . 47.5 m -104.65 112.66 25.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.603 -0.685 . . . . 0.0 110.069 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 59.4 m -104.27 98.74 8.49 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.641 -0.662 . . . . 0.0 110.731 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.77 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 86.4 m-85 -78.57 172.35 13.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.546 -0.721 . . . . 0.0 109.831 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.582 ' HG2' HG22 ' A' ' 18' ' ' THR . 22.7 mttm -142.22 121.23 12.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.488 -0.757 . . . . 0.0 110.335 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.546 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 53.8 tp -100.87 118.24 36.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.434 -0.791 . . . . 0.0 110.338 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.601 HG22 ' HA ' ' A' ' 54' ' ' THR . 5.1 tp -66.91 168.19 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.536 HD11 ' OG1' ' A' ' 17' ' ' THR . 79.7 mt -130.63 74.37 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.181 -0.949 . . . . 0.0 110.711 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.588 ' HB3' HG23 ' A' ' 56' ' ' THR . 3.0 m-20 -96.11 48.91 1.12 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.81 157.35 15.01 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -74.54 -6.29 47.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.71 -0.876 . . . . 0.0 110.632 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -97.18 -33.83 11.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.247 -0.908 . . . . 0.0 110.275 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.421 ' HB3' HG21 ' A' ' 8' ' ' ILE . 45.5 mt -137.34 170.73 15.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.539 -0.725 . . . . 0.0 110.454 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -157.21 134.33 10.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.539 -0.726 . . . . 0.0 110.273 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.13 -144.42 16.36 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.455 ' HG2' HD12 ' A' ' 7' ' ' ILE . 11.2 mt-10 -136.18 153.34 51.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.598 -0.942 . . . . 0.0 110.244 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.536 ' OG1' HD11 ' A' ' 8' ' ' ILE . 5.2 m -130.93 147.83 52.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.704 . . . . 0.0 110.052 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.582 HG22 ' HG2' ' A' ' 5' ' ' LYS . 67.0 p -129.35 165.64 21.1 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.555 -0.716 . . . . 0.0 110.303 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.4 t -156.42 -176.24 5.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.695 . . . . 0.0 110.119 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.81 92.95 3.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.556 -0.715 . . . . 0.0 110.421 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.65 179.54 4.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.421 -0.799 . . . . 0.0 110.088 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -100.43 -25.55 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.615 -0.678 . . . . 0.0 110.02 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -167.81 176.25 6.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.507 -0.746 . . . . 0.0 110.014 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.97 -25.42 60.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.471 -0.768 . . . . 0.0 110.789 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.0 -25.43 65.26 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.467 -0.771 . . . . 0.0 110.752 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.6 m -111.95 -27.46 8.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.376 -0.827 . . . . 0.0 110.66 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.77 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.74 -54.48 44.71 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.516 -0.74 . . . . 0.0 110.461 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -57.44 -39.3 75.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.525 -0.735 . . . . 0.0 110.697 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -56.41 -36.74 69.28 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.274 -0.891 . . . . 0.0 110.588 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.5 t -84.88 -47.59 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.606 -0.684 . . . . 0.0 109.975 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.501 ' HB3' HD22 ' A' ' 6' ' ' LEU . 8.8 m-85 -65.08 -37.22 86.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.584 -0.698 . . . . 0.0 110.135 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -63.65 -45.01 92.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.465 -0.772 . . . . 0.0 109.177 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -62.88 -29.0 70.42 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.537 0.684 . . . . 0.0 109.616 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -73.0 -47.39 45.58 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -73.61 -35.78 65.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.691 -0.63 . . . . 0.0 109.766 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -56.05 -49.6 73.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.528 -0.733 . . . . 0.0 110.599 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -69.45 -46.9 65.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.642 -0.661 . . . . 0.0 109.986 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -61.53 -42.05 98.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.571 -0.706 . . . . 0.0 110.023 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.54 50.18 0.82 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.757 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 86.1 mt -110.64 61.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.538 -0.978 . . . . 0.0 110.173 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -81.45 60.6 4.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.533 -0.729 . . . . 0.0 109.166 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.6 -139.04 7.77 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -116.38 107.1 14.38 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.546 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 37.2 m95 -77.3 143.46 38.83 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.19 0.995 . . . . 0.0 112.374 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 44' ' ' TRP . 3.3 p -154.43 131.01 10.64 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -104.62 138.51 40.85 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.643 -0.661 . . . . 0.0 109.959 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -114.28 116.62 29.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.689 -0.632 . . . . 0.0 109.937 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -70.31 -25.19 63.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.725 -0.609 . . . . 0.0 110.566 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.05 -38.32 56.68 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.41 -0.806 . . . . 0.0 110.757 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.7 p -142.75 13.34 1.9 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.625 -0.672 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.08 90.74 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.079 -1.013 . . . . 0.0 111.013 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 5' ' ' LYS . 56.2 m -157.35 110.0 2.46 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.325 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 87.3 m-85 -64.24 129.05 38.42 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.601 ' HA ' HG22 ' A' ' 7' ' ' ILE . 47.6 m -119.96 99.03 6.38 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.193 -1.003 . . . . 0.0 112.904 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.567 HG11 HG21 ' A' ' 40' ' ' ILE . 9.3 p -102.85 165.74 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.469 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.588 HG23 ' HB3' ' A' ' 9' ' ' ASN . 85.9 m -162.31 114.49 1.67 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.767 -0.583 . . . . 0.0 109.909 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.089 179.715 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.052 0.453 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.601 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 21.1 m -87.0 112.91 22.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.529 -0.732 . . . . 0.0 110.256 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.6 m -90.89 88.48 7.06 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.701 -0.625 . . . . 0.0 110.637 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.798 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.6 m-85 -71.15 167.94 18.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.457 -0.777 . . . . 0.0 109.909 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -136.19 132.89 36.52 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.496 -0.753 . . . . 0.0 110.254 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.595 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 58.1 tp -109.41 117.57 34.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.355 -0.841 . . . . 0.0 110.316 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.676 HD12 ' CG ' ' A' ' 16' ' ' GLU . 4.1 tp -66.57 171.1 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.445 HG21 ' HB3' ' A' ' 13' ' ' LEU . 78.2 mt -133.84 74.93 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 110.717 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -96.58 47.58 1.07 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.348 -0.845 . . . . 0.0 108.912 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.21 153.99 16.91 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.85 -9.45 57.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.929 . . . . 0.0 110.631 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.6 m -92.14 -32.6 15.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.182 -0.949 . . . . 0.0 110.432 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.445 ' HB3' HG21 ' A' ' 8' ' ' ILE . 34.0 mt -142.21 170.23 16.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.374 -0.828 . . . . 0.0 110.768 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -153.97 136.51 15.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.68 -0.637 . . . . 0.0 110.294 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.14 -147.24 18.04 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.676 ' CG ' HD12 ' A' ' 7' ' ' ILE . 9.6 mt-10 -139.08 162.73 34.23 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.597 -0.943 . . . . 0.0 110.264 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.45 HG22 ' N ' ' A' ' 18' ' ' THR . 27.4 m -140.11 168.54 19.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.585 -0.697 . . . . 0.0 110.221 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.45 ' N ' HG22 ' A' ' 17' ' ' THR . 40.2 p -137.65 168.32 19.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.512 -0.742 . . . . 0.0 110.175 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.484 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.2 t -158.9 -173.2 4.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.599 -0.688 . . . . 0.0 110.36 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -126.95 96.91 4.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.538 -0.726 . . . . 0.0 110.079 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.717 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -130.28 140.17 50.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.57 -0.706 . . . . 0.0 110.134 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.605 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.3 p -60.86 -29.68 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.624 -0.672 . . . . 0.0 110.002 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.605 ' OD1' HG13 ' A' ' 22' ' ' VAL . 42.6 p-10 -167.42 -178.24 3.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.678 . . . . 0.0 110.286 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.437 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.88 -24.82 39.49 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.508 -0.745 . . . . 0.0 110.968 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.88 -29.6 68.44 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.486 -0.759 . . . . 0.0 110.32 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.717 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 7.5 m -107.5 -26.53 10.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.575 -0.703 . . . . 0.0 110.394 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.798 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.3 -63.45 1.3 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.434 -0.791 . . . . 0.0 110.413 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -58.26 -36.81 73.81 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.481 -0.762 . . . . 0.0 110.126 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -57.6 -38.42 74.88 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.437 -0.789 . . . . 0.0 110.07 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 26' ' ' THR . 91.0 t -83.93 -48.09 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.662 -0.649 . . . . 0.0 109.726 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.484 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.1 m-85 -61.97 -35.12 77.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.648 -0.658 . . . . 0.0 109.91 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -63.97 -46.02 86.51 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.563 -0.711 . . . . 0.0 109.086 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -62.31 -31.91 72.59 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.628 0.727 . . . . 0.0 109.403 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -69.31 -54.3 15.27 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.697 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.17 -40.25 95.73 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.698 -0.626 . . . . 0.0 109.827 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.59 -42.25 87.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.573 -0.705 . . . . 0.0 110.451 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.42 -52.22 28.97 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.605 -0.685 . . . . 0.0 110.017 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -63.75 -50.37 69.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.596 -0.69 . . . . 0.0 109.922 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.24 58.53 0.18 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.697 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.9 mt -125.56 67.18 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.472 -1.017 . . . . 0.0 110.401 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -89.81 53.56 2.6 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.83 -138.33 3.08 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.63 110.92 21.36 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.982 -0.716 . . . . 0.0 109.384 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.595 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 32.9 m95 -81.47 143.56 31.99 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 122.131 0.967 . . . . 0.0 112.228 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 44' ' ' TRP . 2.1 p -154.0 132.05 11.75 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.419 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 25.3 t80 -105.35 129.0 53.78 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.657 -0.652 . . . . 0.0 110.166 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -102.16 120.34 40.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.716 -0.615 . . . . 0.0 109.981 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -73.04 -20.14 61.04 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.665 -0.647 . . . . 0.0 110.678 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.87 -41.18 67.25 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.314 -0.866 . . . . 0.0 110.861 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.6 p -144.9 18.21 1.61 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.57 -0.706 . . . . 0.0 110.744 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.419 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 0.7 OUTLIER 51.31 93.19 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.16 -0.962 . . . . 0.0 110.78 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.7 m -157.19 106.42 2.18 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.175 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -63.94 127.33 30.91 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.642 HG23 HG21 ' A' ' 7' ' ' ILE . 88.9 m -117.17 104.2 10.96 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.344 -0.848 . . . . 0.0 112.597 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.557 HG21 HG22 ' A' ' 40' ' ' ILE . 11.4 p -105.21 167.11 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.846 . . . . 0.0 109.207 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.472 ' N ' HG22 ' A' ' 55' ' ' VAL . 97.8 m -160.8 108.04 1.52 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.724 -0.61 . . . . 0.0 109.714 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.182 -179.862 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tpp . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.0 0.429 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.505 HG22 ' CE2' ' A' ' 4' ' ' PHE . 57.9 m -91.09 112.54 24.49 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.579 -0.701 . . . . 0.0 110.167 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.0 m -104.76 104.43 14.22 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.567 -0.708 . . . . 0.0 110.617 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.708 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 77.3 m-85 -84.82 178.52 7.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.54 -0.725 . . . . 0.0 109.742 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 52' ' ' THR . 23.4 ttpt -149.56 109.67 4.13 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.445 -0.785 . . . . 0.0 110.644 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.54 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 58.1 tp -90.6 121.37 32.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.414 -0.804 . . . . 0.0 110.324 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.64 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.9 tp -72.0 168.23 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.485 HD12 ' N ' ' A' ' 16' ' ' GLU . 75.4 mt -130.05 72.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.208 -0.933 . . . . 0.0 110.796 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.558 ' HB3' HG23 ' A' ' 56' ' ' THR . 37.3 m-20 -96.93 49.18 1.07 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.472 -0.768 . . . . 0.0 109.174 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.14 165.42 13.2 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.01 2.66 29.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.593 -0.946 . . . . 0.0 110.732 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -111.98 -29.27 7.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.119 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.695 HD11 ' OD1' ' A' ' 38' ' ' ASN . 80.1 mt -135.6 166.26 23.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.477 -0.764 . . . . 0.0 110.609 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -154.05 132.29 11.89 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.696 -0.627 . . . . 0.0 110.161 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.09 -129.82 5.07 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.485 ' N ' HD12 ' A' ' 8' ' ' ILE . 6.4 pt-20 -159.25 152.44 22.3 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.581 -0.953 . . . . 0.0 110.592 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.4 m -125.5 154.12 42.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.616 -0.677 . . . . 0.0 110.068 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 p -139.5 150.87 45.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.457 -0.777 . . . . 0.0 110.391 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.673 HG22 ' CE2' ' A' ' 31' ' ' PHE . 8.4 t -153.12 147.66 26.07 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.616 -0.677 . . . . 0.0 110.202 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -85.04 112.65 20.82 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.506 -0.746 . . . . 0.0 110.381 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.86 -171.15 2.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.498 -0.751 . . . . 0.0 110.032 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -109.46 -27.2 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.618 -0.676 . . . . 0.0 110.067 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -170.13 173.8 5.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.464 -0.772 . . . . 0.0 110.185 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.2 -26.25 64.67 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.571 -0.705 . . . . 0.0 110.715 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.37 -26.56 65.19 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.463 -0.773 . . . . 0.0 110.621 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.4 m -109.45 -32.54 7.11 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.5 -0.75 . . . . 0.0 110.31 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.708 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.15 -52.61 64.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.5 -0.75 . . . . 0.0 110.427 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -59.15 -43.17 92.03 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.518 -0.739 . . . . 0.0 110.302 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -57.52 -34.75 69.44 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.369 -0.832 . . . . 0.0 110.319 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 83.6 t -84.99 -48.44 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.585 -0.697 . . . . 0.0 109.84 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.673 ' CE2' HG22 ' A' ' 19' ' ' THR . 3.9 m-85 -65.39 -36.09 82.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.594 -0.691 . . . . 0.0 110.183 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -63.87 -46.59 84.26 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.477 -0.764 . . . . 0.0 109.341 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -59.9 -30.71 69.2 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.541 0.686 . . . . 0.0 109.822 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -70.33 -52.69 20.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.687 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.18 -38.49 91.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.701 -0.624 . . . . 0.0 110.042 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -57.14 -45.89 83.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.45 -0.781 . . . . 0.0 110.563 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.83 -49.89 54.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.612 -0.68 . . . . 0.0 110.02 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.695 ' OD1' HD11 ' A' ' 13' ' ' LEU . 15.8 m-80 -62.5 -42.88 99.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.613 -0.679 . . . . 0.0 110.032 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.51 47.83 0.53 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.687 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 83.6 mt -119.07 74.58 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.53 -0.983 . . . . 0.0 110.409 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -97.78 39.69 1.2 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.67 -138.01 0.03 OUTLIER Glycine 0 N--CA 1.488 2.159 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -112.24 112.49 24.12 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.54 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 29.6 m95 -82.38 143.86 30.93 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.24 1.019 . . . . 0.0 112.499 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 44' ' ' TRP . 2.4 p -155.24 131.89 10.55 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -102.09 128.65 48.47 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.644 -0.66 . . . . 0.0 110.263 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -99.78 104.57 16.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.673 -0.642 . . . . 0.0 109.866 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -64.52 -21.45 66.68 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.594 -0.691 . . . . 0.0 110.881 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.428 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.29 -38.41 63.1 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.286 -0.884 . . . . 0.0 110.788 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.428 HG23 ' C ' ' A' ' 49' ' ' ALA . 74.3 p -147.65 21.12 1.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.607 -0.683 . . . . 0.0 110.617 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER 50.27 90.83 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.211 -0.931 . . . . 0.0 111.129 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 5' ' ' LYS . 88.4 m -155.29 103.59 2.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.523 -0.735 . . . . 0.0 110.717 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 86.8 m-85 -60.92 132.21 53.13 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.64 ' HA ' HG22 ' A' ' 7' ' ' ILE . 52.7 m -122.66 98.84 6.1 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.133 -1.027 . . . . 0.0 113.119 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.541 HG21 HG22 ' A' ' 40' ' ' ILE . 11.2 p -102.87 166.7 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.333 -0.854 . . . . 0.0 109.144 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.558 HG23 ' HB3' ' A' ' 9' ' ' ASN . 91.6 m -160.84 109.99 1.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.659 -0.65 . . . . 0.0 109.762 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.263 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 mmt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.125 0.488 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.516 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 90.5 m -61.38 159.32 12.79 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.534 -0.729 . . . . 0.0 110.007 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.5 m -139.92 107.44 5.58 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.582 -0.699 . . . . 0.0 110.436 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.797 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 97.4 m-85 -96.06 169.68 9.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.654 -0.654 . . . . 0.0 109.996 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -139.3 119.46 13.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.48 -0.763 . . . . 0.0 110.423 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.63 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 50.2 tp -98.75 121.99 41.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.486 -0.759 . . . . 0.0 110.243 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.604 HG22 ' HA ' ' A' ' 54' ' ' THR . 5.0 tp -70.26 171.78 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 82.8 mt -132.09 71.74 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.175 -0.953 . . . . 0.0 110.523 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.432 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.8 m-20 -96.17 46.81 1.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.478 -0.764 . . . . 0.0 109.085 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.54 158.27 17.3 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -73.39 -7.86 53.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.759 -0.847 . . . . 0.0 110.525 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.2 m -96.81 -32.77 11.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.208 -0.932 . . . . 0.0 110.273 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.9 mt -136.5 173.85 11.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.498 -0.751 . . . . 0.0 110.6 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -153.22 128.47 9.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.655 -0.653 . . . . 0.0 110.179 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.02 -142.6 14.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.01 -178.9 6.54 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.997 . . . . 0.0 110.347 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 6' ' ' LEU . 7.0 t -162.74 159.77 24.61 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.588 -0.695 . . . . 0.0 110.278 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.4 p -134.52 156.46 48.6 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.57 -0.706 . . . . 0.0 110.177 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.582 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.5 t -142.62 -173.17 3.8 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.538 -0.727 . . . . 0.0 110.305 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -122.45 101.93 7.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.611 -0.681 . . . . 0.0 110.2 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.446 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -127.36 170.31 12.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.592 -0.692 . . . . 0.0 110.087 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -87.01 -26.93 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.64 -0.662 . . . . 0.0 109.902 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -175.24 -179.03 1.25 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.41 -0.806 . . . . 0.0 109.772 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.435 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.39 -25.88 38.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.392 -0.817 . . . . 0.0 110.936 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.24 -25.66 65.82 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.573 -0.705 . . . . 0.0 110.552 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.446 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 7.3 m -112.74 -26.17 8.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.476 -0.765 . . . . 0.0 110.359 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.797 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.6 -58.74 7.22 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.441 -0.787 . . . . 0.0 110.422 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -60.08 -41.3 92.17 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.604 -0.685 . . . . 0.0 110.143 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -56.74 -38.44 72.41 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.362 -0.836 . . . . 0.0 110.346 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 26' ' ' THR . 84.0 t -82.63 -48.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.622 -0.674 . . . . 0.0 109.975 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.582 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.3 m-85 -64.33 -32.81 74.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.531 -0.731 . . . . 0.0 110.19 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -64.75 -45.77 85.01 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.415 -0.803 . . . . 0.0 108.934 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -62.53 -33.12 74.28 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.659 0.743 . . . . 0.0 109.391 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -66.13 -51.48 57.52 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.788 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -67.61 -42.52 82.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.77 -0.581 . . . . 0.0 110.095 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -56.94 -36.14 69.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.47 -0.768 . . . . 0.0 110.537 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -62.98 -59.19 5.16 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.562 -0.711 . . . . 0.0 110.094 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -67.87 -47.25 69.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.656 -0.652 . . . . 0.0 110.017 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.33 60.0 0.19 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.788 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 85.2 mt -115.8 62.91 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.475 -1.015 . . . . 0.0 110.145 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -86.2 56.53 4.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.443 -0.786 . . . . 0.0 109.037 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.68 -136.53 3.01 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -117.43 99.42 6.98 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.842 -0.799 . . . . 0.0 109.298 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.63 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 30.8 m95 -69.16 143.38 54.09 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.225 1.012 . . . . 0.0 112.541 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 44' ' ' TRP . 3.0 p -153.41 131.41 11.78 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -101.79 138.14 39.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.641 -0.662 . . . . 0.0 110.166 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -105.92 103.5 13.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.725 -0.61 . . . . 0.0 109.784 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.12 -21.96 66.54 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.672 -0.643 . . . . 0.0 110.657 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.434 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.95 -39.41 65.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.295 -0.878 . . . . 0.0 110.84 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.434 HG23 ' C ' ' A' ' 49' ' ' ALA . 73.8 p -148.14 22.75 1.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.483 -0.76 . . . . 0.0 110.7 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.443 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.3 91.32 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.21 -0.931 . . . . 0.0 110.816 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.4 m -153.99 102.71 2.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.484 -0.76 . . . . 0.0 111.119 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.431 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 75.3 m-85 -63.26 133.73 54.69 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.604 ' HA ' HG22 ' A' ' 7' ' ' ILE . 52.6 m -126.3 101.84 6.91 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.347 -0.941 . . . . 0.0 112.883 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.567 HG21 HG22 ' A' ' 40' ' ' ILE . 10.6 p -104.26 165.81 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.374 -0.829 . . . . 0.0 109.322 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.466 ' N ' HG22 ' A' ' 55' ' ' VAL . 76.0 m -162.24 119.37 2.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.753 -0.592 . . . . 0.0 110.074 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.173 179.588 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mtt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.071 0.463 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.599 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 47.9 m -89.41 112.23 23.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.545 -0.722 . . . . 0.0 110.271 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.2 m -88.87 93.97 9.77 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.591 -0.693 . . . . 0.0 110.76 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.684 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 94.0 m-85 -76.92 167.9 21.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.5 -0.75 . . . . 0.0 109.963 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -138.92 123.84 18.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.525 -0.735 . . . . 0.0 110.352 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.608 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 44.8 tp -100.0 124.26 45.16 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.476 -0.765 . . . . 0.0 110.317 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.657 HG22 ' HA ' ' A' ' 54' ' ' THR . 5.5 tp -74.6 168.2 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 13' ' ' LEU . 72.6 mt -127.84 73.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.41 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.501 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.3 m-20 -95.13 47.58 1.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.37 -0.831 . . . . 0.0 108.985 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.74 159.33 14.21 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -79.19 -1.53 36.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.759 -0.848 . . . . 0.0 110.364 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.8 m -99.87 -32.4 11.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 110.035 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.431 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -146.36 172.0 14.16 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.513 -0.742 . . . . 0.0 110.379 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.59 145.18 19.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.573 -0.705 . . . . 0.0 110.267 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.89 -132.11 6.01 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -154.23 163.19 40.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.59 -0.947 . . . . 0.0 110.349 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.1 m -149.58 145.48 26.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.566 -0.709 . . . . 0.0 110.141 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.3 p -132.68 167.2 20.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.585 -0.697 . . . . 0.0 110.24 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.692 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.1 t -162.94 170.15 18.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.617 -0.677 . . . . 0.0 110.305 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -101.68 123.38 45.58 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.626 -0.671 . . . . 0.0 110.143 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -151.89 146.41 25.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.568 -0.707 . . . . 0.0 110.264 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.446 HG13 ' OD1' ' A' ' 23' ' ' ASP . 10.4 p -61.39 -34.25 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.595 -0.691 . . . . 0.0 110.056 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.512 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 39.3 p30 -170.19 177.03 4.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.592 -0.692 . . . . 0.0 110.281 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.461 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.45 -26.86 21.93 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.518 -0.739 . . . . 0.0 111.021 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.512 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.48 -23.33 57.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.539 -0.725 . . . . 0.0 110.554 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.6 m -118.0 -14.14 10.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.499 -0.751 . . . . 0.0 111.088 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.684 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -72.14 -50.07 30.85 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.228 -0.92 . . . . 0.0 110.406 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.52 -30.68 68.76 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.482 -0.761 . . . . 0.0 110.412 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -58.9 -40.46 84.54 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.376 -0.827 . . . . 0.0 110.341 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.0 t -82.99 -42.21 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.517 -0.739 . . . . 0.0 109.867 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.692 ' CZ ' HG22 ' A' ' 19' ' ' THR . 13.1 m-85 -68.27 -35.37 77.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.573 -0.704 . . . . 0.0 110.119 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -63.77 -46.66 84.23 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.473 -0.767 . . . . 0.0 109.128 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -62.64 -30.95 71.75 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.611 0.72 . . . . 0.0 109.467 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -69.7 -47.84 61.76 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.71 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -73.61 -33.76 64.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.68 -0.637 . . . . 0.0 110.001 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -60.68 -52.23 66.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.623 -0.673 . . . . 0.0 110.417 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.6 -35.54 78.14 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 110.52 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -79.29 -42.42 25.84 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.562 -0.711 . . . . 0.0 110.312 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.3 41.0 1.19 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.71 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 79.8 mt -99.64 59.52 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.549 -0.971 . . . . 0.0 110.166 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -80.84 61.48 4.49 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.36 -138.32 7.84 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -117.39 102.1 8.95 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.981 -0.717 . . . . 0.0 109.332 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.608 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 37.0 m95 -71.91 142.68 49.49 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.191 0.996 . . . . 0.0 112.516 -178.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -151.93 132.52 13.92 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.408 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 25.0 t80 -108.39 138.04 45.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.645 -0.659 . . . . 0.0 110.285 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.06 123.4 49.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.69 -0.631 . . . . 0.0 109.602 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -78.01 -24.25 48.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.624 -0.672 . . . . 0.0 110.619 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.06 -39.43 66.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.382 -0.824 . . . . 0.0 110.834 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.5 p -141.77 12.86 2.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.599 -0.688 . . . . 0.0 111.102 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.46 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.95 94.41 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.133 -0.98 . . . . 0.0 111.205 179.517 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.2 m -157.9 105.33 1.97 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.549 -0.719 . . . . 0.0 110.761 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -60.67 132.96 55.53 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.461 -0.774 . . . . 0.0 109.169 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.657 ' HA ' HG22 ' A' ' 7' ' ' ILE . 58.7 m -125.82 99.9 6.16 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.207 -0.997 . . . . 0.0 112.666 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 40' ' ' ILE . 11.2 p -102.17 167.47 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.88 . . . . 0.0 109.271 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.501 HG23 ' HB3' ' A' ' 9' ' ' ASN . 98.9 m -160.28 109.2 1.71 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.593 -0.692 . . . . 0.0 109.894 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.274 -179.992 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.067 0.46 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.555 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 63.0 m -145.32 111.86 5.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.517 -0.739 . . . . 0.0 110.201 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.623 ' O ' HG23 ' A' ' 3' ' ' THR . 7.5 t -87.82 95.15 9.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.66 -0.65 . . . . 0.0 110.819 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.764 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.5 m-85 -77.1 171.48 14.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.42 -0.8 . . . . 0.0 109.819 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -139.31 128.89 24.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.49 -0.756 . . . . 0.0 110.331 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.611 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 41.1 tp -103.41 122.62 45.25 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.385 -0.822 . . . . 0.0 110.432 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.65 HG21 HG23 ' A' ' 54' ' ' THR . 5.0 tp -70.74 171.13 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.43 HG21 ' HB3' ' A' ' 13' ' ' LEU . 73.9 mt -133.8 74.4 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.644 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.677 ' HB3' HG23 ' A' ' 56' ' ' THR . 27.7 m-20 -95.86 47.73 1.11 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.545 -0.722 . . . . 0.0 109.138 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.42 163.66 13.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -82.3 2.65 31.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.651 -0.911 . . . . 0.0 110.791 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 m -111.5 -28.87 7.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.19 -0.943 . . . . 0.0 110.138 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.43 ' HB3' HG21 ' A' ' 8' ' ' ILE . 6.3 mt -136.93 167.3 21.76 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.558 -0.714 . . . . 0.0 110.393 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -155.75 138.04 14.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.538 -0.726 . . . . 0.0 110.213 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.07 -133.23 7.32 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -163.75 163.02 24.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.533 -0.98 . . . . 0.0 110.262 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.9 m -144.56 150.32 37.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.551 -0.718 . . . . 0.0 110.281 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.2 p -126.91 161.27 28.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.592 -0.693 . . . . 0.0 110.247 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.4 t -153.08 -171.59 3.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.506 -0.746 . . . . 0.0 110.382 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -115.97 109.25 17.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.54 -0.725 . . . . 0.0 110.152 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.36 138.55 38.39 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.601 -0.687 . . . . 0.0 110.155 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.8 m -57.4 -30.51 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.571 -0.705 . . . . 0.0 110.515 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.631 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 23.2 p30 -172.47 -179.56 2.25 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.407 -0.808 . . . . 0.0 110.283 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.451 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.18 -25.2 31.09 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.502 -0.749 . . . . 0.0 110.876 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.631 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -60.27 -25.88 66.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.49 -0.756 . . . . 0.0 110.605 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.9 m -113.3 -25.86 8.65 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.435 -0.791 . . . . 0.0 110.64 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.764 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.14 -49.09 78.19 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.458 -0.776 . . . . 0.0 110.569 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -61.6 -36.47 80.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.607 -0.683 . . . . 0.0 110.447 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -56.72 -40.06 75.02 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.327 -0.858 . . . . 0.0 110.744 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.4 -45.52 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.483 -0.761 . . . . 0.0 110.065 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 12.7 m-85 -66.91 -35.87 80.99 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.622 -0.674 . . . . 0.0 110.3 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.5 tttm -63.61 -44.06 95.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.488 -0.758 . . . . 0.0 109.35 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.33 -30.68 71.72 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.61 0.719 . . . . 0.0 109.565 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -70.02 -44.24 69.7 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.627 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -76.47 -41.54 46.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.716 -0.615 . . . . 0.0 109.802 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -58.95 -37.77 77.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.624 -0.672 . . . . 0.0 110.4 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -69.68 -50.75 40.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.602 -0.686 . . . . 0.0 110.058 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -69.87 -50.0 46.76 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.531 -0.731 . . . . 0.0 110.018 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.92 50.99 0.17 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.627 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 77.9 mt -115.79 74.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.52 -0.988 . . . . 0.0 110.298 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.25 39.54 1.23 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.85 -137.25 0.02 OUTLIER Glycine 0 N--CA 1.488 2.127 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -111.89 109.61 19.5 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.888 -0.772 . . . . 0.0 108.973 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.611 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 35.1 m95 -79.81 143.78 34.11 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.042 0.925 . . . . 0.0 112.062 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 44' ' ' TRP . 1.8 p -155.29 132.8 11.14 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -101.92 137.41 40.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.726 -0.609 . . . . 0.0 110.109 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -108.28 114.32 28.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.766 -0.584 . . . . 0.0 109.829 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -69.8 -18.04 63.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.666 -0.646 . . . . 0.0 110.896 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.419 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.8 -42.58 72.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.234 -0.916 . . . . 0.0 110.788 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.419 HG23 ' C ' ' A' ' 49' ' ' ALA . 70.9 p -147.14 22.92 1.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.549 -0.719 . . . . 0.0 110.559 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.442 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER 51.67 94.69 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.322 -0.862 . . . . 0.0 110.859 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.4 m -156.94 107.5 2.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.456 -0.778 . . . . 0.0 111.269 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -63.65 132.57 51.54 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.65 HG23 HG21 ' A' ' 7' ' ' ILE . 61.0 m -124.08 99.52 6.28 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.254 -0.979 . . . . 0.0 113.08 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.5 HG21 HG22 ' A' ' 40' ' ' ILE . 11.9 p -102.03 167.67 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 108.917 177.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.677 HG23 ' HB3' ' A' ' 9' ' ' ASN . 97.8 m -160.19 109.42 1.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.573 -0.705 . . . . 0.0 110.034 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.184 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.064 0.459 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.571 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 46.1 m -151.59 112.66 4.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.552 -0.718 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.5 m -85.34 95.94 9.39 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.656 -0.652 . . . . 0.0 110.697 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.645 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 89.8 m-85 -80.55 165.67 21.89 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.52 -0.738 . . . . 0.0 109.717 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.7 ttpp -139.62 118.61 12.57 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.426 -0.796 . . . . 0.0 110.521 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.624 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 46.9 tp -95.95 125.24 40.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.424 -0.797 . . . . 0.0 110.241 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.669 HG21 HG23 ' A' ' 54' ' ' THR . 4.3 tp -73.48 168.55 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.6 mt -128.93 73.18 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.195 -0.94 . . . . 0.0 110.45 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.498 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.8 m-20 -96.64 47.2 1.06 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.451 -0.781 . . . . 0.0 109.147 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.29 166.92 20.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -85.84 7.24 24.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.691 -0.888 . . . . 0.0 110.456 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.3 m -115.43 -33.35 5.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.973 . . . . 0.0 110.086 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 mt -137.45 167.64 21.22 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.486 -0.759 . . . . 0.0 110.571 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -153.23 139.14 18.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.596 -0.69 . . . . 0.0 110.369 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.08 -144.6 16.23 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -142.68 168.14 20.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.573 -0.957 . . . . 0.0 110.255 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.6 m -157.67 133.38 9.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.564 -0.71 . . . . 0.0 110.181 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.2 p -112.86 167.5 10.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.54 -0.725 . . . . 0.0 110.25 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.632 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.7 t -159.35 167.68 28.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.499 -0.751 . . . . 0.0 110.29 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -98.51 112.19 24.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.618 -0.676 . . . . 0.0 110.219 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.88 137.9 31.71 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.586 -0.696 . . . . 0.0 110.052 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.64 HG23 ' OD1' ' A' ' 23' ' ' ASP . 33.9 m -60.46 -30.33 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.506 -0.746 . . . . 0.0 110.254 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.64 ' OD1' HG23 ' A' ' 22' ' ' VAL . 46.6 p-10 -170.67 -179.65 2.97 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.574 -0.703 . . . . 0.0 110.326 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.461 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -55.51 -24.39 31.43 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.584 -0.698 . . . . 0.0 110.87 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.43 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.67 -28.11 65.43 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.46 -0.775 . . . . 0.0 110.512 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 30' ' ' VAL . 46.5 m -109.43 -27.29 9.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.585 -0.697 . . . . 0.0 110.291 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.645 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -61.6 -61.32 2.61 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.537 -0.727 . . . . 0.0 110.062 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -58.85 -38.36 78.54 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.562 -0.711 . . . . 0.0 109.921 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -58.69 -40.13 82.69 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.575 -0.703 . . . . 0.0 109.735 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 26' ' ' THR . 97.9 t -82.6 -47.89 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.692 -0.63 . . . . 0.0 109.509 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.632 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.1 m-85 -61.18 -32.71 72.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.629 -0.669 . . . . 0.0 109.998 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -65.5 -46.21 80.57 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.93 -30.94 71.24 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.65 0.738 . . . . 0.0 109.471 178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -69.14 -54.29 15.73 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.715 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.3 -37.77 86.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.689 -0.632 . . . . 0.0 109.956 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -59.6 -33.34 71.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.512 -0.743 . . . . 0.0 110.428 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -70.68 -36.64 73.41 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.648 -0.657 . . . . 0.0 110.287 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -88.47 -27.9 21.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.581 -0.699 . . . . 0.0 110.161 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.82 39.73 3.3 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.715 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.8 mt -95.77 65.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.551 -0.97 . . . . 0.0 110.199 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -87.83 54.66 3.18 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.62 -137.01 2.64 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.71 105.29 11.84 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.939 -0.742 . . . . 0.0 109.202 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.624 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 31.7 m95 -74.13 143.38 45.34 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.138 0.97 . . . . 0.0 112.413 -177.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 44' ' ' TRP . 8.6 p -153.83 131.49 11.48 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -102.27 129.69 48.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.681 -0.637 . . . . 0.0 110.198 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.27 117.66 35.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.675 -0.64 . . . . 0.0 109.879 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.13 -13.16 61.13 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.648 -0.657 . . . . 0.0 111.005 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.425 ' C ' HG23 ' A' ' 50' ' ' THR . . . -56.66 -43.19 80.14 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.174 -0.954 . . . . 0.0 110.549 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.425 HG23 ' C ' ' A' ' 49' ' ' ALA . 73.7 p -147.49 24.33 1.11 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.609 -0.682 . . . . 0.0 110.435 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.439 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.69 93.45 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.305 -0.872 . . . . 0.0 110.853 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.4 m -156.48 105.11 2.24 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.903 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 91.6 m-85 -62.7 132.84 53.63 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.669 HG23 HG21 ' A' ' 7' ' ' ILE . 61.5 m -124.22 101.43 7.19 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.866 -178.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.551 HG11 HG21 ' A' ' 40' ' ' ILE . 11.2 p -102.51 166.59 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.349 -0.844 . . . . 0.0 109.167 177.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.498 HG23 ' HB3' ' A' ' 9' ' ' ASN . 98.9 m -160.52 110.12 1.74 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.653 -0.654 . . . . 0.0 109.865 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.23 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 mtp . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.132 0.492 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.501 HG22 ' CE2' ' A' ' 4' ' ' PHE . 60.4 m -83.47 123.05 29.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.588 -0.695 . . . . 0.0 110.041 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.0 m -115.01 102.24 9.76 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.564 -0.71 . . . . 0.0 110.77 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.78 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 94.9 m-85 -82.77 -177.22 6.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.586 -0.696 . . . . 0.0 109.746 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.528 ' O ' HG23 ' A' ' 52' ' ' THR . 84.9 tttt -152.2 114.85 4.57 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.43 -0.794 . . . . 0.0 110.396 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.526 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 14.1 tp -93.51 140.03 30.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.269 -0.894 . . . . 0.0 110.277 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.7 tp -89.96 165.2 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.474 HG21 ' HB3' ' A' ' 13' ' ' LEU . 48.7 mm -126.44 77.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -0.903 . . . . 0.0 110.514 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.732 ' HB3' HG23 ' A' ' 56' ' ' THR . 3.0 m-20 -98.83 48.93 0.97 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.58 161.63 12.64 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -76.96 -12.47 59.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.767 -0.843 . . . . 0.0 110.435 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.8 m -91.1 -29.97 17.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 110.158 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.474 ' HB3' HG21 ' A' ' 8' ' ' ILE . 24.6 mt -141.14 167.64 21.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 110.49 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -153.82 131.48 11.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.645 -0.659 . . . . 0.0 110.057 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.401 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 135.95 -124.67 3.33 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -165.91 172.54 11.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.521 -0.987 . . . . 0.0 110.43 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.1 m -152.87 161.37 42.63 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.55 -0.719 . . . . 0.0 110.241 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 p -137.96 171.26 14.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.614 -0.679 . . . . 0.0 110.207 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.552 HG22 ' CE2' ' A' ' 31' ' ' PHE . 7.7 t -161.77 164.03 29.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.588 -0.695 . . . . 0.0 110.341 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -102.34 93.69 5.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.574 -0.704 . . . . 0.0 110.159 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.406 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -117.36 -172.45 2.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.553 -0.717 . . . . 0.0 110.214 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -112.14 -25.82 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.656 -0.653 . . . . 0.0 110.154 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -166.84 177.96 6.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.521 -0.737 . . . . 0.0 110.023 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.25 -25.84 59.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.723 . . . . 0.0 110.812 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.13 -45.33 93.36 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.451 -0.78 . . . . 0.0 110.458 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 30' ' ' VAL . 6.7 m -87.61 -28.04 22.14 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.495 -0.753 . . . . 0.0 110.433 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.78 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -64.57 -63.47 1.12 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.533 -0.729 . . . . 0.0 110.402 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -57.9 -42.67 85.2 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.518 -0.739 . . . . 0.0 110.311 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -55.61 -39.3 70.59 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.382 -0.824 . . . . 0.0 110.248 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 26' ' ' THR . 88.3 t -82.31 -49.03 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.701 -0.624 . . . . 0.0 109.893 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.552 ' CE2' HG22 ' A' ' 19' ' ' THR . 5.6 m-85 -62.95 -33.62 75.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.65 -0.656 . . . . 0.0 110.337 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -65.21 -45.87 82.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.414 -0.804 . . . . 0.0 109.094 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -61.71 -31.72 71.88 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.625 0.726 . . . . 0.0 109.552 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -68.43 -53.4 23.92 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.616 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.14 -47.25 80.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.733 -0.605 . . . . 0.0 109.784 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -58.03 -28.11 64.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.603 -0.686 . . . . 0.0 110.43 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.88 -47.19 19.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.608 -0.683 . . . . 0.0 110.194 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -76.22 -43.12 43.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.562 -0.711 . . . . 0.0 110.063 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.23 51.09 0.18 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.616 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 83.9 mt -122.57 73.52 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.463 -1.022 . . . . 0.0 110.231 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.97 39.7 1.26 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.56 -137.79 0.02 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -111.94 111.91 23.18 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.526 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 28.4 m95 -80.59 142.82 33.69 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.233 1.016 . . . . 0.0 112.467 -177.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 44' ' ' TRP . 3.0 p -153.93 132.95 12.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -103.16 140.5 37.27 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.649 -0.657 . . . . 0.0 110.156 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.6 116.63 30.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.643 -0.661 . . . . 0.0 110.004 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -71.2 -15.14 62.45 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.646 -0.659 . . . . 0.0 111.147 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.426 ' C ' HG23 ' A' ' 50' ' ' THR . . . -55.99 -43.48 77.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.206 -0.934 . . . . 0.0 110.681 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.426 HG23 ' C ' ' A' ' 49' ' ' ALA . 68.8 p -147.47 23.02 1.15 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.566 -0.709 . . . . 0.0 110.569 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.448 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.51 88.99 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.246 -0.909 . . . . 0.0 110.764 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 5' ' ' LYS . 88.2 m -151.95 106.16 3.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.448 -0.782 . . . . 0.0 110.872 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.433 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 86.0 m-85 -62.98 137.11 58.17 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.419 -0.801 . . . . 0.0 108.842 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.628 ' HA ' HG22 ' A' ' 7' ' ' ILE . 55.8 m -126.81 95.09 4.22 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.124 -1.03 . . . . 0.0 113.231 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.514 HG11 ' CG2' ' A' ' 40' ' ' ILE . 11.5 p -97.4 167.34 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 109.145 177.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.732 HG23 ' HB3' ' A' ' 9' ' ' ASN . 97.9 m -160.58 111.62 1.85 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.549 -0.719 . . . . 0.0 110.126 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.05 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.2 mtt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.107 0.479 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.631 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 8.7 m -87.32 114.24 23.76 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.546 -0.721 . . . . 0.0 110.194 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.605 ' O ' HG23 ' A' ' 3' ' ' THR . 8.8 t -95.13 79.97 3.58 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.533 -0.729 . . . . 0.0 110.892 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.803 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 98.1 m-85 -62.13 179.62 0.28 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.335 -0.853 . . . . 0.0 109.779 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.462 ' HB3' HG23 ' A' ' 52' ' ' THR . 26.6 tttt -153.9 126.46 8.1 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.524 -0.735 . . . . 0.0 110.353 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.582 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 46.3 tp -103.87 135.43 45.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.459 -0.776 . . . . 0.0 110.189 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.59 HG21 HG23 ' A' ' 54' ' ' THR . 2.6 tp -86.78 168.69 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 13' ' ' LEU . 83.8 mt -128.43 72.64 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.203 -0.936 . . . . 0.0 110.634 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.626 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.1 m-80 -95.6 48.47 1.14 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 0.0 108.969 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.95 154.56 16.53 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -72.42 -6.99 47.43 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.665 -0.903 . . . . 0.0 110.942 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -96.99 -30.75 12.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.202 -0.936 . . . . 0.0 110.283 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.563 ' O ' HG22 ' A' ' 8' ' ' ILE . 2.5 tp -145.21 157.58 44.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.497 -0.752 . . . . 0.0 110.433 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -140.13 136.01 33.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.591 -0.693 . . . . 0.0 110.497 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.72 -140.57 10.87 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -151.72 168.55 24.69 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.541 -0.976 . . . . 0.0 110.434 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.2 m -150.54 148.49 28.75 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.588 -0.695 . . . . 0.0 110.265 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.455 HG23 ' HE3' ' A' ' 5' ' ' LYS . 9.1 p -131.13 168.38 17.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.578 -0.701 . . . . 0.0 110.155 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.791 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.6 t -164.32 179.09 7.02 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.588 -0.695 . . . . 0.0 110.378 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.96 128.25 54.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.714 . . . . 0.0 110.111 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.565 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -154.25 138.3 16.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.598 -0.689 . . . . 0.0 110.189 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.9 m -59.35 -26.7 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.505 -0.747 . . . . 0.0 110.45 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.562 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 30.3 p30 -173.12 -178.24 1.73 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.452 -0.78 . . . . 0.0 110.304 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.91 -25.29 56.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.54 -0.725 . . . . 0.0 110.869 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.562 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.04 -27.17 65.23 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.456 -0.778 . . . . 0.0 110.397 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.565 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 5.9 m -109.71 -27.84 9.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.518 -0.739 . . . . 0.0 110.305 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.803 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.02 -62.98 1.47 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.536 -0.727 . . . . 0.0 110.233 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -58.47 -32.48 68.8 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.521 -0.737 . . . . 0.0 110.166 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -56.61 -45.56 81.4 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.414 -0.804 . . . . 0.0 110.156 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.8 t -80.18 -45.05 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.653 -0.654 . . . . 0.0 109.697 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.791 ' CZ ' HG22 ' A' ' 19' ' ' THR . 12.6 m-85 -61.88 -33.56 74.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.597 -0.689 . . . . 0.0 110.04 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -64.52 -46.65 82.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.457 -0.777 . . . . 0.0 109.058 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -63.15 -33.5 75.6 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.608 0.718 . . . . 0.0 109.329 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.426 ' CD2' HD23 ' A' ' 6' ' ' LEU . 18.8 t80 -65.2 -46.67 79.76 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.571 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -72.99 -38.2 66.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.718 -0.614 . . . . 0.0 109.651 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -60.27 -45.3 93.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.539 -0.726 . . . . 0.0 110.316 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -60.28 -53.35 58.73 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.585 -0.697 . . . . 0.0 110.358 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -69.18 -48.24 62.74 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.525 -0.735 . . . . 0.0 110.033 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.44 46.11 0.3 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.571 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.1 mt -108.79 77.03 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.501 -0.999 . . . . 0.0 110.454 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -98.99 39.28 1.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.74 -138.35 0.02 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -112.45 111.05 21.62 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.842 -0.799 . . . . 0.0 108.956 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.582 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 29.3 m95 -80.31 143.56 33.51 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.182 0.991 . . . . 0.0 112.483 -178.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 44' ' ' TRP . 1.6 p -152.91 132.28 12.86 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.402 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 14.5 t80 -104.81 120.87 42.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.678 -0.638 . . . . 0.0 110.111 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -90.77 111.39 22.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.649 -0.657 . . . . 0.0 110.087 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -66.72 -15.76 63.76 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.601 -0.687 . . . . 0.0 110.849 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.416 ' C ' HG23 ' A' ' 50' ' ' THR . . . -55.09 -42.69 73.18 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.168 -0.957 . . . . 0.0 110.812 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.416 HG23 ' C ' ' A' ' 49' ' ' ALA . 81.0 p -147.07 24.12 1.17 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.53 -0.731 . . . . 0.0 110.527 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.445 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 4.3 mptt 51.79 87.35 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.247 -0.908 . . . . 0.0 110.78 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.462 HG23 ' HB3' ' A' ' 5' ' ' LYS . 58.4 m -150.88 103.65 3.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.513 -0.742 . . . . 0.0 110.728 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -62.5 134.84 56.98 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.489 -0.757 . . . . 0.0 109.112 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.59 HG23 HG21 ' A' ' 7' ' ' ILE . 75.7 m -125.72 104.05 8.15 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 119.354 -0.938 . . . . 0.0 112.71 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.519 HG21 HG22 ' A' ' 40' ' ' ILE . 11.1 p -104.73 167.24 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.279 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.626 HG23 ' HB3' ' A' ' 9' ' ' ASN . 93.2 m -159.79 109.59 1.85 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.586 -0.696 . . . . 0.0 109.801 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.098 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mtt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.047 0.451 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.554 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 40.2 m -72.01 111.64 7.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.576 -0.702 . . . . 0.0 110.011 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 58.8 m -89.87 96.73 10.81 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.588 -0.695 . . . . 0.0 110.662 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.766 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 87.6 m-85 -79.34 170.03 17.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.528 -0.732 . . . . 0.0 109.77 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.735 ' HG3' HG22 ' A' ' 18' ' ' THR . 2.2 mtpp -140.09 124.57 18.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.456 -0.778 . . . . 0.0 110.474 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.607 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 53.3 tp -101.94 120.42 40.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.426 -0.796 . . . . 0.0 109.817 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.635 HG21 HG23 ' A' ' 54' ' ' THR . 2.5 tt -69.36 172.75 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 13' ' ' LEU . 76.8 mt -135.39 75.39 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 119.414 -0.915 . . . . 0.0 110.676 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -96.68 47.59 1.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.89 154.46 16.63 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.0 tttp -71.25 -9.78 58.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.688 -0.889 . . . . 0.0 110.611 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.0 m -91.44 -33.44 15.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.215 -0.928 . . . . 0.0 110.273 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.462 ' O ' HG22 ' A' ' 8' ' ' ILE . 23.8 mt -142.13 167.5 21.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.465 -0.772 . . . . 0.0 110.638 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -147.52 136.78 22.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.634 -0.666 . . . . 0.0 110.198 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.401 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 127.26 -137.41 9.87 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -155.96 152.2 27.9 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.591 -0.947 . . . . 0.0 110.356 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.8 m -122.94 160.67 25.72 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.626 -0.671 . . . . 0.0 110.223 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.735 HG22 ' HG3' ' A' ' 5' ' ' LYS . 20.4 p -128.67 174.87 9.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.538 -0.726 . . . . 0.0 110.296 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.484 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.5 t -167.14 -173.26 2.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.526 -0.734 . . . . 0.0 110.328 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -128.56 101.97 6.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 0.0 110.177 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.0 155.07 47.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.605 -0.684 . . . . 0.0 110.135 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.42 HG13 ' OD2' ' A' ' 23' ' ' ASP . 7.8 p -74.42 -23.84 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.59 -0.694 . . . . 0.0 110.287 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.721 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 3.9 p30 -171.62 176.04 3.84 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.311 -0.868 . . . . 0.0 110.385 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.451 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -57.12 -29.61 63.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.553 -0.717 . . . . 0.0 110.992 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.721 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -57.89 -24.4 57.52 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.458 -0.776 . . . . 0.0 110.614 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.9 m -110.94 -27.98 8.56 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.466 -0.771 . . . . 0.0 110.355 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.766 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.81 -52.75 63.73 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.506 -0.746 . . . . 0.0 110.278 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -57.66 -39.87 78.03 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.554 -0.716 . . . . 0.0 110.415 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -56.9 -39.11 73.8 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.332 -0.855 . . . . 0.0 110.288 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.3 t -80.91 -49.19 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.665 -0.647 . . . . 0.0 110.105 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.484 ' CZ ' HG22 ' A' ' 19' ' ' THR . 6.2 m-85 -65.01 -33.08 75.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.594 -0.691 . . . . 0.0 110.409 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -64.1 -46.85 82.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.439 -0.788 . . . . 0.0 109.232 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -61.5 -31.97 71.98 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.619 0.724 . . . . 0.0 109.675 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.409 ' CD2' HD23 ' A' ' 6' ' ' LEU . 15.8 t80 -67.88 -42.96 80.44 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.63 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -78.45 -38.89 40.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.614 -0.678 . . . . 0.0 110.017 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -58.29 -52.19 66.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.467 -0.77 . . . . 0.0 110.28 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.6 -47.22 86.45 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.647 -0.658 . . . . 0.0 110.108 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -65.37 -45.9 82.24 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.555 -0.716 . . . . 0.0 110.037 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.44 36.93 0.88 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.63 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.1 mt -104.21 69.05 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.43 -1.041 . . . . 0.0 110.29 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -92.23 49.35 1.5 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.54 -0.725 . . . . 0.0 109.324 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.1 -137.09 0.84 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.17 112.24 22.21 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.893 -0.769 . . . . 0.0 109.11 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.607 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 25.2 m95 -81.09 143.11 32.67 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.247 1.023 . . . . 0.0 112.445 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 p -150.98 131.82 14.13 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.416 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 31.1 t80 -105.05 128.81 53.5 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.669 -0.645 . . . . 0.0 110.031 -178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -102.47 111.26 23.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.676 -0.64 . . . . 0.0 109.953 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -66.69 -23.9 66.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.719 -0.613 . . . . 0.0 110.588 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.65 -38.78 64.46 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.404 -0.81 . . . . 0.0 110.851 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.2 p -143.26 14.71 1.84 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.541 -0.724 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 4.4 mptt 50.92 87.12 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.074 -1.016 . . . . 0.0 110.712 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.5 m -149.64 105.59 3.46 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.118 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.439 ' O ' HD12 ' A' ' 6' ' ' LEU . 82.4 m-85 -62.25 123.72 18.94 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.635 HG23 HG21 ' A' ' 7' ' ' ILE . 63.3 m -117.39 104.15 10.83 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.175 -0.953 . . . . 0.0 112.854 -178.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.536 HG11 HG21 ' A' ' 40' ' ' ILE . 10.4 p -106.38 164.67 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.353 -0.842 . . . . 0.0 109.377 177.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.459 ' N ' HG22 ' A' ' 55' ' ' VAL . 64.0 m -163.91 116.11 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.384 179.96 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mtp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.106 0.479 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.463 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 86.3 m -99.91 112.08 24.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.584 -0.698 . . . . 0.0 110.237 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.618 ' O ' HG23 ' A' ' 3' ' ' THR . 8.7 t -88.04 104.29 16.52 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.701 -0.624 . . . . 0.0 110.756 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.622 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 83.9 m-85 -86.79 176.45 7.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.387 -0.821 . . . . 0.0 109.87 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.528 ' O ' HG23 ' A' ' 52' ' ' THR . 25.0 ttmt -146.75 115.82 6.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.47 -0.769 . . . . 0.0 110.245 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.606 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 48.3 tp -93.66 122.39 36.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.545 -0.722 . . . . 0.0 110.157 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.652 HG21 HG23 ' A' ' 54' ' ' THR . 5.0 tp -70.44 171.64 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.537 HG21 ' HB3' ' A' ' 13' ' ' LEU . 84.9 mt -132.26 71.73 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.216 -0.928 . . . . 0.0 110.564 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.475 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.0 m-20 -95.43 48.07 1.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.499 -0.751 . . . . 0.0 109.062 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.5 159.79 14.05 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -75.66 -6.16 49.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.707 -0.878 . . . . 0.0 110.564 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.401 ' H ' HG22 ' A' ' 12' ' ' THR . 9.9 t -100.17 -27.09 13.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.666 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.537 ' HB3' HG21 ' A' ' 8' ' ' ILE . 17.4 mt -143.78 163.59 32.9 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.425 -0.797 . . . . 0.0 110.577 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -147.9 131.95 17.25 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.588 -0.695 . . . . 0.0 110.2 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.71 -132.63 6.25 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.482 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.2 pt-20 -162.54 159.04 24.31 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.51 -0.994 . . . . 0.0 110.326 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 18' ' ' THR . 48.7 m -138.84 165.1 27.92 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.501 -0.749 . . . . 0.0 110.275 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.421 ' N ' HG22 ' A' ' 17' ' ' THR . 29.6 p -135.27 168.84 18.44 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.584 -0.697 . . . . 0.0 110.262 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.642 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.1 t -164.62 168.9 17.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.55 -0.719 . . . . 0.0 110.194 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -101.54 116.32 32.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.488 -0.757 . . . . 0.0 110.262 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -144.88 142.78 30.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.567 -0.708 . . . . 0.0 110.095 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.43 HG23 ' N ' ' A' ' 23' ' ' ASP . 33.7 m -57.35 -37.32 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.449 -0.782 . . . . 0.0 110.095 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.43 ' N ' HG23 ' A' ' 22' ' ' VAL . 1.5 t70 -172.34 -172.49 0.94 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.699 -0.626 . . . . 0.0 109.773 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.455 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.98 -23.14 12.22 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.461 -0.774 . . . . 0.0 111.174 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.28 -35.9 74.58 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.471 -0.768 . . . . 0.0 110.718 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.5 m -106.64 -25.39 11.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.445 -0.784 . . . . 0.0 110.811 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.622 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -57.83 -60.61 3.43 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.407 -0.808 . . . . 0.0 110.733 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -57.01 -40.09 75.98 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.521 -0.737 . . . . 0.0 110.568 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -57.65 -37.89 74.12 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.366 -0.834 . . . . 0.0 110.144 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 99.5 t -82.46 -48.7 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.64 -0.663 . . . . 0.0 109.851 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.642 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.1 m-85 -63.85 -33.17 75.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.551 -0.718 . . . . 0.0 110.212 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -64.76 -44.98 88.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.5 -0.75 . . . . 0.0 109.086 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -61.85 -27.63 68.92 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.505 0.669 . . . . 0.0 109.779 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -74.4 -53.08 10.31 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.728 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.94 -40.14 92.1 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.581 -0.7 . . . . 0.0 110.18 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -57.72 -49.73 75.55 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.537 -0.727 . . . . 0.0 110.693 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.88 -55.94 27.07 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.522 -0.736 . . . . 0.0 110.2 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -60.96 -47.68 85.34 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.563 -0.711 . . . . 0.0 110.082 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.71 64.58 0.3 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.728 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 82.4 mt -126.01 79.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.545 -0.974 . . . . 0.0 110.148 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -95.39 43.95 1.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.52 -140.48 0.64 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -118.78 111.33 18.32 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.606 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 26.0 m95 -77.13 143.9 38.81 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.178 0.99 . . . . 0.0 112.416 -177.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.6 p -151.27 132.77 14.72 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -104.41 113.71 27.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.621 -0.674 . . . . 0.0 110.122 -178.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -88.66 116.27 26.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.674 -0.641 . . . . 0.0 109.957 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.15 -15.78 61.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.625 -0.672 . . . . 0.0 110.845 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.437 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.97 -39.43 65.96 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.189 -0.944 . . . . 0.0 110.766 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.437 HG23 ' C ' ' A' ' 49' ' ' ALA . 69.1 p -148.47 20.11 1.06 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.561 -0.712 . . . . 0.0 110.702 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.52 85.89 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.194 -0.941 . . . . 0.0 110.837 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 5' ' ' LYS . 89.5 m -150.39 105.51 3.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.559 -0.713 . . . . 0.0 110.494 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.434 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 90.0 m-85 -60.02 126.98 29.62 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.652 HG23 HG21 ' A' ' 7' ' ' ILE . 48.7 m -119.96 100.03 6.97 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.984 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.69 HG11 HG21 ' A' ' 40' ' ' ILE . 10.6 p -100.83 166.93 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.44 -0.788 . . . . 0.0 109.021 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 9' ' ' ASN . 90.1 m -158.68 109.81 2.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.515 -0.74 . . . . 0.0 110.295 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.288 179.917 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.101 0.477 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.567 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 55.6 m -77.75 145.53 36.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.597 -0.689 . . . . 0.0 110.177 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 65.6 m -122.75 96.65 5.11 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.617 -0.677 . . . . 0.0 110.44 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.652 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 97.4 m-85 -81.41 175.34 10.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.585 -0.697 . . . . 0.0 110.081 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.498 ' HB3' HG23 ' A' ' 52' ' ' THR . 16.0 ttpt -151.33 127.78 10.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.523 -0.736 . . . . 0.0 110.185 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.618 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 48.0 tp -104.73 125.21 50.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.494 -0.754 . . . . 0.0 110.442 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.728 HG21 HG23 ' A' ' 54' ' ' THR . 2.1 tp -75.17 171.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.474 HD12 ' C ' ' A' ' 15' ' ' GLY . 78.0 mt -130.8 74.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.179 -0.951 . . . . 0.0 110.674 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.54 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.7 m-20 -97.3 46.91 1.03 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.31 -0.869 . . . . 0.0 108.796 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.93 165.17 17.36 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.94 4.58 29.0 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.726 -0.867 . . . . 0.0 110.643 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -114.87 -26.86 7.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 110.484 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.3 tp -143.39 166.8 23.77 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.831 . . . . 0.0 110.769 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -153.53 143.23 21.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.559 -0.713 . . . . 0.0 110.27 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.474 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 134.05 -142.62 14.13 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -142.5 172.07 13.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.568 -0.96 . . . . 0.0 110.341 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.9 m -155.9 132.72 10.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.628 -0.67 . . . . 0.0 110.02 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.0 p -119.81 167.24 12.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.514 -0.741 . . . . 0.0 110.357 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.677 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.0 t -167.17 166.06 15.15 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.618 -0.677 . . . . 0.0 110.265 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -100.29 111.06 23.31 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.564 -0.71 . . . . 0.0 110.218 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.454 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -135.01 139.67 45.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.583 -0.698 . . . . 0.0 110.199 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.73 -28.8 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.543 -0.723 . . . . 0.0 110.408 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.598 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 27.5 p30 -173.87 -176.45 1.21 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.431 -0.793 . . . . 0.0 110.34 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -57.99 -23.94 56.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.613 -0.679 . . . . 0.0 110.809 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.598 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.65 -29.38 67.99 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.453 -0.779 . . . . 0.0 110.281 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.454 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 30.2 m -106.29 -28.17 10.57 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.55 -0.719 . . . . 0.0 110.154 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.652 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . . . -61.3 -59.89 4.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.562 -0.711 . . . . 0.0 110.097 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -59.77 -43.79 94.17 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.601 -0.687 . . . . 0.0 110.215 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -54.64 -40.22 68.78 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.284 -0.885 . . . . 0.0 110.229 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 26' ' ' THR . 97.8 t -82.17 -48.52 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.697 -0.627 . . . . 0.0 109.918 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.677 ' CZ ' HG22 ' A' ' 19' ' ' THR . 13.5 m-85 -62.16 -32.73 73.38 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.653 -0.654 . . . . 0.0 110.304 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -66.31 -42.86 87.68 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.046 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -62.42 -30.11 70.99 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.505 0.669 . . . . 0.0 109.678 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -70.22 -50.68 37.47 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.673 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -67.24 -37.47 83.59 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.629 -0.67 . . . . 0.0 110.075 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -57.0 -36.47 70.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.479 -0.763 . . . . 0.0 110.65 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -69.83 -41.29 75.14 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.519 -0.738 . . . . 0.0 110.174 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -80.84 -27.98 36.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.596 -0.69 . . . . 0.0 110.269 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.82 38.35 4.68 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.673 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 76.8 mt -89.5 66.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.548 -0.972 . . . . 0.0 110.226 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -85.63 56.97 4.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.569 -0.707 . . . . 0.0 109.15 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.33 -138.21 4.98 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.47 102.19 8.72 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.868 -0.784 . . . . 0.0 109.161 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.618 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 32.6 m95 -69.88 143.13 52.88 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.153 0.977 . . . . 0.0 112.457 -177.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 44' ' ' TRP . 3.4 p -152.0 131.83 13.28 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -107.26 152.72 23.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.635 -0.666 . . . . 0.0 110.059 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -126.98 113.72 16.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.687 -0.633 . . . . 0.0 109.911 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -67.61 -23.05 65.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.703 -0.623 . . . . 0.0 110.833 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.75 -40.15 62.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.275 -0.891 . . . . 0.0 110.718 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.2 p -144.98 16.46 1.57 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.667 -0.645 . . . . 0.0 110.744 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.461 ' HG2' ' CE2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.81 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.121 -0.987 . . . . 0.0 110.876 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.498 HG23 ' HB3' ' A' ' 5' ' ' LYS . 63.6 m -152.78 102.46 2.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.494 -0.754 . . . . 0.0 110.949 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -63.0 136.75 58.0 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.728 HG23 HG21 ' A' ' 7' ' ' ILE . 86.4 m -129.37 103.04 6.69 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.37 -0.932 . . . . 0.0 112.322 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.598 HG11 HG21 ' A' ' 40' ' ' ILE . 10.7 p -102.54 167.04 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 0.0 109.265 177.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.54 HG23 ' HB3' ' A' ' 9' ' ' ASN . 92.0 m -160.71 112.65 1.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.595 -0.69 . . . . 0.0 110.273 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.086 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 tpp . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.06 0.457 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.477 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 93.9 m -134.93 112.97 11.07 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.63 -0.669 . . . . 0.0 110.124 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.2 m -88.58 104.27 16.68 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.606 -0.684 . . . . 0.0 110.707 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.663 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 88.8 m-85 -85.57 179.6 7.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.548 -0.72 . . . . 0.0 109.821 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.3 mtmm -144.44 117.24 8.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.438 -0.789 . . . . 0.0 110.575 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.583 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 34.7 tp -99.47 121.66 41.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.464 -0.772 . . . . 0.0 110.164 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.65 HG21 HG23 ' A' ' 54' ' ' THR . 4.8 tp -70.69 169.3 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.529 HD11 ' OG1' ' A' ' 17' ' ' THR . 81.2 mt -131.33 77.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 110.856 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.532 ' HB3' HG23 ' A' ' 56' ' ' THR . 71.5 m-20 -97.24 46.93 1.03 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.225 -0.922 . . . . 0.0 108.633 178.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.12 153.04 16.97 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.59 -8.09 53.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.756 -0.849 . . . . 0.0 110.716 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -94.14 -30.88 14.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.215 -0.928 . . . . 0.0 110.4 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -145.63 174.78 10.89 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.423 -0.798 . . . . 0.0 110.498 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -165.72 142.58 5.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.608 -0.682 . . . . 0.0 110.48 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.5 -121.74 2.75 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -157.07 153.05 27.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.973 . . . . 0.0 110.304 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.529 ' OG1' HD11 ' A' ' 8' ' ' ILE . 4.4 m -138.9 142.67 38.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.553 -0.717 . . . . 0.0 110.244 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -124.61 153.09 42.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.617 -0.677 . . . . 0.0 110.184 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.734 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.9 t -151.35 142.24 22.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.554 -0.716 . . . . 0.0 110.285 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.49 114.66 16.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.594 -0.691 . . . . 0.0 110.34 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -142.4 139.87 31.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.463 -0.773 . . . . 0.0 110.054 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 23' ' ' ASP . 33.2 m -56.46 -36.45 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.481 -0.762 . . . . 0.0 110.23 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' N ' HG23 ' A' ' 22' ' ' VAL . 3.6 t70 -172.66 -173.27 0.99 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.595 -0.691 . . . . 0.0 109.934 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.5 -22.36 12.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.403 -0.811 . . . . 0.0 111.269 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.71 66.77 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.355 -0.841 . . . . 0.0 110.505 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.5 m -116.44 -21.69 9.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.466 -0.771 . . . . 0.0 110.954 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.663 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -57.3 -62.97 1.39 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.318 -0.864 . . . . 0.0 110.667 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -59.98 -36.41 77.09 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.45 -0.781 . . . . 0.0 110.086 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -57.6 -43.68 84.86 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.486 -0.759 . . . . 0.0 109.962 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.6 t -78.77 -48.23 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.713 -0.617 . . . . 0.0 109.667 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.734 ' CZ ' HG22 ' A' ' 19' ' ' THR . 4.9 m-85 -61.33 -32.81 72.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.621 -0.675 . . . . 0.0 110.262 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -64.07 -42.94 96.8 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.433 -0.792 . . . . 0.0 108.9 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -64.56 -32.31 73.9 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.643 0.735 . . . . 0.0 109.341 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -68.04 -56.02 10.42 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -59.9 -41.38 91.5 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.716 -0.615 . . . . 0.0 110.287 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -56.77 -37.92 71.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.483 -0.76 . . . . 0.0 110.643 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.14 -37.87 84.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.596 -0.69 . . . . 0.0 110.284 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -91.21 -30.72 16.49 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.511 -0.743 . . . . 0.0 110.178 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.06 44.3 1.77 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.757 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 79.8 mt -95.08 62.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.486 -1.008 . . . . 0.0 110.159 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.85 59.16 5.05 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.66 -138.47 6.4 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -115.13 103.15 10.58 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.845 -0.797 . . . . 0.0 109.015 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.583 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 38.5 m95 -73.18 143.34 47.26 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 122.161 0.981 . . . . 0.0 112.195 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 44' ' ' TRP . 7.0 p -155.91 131.43 9.61 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -105.71 133.07 51.03 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.655 -0.653 . . . . 0.0 109.955 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -104.3 109.97 22.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.77 -0.581 . . . . 0.0 109.888 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.6 -20.99 66.59 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.656 -0.653 . . . . 0.0 110.588 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.433 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.87 -37.84 60.86 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.263 -0.898 . . . . 0.0 110.958 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.433 HG23 ' C ' ' A' ' 49' ' ' ALA . 73.6 p -147.68 19.89 1.16 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.573 -0.704 . . . . 0.0 110.826 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.442 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 50.63 85.38 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.154 -0.966 . . . . 0.0 110.875 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.3 m -151.43 105.81 3.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.467 -0.771 . . . . 0.0 111.035 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.468 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 84.1 m-85 -62.83 137.6 58.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.485 -0.76 . . . . 0.0 109.071 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.65 HG23 HG21 ' A' ' 7' ' ' ILE . 68.3 m -128.79 98.76 5.08 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.316 -0.954 . . . . 0.0 112.764 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 40' ' ' ILE . 11.0 p -101.86 166.46 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 109.254 177.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.532 HG23 ' HB3' ' A' ' 9' ' ' ASN . 82.8 m -161.67 111.06 1.55 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.725 -0.609 . . . . 0.0 109.657 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.24 -179.999 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.034 0.445 . . . . 0.0 110.038 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.499 HG22 ' CE2' ' A' ' 4' ' ' PHE . 87.1 m -82.56 112.41 19.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.538 -0.726 . . . . 0.0 110.16 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 19' ' ' THR . 4.6 m -110.58 92.23 3.97 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.603 -0.686 . . . . 0.0 110.506 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.9 m-85 -67.35 169.38 9.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.568 -0.707 . . . . 0.0 109.961 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.631 ' HG2' HG22 ' A' ' 18' ' ' THR . 64.0 mttt -140.41 120.16 13.41 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.576 -0.703 . . . . 0.0 110.491 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.597 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 28.7 tp -98.95 130.41 45.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.512 -0.743 . . . . 0.0 109.919 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.635 HG21 HG23 ' A' ' 54' ' ' THR . 2.4 tp -78.95 171.81 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 13' ' ' LEU . 83.2 mt -132.63 72.12 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.258 -0.901 . . . . 0.0 110.431 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.609 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.0 m-20 -93.94 50.55 1.43 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.43 156.07 15.9 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -71.64 -13.43 61.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.716 -0.873 . . . . 0.0 110.492 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.5 m -88.57 -33.44 17.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.272 -0.893 . . . . 0.0 110.38 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.521 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.4 mt -144.1 162.81 35.32 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.406 -0.809 . . . . 0.0 110.832 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -143.35 136.71 28.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.67 -0.644 . . . . 0.0 110.146 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.401 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 133.23 -145.41 17.44 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -144.57 166.8 24.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.537 -0.978 . . . . 0.0 110.275 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.0 m -139.33 168.84 18.93 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.73 . . . . 0.0 110.211 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.631 HG22 ' HG2' ' A' ' 5' ' ' LYS . 10.0 p -137.55 165.43 26.32 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.526 -0.734 . . . . 0.0 110.354 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 3' ' ' THR . 7.9 t -146.78 163.03 37.32 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.507 -0.745 . . . . 0.0 110.262 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -111.97 87.63 2.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.499 -0.75 . . . . 0.0 110.24 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.654 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -126.29 -171.76 2.47 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.529 -0.732 . . . . 0.0 110.206 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.7 p -112.41 -25.84 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.563 -0.711 . . . . 0.0 110.224 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -164.91 174.4 10.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.469 -0.77 . . . . 0.0 110.0 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.591 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -54.08 -23.5 14.04 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.422 -0.799 . . . . 0.0 110.781 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.56 -42.84 79.26 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.392 -0.817 . . . . 0.0 109.996 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.654 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 85.6 m -87.93 -34.03 18.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.649 -0.657 . . . . 0.0 109.413 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.591 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -63.25 -178.8 0.27 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.673 -0.642 . . . . 0.0 109.595 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 66.36 -63.01 0.26 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.546 -0.721 . . . . 0.0 110.528 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.83 -34.72 60.13 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.999 -1.063 . . . . 0.0 110.246 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.3 t -82.17 -50.23 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.698 -0.626 . . . . 0.0 109.666 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.539 ' HB3' HD22 ' A' ' 6' ' ' LEU . 4.6 m-85 -62.86 -33.65 75.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.586 -0.696 . . . . 0.0 109.856 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -63.7 -41.32 98.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.593 -0.692 . . . . 0.0 109.28 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -60.97 -31.78 71.35 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.642 0.734 . . . . 0.0 109.714 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -71.53 -55.73 7.28 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.776 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -65.51 -47.18 76.84 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.68 -0.638 . . . . 0.0 110.31 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -56.18 -28.36 57.91 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.491 -0.756 . . . . 0.0 110.519 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.41 -39.64 24.65 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.69 -0.631 . . . . 0.0 110.048 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -79.13 -46.89 17.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.65 -0.656 . . . . 0.0 110.003 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.79 60.06 0.18 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.776 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 86.4 mt -124.04 67.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.549 -0.971 . . . . 0.0 110.173 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.26 53.29 2.6 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.93 -138.47 2.71 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -115.56 101.11 8.57 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.857 -0.79 . . . . 0.0 109.337 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.597 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 34.3 m95 -70.02 143.52 52.52 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 122.002 0.906 . . . . 0.0 112.098 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 44' ' ' TRP . 12.2 p -155.01 130.51 9.81 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -103.08 146.14 28.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.665 -0.647 . . . . 0.0 109.783 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -118.31 116.89 27.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.72 -0.612 . . . . 0.0 109.857 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -71.42 -21.2 62.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.666 -0.646 . . . . 0.0 110.584 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.83 -40.52 66.5 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.269 -0.895 . . . . 0.0 110.806 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.8 p -144.83 17.19 1.61 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.605 -0.684 . . . . 0.0 110.789 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.456 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.27 91.61 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.187 -0.945 . . . . 0.0 111.043 179.724 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 5' ' ' LYS . 59.8 m -158.59 104.8 1.81 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.45 -0.781 . . . . 0.0 110.715 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.501 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 93.1 m-85 -62.16 139.49 58.47 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.635 HG23 HG21 ' A' ' 7' ' ' ILE . 25.2 m -131.51 102.7 6.04 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.954 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.549 HG21 HG22 ' A' ' 40' ' ' ILE . 11.3 p -102.97 166.95 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.347 -0.846 . . . . 0.0 109.17 177.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.609 HG23 ' HB3' ' A' ' 9' ' ' ASN . 99.8 m -160.92 115.09 2.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.666 -0.646 . . . . 0.0 109.964 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.127 179.807 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 mmt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.058 0.456 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.452 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 62.8 m -116.03 112.09 21.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.572 -0.705 . . . . 0.0 110.198 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.6 m -92.26 103.01 15.51 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.604 -0.685 . . . . 0.0 110.503 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.756 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 79.5 m-85 -84.68 170.05 13.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.586 -0.696 . . . . 0.0 110.068 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.66 145.29 38.26 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.571 -0.705 . . . . 0.0 109.889 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 53' ' ' PHE . 18.3 tp -123.12 135.2 54.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.484 -0.76 . . . . 0.0 110.436 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.638 HG21 HG23 ' A' ' 54' ' ' THR . 3.8 tp -85.56 156.0 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.723 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.472 HG21 ' HB3' ' A' ' 13' ' ' LEU . 49.5 mm -120.51 74.78 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.368 -179.632 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.587 ' HB3' HG23 ' A' ' 56' ' ' THR . 5.9 m-20 -95.7 47.35 1.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 178.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.74 153.28 17.59 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -69.28 -10.91 60.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.627 -0.925 . . . . 0.0 110.452 179.17 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.2 m -87.66 -37.76 16.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 110.256 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.472 ' HB3' HG21 ' A' ' 8' ' ' ILE . 18.1 mt -138.62 172.44 12.88 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.45 -0.781 . . . . 0.0 110.778 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -151.9 135.93 16.53 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.602 -0.686 . . . . 0.0 110.094 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.12 -145.46 15.73 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -146.18 178.2 8.41 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.585 -0.95 . . . . 0.0 110.406 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.4 m -159.71 152.87 22.01 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 110.16 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.0 p -124.51 163.4 21.94 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.561 -0.712 . . . . 0.0 110.349 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 t -150.5 -171.54 3.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.633 -0.667 . . . . 0.0 110.211 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.35 98.35 5.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.549 -0.719 . . . . 0.0 110.33 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.403 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -128.3 148.54 50.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.456 -0.777 . . . . 0.0 109.844 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.8 p -63.35 -36.43 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.041 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -169.75 -174.9 1.96 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.606 -0.683 . . . . 0.0 110.081 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -54.54 -26.02 29.4 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.504 -0.747 . . . . 0.0 111.074 -179.523 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.87 -28.64 69.02 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.506 -0.747 . . . . 0.0 110.3 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.403 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 4.5 m -113.03 -25.81 8.78 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.596 -0.69 . . . . 0.0 110.464 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.756 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.58 -61.74 2.37 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.471 -0.768 . . . . 0.0 110.496 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -57.7 -34.42 69.43 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.55 -0.719 . . . . 0.0 110.166 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -58.01 -36.86 73.28 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.37 -0.831 . . . . 0.0 109.996 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.2 t -84.59 -48.6 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.67 -0.644 . . . . 0.0 109.674 179.477 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -62.31 -37.01 83.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.623 -0.673 . . . . 0.0 110.008 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -62.76 -47.28 84.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.572 -0.705 . . . . 0.0 109.169 179.413 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -63.21 -34.19 77.1 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.708 0.766 . . . . 0.0 109.286 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -65.81 -53.31 41.83 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.62 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.89 -45.72 84.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.735 -0.603 . . . . 0.0 109.895 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -58.82 -37.03 75.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 110.349 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -65.46 -54.17 32.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.659 -0.651 . . . . 0.0 109.949 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -69.61 -49.24 55.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.566 -0.709 . . . . 0.0 109.852 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.69 54.17 0.11 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.62 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.1 mt -119.97 70.32 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.427 -1.043 . . . . 0.0 110.236 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -94.55 48.82 1.23 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.626 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.16 -138.24 0.6 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -110.31 111.7 23.18 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.474 ' O ' HG23 ' A' ' 45' ' ' THR . 35.9 m95 -83.83 143.27 30.04 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.213 1.006 . . . . 0.0 112.738 -177.904 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 44' ' ' TRP . 1.7 p -154.7 131.72 10.91 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.606 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -101.03 143.94 30.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.65 -0.656 . . . . 0.0 110.306 -178.454 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -115.75 109.58 17.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.726 -0.609 . . . . 0.0 109.775 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -67.13 -21.8 65.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.646 -0.659 . . . . 0.0 110.593 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.449 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.4 -40.26 64.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.318 -0.864 . . . . 0.0 110.805 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.449 HG23 ' C ' ' A' ' 49' ' ' ALA . 80.1 p -148.82 21.04 1.01 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.549 -0.719 . . . . 0.0 110.676 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.439 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.54 92.74 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.168 -0.957 . . . . 0.0 110.744 179.874 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.1 m -152.57 101.64 2.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.355 -0.841 . . . . 0.0 111.515 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.403 ' O ' HD12 ' A' ' 6' ' ' LEU . 91.6 m-85 -63.49 124.21 20.74 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.272 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.638 HG23 HG21 ' A' ' 7' ' ' ILE . 63.0 m -115.23 96.66 5.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.263 -0.898 . . . . 0.0 113.14 -177.532 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.533 HG21 HG22 ' A' ' 40' ' ' ILE . 10.4 p -99.24 166.89 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 177.339 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.587 HG23 ' HB3' ' A' ' 9' ' ' ASN . 92.5 m -157.5 105.77 2.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.606 -0.684 . . . . 0.0 109.749 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.254 -179.723 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 121.092 0.472 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.568 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 44.1 m -99.14 111.31 23.73 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.546 -0.721 . . . . 0.0 110.362 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.2 m -85.53 90.83 8.08 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.589 -0.694 . . . . 0.0 110.623 -179.687 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.568 ' CZ ' HG21 ' A' ' 2' ' ' THR . 96.5 m-85 -73.28 170.34 15.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.478 -0.764 . . . . 0.0 109.81 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -141.44 139.71 33.45 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.467 -0.77 . . . . 0.0 110.583 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.528 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 38.9 tp -114.3 121.39 43.5 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.636 -0.665 . . . . 0.0 109.95 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.666 HG21 HG23 ' A' ' 54' ' ' THR . 3.8 tp -71.47 166.26 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.666 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 13' ' ' LEU . 71.5 mt -127.7 72.51 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.335 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.535 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.6 m-20 -93.62 49.17 1.34 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.456 -0.777 . . . . 0.0 109.107 179.117 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.4 149.7 18.81 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -66.71 -13.63 61.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.649 -0.913 . . . . 0.0 110.41 179.406 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.6 m -85.05 -37.59 20.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.243 -0.911 . . . . 0.0 110.446 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.463 ' O ' HG22 ' A' ' 8' ' ' ILE . 10.0 mt -141.38 170.06 16.43 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.444 -0.785 . . . . 0.0 110.769 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -151.22 141.49 22.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.611 -0.681 . . . . 0.0 110.177 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.401 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 129.95 -149.73 18.89 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -144.4 160.3 41.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.535 -0.98 . . . . 0.0 110.351 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.7 m -147.89 147.84 30.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.585 -0.697 . . . . 0.0 110.207 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -119.27 171.23 8.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.529 -0.732 . . . . 0.0 110.225 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.449 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 7.9 t -142.97 -170.43 3.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.548 -0.72 . . . . 0.0 110.369 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -126.86 88.59 2.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.622 -0.674 . . . . 0.0 110.123 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.809 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -130.64 137.89 49.82 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.608 -0.682 . . . . 0.0 110.3 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.1 m -59.39 -25.45 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.527 -0.733 . . . . 0.0 110.574 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.718 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 26.1 p30 -170.87 179.95 3.0 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.401 -0.812 . . . . 0.0 110.404 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.585 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -55.18 -22.84 18.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.478 -0.764 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.718 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -56.04 -45.14 79.28 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.307 -0.87 . . . . 0.0 110.173 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.809 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 62.7 m -85.83 -31.63 22.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.649 -0.657 . . . . 0.0 109.541 179.262 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . . . -62.26 -176.93 0.11 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.698 -0.626 . . . . 0.0 109.611 179.44 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 66.63 -61.73 0.3 Allowed 'General case' 0 N--CA 1.508 2.455 0 O-C-N 121.508 -0.745 . . . . 0.0 110.75 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -55.63 -34.22 64.73 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.064 -1.022 . . . . 0.0 110.268 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.0 t -83.49 -49.81 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.599 -0.688 . . . . 0.0 109.768 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.449 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 7.7 m-85 -63.17 -34.19 77.09 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.578 -0.701 . . . . 0.0 109.668 179.837 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -63.56 -41.23 98.42 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.628 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -62.8 -33.83 76.01 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.701 0.763 . . . . 0.0 109.544 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -68.02 -51.47 46.58 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.015 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.728 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -68.53 -49.07 62.34 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.792 -0.567 . . . . 0.0 110.078 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -55.94 -29.78 60.67 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.468 -0.77 . . . . 0.0 110.356 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.36 -40.16 89.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.681 -0.637 . . . . 0.0 109.822 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.26 -44.15 10.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.624 -0.672 . . . . 0.0 109.983 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.52 38.62 0.51 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.728 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.9 mt -93.32 64.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.379 -1.071 . . . . 0.0 109.908 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.3 54.77 3.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.503 -0.748 . . . . 0.0 108.999 178.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.76 -136.55 1.8 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.038 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -114.08 102.09 9.84 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.932 -0.746 . . . . 0.0 109.035 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.528 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 40.4 m95 -74.44 142.41 44.94 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.154 0.978 . . . . 0.0 112.226 -178.133 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 44' ' ' TRP . 4.5 p -153.22 131.3 11.85 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.657 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.429 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 13.7 t80 -107.5 113.56 26.97 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.877 -178.529 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.37 118.62 26.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.699 -0.626 . . . . 0.0 109.929 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -69.76 -23.41 63.36 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.72 -0.612 . . . . 0.0 110.36 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.38 -37.12 55.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.416 -0.803 . . . . 0.0 111.015 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.3 p -144.34 14.51 1.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.482 -0.761 . . . . 0.0 111.12 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HG3' ' CE2' ' A' ' 46' ' ' TYR . 1.0 OUTLIER 50.97 86.72 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.043 -1.036 . . . . 0.0 110.82 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.1 m -153.14 107.48 3.12 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.515 -0.741 . . . . 0.0 110.934 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -64.06 124.15 20.86 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.745 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.666 HG23 HG21 ' A' ' 7' ' ' ILE . 91.7 m -116.14 98.32 6.55 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.283 -0.886 . . . . 0.0 112.888 -177.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.569 HG21 HG22 ' A' ' 40' ' ' ILE . 10.3 p -98.13 166.75 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.887 . . . . 0.0 109.395 177.478 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.535 HG23 ' HB3' ' A' ' 9' ' ' ASN . 99.7 m -160.78 108.84 1.58 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.648 -0.657 . . . . 0.0 109.751 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.13 -179.961 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 mtm . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.082 0.468 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.632 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 5.7 m -102.7 113.85 27.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.534 -0.729 . . . . 0.0 110.118 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.597 ' O ' HG23 ' A' ' 3' ' ' THR . 8.9 t -96.35 79.24 3.1 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.68 -0.637 . . . . 0.0 110.99 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.789 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 97.4 m-85 -62.14 166.38 4.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.321 -0.862 . . . . 0.0 109.6 179.445 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.404 ' HB3' HG23 ' A' ' 52' ' ' THR . 37.4 ttpt -137.4 122.21 18.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.403 -0.811 . . . . 0.0 110.658 -179.778 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.65 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 47.0 tp -99.88 130.59 46.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.546 -0.721 . . . . 0.0 110.049 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.662 HG21 HG23 ' A' ' 54' ' ' THR . 3.4 tp -81.75 165.52 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.721 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 13' ' ' LEU . 70.1 mt -124.11 73.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.251 -0.906 . . . . 0.0 110.279 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.17 46.79 1.12 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 0.0 108.967 178.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.22 158.1 15.66 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.401 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -76.31 -5.07 45.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.767 -0.843 . . . . 0.0 110.604 179.386 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.73 ' O ' HD22 ' A' ' 13' ' ' LEU . 5.2 m -99.15 -36.84 9.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.191 -0.943 . . . . 0.0 110.273 -179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.73 HD22 ' O ' ' A' ' 12' ' ' THR . 0.5 OUTLIER -137.33 164.29 28.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.444 -0.785 . . . . 0.0 110.53 -179.948 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.16 138.4 19.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.602 -0.686 . . . . 0.0 110.326 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.492 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 139.21 -141.94 12.34 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -145.71 157.94 43.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.546 -0.973 . . . . 0.0 110.396 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.9 m -146.39 137.91 24.63 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.613 -0.679 . . . . 0.0 110.123 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.3 p -119.48 164.16 16.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.538 -0.727 . . . . 0.0 110.264 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.593 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.5 t -152.8 -166.26 2.41 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.589 -0.694 . . . . 0.0 110.285 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -131.12 122.66 27.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.712 -0.617 . . . . 0.0 110.204 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.481 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -151.08 158.71 44.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.575 -0.703 . . . . 0.0 110.197 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 22' ' ' VAL . 8.4 p -77.3 -25.44 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.583 -0.698 . . . . 0.0 110.156 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.566 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 25.8 p30 -172.41 179.61 2.47 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.406 -0.809 . . . . 0.0 110.277 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.416 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.61 -25.66 53.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.541 -0.725 . . . . 0.0 110.807 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.566 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.99 -27.32 65.31 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.484 -0.76 . . . . 0.0 110.489 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.481 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 62.5 m -109.27 -27.87 9.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.505 -0.747 . . . . 0.0 110.313 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.789 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.64 -55.64 31.95 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.522 -0.736 . . . . 0.0 110.324 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -59.22 -42.11 90.22 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.573 -0.704 . . . . 0.0 110.333 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -57.59 -35.77 70.85 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.336 -0.853 . . . . 0.0 110.177 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 26' ' ' THR . 87.9 t -83.42 -49.04 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.692 -0.63 . . . . 0.0 110.004 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.593 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.2 m-85 -65.44 -35.45 80.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.56 -0.713 . . . . 0.0 110.329 -179.69 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -64.06 -41.98 97.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.435 -0.791 . . . . 0.0 109.377 179.585 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -60.6 -29.63 69.33 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.561 0.696 . . . . 0.0 109.957 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -73.22 -54.11 9.23 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.212 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.695 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.41 -44.14 92.18 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.665 -0.647 . . . . 0.0 110.073 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -56.38 -37.33 69.96 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.494 -0.754 . . . . 0.0 110.581 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -75.1 -50.38 16.56 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.652 -0.655 . . . . 0.0 110.146 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -65.8 -48.5 71.51 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.528 -0.732 . . . . 0.0 110.067 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.3 62.05 0.2 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.695 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 85.5 mt -129.56 77.22 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.472 -1.016 . . . . 0.0 110.458 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.76 40.7 1.15 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.15 -136.14 0.02 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.479 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -120.22 100.79 7.39 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.82 -0.812 . . . . 0.0 109.011 179.284 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.65 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 27.8 m95 -67.38 142.97 56.56 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.218 1.008 . . . . 0.0 112.478 -177.76 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.5 p -151.72 131.6 13.31 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.801 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -103.13 128.55 50.02 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.696 -0.628 . . . . 0.0 109.967 -178.714 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -97.59 108.2 20.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.686 -0.634 . . . . 0.0 110.019 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -65.97 -20.08 66.08 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.645 -0.659 . . . . 0.0 110.633 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.442 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.71 -38.6 64.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.282 -0.886 . . . . 0.0 110.812 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.442 HG23 ' C ' ' A' ' 49' ' ' ALA . 71.6 p -148.61 22.18 1.02 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.522 -0.736 . . . . 0.0 110.752 -179.874 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.88 90.75 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.128 -0.982 . . . . 0.0 110.928 179.828 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 5' ' ' LYS . 60.1 m -156.67 106.37 2.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.477 -0.764 . . . . 0.0 110.857 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -62.27 136.58 57.99 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.535 -0.728 . . . . 0.0 109.095 178.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.662 HG23 HG21 ' A' ' 7' ' ' ILE . 70.4 m -129.77 101.57 5.94 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.558 -178.559 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.54 HG21 HG22 ' A' ' 40' ' ' ILE . 10.2 p -102.81 165.4 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.612 177.706 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.468 ' N ' HG22 ' A' ' 55' ' ' VAL . 59.4 m -163.49 115.34 1.45 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.875 -0.516 . . . . 0.0 109.751 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.34 179.521 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ptp . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.108 0.48 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.736 HG22 ' O ' ' A' ' 21' ' ' ALA . 9.9 t -109.8 -171.39 1.83 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.533 -0.729 . . . . 0.0 110.234 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.7 m -129.49 96.11 4.18 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.539 -0.725 . . . . 0.0 110.739 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.759 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 84.9 m-85 -77.6 169.34 18.46 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.533 -0.729 . . . . 0.0 109.644 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -140.14 113.61 8.57 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.503 -0.748 . . . . 0.0 110.418 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.622 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 42.8 tp -94.03 122.31 36.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.565 -0.709 . . . . 0.0 109.966 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.632 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.9 tp -72.92 166.83 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.714 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.498 HD12 ' C ' ' A' ' 15' ' ' GLY . 73.8 mt -128.67 73.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.527 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.651 ' HB3' HG23 ' A' ' 56' ' ' THR . 5.7 m-20 -94.37 49.55 1.3 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.416 -0.802 . . . . 0.0 109.124 178.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.31 151.79 18.32 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.6 -10.1 56.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.678 -0.895 . . . . 0.0 110.613 179.426 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.1 m -90.38 -32.49 16.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 110.373 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 13' ' ' LEU . 28.3 mt -143.34 173.12 11.89 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.451 -0.781 . . . . 0.0 110.917 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -156.69 140.68 16.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.618 -0.676 . . . . 0.0 110.129 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.498 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 128.11 -134.48 8.19 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.402 ' N ' HD12 ' A' ' 8' ' ' ILE . 6.8 pt-20 -162.1 164.98 27.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.518 -0.99 . . . . 0.0 110.286 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.411 HG22 ' N ' ' A' ' 18' ' ' THR . 76.2 m -138.69 164.06 30.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.542 -0.724 . . . . 0.0 110.339 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.411 ' N ' HG22 ' A' ' 17' ' ' THR . 25.6 p -136.98 161.06 37.09 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.57 -0.706 . . . . 0.0 110.204 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.598 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.6 t -169.78 148.43 3.58 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.543 -0.723 . . . . 0.0 110.192 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 2' ' ' THR . 43.5 mt-10 -82.36 132.43 35.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.495 -0.753 . . . . 0.0 110.13 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.736 ' O ' HG22 ' A' ' 2' ' ' THR . . . -155.36 140.98 17.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.358 -0.839 . . . . 0.0 110.473 -179.814 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.6 m -58.8 -32.59 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.571 -0.706 . . . . 0.0 110.405 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.598 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 30.0 p30 -170.14 179.11 3.62 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.546 -0.721 . . . . 0.0 110.294 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.98 -24.67 40.01 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.492 -0.755 . . . . 0.0 110.847 -179.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.598 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.67 -35.13 72.09 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.438 -0.789 . . . . 0.0 110.508 -179.889 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.5 m -97.4 -25.58 15.16 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.52 -0.737 . . . . 0.0 110.506 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.759 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -66.62 -58.51 5.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.436 -0.79 . . . . 0.0 110.467 -179.742 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -57.23 -42.12 80.79 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.573 -0.704 . . . . 0.0 110.597 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -55.99 -40.65 73.63 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.298 -0.876 . . . . 0.0 110.196 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.4 t -80.18 -49.41 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.626 -0.671 . . . . 0.0 109.733 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.598 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.7 m-85 -61.77 -30.51 70.84 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.098 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -65.11 -43.76 90.97 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.168 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -62.57 -30.86 71.63 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.606 0.717 . . . . 0.0 109.439 178.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -70.95 -50.28 36.36 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.171 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.686 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -69.93 -42.92 72.65 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.638 -0.664 . . . . 0.0 109.989 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -58.7 -38.29 77.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.563 -0.711 . . . . 0.0 110.517 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -71.3 -51.96 21.54 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.551 -0.718 . . . . 0.0 110.037 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -66.66 -48.85 68.07 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.544 -0.722 . . . . 0.0 109.931 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.14 61.45 0.19 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.686 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 83.1 mt -126.18 68.23 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.519 -0.989 . . . . 0.0 110.331 179.657 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.76 52.92 2.42 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.792 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.49 -140.28 4.08 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.2 110.52 21.06 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.904 -0.762 . . . . 0.0 109.471 179.53 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.622 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 31.6 m95 -80.23 143.9 33.35 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.125 0.964 . . . . 0.0 112.318 -178.134 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 44' ' ' TRP . 2.7 p -157.48 131.65 8.29 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -107.43 146.03 32.23 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.704 -0.623 . . . . 0.0 109.894 -178.647 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.487 ' OD1' ' HB3' ' A' ' 49' ' ' ALA . 23.3 t0 -118.36 114.99 23.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.716 -0.615 . . . . 0.0 109.929 179.853 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -69.31 -24.05 63.88 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.666 -0.646 . . . . 0.0 110.542 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.487 ' HB3' ' OD1' ' A' ' 47' ' ' ASP . . . -52.48 -36.82 55.78 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.37 -0.831 . . . . 0.0 110.832 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.431 HG23 ' C ' ' A' ' 49' ' ' ALA . 77.1 p -147.81 17.71 1.13 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.574 -0.703 . . . . 0.0 110.88 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.46 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.26 93.06 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.221 -0.924 . . . . 0.0 111.01 179.793 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.4 m -157.72 105.27 2.01 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.233 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -64.67 136.56 57.09 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.632 ' HA ' HG22 ' A' ' 7' ' ' ILE . 51.1 m -127.59 100.02 5.82 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.887 -178.506 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.513 HG11 HG21 ' A' ' 40' ' ' ILE . 11.4 p -104.88 166.65 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 108.974 177.093 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.651 HG23 ' HB3' ' A' ' 9' ' ' ASN . 94.1 m -161.12 112.33 1.79 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.719 -0.613 . . . . 0.0 109.778 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.158 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptt? . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.106 0.479 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.562 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 63.3 m -112.61 112.12 23.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.565 -0.71 . . . . 0.0 110.32 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 19' ' ' THR . 42.0 m -96.19 94.39 7.48 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.654 -0.654 . . . . 0.0 110.417 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.77 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.4 m-85 -72.14 167.49 20.17 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.528 -0.732 . . . . 0.0 109.966 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.553 ' HG2' HG22 ' A' ' 18' ' ' THR . 12.1 mtmt -132.77 115.82 15.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.544 -0.722 . . . . 0.0 110.317 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.671 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -94.09 111.84 23.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.518 -0.738 . . . . 0.0 110.263 -179.977 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.635 HG22 ' HA ' ' A' ' 54' ' ' THR . 3.8 tp -63.74 171.32 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.074 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.478 HD11 ' OG1' ' A' ' 17' ' ' THR . 74.0 mt -133.23 74.53 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.928 . . . . 0.0 110.678 -179.872 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.484 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.4 m-80 -95.56 48.0 1.13 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.875 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.18 156.81 15.36 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.347 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -74.47 -6.57 49.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.766 -0.844 . . . . 0.0 110.346 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.9 m -92.64 -37.1 12.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 110.133 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.406 ' HB3' HG21 ' A' ' 8' ' ' ILE . 7.3 mt -139.78 176.06 9.06 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.536 -0.728 . . . . 0.0 110.527 -180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.15 138.9 11.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.574 -0.704 . . . . 0.0 110.225 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.26 -136.54 9.04 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -144.46 162.91 35.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.56 -0.965 . . . . 0.0 110.332 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.478 ' OG1' HD11 ' A' ' 8' ' ' ILE . 5.6 m -146.67 130.23 16.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.598 -0.689 . . . . 0.0 110.107 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.553 HG22 ' HG2' ' A' ' 5' ' ' LYS . 66.8 p -112.4 174.88 5.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.628 -0.67 . . . . 0.0 110.323 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.567 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.4 t -166.54 -170.55 1.66 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.573 -0.705 . . . . 0.0 110.246 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -120.95 105.72 10.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.545 -0.722 . . . . 0.0 110.222 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.519 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -136.43 140.81 43.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.557 -0.714 . . . . 0.0 110.138 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.609 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.1 p -61.85 -30.67 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.552 -0.718 . . . . 0.0 109.909 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.609 ' OD1' HG13 ' A' ' 22' ' ' VAL . 48.4 p-10 -168.89 179.11 4.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.67 -0.644 . . . . 0.0 110.142 179.812 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.421 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.56 -23.01 14.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.489 -0.757 . . . . 0.0 111.137 -179.575 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.426 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.86 -32.1 70.39 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.391 -0.818 . . . . 0.0 110.441 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.519 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 5.4 m -104.05 -26.99 12.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.529 -0.732 . . . . 0.0 110.47 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.77 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.67 -58.17 9.59 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.526 -0.734 . . . . 0.0 110.495 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -58.43 -45.09 89.19 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.483 -0.76 . . . . 0.0 110.521 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -54.4 -41.0 68.75 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.254 -0.903 . . . . 0.0 110.507 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.2 t -81.39 -47.89 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.649 -0.657 . . . . 0.0 110.091 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CZ ' HG22 ' A' ' 19' ' ' THR . 4.5 m-85 -63.84 -32.72 74.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.694 . . . . 0.0 110.212 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -64.93 -42.97 94.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -63.64 -33.54 75.84 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.712 0.767 . . . . 0.0 109.099 178.748 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -66.06 -57.01 8.68 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.745 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.805 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.65 -46.18 91.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.753 -0.592 . . . . 0.0 110.085 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -57.48 -34.85 69.45 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.578 -0.701 . . . . 0.0 110.566 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.19 -48.47 67.83 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.537 -0.727 . . . . 0.0 110.135 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -76.49 -47.26 23.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.58 -0.7 . . . . 0.0 110.041 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.22 69.17 0.19 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.805 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 81.7 mt -127.44 60.82 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.997 . . . . 0.0 110.343 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -82.46 60.72 5.26 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.697 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.8 -140.8 10.05 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -178.649 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -114.04 105.5 13.3 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.922 -0.752 . . . . 0.0 109.039 179.604 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.671 ' HH2' HD11 ' A' ' 6' ' ' LEU . 55.9 m95 -75.78 143.27 42.05 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.04 0.924 . . . . 0.0 112.209 -178.17 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 44' ' ' TRP . 4.1 p -153.16 132.08 12.49 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.783 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.412 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 48.7 t80 -99.82 131.62 45.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.744 -0.597 . . . . 0.0 110.18 -178.509 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.16 119.15 38.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.754 -0.591 . . . . 0.0 109.951 179.746 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.24 -21.32 56.51 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.591 -0.693 . . . . 0.0 110.719 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.424 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.07 -40.39 67.16 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.311 -0.868 . . . . 0.0 110.829 -179.691 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.424 HG23 ' C ' ' A' ' 49' ' ' ALA . 70.0 p -147.55 19.51 1.18 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.585 -0.697 . . . . 0.0 110.84 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.412 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 0.6 OUTLIER 51.68 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.195 -0.941 . . . . 0.0 111.004 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 5' ' ' LYS . 57.1 m -158.54 108.33 2.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.513 -0.742 . . . . 0.0 110.684 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.503 ' O ' HD23 ' A' ' 6' ' ' LEU . 64.9 m-85 -62.22 127.44 31.36 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.576 -0.703 . . . . 0.0 109.177 179.146 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.635 ' HA ' HG22 ' A' ' 7' ' ' ILE . 58.1 m -120.3 105.39 10.88 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.398 -0.921 . . . . 0.0 112.47 -178.465 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.598 HG11 HG21 ' A' ' 40' ' ' ILE . 11.9 p -109.57 168.14 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.468 -0.77 . . . . 0.0 108.954 177.478 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 9' ' ' ASN . 96.5 m -160.04 109.7 1.81 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.471 -0.768 . . . . 0.0 110.013 -179.511 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.242 -179.941 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.055 0.455 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.525 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 71.4 m -97.66 111.96 24.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.619 -0.676 . . . . 0.0 110.136 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.5 m -93.54 91.4 7.08 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.623 -0.673 . . . . 0.0 110.576 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.666 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.8 m-85 -69.15 173.49 5.55 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.542 -0.724 . . . . 0.0 109.934 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.47 ' O ' HG23 ' A' ' 52' ' ' THR . 5.3 mtpm? -139.56 110.54 6.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.454 -0.778 . . . . 0.0 110.416 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.6 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -91.28 109.63 20.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.535 -0.728 . . . . 0.0 110.068 179.872 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.661 HG21 HG23 ' A' ' 54' ' ' THR . 2.7 tt -63.06 171.75 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.341 -0.849 . . . . 0.0 108.854 179.315 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.518 HG21 ' HB3' ' A' ' 13' ' ' LEU . 80.1 mt -133.64 71.94 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.438 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.477 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.7 m-20 -95.12 47.7 1.15 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.423 -0.798 . . . . 0.0 109.175 179.125 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.96 160.24 13.52 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.524 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -76.43 -7.36 54.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.653 -0.91 . . . . 0.0 110.461 179.202 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.2 t -98.34 -23.51 15.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.458 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.518 ' HB3' HG21 ' A' ' 8' ' ' ILE . 35.8 mt -147.21 163.62 35.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.321 -0.862 . . . . 0.0 110.495 179.848 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.47 132.68 17.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.64 -0.663 . . . . 0.0 110.146 179.864 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.4 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 133.06 -142.07 13.54 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -145.84 171.59 14.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.537 -0.978 . . . . 0.0 110.239 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 m -147.53 156.6 42.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.632 -0.667 . . . . 0.0 110.158 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.5 p -138.59 155.56 48.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.563 -0.711 . . . . 0.0 110.256 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.723 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.3 t -154.8 160.38 41.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.584 -0.698 . . . . 0.0 110.283 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -90.02 106.72 18.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.599 -0.688 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.05 139.28 45.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.622 -0.674 . . . . 0.0 110.216 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.494 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.2 p -59.21 -34.59 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.547 -0.721 . . . . 0.0 110.1 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.588 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 51.3 p30 -169.3 -178.77 3.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.586 -0.696 . . . . 0.0 110.271 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.416 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.98 -23.0 17.1 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.531 -0.73 . . . . 0.0 111.053 -179.828 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.588 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.06 -26.32 62.35 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.49 -0.756 . . . . 0.0 110.701 -179.672 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.1 m -114.76 -24.85 8.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.422 -0.799 . . . . 0.0 110.691 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.666 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.1 -60.03 4.52 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.402 -0.811 . . . . 0.0 110.415 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -59.42 -37.2 77.43 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.542 -0.724 . . . . 0.0 110.401 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -56.72 -44.73 81.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.423 -0.798 . . . . 0.0 110.578 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.0 t -80.13 -43.34 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.52 -0.737 . . . . 0.0 109.96 179.732 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.723 ' CZ ' HG22 ' A' ' 19' ' ' THR . 10.3 m-85 -65.52 -35.2 80.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.554 -0.717 . . . . 0.0 110.329 -179.727 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -63.64 -45.48 90.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 108.991 179.286 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -63.43 -32.84 74.39 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.69 0.757 . . . . 0.0 109.136 178.883 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -66.48 -56.58 10.22 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.802 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.783 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -59.56 -45.87 90.58 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.695 -0.628 . . . . 0.0 110.15 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -58.51 -32.49 68.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.57 -0.706 . . . . 0.0 110.328 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -60.94 -59.93 4.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.599 -0.688 . . . . 0.0 109.968 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -72.5 -45.98 56.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.624 -0.673 . . . . 0.0 109.828 179.66 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.36 72.89 0.23 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.725 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.783 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.4 mt -122.9 62.06 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.482 -1.011 . . . . 0.0 110.004 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.78 61.12 5.0 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.919 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.72 -140.76 9.98 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -178.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -116.62 104.53 11.48 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.877 -0.778 . . . . 0.0 109.038 179.563 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.6 ' HH2' HD11 ' A' ' 6' ' ' LEU . 53.6 m95 -73.98 143.94 45.41 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 122.084 0.945 . . . . 0.0 112.248 -178.112 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 44' ' ' TRP . 2.0 p -153.84 132.13 11.95 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.75 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.406 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 26.4 t80 -103.74 139.08 39.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.618 -0.676 . . . . 0.0 110.186 -178.721 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -113.34 122.05 46.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.718 -0.613 . . . . 0.0 109.843 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -75.89 -19.5 58.78 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.732 -0.605 . . . . 0.0 110.778 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.444 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.37 -39.18 66.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.24 -0.913 . . . . 0.0 110.774 -179.718 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.444 HG23 ' C ' ' A' ' 49' ' ' ALA . 74.4 p -148.18 18.56 1.09 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.561 -0.712 . . . . 0.0 110.752 -179.985 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.3 94.97 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.23 -0.919 . . . . 0.0 110.927 179.977 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 5' ' ' LYS . 70.2 m -156.22 108.78 2.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.472 -0.767 . . . . 0.0 111.015 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.463 ' O ' HD23 ' A' ' 6' ' ' LEU . 77.1 m-85 -65.17 127.58 32.28 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.59 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.661 HG23 HG21 ' A' ' 7' ' ' ILE . 45.7 m -120.23 102.87 8.79 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.753 -178.214 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.587 HG11 HG21 ' A' ' 40' ' ' ILE . 10.6 p -105.72 167.33 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.374 -0.829 . . . . 0.0 108.99 177.372 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.477 HG23 ' HB3' ' A' ' 9' ' ' ASN . 99.4 m -160.35 111.07 1.85 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.555 -0.716 . . . . 0.0 110.097 -179.603 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.169 179.87 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.5 mmm . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.096 0.474 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.495 HG22 ' CE2' ' A' ' 4' ' ' PHE . 92.6 m -103.07 112.12 24.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.633 -0.667 . . . . 0.0 110.153 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.5 m -92.95 108.53 20.07 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.618 -0.676 . . . . 0.0 110.437 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.792 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 73.7 m-85 -88.47 174.12 8.3 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.587 -0.696 . . . . 0.0 110.098 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.443 ' HB3' HG23 ' A' ' 52' ' ' THR . 0.4 OUTLIER -142.68 112.97 7.18 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 110.406 179.937 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.591 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -96.09 112.62 24.3 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.496 -0.753 . . . . 0.0 109.941 179.731 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.657 HG21 HG23 ' A' ' 54' ' ' THR . 2.4 tt -65.37 172.58 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.977 179.338 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.479 HG21 ' HB3' ' A' ' 13' ' ' LEU . 77.6 mt -133.98 72.33 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.384 -0.822 . . . . 0.0 110.383 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -95.23 47.17 1.13 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.439 -0.788 . . . . 0.0 109.272 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.32 160.7 13.38 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -77.64 -2.72 37.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.734 -0.862 . . . . 0.0 110.495 179.309 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -101.45 -30.44 11.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.969 . . . . 0.0 109.951 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.479 ' HB3' HG21 ' A' ' 8' ' ' ILE . 60.4 mt -140.01 165.9 26.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.482 -0.761 . . . . 0.0 110.508 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -151.11 132.41 14.54 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.643 -0.661 . . . . 0.0 110.218 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 131.84 -133.44 7.17 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -162.52 160.36 25.97 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.547 -0.972 . . . . 0.0 110.428 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.2 m -140.79 143.13 34.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.572 -0.705 . . . . 0.0 110.069 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.5 p -122.84 150.16 43.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.505 -0.747 . . . . 0.0 110.403 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.705 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.8 t -143.54 -172.09 3.65 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.647 -0.658 . . . . 0.0 110.247 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -114.34 107.73 15.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.59 -0.694 . . . . 0.0 110.146 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -132.63 147.8 52.35 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.586 -0.696 . . . . 0.0 110.096 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.6 p -65.7 -31.69 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.542 -0.724 . . . . 0.0 109.57 179.482 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -173.07 -174.94 1.12 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.587 -0.696 . . . . 0.0 109.952 179.574 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.457 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.27 -24.77 12.33 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.456 -0.777 . . . . 0.0 111.162 -179.458 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.59 78.14 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.497 -0.752 . . . . 0.0 110.377 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.589 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 5.1 m -100.78 -28.18 12.95 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.56 -0.712 . . . . 0.0 110.431 -179.88 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.792 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -61.42 -61.89 2.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.476 -0.765 . . . . 0.0 110.294 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -60.52 -37.28 80.66 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.596 -0.69 . . . . 0.0 110.25 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -57.6 -43.62 84.84 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.424 -0.798 . . . . 0.0 110.391 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.26 -45.81 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.585 -0.697 . . . . 0.0 109.819 179.691 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.705 ' CZ ' HG22 ' A' ' 19' ' ' THR . 11.5 m-85 -64.01 -33.21 75.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.573 -0.704 . . . . 0.0 110.283 -179.782 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -64.57 -45.09 88.51 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.132 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -63.02 -33.61 75.8 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.697 0.761 . . . . 0.0 109.18 178.911 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -64.5 -54.98 23.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.751 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.806 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.27 -44.27 96.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.784 -0.573 . . . . 0.0 110.023 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -57.92 -35.79 71.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.556 -0.715 . . . . 0.0 110.484 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.47 -43.35 99.02 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.624 -0.672 . . . . 0.0 110.023 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.423 ' CG ' HD11 ' A' ' 13' ' ' LEU . 71.2 m-80 -84.31 -42.46 15.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.625 -0.672 . . . . 0.0 109.922 179.814 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.51 47.47 0.41 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.722 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.806 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 79.6 mt -96.91 63.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.463 -1.022 . . . . 0.0 110.168 179.798 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.4 59.56 4.64 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.89 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.53 -139.71 8.1 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.046 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -118.59 103.09 9.39 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.307 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.591 ' CH2' HD11 ' A' ' 6' ' ' LEU . 53.1 m95 -71.62 142.73 49.95 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.065 0.936 . . . . 0.0 112.266 -177.854 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p -150.26 131.62 14.64 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.678 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -108.97 123.56 49.3 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.719 -0.613 . . . . 0.0 110.099 -178.606 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -100.93 119.05 38.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.708 -0.62 . . . . 0.0 109.834 179.599 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.36 -19.41 62.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.672 -0.643 . . . . 0.0 110.812 -179.746 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.427 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.12 -37.69 55.02 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.214 -0.929 . . . . 0.0 110.877 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.427 HG23 ' C ' ' A' ' 49' ' ' ALA . 75.7 p -147.06 17.37 1.22 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.628 -0.67 . . . . 0.0 110.754 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.87 86.67 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.18 -0.95 . . . . 0.0 110.948 179.817 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.443 HG23 ' HB3' ' A' ' 5' ' ' LYS . 86.6 m -151.51 105.7 3.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.483 -0.761 . . . . 0.0 110.766 -179.875 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.442 ' O ' HD23 ' A' ' 6' ' ' LEU . 97.6 m-85 -62.06 129.14 39.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.462 -0.774 . . . . 0.0 108.971 178.981 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.657 HG23 HG21 ' A' ' 7' ' ' ILE . 57.5 m -121.92 102.13 7.99 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.451 -178.668 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.624 HG11 HG21 ' A' ' 40' ' ' ILE . 10.2 p -103.16 167.46 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.381 -0.824 . . . . 0.0 109.319 177.744 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.459 ' N ' HG22 ' A' ' 55' ' ' VAL . 99.7 m -159.99 110.33 1.87 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.598 -0.689 . . . . 0.0 110.159 -179.474 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.068 179.721 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.006 0.432 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.564 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 67.5 m -91.27 111.16 22.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.619 -0.676 . . . . 0.0 110.259 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.5 m -80.87 101.97 9.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.611 -0.681 . . . . 0.0 110.573 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.705 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 74.9 m-85 -88.2 166.95 14.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.545 -0.722 . . . . 0.0 109.813 179.652 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -134.02 118.56 17.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.416 -0.803 . . . . 0.0 110.414 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.586 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -99.21 112.87 24.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.51 -0.744 . . . . 0.0 110.384 -179.926 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.609 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.5 tp -66.08 167.31 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.07 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.486 HD12 ' C ' ' A' ' 15' ' ' GLY . 73.6 mt -129.0 72.8 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.33 -0.856 . . . . 0.0 110.459 -179.849 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.548 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.2 m-80 -95.87 47.82 1.11 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.264 -0.898 . . . . 0.0 108.999 179.014 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.67 166.43 16.92 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -86.04 6.89 26.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.75 -0.853 . . . . 0.0 110.375 179.066 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -113.95 -30.85 6.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.915 . . . . 0.0 110.067 179.891 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.3 169.67 17.15 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.435 -0.791 . . . . 0.0 110.507 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -153.1 143.41 22.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.608 -0.682 . . . . 0.0 110.258 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.486 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 132.64 -140.73 12.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -153.67 155.91 36.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.631 -0.923 . . . . 0.0 110.209 -179.875 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.474 ' C ' HG23 ' A' ' 18' ' ' THR . 7.9 m -134.94 169.5 17.31 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.6 -0.687 . . . . 0.0 110.281 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.474 HG23 ' C ' ' A' ' 17' ' ' THR . 41.5 p -151.66 150.17 29.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.613 -0.679 . . . . 0.0 110.133 179.929 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.893 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.3 t -156.36 142.86 18.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.593 -0.692 . . . . 0.0 110.236 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -67.07 124.18 22.33 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.585 -0.697 . . . . 0.0 110.24 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.01 140.58 25.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.524 -0.735 . . . . 0.0 110.208 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.454 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.2 p -58.54 -35.24 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.548 -0.72 . . . . 0.0 110.14 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.62 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 35.7 p30 -171.24 -170.79 0.87 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.564 -0.71 . . . . 0.0 110.159 179.546 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.436 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.68 -25.54 54.18 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.507 -0.746 . . . . 0.0 110.844 -179.812 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.62 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.64 -51.88 67.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.464 -0.773 . . . . 0.0 110.429 -179.778 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.8 m -84.56 -27.6 27.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.477 -0.764 . . . . 0.0 110.338 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.705 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -61.39 -59.34 5.42 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.592 -0.692 . . . . 0.0 110.245 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -61.81 -32.63 72.95 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.569 -0.707 . . . . 0.0 110.268 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -57.87 -45.84 85.76 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.42 -0.8 . . . . 0.0 110.445 -179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.0 t -79.54 -42.57 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.61 -0.681 . . . . 0.0 109.879 179.716 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.893 ' CZ ' HG22 ' A' ' 19' ' ' THR . 12.5 m-85 -65.9 -33.85 76.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.631 -0.668 . . . . 0.0 110.182 -179.808 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -64.04 -47.39 80.38 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.305 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -63.64 -33.28 75.28 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.672 0.748 . . . . 0.0 109.081 178.789 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -64.32 -54.51 31.93 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.599 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.772 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.12 -40.17 95.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.825 -0.547 . . . . 0.0 110.014 179.881 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -58.95 -37.29 76.41 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.532 -0.73 . . . . 0.0 110.488 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -64.19 -40.03 95.23 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.55 -0.719 . . . . 0.0 110.265 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -86.38 -29.03 23.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.543 -0.723 . . . . 0.0 110.15 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.74 49.68 1.36 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.772 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.8 mt -103.4 62.7 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.603 -0.939 . . . . 0.0 110.286 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -85.12 58.57 5.11 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.795 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.99 -138.97 6.22 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 -178.848 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -116.74 102.94 9.85 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.497 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.586 ' CH2' HD11 ' A' ' 6' ' ' LEU . 53.0 m95 -72.79 141.39 48.07 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.101 0.953 . . . . 0.0 112.401 -177.915 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.4 132.45 19.27 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.299 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.412 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 53.9 t80 -105.53 113.24 26.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.635 -0.666 . . . . 0.0 110.128 -178.485 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.87 104.12 14.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.702 -0.624 . . . . 0.0 109.826 179.647 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -65.04 -24.83 67.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.676 -0.64 . . . . 0.0 110.553 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.95 -34.81 60.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.414 -0.804 . . . . 0.0 110.787 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.1 p -144.9 15.66 1.56 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.621 -0.674 . . . . 0.0 110.982 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.438 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 50.3 90.34 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.129 -0.982 . . . . 0.0 111.097 179.81 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.7 m -154.89 107.15 2.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.538 -0.726 . . . . 0.0 110.853 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.456 ' O ' HD23 ' A' ' 6' ' ' LEU . 82.6 m-85 -62.08 125.4 23.75 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.483 -0.761 . . . . 0.0 109.041 178.858 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.609 ' HA ' HG22 ' A' ' 7' ' ' ILE . 60.5 m -120.27 100.01 6.92 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.251 -0.98 . . . . 0.0 112.54 -178.618 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.553 HG11 HG21 ' A' ' 40' ' ' ILE . 10.8 p -103.7 167.28 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.39 -0.819 . . . . 0.0 109.212 177.597 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.548 HG23 ' HB3' ' A' ' 9' ' ' ASN . 99.2 m -160.65 109.89 1.69 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.667 -0.646 . . . . 0.0 109.762 -179.785 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.249 -179.922 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.007 0.432 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.459 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 89.2 m -83.72 111.56 19.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.594 -0.691 . . . . 0.0 110.222 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.599 ' O ' HG23 ' A' ' 3' ' ' THR . 8.1 t -80.99 105.86 12.55 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.634 -0.666 . . . . 0.0 110.503 -179.854 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.708 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 60.4 m-85 -90.37 164.42 14.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.447 -0.783 . . . . 0.0 109.966 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.459 ' CB ' HG23 ' A' ' 52' ' ' THR . 18.1 mttm -130.38 122.29 27.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.461 -0.775 . . . . 0.0 110.569 179.964 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.561 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -105.5 110.55 22.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.527 -0.733 . . . . 0.0 109.939 179.81 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.606 HG22 ' HA ' ' A' ' 54' ' ' THR . 2.6 tp -62.74 166.9 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.353 -0.842 . . . . 0.0 109.007 179.482 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.46 HG21 ' HB3' ' A' ' 13' ' ' LEU . 79.8 mt -130.8 72.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.303 -0.873 . . . . 0.0 110.489 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.507 ' HB3' HG23 ' A' ' 56' ' ' THR . 34.6 m-20 -97.12 49.58 1.06 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.449 -0.782 . . . . 0.0 109.257 179.197 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.71 163.25 12.49 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -78.18 -2.05 35.7 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.646 -0.914 . . . . 0.0 110.874 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.778 ' HB ' HD12 ' A' ' 13' ' ' LEU . 19.5 m -107.34 -28.03 10.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.232 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.778 HD12 ' HB ' ' A' ' 12' ' ' THR . 4.3 mp -135.13 164.8 26.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.521 -0.737 . . . . 0.0 110.303 179.749 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -154.71 126.78 7.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.571 -0.706 . . . . 0.0 110.313 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.07 -140.01 11.33 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -144.85 171.77 13.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.637 -0.92 . . . . 0.0 110.376 -179.853 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.485 HG23 ' CE1' ' A' ' 31' ' ' PHE . 7.0 t -154.98 157.79 38.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.628 -0.67 . . . . 0.0 109.976 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.9 p -140.42 149.43 42.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.546 -0.721 . . . . 0.0 110.513 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.843 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.5 t -146.35 162.15 38.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.626 -0.671 . . . . 0.0 109.994 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -88.22 107.16 18.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.567 -0.708 . . . . 0.0 110.281 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.96 138.56 50.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.611 -0.681 . . . . 0.0 110.1 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.68 -31.81 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.614 -0.679 . . . . 0.0 110.248 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.515 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 14.7 p30 -171.32 179.99 2.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.504 -0.747 . . . . 0.0 110.377 179.856 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.45 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.79 -31.47 64.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.489 -0.757 . . . . 0.0 110.78 -179.573 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.515 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -60.27 -28.47 68.09 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.536 -0.727 . . . . 0.0 110.266 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.3 m -108.14 -27.99 9.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.58 -0.7 . . . . 0.0 110.304 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.708 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.2 -54.95 39.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.508 -0.745 . . . . 0.0 110.236 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -60.06 -31.82 70.36 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.573 -0.705 . . . . 0.0 110.239 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -58.26 -40.62 82.29 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.342 -0.849 . . . . 0.0 110.35 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.0 t -82.19 -44.93 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.585 -0.697 . . . . 0.0 109.851 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.843 ' CZ ' HG22 ' A' ' 19' ' ' THR . 9.1 m-85 -65.85 -37.84 87.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.65 -0.656 . . . . 0.0 110.229 -179.808 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -62.07 -46.05 90.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.465 -0.772 . . . . 0.0 109.387 179.665 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -62.47 -34.24 76.44 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.782 0.801 . . . . 0.0 109.339 179.083 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.64 -49.36 68.96 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.749 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -73.25 -45.15 57.53 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.769 -0.582 . . . . 0.0 110.444 -179.758 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -56.26 -39.84 73.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.423 -0.798 . . . . 0.0 110.617 -179.715 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -75.13 -31.54 61.11 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.606 -0.684 . . . . 0.0 110.11 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -80.14 -40.89 26.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.546 -0.721 . . . . 0.0 110.006 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.43 37.15 0.94 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.749 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.7 mt -103.64 62.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.528 -0.984 . . . . 0.0 110.174 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -85.67 57.35 4.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.51 -0.744 . . . . 0.0 109.008 178.917 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.47 -138.69 5.23 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -178.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -116.3 105.14 12.21 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.43 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.561 ' HH2' HD11 ' A' ' 6' ' ' LEU . 52.8 m95 -74.63 142.22 44.59 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.182 0.992 . . . . 0.0 112.459 -177.964 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.05 132.59 17.72 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.452 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -106.48 111.74 24.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.646 -0.659 . . . . 0.0 110.262 -178.357 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.16 112.02 20.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.694 -0.629 . . . . 0.0 109.778 179.662 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -70.32 -21.78 62.88 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.639 -0.663 . . . . 0.0 110.663 -179.766 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.454 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.94 -35.24 58.41 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.311 -0.868 . . . . 0.0 110.955 -179.784 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.454 HG23 ' C ' ' A' ' 49' ' ' ALA . 70.9 p -148.16 18.41 1.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.537 -0.727 . . . . 0.0 110.932 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.72 93.14 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.182 -0.949 . . . . 0.0 110.989 179.713 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.459 HG23 ' CB ' ' A' ' 5' ' ' LYS . 62.4 m -158.66 104.68 1.79 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.454 -0.779 . . . . 0.0 110.886 -179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.485 ' O ' HD23 ' A' ' 6' ' ' LEU . 98.7 m-85 -61.05 128.52 36.82 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.423 -0.798 . . . . 0.0 109.149 179.014 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.606 ' HA ' HG22 ' A' ' 7' ' ' ILE . 85.0 m -120.7 101.21 7.58 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.522 -178.404 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.568 HG11 HG21 ' A' ' 40' ' ' ILE . 9.5 p -103.9 166.87 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.863 . . . . 0.0 109.309 177.599 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 9' ' ' ASN . 95.0 m -160.72 110.02 1.68 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.62 -0.675 . . . . 0.0 109.835 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.19 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.042 0.449 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.513 HG22 ' CE2' ' A' ' 4' ' ' PHE . 55.0 m -92.71 111.89 23.65 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.551 -0.718 . . . . 0.0 110.149 179.877 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 19' ' ' THR . 6.6 m -106.66 96.1 6.21 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.585 -0.697 . . . . 0.0 110.624 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.737 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 92.1 m-85 -73.59 -178.85 3.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.538 -0.726 . . . . 0.0 109.838 179.606 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -146.74 110.75 5.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.49 -0.756 . . . . 0.0 110.289 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.66 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -92.27 110.67 22.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.502 -0.749 . . . . 0.0 110.364 -179.771 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.655 HG21 HG23 ' A' ' 54' ' ' THR . 3.4 tp -64.22 170.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.286 -0.884 . . . . 0.0 108.653 178.997 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.511 HD11 ' OG1' ' A' ' 17' ' ' THR . 78.0 mt -131.53 74.2 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.245 -0.909 . . . . 0.0 110.722 -179.655 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.429 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.5 m-20 -96.07 47.13 1.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.458 -0.776 . . . . 0.0 109.052 179.022 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.1 161.9 13.29 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.602 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -79.74 -0.53 34.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.771 -0.84 . . . . 0.0 110.587 179.315 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -104.79 -30.82 9.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.981 . . . . 0.0 109.928 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.473 ' HB3' HG21 ' A' ' 8' ' ' ILE . 54.8 mt -138.54 166.02 25.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.635 -0.666 . . . . 0.0 110.363 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -154.63 132.81 11.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.573 -0.704 . . . . 0.0 110.202 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.89 -147.29 19.12 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -144.88 122.25 11.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.555 -0.967 . . . . 0.0 110.368 179.955 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.511 ' OG1' HD11 ' A' ' 8' ' ' ILE . 62.5 m -109.67 149.81 29.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.631 -0.668 . . . . 0.0 110.253 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.8 p -131.94 162.41 30.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.56 -0.712 . . . . 0.0 110.164 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.628 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.6 t -142.93 -172.55 3.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.561 -0.712 . . . . 0.0 110.328 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -123.53 89.36 3.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.614 -0.679 . . . . 0.0 110.153 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -116.19 -177.25 3.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.585 -0.697 . . . . 0.0 109.982 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.17 -24.88 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.728 . . . . 0.0 110.326 179.822 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -168.11 175.56 6.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.452 -0.78 . . . . 0.0 110.156 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.407 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -57.88 -25.14 60.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.516 -0.74 . . . . 0.0 110.744 -179.772 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.7 -27.96 66.89 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.472 -0.767 . . . . 0.0 110.502 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.4 m -109.27 -27.23 9.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.551 -0.718 . . . . 0.0 110.417 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.737 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -62.0 -62.96 1.42 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.505 -0.747 . . . . 0.0 110.407 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -58.17 -41.65 84.33 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.519 -0.738 . . . . 0.0 110.528 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.6 tttm -55.68 -42.49 75.24 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.362 -0.836 . . . . 0.0 110.314 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.2 t -80.27 -48.13 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.674 . . . . 0.0 109.934 179.545 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.628 ' CZ ' HG22 ' A' ' 19' ' ' THR . 5.4 m-85 -62.05 -33.75 74.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.585 -0.697 . . . . 0.0 110.22 -179.676 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -63.7 -43.84 95.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.425 -0.797 . . . . 0.0 108.924 179.19 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -62.71 -33.5 75.23 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.728 0.775 . . . . 0.0 109.298 178.837 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -67.26 -56.48 9.63 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.928 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.758 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.56 -41.44 94.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.736 -0.602 . . . . 0.0 110.302 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -58.11 -36.93 73.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.51 -0.744 . . . . 0.0 110.605 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.38 -42.4 68.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.545 -0.722 . . . . 0.0 110.18 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -77.77 -28.93 50.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.573 -0.705 . . . . 0.0 110.215 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.88 55.06 0.95 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.876 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.758 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.0 mt -115.44 59.7 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.485 -1.009 . . . . 0.0 110.353 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.15 60.77 5.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.658 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.05 -138.93 7.97 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -178.553 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -115.4 103.57 10.91 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.948 -0.736 . . . . 0.0 109.28 179.629 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.66 ' HH2' HD11 ' A' ' 6' ' ' LEU . 55.6 m95 -73.92 143.38 45.77 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.146 0.974 . . . . 0.0 112.497 -177.968 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -151.22 133.31 15.21 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 178.656 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -104.0 139.17 39.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.593 -0.692 . . . . 0.0 110.313 -178.41 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -112.74 113.57 25.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.687 -0.633 . . . . 0.0 109.976 179.794 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -69.68 -21.37 63.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.701 -0.624 . . . . 0.0 110.847 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.44 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.6 -40.48 65.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.293 -0.879 . . . . 0.0 110.814 -179.592 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.44 HG23 ' C ' ' A' ' 49' ' ' ALA . 66.5 p -148.84 20.28 1.01 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.555 -0.716 . . . . 0.0 110.597 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.45 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER 52.1 93.46 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.174 -0.954 . . . . 0.0 110.63 179.948 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.6 m -151.41 103.17 2.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.497 -0.752 . . . . 0.0 111.112 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.518 ' O ' HD23 ' A' ' 6' ' ' LEU . 78.2 m-85 -63.44 123.41 18.68 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.451 -0.781 . . . . 0.0 109.018 178.786 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.655 HG23 HG21 ' A' ' 7' ' ' ILE . 62.9 m -116.92 103.78 10.63 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.323 -0.951 . . . . 0.0 112.619 -178.349 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.567 HG11 HG21 ' A' ' 40' ' ' ILE . 11.4 p -106.02 168.27 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.409 -0.807 . . . . 0.0 109.002 177.396 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.461 ' N ' HG22 ' A' ' 55' ' ' VAL . 99.7 m -160.2 108.9 1.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.543 -0.723 . . . . 0.0 110.028 -179.558 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.168 179.884 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.157 0.503 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.565 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 79.1 m -102.84 112.19 24.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.567 -0.708 . . . . 0.0 110.278 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.625 ' O ' HG23 ' A' ' 3' ' ' THR . 8.1 t -89.44 99.39 12.4 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.65 -0.656 . . . . 0.0 110.585 -179.844 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.715 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 90.6 m-85 -80.68 176.56 9.69 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.364 -0.835 . . . . 0.0 110.005 179.885 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.52 ' HB3' HG23 ' A' ' 52' ' ' THR . 16.8 mttt -141.95 110.46 6.07 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.428 -0.795 . . . . 0.0 110.272 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.607 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -93.62 111.54 23.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.489 -0.757 . . . . 0.0 110.467 -179.92 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.635 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.5 tp -64.18 170.29 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.948 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.498 HD11 ' OG1' ' A' ' 17' ' ' THR . 77.8 mt -132.43 74.72 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.772 -179.788 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.434 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.5 m-20 -95.72 49.33 1.16 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.811 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.43 160.75 13.17 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.327 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -80.6 -0.16 36.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.769 -0.842 . . . . 0.0 110.47 179.015 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -102.14 -31.81 10.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.134 -0.979 . . . . 0.0 109.951 179.855 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -144.9 170.49 16.04 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.508 -0.745 . . . . 0.0 110.401 -179.978 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -154.12 142.77 20.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.618 -0.676 . . . . 0.0 110.374 -179.793 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.432 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 127.55 -164.34 21.02 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.963 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -119.88 145.31 46.8 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.551 -0.97 . . . . 0.0 110.315 -179.955 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.498 ' OG1' HD11 ' A' ' 8' ' ' ILE . 7.0 m -121.75 146.2 47.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.586 -0.696 . . . . 0.0 110.225 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.9 p -130.08 166.94 19.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.57 -0.706 . . . . 0.0 110.179 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.629 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.4 t -167.01 -179.5 4.69 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.568 -0.708 . . . . 0.0 110.3 -179.921 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -112.55 101.18 9.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.546 -0.721 . . . . 0.0 110.209 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.48 146.21 50.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.589 -0.694 . . . . 0.0 110.219 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.1 p -70.17 -26.28 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.546 -0.721 . . . . 0.0 110.186 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.721 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 8.1 p30 -170.37 177.94 3.92 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.412 -0.805 . . . . 0.0 110.465 179.734 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.13 -25.84 47.71 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.578 -0.701 . . . . 0.0 111.139 -179.425 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.721 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.11 -39.26 81.72 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.372 -0.83 . . . . 0.0 110.334 -179.776 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.6 m -94.41 -29.63 14.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.594 -0.691 . . . . 0.0 110.087 179.914 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.715 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -61.02 -55.91 27.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.595 -0.69 . . . . 0.0 110.226 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -61.97 -37.32 84.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.568 -0.708 . . . . 0.0 110.3 -179.949 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -58.36 -41.9 85.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.379 -0.825 . . . . 0.0 110.387 -179.958 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.8 t -81.37 -44.21 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.558 -0.714 . . . . 0.0 109.813 179.666 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.629 ' CZ ' HG22 ' A' ' 19' ' ' THR . 11.2 m-85 -65.75 -36.46 83.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.602 -0.686 . . . . 0.0 110.192 -179.861 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -63.13 -45.17 93.23 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.469 -0.769 . . . . 0.0 109.15 179.366 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -63.25 -31.06 72.12 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.657 0.742 . . . . 0.0 109.27 178.713 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -69.67 -51.06 38.06 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.866 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.789 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -69.31 -41.27 76.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.627 -0.671 . . . . 0.0 110.002 179.9 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -58.49 -44.53 89.43 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.746 . . . . 0.0 110.423 -179.977 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.74 -46.21 83.18 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.59 -0.694 . . . . 0.0 110.204 -179.952 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -70.84 -50.19 38.01 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.535 -0.728 . . . . 0.0 110.07 179.941 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.61 58.08 0.19 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.789 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 82.2 mt -116.05 59.82 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.548 -0.971 . . . . 0.0 110.234 179.826 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.97 62.89 3.51 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.872 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.18 -141.99 12.84 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -178.813 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -114.73 111.47 21.31 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.944 -0.739 . . . . 0.0 109.039 179.152 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.607 ' HH2' HD11 ' A' ' 6' ' ' LEU . 52.8 m95 -80.39 143.22 33.66 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.038 0.923 . . . . 0.0 112.264 -177.887 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 p -152.17 133.62 14.54 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 178.911 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -104.09 139.98 38.41 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.194 -178.636 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -109.54 108.9 19.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.65 -0.656 . . . . 0.0 109.938 179.724 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -67.62 -21.08 65.41 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.707 -0.621 . . . . 0.0 110.759 -179.866 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.422 ' C ' HG23 ' A' ' 50' ' ' THR . . . -55.15 -41.79 72.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.29 -0.881 . . . . 0.0 110.747 -179.726 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.422 HG23 ' C ' ' A' ' 49' ' ' ALA . 67.2 p -146.84 21.75 1.26 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.6 -0.688 . . . . 0.0 110.617 -179.932 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.451 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.31 95.32 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.235 -0.916 . . . . 0.0 110.753 179.804 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.52 HG23 ' HB3' ' A' ' 5' ' ' LYS . 26.8 m -154.81 102.75 2.38 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.213 -179.841 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.436 ' O ' HD23 ' A' ' 6' ' ' LEU . 71.4 m-85 -63.81 128.9 37.86 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.708 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.635 ' HA ' HG22 ' A' ' 7' ' ' ILE . 61.1 m -122.65 106.76 11.24 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.588 -178.583 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.611 HG11 HG21 ' A' ' 40' ' ' ILE . 11.0 p -110.69 167.35 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.436 -0.79 . . . . 0.0 109.143 177.481 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.467 ' N ' HG22 ' A' ' 55' ' ' VAL . 78.7 m -161.39 111.42 1.65 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.642 -0.661 . . . . 0.0 109.83 -179.791 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.137 179.903 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.08 0.467 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.566 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 68.5 m -143.29 112.27 6.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.638 -0.664 . . . . 0.0 110.137 179.971 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.4 m -84.43 94.31 8.49 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.606 -0.684 . . . . 0.0 110.698 -179.679 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.798 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.7 m-85 -77.47 177.86 7.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.521 -0.737 . . . . 0.0 109.736 179.518 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.479 ' HB3' HG23 ' A' ' 52' ' ' THR . 8.3 ttmm -142.93 112.11 6.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.417 -0.802 . . . . 0.0 110.608 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.656 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -94.14 116.84 29.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.523 -0.736 . . . . 0.0 110.378 179.95 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.696 HG21 HG23 ' A' ' 54' ' ' THR . 2.7 tt -70.79 173.38 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.457 -0.777 . . . . 0.0 109.023 179.287 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.413 ' HB ' ' N ' ' A' ' 15' ' ' GLY . 83.0 mt -132.63 75.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.835 . . . . 0.0 110.161 179.903 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.01 45.2 1.04 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.526 -0.734 . . . . 0.0 109.204 179.379 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.04 158.92 15.89 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.74 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -76.7 -3.61 38.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.705 -0.879 . . . . 0.0 110.598 179.358 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 m -101.84 -33.1 9.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 110.217 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.609 HD11 ' CG ' ' A' ' 38' ' ' ASN . 73.0 mt -132.7 175.29 9.46 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.497 -0.752 . . . . 0.0 110.483 179.932 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -159.69 133.46 7.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.651 -0.656 . . . . 0.0 110.125 -179.866 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.413 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 132.46 -145.9 17.71 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.826 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -135.97 175.52 9.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.529 -0.983 . . . . 0.0 110.321 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.9 m -150.73 134.42 16.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.527 -0.733 . . . . 0.0 110.262 179.899 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.3 p -121.56 161.82 21.69 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.537 -0.727 . . . . 0.0 110.335 -179.968 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.752 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 9.1 t -165.66 -179.52 5.43 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.56 -0.712 . . . . 0.0 110.272 179.921 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.42 119.58 39.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.607 -0.683 . . . . 0.0 110.061 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.471 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -147.07 139.03 24.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.585 -0.697 . . . . 0.0 110.142 -179.892 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.0 m -57.98 -33.71 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.474 -0.766 . . . . 0.0 110.598 -179.932 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.708 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 15.4 p30 -170.35 -174.21 1.64 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.519 -0.738 . . . . 0.0 110.33 179.84 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.46 -27.15 56.12 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.523 -0.735 . . . . 0.0 110.739 -179.755 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.708 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.74 -26.46 65.67 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.474 -0.766 . . . . 0.0 110.32 179.861 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.471 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 50.2 m -110.0 -27.38 9.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.539 -0.725 . . . . 0.0 110.249 179.908 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.798 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.55 -60.68 3.45 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.624 -0.672 . . . . 0.0 110.361 -179.917 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -59.93 -36.15 76.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.555 -0.716 . . . . 0.0 110.158 -179.985 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -57.66 -45.23 85.81 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.461 -0.774 . . . . 0.0 110.49 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.03 -43.91 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.561 -0.712 . . . . 0.0 110.134 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.752 ' CZ ' HG22 ' A' ' 19' ' ' THR . 8.0 m-85 -66.77 -34.06 76.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.583 -0.698 . . . . 0.0 110.291 -179.679 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -63.95 -40.57 96.73 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.393 -0.817 . . . . 0.0 108.897 179.212 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -63.35 -33.92 76.58 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.733 0.777 . . . . 0.0 109.239 179.003 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.68 -59.31 3.7 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.735 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.794 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -59.85 -46.78 88.2 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.752 -0.592 . . . . 0.0 110.275 179.894 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -55.95 -27.96 54.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.524 -0.735 . . . . 0.0 110.712 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.89 -52.56 49.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.577 -0.702 . . . . 0.0 109.973 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.609 ' CG ' HD11 ' A' ' 13' ' ' LEU . 43.0 m-80 -78.13 -45.0 24.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.596 -0.69 . . . . 0.0 109.994 179.856 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.47 53.16 0.18 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.769 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.794 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.1 mt -103.13 63.03 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.514 -0.992 . . . . 0.0 110.052 179.63 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.92 56.35 3.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.414 -0.804 . . . . 0.0 108.907 178.879 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.56 -137.31 3.66 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.123 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -116.03 101.16 8.5 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.403 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.656 ' CH2' HD11 ' A' ' 6' ' ' LEU . 49.9 m95 -71.77 142.52 49.71 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.998 0.904 . . . . 0.0 111.846 -178.197 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 p -151.24 132.19 14.24 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.939 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.401 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 13.3 t80 -103.17 139.35 38.77 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.679 -0.638 . . . . 0.0 110.108 -178.701 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.25 104.76 13.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.775 -0.578 . . . . 0.0 109.511 179.432 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -63.2 -20.87 65.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.676 -0.64 . . . . 0.0 110.798 -179.568 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.445 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.26 -40.05 67.44 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.287 -0.883 . . . . 0.0 110.703 -179.765 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.445 HG23 ' C ' ' A' ' 49' ' ' ALA . 68.0 p -148.14 21.84 1.09 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.621 -0.674 . . . . 0.0 110.516 179.998 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.445 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.56 91.36 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.198 -0.939 . . . . 0.0 110.743 179.976 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.479 HG23 ' HB3' ' A' ' 5' ' ' LYS . 20.4 m -150.23 98.54 2.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.462 -0.774 . . . . 0.0 111.23 -179.807 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.456 ' O ' HD23 ' A' ' 6' ' ' LEU . 66.3 m-85 -61.81 127.8 33.17 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.391 -0.818 . . . . 0.0 108.959 178.656 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.696 HG23 HG21 ' A' ' 7' ' ' ILE . 91.7 m -123.67 107.63 11.69 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.451 -178.499 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.545 HG21 HG22 ' A' ' 40' ' ' ILE . 11.6 p -107.96 167.4 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.358 -0.839 . . . . 0.0 108.917 177.401 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.462 ' N ' HG22 ' A' ' 55' ' ' VAL . 99.2 m -160.7 111.01 1.77 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.636 -0.665 . . . . 0.0 109.984 -179.703 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.102 179.811 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 mtt . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.099 0.476 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.552 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 86.6 m -97.62 112.72 24.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.547 -0.72 . . . . 0.0 110.155 -179.99 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.608 ' O ' HG23 ' A' ' 3' ' ' THR . 7.2 t -82.36 99.94 9.68 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.628 -0.67 . . . . 0.0 110.503 -179.95 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.647 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 89.6 m-85 -84.76 170.52 13.15 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.351 -0.843 . . . . 0.0 109.771 179.696 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.519 ' HB3' HG23 ' A' ' 52' ' ' THR . 7.5 tttt -139.96 115.31 9.89 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.417 -0.802 . . . . 0.0 110.466 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.627 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -96.95 113.16 24.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.5 -0.75 . . . . 0.0 110.479 -179.915 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.672 HG21 HG23 ' A' ' 54' ' ' THR . 2.7 tp -65.42 170.01 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.133 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 13' ' ' LEU . 83.8 mt -131.17 73.17 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.237 179.734 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.18 48.15 1.23 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.475 -0.766 . . . . 0.0 109.092 179.094 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.97 156.0 15.81 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.464 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -74.18 -6.35 47.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.746 -0.855 . . . . 0.0 110.408 179.185 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.8 m -94.94 -31.52 13.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.167 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.537 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -147.47 164.51 33.13 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.489 -0.757 . . . . 0.0 110.604 -179.869 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -144.73 140.27 28.45 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.62 -0.675 . . . . 0.0 110.311 -179.877 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 132.6 -144.47 16.33 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.605 ' HG2' HD12 ' A' ' 7' ' ' ILE . 51.3 mt-10 -144.26 162.34 36.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.505 -0.997 . . . . 0.0 110.281 -179.979 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.4 m -137.8 143.44 41.06 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.598 -0.689 . . . . 0.0 109.951 179.788 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.2 p -127.21 153.67 45.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.592 -0.692 . . . . 0.0 110.297 -179.874 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.842 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 9.0 t -159.04 156.14 28.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.605 -0.685 . . . . 0.0 110.236 179.848 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -86.23 123.76 31.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.579 -0.701 . . . . 0.0 110.148 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.14 144.9 29.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.595 -0.691 . . . . 0.0 110.271 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.18 -36.06 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.565 -0.709 . . . . 0.0 110.195 -179.998 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.589 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 4.2 p30 -170.81 -168.38 0.67 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.561 -0.712 . . . . 0.0 110.389 179.787 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.421 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.88 -33.52 66.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.593 -0.692 . . . . 0.0 111.214 -179.287 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.589 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -55.02 -48.05 73.89 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.349 -0.845 . . . . 0.0 110.826 -179.51 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.9 m -85.87 -27.54 24.99 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.543 -0.723 . . . . 0.0 110.306 179.998 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.647 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.42 -61.21 2.76 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.537 -0.727 . . . . 0.0 110.303 -179.922 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -59.81 -38.79 82.95 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.554 -0.716 . . . . 0.0 110.382 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -55.95 -40.44 73.22 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.326 -0.859 . . . . 0.0 110.617 -179.893 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.5 t -82.05 -47.36 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.588 -0.695 . . . . 0.0 110.148 179.863 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.842 ' CZ ' HG22 ' A' ' 19' ' ' THR . 8.1 m-85 -64.68 -35.25 80.42 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.529 -0.732 . . . . 0.0 110.292 -179.771 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.59 -43.81 95.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.498 -0.751 . . . . 0.0 109.17 179.441 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -60.77 -32.39 71.71 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.677 0.751 . . . . 0.0 109.539 179.07 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -68.86 -55.44 11.08 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.881 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.786 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -65.55 -44.18 87.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.746 -0.596 . . . . 0.0 110.209 -179.948 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -56.24 -32.13 64.19 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.491 -0.756 . . . . 0.0 110.439 -179.839 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -70.48 -52.77 19.65 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.649 -0.657 . . . . 0.0 109.883 179.692 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -68.54 -41.68 79.52 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.596 -0.69 . . . . 0.0 109.759 179.652 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.44 44.05 0.62 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.685 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.786 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 81.2 mt -96.51 63.1 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.522 -0.987 . . . . 0.0 110.204 179.762 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -83.73 58.52 4.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.578 -0.701 . . . . 0.0 109.292 179.163 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.47 -137.69 5.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.33 100.95 7.63 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.183 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.627 ' CH2' HD11 ' A' ' 6' ' ' LEU . 52.8 m95 -69.73 142.68 53.25 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.131 0.967 . . . . 0.0 112.489 -177.775 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -149.88 131.81 15.19 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.567 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.4 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 21.8 t80 -106.29 134.84 48.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.638 -0.663 . . . . 0.0 110.159 -178.454 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.61 110.5 22.71 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.661 -0.649 . . . . 0.0 109.848 179.57 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -67.3 -24.64 65.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.637 -0.664 . . . . 0.0 110.623 -179.672 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.405 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.42 -37.44 56.74 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.325 -0.859 . . . . 0.0 110.899 -179.655 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.405 HG23 ' C ' ' A' ' 49' ' ' ALA . 72.1 p -145.93 16.83 1.41 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.623 -0.673 . . . . 0.0 110.839 179.837 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.442 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.13 93.06 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.084 -1.01 . . . . 0.0 110.729 179.939 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.519 HG23 ' HB3' ' A' ' 5' ' ' LYS . 91.9 m -155.49 104.06 2.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.523 -0.736 . . . . 0.0 111.051 -179.697 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.437 ' O ' HD23 ' A' ' 6' ' ' LEU . 86.1 m-85 -62.44 132.17 51.64 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.498 -0.751 . . . . 0.0 109.037 178.88 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.672 HG23 HG21 ' A' ' 7' ' ' ILE . 77.1 m -126.9 105.17 8.45 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.396 -0.922 . . . . 0.0 112.426 -178.686 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.58 HG11 HG21 ' A' ' 40' ' ' ILE . 9.2 p -107.2 166.43 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.341 -0.85 . . . . 0.0 109.443 177.694 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.447 ' N ' HG22 ' A' ' 55' ' ' VAL . 86.9 m -162.33 117.02 1.85 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.673 -0.642 . . . . 0.0 110.107 -179.525 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.411 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 3.5 mt-10 . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.124 179.456 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.6 mtt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.108 0.48 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.554 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 62.2 m -120.65 112.57 19.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.558 -0.714 . . . . 0.0 110.383 -179.962 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.7 m -94.26 93.43 7.74 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.508 -0.745 . . . . 0.0 110.481 -179.835 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.707 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 97.5 m-85 -71.77 169.72 15.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.579 -0.701 . . . . 0.0 109.978 179.824 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.509 ' HG2' HG22 ' A' ' 18' ' ' THR . 2.7 mttt -136.22 114.15 11.28 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.532 -0.73 . . . . 0.0 110.413 -179.825 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.659 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -93.98 111.98 23.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.485 -0.759 . . . . 0.0 110.554 -179.969 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.637 HG21 HG23 ' A' ' 54' ' ' THR . 3.6 tp -63.51 171.06 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.061 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.479 HD11 ' OG1' ' A' ' 17' ' ' THR . 82.8 mt -133.05 74.03 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.559 -179.91 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -96.16 46.46 1.08 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.854 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.05 156.83 16.72 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.692 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -75.48 -5.83 47.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.766 -0.844 . . . . 0.0 110.383 179.117 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.47 HG22 HD12 ' A' ' 13' ' ' LEU . 7.5 m -93.88 -34.74 13.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.136 179.941 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.47 HD12 HG22 ' A' ' 12' ' ' THR . 0.6 OUTLIER -139.52 -176.34 4.51 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.536 -179.994 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -163.47 134.56 4.7 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.644 -0.66 . . . . 0.0 110.167 -179.953 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.89 -141.93 12.97 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.932 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -138.88 161.81 36.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.573 -0.957 . . . . 0.0 110.306 -179.796 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.479 ' OG1' HD11 ' A' ' 8' ' ' ILE . 6.1 m -136.87 140.34 42.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.581 -0.699 . . . . 0.0 110.175 -179.965 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.509 HG22 ' HG2' ' A' ' 5' ' ' LYS . 38.7 p -129.55 159.44 36.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.492 -0.755 . . . . 0.0 110.398 -179.794 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.746 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.9 t -162.14 171.31 17.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.566 -0.709 . . . . 0.0 110.231 179.657 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.13 105.45 16.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.552 -0.718 . . . . 0.0 110.155 179.982 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.17 139.03 49.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.542 -0.724 . . . . 0.0 110.232 179.89 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 p -59.4 -33.36 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.566 -0.709 . . . . 0.0 110.179 179.953 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.586 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 30.3 p30 -170.04 -179.36 3.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.554 -0.716 . . . . 0.0 110.344 179.887 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.2 -24.83 44.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.49 -0.756 . . . . 0.0 110.862 -179.831 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.586 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.68 -30.48 67.41 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.447 -0.783 . . . . 0.0 110.472 -179.776 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 30' ' ' VAL . 25.2 m -109.48 -27.13 9.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.525 -0.735 . . . . 0.0 110.313 179.936 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.707 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.35 -42.77 96.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.501 -0.749 . . . . 0.0 110.127 179.916 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.87 -45.76 63.84 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.66 -0.65 . . . . 0.0 110.251 179.84 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -56.04 -31.9 63.56 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.243 -0.911 . . . . 0.0 110.551 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 26' ' ' THR . 60.0 t -87.01 -48.44 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.652 -0.655 . . . . 0.0 110.104 -179.937 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.746 ' CZ ' HG22 ' A' ' 19' ' ' THR . 6.3 m-85 -67.56 -38.79 84.63 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.981 -179.731 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -62.63 -43.87 97.71 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.515 -0.741 . . . . 0.0 109.093 179.226 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.6 tp60 -64.04 -34.12 77.29 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.761 0.791 . . . . 0.0 109.123 178.792 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -64.91 -57.71 8.07 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.676 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.781 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -58.96 -40.76 85.7 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.777 -0.577 . . . . 0.0 110.292 -179.895 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -58.01 -36.74 73.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.539 -0.726 . . . . 0.0 110.467 -179.879 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.96 -44.47 89.29 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.556 -0.715 . . . . 0.0 109.825 179.773 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -77.57 -40.37 42.58 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.673 -0.642 . . . . 0.0 109.971 179.729 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.87 40.83 0.88 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.82 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.781 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 75.8 mt -97.52 63.73 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.52 -0.988 . . . . 0.0 110.239 179.799 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -85.64 57.38 4.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.492 -0.755 . . . . 0.0 109.09 178.895 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.64 -139.32 6.17 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -178.839 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.55 108.72 17.92 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.859 -0.789 . . . . 0.0 109.008 179.455 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.659 ' HH2' HD11 ' A' ' 6' ' ' LEU . 57.9 m95 -79.59 142.49 35.63 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.118 0.961 . . . . 0.0 112.349 -177.794 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 44' ' ' TRP . 6.2 p -153.7 131.9 11.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.786 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.41 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 21.8 t80 -97.04 125.48 41.51 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.701 -0.625 . . . . 0.0 110.202 -178.506 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -87.72 98.46 11.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.751 -0.593 . . . . 0.0 109.746 179.584 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -63.4 -19.19 64.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.589 -0.694 . . . . 0.0 110.767 -179.767 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.444 ' C ' HG23 ' A' ' 50' ' ' THR . . . -55.6 -42.54 74.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.269 -0.895 . . . . 0.0 110.661 -179.77 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.444 HG23 ' C ' ' A' ' 49' ' ' ALA . 75.2 p -148.45 27.82 0.9 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.627 -0.671 . . . . 0.0 110.356 -179.871 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.441 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 5.6 mptt 52.52 96.8 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.336 -0.853 . . . . 0.0 110.809 -179.964 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.0 m -158.19 104.25 1.86 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.45 -0.781 . . . . 0.0 110.829 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.451 ' O ' HD23 ' A' ' 6' ' ' LEU . 64.3 m-85 -63.05 131.86 50.02 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.522 -0.736 . . . . 0.0 109.026 178.969 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.637 HG23 HG21 ' A' ' 7' ' ' ILE . 80.7 m -125.77 110.11 13.33 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.432 -0.907 . . . . 0.0 112.421 -178.528 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.568 HG11 HG21 ' A' ' 40' ' ' ILE . 11.3 p -114.35 167.4 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.37 -0.831 . . . . 0.0 109.35 177.726 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.456 ' N ' HG22 ' A' ' 55' ' ' VAL . 85.3 m -161.65 112.34 1.66 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.623 -0.673 . . . . 0.0 110.084 -179.649 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.172 179.764 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtm . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.1 0.476 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.592 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 40.2 m -101.27 112.94 25.59 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.581 -0.7 . . . . 0.0 110.371 -179.861 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 m -89.23 91.91 8.96 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.604 -0.685 . . . . 0.0 110.615 -179.791 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.665 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 97.3 m-85 -74.08 170.07 16.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.45 -0.781 . . . . 0.0 109.834 179.661 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -134.23 114.55 13.16 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.419 -0.801 . . . . 0.0 110.323 179.901 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.579 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -94.87 110.69 22.54 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.687 . . . . 0.0 110.399 -179.948 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 54' ' ' THR . 2.1 tt -65.46 162.64 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.044 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.405 HG21 ' HB3' ' A' ' 13' ' ' LEU . 49.0 mm -125.37 76.97 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.397 -179.741 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -96.13 47.33 1.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.991 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.23 159.58 13.82 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.217 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.0 tptt -77.83 -3.24 40.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.787 -0.831 . . . . 0.0 110.394 179.163 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.5 m -99.79 -32.01 11.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 110.14 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.537 HD11 ' OD1' ' A' ' 38' ' ' ASN . 55.9 mt -140.49 173.98 10.97 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.508 -0.745 . . . . 0.0 110.559 -179.916 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -160.73 135.98 7.84 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.63 -0.669 . . . . 0.0 109.994 179.795 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.07 -144.49 16.46 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -137.47 151.65 48.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.564 -0.963 . . . . 0.0 110.446 -179.851 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 m -130.84 144.87 51.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.613 -0.679 . . . . 0.0 110.08 179.857 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.8 p -131.8 139.8 48.99 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.549 -0.719 . . . . 0.0 110.355 -179.837 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.895 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.9 t -146.04 134.01 21.4 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 110.353 179.942 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.91 129.1 39.36 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.592 -0.692 . . . . 0.0 110.455 -179.919 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.53 140.67 19.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.561 -0.712 . . . . 0.0 109.989 179.887 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.47 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.2 p -58.58 -36.36 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.479 -0.763 . . . . 0.0 110.225 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.549 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 39.4 p30 -169.92 -176.01 2.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.578 -0.701 . . . . 0.0 110.209 179.621 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.453 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.57 -26.36 54.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.535 -0.728 . . . . 0.0 110.786 -179.667 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.549 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.48 -29.6 67.94 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.467 -0.771 . . . . 0.0 110.319 -179.895 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 30' ' ' VAL . 11.7 m -106.26 -27.39 11.06 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.583 -0.698 . . . . 0.0 110.382 179.952 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.665 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.73 -50.04 75.4 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.481 -0.762 . . . . 0.0 110.32 -179.981 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -62.19 -46.22 89.89 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.591 -0.693 . . . . 0.0 110.078 179.862 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -55.73 -34.68 65.37 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.445 -0.784 . . . . 0.0 110.873 -179.801 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 26' ' ' THR . 65.2 t -84.66 -47.65 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.502 -0.749 . . . . 0.0 110.274 -179.829 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.895 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.5 m-85 -68.11 -37.88 81.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.547 -0.721 . . . . 0.0 110.188 -179.76 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -62.26 -45.78 91.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.73 . . . . 0.0 109.367 179.661 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -60.95 -29.91 69.92 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.608 0.718 . . . . 0.0 109.619 179.004 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -72.53 -59.16 2.86 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.832 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.805 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.68 -49.42 77.57 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.728 -0.608 . . . . 0.0 110.194 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -56.1 -33.0 64.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.547 -0.721 . . . . 0.0 110.666 -179.816 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.16 -31.23 49.57 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.58 -0.7 . . . . 0.0 110.025 179.886 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.537 ' OD1' HD11 ' A' ' 13' ' ' LEU . 3.7 m-80 -83.47 -47.26 11.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.602 -0.686 . . . . 0.0 110.028 179.908 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.93 48.88 0.15 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.93 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.805 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 79.1 mt -116.26 58.52 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.505 -0.997 . . . . 0.0 110.391 179.935 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -81.35 60.55 4.46 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.433 -0.792 . . . . 0.0 109.013 178.918 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.96 -139.68 8.88 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -178.87 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -114.43 110.25 19.57 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.397 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.579 ' HH2' HD11 ' A' ' 6' ' ' LEU . 55.5 m95 -80.31 142.93 34.04 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.131 0.967 . . . . 0.0 112.456 -177.852 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 44' ' ' TRP . 7.0 p -153.04 130.95 11.73 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.853 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.417 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 14.3 t80 -102.07 128.76 48.38 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.693 -0.629 . . . . 0.0 109.848 -178.742 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.6 110.67 22.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.712 -0.617 . . . . 0.0 109.887 179.726 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -69.69 -22.9 63.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.706 -0.621 . . . . 0.0 110.686 -179.913 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.41 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.92 -39.56 68.95 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.424 -0.798 . . . . 0.0 110.939 -179.769 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.41 HG23 ' C ' ' A' ' 49' ' ' ALA . 77.8 p -145.77 19.22 1.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.53 -0.731 . . . . 0.0 110.974 -179.873 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.417 ' HG3' ' CE2' ' A' ' 46' ' ' TYR . 0.3 OUTLIER 51.88 95.65 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.23 -0.918 . . . . 0.0 110.957 179.7 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.1 m -158.7 106.46 1.87 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.499 -0.75 . . . . 0.0 110.683 179.83 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.436 ' O ' HD23 ' A' ' 6' ' ' LEU . 69.3 m-85 -63.65 129.38 39.92 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.948 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.645 ' HA ' HG22 ' A' ' 7' ' ' ILE . 56.7 m -123.25 107.2 11.42 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.36 -178.472 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.604 HG11 HG21 ' A' ' 40' ' ' ILE . 10.6 p -110.82 167.16 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.845 . . . . 0.0 109.436 177.791 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.457 ' N ' HG22 ' A' ' 55' ' ' VAL . 83.7 m -161.61 116.37 2.0 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.652 -0.655 . . . . 0.0 110.06 -179.782 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 . . . . . 0 N--CA 1.498 1.951 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.387 179.746 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mmt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.175 0.512 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.545 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 32.7 m -119.1 112.39 19.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.58 -0.7 . . . . 0.0 110.222 179.922 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 51.3 m -95.08 91.31 6.28 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.622 -0.674 . . . . 0.0 110.492 -179.767 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.663 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.8 m-85 -69.89 172.43 7.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.548 -0.72 . . . . 0.0 109.836 179.713 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -140.59 116.31 10.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.476 -0.765 . . . . 0.0 110.555 -179.659 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.635 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -96.27 112.77 24.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.536 -0.727 . . . . 0.0 110.423 -179.9 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.614 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.2 tp -63.01 172.67 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.005 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.734 HD11 ' OG1' ' A' ' 17' ' ' THR . 74.2 mt -135.61 70.24 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.209 -0.932 . . . . 0.0 110.974 -179.724 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -93.59 50.12 1.44 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.316 -0.865 . . . . 0.0 109.033 178.539 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.04 155.31 16.18 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.303 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -11.82 61.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.639 -0.918 . . . . 0.0 110.247 179.138 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -86.75 -36.11 18.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 110.332 -179.849 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.504 ' HB3' HG21 ' A' ' 8' ' ' ILE . 17.8 mt -138.67 -173.26 3.51 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 110.655 -179.912 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.15 127.08 2.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.603 -0.685 . . . . 0.0 110.345 179.94 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.99 -137.85 9.45 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.858 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -143.92 173.38 11.76 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.553 -0.969 . . . . 0.0 110.396 -179.858 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.734 ' OG1' HD11 ' A' ' 8' ' ' ILE . 7.4 m -153.26 146.8 25.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.622 -0.674 . . . . 0.0 110.175 179.864 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.3 p -132.5 170.19 15.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.628 -0.67 . . . . 0.0 110.226 179.965 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.74 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.3 t -165.58 179.43 6.07 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.573 -0.705 . . . . 0.0 110.166 -179.938 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -104.58 102.04 11.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.564 -0.71 . . . . 0.0 110.255 179.988 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.42 135.4 49.45 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.58 -0.7 . . . . 0.0 110.187 179.972 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.8 m -60.48 -27.23 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.497 -0.752 . . . . 0.0 110.345 179.955 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.453 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 31.1 p30 -172.79 178.43 2.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.422 -0.798 . . . . 0.0 110.221 179.67 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.02 -27.54 45.17 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.504 -0.747 . . . . 0.0 110.763 -179.606 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.453 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -63.37 -24.09 67.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.6 -0.688 . . . . 0.0 110.49 179.934 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 m -108.11 -26.11 10.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.449 -0.782 . . . . 0.0 110.628 -179.738 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.663 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -69.38 -48.24 61.78 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.495 -0.753 . . . . 0.0 110.35 -179.813 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -60.18 -41.53 93.07 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.564 -0.71 . . . . 0.0 110.488 -179.867 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -58.55 -36.36 73.78 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.379 -0.826 . . . . 0.0 110.591 -179.874 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.88 -41.56 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.516 -0.74 . . . . 0.0 110.222 -179.922 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.74 ' CZ ' HG22 ' A' ' 19' ' ' THR . 11.0 m-85 -72.5 -39.04 67.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.519 -0.738 . . . . 0.0 110.32 -179.851 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.4 tttt -62.03 -45.49 93.37 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.387 -0.821 . . . . 0.0 109.173 179.335 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -62.43 -33.06 74.05 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.721 0.772 . . . . 0.0 109.339 179.023 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -67.5 -56.71 8.45 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.847 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.789 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -61.07 -38.69 87.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.749 -0.595 . . . . 0.0 110.148 179.997 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -58.11 -39.96 79.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.503 -0.748 . . . . 0.0 110.557 -179.843 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -69.66 -43.04 73.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.567 -0.708 . . . . 0.0 110.134 -179.946 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -75.34 -28.9 59.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.589 -0.695 . . . . 0.0 110.102 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.06 52.25 1.39 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.886 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.789 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 83.9 mt -109.22 61.24 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.501 -0.999 . . . . 0.0 110.256 179.94 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -84.05 57.89 4.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.439 -0.788 . . . . 0.0 108.993 178.791 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.46 -138.04 5.56 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -178.916 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -116.79 101.22 8.36 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.874 -0.78 . . . . 0.0 109.365 179.484 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.635 ' CH2' HD11 ' A' ' 6' ' ' LEU . 52.6 m95 -71.74 143.06 49.73 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 122.02 0.914 . . . . 0.0 112.176 -178.2 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.66 131.74 14.37 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.464 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.404 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 38.5 t80 -105.02 131.73 52.17 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.713 -0.617 . . . . 0.0 110.294 -178.365 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -106.74 119.22 38.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.662 -0.649 . . . . 0.0 109.819 179.546 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -73.22 -21.46 60.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.655 -0.653 . . . . 0.0 110.707 -179.762 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.429 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.67 -38.23 60.14 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.257 -0.902 . . . . 0.0 110.804 -179.781 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.429 HG23 ' C ' ' A' ' 49' ' ' ALA . 76.0 p -146.88 17.15 1.25 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.594 -0.691 . . . . 0.0 110.86 179.889 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 50.88 93.33 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.122 -0.986 . . . . 0.0 110.697 179.953 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.0 m -154.86 106.87 2.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.464 -0.772 . . . . 0.0 110.94 -179.662 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.473 ' O ' HD23 ' A' ' 6' ' ' LEU . 79.1 m-85 -61.93 130.12 44.15 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.698 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.614 ' HA ' HG22 ' A' ' 7' ' ' ILE . 85.0 m -123.39 107.23 11.39 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.539 -178.598 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.564 HG11 HG21 ' A' ' 40' ' ' ILE . 11.1 p -111.64 166.94 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.452 -0.78 . . . . 0.0 109.15 177.536 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.451 ' N ' HG22 ' A' ' 55' ' ' VAL . 90.8 m -161.88 111.89 1.57 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.766 -0.584 . . . . 0.0 109.796 -179.857 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.163 179.86 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mtt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.1 0.476 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.617 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 12.0 m -151.16 112.14 4.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.578 -0.702 . . . . 0.0 110.23 -179.969 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.608 ' O ' HG23 ' A' ' 3' ' ' THR . 8.0 t -87.81 84.29 7.05 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.684 -0.635 . . . . 0.0 110.8 -179.616 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.634 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 92.9 m-85 -68.6 167.82 14.28 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.357 -0.84 . . . . 0.0 109.938 179.72 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.509 ' HG3' HG22 ' A' ' 18' ' ' THR . 22.8 mttt -131.21 114.75 15.46 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.524 -0.735 . . . . 0.0 110.308 179.974 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.628 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -95.12 109.63 21.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.498 -0.752 . . . . 0.0 110.256 179.916 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.601 HG21 HG23 ' A' ' 54' ' ' THR . 4.1 tp -63.24 169.56 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.166 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.526 HD12 ' C ' ' A' ' 15' ' ' GLY . 81.2 mt -130.84 71.52 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.589 -179.575 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -94.68 48.3 1.2 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.383 -0.823 . . . . 0.0 108.978 178.947 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.8 160.29 17.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.504 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -1.62 35.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.776 -0.837 . . . . 0.0 110.583 179.205 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.806 ' O ' HD22 ' A' ' 13' ' ' LEU . 9.1 m -103.0 -37.58 7.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.318 -179.928 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.806 HD22 ' O ' ' A' ' 12' ' ' THR . 0.9 OUTLIER -134.65 176.54 8.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.486 -0.759 . . . . 0.0 110.589 -179.981 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -157.14 137.85 13.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.528 -0.732 . . . . 0.0 110.274 -179.962 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.526 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 134.02 -153.5 20.95 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.946 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -143.04 157.74 44.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.558 -0.966 . . . . 0.0 110.248 -179.961 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.7 t -144.16 164.49 30.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.556 -0.715 . . . . 0.0 110.304 179.993 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.509 HG22 ' HG3' ' A' ' 5' ' ' LYS . 11.9 p -135.84 174.21 10.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.573 -0.704 . . . . 0.0 110.189 179.941 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.623 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.6 t -161.98 -168.59 1.96 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.583 -0.698 . . . . 0.0 110.369 -179.951 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.26 103.23 8.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.637 -0.664 . . . . 0.0 110.387 179.9 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -133.56 143.18 48.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.485 -0.76 . . . . 0.0 110.238 -179.888 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.603 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.8 p -60.72 -31.6 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.584 -0.698 . . . . 0.0 109.927 179.789 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.603 ' OD1' HG13 ' A' ' 22' ' ' VAL . 50.9 p-10 -170.18 179.1 3.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.635 -0.666 . . . . 0.0 110.148 179.723 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.446 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.04 -25.56 45.4 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.508 -0.745 . . . . 0.0 110.855 -179.647 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.23 -26.51 64.95 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.52 -0.737 . . . . 0.0 110.533 -179.855 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.3 m -111.36 -26.98 8.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.521 -0.737 . . . . 0.0 110.46 -179.896 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.634 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.96 -53.51 56.99 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.498 -0.751 . . . . 0.0 110.317 -179.868 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -59.78 -37.72 79.84 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.578 -0.701 . . . . 0.0 110.315 179.94 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -56.32 -43.31 78.85 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.415 -0.803 . . . . 0.0 110.371 179.93 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.7 t -80.29 -46.09 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.611 -0.68 . . . . 0.0 109.852 179.633 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.623 ' CZ ' HG22 ' A' ' 19' ' ' THR . 9.2 m-85 -63.22 -35.52 80.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.607 -0.683 . . . . 0.0 110.355 -179.749 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -63.54 -42.71 98.4 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.411 -0.806 . . . . 0.0 109.138 179.438 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -63.25 -33.97 76.65 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.735 0.779 . . . . 0.0 109.205 178.898 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -66.63 -58.67 4.67 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.745 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.809 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.6 -34.11 73.72 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.712 -0.618 . . . . 0.0 110.061 179.799 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -55.16 -54.13 47.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.613 -0.68 . . . . 0.0 110.741 -179.924 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.18 -44.35 96.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.573 -0.705 . . . . 0.0 110.13 179.923 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -67.5 -29.64 69.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.597 -0.689 . . . . 0.0 110.072 179.87 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.6 50.96 2.42 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.987 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.809 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 83.1 mt -107.52 61.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.569 -0.96 . . . . 0.0 110.208 179.936 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.07 61.62 4.71 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 178.612 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.23 -140.73 10.23 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -178.685 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -116.02 103.54 10.68 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.572 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.628 ' HH2' HD11 ' A' ' 6' ' ' LEU . 52.0 m95 -73.73 142.13 46.33 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.044 0.926 . . . . 0.0 112.129 -178.211 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 p -149.71 131.96 15.49 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.722 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.433 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 45.9 t80 -103.7 127.8 51.12 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.718 -0.614 . . . . 0.0 110.014 -178.452 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -98.02 120.61 38.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.706 -0.621 . . . . 0.0 110.075 179.902 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.48 -23.03 53.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.677 -0.639 . . . . 0.0 110.489 179.961 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.402 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.4 -40.66 68.46 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.39 -0.819 . . . . 0.0 110.894 -179.733 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.402 HG23 ' C ' ' A' ' 49' ' ' ALA . 73.8 p -145.76 18.0 1.46 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.564 -0.71 . . . . 0.0 111.011 -179.899 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 0.2 OUTLIER 52.15 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.115 -0.99 . . . . 0.0 110.962 179.715 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.0 m -156.2 104.68 2.26 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.431 -0.793 . . . . 0.0 110.996 -179.949 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.462 ' O ' HD23 ' A' ' 6' ' ' LEU . 63.7 m-85 -61.48 123.9 19.14 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.522 -0.736 . . . . 0.0 109.129 178.839 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.601 HG23 HG21 ' A' ' 7' ' ' ILE . 60.4 m -119.49 104.89 10.72 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.667 -178.453 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.59 HG11 HG21 ' A' ' 40' ' ' ILE . 10.6 p -107.32 167.02 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.241 177.554 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.459 ' N ' HG22 ' A' ' 55' ' ' VAL . 99.5 m -159.09 109.17 1.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.647 -0.658 . . . . 0.0 109.902 -179.766 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.122 -179.929 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mtm . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.103 0.478 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.72 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 33.1 m -77.79 165.22 24.44 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.565 -0.709 . . . . 0.0 110.217 -179.921 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.412 ' N ' HG22 ' A' ' 2' ' ' THR . 90.0 m -143.3 91.16 2.24 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.643 -0.661 . . . . 0.0 109.902 179.88 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.72 ' CZ ' HG21 ' A' ' 2' ' ' THR . 83.6 m-85 -80.95 175.88 10.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.555 -0.716 . . . . 0.0 110.253 -179.608 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.633 ' CB ' HG23 ' A' ' 52' ' ' THR . 26.7 mttt -137.49 142.16 41.49 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.673 -0.642 . . . . 0.0 109.96 179.728 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.536 HD13 ' C ' ' A' ' 6' ' ' LEU . 3.4 tm? -115.62 99.8 7.59 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.527 -0.733 . . . . 0.0 110.191 -179.614 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.748 HG21 HG23 ' A' ' 54' ' ' THR . 2.0 tp -63.16 124.68 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.465 -0.772 . . . . 0.0 108.96 179.625 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.589 HG21 ' HB3' ' A' ' 13' ' ' LEU . 10.0 mt -92.65 68.27 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.524 -0.735 . . . . 0.0 110.605 -178.907 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.478 ' HB3' HG23 ' A' ' 56' ' ' THR . 18.1 m-20 -89.19 53.0 2.52 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.199 -0.938 . . . . 0.0 109.221 178.966 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.3 169.0 17.0 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.483 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -83.72 5.48 24.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.749 -0.853 . . . . 0.0 110.499 179.088 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.5 m -114.29 -30.45 6.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 110.245 -179.931 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.589 ' HB3' HG21 ' A' ' 8' ' ' ILE . 13.2 mt -137.1 179.24 6.5 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.373 -0.829 . . . . 0.0 110.741 -179.903 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.03 134.45 4.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.625 -0.672 . . . . 0.0 110.084 -179.938 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.11 -150.1 21.54 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.921 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -139.06 155.32 48.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.624 -0.927 . . . . 0.0 110.298 -179.883 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.4 ' OG1' HD11 ' A' ' 8' ' ' ILE . 76.8 m -126.04 156.08 40.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 110.089 -179.99 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.5 p -145.38 144.98 30.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.587 -0.695 . . . . 0.0 110.323 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.499 HG22 ' CE1' ' A' ' 31' ' ' PHE . 9.7 t -156.17 144.78 20.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.57 -0.706 . . . . 0.0 110.202 179.775 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.23 112.6 12.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.567 -0.708 . . . . 0.0 109.778 179.712 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.91 144.42 50.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.605 -0.685 . . . . 0.0 110.027 -179.864 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.8 m -60.6 -33.48 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.522 -0.736 . . . . 0.0 110.239 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.656 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 24.0 p30 -175.26 -175.35 0.82 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.462 -0.774 . . . . 0.0 110.254 179.422 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.8 -25.19 55.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.545 -0.722 . . . . 0.0 110.876 -179.725 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.656 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.24 -26.52 63.0 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.462 -0.774 . . . . 0.0 110.543 -179.83 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.5 m -111.49 -25.91 9.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.529 -0.732 . . . . 0.0 110.559 -179.882 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.704 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.66 -57.41 13.03 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.457 -0.777 . . . . 0.0 110.45 -179.825 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -59.18 -36.28 75.06 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.465 -0.772 . . . . 0.0 110.416 -179.986 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -61.06 -41.54 96.81 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.351 -0.843 . . . . 0.0 109.864 179.764 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.9 t -83.51 -39.34 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.578 -0.701 . . . . 0.0 109.337 179.278 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.499 ' CE1' HG22 ' A' ' 19' ' ' THR . 5.0 m-30 -66.45 -35.41 80.23 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.703 -0.623 . . . . 0.0 109.644 179.558 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -69.43 -45.45 69.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.663 -0.648 . . . . 0.0 109.624 179.712 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -61.94 -32.18 72.58 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.625 0.726 . . . . 0.0 109.671 179.397 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -67.65 -48.48 66.55 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.063 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.696 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -75.19 -33.09 61.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.781 -0.574 . . . . 0.0 110.391 -179.679 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -58.69 -45.24 89.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.497 -0.752 . . . . 0.0 110.399 -179.814 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.03 -36.98 72.57 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.599 -0.688 . . . . 0.0 110.156 179.941 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -74.43 -34.8 63.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.617 -0.677 . . . . 0.0 110.049 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.59 35.5 3.53 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.965 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.696 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 81.6 mt -100.09 69.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.537 -0.978 . . . . 0.0 110.204 179.991 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.08 51.5 1.81 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.692 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.71 -136.81 0.75 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -178.711 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -113.95 102.95 10.68 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.641 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.463 ' CH2' HD21 ' A' ' 6' ' ' LEU . 35.2 m95 -74.02 142.0 45.78 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.113 0.959 . . . . 0.0 112.161 -178.101 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 44' ' ' TRP . 4.3 p -152.58 132.17 13.06 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.022 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.432 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 53.8 t80 -103.8 103.75 13.67 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.71 -0.618 . . . . 0.0 109.951 -178.846 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.78 109.32 15.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.686 -0.634 . . . . 0.0 109.839 179.781 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -64.62 -22.12 66.89 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.706 -0.621 . . . . 0.0 110.437 -179.965 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.79 -35.54 44.33 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.331 -0.855 . . . . 0.0 110.791 -179.855 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.0 p -145.4 15.48 1.46 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.545 -0.722 . . . . 0.0 110.95 179.862 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.44 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.01 82.24 0.06 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.092 -1.005 . . . . 0.0 110.716 179.818 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.633 HG23 ' CB ' ' A' ' 5' ' ' LYS . 26.6 m -150.11 110.71 4.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.38 -0.825 . . . . 0.0 111.429 -179.642 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -65.53 112.76 3.75 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.439 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.748 HG23 HG21 ' A' ' 7' ' ' ILE . 88.4 m -104.85 99.41 9.05 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.918 -177.545 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.516 HG21 HG22 ' A' ' 40' ' ' ILE . 10.7 p -100.38 164.92 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 0.0 108.972 177.044 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.478 HG23 ' HB3' ' A' ' 9' ' ' ASN . 90.0 m -160.62 110.53 1.75 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.722 -0.611 . . . . 0.0 110.135 -179.677 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.038 179.824 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 ptt? . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.128 0.489 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.643 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 4.1 m -103.85 114.75 29.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.624 -0.672 . . . . 0.0 110.048 179.991 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 m -89.08 86.68 6.95 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.585 -0.697 . . . . 0.0 110.627 -179.576 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.728 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 66.0 m-85 -76.05 169.73 17.62 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.458 -0.776 . . . . 0.0 109.788 179.684 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 52' ' ' THR . 11.0 mtmm -141.45 105.3 4.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.482 -0.761 . . . . 0.0 110.392 -179.928 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.524 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -90.61 107.34 19.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.495 -0.753 . . . . 0.0 110.041 179.817 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 54' ' ' THR . 2.8 tp -64.2 160.2 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 119.616 -0.834 . . . . 0.0 108.921 179.231 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 13' ' ' LEU . 49.0 mm -123.31 76.84 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.456 -179.735 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.9 48.3 1.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.784 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.9 153.16 17.76 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.234 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -12.61 61.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.686 -0.89 . . . . 0.0 110.283 179.178 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.6 m -85.98 -35.75 20.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.898 . . . . 0.0 110.336 -179.999 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.438 ' O ' HG22 ' A' ' 8' ' ' ILE . 38.9 mt -143.72 171.43 14.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.521 -0.737 . . . . 0.0 110.545 -179.902 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.96 137.54 13.13 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.611 -0.681 . . . . 0.0 110.105 179.89 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.28 -138.05 9.43 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.962 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -141.08 165.53 27.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.971 . . . . 0.0 110.298 -179.917 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.1 m -151.75 128.47 10.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.582 -0.699 . . . . 0.0 110.1 179.977 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.428 HG22 ' HG2' ' A' ' 5' ' ' LYS . 26.4 p -126.32 149.4 49.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.735 . . . . 0.0 110.374 -179.915 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.831 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 9.0 t -150.56 129.14 12.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.621 -0.675 . . . . 0.0 110.179 179.807 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -60.91 118.48 6.75 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.513 -0.742 . . . . 0.0 110.101 179.868 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.84 156.89 45.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.58 -0.7 . . . . 0.0 110.319 -179.786 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 p -65.0 -37.0 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.621 -0.674 . . . . 0.0 110.063 179.963 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -174.73 -173.67 0.74 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.517 -0.739 . . . . 0.0 109.964 179.8 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -54.77 -24.15 21.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.43 -0.794 . . . . 0.0 111.018 -179.643 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.66 -43.79 85.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.402 -0.811 . . . . 0.0 110.504 -179.892 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.3 m -94.7 -29.97 14.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.572 -0.705 . . . . 0.0 110.254 179.907 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.728 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.76 -62.21 2.04 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.488 -0.758 . . . . 0.0 110.419 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.17 -35.26 74.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.652 -0.655 . . . . 0.0 110.308 179.988 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -60.35 -41.94 94.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.29 -0.881 . . . . 0.0 110.114 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.7 t -81.45 -41.28 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.605 -0.684 . . . . 0.0 109.648 179.562 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.831 ' CZ ' HG22 ' A' ' 19' ' ' THR . 14.7 m-85 -67.66 -38.37 83.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 0.0 110.155 -179.934 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -63.34 -47.89 80.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.535 -0.728 . . . . 0.0 109.654 179.723 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -59.82 -32.92 71.11 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.732 0.777 . . . . 0.0 109.452 179.241 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.402 ' OH ' HD12 ' A' ' 8' ' ' ILE . 2.3 t80 -66.99 -59.2 3.68 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.717 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.799 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -61.96 -44.66 96.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.729 -0.607 . . . . 0.0 109.995 179.703 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -56.0 -42.4 76.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.537 -0.727 . . . . 0.0 110.61 -179.777 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.22 -41.65 85.38 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.596 -0.69 . . . . 0.0 109.9 179.862 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -72.86 -51.66 17.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.577 -0.702 . . . . 0.0 109.856 179.779 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.8 43.72 0.23 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.686 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.799 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.3 mt -104.5 59.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.515 -0.991 . . . . 0.0 110.256 179.755 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -80.74 60.95 4.22 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.47 -0.769 . . . . 0.0 109.058 178.961 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.7 -138.34 7.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -178.906 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.79 102.78 9.39 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.891 -0.77 . . . . 0.0 109.07 179.281 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.524 ' HH2' HD11 ' A' ' 6' ' ' LEU . 53.3 m95 -73.03 142.62 47.68 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.207 1.004 . . . . 0.0 112.574 -177.705 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.3 p -150.46 131.49 14.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.411 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -106.58 128.86 54.47 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.637 -0.664 . . . . 0.0 110.329 -178.288 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -100.73 111.28 23.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.697 -0.627 . . . . 0.0 109.911 179.707 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -68.91 -24.69 64.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.689 -0.632 . . . . 0.0 110.525 -179.881 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.43 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.31 -36.33 52.93 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.353 -0.842 . . . . 0.0 110.969 -179.695 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.43 HG23 ' C ' ' A' ' 49' ' ' ALA . 77.3 p -147.2 16.86 1.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.514 -0.741 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.459 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.36 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.149 -0.969 . . . . 0.0 110.809 179.798 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 5' ' ' LYS . 74.9 m -159.64 104.27 1.58 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.423 -0.798 . . . . 0.0 111.209 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.471 ' HE2' ' HB1' ' A' ' 27' ' ' ALA . 96.7 m-85 -65.0 128.12 34.43 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.557 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.672 ' HA ' HG22 ' A' ' 7' ' ' ILE . 61.8 m -120.39 103.11 8.93 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.34 -178.52 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.584 HG11 HG21 ' A' ' 40' ' ' ILE . 8.5 p -106.13 165.74 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 0.0 109.56 177.935 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.449 ' N ' HG22 ' A' ' 55' ' ' VAL . 84.4 m -162.54 117.08 1.79 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.785 -0.572 . . . . 0.0 109.88 -179.744 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.991 179.691 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmt . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.104 0.478 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.465 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 77.7 m -84.1 112.35 20.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.619 -0.675 . . . . 0.0 110.246 -179.929 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.4 m -93.47 103.8 15.98 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.631 -0.668 . . . . 0.0 110.446 -179.87 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.739 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 84.7 m-85 -84.11 179.54 7.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.515 -0.74 . . . . 0.0 110.178 179.938 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.547 ' HB3' HG23 ' A' ' 52' ' ' THR . 5.7 ttmt -145.69 111.94 5.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.527 -0.733 . . . . 0.0 110.502 179.966 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.515 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -92.72 111.45 23.06 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.435 -0.79 . . . . 0.0 110.321 -179.959 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.643 HG21 HG23 ' A' ' 54' ' ' THR . 3.6 tt -65.03 174.01 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.357 -0.84 . . . . 0.0 108.801 179.205 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 13' ' ' LEU . 76.1 mt -135.0 74.51 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.658 -179.888 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -96.28 49.73 1.14 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.953 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.71 160.95 13.19 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.327 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm -78.15 -7.44 57.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.724 -0.868 . . . . 0.0 110.463 179.201 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 12' ' ' THR . 10.0 t -98.23 -25.56 14.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.164 -0.96 . . . . 0.0 110.701 -179.77 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.471 ' O ' HG22 ' A' ' 8' ' ' ILE . 3.6 tp -150.09 164.67 34.97 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.416 -0.802 . . . . 0.0 110.744 -179.875 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.16 140.11 23.99 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.61 -0.681 . . . . 0.0 110.412 -179.773 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.406 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 132.79 -144.69 16.63 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.978 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -142.7 170.56 15.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.485 -1.009 . . . . 0.0 110.277 -179.942 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.7 m -144.06 161.39 38.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.64 -0.663 . . . . 0.0 110.188 179.991 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.8 p -144.54 151.09 38.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.543 -0.723 . . . . 0.0 110.41 -179.838 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.782 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.6 t -155.99 164.56 38.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.584 -0.698 . . . . 0.0 110.064 179.795 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -94.87 109.72 21.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.526 -0.733 . . . . 0.0 110.292 -179.959 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.47 143.15 47.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.612 -0.68 . . . . 0.0 109.95 179.9 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 23' ' ' ASP . 33.5 m -57.4 -38.84 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.451 -0.781 . . . . 0.0 110.232 179.808 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.455 ' N ' HG23 ' A' ' 22' ' ' VAL . 1.3 t0 -172.93 -170.2 0.63 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.623 -0.673 . . . . 0.0 109.771 179.58 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.419 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.48 -22.57 21.44 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.474 -0.766 . . . . 0.0 111.096 -179.673 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.64 -27.9 69.54 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.461 -0.774 . . . . 0.0 110.55 -179.738 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.7 m -114.37 -25.65 8.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.468 -0.77 . . . . 0.0 110.684 -179.63 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.739 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.77 -62.28 1.99 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.453 -0.779 . . . . 0.0 110.628 -179.708 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.86 -45.04 86.87 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.446 -0.784 . . . . 0.0 110.446 179.934 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -53.29 -44.03 67.96 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.391 -0.818 . . . . 0.0 110.727 -179.956 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.1 t -78.25 -48.88 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.54 -0.725 . . . . 0.0 109.983 179.74 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.782 ' CZ ' HG22 ' A' ' 19' ' ' THR . 3.9 m-85 -62.11 -31.16 71.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 110.238 -179.55 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -64.88 -39.38 93.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.393 -0.817 . . . . 0.0 108.92 179.262 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -61.88 -30.04 70.6 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.56 0.695 . . . . 0.0 109.704 179.083 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -73.18 -54.86 7.41 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.196 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.738 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -63.65 -48.78 75.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.738 -0.601 . . . . 0.0 110.149 179.974 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -55.95 -28.71 58.22 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.516 -0.74 . . . . 0.0 110.515 -179.897 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.62 -38.39 29.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.658 -0.651 . . . . 0.0 110.056 179.909 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -80.59 -34.41 35.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.56 -0.713 . . . . 0.0 110.058 179.927 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.54 49.13 0.61 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.906 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.738 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 85.1 mt -115.15 67.92 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.52 -0.988 . . . . 0.0 110.329 179.852 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -90.83 51.88 2.06 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.771 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.49 -139.14 2.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -178.957 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -114.83 108.53 16.87 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.356 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.515 ' CH2' HD11 ' A' ' 6' ' ' LEU . 46.0 m95 -77.14 142.08 39.87 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.1 0.953 . . . . 0.0 112.321 -177.985 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.1 p -147.49 133.1 18.79 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.752 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.413 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 71.7 t80 -100.49 131.97 46.13 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.712 -0.618 . . . . 0.0 110.454 -178.357 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -100.79 125.29 47.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.678 -0.639 . . . . 0.0 109.946 179.81 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -82.04 -18.49 43.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.69 -0.631 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.43 ' C ' HG23 ' A' ' 50' ' ' THR . . . -57.01 -44.74 83.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.271 -0.893 . . . . 0.0 110.725 -179.7 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.43 HG23 ' C ' ' A' ' 49' ' ' ALA . 70.2 p -147.37 23.81 1.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.519 -0.738 . . . . 0.0 110.65 -179.588 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.43 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 1.3 mppt? 52.42 95.38 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.239 -0.913 . . . . 0.0 110.727 179.953 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.547 HG23 ' HB3' ' A' ' 5' ' ' LYS . 90.7 m -151.76 101.79 2.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.53 -0.731 . . . . 0.0 110.749 -179.964 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.469 ' O ' HD23 ' A' ' 6' ' ' LEU . 81.4 m-85 -61.08 124.16 19.73 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.811 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.643 HG23 HG21 ' A' ' 7' ' ' ILE . 62.3 m -117.98 105.47 11.93 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.387 -0.925 . . . . 0.0 112.611 -178.197 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.571 HG11 HG21 ' A' ' 40' ' ' ILE . 10.8 p -105.87 168.04 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.42 -0.8 . . . . 0.0 109.128 177.538 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.471 ' N ' HG22 ' A' ' 55' ' ' VAL . 95.1 m -158.28 108.14 2.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.564 -0.71 . . . . 0.0 109.948 -179.676 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.17 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.581 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 70.4 m . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.07 0.462 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.0 m -78.67 99.57 6.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.639 -0.663 . . . . 0.0 110.76 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.71 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 73.2 m-85 -87.45 167.4 14.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.555 -0.716 . . . . 0.0 109.907 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.571 ' CG ' HG22 ' A' ' 18' ' ' THR . 3.6 mtpt -138.75 129.87 26.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.464 -0.772 . . . . 0.0 110.435 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.536 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 44.3 tp -106.5 123.06 47.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.509 -0.744 . . . . 0.0 110.209 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.616 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.6 tp -75.42 165.98 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.6 mt -127.89 72.66 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.225 -0.922 . . . . 0.0 110.676 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.522 ' HB3' HG23 ' A' ' 56' ' ' THR . 71.5 m-20 -95.38 49.19 1.18 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.274 -0.892 . . . . 0.0 109.029 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.69 166.5 14.96 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -84.89 6.35 25.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.724 -0.868 . . . . 0.0 110.608 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 m -116.84 -30.76 5.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 110.482 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.5 mt -135.71 173.11 12.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 110.783 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.38 139.38 3.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.66 -0.65 . . . . 0.0 110.294 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.37 -136.1 7.68 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -153.99 154.36 33.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.617 -0.931 . . . . 0.0 110.287 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.9 m -143.82 155.23 44.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.59 -0.694 . . . . 0.0 110.211 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.571 HG22 ' CG ' ' A' ' 5' ' ' LYS . 74.0 p -133.25 173.9 10.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.563 -0.711 . . . . 0.0 110.329 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.554 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.6 t -164.11 -170.32 2.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.64 -0.663 . . . . 0.0 110.167 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.56 100.11 6.09 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.639 -0.663 . . . . 0.0 110.4 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.84 142.69 50.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.465 -0.772 . . . . 0.0 110.01 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.81 -30.39 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.576 -0.702 . . . . 0.0 110.048 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.556 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 24.1 p30 -170.06 176.08 4.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.611 -0.681 . . . . 0.0 110.323 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.78 -25.15 26.15 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.515 -0.741 . . . . 0.0 110.969 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.556 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -60.06 -27.0 66.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.492 -0.755 . . . . 0.0 110.431 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.2 m -112.1 -27.99 8.16 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.499 -0.751 . . . . 0.0 110.364 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.71 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.69 -49.6 77.11 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.487 -0.758 . . . . 0.0 110.375 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -59.14 -40.19 84.72 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.541 -0.724 . . . . 0.0 110.309 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -56.94 -35.5 69.16 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.35 -0.844 . . . . 0.0 110.363 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 93.8 t -84.39 -48.19 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.601 -0.687 . . . . 0.0 110.056 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.554 ' CZ ' HG22 ' A' ' 19' ' ' THR . 9.7 m-85 -65.87 -36.82 84.5 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 110.206 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.1 tptt -63.44 -44.89 93.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.518 -0.739 . . . . 0.0 109.43 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -60.72 -31.57 70.87 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.609 0.718 . . . . 0.0 109.708 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -70.7 -57.14 4.99 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.735 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.33 -47.22 85.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.751 -0.593 . . . . 0.0 110.022 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -54.94 -32.95 61.81 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.474 -0.766 . . . . 0.0 110.591 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.42 -49.99 43.13 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.615 -0.678 . . . . 0.0 109.985 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -71.35 -46.34 60.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.569 -0.707 . . . . 0.0 109.886 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.47 43.26 0.29 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.735 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 81.1 mt -105.59 71.32 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.447 -1.031 . . . . 0.0 110.245 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -95.4 46.05 1.1 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.2 -135.85 0.1 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -115.47 102.19 9.58 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.536 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 38.3 m95 -72.56 142.42 48.44 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.177 0.989 . . . . 0.0 112.456 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -150.9 133.05 15.32 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.425 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 63.2 t80 -102.83 109.24 20.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.664 -0.648 . . . . 0.0 110.206 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.34 109.33 16.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.655 -0.653 . . . . 0.0 110.096 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -67.6 -20.61 65.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.693 -0.629 . . . . 0.0 110.767 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.39 -42.56 67.08 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.251 -0.906 . . . . 0.0 110.859 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.7 p -141.31 18.7 2.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.585 -0.697 . . . . 0.0 110.685 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.435 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER 50.31 90.35 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.151 -0.968 . . . . 0.0 111.152 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 57.6 m -156.59 108.46 2.48 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.789 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 93.1 m-85 -60.37 123.29 16.84 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.616 ' HA ' HG22 ' A' ' 7' ' ' ILE . 48.4 m -115.5 94.53 4.75 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.242 -0.983 . . . . 0.0 112.846 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.549 HG21 HG22 ' A' ' 40' ' ' ILE . 11.0 p -95.55 166.84 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.128 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.522 HG23 ' HB3' ' A' ' 9' ' ' ASN . 95.4 m -160.26 108.1 1.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.677 -0.639 . . . . 0.0 109.86 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.214 -179.922 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.684 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 22.4 m . . . . . 0 N--CA 1.495 1.777 0 CA-C-O 121.001 0.429 . . . . 0.0 110.091 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.8 m -118.22 91.24 3.51 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.593 -0.692 . . . . 0.0 110.524 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.71 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 98.6 m-85 -80.34 168.69 18.72 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.594 -0.691 . . . . 0.0 109.967 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -145.88 115.79 7.34 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.463 -0.773 . . . . 0.0 110.372 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.62 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 30.1 tp -94.11 127.18 39.78 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.422 -0.799 . . . . 0.0 110.2 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.655 HG21 HG23 ' A' ' 54' ' ' THR . 2.4 tp -76.47 170.12 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 16' ' ' GLU . 78.8 mt -129.99 71.13 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.22 -0.925 . . . . 0.0 110.715 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.538 ' HB3' HG23 ' A' ' 56' ' ' THR . 5.8 m-20 -96.15 47.25 1.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.506 -0.746 . . . . 0.0 109.22 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.43 167.0 24.47 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -82.32 3.12 29.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.76 -0.847 . . . . 0.0 110.754 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 m -116.88 -30.63 5.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.104 -0.997 . . . . 0.0 110.455 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.415 ' HB3' HG21 ' A' ' 8' ' ' ILE . 54.9 mt -128.7 172.48 11.2 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.455 -0.778 . . . . 0.0 110.694 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -154.99 131.76 10.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.696 -0.627 . . . . 0.0 109.932 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.71 -140.22 11.55 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.457 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.1 pt-20 -147.82 178.04 8.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.565 -0.962 . . . . 0.0 110.42 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.413 ' OG1' HD11 ' A' ' 8' ' ' ILE . 19.7 m -152.27 128.94 10.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.542 -0.724 . . . . 0.0 110.162 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.3 p -114.53 155.77 25.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.574 -0.704 . . . . 0.0 110.256 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.791 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.1 t -160.55 153.51 21.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.597 -0.689 . . . . 0.0 110.309 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -86.71 112.41 21.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.524 -0.735 . . . . 0.0 110.326 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.6 147.32 52.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.642 -0.661 . . . . 0.0 110.048 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 p -64.25 -33.58 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.531 -0.73 . . . . 0.0 110.227 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.617 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 27.2 p30 -170.86 -177.85 2.38 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.486 -0.759 . . . . 0.0 110.362 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -54.36 -25.24 23.18 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.477 -0.764 . . . . 0.0 111.003 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.617 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.24 -46.01 89.64 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.443 -0.785 . . . . 0.0 110.315 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.525 ' O ' HG23 ' A' ' 30' ' ' VAL . 34.5 m -90.2 -26.48 20.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.605 -0.684 . . . . 0.0 110.168 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.71 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.75 -62.32 1.96 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.55 -0.719 . . . . 0.0 110.217 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -60.36 -37.06 79.54 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.505 -0.747 . . . . 0.0 109.972 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.4 ttpt -58.42 -37.16 74.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.446 -0.783 . . . . 0.0 110.073 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 26' ' ' THR . 90.1 t -84.55 -45.84 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.689 -0.632 . . . . 0.0 109.786 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.791 ' CZ ' HG22 ' A' ' 19' ' ' THR . 14.0 m-85 -66.41 -34.01 77.0 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.636 -0.665 . . . . 0.0 110.207 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -66.15 -46.21 78.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.442 -0.786 . . . . 0.0 109.015 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -61.11 -30.91 70.65 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.634 0.73 . . . . 0.0 109.381 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -69.26 -55.74 9.62 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.708 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -63.07 -38.86 92.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.712 -0.617 . . . . 0.0 109.797 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -59.02 -34.05 71.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.528 -0.733 . . . . 0.0 110.357 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -78.03 -47.67 17.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.657 -0.652 . . . . 0.0 110.141 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -69.76 -41.91 74.57 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.593 -0.692 . . . . 0.0 110.087 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.34 62.54 0.4 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.708 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 87.0 mt -127.65 81.47 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.552 -0.97 . . . . 0.0 110.421 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -98.76 37.67 1.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.04 -140.24 0.02 OUTLIER Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -114.56 110.7 20.22 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.62 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 29.9 m95 -77.88 143.03 38.09 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 122.205 1.003 . . . . 0.0 112.364 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 44' ' ' TRP . 6.0 p -153.94 132.12 11.86 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -105.65 143.77 33.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.63 -0.669 . . . . 0.0 110.06 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.69 108.73 18.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.765 -0.584 . . . . 0.0 109.804 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.6 -23.03 65.33 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.638 -0.664 . . . . 0.0 110.62 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.442 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.23 -37.55 64.74 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.309 -0.87 . . . . 0.0 110.788 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.442 HG23 ' C ' ' A' ' 49' ' ' ALA . 72.5 p -147.79 19.04 1.15 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.518 -0.739 . . . . 0.0 110.766 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.443 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.6 94.56 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.204 -0.935 . . . . 0.0 110.886 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.9 m -159.1 100.72 1.56 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.559 -0.713 . . . . 0.0 110.791 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 91.0 m-85 -61.95 140.1 58.35 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.445 -0.785 . . . . 0.0 109.006 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.655 HG23 HG21 ' A' ' 7' ' ' ILE . 55.8 m -131.87 100.03 4.95 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.272 -0.971 . . . . 0.0 112.69 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.557 HG21 HG22 ' A' ' 40' ' ' ILE . 10.3 p -101.61 166.25 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.22 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.538 HG23 ' HB3' ' A' ' 9' ' ' ASN . 93.4 m -160.79 112.26 1.86 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.661 -0.649 . . . . 0.0 109.931 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 118.016 -0.993 . . . . 0.0 110.13 179.943 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.572 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 62.0 m . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.072 0.463 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.6 m -84.81 95.44 8.98 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.633 -0.667 . . . . 0.0 110.696 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.742 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 95.8 m-85 -79.77 173.99 12.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.48 -0.763 . . . . 0.0 109.778 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.529 ' CG ' HG22 ' A' ' 18' ' ' THR . 8.8 mtmt -142.67 123.26 14.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.486 -0.759 . . . . 0.0 110.658 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.607 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 47.4 tp -101.16 127.61 47.64 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.425 -0.797 . . . . 0.0 109.897 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.687 HG21 HG23 ' A' ' 54' ' ' THR . 2.8 tt -77.39 174.06 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.493 HG21 ' HB3' ' A' ' 13' ' ' LEU . 86.2 mt -133.14 73.33 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.32 -0.862 . . . . 0.0 110.444 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.543 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.5 m-20 -95.82 47.79 1.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.414 -0.804 . . . . 0.0 109.004 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.72 154.78 16.45 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -71.81 -9.1 57.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.704 -0.88 . . . . 0.0 110.396 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -90.31 -34.57 15.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 110.281 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.493 ' HB3' HG21 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -144.82 167.39 22.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.474 -0.766 . . . . 0.0 110.769 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -147.62 137.29 22.69 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.569 -0.707 . . . . 0.0 110.195 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.8 -136.81 8.7 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -146.97 168.64 20.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.53 -0.983 . . . . 0.0 110.326 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.2 m -143.45 149.87 38.22 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.638 -0.664 . . . . 0.0 110.125 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.529 HG22 ' CG ' ' A' ' 5' ' ' LYS . 20.8 p -131.41 157.66 42.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.534 -0.729 . . . . 0.0 110.297 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.79 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.6 t -160.98 168.12 25.17 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.566 -0.708 . . . . 0.0 110.235 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.26 124.22 44.16 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.602 -0.686 . . . . 0.0 110.145 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.03 138.15 20.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.6 -0.688 . . . . 0.0 110.181 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.49 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.8 p -60.08 -34.3 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.537 -0.727 . . . . 0.0 110.064 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.57 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 51.2 p30 -169.65 -173.91 1.75 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.61 -0.681 . . . . 0.0 110.306 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.85 -23.83 47.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.594 -0.691 . . . . 0.0 110.932 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.57 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.09 -31.49 68.95 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.395 -0.816 . . . . 0.0 110.36 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.548 ' O ' HG23 ' A' ' 30' ' ' VAL . 52.2 m -110.66 -24.3 10.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.57 -0.706 . . . . 0.0 110.447 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.742 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.27 -62.11 2.08 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.425 -0.797 . . . . 0.0 110.23 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -60.2 -39.8 87.82 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.555 -0.716 . . . . 0.0 109.903 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -57.64 -37.22 72.96 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.469 -0.769 . . . . 0.0 110.236 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 26' ' ' THR . 98.4 t -83.42 -48.64 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.699 -0.626 . . . . 0.0 109.871 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.79 ' CZ ' HG22 ' A' ' 19' ' ' THR . 5.4 m-85 -64.39 -34.11 77.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.551 -0.718 . . . . 0.0 110.11 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -64.61 -44.03 91.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.482 -0.761 . . . . 0.0 109.166 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -60.99 -35.36 76.62 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.84 0.829 . . . . 0.0 109.474 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -65.24 -53.54 42.84 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.702 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -63.91 -40.97 97.73 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.715 -0.615 . . . . 0.0 110.048 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -57.32 -39.83 76.66 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.56 -0.712 . . . . 0.0 110.451 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.71 -56.63 11.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.581 -0.699 . . . . 0.0 110.01 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -64.34 -51.35 63.81 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.588 -0.695 . . . . 0.0 109.903 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.92 55.84 0.16 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.702 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 82.0 mt -118.72 73.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.53 -0.982 . . . . 0.0 110.278 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -95.64 43.2 1.09 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.57 -137.08 0.07 OUTLIER Glycine 0 N--CA 1.488 2.127 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -114.6 107.63 15.75 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.607 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 35.0 m95 -77.26 143.51 38.85 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.055 0.931 . . . . 0.0 112.359 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 44' ' ' TRP . 3.6 p -152.65 132.01 12.87 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.412 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 31.0 t80 -102.36 124.91 48.77 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.717 -0.615 . . . . 0.0 110.083 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -95.05 113.57 25.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.689 -0.632 . . . . 0.0 109.975 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.51 -15.09 63.18 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.672 -0.643 . . . . 0.0 110.928 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.437 ' C ' HG23 ' A' ' 50' ' ' THR . . . -56.46 -44.34 80.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.222 -0.924 . . . . 0.0 110.719 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.437 HG23 ' C ' ' A' ' 49' ' ' ALA . 68.6 p -147.59 25.11 1.08 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.494 -0.754 . . . . 0.0 110.628 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.456 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.44 89.87 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.357 -0.839 . . . . 0.0 110.841 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 83.2 m -150.46 101.76 2.99 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.478 -0.764 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.471 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 85.6 m-85 -61.98 127.84 33.31 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.448 -0.783 . . . . 0.0 108.939 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.687 HG23 HG21 ' A' ' 7' ' ' ILE . 55.6 m -121.06 101.5 7.71 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.338 -0.945 . . . . 0.0 113.027 -178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.531 HG21 HG22 ' A' ' 40' ' ' ILE . 11.3 p -101.07 167.85 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 108.981 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.543 HG23 ' HB3' ' A' ' 9' ' ' ASN . 98.5 m -159.82 109.14 1.81 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.521 -0.737 . . . . 0.0 109.977 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.185 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.53 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 33.7 m . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.121 0.486 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.7 m -97.77 97.48 9.02 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.607 -0.683 . . . . 0.0 110.552 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.817 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 95.2 m-85 -78.65 175.88 9.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.544 -0.723 . . . . 0.0 109.753 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.431 ' HB3' HG23 ' A' ' 52' ' ' THR . 23.8 tttt -144.51 119.6 10.08 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.401 -0.812 . . . . 0.0 110.621 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.632 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 42.6 tp -100.04 130.67 46.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.298 -0.876 . . . . 0.0 110.48 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.612 HG22 ' HA ' ' A' ' 54' ' ' THR . 3.6 tp -80.36 168.24 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 13' ' ' LEU . 79.7 mt -129.41 74.76 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 111.007 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.436 ' HB3' HG23 ' A' ' 56' ' ' THR . 97.2 m-20 -97.65 47.8 1.02 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.322 -0.861 . . . . 0.0 108.924 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.03 165.94 15.39 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -85.6 6.83 25.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.702 -0.881 . . . . 0.0 110.444 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -113.46 -31.96 6.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.921 . . . . 0.0 109.989 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.467 ' O ' HG22 ' A' ' 8' ' ' ILE . 2.1 tp -140.43 167.44 22.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.558 -0.714 . . . . 0.0 110.375 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -155.26 140.62 17.69 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.592 -0.692 . . . . 0.0 110.323 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.69 -134.64 7.58 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.54 161.7 42.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.621 -0.929 . . . . 0.0 110.386 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.3 m -145.81 151.1 37.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.634 -0.666 . . . . 0.0 110.068 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 p -130.76 157.1 43.75 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.568 -0.708 . . . . 0.0 110.282 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.41 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.3 t -149.29 -172.05 4.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.562 -0.711 . . . . 0.0 110.252 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -123.85 103.94 8.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.486 -0.759 . . . . 0.0 110.249 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.761 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -129.02 153.47 47.56 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.56 -0.712 . . . . 0.0 110.116 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.54 -22.2 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.573 -0.705 . . . . 0.0 110.46 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.566 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 44.2 p30 -172.35 -177.92 1.9 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.316 -0.865 . . . . 0.0 110.203 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.406 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.45 -24.57 20.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.523 -0.736 . . . . 0.0 111.064 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.566 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.49 -52.13 66.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.463 -0.773 . . . . 0.0 110.479 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.761 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 31.1 m -80.6 -26.52 37.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.571 -0.705 . . . . 0.0 110.509 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.817 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.93 -64.03 1.09 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.498 -0.751 . . . . 0.0 110.495 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -60.13 -40.02 88.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.532 -0.73 . . . . 0.0 110.115 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -57.1 -38.39 73.31 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.456 -0.778 . . . . 0.0 110.313 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 26' ' ' THR . 87.7 t -83.06 -48.61 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.614 -0.679 . . . . 0.0 109.922 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.502 ' HB3' HD22 ' A' ' 6' ' ' LEU . 9.1 m-85 -63.63 -34.09 77.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.614 -0.679 . . . . 0.0 110.112 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -64.31 -45.84 86.17 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.461 -0.774 . . . . 0.0 109.095 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -62.15 -29.2 70.18 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.601 0.715 . . . . 0.0 109.618 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -72.15 -54.2 10.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.755 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.52 -38.6 84.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.672 -0.642 . . . . 0.0 110.293 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -58.21 -38.52 76.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.483 -0.76 . . . . 0.0 110.667 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -68.33 -38.88 81.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.573 -0.704 . . . . 0.0 110.26 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -81.94 -32.7 30.69 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.603 -0.686 . . . . 0.0 110.109 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.75 48.3 1.28 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.755 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 81.7 mt -104.53 62.84 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.584 -0.95 . . . . 0.0 110.225 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -83.01 59.73 5.08 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.11 -141.53 10.23 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -113.54 109.55 18.81 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.894 -0.768 . . . . 0.0 109.029 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.632 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 32.9 m95 -78.44 143.38 36.77 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.064 0.935 . . . . 0.0 112.178 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 44' ' ' TRP . 7.6 p -155.1 132.78 11.31 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -103.0 158.76 16.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.652 -0.655 . . . . 0.0 110.167 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.03 111.99 12.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.834 -0.541 . . . . 0.0 109.66 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.98 -20.18 65.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.692 -0.63 . . . . 0.0 110.814 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.435 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.77 -41.08 70.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.296 -0.878 . . . . 0.0 110.746 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.435 HG23 ' C ' ' A' ' 49' ' ' ALA . 69.6 p -147.7 20.72 1.16 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.563 -0.71 . . . . 0.0 110.757 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.439 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.65 89.6 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.217 -0.927 . . . . 0.0 110.72 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.431 HG23 ' HB3' ' A' ' 5' ' ' LYS . 7.0 m -151.1 102.96 2.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.349 -0.844 . . . . 0.0 111.516 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.541 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 73.3 m-85 -64.13 133.77 53.6 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.612 ' HA ' HG22 ' A' ' 7' ' ' ILE . 71.1 m -125.94 100.43 6.37 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.766 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.562 HG11 HG21 ' A' ' 40' ' ' ILE . 11.5 p -103.26 166.97 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.371 -0.831 . . . . 0.0 109.171 177.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.474 ' N ' HG22 ' A' ' 55' ' ' VAL . 97.3 m -160.3 110.75 1.84 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.655 -0.653 . . . . 0.0 109.782 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.182 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.579 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 62.0 m . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.121 0.486 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.4 m -85.7 95.01 9.24 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.642 -0.661 . . . . 0.0 110.596 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.796 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.4 m-85 -77.81 176.08 9.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.44 -0.788 . . . . 0.0 109.735 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -142.79 124.94 15.36 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.499 -0.751 . . . . 0.0 110.383 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.583 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 54.4 tp -104.02 118.82 37.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.454 -0.779 . . . . 0.0 110.204 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.698 HG21 HG23 ' A' ' 54' ' ' THR . 2.7 tp -68.84 171.16 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.426 HD11 ' OG1' ' A' ' 17' ' ' THR . 81.1 mt -131.48 74.98 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.228 -0.92 . . . . 0.0 110.597 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.512 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.3 m-20 -98.01 45.99 1.02 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.76 164.63 15.32 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -81.94 1.48 35.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.777 -0.837 . . . . 0.0 110.491 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.4 m -108.43 -31.41 7.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.206 -0.934 . . . . 0.0 110.152 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.568 HD11 ' OD1' ' A' ' 38' ' ' ASN . 50.1 mt -137.53 168.58 19.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.466 -0.771 . . . . 0.0 110.608 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -154.76 134.02 12.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.655 -0.653 . . . . 0.0 110.015 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.72 -143.7 15.13 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -135.71 160.58 38.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.539 -0.977 . . . . 0.0 110.3 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.426 ' OG1' HD11 ' A' ' 8' ' ' ILE . 17.5 m -135.53 158.62 43.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.541 -0.724 . . . . 0.0 110.116 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.9 p -142.99 154.53 44.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.58 -0.7 . . . . 0.0 110.431 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.767 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.7 t -159.77 159.55 32.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.608 -0.683 . . . . 0.0 110.228 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -93.19 121.07 34.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.552 -0.718 . . . . 0.0 110.183 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.27 138.39 23.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.582 -0.699 . . . . 0.0 110.174 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.8 m -59.31 -32.59 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.508 -0.745 . . . . 0.0 110.445 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.669 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 24.8 p30 -171.01 -178.24 2.42 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.586 -0.696 . . . . 0.0 110.319 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -54.79 -25.25 26.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.474 -0.766 . . . . 0.0 110.962 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.669 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.19 -26.53 64.89 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.488 -0.758 . . . . 0.0 110.374 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.4 m -113.82 -25.75 8.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.518 -0.739 . . . . 0.0 110.556 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.796 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.11 -60.76 3.25 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.417 -0.802 . . . . 0.0 110.408 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -59.88 -35.76 75.51 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.601 -0.687 . . . . 0.0 110.266 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -57.65 -38.99 76.0 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.401 -0.812 . . . . 0.0 110.189 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.0 t -83.79 -47.44 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.667 -0.646 . . . . 0.0 109.816 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.767 ' CZ ' HG22 ' A' ' 19' ' ' THR . 8.0 m-85 -62.68 -34.98 78.22 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.577 -0.702 . . . . 0.0 109.906 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -64.03 -46.94 82.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.409 -0.807 . . . . 0.0 109.084 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -62.15 -31.92 72.47 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.698 0.761 . . . . 0.0 109.472 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -68.16 -50.35 55.11 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.743 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -68.13 -37.25 80.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.764 -0.585 . . . . 0.0 109.929 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -58.06 -46.75 84.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.577 -0.702 . . . . 0.0 110.533 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -60.59 -56.95 15.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.579 -0.701 . . . . 0.0 110.324 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.568 ' OD1' HD11 ' A' ' 13' ' ' LEU . 53.7 m-80 -63.71 -45.93 87.73 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.58 -0.7 . . . . 0.0 110.136 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.97 63.07 0.39 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.743 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 85.5 mt -118.04 63.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.528 -0.984 . . . . 0.0 110.133 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -83.31 59.54 5.08 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.82 -138.77 7.2 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -115.97 106.27 13.59 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.583 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 37.3 m95 -76.5 142.36 40.95 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.212 1.005 . . . . 0.0 112.419 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -150.3 132.18 15.12 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.413 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 18.9 t80 -105.75 133.7 50.05 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.625 -0.672 . . . . 0.0 110.072 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -103.6 112.9 26.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.712 -0.618 . . . . 0.0 109.922 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -69.29 -23.05 63.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.647 -0.658 . . . . 0.0 110.561 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.98 -40.87 67.27 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.317 -0.864 . . . . 0.0 110.721 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.5 p -145.06 18.43 1.59 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.576 -0.702 . . . . 0.0 110.863 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HG3' ' CE2' ' A' ' 46' ' ' TYR . 5.0 mptt 51.24 92.71 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.177 -0.952 . . . . 0.0 111.084 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.6 m -154.42 101.58 2.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.483 -0.761 . . . . 0.0 110.707 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -62.0 129.22 39.89 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.557 -0.714 . . . . 0.0 109.095 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.698 HG23 HG21 ' A' ' 7' ' ' ILE . 75.7 m -121.34 100.81 7.25 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.649 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.599 HG11 HG21 ' A' ' 40' ' ' ILE . 10.6 p -101.24 167.25 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.526 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.512 HG23 ' HB3' ' A' ' 9' ' ' ASN . 89.4 m -160.8 109.05 1.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.698 -0.626 . . . . 0.0 109.784 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.19 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.595 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 32.1 m . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.033 0.444 . . . . 0.0 110.362 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.0 m -93.79 97.61 10.53 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.61 -0.681 . . . . 0.0 110.874 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.595 ' CZ ' HG21 ' A' ' 2' ' ' THR . 92.9 m-85 -81.85 171.26 14.7 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.466 -0.771 . . . . 0.0 109.839 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.44 ' O ' HG23 ' A' ' 52' ' ' THR . 10.5 mttt -144.04 122.33 12.29 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.506 -0.746 . . . . 0.0 110.41 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.545 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 49.4 tp -99.49 123.94 44.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.558 -0.714 . . . . 0.0 110.141 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.606 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.9 tp -76.38 166.39 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.526 HD12 ' N ' ' A' ' 16' ' ' GLU . 81.0 mt -128.58 74.76 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.213 -0.93 . . . . 0.0 110.488 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.651 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.9 m-20 -95.57 47.95 1.13 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.414 -0.804 . . . . 0.0 108.901 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.94 151.85 17.61 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -71.14 -9.41 58.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.656 -0.908 . . . . 0.0 110.4 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 m -89.03 -36.13 15.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.43 174.58 10.81 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.455 -0.778 . . . . 0.0 110.59 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.3 tttt -156.24 144.42 19.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.697 . . . . 0.0 110.403 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.65 -123.05 3.23 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.526 ' N ' HD12 ' A' ' 8' ' ' ILE . 12.3 tt0 -164.77 166.88 19.46 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.566 -0.961 . . . . 0.0 110.101 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 m -135.63 148.31 48.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.541 -0.725 . . . . 0.0 110.231 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.7 p -137.78 146.44 43.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.541 -0.724 . . . . 0.0 110.245 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.671 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.2 t -163.76 134.26 4.38 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.596 -0.69 . . . . 0.0 110.141 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.05 112.1 2.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.561 -0.712 . . . . 0.0 110.29 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.472 ' HB3' ' HD2' ' A' ' 4' ' ' PHE . . . -129.88 137.58 50.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.495 -0.753 . . . . 0.0 110.176 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.594 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.3 p -60.02 -32.4 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.53 -0.731 . . . . 0.0 110.25 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.594 ' OD1' HG13 ' A' ' 22' ' ' VAL . 51.8 p-10 -171.68 174.86 4.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.454 -0.779 . . . . 0.0 110.294 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.436 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.87 -24.82 17.17 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.54 -0.725 . . . . 0.0 110.928 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.24 -38.87 92.85 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.49 -0.757 . . . . 0.0 110.097 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.9 m -93.35 -27.6 16.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.525 -0.734 . . . . 0.0 110.358 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.697 ' HB1' ' HE2' ' A' ' 31' ' ' PHE . . . -66.41 -52.35 47.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.526 -0.734 . . . . 0.0 110.448 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.48 -37.47 70.39 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.499 -0.751 . . . . 0.0 110.549 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -60.31 -33.48 72.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.41 -0.806 . . . . 0.0 109.787 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.6 t -87.32 -44.19 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.651 . . . . 0.0 109.564 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.697 ' HE2' ' HB1' ' A' ' 27' ' ' ALA . 30.1 m-85 -66.28 -39.02 89.13 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.627 -0.671 . . . . 0.0 109.767 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -62.81 -50.9 69.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.608 -0.683 . . . . 0.0 109.551 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -61.26 -31.17 70.98 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.607 0.718 . . . . 0.0 109.63 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -68.55 -46.45 69.47 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.601 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -72.78 -38.67 67.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.739 -0.6 . . . . 0.0 109.91 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -58.76 -49.24 78.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.538 -0.726 . . . . 0.0 110.393 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -61.54 -56.05 24.28 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.683 -0.635 . . . . 0.0 110.123 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -60.91 -48.38 82.08 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.602 -0.686 . . . . 0.0 110.108 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.36 49.61 0.27 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.601 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.7 mt -117.65 75.47 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.515 -0.991 . . . . 0.0 110.398 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -98.36 39.95 1.21 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.88 -137.83 0.02 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -113.27 112.6 24.01 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.545 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 29.9 m95 -81.89 142.88 32.09 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.213 1.006 . . . . 0.0 112.686 -177.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 44' ' ' TRP . 2.4 p -152.68 131.28 12.27 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -100.59 108.41 20.32 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.742 -0.599 . . . . 0.0 109.997 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -78.53 100.4 6.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.698 -0.626 . . . . 0.0 109.967 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -62.34 -24.59 67.42 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.714 -0.616 . . . . 0.0 110.439 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.427 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.07 -34.03 54.73 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.371 -0.831 . . . . 0.0 111.043 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.427 HG23 ' C ' ' A' ' 49' ' ' ALA . 75.8 p -147.15 17.67 1.21 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.523 -0.736 . . . . 0.0 110.905 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER 50.55 87.0 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.117 -0.989 . . . . 0.0 111.066 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 5' ' ' LYS . 60.6 m -155.17 108.56 2.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.536 -0.727 . . . . 0.0 110.755 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 83.5 m-85 -61.14 126.16 26.35 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.606 ' HA ' HG22 ' A' ' 7' ' ' ILE . 44.7 m -118.83 96.6 5.32 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.223 -0.991 . . . . 0.0 113.079 -178.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.531 HG21 HG22 ' A' ' 40' ' ' ILE . 11.0 p -100.01 167.12 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 109.19 177.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.651 HG23 ' HB3' ' A' ' 9' ' ' ASN . 84.9 m -160.64 109.38 1.65 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.588 -0.695 . . . . 0.0 109.814 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.062 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.484 HG22 ' CE2' ' A' ' 4' ' ' PHE . 47.5 m . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.029 0.442 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 59.4 m -104.27 98.74 8.49 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.641 -0.662 . . . . 0.0 110.731 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.77 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 86.4 m-85 -78.57 172.35 13.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.546 -0.721 . . . . 0.0 109.831 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.582 ' HG2' HG22 ' A' ' 18' ' ' THR . 22.7 mttm -142.22 121.23 12.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.488 -0.757 . . . . 0.0 110.335 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.546 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 53.8 tp -100.87 118.24 36.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.434 -0.791 . . . . 0.0 110.338 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.601 HG22 ' HA ' ' A' ' 54' ' ' THR . 5.1 tp -66.91 168.19 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.536 HD11 ' OG1' ' A' ' 17' ' ' THR . 79.7 mt -130.63 74.37 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.181 -0.949 . . . . 0.0 110.711 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.588 ' HB3' HG23 ' A' ' 56' ' ' THR . 3.0 m-20 -96.11 48.91 1.12 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.81 157.35 15.01 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -74.54 -6.29 47.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.71 -0.876 . . . . 0.0 110.632 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -97.18 -33.83 11.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.247 -0.908 . . . . 0.0 110.275 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.421 ' HB3' HG21 ' A' ' 8' ' ' ILE . 45.5 mt -137.34 170.73 15.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.539 -0.725 . . . . 0.0 110.454 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -157.21 134.33 10.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.539 -0.726 . . . . 0.0 110.273 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.13 -144.42 16.36 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.455 ' HG2' HD12 ' A' ' 7' ' ' ILE . 11.2 mt-10 -136.18 153.34 51.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.598 -0.942 . . . . 0.0 110.244 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.536 ' OG1' HD11 ' A' ' 8' ' ' ILE . 5.2 m -130.93 147.83 52.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.704 . . . . 0.0 110.052 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.582 HG22 ' HG2' ' A' ' 5' ' ' LYS . 67.0 p -129.35 165.64 21.1 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.555 -0.716 . . . . 0.0 110.303 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.4 t -156.42 -176.24 5.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.695 . . . . 0.0 110.119 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.81 92.95 3.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.556 -0.715 . . . . 0.0 110.421 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.65 179.54 4.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.421 -0.799 . . . . 0.0 110.088 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -100.43 -25.55 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.615 -0.678 . . . . 0.0 110.02 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -167.81 176.25 6.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.507 -0.746 . . . . 0.0 110.014 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.97 -25.42 60.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.471 -0.768 . . . . 0.0 110.789 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.0 -25.43 65.26 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.467 -0.771 . . . . 0.0 110.752 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.6 m -111.95 -27.46 8.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.376 -0.827 . . . . 0.0 110.66 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.77 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.74 -54.48 44.71 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.516 -0.74 . . . . 0.0 110.461 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -57.44 -39.3 75.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.525 -0.735 . . . . 0.0 110.697 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -56.41 -36.74 69.28 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.274 -0.891 . . . . 0.0 110.588 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.5 t -84.88 -47.59 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.606 -0.684 . . . . 0.0 109.975 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.501 ' HB3' HD22 ' A' ' 6' ' ' LEU . 8.8 m-85 -65.08 -37.22 86.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.584 -0.698 . . . . 0.0 110.135 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -63.65 -45.01 92.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.465 -0.772 . . . . 0.0 109.177 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -62.88 -29.0 70.42 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.537 0.684 . . . . 0.0 109.616 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -73.0 -47.39 45.58 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -73.61 -35.78 65.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.691 -0.63 . . . . 0.0 109.766 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -56.05 -49.6 73.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.528 -0.733 . . . . 0.0 110.599 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -69.45 -46.9 65.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.642 -0.661 . . . . 0.0 109.986 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -61.53 -42.05 98.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.571 -0.706 . . . . 0.0 110.023 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.54 50.18 0.82 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.757 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 86.1 mt -110.64 61.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.538 -0.978 . . . . 0.0 110.173 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -81.45 60.6 4.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.533 -0.729 . . . . 0.0 109.166 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.6 -139.04 7.77 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -116.38 107.1 14.38 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.546 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 37.2 m95 -77.3 143.46 38.83 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.19 0.995 . . . . 0.0 112.374 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 44' ' ' TRP . 3.3 p -154.43 131.01 10.64 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -104.62 138.51 40.85 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.643 -0.661 . . . . 0.0 109.959 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -114.28 116.62 29.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.689 -0.632 . . . . 0.0 109.937 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -70.31 -25.19 63.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.725 -0.609 . . . . 0.0 110.566 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.05 -38.32 56.68 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.41 -0.806 . . . . 0.0 110.757 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.7 p -142.75 13.34 1.9 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.625 -0.672 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.08 90.74 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.079 -1.013 . . . . 0.0 111.013 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 5' ' ' LYS . 56.2 m -157.35 110.0 2.46 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.325 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 87.3 m-85 -64.24 129.05 38.42 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.601 ' HA ' HG22 ' A' ' 7' ' ' ILE . 47.6 m -119.96 99.03 6.38 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.193 -1.003 . . . . 0.0 112.904 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.567 HG11 HG21 ' A' ' 40' ' ' ILE . 9.3 p -102.85 165.74 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.469 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.588 HG23 ' HB3' ' A' ' 9' ' ' ASN . 85.9 m -162.31 114.49 1.67 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.767 -0.583 . . . . 0.0 109.909 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.089 179.715 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.601 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 21.1 m . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.111 0.482 . . . . 0.0 110.256 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.6 m -90.89 88.48 7.06 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.701 -0.625 . . . . 0.0 110.637 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.798 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.6 m-85 -71.15 167.94 18.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.457 -0.777 . . . . 0.0 109.909 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -136.19 132.89 36.52 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.496 -0.753 . . . . 0.0 110.254 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.595 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 58.1 tp -109.41 117.57 34.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.355 -0.841 . . . . 0.0 110.316 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.676 HD12 ' CG ' ' A' ' 16' ' ' GLU . 4.1 tp -66.57 171.1 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.445 HG21 ' HB3' ' A' ' 13' ' ' LEU . 78.2 mt -133.84 74.93 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 110.717 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -96.58 47.58 1.07 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.348 -0.845 . . . . 0.0 108.912 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.21 153.99 16.91 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.85 -9.45 57.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.929 . . . . 0.0 110.631 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.6 m -92.14 -32.6 15.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.182 -0.949 . . . . 0.0 110.432 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.445 ' HB3' HG21 ' A' ' 8' ' ' ILE . 34.0 mt -142.21 170.23 16.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.374 -0.828 . . . . 0.0 110.768 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -153.97 136.51 15.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.68 -0.637 . . . . 0.0 110.294 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.14 -147.24 18.04 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.676 ' CG ' HD12 ' A' ' 7' ' ' ILE . 9.6 mt-10 -139.08 162.73 34.23 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.597 -0.943 . . . . 0.0 110.264 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.45 HG22 ' N ' ' A' ' 18' ' ' THR . 27.4 m -140.11 168.54 19.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.585 -0.697 . . . . 0.0 110.221 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.45 ' N ' HG22 ' A' ' 17' ' ' THR . 40.2 p -137.65 168.32 19.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.512 -0.742 . . . . 0.0 110.175 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.484 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.2 t -158.9 -173.2 4.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.599 -0.688 . . . . 0.0 110.36 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -126.95 96.91 4.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.538 -0.726 . . . . 0.0 110.079 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.717 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -130.28 140.17 50.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.57 -0.706 . . . . 0.0 110.134 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.605 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.3 p -60.86 -29.68 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.624 -0.672 . . . . 0.0 110.002 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.605 ' OD1' HG13 ' A' ' 22' ' ' VAL . 42.6 p-10 -167.42 -178.24 3.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.678 . . . . 0.0 110.286 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.437 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.88 -24.82 39.49 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.508 -0.745 . . . . 0.0 110.968 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.88 -29.6 68.44 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.486 -0.759 . . . . 0.0 110.32 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.717 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 7.5 m -107.5 -26.53 10.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.575 -0.703 . . . . 0.0 110.394 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.798 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.3 -63.45 1.3 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.434 -0.791 . . . . 0.0 110.413 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -58.26 -36.81 73.81 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.481 -0.762 . . . . 0.0 110.126 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -57.6 -38.42 74.88 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.437 -0.789 . . . . 0.0 110.07 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 26' ' ' THR . 91.0 t -83.93 -48.09 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.662 -0.649 . . . . 0.0 109.726 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.484 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.1 m-85 -61.97 -35.12 77.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.648 -0.658 . . . . 0.0 109.91 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -63.97 -46.02 86.51 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.563 -0.711 . . . . 0.0 109.086 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -62.31 -31.91 72.59 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.628 0.727 . . . . 0.0 109.403 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -69.31 -54.3 15.27 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.697 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.17 -40.25 95.73 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.698 -0.626 . . . . 0.0 109.827 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.59 -42.25 87.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.573 -0.705 . . . . 0.0 110.451 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.42 -52.22 28.97 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.605 -0.685 . . . . 0.0 110.017 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -63.75 -50.37 69.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.596 -0.69 . . . . 0.0 109.922 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.24 58.53 0.18 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.697 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.9 mt -125.56 67.18 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.472 -1.017 . . . . 0.0 110.401 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -89.81 53.56 2.6 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.83 -138.33 3.08 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.63 110.92 21.36 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.982 -0.716 . . . . 0.0 109.384 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.595 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 32.9 m95 -81.47 143.56 31.99 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 122.131 0.967 . . . . 0.0 112.228 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 44' ' ' TRP . 2.1 p -154.0 132.05 11.75 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.419 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 25.3 t80 -105.35 129.0 53.78 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.657 -0.652 . . . . 0.0 110.166 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -102.16 120.34 40.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.716 -0.615 . . . . 0.0 109.981 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -73.04 -20.14 61.04 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.665 -0.647 . . . . 0.0 110.678 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.87 -41.18 67.25 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.314 -0.866 . . . . 0.0 110.861 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.6 p -144.9 18.21 1.61 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.57 -0.706 . . . . 0.0 110.744 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.419 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 0.7 OUTLIER 51.31 93.19 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.16 -0.962 . . . . 0.0 110.78 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.7 m -157.19 106.42 2.18 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.175 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -63.94 127.33 30.91 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.642 HG23 HG21 ' A' ' 7' ' ' ILE . 88.9 m -117.17 104.2 10.96 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.344 -0.848 . . . . 0.0 112.597 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.557 HG21 HG22 ' A' ' 40' ' ' ILE . 11.4 p -105.21 167.11 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.846 . . . . 0.0 109.207 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.472 ' N ' HG22 ' A' ' 55' ' ' VAL . 97.8 m -160.8 108.04 1.52 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.724 -0.61 . . . . 0.0 109.714 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.182 -179.862 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.505 HG22 ' CE2' ' A' ' 4' ' ' PHE . 57.9 m . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 121.113 0.482 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.0 m -104.76 104.43 14.22 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.567 -0.708 . . . . 0.0 110.617 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.708 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 77.3 m-85 -84.82 178.52 7.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.54 -0.725 . . . . 0.0 109.742 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 52' ' ' THR . 23.4 ttpt -149.56 109.67 4.13 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.445 -0.785 . . . . 0.0 110.644 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.54 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 58.1 tp -90.6 121.37 32.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.414 -0.804 . . . . 0.0 110.324 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.64 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.9 tp -72.0 168.23 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.485 HD12 ' N ' ' A' ' 16' ' ' GLU . 75.4 mt -130.05 72.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.208 -0.933 . . . . 0.0 110.796 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.558 ' HB3' HG23 ' A' ' 56' ' ' THR . 37.3 m-20 -96.93 49.18 1.07 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.472 -0.768 . . . . 0.0 109.174 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.14 165.42 13.2 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.01 2.66 29.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.593 -0.946 . . . . 0.0 110.732 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -111.98 -29.27 7.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.119 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.695 HD11 ' OD1' ' A' ' 38' ' ' ASN . 80.1 mt -135.6 166.26 23.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.477 -0.764 . . . . 0.0 110.609 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -154.05 132.29 11.89 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.696 -0.627 . . . . 0.0 110.161 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.09 -129.82 5.07 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.485 ' N ' HD12 ' A' ' 8' ' ' ILE . 6.4 pt-20 -159.25 152.44 22.3 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.581 -0.953 . . . . 0.0 110.592 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.4 m -125.5 154.12 42.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.616 -0.677 . . . . 0.0 110.068 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 p -139.5 150.87 45.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.457 -0.777 . . . . 0.0 110.391 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.673 HG22 ' CE2' ' A' ' 31' ' ' PHE . 8.4 t -153.12 147.66 26.07 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.616 -0.677 . . . . 0.0 110.202 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -85.04 112.65 20.82 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.506 -0.746 . . . . 0.0 110.381 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.86 -171.15 2.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.498 -0.751 . . . . 0.0 110.032 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -109.46 -27.2 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.618 -0.676 . . . . 0.0 110.067 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -170.13 173.8 5.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.464 -0.772 . . . . 0.0 110.185 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.2 -26.25 64.67 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.571 -0.705 . . . . 0.0 110.715 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.37 -26.56 65.19 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.463 -0.773 . . . . 0.0 110.621 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.4 m -109.45 -32.54 7.11 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.5 -0.75 . . . . 0.0 110.31 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.708 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.15 -52.61 64.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.5 -0.75 . . . . 0.0 110.427 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -59.15 -43.17 92.03 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.518 -0.739 . . . . 0.0 110.302 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -57.52 -34.75 69.44 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.369 -0.832 . . . . 0.0 110.319 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 83.6 t -84.99 -48.44 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.585 -0.697 . . . . 0.0 109.84 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.673 ' CE2' HG22 ' A' ' 19' ' ' THR . 3.9 m-85 -65.39 -36.09 82.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.594 -0.691 . . . . 0.0 110.183 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -63.87 -46.59 84.26 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.477 -0.764 . . . . 0.0 109.341 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -59.9 -30.71 69.2 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.541 0.686 . . . . 0.0 109.822 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -70.33 -52.69 20.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.687 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.18 -38.49 91.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.701 -0.624 . . . . 0.0 110.042 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -57.14 -45.89 83.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.45 -0.781 . . . . 0.0 110.563 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.83 -49.89 54.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.612 -0.68 . . . . 0.0 110.02 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.695 ' OD1' HD11 ' A' ' 13' ' ' LEU . 15.8 m-80 -62.5 -42.88 99.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.613 -0.679 . . . . 0.0 110.032 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.51 47.83 0.53 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.687 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 83.6 mt -119.07 74.58 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.53 -0.983 . . . . 0.0 110.409 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -97.78 39.69 1.2 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.67 -138.01 0.03 OUTLIER Glycine 0 N--CA 1.488 2.159 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -112.24 112.49 24.12 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.54 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 29.6 m95 -82.38 143.86 30.93 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.24 1.019 . . . . 0.0 112.499 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 44' ' ' TRP . 2.4 p -155.24 131.89 10.55 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -102.09 128.65 48.47 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.644 -0.66 . . . . 0.0 110.263 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -99.78 104.57 16.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.673 -0.642 . . . . 0.0 109.866 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -64.52 -21.45 66.68 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.594 -0.691 . . . . 0.0 110.881 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.428 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.29 -38.41 63.1 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.286 -0.884 . . . . 0.0 110.788 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.428 HG23 ' C ' ' A' ' 49' ' ' ALA . 74.3 p -147.65 21.12 1.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.607 -0.683 . . . . 0.0 110.617 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER 50.27 90.83 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.211 -0.931 . . . . 0.0 111.129 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 5' ' ' LYS . 88.4 m -155.29 103.59 2.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.523 -0.735 . . . . 0.0 110.717 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 86.8 m-85 -60.92 132.21 53.13 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.64 ' HA ' HG22 ' A' ' 7' ' ' ILE . 52.7 m -122.66 98.84 6.1 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.133 -1.027 . . . . 0.0 113.119 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.541 HG21 HG22 ' A' ' 40' ' ' ILE . 11.2 p -102.87 166.7 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.333 -0.854 . . . . 0.0 109.144 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.558 HG23 ' HB3' ' A' ' 9' ' ' ASN . 91.6 m -160.84 109.99 1.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.659 -0.65 . . . . 0.0 109.762 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.263 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.516 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 90.5 m . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.036 0.446 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.5 m -139.92 107.44 5.58 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.582 -0.699 . . . . 0.0 110.436 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.797 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 97.4 m-85 -96.06 169.68 9.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.654 -0.654 . . . . 0.0 109.996 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -139.3 119.46 13.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.48 -0.763 . . . . 0.0 110.423 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.63 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 50.2 tp -98.75 121.99 41.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.486 -0.759 . . . . 0.0 110.243 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.604 HG22 ' HA ' ' A' ' 54' ' ' THR . 5.0 tp -70.26 171.78 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 82.8 mt -132.09 71.74 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.175 -0.953 . . . . 0.0 110.523 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.432 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.8 m-20 -96.17 46.81 1.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.478 -0.764 . . . . 0.0 109.085 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.54 158.27 17.3 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -73.39 -7.86 53.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.759 -0.847 . . . . 0.0 110.525 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.2 m -96.81 -32.77 11.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.208 -0.932 . . . . 0.0 110.273 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.9 mt -136.5 173.85 11.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.498 -0.751 . . . . 0.0 110.6 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -153.22 128.47 9.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.655 -0.653 . . . . 0.0 110.179 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.02 -142.6 14.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.01 -178.9 6.54 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.997 . . . . 0.0 110.347 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 6' ' ' LEU . 7.0 t -162.74 159.77 24.61 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.588 -0.695 . . . . 0.0 110.278 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.4 p -134.52 156.46 48.6 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.57 -0.706 . . . . 0.0 110.177 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.582 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.5 t -142.62 -173.17 3.8 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.538 -0.727 . . . . 0.0 110.305 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -122.45 101.93 7.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.611 -0.681 . . . . 0.0 110.2 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.446 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -127.36 170.31 12.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.592 -0.692 . . . . 0.0 110.087 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -87.01 -26.93 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.64 -0.662 . . . . 0.0 109.902 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -175.24 -179.03 1.25 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.41 -0.806 . . . . 0.0 109.772 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.435 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.39 -25.88 38.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.392 -0.817 . . . . 0.0 110.936 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.24 -25.66 65.82 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.573 -0.705 . . . . 0.0 110.552 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.446 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 7.3 m -112.74 -26.17 8.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.476 -0.765 . . . . 0.0 110.359 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.797 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.6 -58.74 7.22 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.441 -0.787 . . . . 0.0 110.422 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -60.08 -41.3 92.17 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.604 -0.685 . . . . 0.0 110.143 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -56.74 -38.44 72.41 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.362 -0.836 . . . . 0.0 110.346 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 26' ' ' THR . 84.0 t -82.63 -48.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.622 -0.674 . . . . 0.0 109.975 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.582 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.3 m-85 -64.33 -32.81 74.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.531 -0.731 . . . . 0.0 110.19 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -64.75 -45.77 85.01 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.415 -0.803 . . . . 0.0 108.934 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -62.53 -33.12 74.28 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.659 0.743 . . . . 0.0 109.391 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -66.13 -51.48 57.52 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.788 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -67.61 -42.52 82.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.77 -0.581 . . . . 0.0 110.095 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -56.94 -36.14 69.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.47 -0.768 . . . . 0.0 110.537 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -62.98 -59.19 5.16 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.562 -0.711 . . . . 0.0 110.094 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -67.87 -47.25 69.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.656 -0.652 . . . . 0.0 110.017 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.33 60.0 0.19 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.788 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 85.2 mt -115.8 62.91 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.475 -1.015 . . . . 0.0 110.145 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -86.2 56.53 4.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.443 -0.786 . . . . 0.0 109.037 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.68 -136.53 3.01 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -117.43 99.42 6.98 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.842 -0.799 . . . . 0.0 109.298 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.63 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 30.8 m95 -69.16 143.38 54.09 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.225 1.012 . . . . 0.0 112.541 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 44' ' ' TRP . 3.0 p -153.41 131.41 11.78 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -101.79 138.14 39.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.641 -0.662 . . . . 0.0 110.166 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -105.92 103.5 13.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.725 -0.61 . . . . 0.0 109.784 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.12 -21.96 66.54 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.672 -0.643 . . . . 0.0 110.657 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.434 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.95 -39.41 65.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.295 -0.878 . . . . 0.0 110.84 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.434 HG23 ' C ' ' A' ' 49' ' ' ALA . 73.8 p -148.14 22.75 1.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.483 -0.76 . . . . 0.0 110.7 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.443 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.3 91.32 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.21 -0.931 . . . . 0.0 110.816 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.4 m -153.99 102.71 2.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.484 -0.76 . . . . 0.0 111.119 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.431 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 75.3 m-85 -63.26 133.73 54.69 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.604 ' HA ' HG22 ' A' ' 7' ' ' ILE . 52.6 m -126.3 101.84 6.91 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.347 -0.941 . . . . 0.0 112.883 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.567 HG21 HG22 ' A' ' 40' ' ' ILE . 10.6 p -104.26 165.81 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.374 -0.829 . . . . 0.0 109.322 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.466 ' N ' HG22 ' A' ' 55' ' ' VAL . 76.0 m -162.24 119.37 2.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.753 -0.592 . . . . 0.0 110.074 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.173 179.588 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.599 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 47.9 m . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 121.103 0.478 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.2 m -88.87 93.97 9.77 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.591 -0.693 . . . . 0.0 110.76 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.684 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 94.0 m-85 -76.92 167.9 21.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.5 -0.75 . . . . 0.0 109.963 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -138.92 123.84 18.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.525 -0.735 . . . . 0.0 110.352 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.608 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 44.8 tp -100.0 124.26 45.16 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.476 -0.765 . . . . 0.0 110.317 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.657 HG22 ' HA ' ' A' ' 54' ' ' THR . 5.5 tp -74.6 168.2 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 13' ' ' LEU . 72.6 mt -127.84 73.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.41 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.501 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.3 m-20 -95.13 47.58 1.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.37 -0.831 . . . . 0.0 108.985 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.74 159.33 14.21 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -79.19 -1.53 36.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.759 -0.848 . . . . 0.0 110.364 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.8 m -99.87 -32.4 11.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 110.035 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.431 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -146.36 172.0 14.16 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.513 -0.742 . . . . 0.0 110.379 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.59 145.18 19.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.573 -0.705 . . . . 0.0 110.267 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.89 -132.11 6.01 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -154.23 163.19 40.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.59 -0.947 . . . . 0.0 110.349 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.1 m -149.58 145.48 26.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.566 -0.709 . . . . 0.0 110.141 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.3 p -132.68 167.2 20.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.585 -0.697 . . . . 0.0 110.24 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.692 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.1 t -162.94 170.15 18.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.617 -0.677 . . . . 0.0 110.305 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -101.68 123.38 45.58 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.626 -0.671 . . . . 0.0 110.143 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -151.89 146.41 25.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.568 -0.707 . . . . 0.0 110.264 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.446 HG13 ' OD1' ' A' ' 23' ' ' ASP . 10.4 p -61.39 -34.25 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.595 -0.691 . . . . 0.0 110.056 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.512 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 39.3 p30 -170.19 177.03 4.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.592 -0.692 . . . . 0.0 110.281 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.461 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.45 -26.86 21.93 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.518 -0.739 . . . . 0.0 111.021 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.512 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.48 -23.33 57.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.539 -0.725 . . . . 0.0 110.554 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.6 m -118.0 -14.14 10.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.499 -0.751 . . . . 0.0 111.088 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.684 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -72.14 -50.07 30.85 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.228 -0.92 . . . . 0.0 110.406 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.52 -30.68 68.76 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.482 -0.761 . . . . 0.0 110.412 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -58.9 -40.46 84.54 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.376 -0.827 . . . . 0.0 110.341 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.0 t -82.99 -42.21 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.517 -0.739 . . . . 0.0 109.867 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.692 ' CZ ' HG22 ' A' ' 19' ' ' THR . 13.1 m-85 -68.27 -35.37 77.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.573 -0.704 . . . . 0.0 110.119 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -63.77 -46.66 84.23 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.473 -0.767 . . . . 0.0 109.128 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -62.64 -30.95 71.75 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.611 0.72 . . . . 0.0 109.467 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -69.7 -47.84 61.76 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.71 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -73.61 -33.76 64.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.68 -0.637 . . . . 0.0 110.001 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -60.68 -52.23 66.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.623 -0.673 . . . . 0.0 110.417 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.6 -35.54 78.14 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 110.52 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -79.29 -42.42 25.84 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.562 -0.711 . . . . 0.0 110.312 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.3 41.0 1.19 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.71 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 79.8 mt -99.64 59.52 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.549 -0.971 . . . . 0.0 110.166 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -80.84 61.48 4.49 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.36 -138.32 7.84 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -117.39 102.1 8.95 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.981 -0.717 . . . . 0.0 109.332 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.608 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 37.0 m95 -71.91 142.68 49.49 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.191 0.996 . . . . 0.0 112.516 -178.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -151.93 132.52 13.92 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.408 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 25.0 t80 -108.39 138.04 45.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.645 -0.659 . . . . 0.0 110.285 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.06 123.4 49.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.69 -0.631 . . . . 0.0 109.602 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -78.01 -24.25 48.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.624 -0.672 . . . . 0.0 110.619 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.06 -39.43 66.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.382 -0.824 . . . . 0.0 110.834 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.5 p -141.77 12.86 2.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.599 -0.688 . . . . 0.0 111.102 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.46 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.95 94.41 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.133 -0.98 . . . . 0.0 111.205 179.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.2 m -157.9 105.33 1.97 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.549 -0.719 . . . . 0.0 110.761 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -60.67 132.96 55.53 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.461 -0.774 . . . . 0.0 109.169 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.657 ' HA ' HG22 ' A' ' 7' ' ' ILE . 58.7 m -125.82 99.9 6.16 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.207 -0.997 . . . . 0.0 112.666 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 40' ' ' ILE . 11.2 p -102.17 167.47 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.88 . . . . 0.0 109.271 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.501 HG23 ' HB3' ' A' ' 9' ' ' ASN . 98.9 m -160.28 109.2 1.71 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.593 -0.692 . . . . 0.0 109.894 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.274 -179.992 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.555 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 63.0 m . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.111 0.481 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 3' ' ' THR . 7.5 t -87.82 95.15 9.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.66 -0.65 . . . . 0.0 110.819 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.764 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.5 m-85 -77.1 171.48 14.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.42 -0.8 . . . . 0.0 109.819 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -139.31 128.89 24.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.49 -0.756 . . . . 0.0 110.331 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.611 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 41.1 tp -103.41 122.62 45.25 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.385 -0.822 . . . . 0.0 110.432 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.65 HG21 HG23 ' A' ' 54' ' ' THR . 5.0 tp -70.74 171.13 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.43 HG21 ' HB3' ' A' ' 13' ' ' LEU . 73.9 mt -133.8 74.4 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.644 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.677 ' HB3' HG23 ' A' ' 56' ' ' THR . 27.7 m-20 -95.86 47.73 1.11 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.545 -0.722 . . . . 0.0 109.138 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.42 163.66 13.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -82.3 2.65 31.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.651 -0.911 . . . . 0.0 110.791 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 m -111.5 -28.87 7.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.19 -0.943 . . . . 0.0 110.138 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.43 ' HB3' HG21 ' A' ' 8' ' ' ILE . 6.3 mt -136.93 167.3 21.76 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.558 -0.714 . . . . 0.0 110.393 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -155.75 138.04 14.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.538 -0.726 . . . . 0.0 110.213 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.07 -133.23 7.32 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -163.75 163.02 24.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.533 -0.98 . . . . 0.0 110.262 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.9 m -144.56 150.32 37.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.551 -0.718 . . . . 0.0 110.281 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.2 p -126.91 161.27 28.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.592 -0.693 . . . . 0.0 110.247 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.4 t -153.08 -171.59 3.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.506 -0.746 . . . . 0.0 110.382 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -115.97 109.25 17.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.54 -0.725 . . . . 0.0 110.152 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.36 138.55 38.39 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.601 -0.687 . . . . 0.0 110.155 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.8 m -57.4 -30.51 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.571 -0.705 . . . . 0.0 110.515 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.631 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 23.2 p30 -172.47 -179.56 2.25 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.407 -0.808 . . . . 0.0 110.283 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.451 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.18 -25.2 31.09 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.502 -0.749 . . . . 0.0 110.876 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.631 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -60.27 -25.88 66.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.49 -0.756 . . . . 0.0 110.605 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.9 m -113.3 -25.86 8.65 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.435 -0.791 . . . . 0.0 110.64 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.764 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.14 -49.09 78.19 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.458 -0.776 . . . . 0.0 110.569 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -61.6 -36.47 80.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.607 -0.683 . . . . 0.0 110.447 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -56.72 -40.06 75.02 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.327 -0.858 . . . . 0.0 110.744 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.4 -45.52 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.483 -0.761 . . . . 0.0 110.065 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 12.7 m-85 -66.91 -35.87 80.99 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.622 -0.674 . . . . 0.0 110.3 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.5 tttm -63.61 -44.06 95.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.488 -0.758 . . . . 0.0 109.35 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.33 -30.68 71.72 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.61 0.719 . . . . 0.0 109.565 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -70.02 -44.24 69.7 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.627 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -76.47 -41.54 46.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.716 -0.615 . . . . 0.0 109.802 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -58.95 -37.77 77.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.624 -0.672 . . . . 0.0 110.4 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -69.68 -50.75 40.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.602 -0.686 . . . . 0.0 110.058 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -69.87 -50.0 46.76 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.531 -0.731 . . . . 0.0 110.018 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.92 50.99 0.17 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.627 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 77.9 mt -115.79 74.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.52 -0.988 . . . . 0.0 110.298 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.25 39.54 1.23 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.85 -137.25 0.02 OUTLIER Glycine 0 N--CA 1.488 2.127 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -111.89 109.61 19.5 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.888 -0.772 . . . . 0.0 108.973 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.611 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 35.1 m95 -79.81 143.78 34.11 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.042 0.925 . . . . 0.0 112.062 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 44' ' ' TRP . 1.8 p -155.29 132.8 11.14 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -101.92 137.41 40.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.726 -0.609 . . . . 0.0 110.109 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -108.28 114.32 28.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.766 -0.584 . . . . 0.0 109.829 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -69.8 -18.04 63.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.666 -0.646 . . . . 0.0 110.896 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.419 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.8 -42.58 72.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.234 -0.916 . . . . 0.0 110.788 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.419 HG23 ' C ' ' A' ' 49' ' ' ALA . 70.9 p -147.14 22.92 1.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.549 -0.719 . . . . 0.0 110.559 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.442 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER 51.67 94.69 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.322 -0.862 . . . . 0.0 110.859 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.4 m -156.94 107.5 2.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.456 -0.778 . . . . 0.0 111.269 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -63.65 132.57 51.54 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.65 HG23 HG21 ' A' ' 7' ' ' ILE . 61.0 m -124.08 99.52 6.28 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.254 -0.979 . . . . 0.0 113.08 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.5 HG21 HG22 ' A' ' 40' ' ' ILE . 11.9 p -102.03 167.67 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 108.917 177.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.677 HG23 ' HB3' ' A' ' 9' ' ' ASN . 97.8 m -160.19 109.42 1.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.573 -0.705 . . . . 0.0 110.034 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.184 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.571 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 46.1 m . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.13 0.49 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.5 m -85.34 95.94 9.39 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.656 -0.652 . . . . 0.0 110.697 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.645 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 89.8 m-85 -80.55 165.67 21.89 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.52 -0.738 . . . . 0.0 109.717 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.7 ttpp -139.62 118.61 12.57 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.426 -0.796 . . . . 0.0 110.521 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.624 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 46.9 tp -95.95 125.24 40.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.424 -0.797 . . . . 0.0 110.241 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.669 HG21 HG23 ' A' ' 54' ' ' THR . 4.3 tp -73.48 168.55 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.6 mt -128.93 73.18 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.195 -0.94 . . . . 0.0 110.45 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.498 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.8 m-20 -96.64 47.2 1.06 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.451 -0.781 . . . . 0.0 109.147 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.29 166.92 20.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -85.84 7.24 24.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.691 -0.888 . . . . 0.0 110.456 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.3 m -115.43 -33.35 5.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.973 . . . . 0.0 110.086 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 mt -137.45 167.64 21.22 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.486 -0.759 . . . . 0.0 110.571 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -153.23 139.14 18.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.596 -0.69 . . . . 0.0 110.369 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.08 -144.6 16.23 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -142.68 168.14 20.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.573 -0.957 . . . . 0.0 110.255 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.6 m -157.67 133.38 9.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.564 -0.71 . . . . 0.0 110.181 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.2 p -112.86 167.5 10.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.54 -0.725 . . . . 0.0 110.25 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.632 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.7 t -159.35 167.68 28.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.499 -0.751 . . . . 0.0 110.29 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -98.51 112.19 24.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.618 -0.676 . . . . 0.0 110.219 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.88 137.9 31.71 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.586 -0.696 . . . . 0.0 110.052 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.64 HG23 ' OD1' ' A' ' 23' ' ' ASP . 33.9 m -60.46 -30.33 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.506 -0.746 . . . . 0.0 110.254 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.64 ' OD1' HG23 ' A' ' 22' ' ' VAL . 46.6 p-10 -170.67 -179.65 2.97 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.574 -0.703 . . . . 0.0 110.326 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.461 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -55.51 -24.39 31.43 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.584 -0.698 . . . . 0.0 110.87 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.43 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.67 -28.11 65.43 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.46 -0.775 . . . . 0.0 110.512 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 30' ' ' VAL . 46.5 m -109.43 -27.29 9.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.585 -0.697 . . . . 0.0 110.291 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.645 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -61.6 -61.32 2.61 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.537 -0.727 . . . . 0.0 110.062 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -58.85 -38.36 78.54 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.562 -0.711 . . . . 0.0 109.921 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -58.69 -40.13 82.69 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.575 -0.703 . . . . 0.0 109.735 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 26' ' ' THR . 97.9 t -82.6 -47.89 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.692 -0.63 . . . . 0.0 109.509 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.632 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.1 m-85 -61.18 -32.71 72.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.629 -0.669 . . . . 0.0 109.998 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -65.5 -46.21 80.57 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -61.93 -30.94 71.24 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.65 0.738 . . . . 0.0 109.471 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -69.14 -54.29 15.73 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.715 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.3 -37.77 86.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.689 -0.632 . . . . 0.0 109.956 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -59.6 -33.34 71.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.512 -0.743 . . . . 0.0 110.428 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -70.68 -36.64 73.41 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.648 -0.657 . . . . 0.0 110.287 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -88.47 -27.9 21.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.581 -0.699 . . . . 0.0 110.161 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.82 39.73 3.3 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.715 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.8 mt -95.77 65.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.551 -0.97 . . . . 0.0 110.199 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -87.83 54.66 3.18 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.62 -137.01 2.64 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.71 105.29 11.84 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.939 -0.742 . . . . 0.0 109.202 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.624 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 31.7 m95 -74.13 143.38 45.34 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.138 0.97 . . . . 0.0 112.413 -177.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 44' ' ' TRP . 8.6 p -153.83 131.49 11.48 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -102.27 129.69 48.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.681 -0.637 . . . . 0.0 110.198 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.27 117.66 35.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.675 -0.64 . . . . 0.0 109.879 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.13 -13.16 61.13 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.648 -0.657 . . . . 0.0 111.005 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.425 ' C ' HG23 ' A' ' 50' ' ' THR . . . -56.66 -43.19 80.14 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.174 -0.954 . . . . 0.0 110.549 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.425 HG23 ' C ' ' A' ' 49' ' ' ALA . 73.7 p -147.49 24.33 1.11 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.609 -0.682 . . . . 0.0 110.435 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.439 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.69 93.45 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.305 -0.872 . . . . 0.0 110.853 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.4 m -156.48 105.11 2.24 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.903 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 91.6 m-85 -62.7 132.84 53.63 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.669 HG23 HG21 ' A' ' 7' ' ' ILE . 61.5 m -124.22 101.43 7.19 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.866 -178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.551 HG11 HG21 ' A' ' 40' ' ' ILE . 11.2 p -102.51 166.59 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.349 -0.844 . . . . 0.0 109.167 177.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.498 HG23 ' HB3' ' A' ' 9' ' ' ASN . 98.9 m -160.52 110.12 1.74 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.653 -0.654 . . . . 0.0 109.865 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.23 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.501 HG22 ' CE2' ' A' ' 4' ' ' PHE . 60.4 m . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.055 0.455 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.0 m -115.01 102.24 9.76 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.564 -0.71 . . . . 0.0 110.77 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.78 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 94.9 m-85 -82.77 -177.22 6.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.586 -0.696 . . . . 0.0 109.746 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.528 ' O ' HG23 ' A' ' 52' ' ' THR . 84.9 tttt -152.2 114.85 4.57 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.43 -0.794 . . . . 0.0 110.396 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.526 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 14.1 tp -93.51 140.03 30.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.269 -0.894 . . . . 0.0 110.277 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.7 tp -89.96 165.2 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.474 HG21 ' HB3' ' A' ' 13' ' ' LEU . 48.7 mm -126.44 77.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -0.903 . . . . 0.0 110.514 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.732 ' HB3' HG23 ' A' ' 56' ' ' THR . 3.0 m-20 -98.83 48.93 0.97 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.58 161.63 12.64 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -76.96 -12.47 59.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.767 -0.843 . . . . 0.0 110.435 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.8 m -91.1 -29.97 17.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 110.158 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.474 ' HB3' HG21 ' A' ' 8' ' ' ILE . 24.6 mt -141.14 167.64 21.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 110.49 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -153.82 131.48 11.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.645 -0.659 . . . . 0.0 110.057 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.401 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 135.95 -124.67 3.33 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -165.91 172.54 11.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.521 -0.987 . . . . 0.0 110.43 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.1 m -152.87 161.37 42.63 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.55 -0.719 . . . . 0.0 110.241 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 p -137.96 171.26 14.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.614 -0.679 . . . . 0.0 110.207 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.552 HG22 ' CE2' ' A' ' 31' ' ' PHE . 7.7 t -161.77 164.03 29.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.588 -0.695 . . . . 0.0 110.341 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -102.34 93.69 5.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.574 -0.704 . . . . 0.0 110.159 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.406 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -117.36 -172.45 2.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.553 -0.717 . . . . 0.0 110.214 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -112.14 -25.82 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.656 -0.653 . . . . 0.0 110.154 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -166.84 177.96 6.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.521 -0.737 . . . . 0.0 110.023 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.25 -25.84 59.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.723 . . . . 0.0 110.812 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.13 -45.33 93.36 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.451 -0.78 . . . . 0.0 110.458 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 30' ' ' VAL . 6.7 m -87.61 -28.04 22.14 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.495 -0.753 . . . . 0.0 110.433 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.78 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -64.57 -63.47 1.12 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.533 -0.729 . . . . 0.0 110.402 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -57.9 -42.67 85.2 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.518 -0.739 . . . . 0.0 110.311 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -55.61 -39.3 70.59 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.382 -0.824 . . . . 0.0 110.248 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 26' ' ' THR . 88.3 t -82.31 -49.03 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.701 -0.624 . . . . 0.0 109.893 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.552 ' CE2' HG22 ' A' ' 19' ' ' THR . 5.6 m-85 -62.95 -33.62 75.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.65 -0.656 . . . . 0.0 110.337 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -65.21 -45.87 82.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.414 -0.804 . . . . 0.0 109.094 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -61.71 -31.72 71.88 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.625 0.726 . . . . 0.0 109.552 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -68.43 -53.4 23.92 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.616 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.14 -47.25 80.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.733 -0.605 . . . . 0.0 109.784 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -58.03 -28.11 64.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.603 -0.686 . . . . 0.0 110.43 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.88 -47.19 19.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.608 -0.683 . . . . 0.0 110.194 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -76.22 -43.12 43.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.562 -0.711 . . . . 0.0 110.063 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.23 51.09 0.18 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.616 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 83.9 mt -122.57 73.52 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.463 -1.022 . . . . 0.0 110.231 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.97 39.7 1.26 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.56 -137.79 0.02 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -111.94 111.91 23.18 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.526 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 28.4 m95 -80.59 142.82 33.69 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.233 1.016 . . . . 0.0 112.467 -177.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 44' ' ' TRP . 3.0 p -153.93 132.95 12.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -103.16 140.5 37.27 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.649 -0.657 . . . . 0.0 110.156 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.6 116.63 30.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.643 -0.661 . . . . 0.0 110.004 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -71.2 -15.14 62.45 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.646 -0.659 . . . . 0.0 111.147 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.426 ' C ' HG23 ' A' ' 50' ' ' THR . . . -55.99 -43.48 77.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.206 -0.934 . . . . 0.0 110.681 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.426 HG23 ' C ' ' A' ' 49' ' ' ALA . 68.8 p -147.47 23.02 1.15 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.566 -0.709 . . . . 0.0 110.569 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.448 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.51 88.99 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.246 -0.909 . . . . 0.0 110.764 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 5' ' ' LYS . 88.2 m -151.95 106.16 3.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.448 -0.782 . . . . 0.0 110.872 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.433 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 86.0 m-85 -62.98 137.11 58.17 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.419 -0.801 . . . . 0.0 108.842 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.628 ' HA ' HG22 ' A' ' 7' ' ' ILE . 55.8 m -126.81 95.09 4.22 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.124 -1.03 . . . . 0.0 113.231 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.514 HG11 ' CG2' ' A' ' 40' ' ' ILE . 11.5 p -97.4 167.34 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 109.145 177.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.732 HG23 ' HB3' ' A' ' 9' ' ' ASN . 97.9 m -160.58 111.62 1.85 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.549 -0.719 . . . . 0.0 110.126 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.05 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.631 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 8.7 m . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.136 0.493 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 3' ' ' THR . 8.8 t -95.13 79.97 3.58 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.533 -0.729 . . . . 0.0 110.892 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.803 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 98.1 m-85 -62.13 179.62 0.28 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.335 -0.853 . . . . 0.0 109.779 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.462 ' HB3' HG23 ' A' ' 52' ' ' THR . 26.6 tttt -153.9 126.46 8.1 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.524 -0.735 . . . . 0.0 110.353 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.582 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 46.3 tp -103.87 135.43 45.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.459 -0.776 . . . . 0.0 110.189 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.59 HG21 HG23 ' A' ' 54' ' ' THR . 2.6 tp -86.78 168.69 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 13' ' ' LEU . 83.8 mt -128.43 72.64 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.203 -0.936 . . . . 0.0 110.634 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.626 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.1 m-80 -95.6 48.47 1.14 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 0.0 108.969 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.95 154.56 16.53 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -72.42 -6.99 47.43 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.665 -0.903 . . . . 0.0 110.942 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -96.99 -30.75 12.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.202 -0.936 . . . . 0.0 110.283 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.563 ' O ' HG22 ' A' ' 8' ' ' ILE . 2.5 tp -145.21 157.58 44.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.497 -0.752 . . . . 0.0 110.433 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -140.13 136.01 33.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.591 -0.693 . . . . 0.0 110.497 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.72 -140.57 10.87 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -151.72 168.55 24.69 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.541 -0.976 . . . . 0.0 110.434 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.2 m -150.54 148.49 28.75 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.588 -0.695 . . . . 0.0 110.265 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.455 HG23 ' HE3' ' A' ' 5' ' ' LYS . 9.1 p -131.13 168.38 17.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.578 -0.701 . . . . 0.0 110.155 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.791 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.6 t -164.32 179.09 7.02 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.588 -0.695 . . . . 0.0 110.378 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.96 128.25 54.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.714 . . . . 0.0 110.111 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.565 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -154.25 138.3 16.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.598 -0.689 . . . . 0.0 110.189 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.9 m -59.35 -26.7 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.505 -0.747 . . . . 0.0 110.45 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.562 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 30.3 p30 -173.12 -178.24 1.73 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.452 -0.78 . . . . 0.0 110.304 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.91 -25.29 56.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.54 -0.725 . . . . 0.0 110.869 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.562 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.04 -27.17 65.23 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.456 -0.778 . . . . 0.0 110.397 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.565 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 5.9 m -109.71 -27.84 9.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.518 -0.739 . . . . 0.0 110.305 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.803 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.02 -62.98 1.47 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.536 -0.727 . . . . 0.0 110.233 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -58.47 -32.48 68.8 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.521 -0.737 . . . . 0.0 110.166 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -56.61 -45.56 81.4 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.414 -0.804 . . . . 0.0 110.156 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.8 t -80.18 -45.05 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.653 -0.654 . . . . 0.0 109.697 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.791 ' CZ ' HG22 ' A' ' 19' ' ' THR . 12.6 m-85 -61.88 -33.56 74.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.597 -0.689 . . . . 0.0 110.04 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -64.52 -46.65 82.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.457 -0.777 . . . . 0.0 109.058 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -63.15 -33.5 75.6 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.608 0.718 . . . . 0.0 109.329 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.426 ' CD2' HD23 ' A' ' 6' ' ' LEU . 18.8 t80 -65.2 -46.67 79.76 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.571 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -72.99 -38.2 66.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.718 -0.614 . . . . 0.0 109.651 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -60.27 -45.3 93.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.539 -0.726 . . . . 0.0 110.316 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -60.28 -53.35 58.73 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.585 -0.697 . . . . 0.0 110.358 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -69.18 -48.24 62.74 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.525 -0.735 . . . . 0.0 110.033 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.44 46.11 0.3 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.571 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.1 mt -108.79 77.03 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.501 -0.999 . . . . 0.0 110.454 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -98.99 39.28 1.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.74 -138.35 0.02 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -112.45 111.05 21.62 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.842 -0.799 . . . . 0.0 108.956 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.582 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 29.3 m95 -80.31 143.56 33.51 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.182 0.991 . . . . 0.0 112.483 -178.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 44' ' ' TRP . 1.6 p -152.91 132.28 12.86 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.402 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 14.5 t80 -104.81 120.87 42.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.678 -0.638 . . . . 0.0 110.111 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -90.77 111.39 22.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.649 -0.657 . . . . 0.0 110.087 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -66.72 -15.76 63.76 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.601 -0.687 . . . . 0.0 110.849 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.416 ' C ' HG23 ' A' ' 50' ' ' THR . . . -55.09 -42.69 73.18 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.168 -0.957 . . . . 0.0 110.812 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.416 HG23 ' C ' ' A' ' 49' ' ' ALA . 81.0 p -147.07 24.12 1.17 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.53 -0.731 . . . . 0.0 110.527 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.445 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 4.3 mptt 51.79 87.35 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.247 -0.908 . . . . 0.0 110.78 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.462 HG23 ' HB3' ' A' ' 5' ' ' LYS . 58.4 m -150.88 103.65 3.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.513 -0.742 . . . . 0.0 110.728 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -62.5 134.84 56.98 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.489 -0.757 . . . . 0.0 109.112 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.59 HG23 HG21 ' A' ' 7' ' ' ILE . 75.7 m -125.72 104.05 8.15 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 119.354 -0.938 . . . . 0.0 112.71 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.519 HG21 HG22 ' A' ' 40' ' ' ILE . 11.1 p -104.73 167.24 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.279 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.626 HG23 ' HB3' ' A' ' 9' ' ' ASN . 93.2 m -159.79 109.59 1.85 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.586 -0.696 . . . . 0.0 109.801 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.098 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.554 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 40.2 m . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.253 0.549 . . . . 0.0 110.011 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 58.8 m -89.87 96.73 10.81 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.588 -0.695 . . . . 0.0 110.662 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.766 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 87.6 m-85 -79.34 170.03 17.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.528 -0.732 . . . . 0.0 109.77 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.735 ' HG3' HG22 ' A' ' 18' ' ' THR . 2.2 mtpp -140.09 124.57 18.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.456 -0.778 . . . . 0.0 110.474 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.607 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 53.3 tp -101.94 120.42 40.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.426 -0.796 . . . . 0.0 109.817 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.635 HG21 HG23 ' A' ' 54' ' ' THR . 2.5 tt -69.36 172.75 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 13' ' ' LEU . 76.8 mt -135.39 75.39 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 119.414 -0.915 . . . . 0.0 110.676 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -96.68 47.59 1.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.89 154.46 16.63 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.0 tttp -71.25 -9.78 58.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.688 -0.889 . . . . 0.0 110.611 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.0 m -91.44 -33.44 15.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.215 -0.928 . . . . 0.0 110.273 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.462 ' O ' HG22 ' A' ' 8' ' ' ILE . 23.8 mt -142.13 167.5 21.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.465 -0.772 . . . . 0.0 110.638 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -147.52 136.78 22.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.634 -0.666 . . . . 0.0 110.198 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.401 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 127.26 -137.41 9.87 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -155.96 152.2 27.9 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.591 -0.947 . . . . 0.0 110.356 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.8 m -122.94 160.67 25.72 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.626 -0.671 . . . . 0.0 110.223 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.735 HG22 ' HG3' ' A' ' 5' ' ' LYS . 20.4 p -128.67 174.87 9.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.538 -0.726 . . . . 0.0 110.296 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.484 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.5 t -167.14 -173.26 2.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.526 -0.734 . . . . 0.0 110.328 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -128.56 101.97 6.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 0.0 110.177 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.0 155.07 47.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.605 -0.684 . . . . 0.0 110.135 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.42 HG13 ' OD2' ' A' ' 23' ' ' ASP . 7.8 p -74.42 -23.84 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.59 -0.694 . . . . 0.0 110.287 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.721 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 3.9 p30 -171.62 176.04 3.84 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.311 -0.868 . . . . 0.0 110.385 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.451 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -57.12 -29.61 63.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.553 -0.717 . . . . 0.0 110.992 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.721 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -57.89 -24.4 57.52 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.458 -0.776 . . . . 0.0 110.614 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.9 m -110.94 -27.98 8.56 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.466 -0.771 . . . . 0.0 110.355 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.766 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.81 -52.75 63.73 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.506 -0.746 . . . . 0.0 110.278 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -57.66 -39.87 78.03 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.554 -0.716 . . . . 0.0 110.415 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -56.9 -39.11 73.8 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.332 -0.855 . . . . 0.0 110.288 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.3 t -80.91 -49.19 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.665 -0.647 . . . . 0.0 110.105 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.484 ' CZ ' HG22 ' A' ' 19' ' ' THR . 6.2 m-85 -65.01 -33.08 75.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.594 -0.691 . . . . 0.0 110.409 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -64.1 -46.85 82.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.439 -0.788 . . . . 0.0 109.232 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -61.5 -31.97 71.98 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.619 0.724 . . . . 0.0 109.675 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.409 ' CD2' HD23 ' A' ' 6' ' ' LEU . 15.8 t80 -67.88 -42.96 80.44 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.63 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -78.45 -38.89 40.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.614 -0.678 . . . . 0.0 110.017 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -58.29 -52.19 66.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.467 -0.77 . . . . 0.0 110.28 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.6 -47.22 86.45 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.647 -0.658 . . . . 0.0 110.108 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -65.37 -45.9 82.24 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.555 -0.716 . . . . 0.0 110.037 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.44 36.93 0.88 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.63 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.1 mt -104.21 69.05 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.43 -1.041 . . . . 0.0 110.29 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -92.23 49.35 1.5 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.54 -0.725 . . . . 0.0 109.324 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.1 -137.09 0.84 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.17 112.24 22.21 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.893 -0.769 . . . . 0.0 109.11 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.607 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 25.2 m95 -81.09 143.11 32.67 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.247 1.023 . . . . 0.0 112.445 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 p -150.98 131.82 14.13 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.416 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 31.1 t80 -105.05 128.81 53.5 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.669 -0.645 . . . . 0.0 110.031 -178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -102.47 111.26 23.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.676 -0.64 . . . . 0.0 109.953 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -66.69 -23.9 66.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.719 -0.613 . . . . 0.0 110.588 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.65 -38.78 64.46 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.404 -0.81 . . . . 0.0 110.851 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.2 p -143.26 14.71 1.84 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.541 -0.724 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 4.4 mptt 50.92 87.12 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.074 -1.016 . . . . 0.0 110.712 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.5 m -149.64 105.59 3.46 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.118 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.439 ' O ' HD12 ' A' ' 6' ' ' LEU . 82.4 m-85 -62.25 123.72 18.94 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.635 HG23 HG21 ' A' ' 7' ' ' ILE . 63.3 m -117.39 104.15 10.83 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.175 -0.953 . . . . 0.0 112.854 -178.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.536 HG11 HG21 ' A' ' 40' ' ' ILE . 10.4 p -106.38 164.67 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.353 -0.842 . . . . 0.0 109.377 177.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.459 ' N ' HG22 ' A' ' 55' ' ' VAL . 64.0 m -163.91 116.11 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.384 179.96 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.463 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 86.3 m . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.111 0.481 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 3' ' ' THR . 8.7 t -88.04 104.29 16.52 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.701 -0.624 . . . . 0.0 110.756 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.622 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 83.9 m-85 -86.79 176.45 7.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.387 -0.821 . . . . 0.0 109.87 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.528 ' O ' HG23 ' A' ' 52' ' ' THR . 25.0 ttmt -146.75 115.82 6.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.47 -0.769 . . . . 0.0 110.245 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.606 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 48.3 tp -93.66 122.39 36.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.545 -0.722 . . . . 0.0 110.157 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.652 HG21 HG23 ' A' ' 54' ' ' THR . 5.0 tp -70.44 171.64 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.537 HG21 ' HB3' ' A' ' 13' ' ' LEU . 84.9 mt -132.26 71.73 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.216 -0.928 . . . . 0.0 110.564 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.475 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.0 m-20 -95.43 48.07 1.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.499 -0.751 . . . . 0.0 109.062 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.5 159.79 14.05 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -75.66 -6.16 49.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.707 -0.878 . . . . 0.0 110.564 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.401 ' H ' HG22 ' A' ' 12' ' ' THR . 9.9 t -100.17 -27.09 13.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.666 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.537 ' HB3' HG21 ' A' ' 8' ' ' ILE . 17.4 mt -143.78 163.59 32.9 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.425 -0.797 . . . . 0.0 110.577 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -147.9 131.95 17.25 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.588 -0.695 . . . . 0.0 110.2 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.71 -132.63 6.25 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.482 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.2 pt-20 -162.54 159.04 24.31 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.51 -0.994 . . . . 0.0 110.326 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 18' ' ' THR . 48.7 m -138.84 165.1 27.92 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.501 -0.749 . . . . 0.0 110.275 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.421 ' N ' HG22 ' A' ' 17' ' ' THR . 29.6 p -135.27 168.84 18.44 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.584 -0.697 . . . . 0.0 110.262 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.642 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.1 t -164.62 168.9 17.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.55 -0.719 . . . . 0.0 110.194 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -101.54 116.32 32.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.488 -0.757 . . . . 0.0 110.262 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -144.88 142.78 30.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.567 -0.708 . . . . 0.0 110.095 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.43 HG23 ' N ' ' A' ' 23' ' ' ASP . 33.7 m -57.35 -37.32 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.449 -0.782 . . . . 0.0 110.095 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.43 ' N ' HG23 ' A' ' 22' ' ' VAL . 1.5 t70 -172.34 -172.49 0.94 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.699 -0.626 . . . . 0.0 109.773 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.455 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.98 -23.14 12.22 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.461 -0.774 . . . . 0.0 111.174 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.28 -35.9 74.58 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.471 -0.768 . . . . 0.0 110.718 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.5 m -106.64 -25.39 11.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.445 -0.784 . . . . 0.0 110.811 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.622 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -57.83 -60.61 3.43 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.407 -0.808 . . . . 0.0 110.733 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -57.01 -40.09 75.98 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.521 -0.737 . . . . 0.0 110.568 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -57.65 -37.89 74.12 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.366 -0.834 . . . . 0.0 110.144 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 99.5 t -82.46 -48.7 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.64 -0.663 . . . . 0.0 109.851 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.642 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.1 m-85 -63.85 -33.17 75.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.551 -0.718 . . . . 0.0 110.212 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -64.76 -44.98 88.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.5 -0.75 . . . . 0.0 109.086 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -61.85 -27.63 68.92 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.505 0.669 . . . . 0.0 109.779 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -74.4 -53.08 10.31 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.728 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.94 -40.14 92.1 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.581 -0.7 . . . . 0.0 110.18 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -57.72 -49.73 75.55 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.537 -0.727 . . . . 0.0 110.693 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.88 -55.94 27.07 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.522 -0.736 . . . . 0.0 110.2 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -60.96 -47.68 85.34 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.563 -0.711 . . . . 0.0 110.082 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.71 64.58 0.3 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.728 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 82.4 mt -126.01 79.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.545 -0.974 . . . . 0.0 110.148 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -95.39 43.95 1.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.52 -140.48 0.64 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -118.78 111.33 18.32 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.606 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 26.0 m95 -77.13 143.9 38.81 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.178 0.99 . . . . 0.0 112.416 -177.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.6 p -151.27 132.77 14.72 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -104.41 113.71 27.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.621 -0.674 . . . . 0.0 110.122 -178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -88.66 116.27 26.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.674 -0.641 . . . . 0.0 109.957 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.15 -15.78 61.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.625 -0.672 . . . . 0.0 110.845 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.437 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.97 -39.43 65.96 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.189 -0.944 . . . . 0.0 110.766 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.437 HG23 ' C ' ' A' ' 49' ' ' ALA . 69.1 p -148.47 20.11 1.06 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.561 -0.712 . . . . 0.0 110.702 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.52 85.89 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.194 -0.941 . . . . 0.0 110.837 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 5' ' ' LYS . 89.5 m -150.39 105.51 3.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.559 -0.713 . . . . 0.0 110.494 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.434 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 90.0 m-85 -60.02 126.98 29.62 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.652 HG23 HG21 ' A' ' 7' ' ' ILE . 48.7 m -119.96 100.03 6.97 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.984 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.69 HG11 HG21 ' A' ' 40' ' ' ILE . 10.6 p -100.83 166.93 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.44 -0.788 . . . . 0.0 109.021 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 9' ' ' ASN . 90.1 m -158.68 109.81 2.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.515 -0.74 . . . . 0.0 110.295 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.288 179.917 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.567 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 55.6 m . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.066 0.46 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 65.6 m -122.75 96.65 5.11 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.617 -0.677 . . . . 0.0 110.44 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.652 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 97.4 m-85 -81.41 175.34 10.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.585 -0.697 . . . . 0.0 110.081 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.498 ' HB3' HG23 ' A' ' 52' ' ' THR . 16.0 ttpt -151.33 127.78 10.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.523 -0.736 . . . . 0.0 110.185 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.618 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 48.0 tp -104.73 125.21 50.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.494 -0.754 . . . . 0.0 110.442 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.728 HG21 HG23 ' A' ' 54' ' ' THR . 2.1 tp -75.17 171.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.474 HD12 ' C ' ' A' ' 15' ' ' GLY . 78.0 mt -130.8 74.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.179 -0.951 . . . . 0.0 110.674 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.54 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.7 m-20 -97.3 46.91 1.03 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.31 -0.869 . . . . 0.0 108.796 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.93 165.17 17.36 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.94 4.58 29.0 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.726 -0.867 . . . . 0.0 110.643 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -114.87 -26.86 7.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 110.484 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.3 tp -143.39 166.8 23.77 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.831 . . . . 0.0 110.769 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -153.53 143.23 21.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.559 -0.713 . . . . 0.0 110.27 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.474 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 134.05 -142.62 14.13 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -142.5 172.07 13.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.568 -0.96 . . . . 0.0 110.341 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.9 m -155.9 132.72 10.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.628 -0.67 . . . . 0.0 110.02 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.0 p -119.81 167.24 12.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.514 -0.741 . . . . 0.0 110.357 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.677 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.0 t -167.17 166.06 15.15 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.618 -0.677 . . . . 0.0 110.265 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -100.29 111.06 23.31 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.564 -0.71 . . . . 0.0 110.218 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.454 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -135.01 139.67 45.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.583 -0.698 . . . . 0.0 110.199 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.73 -28.8 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.543 -0.723 . . . . 0.0 110.408 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.598 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 27.5 p30 -173.87 -176.45 1.21 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.431 -0.793 . . . . 0.0 110.34 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -57.99 -23.94 56.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.613 -0.679 . . . . 0.0 110.809 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.598 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.65 -29.38 67.99 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.453 -0.779 . . . . 0.0 110.281 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.454 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 30.2 m -106.29 -28.17 10.57 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.55 -0.719 . . . . 0.0 110.154 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.652 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . . . -61.3 -59.89 4.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.562 -0.711 . . . . 0.0 110.097 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -59.77 -43.79 94.17 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.601 -0.687 . . . . 0.0 110.215 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -54.64 -40.22 68.78 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.284 -0.885 . . . . 0.0 110.229 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 26' ' ' THR . 97.8 t -82.17 -48.52 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.697 -0.627 . . . . 0.0 109.918 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.677 ' CZ ' HG22 ' A' ' 19' ' ' THR . 13.5 m-85 -62.16 -32.73 73.38 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.653 -0.654 . . . . 0.0 110.304 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -66.31 -42.86 87.68 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.046 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -62.42 -30.11 70.99 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.505 0.669 . . . . 0.0 109.678 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -70.22 -50.68 37.47 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.673 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -67.24 -37.47 83.59 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.629 -0.67 . . . . 0.0 110.075 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -57.0 -36.47 70.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.479 -0.763 . . . . 0.0 110.65 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -69.83 -41.29 75.14 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.519 -0.738 . . . . 0.0 110.174 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -80.84 -27.98 36.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.596 -0.69 . . . . 0.0 110.269 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.82 38.35 4.68 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.673 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 76.8 mt -89.5 66.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.548 -0.972 . . . . 0.0 110.226 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -85.63 56.97 4.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.569 -0.707 . . . . 0.0 109.15 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.33 -138.21 4.98 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.47 102.19 8.72 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.868 -0.784 . . . . 0.0 109.161 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.618 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 32.6 m95 -69.88 143.13 52.88 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.153 0.977 . . . . 0.0 112.457 -177.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 44' ' ' TRP . 3.4 p -152.0 131.83 13.28 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -107.26 152.72 23.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.635 -0.666 . . . . 0.0 110.059 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -126.98 113.72 16.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.687 -0.633 . . . . 0.0 109.911 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -67.61 -23.05 65.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.703 -0.623 . . . . 0.0 110.833 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.75 -40.15 62.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.275 -0.891 . . . . 0.0 110.718 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.2 p -144.98 16.46 1.57 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.667 -0.645 . . . . 0.0 110.744 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.461 ' HG2' ' CE2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.81 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.121 -0.987 . . . . 0.0 110.876 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.498 HG23 ' HB3' ' A' ' 5' ' ' LYS . 63.6 m -152.78 102.46 2.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.494 -0.754 . . . . 0.0 110.949 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -63.0 136.75 58.0 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.728 HG23 HG21 ' A' ' 7' ' ' ILE . 86.4 m -129.37 103.04 6.69 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.37 -0.932 . . . . 0.0 112.322 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.598 HG11 HG21 ' A' ' 40' ' ' ILE . 10.7 p -102.54 167.04 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 0.0 109.265 177.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.54 HG23 ' HB3' ' A' ' 9' ' ' ASN . 92.0 m -160.71 112.65 1.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.595 -0.69 . . . . 0.0 110.273 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.086 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.477 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 93.9 m . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.126 0.489 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.2 m -88.58 104.27 16.68 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.606 -0.684 . . . . 0.0 110.707 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.663 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 88.8 m-85 -85.57 179.6 7.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.548 -0.72 . . . . 0.0 109.821 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.3 mtmm -144.44 117.24 8.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.438 -0.789 . . . . 0.0 110.575 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.583 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 34.7 tp -99.47 121.66 41.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.464 -0.772 . . . . 0.0 110.164 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.65 HG21 HG23 ' A' ' 54' ' ' THR . 4.8 tp -70.69 169.3 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.529 HD11 ' OG1' ' A' ' 17' ' ' THR . 81.2 mt -131.33 77.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 110.856 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.532 ' HB3' HG23 ' A' ' 56' ' ' THR . 71.5 m-20 -97.24 46.93 1.03 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.225 -0.922 . . . . 0.0 108.633 178.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.12 153.04 16.97 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.59 -8.09 53.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.756 -0.849 . . . . 0.0 110.716 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -94.14 -30.88 14.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.215 -0.928 . . . . 0.0 110.4 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -145.63 174.78 10.89 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.423 -0.798 . . . . 0.0 110.498 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -165.72 142.58 5.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.608 -0.682 . . . . 0.0 110.48 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.5 -121.74 2.75 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -157.07 153.05 27.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.973 . . . . 0.0 110.304 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.529 ' OG1' HD11 ' A' ' 8' ' ' ILE . 4.4 m -138.9 142.67 38.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.553 -0.717 . . . . 0.0 110.244 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -124.61 153.09 42.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.617 -0.677 . . . . 0.0 110.184 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.734 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.9 t -151.35 142.24 22.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.554 -0.716 . . . . 0.0 110.285 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.49 114.66 16.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.594 -0.691 . . . . 0.0 110.34 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -142.4 139.87 31.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.463 -0.773 . . . . 0.0 110.054 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 23' ' ' ASP . 33.2 m -56.46 -36.45 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.481 -0.762 . . . . 0.0 110.23 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.417 ' N ' HG23 ' A' ' 22' ' ' VAL . 3.6 t70 -172.66 -173.27 0.99 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.595 -0.691 . . . . 0.0 109.934 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.5 -22.36 12.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.403 -0.811 . . . . 0.0 111.269 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.71 66.77 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.355 -0.841 . . . . 0.0 110.505 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.5 m -116.44 -21.69 9.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.466 -0.771 . . . . 0.0 110.954 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.663 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -57.3 -62.97 1.39 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.318 -0.864 . . . . 0.0 110.667 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -59.98 -36.41 77.09 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.45 -0.781 . . . . 0.0 110.086 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -57.6 -43.68 84.86 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.486 -0.759 . . . . 0.0 109.962 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.6 t -78.77 -48.23 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.713 -0.617 . . . . 0.0 109.667 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.734 ' CZ ' HG22 ' A' ' 19' ' ' THR . 4.9 m-85 -61.33 -32.81 72.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.621 -0.675 . . . . 0.0 110.262 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -64.07 -42.94 96.8 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.433 -0.792 . . . . 0.0 108.9 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -64.56 -32.31 73.9 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.643 0.735 . . . . 0.0 109.341 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -68.04 -56.02 10.42 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -59.9 -41.38 91.5 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.716 -0.615 . . . . 0.0 110.287 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -56.77 -37.92 71.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.483 -0.76 . . . . 0.0 110.643 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.14 -37.87 84.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.596 -0.69 . . . . 0.0 110.284 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -91.21 -30.72 16.49 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.511 -0.743 . . . . 0.0 110.178 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.06 44.3 1.77 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.757 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 79.8 mt -95.08 62.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.486 -1.008 . . . . 0.0 110.159 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.85 59.16 5.05 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.66 -138.47 6.4 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -115.13 103.15 10.58 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.845 -0.797 . . . . 0.0 109.015 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.583 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 38.5 m95 -73.18 143.34 47.26 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 122.161 0.981 . . . . 0.0 112.195 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 44' ' ' TRP . 7.0 p -155.91 131.43 9.61 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -105.71 133.07 51.03 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.655 -0.653 . . . . 0.0 109.955 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -104.3 109.97 22.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.77 -0.581 . . . . 0.0 109.888 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.6 -20.99 66.59 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.656 -0.653 . . . . 0.0 110.588 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.433 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.87 -37.84 60.86 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.263 -0.898 . . . . 0.0 110.958 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.433 HG23 ' C ' ' A' ' 49' ' ' ALA . 73.6 p -147.68 19.89 1.16 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.573 -0.704 . . . . 0.0 110.826 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.442 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 50.63 85.38 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.154 -0.966 . . . . 0.0 110.875 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.3 m -151.43 105.81 3.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.467 -0.771 . . . . 0.0 111.035 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.468 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 84.1 m-85 -62.83 137.6 58.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.485 -0.76 . . . . 0.0 109.071 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.65 HG23 HG21 ' A' ' 7' ' ' ILE . 68.3 m -128.79 98.76 5.08 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.316 -0.954 . . . . 0.0 112.764 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 40' ' ' ILE . 11.0 p -101.86 166.46 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 109.254 177.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.532 HG23 ' HB3' ' A' ' 9' ' ' ASN . 82.8 m -161.67 111.06 1.55 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.725 -0.609 . . . . 0.0 109.657 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.24 -179.999 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.499 HG22 ' CE2' ' A' ' 4' ' ' PHE . 87.1 m . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.112 0.482 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 19' ' ' THR . 4.6 m -110.58 92.23 3.97 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.603 -0.686 . . . . 0.0 110.506 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.9 m-85 -67.35 169.38 9.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.568 -0.707 . . . . 0.0 109.961 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.631 ' HG2' HG22 ' A' ' 18' ' ' THR . 64.0 mttt -140.41 120.16 13.41 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.576 -0.703 . . . . 0.0 110.491 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.597 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 28.7 tp -98.95 130.41 45.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.512 -0.743 . . . . 0.0 109.919 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.635 HG21 HG23 ' A' ' 54' ' ' THR . 2.4 tp -78.95 171.81 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 13' ' ' LEU . 83.2 mt -132.63 72.12 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.258 -0.901 . . . . 0.0 110.431 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.609 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.0 m-20 -93.94 50.55 1.43 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.43 156.07 15.9 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -71.64 -13.43 61.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.716 -0.873 . . . . 0.0 110.492 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.5 m -88.57 -33.44 17.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.272 -0.893 . . . . 0.0 110.38 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.521 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.4 mt -144.1 162.81 35.32 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.406 -0.809 . . . . 0.0 110.832 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -143.35 136.71 28.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.67 -0.644 . . . . 0.0 110.146 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.401 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 133.23 -145.41 17.44 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -144.57 166.8 24.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.537 -0.978 . . . . 0.0 110.275 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.0 m -139.33 168.84 18.93 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.73 . . . . 0.0 110.211 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.631 HG22 ' HG2' ' A' ' 5' ' ' LYS . 10.0 p -137.55 165.43 26.32 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.526 -0.734 . . . . 0.0 110.354 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 3' ' ' THR . 7.9 t -146.78 163.03 37.32 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.507 -0.745 . . . . 0.0 110.262 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -111.97 87.63 2.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.499 -0.75 . . . . 0.0 110.24 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.654 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -126.29 -171.76 2.47 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.529 -0.732 . . . . 0.0 110.206 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.7 p -112.41 -25.84 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.563 -0.711 . . . . 0.0 110.224 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -164.91 174.4 10.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.469 -0.77 . . . . 0.0 110.0 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.591 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -54.08 -23.5 14.04 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.422 -0.799 . . . . 0.0 110.781 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.56 -42.84 79.26 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.392 -0.817 . . . . 0.0 109.996 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.654 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 85.6 m -87.93 -34.03 18.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.649 -0.657 . . . . 0.0 109.413 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.591 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -63.25 -178.8 0.27 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.673 -0.642 . . . . 0.0 109.595 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 66.36 -63.01 0.26 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.546 -0.721 . . . . 0.0 110.528 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.83 -34.72 60.13 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.999 -1.063 . . . . 0.0 110.246 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.3 t -82.17 -50.23 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.698 -0.626 . . . . 0.0 109.666 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.539 ' HB3' HD22 ' A' ' 6' ' ' LEU . 4.6 m-85 -62.86 -33.65 75.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.586 -0.696 . . . . 0.0 109.856 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -63.7 -41.32 98.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.593 -0.692 . . . . 0.0 109.28 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -60.97 -31.78 71.35 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.642 0.734 . . . . 0.0 109.714 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -71.53 -55.73 7.28 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.776 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -65.51 -47.18 76.84 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.68 -0.638 . . . . 0.0 110.31 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -56.18 -28.36 57.91 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.491 -0.756 . . . . 0.0 110.519 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.41 -39.64 24.65 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.69 -0.631 . . . . 0.0 110.048 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -79.13 -46.89 17.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.65 -0.656 . . . . 0.0 110.003 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.79 60.06 0.18 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.776 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 86.4 mt -124.04 67.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.549 -0.971 . . . . 0.0 110.173 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.26 53.29 2.6 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.93 -138.47 2.71 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -115.56 101.11 8.57 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.857 -0.79 . . . . 0.0 109.337 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.597 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 34.3 m95 -70.02 143.52 52.52 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 122.002 0.906 . . . . 0.0 112.098 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 44' ' ' TRP . 12.2 p -155.01 130.51 9.81 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -103.08 146.14 28.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.665 -0.647 . . . . 0.0 109.783 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -118.31 116.89 27.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.72 -0.612 . . . . 0.0 109.857 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -71.42 -21.2 62.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.666 -0.646 . . . . 0.0 110.584 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.83 -40.52 66.5 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.269 -0.895 . . . . 0.0 110.806 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.8 p -144.83 17.19 1.61 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.605 -0.684 . . . . 0.0 110.789 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.456 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.27 91.61 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.187 -0.945 . . . . 0.0 111.043 179.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 5' ' ' LYS . 59.8 m -158.59 104.8 1.81 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.45 -0.781 . . . . 0.0 110.715 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.501 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 93.1 m-85 -62.16 139.49 58.47 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.635 HG23 HG21 ' A' ' 7' ' ' ILE . 25.2 m -131.51 102.7 6.04 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.954 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.549 HG21 HG22 ' A' ' 40' ' ' ILE . 11.3 p -102.97 166.95 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.347 -0.846 . . . . 0.0 109.17 177.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.609 HG23 ' HB3' ' A' ' 9' ' ' ASN . 99.8 m -160.92 115.09 2.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.666 -0.646 . . . . 0.0 109.964 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.127 179.807 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.452 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 62.8 m . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.081 0.467 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.6 m -92.26 103.01 15.51 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.604 -0.685 . . . . 0.0 110.503 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.756 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 79.5 m-85 -84.68 170.05 13.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.586 -0.696 . . . . 0.0 110.068 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.66 145.29 38.26 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.571 -0.705 . . . . 0.0 109.889 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 53' ' ' PHE . 18.3 tp -123.12 135.2 54.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.484 -0.76 . . . . 0.0 110.436 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.638 HG21 HG23 ' A' ' 54' ' ' THR . 3.8 tp -85.56 156.0 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.472 HG21 ' HB3' ' A' ' 13' ' ' LEU . 49.5 mm -120.51 74.78 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.368 -179.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.587 ' HB3' HG23 ' A' ' 56' ' ' THR . 5.9 m-20 -95.7 47.35 1.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 178.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.74 153.28 17.59 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -69.28 -10.91 60.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.627 -0.925 . . . . 0.0 110.452 179.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.2 m -87.66 -37.76 16.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 110.256 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.472 ' HB3' HG21 ' A' ' 8' ' ' ILE . 18.1 mt -138.62 172.44 12.88 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.45 -0.781 . . . . 0.0 110.778 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -151.9 135.93 16.53 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.602 -0.686 . . . . 0.0 110.094 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.12 -145.46 15.73 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -146.18 178.2 8.41 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.585 -0.95 . . . . 0.0 110.406 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.4 m -159.71 152.87 22.01 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 110.16 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.0 p -124.51 163.4 21.94 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.561 -0.712 . . . . 0.0 110.349 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 t -150.5 -171.54 3.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.633 -0.667 . . . . 0.0 110.211 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.35 98.35 5.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.549 -0.719 . . . . 0.0 110.33 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.403 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -128.3 148.54 50.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.456 -0.777 . . . . 0.0 109.844 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.8 p -63.35 -36.43 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.041 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -169.75 -174.9 1.96 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.606 -0.683 . . . . 0.0 110.081 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -54.54 -26.02 29.4 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.504 -0.747 . . . . 0.0 111.074 -179.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.87 -28.64 69.02 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.506 -0.747 . . . . 0.0 110.3 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.403 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 4.5 m -113.03 -25.81 8.78 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.596 -0.69 . . . . 0.0 110.464 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.756 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.58 -61.74 2.37 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.471 -0.768 . . . . 0.0 110.496 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -57.7 -34.42 69.43 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.55 -0.719 . . . . 0.0 110.166 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -58.01 -36.86 73.28 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.37 -0.831 . . . . 0.0 109.996 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.2 t -84.59 -48.6 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.67 -0.644 . . . . 0.0 109.674 179.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -62.31 -37.01 83.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.623 -0.673 . . . . 0.0 110.008 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -62.76 -47.28 84.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.572 -0.705 . . . . 0.0 109.169 179.413 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -63.21 -34.19 77.1 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.708 0.766 . . . . 0.0 109.286 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -65.81 -53.31 41.83 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.62 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.89 -45.72 84.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.735 -0.603 . . . . 0.0 109.895 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -58.82 -37.03 75.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 110.349 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -65.46 -54.17 32.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.659 -0.651 . . . . 0.0 109.949 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -69.61 -49.24 55.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.566 -0.709 . . . . 0.0 109.852 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.69 54.17 0.11 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.62 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.1 mt -119.97 70.32 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.427 -1.043 . . . . 0.0 110.236 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -94.55 48.82 1.23 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.16 -138.24 0.6 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -110.31 111.7 23.18 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.474 ' O ' HG23 ' A' ' 45' ' ' THR . 35.9 m95 -83.83 143.27 30.04 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.213 1.006 . . . . 0.0 112.738 -177.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 44' ' ' TRP . 1.7 p -154.7 131.72 10.91 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -101.03 143.94 30.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.65 -0.656 . . . . 0.0 110.306 -178.454 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -115.75 109.58 17.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.726 -0.609 . . . . 0.0 109.775 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -67.13 -21.8 65.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.646 -0.659 . . . . 0.0 110.593 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.449 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.4 -40.26 64.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.318 -0.864 . . . . 0.0 110.805 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.449 HG23 ' C ' ' A' ' 49' ' ' ALA . 80.1 p -148.82 21.04 1.01 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.549 -0.719 . . . . 0.0 110.676 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.439 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.54 92.74 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.168 -0.957 . . . . 0.0 110.744 179.874 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.1 m -152.57 101.64 2.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.355 -0.841 . . . . 0.0 111.515 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.403 ' O ' HD12 ' A' ' 6' ' ' LEU . 91.6 m-85 -63.49 124.21 20.74 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.272 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.638 HG23 HG21 ' A' ' 7' ' ' ILE . 63.0 m -115.23 96.66 5.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.263 -0.898 . . . . 0.0 113.14 -177.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.533 HG21 HG22 ' A' ' 40' ' ' ILE . 10.4 p -99.24 166.89 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 177.339 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.587 HG23 ' HB3' ' A' ' 9' ' ' ASN . 92.5 m -157.5 105.77 2.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.606 -0.684 . . . . 0.0 109.749 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.254 -179.723 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.568 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 44.1 m . . . . . 0 N--CA 1.494 1.762 0 CA-C-O 121.21 0.529 . . . . 0.0 110.362 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.2 m -85.53 90.83 8.08 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.589 -0.694 . . . . 0.0 110.623 -179.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.568 ' CZ ' HG21 ' A' ' 2' ' ' THR . 96.5 m-85 -73.28 170.34 15.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.478 -0.764 . . . . 0.0 109.81 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -141.44 139.71 33.45 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.467 -0.77 . . . . 0.0 110.583 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.528 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 38.9 tp -114.3 121.39 43.5 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.636 -0.665 . . . . 0.0 109.95 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.666 HG21 HG23 ' A' ' 54' ' ' THR . 3.8 tp -71.47 166.26 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.666 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 13' ' ' LEU . 71.5 mt -127.7 72.51 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.335 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.535 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.6 m-20 -93.62 49.17 1.34 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.456 -0.777 . . . . 0.0 109.107 179.117 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.4 149.7 18.81 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -66.71 -13.63 61.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.649 -0.913 . . . . 0.0 110.41 179.406 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.6 m -85.05 -37.59 20.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.243 -0.911 . . . . 0.0 110.446 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.463 ' O ' HG22 ' A' ' 8' ' ' ILE . 10.0 mt -141.38 170.06 16.43 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.444 -0.785 . . . . 0.0 110.769 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -151.22 141.49 22.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.611 -0.681 . . . . 0.0 110.177 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.401 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 129.95 -149.73 18.89 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -144.4 160.3 41.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.535 -0.98 . . . . 0.0 110.351 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.7 m -147.89 147.84 30.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.585 -0.697 . . . . 0.0 110.207 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -119.27 171.23 8.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.529 -0.732 . . . . 0.0 110.225 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.449 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 7.9 t -142.97 -170.43 3.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.548 -0.72 . . . . 0.0 110.369 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -126.86 88.59 2.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.622 -0.674 . . . . 0.0 110.123 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.809 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -130.64 137.89 49.82 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.608 -0.682 . . . . 0.0 110.3 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.1 m -59.39 -25.45 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.527 -0.733 . . . . 0.0 110.574 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.718 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 26.1 p30 -170.87 179.95 3.0 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.401 -0.812 . . . . 0.0 110.404 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.585 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -55.18 -22.84 18.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.478 -0.764 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.718 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -56.04 -45.14 79.28 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.307 -0.87 . . . . 0.0 110.173 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.809 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 62.7 m -85.83 -31.63 22.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.649 -0.657 . . . . 0.0 109.541 179.262 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . . . -62.26 -176.93 0.11 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.698 -0.626 . . . . 0.0 109.611 179.44 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 66.63 -61.73 0.3 Allowed 'General case' 0 N--CA 1.508 2.455 0 O-C-N 121.508 -0.745 . . . . 0.0 110.75 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -55.63 -34.22 64.73 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.064 -1.022 . . . . 0.0 110.268 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.0 t -83.49 -49.81 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.599 -0.688 . . . . 0.0 109.768 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.449 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 7.7 m-85 -63.17 -34.19 77.09 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.578 -0.701 . . . . 0.0 109.668 179.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -63.56 -41.23 98.42 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -62.8 -33.83 76.01 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.701 0.763 . . . . 0.0 109.544 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -68.02 -51.47 46.58 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.015 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.728 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -68.53 -49.07 62.34 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.792 -0.567 . . . . 0.0 110.078 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -55.94 -29.78 60.67 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.468 -0.77 . . . . 0.0 110.356 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.36 -40.16 89.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.681 -0.637 . . . . 0.0 109.822 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.26 -44.15 10.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.624 -0.672 . . . . 0.0 109.983 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.52 38.62 0.51 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.728 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.9 mt -93.32 64.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.379 -1.071 . . . . 0.0 109.908 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.3 54.77 3.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.503 -0.748 . . . . 0.0 108.999 178.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.76 -136.55 1.8 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.038 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -114.08 102.09 9.84 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.932 -0.746 . . . . 0.0 109.035 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.528 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 40.4 m95 -74.44 142.41 44.94 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.154 0.978 . . . . 0.0 112.226 -178.133 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 44' ' ' TRP . 4.5 p -153.22 131.3 11.85 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.429 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 13.7 t80 -107.5 113.56 26.97 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.877 -178.529 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.37 118.62 26.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.699 -0.626 . . . . 0.0 109.929 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -69.76 -23.41 63.36 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.72 -0.612 . . . . 0.0 110.36 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.38 -37.12 55.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.416 -0.803 . . . . 0.0 111.015 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.3 p -144.34 14.51 1.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.482 -0.761 . . . . 0.0 111.12 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HG3' ' CE2' ' A' ' 46' ' ' TYR . 1.0 OUTLIER 50.97 86.72 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.043 -1.036 . . . . 0.0 110.82 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.1 m -153.14 107.48 3.12 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.515 -0.741 . . . . 0.0 110.934 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -64.06 124.15 20.86 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.666 HG23 HG21 ' A' ' 7' ' ' ILE . 91.7 m -116.14 98.32 6.55 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.283 -0.886 . . . . 0.0 112.888 -177.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.569 HG21 HG22 ' A' ' 40' ' ' ILE . 10.3 p -98.13 166.75 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.887 . . . . 0.0 109.395 177.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.535 HG23 ' HB3' ' A' ' 9' ' ' ASN . 99.7 m -160.78 108.84 1.58 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.648 -0.657 . . . . 0.0 109.751 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.13 -179.961 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.632 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 5.7 m . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.137 0.494 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 3' ' ' THR . 8.9 t -96.35 79.24 3.1 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.68 -0.637 . . . . 0.0 110.99 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.789 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 97.4 m-85 -62.14 166.38 4.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.321 -0.862 . . . . 0.0 109.6 179.445 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.404 ' HB3' HG23 ' A' ' 52' ' ' THR . 37.4 ttpt -137.4 122.21 18.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.403 -0.811 . . . . 0.0 110.658 -179.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.65 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 47.0 tp -99.88 130.59 46.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.546 -0.721 . . . . 0.0 110.049 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.662 HG21 HG23 ' A' ' 54' ' ' THR . 3.4 tp -81.75 165.52 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 13' ' ' LEU . 70.1 mt -124.11 73.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.251 -0.906 . . . . 0.0 110.279 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.17 46.79 1.12 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 0.0 108.967 178.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.22 158.1 15.66 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -76.31 -5.07 45.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.767 -0.843 . . . . 0.0 110.604 179.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.73 ' O ' HD22 ' A' ' 13' ' ' LEU . 5.2 m -99.15 -36.84 9.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.191 -0.943 . . . . 0.0 110.273 -179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.73 HD22 ' O ' ' A' ' 12' ' ' THR . 0.5 OUTLIER -137.33 164.29 28.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.444 -0.785 . . . . 0.0 110.53 -179.948 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.16 138.4 19.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.602 -0.686 . . . . 0.0 110.326 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.492 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 139.21 -141.94 12.34 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -145.71 157.94 43.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.546 -0.973 . . . . 0.0 110.396 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.9 m -146.39 137.91 24.63 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.613 -0.679 . . . . 0.0 110.123 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.3 p -119.48 164.16 16.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.538 -0.727 . . . . 0.0 110.264 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.593 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.5 t -152.8 -166.26 2.41 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.589 -0.694 . . . . 0.0 110.285 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -131.12 122.66 27.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.712 -0.617 . . . . 0.0 110.204 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.481 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -151.08 158.71 44.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.575 -0.703 . . . . 0.0 110.197 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 22' ' ' VAL . 8.4 p -77.3 -25.44 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.583 -0.698 . . . . 0.0 110.156 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.566 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 25.8 p30 -172.41 179.61 2.47 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.406 -0.809 . . . . 0.0 110.277 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.416 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.61 -25.66 53.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.541 -0.725 . . . . 0.0 110.807 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.566 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.99 -27.32 65.31 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.484 -0.76 . . . . 0.0 110.489 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.481 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 62.5 m -109.27 -27.87 9.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.505 -0.747 . . . . 0.0 110.313 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.789 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.64 -55.64 31.95 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.522 -0.736 . . . . 0.0 110.324 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -59.22 -42.11 90.22 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.573 -0.704 . . . . 0.0 110.333 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -57.59 -35.77 70.85 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.336 -0.853 . . . . 0.0 110.177 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 26' ' ' THR . 87.9 t -83.42 -49.04 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.692 -0.63 . . . . 0.0 110.004 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.593 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.2 m-85 -65.44 -35.45 80.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.56 -0.713 . . . . 0.0 110.329 -179.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -64.06 -41.98 97.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.435 -0.791 . . . . 0.0 109.377 179.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -60.6 -29.63 69.33 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.561 0.696 . . . . 0.0 109.957 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -73.22 -54.11 9.23 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.695 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.41 -44.14 92.18 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.665 -0.647 . . . . 0.0 110.073 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -56.38 -37.33 69.96 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.494 -0.754 . . . . 0.0 110.581 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -75.1 -50.38 16.56 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.652 -0.655 . . . . 0.0 110.146 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -65.8 -48.5 71.51 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.528 -0.732 . . . . 0.0 110.067 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.3 62.05 0.2 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.695 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 85.5 mt -129.56 77.22 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.472 -1.016 . . . . 0.0 110.458 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.76 40.7 1.15 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.15 -136.14 0.02 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -120.22 100.79 7.39 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.82 -0.812 . . . . 0.0 109.011 179.284 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.65 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 27.8 m95 -67.38 142.97 56.56 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.218 1.008 . . . . 0.0 112.478 -177.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.5 p -151.72 131.6 13.31 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -103.13 128.55 50.02 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.696 -0.628 . . . . 0.0 109.967 -178.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -97.59 108.2 20.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.686 -0.634 . . . . 0.0 110.019 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -65.97 -20.08 66.08 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.645 -0.659 . . . . 0.0 110.633 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.442 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.71 -38.6 64.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.282 -0.886 . . . . 0.0 110.812 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.442 HG23 ' C ' ' A' ' 49' ' ' ALA . 71.6 p -148.61 22.18 1.02 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.522 -0.736 . . . . 0.0 110.752 -179.874 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.88 90.75 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.128 -0.982 . . . . 0.0 110.928 179.828 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 5' ' ' LYS . 60.1 m -156.67 106.37 2.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.477 -0.764 . . . . 0.0 110.857 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -62.27 136.58 57.99 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.535 -0.728 . . . . 0.0 109.095 178.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.662 HG23 HG21 ' A' ' 7' ' ' ILE . 70.4 m -129.77 101.57 5.94 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.558 -178.559 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.54 HG21 HG22 ' A' ' 40' ' ' ILE . 10.2 p -102.81 165.4 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.612 177.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.468 ' N ' HG22 ' A' ' 55' ' ' VAL . 59.4 m -163.49 115.34 1.45 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.875 -0.516 . . . . 0.0 109.751 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.34 179.521 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.736 HG22 ' O ' ' A' ' 21' ' ' ALA . 9.9 t . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 120.806 0.336 . . . . 0.0 110.234 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.7 m -129.49 96.11 4.18 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.539 -0.725 . . . . 0.0 110.739 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.759 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 84.9 m-85 -77.6 169.34 18.46 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.533 -0.729 . . . . 0.0 109.644 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -140.14 113.61 8.57 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.503 -0.748 . . . . 0.0 110.418 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.622 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 42.8 tp -94.03 122.31 36.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.565 -0.709 . . . . 0.0 109.966 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.632 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.9 tp -72.92 166.83 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.498 HD12 ' C ' ' A' ' 15' ' ' GLY . 73.8 mt -128.67 73.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.527 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.651 ' HB3' HG23 ' A' ' 56' ' ' THR . 5.7 m-20 -94.37 49.55 1.3 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.416 -0.802 . . . . 0.0 109.124 178.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.31 151.79 18.32 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.6 -10.1 56.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.678 -0.895 . . . . 0.0 110.613 179.426 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.1 m -90.38 -32.49 16.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 110.373 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 13' ' ' LEU . 28.3 mt -143.34 173.12 11.89 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.451 -0.781 . . . . 0.0 110.917 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -156.69 140.68 16.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.618 -0.676 . . . . 0.0 110.129 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.498 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 128.11 -134.48 8.19 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.402 ' N ' HD12 ' A' ' 8' ' ' ILE . 6.8 pt-20 -162.1 164.98 27.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.518 -0.99 . . . . 0.0 110.286 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.411 HG22 ' N ' ' A' ' 18' ' ' THR . 76.2 m -138.69 164.06 30.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.542 -0.724 . . . . 0.0 110.339 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.411 ' N ' HG22 ' A' ' 17' ' ' THR . 25.6 p -136.98 161.06 37.09 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.57 -0.706 . . . . 0.0 110.204 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.598 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.6 t -169.78 148.43 3.58 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.543 -0.723 . . . . 0.0 110.192 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 2' ' ' THR . 43.5 mt-10 -82.36 132.43 35.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.495 -0.753 . . . . 0.0 110.13 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.736 ' O ' HG22 ' A' ' 2' ' ' THR . . . -155.36 140.98 17.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.358 -0.839 . . . . 0.0 110.473 -179.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.6 m -58.8 -32.59 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.571 -0.706 . . . . 0.0 110.405 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.598 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 30.0 p30 -170.14 179.11 3.62 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.546 -0.721 . . . . 0.0 110.294 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.98 -24.67 40.01 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.492 -0.755 . . . . 0.0 110.847 -179.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.598 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.67 -35.13 72.09 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.438 -0.789 . . . . 0.0 110.508 -179.889 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.5 m -97.4 -25.58 15.16 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.52 -0.737 . . . . 0.0 110.506 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.759 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -66.62 -58.51 5.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.436 -0.79 . . . . 0.0 110.467 -179.742 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -57.23 -42.12 80.79 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.573 -0.704 . . . . 0.0 110.597 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -55.99 -40.65 73.63 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.298 -0.876 . . . . 0.0 110.196 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.4 t -80.18 -49.41 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.626 -0.671 . . . . 0.0 109.733 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.598 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.7 m-85 -61.77 -30.51 70.84 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.098 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -65.11 -43.76 90.97 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.168 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -62.57 -30.86 71.63 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.606 0.717 . . . . 0.0 109.439 178.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -70.95 -50.28 36.36 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.171 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.686 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -69.93 -42.92 72.65 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.638 -0.664 . . . . 0.0 109.989 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -58.7 -38.29 77.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.563 -0.711 . . . . 0.0 110.517 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -71.3 -51.96 21.54 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.551 -0.718 . . . . 0.0 110.037 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -66.66 -48.85 68.07 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.544 -0.722 . . . . 0.0 109.931 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.14 61.45 0.19 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.686 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 83.1 mt -126.18 68.23 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.519 -0.989 . . . . 0.0 110.331 179.657 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.76 52.92 2.42 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.49 -140.28 4.08 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.2 110.52 21.06 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.904 -0.762 . . . . 0.0 109.471 179.53 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.622 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 31.6 m95 -80.23 143.9 33.35 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.125 0.964 . . . . 0.0 112.318 -178.134 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 44' ' ' TRP . 2.7 p -157.48 131.65 8.29 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -107.43 146.03 32.23 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.704 -0.623 . . . . 0.0 109.894 -178.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.487 ' OD1' ' HB3' ' A' ' 49' ' ' ALA . 23.3 t0 -118.36 114.99 23.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.716 -0.615 . . . . 0.0 109.929 179.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -69.31 -24.05 63.88 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.666 -0.646 . . . . 0.0 110.542 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.487 ' HB3' ' OD1' ' A' ' 47' ' ' ASP . . . -52.48 -36.82 55.78 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.37 -0.831 . . . . 0.0 110.832 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.431 HG23 ' C ' ' A' ' 49' ' ' ALA . 77.1 p -147.81 17.71 1.13 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.574 -0.703 . . . . 0.0 110.88 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.46 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.26 93.06 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.221 -0.924 . . . . 0.0 111.01 179.793 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.4 m -157.72 105.27 2.01 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.233 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -64.67 136.56 57.09 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.632 ' HA ' HG22 ' A' ' 7' ' ' ILE . 51.1 m -127.59 100.02 5.82 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.887 -178.506 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.513 HG11 HG21 ' A' ' 40' ' ' ILE . 11.4 p -104.88 166.65 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 108.974 177.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.651 HG23 ' HB3' ' A' ' 9' ' ' ASN . 94.1 m -161.12 112.33 1.79 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.719 -0.613 . . . . 0.0 109.778 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.158 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.562 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 63.3 m . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 121.095 0.474 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 19' ' ' THR . 42.0 m -96.19 94.39 7.48 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.654 -0.654 . . . . 0.0 110.417 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.77 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.4 m-85 -72.14 167.49 20.17 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.528 -0.732 . . . . 0.0 109.966 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.553 ' HG2' HG22 ' A' ' 18' ' ' THR . 12.1 mtmt -132.77 115.82 15.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.544 -0.722 . . . . 0.0 110.317 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.671 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -94.09 111.84 23.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.518 -0.738 . . . . 0.0 110.263 -179.977 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.635 HG22 ' HA ' ' A' ' 54' ' ' THR . 3.8 tp -63.74 171.32 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.074 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.478 HD11 ' OG1' ' A' ' 17' ' ' THR . 74.0 mt -133.23 74.53 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.928 . . . . 0.0 110.678 -179.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.484 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.4 m-80 -95.56 48.0 1.13 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.18 156.81 15.36 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.347 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -74.47 -6.57 49.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.766 -0.844 . . . . 0.0 110.346 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.9 m -92.64 -37.1 12.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 110.133 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.406 ' HB3' HG21 ' A' ' 8' ' ' ILE . 7.3 mt -139.78 176.06 9.06 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.536 -0.728 . . . . 0.0 110.527 -180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.15 138.9 11.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.574 -0.704 . . . . 0.0 110.225 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.26 -136.54 9.04 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -144.46 162.91 35.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.56 -0.965 . . . . 0.0 110.332 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.478 ' OG1' HD11 ' A' ' 8' ' ' ILE . 5.6 m -146.67 130.23 16.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.598 -0.689 . . . . 0.0 110.107 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.553 HG22 ' HG2' ' A' ' 5' ' ' LYS . 66.8 p -112.4 174.88 5.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.628 -0.67 . . . . 0.0 110.323 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.567 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.4 t -166.54 -170.55 1.66 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.573 -0.705 . . . . 0.0 110.246 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -120.95 105.72 10.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.545 -0.722 . . . . 0.0 110.222 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.519 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -136.43 140.81 43.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.557 -0.714 . . . . 0.0 110.138 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.609 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.1 p -61.85 -30.67 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.552 -0.718 . . . . 0.0 109.909 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.609 ' OD1' HG13 ' A' ' 22' ' ' VAL . 48.4 p-10 -168.89 179.11 4.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.67 -0.644 . . . . 0.0 110.142 179.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.421 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.56 -23.01 14.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.489 -0.757 . . . . 0.0 111.137 -179.575 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.426 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.86 -32.1 70.39 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.391 -0.818 . . . . 0.0 110.441 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.519 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 5.4 m -104.05 -26.99 12.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.529 -0.732 . . . . 0.0 110.47 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.77 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.67 -58.17 9.59 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.526 -0.734 . . . . 0.0 110.495 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -58.43 -45.09 89.19 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.483 -0.76 . . . . 0.0 110.521 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -54.4 -41.0 68.75 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.254 -0.903 . . . . 0.0 110.507 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.2 t -81.39 -47.89 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.649 -0.657 . . . . 0.0 110.091 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CZ ' HG22 ' A' ' 19' ' ' THR . 4.5 m-85 -63.84 -32.72 74.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.694 . . . . 0.0 110.212 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -64.93 -42.97 94.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -63.64 -33.54 75.84 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.712 0.767 . . . . 0.0 109.099 178.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -66.06 -57.01 8.68 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.805 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.65 -46.18 91.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.753 -0.592 . . . . 0.0 110.085 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -57.48 -34.85 69.45 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.578 -0.701 . . . . 0.0 110.566 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.19 -48.47 67.83 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.537 -0.727 . . . . 0.0 110.135 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -76.49 -47.26 23.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.58 -0.7 . . . . 0.0 110.041 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.22 69.17 0.19 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.805 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 81.7 mt -127.44 60.82 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.997 . . . . 0.0 110.343 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -82.46 60.72 5.26 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.8 -140.8 10.05 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -178.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -114.04 105.5 13.3 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.922 -0.752 . . . . 0.0 109.039 179.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.671 ' HH2' HD11 ' A' ' 6' ' ' LEU . 55.9 m95 -75.78 143.27 42.05 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.04 0.924 . . . . 0.0 112.209 -178.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 44' ' ' TRP . 4.1 p -153.16 132.08 12.49 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.783 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.412 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 48.7 t80 -99.82 131.62 45.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.744 -0.597 . . . . 0.0 110.18 -178.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.16 119.15 38.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.754 -0.591 . . . . 0.0 109.951 179.746 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.24 -21.32 56.51 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.591 -0.693 . . . . 0.0 110.719 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.424 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.07 -40.39 67.16 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.311 -0.868 . . . . 0.0 110.829 -179.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.424 HG23 ' C ' ' A' ' 49' ' ' ALA . 70.0 p -147.55 19.51 1.18 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.585 -0.697 . . . . 0.0 110.84 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.412 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 0.6 OUTLIER 51.68 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.195 -0.941 . . . . 0.0 111.004 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 5' ' ' LYS . 57.1 m -158.54 108.33 2.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.513 -0.742 . . . . 0.0 110.684 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.503 ' O ' HD23 ' A' ' 6' ' ' LEU . 64.9 m-85 -62.22 127.44 31.36 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.576 -0.703 . . . . 0.0 109.177 179.146 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.635 ' HA ' HG22 ' A' ' 7' ' ' ILE . 58.1 m -120.3 105.39 10.88 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.398 -0.921 . . . . 0.0 112.47 -178.465 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.598 HG11 HG21 ' A' ' 40' ' ' ILE . 11.9 p -109.57 168.14 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.468 -0.77 . . . . 0.0 108.954 177.478 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 9' ' ' ASN . 96.5 m -160.04 109.7 1.81 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.471 -0.768 . . . . 0.0 110.013 -179.511 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.242 -179.941 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.525 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 71.4 m . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.157 0.503 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.5 m -93.54 91.4 7.08 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.623 -0.673 . . . . 0.0 110.576 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.666 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.8 m-85 -69.15 173.49 5.55 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.542 -0.724 . . . . 0.0 109.934 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.47 ' O ' HG23 ' A' ' 52' ' ' THR . 5.3 mtpm? -139.56 110.54 6.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.454 -0.778 . . . . 0.0 110.416 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.6 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -91.28 109.63 20.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.535 -0.728 . . . . 0.0 110.068 179.872 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.661 HG21 HG23 ' A' ' 54' ' ' THR . 2.7 tt -63.06 171.75 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.341 -0.849 . . . . 0.0 108.854 179.315 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.518 HG21 ' HB3' ' A' ' 13' ' ' LEU . 80.1 mt -133.64 71.94 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.438 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.477 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.7 m-20 -95.12 47.7 1.15 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.423 -0.798 . . . . 0.0 109.175 179.125 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.96 160.24 13.52 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.524 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -76.43 -7.36 54.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.653 -0.91 . . . . 0.0 110.461 179.202 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.2 t -98.34 -23.51 15.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.458 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.518 ' HB3' HG21 ' A' ' 8' ' ' ILE . 35.8 mt -147.21 163.62 35.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.321 -0.862 . . . . 0.0 110.495 179.848 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.47 132.68 17.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.64 -0.663 . . . . 0.0 110.146 179.864 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.4 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 133.06 -142.07 13.54 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -145.84 171.59 14.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.537 -0.978 . . . . 0.0 110.239 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 m -147.53 156.6 42.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.632 -0.667 . . . . 0.0 110.158 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.5 p -138.59 155.56 48.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.563 -0.711 . . . . 0.0 110.256 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.723 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.3 t -154.8 160.38 41.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.584 -0.698 . . . . 0.0 110.283 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -90.02 106.72 18.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.599 -0.688 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.05 139.28 45.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.622 -0.674 . . . . 0.0 110.216 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.494 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.2 p -59.21 -34.59 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.547 -0.721 . . . . 0.0 110.1 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.588 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 51.3 p30 -169.3 -178.77 3.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.586 -0.696 . . . . 0.0 110.271 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.416 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.98 -23.0 17.1 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.531 -0.73 . . . . 0.0 111.053 -179.828 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.588 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.06 -26.32 62.35 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.49 -0.756 . . . . 0.0 110.701 -179.672 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.1 m -114.76 -24.85 8.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.422 -0.799 . . . . 0.0 110.691 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.666 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.1 -60.03 4.52 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.402 -0.811 . . . . 0.0 110.415 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -59.42 -37.2 77.43 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.542 -0.724 . . . . 0.0 110.401 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -56.72 -44.73 81.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.423 -0.798 . . . . 0.0 110.578 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.0 t -80.13 -43.34 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.52 -0.737 . . . . 0.0 109.96 179.732 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.723 ' CZ ' HG22 ' A' ' 19' ' ' THR . 10.3 m-85 -65.52 -35.2 80.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.554 -0.717 . . . . 0.0 110.329 -179.727 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -63.64 -45.48 90.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 108.991 179.286 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -63.43 -32.84 74.39 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.69 0.757 . . . . 0.0 109.136 178.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -66.48 -56.58 10.22 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.783 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -59.56 -45.87 90.58 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.695 -0.628 . . . . 0.0 110.15 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -58.51 -32.49 68.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.57 -0.706 . . . . 0.0 110.328 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -60.94 -59.93 4.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.599 -0.688 . . . . 0.0 109.968 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.428 ' ND2' HD11 ' A' ' 13' ' ' LEU . 72.3 m-80 -72.5 -45.98 56.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.624 -0.673 . . . . 0.0 109.828 179.66 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.36 72.89 0.23 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.725 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.783 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.4 mt -122.9 62.06 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.482 -1.011 . . . . 0.0 110.004 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.78 61.12 5.0 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.72 -140.76 9.98 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -178.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -116.62 104.53 11.48 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.877 -0.778 . . . . 0.0 109.038 179.563 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.6 ' HH2' HD11 ' A' ' 6' ' ' LEU . 53.6 m95 -73.98 143.94 45.41 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 122.084 0.945 . . . . 0.0 112.248 -178.112 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 44' ' ' TRP . 2.0 p -153.84 132.13 11.95 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.75 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.406 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 26.4 t80 -103.74 139.08 39.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.618 -0.676 . . . . 0.0 110.186 -178.721 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -113.34 122.05 46.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.718 -0.613 . . . . 0.0 109.843 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -75.89 -19.5 58.78 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.732 -0.605 . . . . 0.0 110.778 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.444 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.37 -39.18 66.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.24 -0.913 . . . . 0.0 110.774 -179.718 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.444 HG23 ' C ' ' A' ' 49' ' ' ALA . 74.4 p -148.18 18.56 1.09 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.561 -0.712 . . . . 0.0 110.752 -179.985 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.3 94.97 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.23 -0.919 . . . . 0.0 110.927 179.977 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 5' ' ' LYS . 70.2 m -156.22 108.78 2.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.472 -0.767 . . . . 0.0 111.015 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.463 ' O ' HD23 ' A' ' 6' ' ' LEU . 77.1 m-85 -65.17 127.58 32.28 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.59 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.661 HG23 HG21 ' A' ' 7' ' ' ILE . 45.7 m -120.23 102.87 8.79 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.753 -178.214 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.587 HG11 HG21 ' A' ' 40' ' ' ILE . 10.6 p -105.72 167.33 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.374 -0.829 . . . . 0.0 108.99 177.372 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.477 HG23 ' HB3' ' A' ' 9' ' ' ASN . 99.4 m -160.35 111.07 1.85 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.555 -0.716 . . . . 0.0 110.097 -179.603 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.169 179.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.495 HG22 ' CE2' ' A' ' 4' ' ' PHE . 92.6 m . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.14 0.495 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.5 m -92.95 108.53 20.07 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.618 -0.676 . . . . 0.0 110.437 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.792 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 73.7 m-85 -88.47 174.12 8.3 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.587 -0.696 . . . . 0.0 110.098 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.443 ' HB3' HG23 ' A' ' 52' ' ' THR . 0.4 OUTLIER -142.68 112.97 7.18 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 110.406 179.937 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.591 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -96.09 112.62 24.3 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.496 -0.753 . . . . 0.0 109.941 179.731 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.657 HG21 HG23 ' A' ' 54' ' ' THR . 2.4 tt -65.37 172.58 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.977 179.338 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.479 HG21 ' HB3' ' A' ' 13' ' ' LEU . 77.6 mt -133.98 72.33 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.384 -0.822 . . . . 0.0 110.383 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -95.23 47.17 1.13 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.439 -0.788 . . . . 0.0 109.272 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.32 160.7 13.38 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -77.64 -2.72 37.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.734 -0.862 . . . . 0.0 110.495 179.309 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -101.45 -30.44 11.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.969 . . . . 0.0 109.951 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.479 ' HB3' HG21 ' A' ' 8' ' ' ILE . 60.4 mt -140.01 165.9 26.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.482 -0.761 . . . . 0.0 110.508 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -151.11 132.41 14.54 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.643 -0.661 . . . . 0.0 110.218 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 131.84 -133.44 7.17 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -162.52 160.36 25.97 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.547 -0.972 . . . . 0.0 110.428 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.2 m -140.79 143.13 34.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.572 -0.705 . . . . 0.0 110.069 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.5 p -122.84 150.16 43.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.505 -0.747 . . . . 0.0 110.403 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.705 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.8 t -143.54 -172.09 3.65 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.647 -0.658 . . . . 0.0 110.247 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -114.34 107.73 15.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.59 -0.694 . . . . 0.0 110.146 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -132.63 147.8 52.35 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.586 -0.696 . . . . 0.0 110.096 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.6 p -65.7 -31.69 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.542 -0.724 . . . . 0.0 109.57 179.482 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -173.07 -174.94 1.12 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.587 -0.696 . . . . 0.0 109.952 179.574 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.457 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.27 -24.77 12.33 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.456 -0.777 . . . . 0.0 111.162 -179.458 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.59 78.14 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.497 -0.752 . . . . 0.0 110.377 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.589 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 5.1 m -100.78 -28.18 12.95 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.56 -0.712 . . . . 0.0 110.431 -179.88 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.792 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -61.42 -61.89 2.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.476 -0.765 . . . . 0.0 110.294 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -60.52 -37.28 80.66 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.596 -0.69 . . . . 0.0 110.25 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -57.6 -43.62 84.84 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.424 -0.798 . . . . 0.0 110.391 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.26 -45.81 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.585 -0.697 . . . . 0.0 109.819 179.691 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.705 ' CZ ' HG22 ' A' ' 19' ' ' THR . 11.5 m-85 -64.01 -33.21 75.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.573 -0.704 . . . . 0.0 110.283 -179.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -64.57 -45.09 88.51 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.132 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -63.02 -33.61 75.8 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.697 0.761 . . . . 0.0 109.18 178.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -64.5 -54.98 23.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.751 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.806 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.27 -44.27 96.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.784 -0.573 . . . . 0.0 110.023 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -57.92 -35.79 71.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.556 -0.715 . . . . 0.0 110.484 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.47 -43.35 99.02 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.624 -0.672 . . . . 0.0 110.023 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.423 ' CG ' HD11 ' A' ' 13' ' ' LEU . 71.2 m-80 -84.31 -42.46 15.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.625 -0.672 . . . . 0.0 109.922 179.814 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.51 47.47 0.41 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.722 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.806 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 79.6 mt -96.91 63.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.463 -1.022 . . . . 0.0 110.168 179.798 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.4 59.56 4.64 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.89 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.53 -139.71 8.1 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.046 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -118.59 103.09 9.39 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.307 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.591 ' CH2' HD11 ' A' ' 6' ' ' LEU . 53.1 m95 -71.62 142.73 49.95 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.065 0.936 . . . . 0.0 112.266 -177.854 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p -150.26 131.62 14.64 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -108.97 123.56 49.3 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.719 -0.613 . . . . 0.0 110.099 -178.606 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -100.93 119.05 38.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.708 -0.62 . . . . 0.0 109.834 179.599 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.36 -19.41 62.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.672 -0.643 . . . . 0.0 110.812 -179.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.427 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.12 -37.69 55.02 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.214 -0.929 . . . . 0.0 110.877 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.427 HG23 ' C ' ' A' ' 49' ' ' ALA . 75.7 p -147.06 17.37 1.22 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.628 -0.67 . . . . 0.0 110.754 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.87 86.67 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.18 -0.95 . . . . 0.0 110.948 179.817 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.443 HG23 ' HB3' ' A' ' 5' ' ' LYS . 86.6 m -151.51 105.7 3.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.483 -0.761 . . . . 0.0 110.766 -179.875 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.442 ' O ' HD23 ' A' ' 6' ' ' LEU . 97.6 m-85 -62.06 129.14 39.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.462 -0.774 . . . . 0.0 108.971 178.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.657 HG23 HG21 ' A' ' 7' ' ' ILE . 57.5 m -121.92 102.13 7.99 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.451 -178.668 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.624 HG11 HG21 ' A' ' 40' ' ' ILE . 10.2 p -103.16 167.46 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.381 -0.824 . . . . 0.0 109.319 177.744 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.459 ' N ' HG22 ' A' ' 55' ' ' VAL . 99.7 m -159.99 110.33 1.87 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.598 -0.689 . . . . 0.0 110.159 -179.474 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.068 179.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.564 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 67.5 m . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.115 0.483 . . . . 0.0 110.259 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.5 m -80.87 101.97 9.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.611 -0.681 . . . . 0.0 110.573 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.705 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 74.9 m-85 -88.2 166.95 14.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.545 -0.722 . . . . 0.0 109.813 179.652 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -134.02 118.56 17.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.416 -0.803 . . . . 0.0 110.414 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.586 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -99.21 112.87 24.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.51 -0.744 . . . . 0.0 110.384 -179.926 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.609 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.5 tp -66.08 167.31 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.07 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.486 HD12 ' C ' ' A' ' 15' ' ' GLY . 73.6 mt -129.0 72.8 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.33 -0.856 . . . . 0.0 110.459 -179.849 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.548 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.2 m-80 -95.87 47.82 1.11 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.264 -0.898 . . . . 0.0 108.999 179.014 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.67 166.43 16.92 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -86.04 6.89 26.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.75 -0.853 . . . . 0.0 110.375 179.066 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -113.95 -30.85 6.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.915 . . . . 0.0 110.067 179.891 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.3 169.67 17.15 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.435 -0.791 . . . . 0.0 110.507 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -153.1 143.41 22.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.608 -0.682 . . . . 0.0 110.258 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.486 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 132.64 -140.73 12.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -153.67 155.91 36.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.631 -0.923 . . . . 0.0 110.209 -179.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.474 ' C ' HG23 ' A' ' 18' ' ' THR . 7.9 m -134.94 169.5 17.31 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.6 -0.687 . . . . 0.0 110.281 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.474 HG23 ' C ' ' A' ' 17' ' ' THR . 41.5 p -151.66 150.17 29.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.613 -0.679 . . . . 0.0 110.133 179.929 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.893 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.3 t -156.36 142.86 18.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.593 -0.692 . . . . 0.0 110.236 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -67.07 124.18 22.33 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.585 -0.697 . . . . 0.0 110.24 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.01 140.58 25.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.524 -0.735 . . . . 0.0 110.208 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.454 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.2 p -58.54 -35.24 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.548 -0.72 . . . . 0.0 110.14 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.62 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 35.7 p30 -171.24 -170.79 0.87 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.564 -0.71 . . . . 0.0 110.159 179.546 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.436 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.68 -25.54 54.18 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.507 -0.746 . . . . 0.0 110.844 -179.812 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.62 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.64 -51.88 67.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.464 -0.773 . . . . 0.0 110.429 -179.778 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.8 m -84.56 -27.6 27.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.477 -0.764 . . . . 0.0 110.338 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.705 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -61.39 -59.34 5.42 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.592 -0.692 . . . . 0.0 110.245 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -61.81 -32.63 72.95 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.569 -0.707 . . . . 0.0 110.268 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -57.87 -45.84 85.76 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.42 -0.8 . . . . 0.0 110.445 -179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.0 t -79.54 -42.57 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.61 -0.681 . . . . 0.0 109.879 179.716 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.893 ' CZ ' HG22 ' A' ' 19' ' ' THR . 12.5 m-85 -65.9 -33.85 76.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.631 -0.668 . . . . 0.0 110.182 -179.808 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -64.04 -47.39 80.38 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.305 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -63.64 -33.28 75.28 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.672 0.748 . . . . 0.0 109.081 178.789 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -64.32 -54.51 31.93 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.772 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.12 -40.17 95.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.825 -0.547 . . . . 0.0 110.014 179.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -58.95 -37.29 76.41 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.532 -0.73 . . . . 0.0 110.488 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -64.19 -40.03 95.23 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.55 -0.719 . . . . 0.0 110.265 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -86.38 -29.03 23.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.543 -0.723 . . . . 0.0 110.15 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.74 49.68 1.36 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.772 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.8 mt -103.4 62.7 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.603 -0.939 . . . . 0.0 110.286 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -85.12 58.57 5.11 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.795 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.99 -138.97 6.22 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 -178.848 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -116.74 102.94 9.85 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.497 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.586 ' CH2' HD11 ' A' ' 6' ' ' LEU . 53.0 m95 -72.79 141.39 48.07 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.101 0.953 . . . . 0.0 112.401 -177.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.4 132.45 19.27 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.299 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.412 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 53.9 t80 -105.53 113.24 26.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.635 -0.666 . . . . 0.0 110.128 -178.485 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.87 104.12 14.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.702 -0.624 . . . . 0.0 109.826 179.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -65.04 -24.83 67.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.676 -0.64 . . . . 0.0 110.553 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.95 -34.81 60.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.414 -0.804 . . . . 0.0 110.787 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.1 p -144.9 15.66 1.56 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.621 -0.674 . . . . 0.0 110.982 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.438 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 50.3 90.34 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.129 -0.982 . . . . 0.0 111.097 179.81 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.7 m -154.89 107.15 2.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.538 -0.726 . . . . 0.0 110.853 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.456 ' O ' HD23 ' A' ' 6' ' ' LEU . 82.6 m-85 -62.08 125.4 23.75 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.483 -0.761 . . . . 0.0 109.041 178.858 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.609 ' HA ' HG22 ' A' ' 7' ' ' ILE . 60.5 m -120.27 100.01 6.92 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.251 -0.98 . . . . 0.0 112.54 -178.618 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.553 HG11 HG21 ' A' ' 40' ' ' ILE . 10.8 p -103.7 167.28 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.39 -0.819 . . . . 0.0 109.212 177.597 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.548 HG23 ' HB3' ' A' ' 9' ' ' ASN . 99.2 m -160.65 109.89 1.69 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.667 -0.646 . . . . 0.0 109.762 -179.785 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.249 -179.922 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.459 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 89.2 m . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.1 0.476 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 3' ' ' THR . 8.1 t -80.99 105.86 12.55 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.634 -0.666 . . . . 0.0 110.503 -179.854 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.708 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 60.4 m-85 -90.37 164.42 14.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.447 -0.783 . . . . 0.0 109.966 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.459 ' CB ' HG23 ' A' ' 52' ' ' THR . 18.1 mttm -130.38 122.29 27.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.461 -0.775 . . . . 0.0 110.569 179.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.561 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -105.5 110.55 22.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.527 -0.733 . . . . 0.0 109.939 179.81 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.606 HG22 ' HA ' ' A' ' 54' ' ' THR . 2.6 tp -62.74 166.9 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.353 -0.842 . . . . 0.0 109.007 179.482 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.46 HG21 ' HB3' ' A' ' 13' ' ' LEU . 79.8 mt -130.8 72.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.303 -0.873 . . . . 0.0 110.489 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.507 ' HB3' HG23 ' A' ' 56' ' ' THR . 34.6 m-20 -97.12 49.58 1.06 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.449 -0.782 . . . . 0.0 109.257 179.197 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.71 163.25 12.49 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -78.18 -2.05 35.7 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.646 -0.914 . . . . 0.0 110.874 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.778 ' HB ' HD12 ' A' ' 13' ' ' LEU . 19.5 m -107.34 -28.03 10.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.232 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.778 HD12 ' HB ' ' A' ' 12' ' ' THR . 4.3 mp -135.13 164.8 26.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.521 -0.737 . . . . 0.0 110.303 179.749 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -154.71 126.78 7.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.571 -0.706 . . . . 0.0 110.313 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.07 -140.01 11.33 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -144.85 171.77 13.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.637 -0.92 . . . . 0.0 110.376 -179.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.485 HG23 ' CE1' ' A' ' 31' ' ' PHE . 7.0 t -154.98 157.79 38.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.628 -0.67 . . . . 0.0 109.976 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.9 p -140.42 149.43 42.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.546 -0.721 . . . . 0.0 110.513 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.843 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.5 t -146.35 162.15 38.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.626 -0.671 . . . . 0.0 109.994 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -88.22 107.16 18.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.567 -0.708 . . . . 0.0 110.281 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.96 138.56 50.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.611 -0.681 . . . . 0.0 110.1 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.68 -31.81 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.614 -0.679 . . . . 0.0 110.248 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.515 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 14.7 p30 -171.32 179.99 2.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.504 -0.747 . . . . 0.0 110.377 179.856 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.45 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.79 -31.47 64.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.489 -0.757 . . . . 0.0 110.78 -179.573 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.515 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -60.27 -28.47 68.09 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.536 -0.727 . . . . 0.0 110.266 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.3 m -108.14 -27.99 9.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.58 -0.7 . . . . 0.0 110.304 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.708 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.2 -54.95 39.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.508 -0.745 . . . . 0.0 110.236 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -60.06 -31.82 70.36 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.573 -0.705 . . . . 0.0 110.239 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -58.26 -40.62 82.29 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.342 -0.849 . . . . 0.0 110.35 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.0 t -82.19 -44.93 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.585 -0.697 . . . . 0.0 109.851 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.843 ' CZ ' HG22 ' A' ' 19' ' ' THR . 9.1 m-85 -65.85 -37.84 87.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.65 -0.656 . . . . 0.0 110.229 -179.808 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -62.07 -46.05 90.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.465 -0.772 . . . . 0.0 109.387 179.665 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -62.47 -34.24 76.44 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.782 0.801 . . . . 0.0 109.339 179.083 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.64 -49.36 68.96 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.749 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -73.25 -45.15 57.53 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.769 -0.582 . . . . 0.0 110.444 -179.758 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -56.26 -39.84 73.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.423 -0.798 . . . . 0.0 110.617 -179.715 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -75.13 -31.54 61.11 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.606 -0.684 . . . . 0.0 110.11 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -80.14 -40.89 26.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.546 -0.721 . . . . 0.0 110.006 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.43 37.15 0.94 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.749 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.7 mt -103.64 62.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.528 -0.984 . . . . 0.0 110.174 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -85.67 57.35 4.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.51 -0.744 . . . . 0.0 109.008 178.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.47 -138.69 5.23 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -178.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -116.3 105.14 12.21 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.43 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.561 ' HH2' HD11 ' A' ' 6' ' ' LEU . 52.8 m95 -74.63 142.22 44.59 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.182 0.992 . . . . 0.0 112.459 -177.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.05 132.59 17.72 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.452 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -106.48 111.74 24.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.646 -0.659 . . . . 0.0 110.262 -178.357 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.16 112.02 20.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.694 -0.629 . . . . 0.0 109.778 179.662 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -70.32 -21.78 62.88 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.639 -0.663 . . . . 0.0 110.663 -179.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.454 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.94 -35.24 58.41 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.311 -0.868 . . . . 0.0 110.955 -179.784 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.454 HG23 ' C ' ' A' ' 49' ' ' ALA . 70.9 p -148.16 18.41 1.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.537 -0.727 . . . . 0.0 110.932 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.72 93.14 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.182 -0.949 . . . . 0.0 110.989 179.713 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.459 HG23 ' CB ' ' A' ' 5' ' ' LYS . 62.4 m -158.66 104.68 1.79 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.454 -0.779 . . . . 0.0 110.886 -179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.485 ' O ' HD23 ' A' ' 6' ' ' LEU . 98.7 m-85 -61.05 128.52 36.82 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.423 -0.798 . . . . 0.0 109.149 179.014 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.606 ' HA ' HG22 ' A' ' 7' ' ' ILE . 85.0 m -120.7 101.21 7.58 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.522 -178.404 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.568 HG11 HG21 ' A' ' 40' ' ' ILE . 9.5 p -103.9 166.87 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.863 . . . . 0.0 109.309 177.599 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 9' ' ' ASN . 95.0 m -160.72 110.02 1.68 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.62 -0.675 . . . . 0.0 109.835 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.19 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.513 HG22 ' CE2' ' A' ' 4' ' ' PHE . 55.0 m . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.127 0.489 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 19' ' ' THR . 6.6 m -106.66 96.1 6.21 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.585 -0.697 . . . . 0.0 110.624 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.737 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 92.1 m-85 -73.59 -178.85 3.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.538 -0.726 . . . . 0.0 109.838 179.606 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -146.74 110.75 5.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.49 -0.756 . . . . 0.0 110.289 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.66 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -92.27 110.67 22.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.502 -0.749 . . . . 0.0 110.364 -179.771 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.655 HG21 HG23 ' A' ' 54' ' ' THR . 3.4 tp -64.22 170.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.286 -0.884 . . . . 0.0 108.653 178.997 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.511 HD11 ' OG1' ' A' ' 17' ' ' THR . 78.0 mt -131.53 74.2 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.245 -0.909 . . . . 0.0 110.722 -179.655 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.429 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.5 m-20 -96.07 47.13 1.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.458 -0.776 . . . . 0.0 109.052 179.022 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.1 161.9 13.29 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.602 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -79.74 -0.53 34.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.771 -0.84 . . . . 0.0 110.587 179.315 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -104.79 -30.82 9.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.981 . . . . 0.0 109.928 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.473 ' HB3' HG21 ' A' ' 8' ' ' ILE . 54.8 mt -138.54 166.02 25.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.635 -0.666 . . . . 0.0 110.363 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -154.63 132.81 11.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.573 -0.704 . . . . 0.0 110.202 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.89 -147.29 19.12 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -144.88 122.25 11.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.555 -0.967 . . . . 0.0 110.368 179.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.511 ' OG1' HD11 ' A' ' 8' ' ' ILE . 62.5 m -109.67 149.81 29.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.631 -0.668 . . . . 0.0 110.253 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.8 p -131.94 162.41 30.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.56 -0.712 . . . . 0.0 110.164 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.628 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.6 t -142.93 -172.55 3.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.561 -0.712 . . . . 0.0 110.328 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -123.53 89.36 3.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.614 -0.679 . . . . 0.0 110.153 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -116.19 -177.25 3.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.585 -0.697 . . . . 0.0 109.982 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.17 -24.88 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.728 . . . . 0.0 110.326 179.822 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -168.11 175.56 6.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.452 -0.78 . . . . 0.0 110.156 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.407 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -57.88 -25.14 60.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.516 -0.74 . . . . 0.0 110.744 -179.772 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.7 -27.96 66.89 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.472 -0.767 . . . . 0.0 110.502 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.4 m -109.27 -27.23 9.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.551 -0.718 . . . . 0.0 110.417 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.737 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -62.0 -62.96 1.42 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.505 -0.747 . . . . 0.0 110.407 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -58.17 -41.65 84.33 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.519 -0.738 . . . . 0.0 110.528 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.6 tttm -55.68 -42.49 75.24 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.362 -0.836 . . . . 0.0 110.314 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.2 t -80.27 -48.13 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.674 . . . . 0.0 109.934 179.545 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.628 ' CZ ' HG22 ' A' ' 19' ' ' THR . 5.4 m-85 -62.05 -33.75 74.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.585 -0.697 . . . . 0.0 110.22 -179.676 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -63.7 -43.84 95.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.425 -0.797 . . . . 0.0 108.924 179.19 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -62.71 -33.5 75.23 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.728 0.775 . . . . 0.0 109.298 178.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -67.26 -56.48 9.63 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.758 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.56 -41.44 94.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.736 -0.602 . . . . 0.0 110.302 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -58.11 -36.93 73.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.51 -0.744 . . . . 0.0 110.605 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.38 -42.4 68.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.545 -0.722 . . . . 0.0 110.18 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -77.77 -28.93 50.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.573 -0.705 . . . . 0.0 110.215 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.88 55.06 0.95 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.876 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.758 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.0 mt -115.44 59.7 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.485 -1.009 . . . . 0.0 110.353 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.15 60.77 5.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.658 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.05 -138.93 7.97 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -178.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -115.4 103.57 10.91 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.948 -0.736 . . . . 0.0 109.28 179.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.66 ' HH2' HD11 ' A' ' 6' ' ' LEU . 55.6 m95 -73.92 143.38 45.77 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.146 0.974 . . . . 0.0 112.497 -177.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -151.22 133.31 15.21 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 178.656 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -104.0 139.17 39.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.593 -0.692 . . . . 0.0 110.313 -178.41 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -112.74 113.57 25.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.687 -0.633 . . . . 0.0 109.976 179.794 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -69.68 -21.37 63.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.701 -0.624 . . . . 0.0 110.847 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.44 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.6 -40.48 65.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.293 -0.879 . . . . 0.0 110.814 -179.592 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.44 HG23 ' C ' ' A' ' 49' ' ' ALA . 66.5 p -148.84 20.28 1.01 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.555 -0.716 . . . . 0.0 110.597 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.45 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER 52.1 93.46 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.174 -0.954 . . . . 0.0 110.63 179.948 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.6 m -151.41 103.17 2.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.497 -0.752 . . . . 0.0 111.112 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.518 ' O ' HD23 ' A' ' 6' ' ' LEU . 78.2 m-85 -63.44 123.41 18.68 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.451 -0.781 . . . . 0.0 109.018 178.786 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.655 HG23 HG21 ' A' ' 7' ' ' ILE . 62.9 m -116.92 103.78 10.63 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.323 -0.951 . . . . 0.0 112.619 -178.349 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.567 HG11 HG21 ' A' ' 40' ' ' ILE . 11.4 p -106.02 168.27 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.409 -0.807 . . . . 0.0 109.002 177.396 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.461 ' N ' HG22 ' A' ' 55' ' ' VAL . 99.7 m -160.2 108.9 1.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.543 -0.723 . . . . 0.0 110.028 -179.558 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.168 179.884 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.565 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 79.1 m . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.086 0.47 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 3' ' ' THR . 8.1 t -89.44 99.39 12.4 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.65 -0.656 . . . . 0.0 110.585 -179.844 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.715 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 90.6 m-85 -80.68 176.56 9.69 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.364 -0.835 . . . . 0.0 110.005 179.885 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.52 ' HB3' HG23 ' A' ' 52' ' ' THR . 16.8 mttt -141.95 110.46 6.07 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.428 -0.795 . . . . 0.0 110.272 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.607 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -93.62 111.54 23.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.489 -0.757 . . . . 0.0 110.467 -179.92 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.635 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.5 tp -64.18 170.29 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.948 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.498 HD11 ' OG1' ' A' ' 17' ' ' THR . 77.8 mt -132.43 74.72 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.772 -179.788 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.434 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.5 m-20 -95.72 49.33 1.16 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.811 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.43 160.75 13.17 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.327 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -80.6 -0.16 36.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.769 -0.842 . . . . 0.0 110.47 179.015 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -102.14 -31.81 10.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.134 -0.979 . . . . 0.0 109.951 179.855 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -144.9 170.49 16.04 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.508 -0.745 . . . . 0.0 110.401 -179.978 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -154.12 142.77 20.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.618 -0.676 . . . . 0.0 110.374 -179.793 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.432 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 127.55 -164.34 21.02 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.963 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -119.88 145.31 46.8 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.551 -0.97 . . . . 0.0 110.315 -179.955 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.498 ' OG1' HD11 ' A' ' 8' ' ' ILE . 7.0 m -121.75 146.2 47.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.586 -0.696 . . . . 0.0 110.225 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.9 p -130.08 166.94 19.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.57 -0.706 . . . . 0.0 110.179 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.629 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.4 t -167.01 -179.5 4.69 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.568 -0.708 . . . . 0.0 110.3 -179.921 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -112.55 101.18 9.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.546 -0.721 . . . . 0.0 110.209 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.48 146.21 50.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.589 -0.694 . . . . 0.0 110.219 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.1 p -70.17 -26.28 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.546 -0.721 . . . . 0.0 110.186 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.721 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 8.1 p30 -170.37 177.94 3.92 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.412 -0.805 . . . . 0.0 110.465 179.734 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.13 -25.84 47.71 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.578 -0.701 . . . . 0.0 111.139 -179.425 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.721 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.11 -39.26 81.72 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.372 -0.83 . . . . 0.0 110.334 -179.776 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.6 m -94.41 -29.63 14.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.594 -0.691 . . . . 0.0 110.087 179.914 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.715 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -61.02 -55.91 27.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.595 -0.69 . . . . 0.0 110.226 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -61.97 -37.32 84.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.568 -0.708 . . . . 0.0 110.3 -179.949 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -58.36 -41.9 85.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.379 -0.825 . . . . 0.0 110.387 -179.958 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.8 t -81.37 -44.21 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.558 -0.714 . . . . 0.0 109.813 179.666 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.629 ' CZ ' HG22 ' A' ' 19' ' ' THR . 11.2 m-85 -65.75 -36.46 83.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.602 -0.686 . . . . 0.0 110.192 -179.861 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -63.13 -45.17 93.23 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.469 -0.769 . . . . 0.0 109.15 179.366 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -63.25 -31.06 72.12 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.657 0.742 . . . . 0.0 109.27 178.713 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -69.67 -51.06 38.06 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.866 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.789 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -69.31 -41.27 76.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.627 -0.671 . . . . 0.0 110.002 179.9 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -58.49 -44.53 89.43 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.746 . . . . 0.0 110.423 -179.977 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.74 -46.21 83.18 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.59 -0.694 . . . . 0.0 110.204 -179.952 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -70.84 -50.19 38.01 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.535 -0.728 . . . . 0.0 110.07 179.941 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.61 58.08 0.19 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.789 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 82.2 mt -116.05 59.82 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.548 -0.971 . . . . 0.0 110.234 179.826 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.97 62.89 3.51 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.872 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.18 -141.99 12.84 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -178.813 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -114.73 111.47 21.31 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.944 -0.739 . . . . 0.0 109.039 179.152 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.607 ' HH2' HD11 ' A' ' 6' ' ' LEU . 52.8 m95 -80.39 143.22 33.66 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.038 0.923 . . . . 0.0 112.264 -177.887 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 p -152.17 133.62 14.54 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 178.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -104.09 139.98 38.41 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.194 -178.636 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -109.54 108.9 19.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.65 -0.656 . . . . 0.0 109.938 179.724 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -67.62 -21.08 65.41 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.707 -0.621 . . . . 0.0 110.759 -179.866 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.422 ' C ' HG23 ' A' ' 50' ' ' THR . . . -55.15 -41.79 72.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.29 -0.881 . . . . 0.0 110.747 -179.726 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.422 HG23 ' C ' ' A' ' 49' ' ' ALA . 67.2 p -146.84 21.75 1.26 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.6 -0.688 . . . . 0.0 110.617 -179.932 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.451 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.31 95.32 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.235 -0.916 . . . . 0.0 110.753 179.804 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.52 HG23 ' HB3' ' A' ' 5' ' ' LYS . 26.8 m -154.81 102.75 2.38 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.213 -179.841 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.436 ' O ' HD23 ' A' ' 6' ' ' LEU . 71.4 m-85 -63.81 128.9 37.86 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.708 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.635 ' HA ' HG22 ' A' ' 7' ' ' ILE . 61.1 m -122.65 106.76 11.24 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.588 -178.583 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.611 HG11 HG21 ' A' ' 40' ' ' ILE . 11.0 p -110.69 167.35 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.436 -0.79 . . . . 0.0 109.143 177.481 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.467 ' N ' HG22 ' A' ' 55' ' ' VAL . 78.7 m -161.39 111.42 1.65 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.642 -0.661 . . . . 0.0 109.83 -179.791 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.137 179.903 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.566 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 68.5 m . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.091 0.472 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.4 m -84.43 94.31 8.49 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.606 -0.684 . . . . 0.0 110.698 -179.679 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.798 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.7 m-85 -77.47 177.86 7.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.521 -0.737 . . . . 0.0 109.736 179.518 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.479 ' HB3' HG23 ' A' ' 52' ' ' THR . 8.3 ttmm -142.93 112.11 6.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.417 -0.802 . . . . 0.0 110.608 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.656 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -94.14 116.84 29.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.523 -0.736 . . . . 0.0 110.378 179.95 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.696 HG21 HG23 ' A' ' 54' ' ' THR . 2.7 tt -70.79 173.38 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.457 -0.777 . . . . 0.0 109.023 179.287 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.413 ' HB ' ' N ' ' A' ' 15' ' ' GLY . 83.0 mt -132.63 75.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.835 . . . . 0.0 110.161 179.903 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.01 45.2 1.04 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.526 -0.734 . . . . 0.0 109.204 179.379 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.04 158.92 15.89 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.74 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -76.7 -3.61 38.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.705 -0.879 . . . . 0.0 110.598 179.358 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 m -101.84 -33.1 9.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 110.217 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.609 HD11 ' CG ' ' A' ' 38' ' ' ASN . 73.0 mt -132.7 175.29 9.46 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.497 -0.752 . . . . 0.0 110.483 179.932 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -159.69 133.46 7.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.651 -0.656 . . . . 0.0 110.125 -179.866 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.413 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 132.46 -145.9 17.71 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.826 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -135.97 175.52 9.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.529 -0.983 . . . . 0.0 110.321 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.9 m -150.73 134.42 16.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.527 -0.733 . . . . 0.0 110.262 179.899 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.3 p -121.56 161.82 21.69 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.537 -0.727 . . . . 0.0 110.335 -179.968 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.752 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 9.1 t -165.66 -179.52 5.43 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.56 -0.712 . . . . 0.0 110.272 179.921 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.42 119.58 39.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.607 -0.683 . . . . 0.0 110.061 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.471 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -147.07 139.03 24.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.585 -0.697 . . . . 0.0 110.142 -179.892 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.0 m -57.98 -33.71 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.474 -0.766 . . . . 0.0 110.598 -179.932 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.708 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 15.4 p30 -170.35 -174.21 1.64 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.519 -0.738 . . . . 0.0 110.33 179.84 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.46 -27.15 56.12 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.523 -0.735 . . . . 0.0 110.739 -179.755 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.708 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.74 -26.46 65.67 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.474 -0.766 . . . . 0.0 110.32 179.861 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.471 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 50.2 m -110.0 -27.38 9.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.539 -0.725 . . . . 0.0 110.249 179.908 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.798 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.55 -60.68 3.45 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.624 -0.672 . . . . 0.0 110.361 -179.917 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -59.93 -36.15 76.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.555 -0.716 . . . . 0.0 110.158 -179.985 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -57.66 -45.23 85.81 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.461 -0.774 . . . . 0.0 110.49 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.03 -43.91 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.561 -0.712 . . . . 0.0 110.134 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.752 ' CZ ' HG22 ' A' ' 19' ' ' THR . 8.0 m-85 -66.77 -34.06 76.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.583 -0.698 . . . . 0.0 110.291 -179.679 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -63.95 -40.57 96.73 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.393 -0.817 . . . . 0.0 108.897 179.212 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -63.35 -33.92 76.58 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.733 0.777 . . . . 0.0 109.239 179.003 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.68 -59.31 3.7 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.735 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.794 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -59.85 -46.78 88.2 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.752 -0.592 . . . . 0.0 110.275 179.894 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -55.95 -27.96 54.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.524 -0.735 . . . . 0.0 110.712 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.89 -52.56 49.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.577 -0.702 . . . . 0.0 109.973 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.609 ' CG ' HD11 ' A' ' 13' ' ' LEU . 43.0 m-80 -78.13 -45.0 24.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.596 -0.69 . . . . 0.0 109.994 179.856 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.47 53.16 0.18 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.769 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.794 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.1 mt -103.13 63.03 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.514 -0.992 . . . . 0.0 110.052 179.63 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.92 56.35 3.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.414 -0.804 . . . . 0.0 108.907 178.879 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.56 -137.31 3.66 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.123 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -116.03 101.16 8.5 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.403 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.656 ' CH2' HD11 ' A' ' 6' ' ' LEU . 49.9 m95 -71.77 142.52 49.71 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.998 0.904 . . . . 0.0 111.846 -178.197 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 p -151.24 132.19 14.24 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.939 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.401 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 13.3 t80 -103.17 139.35 38.77 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.679 -0.638 . . . . 0.0 110.108 -178.701 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.25 104.76 13.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.775 -0.578 . . . . 0.0 109.511 179.432 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -63.2 -20.87 65.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.676 -0.64 . . . . 0.0 110.798 -179.568 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.445 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.26 -40.05 67.44 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.287 -0.883 . . . . 0.0 110.703 -179.765 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.445 HG23 ' C ' ' A' ' 49' ' ' ALA . 68.0 p -148.14 21.84 1.09 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.621 -0.674 . . . . 0.0 110.516 179.998 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.445 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.56 91.36 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.198 -0.939 . . . . 0.0 110.743 179.976 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.479 HG23 ' HB3' ' A' ' 5' ' ' LYS . 20.4 m -150.23 98.54 2.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.462 -0.774 . . . . 0.0 111.23 -179.807 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.456 ' O ' HD23 ' A' ' 6' ' ' LEU . 66.3 m-85 -61.81 127.8 33.17 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.391 -0.818 . . . . 0.0 108.959 178.656 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.696 HG23 HG21 ' A' ' 7' ' ' ILE . 91.7 m -123.67 107.63 11.69 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.451 -178.499 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.545 HG21 HG22 ' A' ' 40' ' ' ILE . 11.6 p -107.96 167.4 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.358 -0.839 . . . . 0.0 108.917 177.401 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.462 ' N ' HG22 ' A' ' 55' ' ' VAL . 99.2 m -160.7 111.01 1.77 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.636 -0.665 . . . . 0.0 109.984 -179.703 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.102 179.811 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.552 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 86.6 m . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.173 0.511 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 3' ' ' THR . 7.2 t -82.36 99.94 9.68 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.628 -0.67 . . . . 0.0 110.503 -179.95 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.647 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 89.6 m-85 -84.76 170.52 13.15 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.351 -0.843 . . . . 0.0 109.771 179.696 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.519 ' HB3' HG23 ' A' ' 52' ' ' THR . 7.5 tttt -139.96 115.31 9.89 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.417 -0.802 . . . . 0.0 110.466 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.627 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -96.95 113.16 24.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.5 -0.75 . . . . 0.0 110.479 -179.915 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.672 HG21 HG23 ' A' ' 54' ' ' THR . 2.7 tp -65.42 170.01 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.133 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 13' ' ' LEU . 83.8 mt -131.17 73.17 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.237 179.734 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.18 48.15 1.23 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.475 -0.766 . . . . 0.0 109.092 179.094 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.97 156.0 15.81 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.464 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -74.18 -6.35 47.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.746 -0.855 . . . . 0.0 110.408 179.185 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.8 m -94.94 -31.52 13.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.167 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.537 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -147.47 164.51 33.13 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.489 -0.757 . . . . 0.0 110.604 -179.869 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -144.73 140.27 28.45 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.62 -0.675 . . . . 0.0 110.311 -179.877 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 132.6 -144.47 16.33 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.605 ' HG2' HD12 ' A' ' 7' ' ' ILE . 51.3 mt-10 -144.26 162.34 36.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.505 -0.997 . . . . 0.0 110.281 -179.979 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.4 m -137.8 143.44 41.06 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.598 -0.689 . . . . 0.0 109.951 179.788 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.2 p -127.21 153.67 45.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.592 -0.692 . . . . 0.0 110.297 -179.874 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.842 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 9.0 t -159.04 156.14 28.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.605 -0.685 . . . . 0.0 110.236 179.848 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -86.23 123.76 31.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.579 -0.701 . . . . 0.0 110.148 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.14 144.9 29.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.595 -0.691 . . . . 0.0 110.271 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.18 -36.06 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.565 -0.709 . . . . 0.0 110.195 -179.998 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.589 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 4.2 p30 -170.81 -168.38 0.67 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.561 -0.712 . . . . 0.0 110.389 179.787 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.421 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.88 -33.52 66.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.593 -0.692 . . . . 0.0 111.214 -179.287 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.589 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -55.02 -48.05 73.89 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.349 -0.845 . . . . 0.0 110.826 -179.51 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.9 m -85.87 -27.54 24.99 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.543 -0.723 . . . . 0.0 110.306 179.998 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.647 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.42 -61.21 2.76 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.537 -0.727 . . . . 0.0 110.303 -179.922 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -59.81 -38.79 82.95 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.554 -0.716 . . . . 0.0 110.382 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -55.95 -40.44 73.22 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.326 -0.859 . . . . 0.0 110.617 -179.893 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.5 t -82.05 -47.36 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.588 -0.695 . . . . 0.0 110.148 179.863 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.842 ' CZ ' HG22 ' A' ' 19' ' ' THR . 8.1 m-85 -64.68 -35.25 80.42 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.529 -0.732 . . . . 0.0 110.292 -179.771 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.59 -43.81 95.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.498 -0.751 . . . . 0.0 109.17 179.441 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -60.77 -32.39 71.71 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.677 0.751 . . . . 0.0 109.539 179.07 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -68.86 -55.44 11.08 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.881 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.786 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -65.55 -44.18 87.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.746 -0.596 . . . . 0.0 110.209 -179.948 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -56.24 -32.13 64.19 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.491 -0.756 . . . . 0.0 110.439 -179.839 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -70.48 -52.77 19.65 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.649 -0.657 . . . . 0.0 109.883 179.692 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -68.54 -41.68 79.52 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.596 -0.69 . . . . 0.0 109.759 179.652 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.44 44.05 0.62 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.685 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.786 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 81.2 mt -96.51 63.1 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.522 -0.987 . . . . 0.0 110.204 179.762 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -83.73 58.52 4.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.578 -0.701 . . . . 0.0 109.292 179.163 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.47 -137.69 5.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.33 100.95 7.63 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.183 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.627 ' CH2' HD11 ' A' ' 6' ' ' LEU . 52.8 m95 -69.73 142.68 53.25 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.131 0.967 . . . . 0.0 112.489 -177.775 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -149.88 131.81 15.19 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.567 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.4 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 21.8 t80 -106.29 134.84 48.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.638 -0.663 . . . . 0.0 110.159 -178.454 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.61 110.5 22.71 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.661 -0.649 . . . . 0.0 109.848 179.57 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -67.3 -24.64 65.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.637 -0.664 . . . . 0.0 110.623 -179.672 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.405 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.42 -37.44 56.74 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.325 -0.859 . . . . 0.0 110.899 -179.655 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.405 HG23 ' C ' ' A' ' 49' ' ' ALA . 72.1 p -145.93 16.83 1.41 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.623 -0.673 . . . . 0.0 110.839 179.837 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.442 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.13 93.06 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.084 -1.01 . . . . 0.0 110.729 179.939 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.519 HG23 ' HB3' ' A' ' 5' ' ' LYS . 91.9 m -155.49 104.06 2.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.523 -0.736 . . . . 0.0 111.051 -179.697 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.437 ' O ' HD23 ' A' ' 6' ' ' LEU . 86.1 m-85 -62.44 132.17 51.64 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.498 -0.751 . . . . 0.0 109.037 178.88 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.672 HG23 HG21 ' A' ' 7' ' ' ILE . 77.1 m -126.9 105.17 8.45 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.396 -0.922 . . . . 0.0 112.426 -178.686 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.58 HG11 HG21 ' A' ' 40' ' ' ILE . 9.2 p -107.2 166.43 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.341 -0.85 . . . . 0.0 109.443 177.694 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.447 ' N ' HG22 ' A' ' 55' ' ' VAL . 86.9 m -162.33 117.02 1.85 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.673 -0.642 . . . . 0.0 110.107 -179.525 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.411 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 3.5 mt-10 . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.124 179.456 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.554 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 62.2 m . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.125 0.488 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.7 m -94.26 93.43 7.74 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.508 -0.745 . . . . 0.0 110.481 -179.835 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.707 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 97.5 m-85 -71.77 169.72 15.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.579 -0.701 . . . . 0.0 109.978 179.824 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.509 ' HG2' HG22 ' A' ' 18' ' ' THR . 2.7 mttt -136.22 114.15 11.28 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.532 -0.73 . . . . 0.0 110.413 -179.825 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.659 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -93.98 111.98 23.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.485 -0.759 . . . . 0.0 110.554 -179.969 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.637 HG21 HG23 ' A' ' 54' ' ' THR . 3.6 tp -63.51 171.06 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.061 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.479 HD11 ' OG1' ' A' ' 17' ' ' THR . 82.8 mt -133.05 74.03 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.559 -179.91 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -96.16 46.46 1.08 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.854 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.05 156.83 16.72 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.692 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -75.48 -5.83 47.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.766 -0.844 . . . . 0.0 110.383 179.117 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.47 HG22 HD12 ' A' ' 13' ' ' LEU . 7.5 m -93.88 -34.74 13.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.136 179.941 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.47 HD12 HG22 ' A' ' 12' ' ' THR . 0.6 OUTLIER -139.52 -176.34 4.51 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.536 -179.994 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -163.47 134.56 4.7 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.644 -0.66 . . . . 0.0 110.167 -179.953 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.89 -141.93 12.97 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.932 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -138.88 161.81 36.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.573 -0.957 . . . . 0.0 110.306 -179.796 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.479 ' OG1' HD11 ' A' ' 8' ' ' ILE . 6.1 m -136.87 140.34 42.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.581 -0.699 . . . . 0.0 110.175 -179.965 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.509 HG22 ' HG2' ' A' ' 5' ' ' LYS . 38.7 p -129.55 159.44 36.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.492 -0.755 . . . . 0.0 110.398 -179.794 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.746 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.9 t -162.14 171.31 17.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.566 -0.709 . . . . 0.0 110.231 179.657 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.13 105.45 16.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.552 -0.718 . . . . 0.0 110.155 179.982 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.17 139.03 49.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.542 -0.724 . . . . 0.0 110.232 179.89 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 p -59.4 -33.36 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.566 -0.709 . . . . 0.0 110.179 179.953 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.586 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 30.3 p30 -170.04 -179.36 3.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.554 -0.716 . . . . 0.0 110.344 179.887 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.2 -24.83 44.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.49 -0.756 . . . . 0.0 110.862 -179.831 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.586 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.68 -30.48 67.41 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.447 -0.783 . . . . 0.0 110.472 -179.776 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 30' ' ' VAL . 25.2 m -109.48 -27.13 9.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.525 -0.735 . . . . 0.0 110.313 179.936 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.707 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.35 -42.77 96.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.501 -0.749 . . . . 0.0 110.127 179.916 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.87 -45.76 63.84 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.66 -0.65 . . . . 0.0 110.251 179.84 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -56.04 -31.9 63.56 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.243 -0.911 . . . . 0.0 110.551 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 26' ' ' THR . 60.0 t -87.01 -48.44 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.652 -0.655 . . . . 0.0 110.104 -179.937 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.746 ' CZ ' HG22 ' A' ' 19' ' ' THR . 6.3 m-85 -67.56 -38.79 84.63 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.981 -179.731 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -62.63 -43.87 97.71 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.515 -0.741 . . . . 0.0 109.093 179.226 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.6 tp60 -64.04 -34.12 77.29 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.761 0.791 . . . . 0.0 109.123 178.792 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -64.91 -57.71 8.07 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.676 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.781 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -58.96 -40.76 85.7 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.777 -0.577 . . . . 0.0 110.292 -179.895 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -58.01 -36.74 73.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.539 -0.726 . . . . 0.0 110.467 -179.879 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.96 -44.47 89.29 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.556 -0.715 . . . . 0.0 109.825 179.773 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -77.57 -40.37 42.58 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.673 -0.642 . . . . 0.0 109.971 179.729 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.87 40.83 0.88 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.82 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.781 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 75.8 mt -97.52 63.73 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.52 -0.988 . . . . 0.0 110.239 179.799 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -85.64 57.38 4.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.492 -0.755 . . . . 0.0 109.09 178.895 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.64 -139.32 6.17 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -178.839 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.55 108.72 17.92 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.859 -0.789 . . . . 0.0 109.008 179.455 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.659 ' HH2' HD11 ' A' ' 6' ' ' LEU . 57.9 m95 -79.59 142.49 35.63 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.118 0.961 . . . . 0.0 112.349 -177.794 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 44' ' ' TRP . 6.2 p -153.7 131.9 11.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.786 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.41 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 21.8 t80 -97.04 125.48 41.51 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.701 -0.625 . . . . 0.0 110.202 -178.506 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -87.72 98.46 11.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.751 -0.593 . . . . 0.0 109.746 179.584 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -63.4 -19.19 64.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.589 -0.694 . . . . 0.0 110.767 -179.767 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.444 ' C ' HG23 ' A' ' 50' ' ' THR . . . -55.6 -42.54 74.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.269 -0.895 . . . . 0.0 110.661 -179.77 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.444 HG23 ' C ' ' A' ' 49' ' ' ALA . 75.2 p -148.45 27.82 0.9 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.627 -0.671 . . . . 0.0 110.356 -179.871 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.441 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 5.6 mptt 52.52 96.8 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.336 -0.853 . . . . 0.0 110.809 -179.964 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.0 m -158.19 104.25 1.86 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.45 -0.781 . . . . 0.0 110.829 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.451 ' O ' HD23 ' A' ' 6' ' ' LEU . 64.3 m-85 -63.05 131.86 50.02 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.522 -0.736 . . . . 0.0 109.026 178.969 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.637 HG23 HG21 ' A' ' 7' ' ' ILE . 80.7 m -125.77 110.11 13.33 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.432 -0.907 . . . . 0.0 112.421 -178.528 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.568 HG11 HG21 ' A' ' 40' ' ' ILE . 11.3 p -114.35 167.4 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.37 -0.831 . . . . 0.0 109.35 177.726 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.456 ' N ' HG22 ' A' ' 55' ' ' VAL . 85.3 m -161.65 112.34 1.66 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.623 -0.673 . . . . 0.0 110.084 -179.649 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.172 179.764 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.592 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 40.2 m . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.105 0.479 . . . . 0.0 110.371 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 m -89.23 91.91 8.96 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.604 -0.685 . . . . 0.0 110.615 -179.791 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.665 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 97.3 m-85 -74.08 170.07 16.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.45 -0.781 . . . . 0.0 109.834 179.661 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -134.23 114.55 13.16 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.419 -0.801 . . . . 0.0 110.323 179.901 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.579 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -94.87 110.69 22.54 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.687 . . . . 0.0 110.399 -179.948 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 54' ' ' THR . 2.1 tt -65.46 162.64 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.044 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.405 HG21 ' HB3' ' A' ' 13' ' ' LEU . 49.0 mm -125.37 76.97 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.397 -179.741 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -96.13 47.33 1.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.991 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.23 159.58 13.82 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.217 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.0 tptt -77.83 -3.24 40.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.787 -0.831 . . . . 0.0 110.394 179.163 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.5 m -99.79 -32.01 11.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 110.14 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.537 HD11 ' OD1' ' A' ' 38' ' ' ASN . 55.9 mt -140.49 173.98 10.97 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.508 -0.745 . . . . 0.0 110.559 -179.916 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -160.73 135.98 7.84 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.63 -0.669 . . . . 0.0 109.994 179.795 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.07 -144.49 16.46 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -137.47 151.65 48.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.564 -0.963 . . . . 0.0 110.446 -179.851 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 m -130.84 144.87 51.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.613 -0.679 . . . . 0.0 110.08 179.857 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.8 p -131.8 139.8 48.99 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.549 -0.719 . . . . 0.0 110.355 -179.837 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.895 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.9 t -146.04 134.01 21.4 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 110.353 179.942 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.91 129.1 39.36 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.592 -0.692 . . . . 0.0 110.455 -179.919 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.53 140.67 19.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.561 -0.712 . . . . 0.0 109.989 179.887 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.47 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.2 p -58.58 -36.36 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.479 -0.763 . . . . 0.0 110.225 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.549 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 39.4 p30 -169.92 -176.01 2.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.578 -0.701 . . . . 0.0 110.209 179.621 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.453 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.57 -26.36 54.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.535 -0.728 . . . . 0.0 110.786 -179.667 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.549 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.48 -29.6 67.94 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.467 -0.771 . . . . 0.0 110.319 -179.895 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 30' ' ' VAL . 11.7 m -106.26 -27.39 11.06 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.583 -0.698 . . . . 0.0 110.382 179.952 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.665 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.73 -50.04 75.4 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.481 -0.762 . . . . 0.0 110.32 -179.981 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -62.19 -46.22 89.89 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.591 -0.693 . . . . 0.0 110.078 179.862 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -55.73 -34.68 65.37 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.445 -0.784 . . . . 0.0 110.873 -179.801 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 26' ' ' THR . 65.2 t -84.66 -47.65 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.502 -0.749 . . . . 0.0 110.274 -179.829 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.895 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.5 m-85 -68.11 -37.88 81.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.547 -0.721 . . . . 0.0 110.188 -179.76 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -62.26 -45.78 91.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.73 . . . . 0.0 109.367 179.661 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -60.95 -29.91 69.92 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.608 0.718 . . . . 0.0 109.619 179.004 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -72.53 -59.16 2.86 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.832 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.805 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.68 -49.42 77.57 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.728 -0.608 . . . . 0.0 110.194 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -56.1 -33.0 64.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.547 -0.721 . . . . 0.0 110.666 -179.816 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.16 -31.23 49.57 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.58 -0.7 . . . . 0.0 110.025 179.886 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.537 ' OD1' HD11 ' A' ' 13' ' ' LEU . 3.7 m-80 -83.47 -47.26 11.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.602 -0.686 . . . . 0.0 110.028 179.908 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.93 48.88 0.15 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.93 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.805 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 79.1 mt -116.26 58.52 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.505 -0.997 . . . . 0.0 110.391 179.935 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -81.35 60.55 4.46 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.433 -0.792 . . . . 0.0 109.013 178.918 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.96 -139.68 8.88 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -178.87 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -114.43 110.25 19.57 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.397 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.579 ' HH2' HD11 ' A' ' 6' ' ' LEU . 55.5 m95 -80.31 142.93 34.04 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.131 0.967 . . . . 0.0 112.456 -177.852 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 44' ' ' TRP . 7.0 p -153.04 130.95 11.73 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.853 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.417 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 14.3 t80 -102.07 128.76 48.38 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.693 -0.629 . . . . 0.0 109.848 -178.742 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.6 110.67 22.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.712 -0.617 . . . . 0.0 109.887 179.726 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -69.69 -22.9 63.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.706 -0.621 . . . . 0.0 110.686 -179.913 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.41 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.92 -39.56 68.95 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.424 -0.798 . . . . 0.0 110.939 -179.769 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.41 HG23 ' C ' ' A' ' 49' ' ' ALA . 77.8 p -145.77 19.22 1.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.53 -0.731 . . . . 0.0 110.974 -179.873 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.417 ' HG3' ' CE2' ' A' ' 46' ' ' TYR . 0.3 OUTLIER 51.88 95.65 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.23 -0.918 . . . . 0.0 110.957 179.7 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.1 m -158.7 106.46 1.87 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.499 -0.75 . . . . 0.0 110.683 179.83 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.436 ' O ' HD23 ' A' ' 6' ' ' LEU . 69.3 m-85 -63.65 129.38 39.92 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.948 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.645 ' HA ' HG22 ' A' ' 7' ' ' ILE . 56.7 m -123.25 107.2 11.42 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.36 -178.472 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.604 HG11 HG21 ' A' ' 40' ' ' ILE . 10.6 p -110.82 167.16 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.845 . . . . 0.0 109.436 177.791 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.457 ' N ' HG22 ' A' ' 55' ' ' VAL . 83.7 m -161.61 116.37 2.0 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.652 -0.655 . . . . 0.0 110.06 -179.782 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 . . . . . 0 N--CA 1.498 1.951 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.387 179.746 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.545 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 32.7 m . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 121.092 0.472 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 51.3 m -95.08 91.31 6.28 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.622 -0.674 . . . . 0.0 110.492 -179.767 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.663 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.8 m-85 -69.89 172.43 7.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.548 -0.72 . . . . 0.0 109.836 179.713 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -140.59 116.31 10.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.476 -0.765 . . . . 0.0 110.555 -179.659 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.635 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -96.27 112.77 24.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.536 -0.727 . . . . 0.0 110.423 -179.9 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.614 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.2 tp -63.01 172.67 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.005 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.734 HD11 ' OG1' ' A' ' 17' ' ' THR . 74.2 mt -135.61 70.24 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.209 -0.932 . . . . 0.0 110.974 -179.724 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -93.59 50.12 1.44 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.316 -0.865 . . . . 0.0 109.033 178.539 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.04 155.31 16.18 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.303 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -11.82 61.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.639 -0.918 . . . . 0.0 110.247 179.138 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -86.75 -36.11 18.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 110.332 -179.849 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.504 ' HB3' HG21 ' A' ' 8' ' ' ILE . 17.8 mt -138.67 -173.26 3.51 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 110.655 -179.912 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.15 127.08 2.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.603 -0.685 . . . . 0.0 110.345 179.94 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.99 -137.85 9.45 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.858 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -143.92 173.38 11.76 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.553 -0.969 . . . . 0.0 110.396 -179.858 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.734 ' OG1' HD11 ' A' ' 8' ' ' ILE . 7.4 m -153.26 146.8 25.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.622 -0.674 . . . . 0.0 110.175 179.864 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.3 p -132.5 170.19 15.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.628 -0.67 . . . . 0.0 110.226 179.965 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.74 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.3 t -165.58 179.43 6.07 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.573 -0.705 . . . . 0.0 110.166 -179.938 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -104.58 102.04 11.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.564 -0.71 . . . . 0.0 110.255 179.988 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.42 135.4 49.45 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.58 -0.7 . . . . 0.0 110.187 179.972 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.8 m -60.48 -27.23 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.497 -0.752 . . . . 0.0 110.345 179.955 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.453 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 31.1 p30 -172.79 178.43 2.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.422 -0.798 . . . . 0.0 110.221 179.67 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.02 -27.54 45.17 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.504 -0.747 . . . . 0.0 110.763 -179.606 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.453 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -63.37 -24.09 67.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.6 -0.688 . . . . 0.0 110.49 179.934 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 m -108.11 -26.11 10.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.449 -0.782 . . . . 0.0 110.628 -179.738 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.663 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -69.38 -48.24 61.78 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.495 -0.753 . . . . 0.0 110.35 -179.813 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -60.18 -41.53 93.07 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.564 -0.71 . . . . 0.0 110.488 -179.867 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -58.55 -36.36 73.78 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.379 -0.826 . . . . 0.0 110.591 -179.874 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.88 -41.56 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.516 -0.74 . . . . 0.0 110.222 -179.922 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.74 ' CZ ' HG22 ' A' ' 19' ' ' THR . 11.0 m-85 -72.5 -39.04 67.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.519 -0.738 . . . . 0.0 110.32 -179.851 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.4 tttt -62.03 -45.49 93.37 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.387 -0.821 . . . . 0.0 109.173 179.335 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -62.43 -33.06 74.05 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.721 0.772 . . . . 0.0 109.339 179.023 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -67.5 -56.71 8.45 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.847 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.789 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -61.07 -38.69 87.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.749 -0.595 . . . . 0.0 110.148 179.997 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -58.11 -39.96 79.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.503 -0.748 . . . . 0.0 110.557 -179.843 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -69.66 -43.04 73.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.567 -0.708 . . . . 0.0 110.134 -179.946 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -75.34 -28.9 59.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.589 -0.695 . . . . 0.0 110.102 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.06 52.25 1.39 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.886 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.789 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 83.9 mt -109.22 61.24 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.501 -0.999 . . . . 0.0 110.256 179.94 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -84.05 57.89 4.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.439 -0.788 . . . . 0.0 108.993 178.791 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.46 -138.04 5.56 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -178.916 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -116.79 101.22 8.36 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.874 -0.78 . . . . 0.0 109.365 179.484 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.635 ' CH2' HD11 ' A' ' 6' ' ' LEU . 52.6 m95 -71.74 143.06 49.73 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 122.02 0.914 . . . . 0.0 112.176 -178.2 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.66 131.74 14.37 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.464 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.404 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 38.5 t80 -105.02 131.73 52.17 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.713 -0.617 . . . . 0.0 110.294 -178.365 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -106.74 119.22 38.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.662 -0.649 . . . . 0.0 109.819 179.546 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -73.22 -21.46 60.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.655 -0.653 . . . . 0.0 110.707 -179.762 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.429 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.67 -38.23 60.14 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.257 -0.902 . . . . 0.0 110.804 -179.781 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.429 HG23 ' C ' ' A' ' 49' ' ' ALA . 76.0 p -146.88 17.15 1.25 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.594 -0.691 . . . . 0.0 110.86 179.889 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 50.88 93.33 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.122 -0.986 . . . . 0.0 110.697 179.953 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.0 m -154.86 106.87 2.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.464 -0.772 . . . . 0.0 110.94 -179.662 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.473 ' O ' HD23 ' A' ' 6' ' ' LEU . 79.1 m-85 -61.93 130.12 44.15 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.698 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.614 ' HA ' HG22 ' A' ' 7' ' ' ILE . 85.0 m -123.39 107.23 11.39 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.539 -178.598 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.564 HG11 HG21 ' A' ' 40' ' ' ILE . 11.1 p -111.64 166.94 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.452 -0.78 . . . . 0.0 109.15 177.536 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.451 ' N ' HG22 ' A' ' 55' ' ' VAL . 90.8 m -161.88 111.89 1.57 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.766 -0.584 . . . . 0.0 109.796 -179.857 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.163 179.86 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.617 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 12.0 m . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.081 0.467 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 3' ' ' THR . 8.0 t -87.81 84.29 7.05 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.684 -0.635 . . . . 0.0 110.8 -179.616 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.634 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 92.9 m-85 -68.6 167.82 14.28 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.357 -0.84 . . . . 0.0 109.938 179.72 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.509 ' HG3' HG22 ' A' ' 18' ' ' THR . 22.8 mttt -131.21 114.75 15.46 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.524 -0.735 . . . . 0.0 110.308 179.974 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.628 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -95.12 109.63 21.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.498 -0.752 . . . . 0.0 110.256 179.916 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.601 HG21 HG23 ' A' ' 54' ' ' THR . 4.1 tp -63.24 169.56 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.166 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.526 HD12 ' C ' ' A' ' 15' ' ' GLY . 81.2 mt -130.84 71.52 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.589 -179.575 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -94.68 48.3 1.2 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.383 -0.823 . . . . 0.0 108.978 178.947 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.8 160.29 17.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.504 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -1.62 35.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.776 -0.837 . . . . 0.0 110.583 179.205 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.806 ' O ' HD22 ' A' ' 13' ' ' LEU . 9.1 m -103.0 -37.58 7.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.318 -179.928 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.806 HD22 ' O ' ' A' ' 12' ' ' THR . 0.9 OUTLIER -134.65 176.54 8.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.486 -0.759 . . . . 0.0 110.589 -179.981 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -157.14 137.85 13.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.528 -0.732 . . . . 0.0 110.274 -179.962 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.526 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 134.02 -153.5 20.95 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.946 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -143.04 157.74 44.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.558 -0.966 . . . . 0.0 110.248 -179.961 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.7 t -144.16 164.49 30.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.556 -0.715 . . . . 0.0 110.304 179.993 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.509 HG22 ' HG3' ' A' ' 5' ' ' LYS . 11.9 p -135.84 174.21 10.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.573 -0.704 . . . . 0.0 110.189 179.941 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.623 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.6 t -161.98 -168.59 1.96 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.583 -0.698 . . . . 0.0 110.369 -179.951 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.26 103.23 8.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.637 -0.664 . . . . 0.0 110.387 179.9 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -133.56 143.18 48.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.485 -0.76 . . . . 0.0 110.238 -179.888 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.603 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.8 p -60.72 -31.6 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.584 -0.698 . . . . 0.0 109.927 179.789 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.603 ' OD1' HG13 ' A' ' 22' ' ' VAL . 50.9 p-10 -170.18 179.1 3.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.635 -0.666 . . . . 0.0 110.148 179.723 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.446 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.04 -25.56 45.4 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.508 -0.745 . . . . 0.0 110.855 -179.647 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.23 -26.51 64.95 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.52 -0.737 . . . . 0.0 110.533 -179.855 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.3 m -111.36 -26.98 8.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.521 -0.737 . . . . 0.0 110.46 -179.896 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.634 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.96 -53.51 56.99 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.498 -0.751 . . . . 0.0 110.317 -179.868 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -59.78 -37.72 79.84 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.578 -0.701 . . . . 0.0 110.315 179.94 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -56.32 -43.31 78.85 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.415 -0.803 . . . . 0.0 110.371 179.93 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.7 t -80.29 -46.09 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.611 -0.68 . . . . 0.0 109.852 179.633 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.623 ' CZ ' HG22 ' A' ' 19' ' ' THR . 9.2 m-85 -63.22 -35.52 80.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.607 -0.683 . . . . 0.0 110.355 -179.749 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -63.54 -42.71 98.4 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.411 -0.806 . . . . 0.0 109.138 179.438 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -63.25 -33.97 76.65 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.735 0.779 . . . . 0.0 109.205 178.898 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -66.63 -58.67 4.67 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.745 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.809 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.6 -34.11 73.72 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.712 -0.618 . . . . 0.0 110.061 179.799 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -55.16 -54.13 47.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.613 -0.68 . . . . 0.0 110.741 -179.924 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.18 -44.35 96.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.573 -0.705 . . . . 0.0 110.13 179.923 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -67.5 -29.64 69.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.597 -0.689 . . . . 0.0 110.072 179.87 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.6 50.96 2.42 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.987 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.809 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 83.1 mt -107.52 61.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.569 -0.96 . . . . 0.0 110.208 179.936 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.07 61.62 4.71 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 178.612 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.23 -140.73 10.23 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -178.685 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -116.02 103.54 10.68 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.572 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.628 ' HH2' HD11 ' A' ' 6' ' ' LEU . 52.0 m95 -73.73 142.13 46.33 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.044 0.926 . . . . 0.0 112.129 -178.211 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 p -149.71 131.96 15.49 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.722 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.433 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 45.9 t80 -103.7 127.8 51.12 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.718 -0.614 . . . . 0.0 110.014 -178.452 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -98.02 120.61 38.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.706 -0.621 . . . . 0.0 110.075 179.902 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.48 -23.03 53.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.677 -0.639 . . . . 0.0 110.489 179.961 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.402 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.4 -40.66 68.46 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.39 -0.819 . . . . 0.0 110.894 -179.733 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.402 HG23 ' C ' ' A' ' 49' ' ' ALA . 73.8 p -145.76 18.0 1.46 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.564 -0.71 . . . . 0.0 111.011 -179.899 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 0.2 OUTLIER 52.15 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.115 -0.99 . . . . 0.0 110.962 179.715 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.0 m -156.2 104.68 2.26 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.431 -0.793 . . . . 0.0 110.996 -179.949 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.462 ' O ' HD23 ' A' ' 6' ' ' LEU . 63.7 m-85 -61.48 123.9 19.14 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.522 -0.736 . . . . 0.0 109.129 178.839 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.601 HG23 HG21 ' A' ' 7' ' ' ILE . 60.4 m -119.49 104.89 10.72 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.667 -178.453 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.59 HG11 HG21 ' A' ' 40' ' ' ILE . 10.6 p -107.32 167.02 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.241 177.554 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.459 ' N ' HG22 ' A' ' 55' ' ' VAL . 99.5 m -159.09 109.17 1.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.647 -0.658 . . . . 0.0 109.902 -179.766 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.122 -179.929 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.72 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 33.1 m . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 121.146 0.498 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.412 ' N ' HG22 ' A' ' 2' ' ' THR . 90.0 m -143.3 91.16 2.24 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.643 -0.661 . . . . 0.0 109.902 179.88 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.72 ' CZ ' HG21 ' A' ' 2' ' ' THR . 83.6 m-85 -80.95 175.88 10.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.555 -0.716 . . . . 0.0 110.253 -179.608 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.633 ' CB ' HG23 ' A' ' 52' ' ' THR . 26.7 mttt -137.49 142.16 41.49 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.673 -0.642 . . . . 0.0 109.96 179.728 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.536 ' C ' HD13 ' A' ' 6' ' ' LEU . 3.4 tm? -115.62 99.8 7.59 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.527 -0.733 . . . . 0.0 110.191 -179.614 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.748 HG21 HG23 ' A' ' 54' ' ' THR . 2.0 tp -63.16 124.68 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.465 -0.772 . . . . 0.0 108.96 179.625 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.589 HG21 ' HB3' ' A' ' 13' ' ' LEU . 10.0 mt -92.65 68.27 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.524 -0.735 . . . . 0.0 110.605 -178.907 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.478 ' HB3' HG23 ' A' ' 56' ' ' THR . 18.1 m-20 -89.19 53.0 2.52 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.199 -0.938 . . . . 0.0 109.221 178.966 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.3 169.0 17.0 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.483 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -83.72 5.48 24.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.749 -0.853 . . . . 0.0 110.499 179.088 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.5 m -114.29 -30.45 6.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 110.245 -179.931 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.589 ' HB3' HG21 ' A' ' 8' ' ' ILE . 13.2 mt -137.1 179.24 6.5 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.373 -0.829 . . . . 0.0 110.741 -179.903 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.03 134.45 4.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.625 -0.672 . . . . 0.0 110.084 -179.938 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.11 -150.1 21.54 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.921 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -139.06 155.32 48.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.624 -0.927 . . . . 0.0 110.298 -179.883 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.4 ' OG1' HD11 ' A' ' 8' ' ' ILE . 76.8 m -126.04 156.08 40.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 110.089 -179.99 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.5 p -145.38 144.98 30.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.587 -0.695 . . . . 0.0 110.323 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.499 HG22 ' CE1' ' A' ' 31' ' ' PHE . 9.7 t -156.17 144.78 20.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.57 -0.706 . . . . 0.0 110.202 179.775 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.23 112.6 12.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.567 -0.708 . . . . 0.0 109.778 179.712 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.91 144.42 50.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.605 -0.685 . . . . 0.0 110.027 -179.864 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.8 m -60.6 -33.48 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.522 -0.736 . . . . 0.0 110.239 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.656 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 24.0 p30 -175.26 -175.35 0.82 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.462 -0.774 . . . . 0.0 110.254 179.422 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.8 -25.19 55.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.545 -0.722 . . . . 0.0 110.876 -179.725 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.656 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.24 -26.52 63.0 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.462 -0.774 . . . . 0.0 110.543 -179.83 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.5 m -111.49 -25.91 9.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.529 -0.732 . . . . 0.0 110.559 -179.882 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.704 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.66 -57.41 13.03 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.457 -0.777 . . . . 0.0 110.45 -179.825 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -59.18 -36.28 75.06 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.465 -0.772 . . . . 0.0 110.416 -179.986 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -61.06 -41.54 96.81 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.351 -0.843 . . . . 0.0 109.864 179.764 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.9 t -83.51 -39.34 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.578 -0.701 . . . . 0.0 109.337 179.278 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.499 ' CE1' HG22 ' A' ' 19' ' ' THR . 5.0 m-30 -66.45 -35.41 80.23 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.703 -0.623 . . . . 0.0 109.644 179.558 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -69.43 -45.45 69.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.663 -0.648 . . . . 0.0 109.624 179.712 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -61.94 -32.18 72.58 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.625 0.726 . . . . 0.0 109.671 179.397 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -67.65 -48.48 66.55 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.063 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.696 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -75.19 -33.09 61.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.781 -0.574 . . . . 0.0 110.391 -179.679 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -58.69 -45.24 89.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.497 -0.752 . . . . 0.0 110.399 -179.814 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.03 -36.98 72.57 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.599 -0.688 . . . . 0.0 110.156 179.941 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -74.43 -34.8 63.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.617 -0.677 . . . . 0.0 110.049 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.59 35.5 3.53 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.965 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.696 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 81.6 mt -100.09 69.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.537 -0.978 . . . . 0.0 110.204 179.991 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.08 51.5 1.81 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.692 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.71 -136.81 0.75 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -178.711 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -113.95 102.95 10.68 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.641 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.463 ' CH2' HD21 ' A' ' 6' ' ' LEU . 35.2 m95 -74.02 142.0 45.78 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.113 0.959 . . . . 0.0 112.161 -178.101 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 44' ' ' TRP . 4.3 p -152.58 132.17 13.06 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.022 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.432 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 53.8 t80 -103.8 103.75 13.67 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.71 -0.618 . . . . 0.0 109.951 -178.846 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.78 109.32 15.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.686 -0.634 . . . . 0.0 109.839 179.781 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -64.62 -22.12 66.89 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.706 -0.621 . . . . 0.0 110.437 -179.965 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.79 -35.54 44.33 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.331 -0.855 . . . . 0.0 110.791 -179.855 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.0 p -145.4 15.48 1.46 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.545 -0.722 . . . . 0.0 110.95 179.862 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.44 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.01 82.24 0.06 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.092 -1.005 . . . . 0.0 110.716 179.818 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.633 HG23 ' CB ' ' A' ' 5' ' ' LYS . 26.6 m -150.11 110.71 4.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.38 -0.825 . . . . 0.0 111.429 -179.642 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -65.53 112.76 3.75 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.439 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.748 HG23 HG21 ' A' ' 7' ' ' ILE . 88.4 m -104.85 99.41 9.05 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.918 -177.545 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.516 HG21 HG22 ' A' ' 40' ' ' ILE . 10.7 p -100.38 164.92 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 0.0 108.972 177.044 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.478 HG23 ' HB3' ' A' ' 9' ' ' ASN . 90.0 m -160.62 110.53 1.75 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.722 -0.611 . . . . 0.0 110.135 -179.677 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.038 179.824 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.643 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 4.1 m . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.169 0.509 . . . . 0.0 110.048 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 m -89.08 86.68 6.95 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.585 -0.697 . . . . 0.0 110.627 -179.576 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.728 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 66.0 m-85 -76.05 169.73 17.62 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.458 -0.776 . . . . 0.0 109.788 179.684 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 52' ' ' THR . 11.0 mtmm -141.45 105.3 4.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.482 -0.761 . . . . 0.0 110.392 -179.928 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.524 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -90.61 107.34 19.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.495 -0.753 . . . . 0.0 110.041 179.817 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 54' ' ' THR . 2.8 tp -64.2 160.2 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 119.616 -0.834 . . . . 0.0 108.921 179.231 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 13' ' ' LEU . 49.0 mm -123.31 76.84 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.456 -179.735 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.9 48.3 1.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.784 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.9 153.16 17.76 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.234 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -12.61 61.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.686 -0.89 . . . . 0.0 110.283 179.178 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.6 m -85.98 -35.75 20.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.898 . . . . 0.0 110.336 -179.999 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.438 ' O ' HG22 ' A' ' 8' ' ' ILE . 38.9 mt -143.72 171.43 14.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.521 -0.737 . . . . 0.0 110.545 -179.902 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.96 137.54 13.13 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.611 -0.681 . . . . 0.0 110.105 179.89 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.28 -138.05 9.43 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.962 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -141.08 165.53 27.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.971 . . . . 0.0 110.298 -179.917 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.1 m -151.75 128.47 10.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.582 -0.699 . . . . 0.0 110.1 179.977 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.428 HG22 ' HG2' ' A' ' 5' ' ' LYS . 26.4 p -126.32 149.4 49.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.735 . . . . 0.0 110.374 -179.915 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.831 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 9.0 t -150.56 129.14 12.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.621 -0.675 . . . . 0.0 110.179 179.807 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -60.91 118.48 6.75 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.513 -0.742 . . . . 0.0 110.101 179.868 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.84 156.89 45.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.58 -0.7 . . . . 0.0 110.319 -179.786 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 p -65.0 -37.0 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.621 -0.674 . . . . 0.0 110.063 179.963 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -174.73 -173.67 0.74 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.517 -0.739 . . . . 0.0 109.964 179.8 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -54.77 -24.15 21.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.43 -0.794 . . . . 0.0 111.018 -179.643 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.66 -43.79 85.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.402 -0.811 . . . . 0.0 110.504 -179.892 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.3 m -94.7 -29.97 14.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.572 -0.705 . . . . 0.0 110.254 179.907 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.728 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.76 -62.21 2.04 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.488 -0.758 . . . . 0.0 110.419 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.17 -35.26 74.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.652 -0.655 . . . . 0.0 110.308 179.988 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -60.35 -41.94 94.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.29 -0.881 . . . . 0.0 110.114 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.7 t -81.45 -41.28 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.605 -0.684 . . . . 0.0 109.648 179.562 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.831 ' CZ ' HG22 ' A' ' 19' ' ' THR . 14.7 m-85 -67.66 -38.37 83.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 0.0 110.155 -179.934 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -63.34 -47.89 80.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.535 -0.728 . . . . 0.0 109.654 179.723 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -59.82 -32.92 71.11 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.732 0.777 . . . . 0.0 109.452 179.241 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.402 ' OH ' HD12 ' A' ' 8' ' ' ILE . 2.3 t80 -66.99 -59.2 3.68 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.717 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.799 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -61.96 -44.66 96.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.729 -0.607 . . . . 0.0 109.995 179.703 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -56.0 -42.4 76.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.537 -0.727 . . . . 0.0 110.61 -179.777 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.22 -41.65 85.38 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.596 -0.69 . . . . 0.0 109.9 179.862 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -72.86 -51.66 17.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.577 -0.702 . . . . 0.0 109.856 179.779 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.8 43.72 0.23 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.686 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.799 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.3 mt -104.5 59.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.515 -0.991 . . . . 0.0 110.256 179.755 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -80.74 60.95 4.22 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.47 -0.769 . . . . 0.0 109.058 178.961 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.7 -138.34 7.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -178.906 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.79 102.78 9.39 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.891 -0.77 . . . . 0.0 109.07 179.281 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.524 ' HH2' HD11 ' A' ' 6' ' ' LEU . 53.3 m95 -73.03 142.62 47.68 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.207 1.004 . . . . 0.0 112.574 -177.705 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.3 p -150.46 131.49 14.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.411 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -106.58 128.86 54.47 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.637 -0.664 . . . . 0.0 110.329 -178.288 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -100.73 111.28 23.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.697 -0.627 . . . . 0.0 109.911 179.707 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -68.91 -24.69 64.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.689 -0.632 . . . . 0.0 110.525 -179.881 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.43 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.31 -36.33 52.93 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.353 -0.842 . . . . 0.0 110.969 -179.695 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.43 HG23 ' C ' ' A' ' 49' ' ' ALA . 77.3 p -147.2 16.86 1.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.514 -0.741 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.459 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.36 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.149 -0.969 . . . . 0.0 110.809 179.798 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 5' ' ' LYS . 74.9 m -159.64 104.27 1.58 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.423 -0.798 . . . . 0.0 111.209 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.471 ' HE2' ' HB1' ' A' ' 27' ' ' ALA . 96.7 m-85 -65.0 128.12 34.43 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.557 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.672 ' HA ' HG22 ' A' ' 7' ' ' ILE . 61.8 m -120.39 103.11 8.93 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.34 -178.52 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.584 HG11 HG21 ' A' ' 40' ' ' ILE . 8.5 p -106.13 165.74 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 0.0 109.56 177.935 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.449 ' N ' HG22 ' A' ' 55' ' ' VAL . 84.4 m -162.54 117.08 1.79 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.785 -0.572 . . . . 0.0 109.88 -179.744 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.991 179.691 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.465 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 77.7 m . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.203 0.525 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.4 m -93.47 103.8 15.98 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.631 -0.668 . . . . 0.0 110.446 -179.87 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.739 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 84.7 m-85 -84.11 179.54 7.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.515 -0.74 . . . . 0.0 110.178 179.938 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.547 ' HB3' HG23 ' A' ' 52' ' ' THR . 5.7 ttmt -145.69 111.94 5.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.527 -0.733 . . . . 0.0 110.502 179.966 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.515 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -92.72 111.45 23.06 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.435 -0.79 . . . . 0.0 110.321 -179.959 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.643 HG21 HG23 ' A' ' 54' ' ' THR . 3.6 tt -65.03 174.01 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.357 -0.84 . . . . 0.0 108.801 179.205 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 13' ' ' LEU . 76.1 mt -135.0 74.51 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.658 -179.888 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -96.28 49.73 1.14 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.953 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.71 160.95 13.19 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.327 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm -78.15 -7.44 57.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.724 -0.868 . . . . 0.0 110.463 179.201 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 12' ' ' THR . 10.0 t -98.23 -25.56 14.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.164 -0.96 . . . . 0.0 110.701 -179.77 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.471 ' O ' HG22 ' A' ' 8' ' ' ILE . 3.6 tp -150.09 164.67 34.97 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.416 -0.802 . . . . 0.0 110.744 -179.875 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.16 140.11 23.99 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.61 -0.681 . . . . 0.0 110.412 -179.773 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.406 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 132.79 -144.69 16.63 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.978 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -142.7 170.56 15.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.485 -1.009 . . . . 0.0 110.277 -179.942 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.7 m -144.06 161.39 38.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.64 -0.663 . . . . 0.0 110.188 179.991 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.8 p -144.54 151.09 38.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.543 -0.723 . . . . 0.0 110.41 -179.838 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.782 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.6 t -155.99 164.56 38.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.584 -0.698 . . . . 0.0 110.064 179.795 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -94.87 109.72 21.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.526 -0.733 . . . . 0.0 110.292 -179.959 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.47 143.15 47.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.612 -0.68 . . . . 0.0 109.95 179.9 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 23' ' ' ASP . 33.5 m -57.4 -38.84 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.451 -0.781 . . . . 0.0 110.232 179.808 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.455 ' N ' HG23 ' A' ' 22' ' ' VAL . 1.3 t0 -172.93 -170.2 0.63 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.623 -0.673 . . . . 0.0 109.771 179.58 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.419 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.48 -22.57 21.44 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.474 -0.766 . . . . 0.0 111.096 -179.673 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.64 -27.9 69.54 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.461 -0.774 . . . . 0.0 110.55 -179.738 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.7 m -114.37 -25.65 8.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.468 -0.77 . . . . 0.0 110.684 -179.63 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.739 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.77 -62.28 1.99 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.453 -0.779 . . . . 0.0 110.628 -179.708 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.86 -45.04 86.87 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.446 -0.784 . . . . 0.0 110.446 179.934 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -53.29 -44.03 67.96 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.391 -0.818 . . . . 0.0 110.727 -179.956 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.1 t -78.25 -48.88 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.54 -0.725 . . . . 0.0 109.983 179.74 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.782 ' CZ ' HG22 ' A' ' 19' ' ' THR . 3.9 m-85 -62.11 -31.16 71.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 110.238 -179.55 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -64.88 -39.38 93.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.393 -0.817 . . . . 0.0 108.92 179.262 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -61.88 -30.04 70.6 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.56 0.695 . . . . 0.0 109.704 179.083 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -73.18 -54.86 7.41 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.196 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.738 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -63.65 -48.78 75.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.738 -0.601 . . . . 0.0 110.149 179.974 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -55.95 -28.71 58.22 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.516 -0.74 . . . . 0.0 110.515 -179.897 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.62 -38.39 29.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.658 -0.651 . . . . 0.0 110.056 179.909 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -80.59 -34.41 35.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.56 -0.713 . . . . 0.0 110.058 179.927 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.54 49.13 0.61 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.906 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.738 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 85.1 mt -115.15 67.92 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.52 -0.988 . . . . 0.0 110.329 179.852 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -90.83 51.88 2.06 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.771 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.49 -139.14 2.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -178.957 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -114.83 108.53 16.87 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.356 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.515 ' CH2' HD11 ' A' ' 6' ' ' LEU . 46.0 m95 -77.14 142.08 39.87 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.1 0.953 . . . . 0.0 112.321 -177.985 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.1 p -147.49 133.1 18.79 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.752 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.413 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 71.7 t80 -100.49 131.97 46.13 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.712 -0.618 . . . . 0.0 110.454 -178.357 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -100.79 125.29 47.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.678 -0.639 . . . . 0.0 109.946 179.81 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -82.04 -18.49 43.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.69 -0.631 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.43 ' C ' HG23 ' A' ' 50' ' ' THR . . . -57.01 -44.74 83.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.271 -0.893 . . . . 0.0 110.725 -179.7 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.43 HG23 ' C ' ' A' ' 49' ' ' ALA . 70.2 p -147.37 23.81 1.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.519 -0.738 . . . . 0.0 110.65 -179.588 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.43 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 1.3 mppt? 52.42 95.38 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.239 -0.913 . . . . 0.0 110.727 179.953 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.547 HG23 ' HB3' ' A' ' 5' ' ' LYS . 90.7 m -151.76 101.79 2.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.53 -0.731 . . . . 0.0 110.749 -179.964 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.469 ' O ' HD23 ' A' ' 6' ' ' LEU . 81.4 m-85 -61.08 124.16 19.73 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.811 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.643 HG23 HG21 ' A' ' 7' ' ' ILE . 62.3 m -117.98 105.47 11.93 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.387 -0.925 . . . . 0.0 112.611 -178.197 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.571 HG11 HG21 ' A' ' 40' ' ' ILE . 10.8 p -105.87 168.04 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.42 -0.8 . . . . 0.0 109.128 177.538 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.471 ' N ' HG22 ' A' ' 55' ' ' VAL . 95.1 m -158.28 108.14 2.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.564 -0.71 . . . . 0.0 109.948 -179.676 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.17 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 mtm . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.079 0.466 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.581 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 70.4 m -102.18 111.99 24.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.573 -0.705 . . . . 0.0 110.184 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.0 m -78.67 99.57 6.66 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.639 -0.663 . . . . 0.0 110.76 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.71 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 73.2 m-85 -87.45 167.4 14.03 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.555 -0.716 . . . . 0.0 109.907 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.571 ' CG ' HG22 ' A' ' 18' ' ' THR . 3.6 mtpt -138.75 129.87 26.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.464 -0.772 . . . . 0.0 110.435 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.536 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 44.3 tp -106.5 123.06 47.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.509 -0.744 . . . . 0.0 110.209 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.616 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.6 tp -75.42 165.98 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.6 mt -127.89 72.66 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.225 -0.922 . . . . 0.0 110.676 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.522 ' HB3' HG23 ' A' ' 56' ' ' THR . 71.5 m-20 -95.38 49.19 1.18 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.274 -0.892 . . . . 0.0 109.029 178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.69 166.5 14.96 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.0 tttm -84.89 6.35 25.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.724 -0.868 . . . . 0.0 110.608 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.1 m -116.84 -30.76 5.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.18 -0.95 . . . . 0.0 110.482 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.5 mt -135.71 173.11 12.07 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.398 -0.814 . . . . 0.0 110.783 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.38 139.38 3.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.66 -0.65 . . . . 0.0 110.294 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.37 -136.1 7.68 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -153.99 154.36 33.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.617 -0.931 . . . . 0.0 110.287 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.9 m -143.82 155.23 44.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.59 -0.694 . . . . 0.0 110.211 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.571 HG22 ' CG ' ' A' ' 5' ' ' LYS . 74.0 p -133.25 173.9 10.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.563 -0.711 . . . . 0.0 110.329 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.554 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.6 t -164.11 -170.32 2.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.64 -0.663 . . . . 0.0 110.167 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.56 100.11 6.09 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.639 -0.663 . . . . 0.0 110.4 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.84 142.69 50.64 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.465 -0.772 . . . . 0.0 110.01 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.81 -30.39 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.576 -0.702 . . . . 0.0 110.048 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.556 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 24.1 p30 -170.06 176.08 4.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.611 -0.681 . . . . 0.0 110.323 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.78 -25.15 26.15 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.515 -0.741 . . . . 0.0 110.969 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.556 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -60.06 -27.0 66.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.492 -0.755 . . . . 0.0 110.431 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.2 m -112.1 -27.99 8.16 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.499 -0.751 . . . . 0.0 110.364 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.71 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.69 -49.6 77.11 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.487 -0.758 . . . . 0.0 110.375 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -59.14 -40.19 84.72 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.541 -0.724 . . . . 0.0 110.309 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -56.94 -35.5 69.16 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.35 -0.844 . . . . 0.0 110.363 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 93.8 t -84.39 -48.19 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.601 -0.687 . . . . 0.0 110.056 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.554 ' CZ ' HG22 ' A' ' 19' ' ' THR . 9.7 m-85 -65.87 -36.82 84.5 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 110.206 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.1 tptt -63.44 -44.89 93.25 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.518 -0.739 . . . . 0.0 109.43 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -60.72 -31.57 70.87 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.609 0.718 . . . . 0.0 109.708 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -70.7 -57.14 4.99 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.735 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.33 -47.22 85.19 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.751 -0.593 . . . . 0.0 110.022 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -54.94 -32.95 61.81 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.474 -0.766 . . . . 0.0 110.591 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.42 -49.99 43.13 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.615 -0.678 . . . . 0.0 109.985 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -71.35 -46.34 60.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.569 -0.707 . . . . 0.0 109.886 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.47 43.26 0.29 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.735 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 81.1 mt -105.59 71.32 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.447 -1.031 . . . . 0.0 110.245 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -95.4 46.05 1.1 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.2 -135.85 0.1 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.404 -1.079 . . . . 0.0 110.404 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -115.47 102.19 9.58 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.536 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 38.3 m95 -72.56 142.42 48.44 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.177 0.989 . . . . 0.0 112.456 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -150.9 133.05 15.32 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.425 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 63.2 t80 -102.83 109.24 20.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.664 -0.648 . . . . 0.0 110.206 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -82.34 109.33 16.5 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.655 -0.653 . . . . 0.0 110.096 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -67.6 -20.61 65.39 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.693 -0.629 . . . . 0.0 110.767 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.39 -42.56 67.08 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.251 -0.906 . . . . 0.0 110.859 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.7 p -141.31 18.7 2.24 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.585 -0.697 . . . . 0.0 110.685 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.435 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.4 OUTLIER 50.31 90.35 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.151 -0.968 . . . . 0.0 111.152 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 57.6 m -156.59 108.46 2.48 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.789 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 93.1 m-85 -60.37 123.29 16.84 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.616 ' HA ' HG22 ' A' ' 7' ' ' ILE . 48.4 m -115.5 94.53 4.75 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.242 -0.983 . . . . 0.0 112.846 -178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.549 HG21 HG22 ' A' ' 40' ' ' ILE . 11.0 p -95.55 166.84 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.128 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.522 HG23 ' HB3' ' A' ' 9' ' ' ASN . 95.4 m -160.26 108.1 1.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.677 -0.639 . . . . 0.0 109.86 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.214 -179.922 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 mtm . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.122 0.487 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.684 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 22.4 m -79.63 145.53 32.99 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.556 -0.715 . . . . 0.0 110.091 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.8 m -118.22 91.24 3.51 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 121.593 -0.692 . . . . 0.0 110.524 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.71 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 98.6 m-85 -80.34 168.69 18.72 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.594 -0.691 . . . . 0.0 109.967 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -145.88 115.79 7.34 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.463 -0.773 . . . . 0.0 110.372 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.62 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 30.1 tp -94.11 127.18 39.78 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.422 -0.799 . . . . 0.0 110.2 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.655 HG21 HG23 ' A' ' 54' ' ' THR . 2.4 tp -76.47 170.12 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.457 HD12 ' N ' ' A' ' 16' ' ' GLU . 78.8 mt -129.99 71.13 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.22 -0.925 . . . . 0.0 110.715 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.538 ' HB3' HG23 ' A' ' 56' ' ' THR . 5.8 m-20 -96.15 47.25 1.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.506 -0.746 . . . . 0.0 109.22 179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.43 167.0 24.47 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -82.32 3.12 29.0 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.76 -0.847 . . . . 0.0 110.754 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.9 m -116.88 -30.63 5.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.104 -0.997 . . . . 0.0 110.455 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.415 ' HB3' HG21 ' A' ' 8' ' ' ILE . 54.9 mt -128.7 172.48 11.2 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.455 -0.778 . . . . 0.0 110.694 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -154.99 131.76 10.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.696 -0.627 . . . . 0.0 109.932 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.71 -140.22 11.55 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.457 ' N ' HD12 ' A' ' 8' ' ' ILE . 1.1 pt-20 -147.82 178.04 8.82 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.565 -0.962 . . . . 0.0 110.42 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.413 ' OG1' HD11 ' A' ' 8' ' ' ILE . 19.7 m -152.27 128.94 10.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.542 -0.724 . . . . 0.0 110.162 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.3 p -114.53 155.77 25.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.574 -0.704 . . . . 0.0 110.256 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.791 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.1 t -160.55 153.51 21.4 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.597 -0.689 . . . . 0.0 110.309 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -86.71 112.41 21.63 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.524 -0.735 . . . . 0.0 110.326 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -132.6 147.32 52.34 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.642 -0.661 . . . . 0.0 110.048 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.9 p -64.25 -33.58 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.531 -0.73 . . . . 0.0 110.227 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.617 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 27.2 p30 -170.86 -177.85 2.38 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.486 -0.759 . . . . 0.0 110.362 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -54.36 -25.24 23.18 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.477 -0.764 . . . . 0.0 111.003 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.617 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.24 -46.01 89.64 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.443 -0.785 . . . . 0.0 110.315 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.525 ' O ' HG23 ' A' ' 30' ' ' VAL . 34.5 m -90.2 -26.48 20.09 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.605 -0.684 . . . . 0.0 110.168 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.71 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.75 -62.32 1.96 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.55 -0.719 . . . . 0.0 110.217 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -60.36 -37.06 79.54 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.505 -0.747 . . . . 0.0 109.972 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.4 ttpt -58.42 -37.16 74.81 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.446 -0.783 . . . . 0.0 110.073 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 26' ' ' THR . 90.1 t -84.55 -45.84 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.689 -0.632 . . . . 0.0 109.786 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.791 ' CZ ' HG22 ' A' ' 19' ' ' THR . 14.0 m-85 -66.41 -34.01 77.0 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.636 -0.665 . . . . 0.0 110.207 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -66.15 -46.21 78.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.442 -0.786 . . . . 0.0 109.015 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -61.11 -30.91 70.65 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.634 0.73 . . . . 0.0 109.381 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -69.26 -55.74 9.62 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.708 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -63.07 -38.86 92.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.712 -0.617 . . . . 0.0 109.797 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -59.02 -34.05 71.44 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.528 -0.733 . . . . 0.0 110.357 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -78.03 -47.67 17.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.657 -0.652 . . . . 0.0 110.141 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -69.76 -41.91 74.57 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.593 -0.692 . . . . 0.0 110.087 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.34 62.54 0.4 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.708 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 87.0 mt -127.65 81.47 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.552 -0.97 . . . . 0.0 110.421 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -98.76 37.67 1.47 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.04 -140.24 0.02 OUTLIER Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -114.56 110.7 20.22 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.62 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 29.9 m95 -77.88 143.03 38.09 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 122.205 1.003 . . . . 0.0 112.364 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 44' ' ' TRP . 6.0 p -153.94 132.12 11.86 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -105.65 143.77 33.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.63 -0.669 . . . . 0.0 110.06 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.69 108.73 18.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.765 -0.584 . . . . 0.0 109.804 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -67.6 -23.03 65.33 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.638 -0.664 . . . . 0.0 110.62 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.442 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.23 -37.55 64.74 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.309 -0.87 . . . . 0.0 110.788 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.442 HG23 ' C ' ' A' ' 49' ' ' ALA . 72.5 p -147.79 19.04 1.15 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.518 -0.739 . . . . 0.0 110.766 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.443 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.6 94.56 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.204 -0.935 . . . . 0.0 110.886 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 73.9 m -159.1 100.72 1.56 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.559 -0.713 . . . . 0.0 110.791 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 91.0 m-85 -61.95 140.1 58.35 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.445 -0.785 . . . . 0.0 109.006 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.655 HG23 HG21 ' A' ' 7' ' ' ILE . 55.8 m -131.87 100.03 4.95 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.272 -0.971 . . . . 0.0 112.69 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.557 HG21 HG22 ' A' ' 40' ' ' ILE . 10.3 p -101.61 166.25 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 109.22 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.538 HG23 ' HB3' ' A' ' 9' ' ' ASN . 93.4 m -160.79 112.26 1.86 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.661 -0.649 . . . . 0.0 109.931 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 118.016 -0.993 . . . . 0.0 110.13 179.943 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.108 0.48 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.572 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 62.0 m -87.43 112.78 22.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.606 -0.684 . . . . 0.0 110.222 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.6 m -84.81 95.44 8.98 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.633 -0.667 . . . . 0.0 110.696 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.742 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 95.8 m-85 -79.77 173.99 12.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.48 -0.763 . . . . 0.0 109.778 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.529 ' CG ' HG22 ' A' ' 18' ' ' THR . 8.8 mtmt -142.67 123.26 14.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.486 -0.759 . . . . 0.0 110.658 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.607 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 47.4 tp -101.16 127.61 47.64 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.425 -0.797 . . . . 0.0 109.897 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.687 HG21 HG23 ' A' ' 54' ' ' THR . 2.8 tt -77.39 174.06 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.493 HG21 ' HB3' ' A' ' 13' ' ' LEU . 86.2 mt -133.14 73.33 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.32 -0.862 . . . . 0.0 110.444 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.543 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.5 m-20 -95.82 47.79 1.11 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.414 -0.804 . . . . 0.0 109.004 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.72 154.78 16.45 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 mmtt -71.81 -9.1 57.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.704 -0.88 . . . . 0.0 110.396 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -90.31 -34.57 15.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 0.0 110.281 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.493 ' HB3' HG21 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -144.82 167.39 22.72 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.474 -0.766 . . . . 0.0 110.769 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -147.62 137.29 22.69 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.569 -0.707 . . . . 0.0 110.195 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.8 -136.81 8.7 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -146.97 168.64 20.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.53 -0.983 . . . . 0.0 110.326 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.2 m -143.45 149.87 38.22 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.638 -0.664 . . . . 0.0 110.125 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.529 HG22 ' CG ' ' A' ' 5' ' ' LYS . 20.8 p -131.41 157.66 42.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.534 -0.729 . . . . 0.0 110.297 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.79 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.6 t -160.98 168.12 25.17 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.566 -0.708 . . . . 0.0 110.235 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.26 124.22 44.16 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.602 -0.686 . . . . 0.0 110.145 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.03 138.15 20.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.6 -0.688 . . . . 0.0 110.181 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.49 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.8 p -60.08 -34.3 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.537 -0.727 . . . . 0.0 110.064 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.57 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 51.2 p30 -169.65 -173.91 1.75 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.61 -0.681 . . . . 0.0 110.306 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.85 -23.83 47.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.594 -0.691 . . . . 0.0 110.932 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.57 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.09 -31.49 68.95 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.395 -0.816 . . . . 0.0 110.36 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.548 ' O ' HG23 ' A' ' 30' ' ' VAL . 52.2 m -110.66 -24.3 10.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.57 -0.706 . . . . 0.0 110.447 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.742 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.27 -62.11 2.08 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.425 -0.797 . . . . 0.0 110.23 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -60.2 -39.8 87.82 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.555 -0.716 . . . . 0.0 109.903 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -57.64 -37.22 72.96 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.469 -0.769 . . . . 0.0 110.236 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 26' ' ' THR . 98.4 t -83.42 -48.64 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.699 -0.626 . . . . 0.0 109.871 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.79 ' CZ ' HG22 ' A' ' 19' ' ' THR . 5.4 m-85 -64.39 -34.11 77.42 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.551 -0.718 . . . . 0.0 110.11 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -64.61 -44.03 91.88 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.482 -0.761 . . . . 0.0 109.166 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -60.99 -35.36 76.62 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.84 0.829 . . . . 0.0 109.474 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -65.24 -53.54 42.84 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.702 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -63.91 -40.97 97.73 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.715 -0.615 . . . . 0.0 110.048 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -57.32 -39.83 76.66 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.56 -0.712 . . . . 0.0 110.451 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.71 -56.63 11.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.581 -0.699 . . . . 0.0 110.01 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -64.34 -51.35 63.81 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.588 -0.695 . . . . 0.0 109.903 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.92 55.84 0.16 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.702 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 82.0 mt -118.72 73.56 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.53 -0.982 . . . . 0.0 110.278 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -95.64 43.2 1.09 Allowed 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.57 -137.08 0.07 OUTLIER Glycine 0 N--CA 1.488 2.127 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -114.6 107.63 15.75 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.607 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 35.0 m95 -77.26 143.51 38.85 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.055 0.931 . . . . 0.0 112.359 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 44' ' ' TRP . 3.6 p -152.65 132.01 12.87 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.412 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 31.0 t80 -102.36 124.91 48.77 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.717 -0.615 . . . . 0.0 110.083 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -95.05 113.57 25.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.689 -0.632 . . . . 0.0 109.975 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -69.51 -15.09 63.18 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.672 -0.643 . . . . 0.0 110.928 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.437 ' C ' HG23 ' A' ' 50' ' ' THR . . . -56.46 -44.34 80.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.222 -0.924 . . . . 0.0 110.719 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.437 HG23 ' C ' ' A' ' 49' ' ' ALA . 68.6 p -147.59 25.11 1.08 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.494 -0.754 . . . . 0.0 110.628 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.456 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.44 89.87 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.357 -0.839 . . . . 0.0 110.841 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 83.2 m -150.46 101.76 2.99 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.478 -0.764 . . . . 0.0 110.89 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.471 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 85.6 m-85 -61.98 127.84 33.31 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.448 -0.783 . . . . 0.0 108.939 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.687 HG23 HG21 ' A' ' 7' ' ' ILE . 55.6 m -121.06 101.5 7.71 Favored 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 119.338 -0.945 . . . . 0.0 113.027 -178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.531 HG21 HG22 ' A' ' 40' ' ' ILE . 11.3 p -101.07 167.85 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 108.981 177.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.543 HG23 ' HB3' ' A' ' 9' ' ' ASN . 98.5 m -159.82 109.14 1.81 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.521 -0.737 . . . . 0.0 109.977 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.185 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.047 0.451 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.53 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 33.7 m -92.27 116.01 28.59 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.53 -0.731 . . . . 0.0 110.424 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.7 m -97.77 97.48 9.02 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.607 -0.683 . . . . 0.0 110.552 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.817 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 95.2 m-85 -78.65 175.88 9.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.544 -0.723 . . . . 0.0 109.753 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.431 ' HB3' HG23 ' A' ' 52' ' ' THR . 23.8 tttt -144.51 119.6 10.08 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.401 -0.812 . . . . 0.0 110.621 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.632 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 42.6 tp -100.04 130.67 46.22 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.298 -0.876 . . . . 0.0 110.48 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.612 HG22 ' HA ' ' A' ' 54' ' ' THR . 3.6 tp -80.36 168.24 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 13' ' ' LEU . 79.7 mt -129.41 74.76 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.0 111.007 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.436 ' HB3' HG23 ' A' ' 56' ' ' THR . 97.2 m-20 -97.65 47.8 1.02 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.322 -0.861 . . . . 0.0 108.924 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.03 165.94 15.39 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -85.6 6.83 25.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.702 -0.881 . . . . 0.0 110.444 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.2 m -113.46 -31.96 6.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.921 . . . . 0.0 109.989 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.467 ' O ' HG22 ' A' ' 8' ' ' ILE . 2.1 tp -140.43 167.44 22.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.558 -0.714 . . . . 0.0 110.375 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -155.26 140.62 17.69 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.592 -0.692 . . . . 0.0 110.323 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.69 -134.64 7.58 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.54 161.7 42.23 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.621 -0.929 . . . . 0.0 110.386 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.3 m -145.81 151.1 37.39 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.634 -0.666 . . . . 0.0 110.068 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.4 p -130.76 157.1 43.75 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.568 -0.708 . . . . 0.0 110.282 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.41 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.3 t -149.29 -172.05 4.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.562 -0.711 . . . . 0.0 110.252 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -123.85 103.94 8.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.486 -0.759 . . . . 0.0 110.249 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.761 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -129.02 153.47 47.56 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.56 -0.712 . . . . 0.0 110.116 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.54 -22.2 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.573 -0.705 . . . . 0.0 110.46 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.566 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 44.2 p30 -172.35 -177.92 1.9 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.316 -0.865 . . . . 0.0 110.203 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.406 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.45 -24.57 20.73 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.523 -0.736 . . . . 0.0 111.064 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.566 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.49 -52.13 66.91 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.463 -0.773 . . . . 0.0 110.479 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.761 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 31.1 m -80.6 -26.52 37.77 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.571 -0.705 . . . . 0.0 110.509 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.817 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.93 -64.03 1.09 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.498 -0.751 . . . . 0.0 110.495 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -60.13 -40.02 88.33 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.532 -0.73 . . . . 0.0 110.115 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -57.1 -38.39 73.31 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.456 -0.778 . . . . 0.0 110.313 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 26' ' ' THR . 87.7 t -83.06 -48.61 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.614 -0.679 . . . . 0.0 109.922 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.502 ' HB3' HD22 ' A' ' 6' ' ' LEU . 9.1 m-85 -63.63 -34.09 77.06 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.614 -0.679 . . . . 0.0 110.112 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.7 tttt -64.31 -45.84 86.17 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.461 -0.774 . . . . 0.0 109.095 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -62.15 -29.2 70.18 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.601 0.715 . . . . 0.0 109.618 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.4 t80 -72.15 -54.2 10.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.755 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.52 -38.6 84.95 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.672 -0.642 . . . . 0.0 110.293 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -58.21 -38.52 76.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.483 -0.76 . . . . 0.0 110.667 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -68.33 -38.88 81.97 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.573 -0.704 . . . . 0.0 110.26 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -81.94 -32.7 30.69 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.603 -0.686 . . . . 0.0 110.109 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.75 48.3 1.28 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.755 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 81.7 mt -104.53 62.84 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.584 -0.95 . . . . 0.0 110.225 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -83.01 59.73 5.08 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.11 -141.53 10.23 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -113.54 109.55 18.81 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.894 -0.768 . . . . 0.0 109.029 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.632 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 32.9 m95 -78.44 143.38 36.77 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 122.064 0.935 . . . . 0.0 112.178 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 44' ' ' TRP . 7.6 p -155.1 132.78 11.31 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -103.0 158.76 16.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.652 -0.655 . . . . 0.0 110.167 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.03 111.99 12.51 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.834 -0.541 . . . . 0.0 109.66 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.98 -20.18 65.01 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.692 -0.63 . . . . 0.0 110.814 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.435 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.77 -41.08 70.08 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.296 -0.878 . . . . 0.0 110.746 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.435 HG23 ' C ' ' A' ' 49' ' ' ALA . 69.6 p -147.7 20.72 1.16 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.563 -0.71 . . . . 0.0 110.757 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.439 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.65 89.6 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.217 -0.927 . . . . 0.0 110.72 179.875 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.431 HG23 ' HB3' ' A' ' 5' ' ' LYS . 7.0 m -151.1 102.96 2.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.349 -0.844 . . . . 0.0 111.516 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.541 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 73.3 m-85 -64.13 133.77 53.6 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.612 ' HA ' HG22 ' A' ' 7' ' ' ILE . 71.1 m -125.94 100.43 6.37 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.317 -0.953 . . . . 0.0 112.766 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.562 HG11 HG21 ' A' ' 40' ' ' ILE . 11.5 p -103.26 166.97 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.371 -0.831 . . . . 0.0 109.171 177.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.474 ' N ' HG22 ' A' ' 55' ' ' VAL . 97.3 m -160.3 110.75 1.84 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.655 -0.653 . . . . 0.0 109.782 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.182 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtm . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.067 0.461 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.579 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 62.0 m -74.02 111.77 9.5 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.57 -0.706 . . . . 0.0 110.211 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.4 m -85.7 95.01 9.24 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.642 -0.661 . . . . 0.0 110.596 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.796 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.4 m-85 -77.81 176.08 9.39 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.44 -0.788 . . . . 0.0 109.735 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.4 mttt -142.79 124.94 15.36 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.499 -0.751 . . . . 0.0 110.383 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.583 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 54.4 tp -104.02 118.82 37.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.454 -0.779 . . . . 0.0 110.204 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.698 HG21 HG23 ' A' ' 54' ' ' THR . 2.7 tp -68.84 171.16 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.426 HD11 ' OG1' ' A' ' 17' ' ' THR . 81.1 mt -131.48 74.98 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.228 -0.92 . . . . 0.0 110.597 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.512 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.3 m-20 -98.01 45.99 1.02 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.76 164.63 15.32 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -81.94 1.48 35.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.777 -0.837 . . . . 0.0 110.491 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.4 m -108.43 -31.41 7.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.206 -0.934 . . . . 0.0 110.152 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.568 HD11 ' OD1' ' A' ' 38' ' ' ASN . 50.1 mt -137.53 168.58 19.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.466 -0.771 . . . . 0.0 110.608 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -154.76 134.02 12.5 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.655 -0.653 . . . . 0.0 110.015 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.72 -143.7 15.13 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -135.71 160.58 38.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.539 -0.977 . . . . 0.0 110.3 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.426 ' OG1' HD11 ' A' ' 8' ' ' ILE . 17.5 m -135.53 158.62 43.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.541 -0.724 . . . . 0.0 110.116 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.9 p -142.99 154.53 44.1 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.58 -0.7 . . . . 0.0 110.431 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.767 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.7 t -159.77 159.55 32.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.608 -0.683 . . . . 0.0 110.228 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -93.19 121.07 34.18 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.552 -0.718 . . . . 0.0 110.183 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.27 138.39 23.79 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.582 -0.699 . . . . 0.0 110.174 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.8 m -59.31 -32.59 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.508 -0.745 . . . . 0.0 110.445 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.669 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 24.8 p30 -171.01 -178.24 2.42 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.586 -0.696 . . . . 0.0 110.319 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -54.79 -25.25 26.83 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.474 -0.766 . . . . 0.0 110.962 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.669 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.19 -26.53 64.89 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.488 -0.758 . . . . 0.0 110.374 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 29.4 m -113.82 -25.75 8.49 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.518 -0.739 . . . . 0.0 110.556 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.796 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.11 -60.76 3.25 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.417 -0.802 . . . . 0.0 110.408 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -59.88 -35.76 75.51 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.601 -0.687 . . . . 0.0 110.266 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -57.65 -38.99 76.0 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.401 -0.812 . . . . 0.0 110.189 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.0 t -83.79 -47.44 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.667 -0.646 . . . . 0.0 109.816 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.767 ' CZ ' HG22 ' A' ' 19' ' ' THR . 8.0 m-85 -62.68 -34.98 78.22 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.577 -0.702 . . . . 0.0 109.906 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 40.3 tttt -64.03 -46.94 82.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.409 -0.807 . . . . 0.0 109.084 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 27.6 tp60 -62.15 -31.92 72.47 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.698 0.761 . . . . 0.0 109.472 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -68.16 -50.35 55.11 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.743 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -68.13 -37.25 80.89 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.764 -0.585 . . . . 0.0 109.929 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -58.06 -46.75 84.88 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.577 -0.702 . . . . 0.0 110.533 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -60.59 -56.95 15.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.579 -0.701 . . . . 0.0 110.324 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.568 ' OD1' HD11 ' A' ' 13' ' ' LEU . 53.7 m-80 -63.71 -45.93 87.73 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.58 -0.7 . . . . 0.0 110.136 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.97 63.07 0.39 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.743 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 85.5 mt -118.04 63.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.528 -0.984 . . . . 0.0 110.133 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -83.31 59.54 5.08 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.82 -138.77 7.2 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -115.97 106.27 13.59 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.583 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 37.3 m95 -76.5 142.36 40.95 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.212 1.005 . . . . 0.0 112.419 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -150.3 132.18 15.12 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.413 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 18.9 t80 -105.75 133.7 50.05 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.625 -0.672 . . . . 0.0 110.072 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -103.6 112.9 26.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.712 -0.618 . . . . 0.0 109.922 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -69.29 -23.05 63.77 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.647 -0.658 . . . . 0.0 110.561 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.98 -40.87 67.27 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.317 -0.864 . . . . 0.0 110.721 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.5 p -145.06 18.43 1.59 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.576 -0.702 . . . . 0.0 110.863 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.413 ' HG3' ' CE2' ' A' ' 46' ' ' TYR . 5.0 mptt 51.24 92.71 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.177 -0.952 . . . . 0.0 111.084 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.6 m -154.42 101.58 2.36 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.483 -0.761 . . . . 0.0 110.707 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -62.0 129.22 39.89 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.557 -0.714 . . . . 0.0 109.095 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.698 HG23 HG21 ' A' ' 7' ' ' ILE . 75.7 m -121.34 100.81 7.25 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.649 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.599 HG11 HG21 ' A' ' 40' ' ' ILE . 10.6 p -101.24 167.25 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.526 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.512 HG23 ' HB3' ' A' ' 9' ' ' ASN . 89.4 m -160.8 109.05 1.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.698 -0.626 . . . . 0.0 109.784 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.19 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.0 mtm . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.146 0.498 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.595 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 32.1 m -85.39 115.7 23.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.585 -0.697 . . . . 0.0 110.362 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.0 m -93.79 97.61 10.53 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.61 -0.681 . . . . 0.0 110.874 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.595 ' CZ ' HG21 ' A' ' 2' ' ' THR . 92.9 m-85 -81.85 171.26 14.7 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.466 -0.771 . . . . 0.0 109.839 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.44 ' O ' HG23 ' A' ' 52' ' ' THR . 10.5 mttt -144.04 122.33 12.29 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.506 -0.746 . . . . 0.0 110.41 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.545 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 49.4 tp -99.49 123.94 44.21 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.558 -0.714 . . . . 0.0 110.141 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.606 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.9 tp -76.38 166.39 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.526 HD12 ' N ' ' A' ' 16' ' ' GLU . 81.0 mt -128.58 74.76 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.213 -0.93 . . . . 0.0 110.488 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.651 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.9 m-20 -95.57 47.95 1.13 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.414 -0.804 . . . . 0.0 108.901 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.94 151.85 17.61 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -71.14 -9.41 58.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.656 -0.908 . . . . 0.0 110.4 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 m -89.03 -36.13 15.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.225 -0.922 . . . . 0.0 110.251 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.43 174.58 10.81 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.455 -0.778 . . . . 0.0 110.59 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 46.3 tttt -156.24 144.42 19.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.585 -0.697 . . . . 0.0 110.403 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.65 -123.05 3.23 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.526 ' N ' HD12 ' A' ' 8' ' ' ILE . 12.3 tt0 -164.77 166.88 19.46 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.566 -0.961 . . . . 0.0 110.101 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 m -135.63 148.31 48.95 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.541 -0.725 . . . . 0.0 110.231 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 56.7 p -137.78 146.44 43.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.541 -0.724 . . . . 0.0 110.245 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.671 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.2 t -163.76 134.26 4.38 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.596 -0.69 . . . . 0.0 110.141 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -63.05 112.1 2.47 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.561 -0.712 . . . . 0.0 110.29 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.472 ' HB3' ' HD2' ' A' ' 4' ' ' PHE . . . -129.88 137.58 50.49 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.495 -0.753 . . . . 0.0 110.176 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.594 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.3 p -60.02 -32.4 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.53 -0.731 . . . . 0.0 110.25 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.594 ' OD1' HG13 ' A' ' 22' ' ' VAL . 51.8 p-10 -171.68 174.86 4.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.454 -0.779 . . . . 0.0 110.294 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.436 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.87 -24.82 17.17 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.54 -0.725 . . . . 0.0 110.928 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.24 -38.87 92.85 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.49 -0.757 . . . . 0.0 110.097 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.9 m -93.35 -27.6 16.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.525 -0.734 . . . . 0.0 110.358 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.697 ' HB1' ' HE2' ' A' ' 31' ' ' PHE . . . -66.41 -52.35 47.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.526 -0.734 . . . . 0.0 110.448 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -56.48 -37.47 70.39 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.499 -0.751 . . . . 0.0 110.549 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mttt -60.31 -33.48 72.43 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.41 -0.806 . . . . 0.0 109.787 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.6 t -87.32 -44.19 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.658 -0.651 . . . . 0.0 109.564 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.697 ' HE2' ' HB1' ' A' ' 27' ' ' ALA . 30.1 m-85 -66.28 -39.02 89.13 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.627 -0.671 . . . . 0.0 109.767 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -62.81 -50.9 69.16 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.608 -0.683 . . . . 0.0 109.551 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -61.26 -31.17 70.98 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.607 0.718 . . . . 0.0 109.63 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -68.55 -46.45 69.47 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.601 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -72.78 -38.67 67.21 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.739 -0.6 . . . . 0.0 109.91 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -58.76 -49.24 78.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.538 -0.726 . . . . 0.0 110.393 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -61.54 -56.05 24.28 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.683 -0.635 . . . . 0.0 110.123 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -60.91 -48.38 82.08 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.602 -0.686 . . . . 0.0 110.108 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.36 49.61 0.27 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.601 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.7 mt -117.65 75.47 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.515 -0.991 . . . . 0.0 110.398 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -98.36 39.95 1.21 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.88 -137.83 0.02 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -113.27 112.6 24.01 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.545 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 29.9 m95 -81.89 142.88 32.09 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.213 1.006 . . . . 0.0 112.686 -177.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 44' ' ' TRP . 2.4 p -152.68 131.28 12.27 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -100.59 108.41 20.32 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.742 -0.599 . . . . 0.0 109.997 -178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -78.53 100.4 6.9 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.698 -0.626 . . . . 0.0 109.967 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -62.34 -24.59 67.42 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.714 -0.616 . . . . 0.0 110.439 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.427 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.07 -34.03 54.73 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.371 -0.831 . . . . 0.0 111.043 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.427 HG23 ' C ' ' A' ' 49' ' ' ALA . 75.8 p -147.15 17.67 1.21 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.523 -0.736 . . . . 0.0 110.905 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER 50.55 87.0 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.117 -0.989 . . . . 0.0 111.066 179.719 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 5' ' ' LYS . 60.6 m -155.17 108.56 2.82 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.536 -0.727 . . . . 0.0 110.755 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 83.5 m-85 -61.14 126.16 26.35 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.606 ' HA ' HG22 ' A' ' 7' ' ' ILE . 44.7 m -118.83 96.6 5.32 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.223 -0.991 . . . . 0.0 113.079 -178.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.531 HG21 HG22 ' A' ' 40' ' ' ILE . 11.0 p -100.01 167.12 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 109.19 177.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.651 HG23 ' HB3' ' A' ' 9' ' ' ASN . 84.9 m -160.64 109.38 1.65 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.588 -0.695 . . . . 0.0 109.814 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.062 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 mtp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.116 0.484 . . . . 0.0 110.31 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.484 HG22 ' CE2' ' A' ' 4' ' ' PHE . 47.5 m -104.65 112.66 25.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.603 -0.685 . . . . 0.0 110.069 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 59.4 m -104.27 98.74 8.49 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.641 -0.662 . . . . 0.0 110.731 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.77 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 86.4 m-85 -78.57 172.35 13.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.546 -0.721 . . . . 0.0 109.831 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.582 ' HG2' HG22 ' A' ' 18' ' ' THR . 22.7 mttm -142.22 121.23 12.87 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.488 -0.757 . . . . 0.0 110.335 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.546 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 53.8 tp -100.87 118.24 36.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.434 -0.791 . . . . 0.0 110.338 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.601 HG22 ' HA ' ' A' ' 54' ' ' THR . 5.1 tp -66.91 168.19 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.536 HD11 ' OG1' ' A' ' 17' ' ' THR . 79.7 mt -130.63 74.37 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.181 -0.949 . . . . 0.0 110.711 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.588 ' HB3' HG23 ' A' ' 56' ' ' THR . 3.0 m-20 -96.11 48.91 1.12 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.81 157.35 15.01 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -74.54 -6.29 47.61 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.71 -0.876 . . . . 0.0 110.632 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -97.18 -33.83 11.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.247 -0.908 . . . . 0.0 110.275 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.421 ' HB3' HG21 ' A' ' 8' ' ' ILE . 45.5 mt -137.34 170.73 15.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.539 -0.725 . . . . 0.0 110.454 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -157.21 134.33 10.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.539 -0.726 . . . . 0.0 110.273 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.13 -144.42 16.36 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.455 ' HG2' HD12 ' A' ' 7' ' ' ILE . 11.2 mt-10 -136.18 153.34 51.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.598 -0.942 . . . . 0.0 110.244 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.536 ' OG1' HD11 ' A' ' 8' ' ' ILE . 5.2 m -130.93 147.83 52.62 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.573 -0.704 . . . . 0.0 110.052 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.582 HG22 ' HG2' ' A' ' 5' ' ' LYS . 67.0 p -129.35 165.64 21.1 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.555 -0.716 . . . . 0.0 110.303 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.4 t -156.42 -176.24 5.86 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.695 . . . . 0.0 110.119 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.81 92.95 3.7 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.556 -0.715 . . . . 0.0 110.421 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -122.65 179.54 4.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.421 -0.799 . . . . 0.0 110.088 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.6 p -100.43 -25.55 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.615 -0.678 . . . . 0.0 110.02 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -167.81 176.25 6.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.507 -0.746 . . . . 0.0 110.014 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.97 -25.42 60.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.471 -0.768 . . . . 0.0 110.789 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.0 -25.43 65.26 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.467 -0.771 . . . . 0.0 110.752 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.6 m -111.95 -27.46 8.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.376 -0.827 . . . . 0.0 110.66 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.77 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.74 -54.48 44.71 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.516 -0.74 . . . . 0.0 110.461 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -57.44 -39.3 75.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.525 -0.735 . . . . 0.0 110.697 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.6 mttm -56.41 -36.74 69.28 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.274 -0.891 . . . . 0.0 110.588 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.5 t -84.88 -47.59 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.606 -0.684 . . . . 0.0 109.975 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.501 ' HB3' HD22 ' A' ' 6' ' ' LEU . 8.8 m-85 -65.08 -37.22 86.8 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.584 -0.698 . . . . 0.0 110.135 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -63.65 -45.01 92.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.465 -0.772 . . . . 0.0 109.177 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -62.88 -29.0 70.42 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.537 0.684 . . . . 0.0 109.616 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -73.0 -47.39 45.58 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -73.61 -35.78 65.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.691 -0.63 . . . . 0.0 109.766 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -56.05 -49.6 73.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.528 -0.733 . . . . 0.0 110.599 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -69.45 -46.9 65.62 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.642 -0.661 . . . . 0.0 109.986 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -61.53 -42.05 98.23 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.571 -0.706 . . . . 0.0 110.023 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.54 50.18 0.82 Allowed Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.757 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 86.1 mt -110.64 61.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.538 -0.978 . . . . 0.0 110.173 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -81.45 60.6 4.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.533 -0.729 . . . . 0.0 109.166 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.6 -139.04 7.77 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -116.38 107.1 14.38 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.546 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 37.2 m95 -77.3 143.46 38.83 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 122.19 0.995 . . . . 0.0 112.374 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 44' ' ' TRP . 3.3 p -154.43 131.01 10.64 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -104.62 138.51 40.85 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.643 -0.661 . . . . 0.0 109.959 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -114.28 116.62 29.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.689 -0.632 . . . . 0.0 109.937 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -70.31 -25.19 63.2 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.725 -0.609 . . . . 0.0 110.566 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.05 -38.32 56.68 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.41 -0.806 . . . . 0.0 110.757 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.7 p -142.75 13.34 1.9 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.625 -0.672 . . . . 0.0 110.962 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.08 90.74 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.079 -1.013 . . . . 0.0 111.013 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 5' ' ' LYS . 56.2 m -157.35 110.0 2.46 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.325 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 87.3 m-85 -64.24 129.05 38.42 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.601 ' HA ' HG22 ' A' ' 7' ' ' ILE . 47.6 m -119.96 99.03 6.38 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.193 -1.003 . . . . 0.0 112.904 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.567 HG11 HG21 ' A' ' 40' ' ' ILE . 9.3 p -102.85 165.74 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.469 177.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.588 HG23 ' HB3' ' A' ' 9' ' ' ASN . 85.9 m -162.31 114.49 1.67 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.767 -0.583 . . . . 0.0 109.909 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.089 179.715 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.052 0.453 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.601 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 21.1 m -87.0 112.91 22.3 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.529 -0.732 . . . . 0.0 110.256 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.6 m -90.89 88.48 7.06 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.701 -0.625 . . . . 0.0 110.637 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.798 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.6 m-85 -71.15 167.94 18.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.457 -0.777 . . . . 0.0 109.909 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -136.19 132.89 36.52 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.496 -0.753 . . . . 0.0 110.254 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.595 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 58.1 tp -109.41 117.57 34.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.355 -0.841 . . . . 0.0 110.316 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.676 HD12 ' CG ' ' A' ' 16' ' ' GLU . 4.1 tp -66.57 171.1 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.445 HG21 ' HB3' ' A' ' 13' ' ' LEU . 78.2 mt -133.84 74.93 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 110.717 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -96.58 47.58 1.07 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.348 -0.845 . . . . 0.0 108.912 178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.21 153.99 16.91 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.85 -9.45 57.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.929 . . . . 0.0 110.631 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.6 m -92.14 -32.6 15.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.182 -0.949 . . . . 0.0 110.432 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.445 ' HB3' HG21 ' A' ' 8' ' ' ILE . 34.0 mt -142.21 170.23 16.1 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.374 -0.828 . . . . 0.0 110.768 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -153.97 136.51 15.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.68 -0.637 . . . . 0.0 110.294 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.14 -147.24 18.04 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.676 ' CG ' HD12 ' A' ' 7' ' ' ILE . 9.6 mt-10 -139.08 162.73 34.23 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.597 -0.943 . . . . 0.0 110.264 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.45 HG22 ' N ' ' A' ' 18' ' ' THR . 27.4 m -140.11 168.54 19.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.585 -0.697 . . . . 0.0 110.221 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.45 ' N ' HG22 ' A' ' 17' ' ' THR . 40.2 p -137.65 168.32 19.91 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.512 -0.742 . . . . 0.0 110.175 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.484 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.2 t -158.9 -173.2 4.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.599 -0.688 . . . . 0.0 110.36 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -126.95 96.91 4.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.538 -0.726 . . . . 0.0 110.079 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.717 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -130.28 140.17 50.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.57 -0.706 . . . . 0.0 110.134 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.605 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.3 p -60.86 -29.68 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.624 -0.672 . . . . 0.0 110.002 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.605 ' OD1' HG13 ' A' ' 22' ' ' VAL . 42.6 p-10 -167.42 -178.24 3.93 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.616 -0.678 . . . . 0.0 110.286 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.437 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.88 -24.82 39.49 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.508 -0.745 . . . . 0.0 110.968 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.88 -29.6 68.44 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.486 -0.759 . . . . 0.0 110.32 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.717 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 7.5 m -107.5 -26.53 10.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.575 -0.703 . . . . 0.0 110.394 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.798 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.3 -63.45 1.3 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.434 -0.791 . . . . 0.0 110.413 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -58.26 -36.81 73.81 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.481 -0.762 . . . . 0.0 110.126 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -57.6 -38.42 74.88 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.437 -0.789 . . . . 0.0 110.07 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 26' ' ' THR . 91.0 t -83.93 -48.09 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.662 -0.649 . . . . 0.0 109.726 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.484 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.1 m-85 -61.97 -35.12 77.55 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.648 -0.658 . . . . 0.0 109.91 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -63.97 -46.02 86.51 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.563 -0.711 . . . . 0.0 109.086 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -62.31 -31.91 72.59 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.628 0.727 . . . . 0.0 109.403 178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.8 t80 -69.31 -54.3 15.27 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.697 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.17 -40.25 95.73 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.698 -0.626 . . . . 0.0 109.827 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -58.59 -42.25 87.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.573 -0.705 . . . . 0.0 110.451 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.42 -52.22 28.97 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.605 -0.685 . . . . 0.0 110.017 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -63.75 -50.37 69.35 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.596 -0.69 . . . . 0.0 109.922 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.24 58.53 0.18 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.697 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.9 mt -125.56 67.18 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.472 -1.017 . . . . 0.0 110.401 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -89.81 53.56 2.6 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.83 -138.33 3.08 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.63 110.92 21.36 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.982 -0.716 . . . . 0.0 109.384 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.595 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 32.9 m95 -81.47 143.56 31.99 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 122.131 0.967 . . . . 0.0 112.228 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 44' ' ' TRP . 2.1 p -154.0 132.05 11.75 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.419 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 25.3 t80 -105.35 129.0 53.78 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.657 -0.652 . . . . 0.0 110.166 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -102.16 120.34 40.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.716 -0.615 . . . . 0.0 109.981 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -73.04 -20.14 61.04 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.665 -0.647 . . . . 0.0 110.678 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.87 -41.18 67.25 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.314 -0.866 . . . . 0.0 110.861 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 68.6 p -144.9 18.21 1.61 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.57 -0.706 . . . . 0.0 110.744 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.419 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 0.7 OUTLIER 51.31 93.19 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.16 -0.962 . . . . 0.0 110.78 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.7 m -157.19 106.42 2.18 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.175 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -63.94 127.33 30.91 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.642 HG23 HG21 ' A' ' 7' ' ' ILE . 88.9 m -117.17 104.2 10.96 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.344 -0.848 . . . . 0.0 112.597 -178.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.557 HG21 HG22 ' A' ' 40' ' ' ILE . 11.4 p -105.21 167.11 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.846 . . . . 0.0 109.207 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.472 ' N ' HG22 ' A' ' 55' ' ' VAL . 97.8 m -160.8 108.04 1.52 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.724 -0.61 . . . . 0.0 109.714 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.182 -179.862 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tpp . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.0 0.429 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.505 HG22 ' CE2' ' A' ' 4' ' ' PHE . 57.9 m -91.09 112.54 24.49 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.579 -0.701 . . . . 0.0 110.167 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.0 m -104.76 104.43 14.22 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.567 -0.708 . . . . 0.0 110.617 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.708 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 77.3 m-85 -84.82 178.52 7.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.54 -0.725 . . . . 0.0 109.742 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.514 ' O ' HG23 ' A' ' 52' ' ' THR . 23.4 ttpt -149.56 109.67 4.13 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.445 -0.785 . . . . 0.0 110.644 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.54 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 58.1 tp -90.6 121.37 32.46 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.414 -0.804 . . . . 0.0 110.324 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.64 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.9 tp -72.0 168.23 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.485 HD12 ' N ' ' A' ' 16' ' ' GLU . 75.4 mt -130.05 72.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.208 -0.933 . . . . 0.0 110.796 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.558 ' HB3' HG23 ' A' ' 56' ' ' THR . 37.3 m-20 -96.93 49.18 1.07 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.472 -0.768 . . . . 0.0 109.174 178.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.14 165.42 13.2 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.01 2.66 29.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.593 -0.946 . . . . 0.0 110.732 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -111.98 -29.27 7.7 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.191 -0.943 . . . . 0.0 110.119 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.695 HD11 ' OD1' ' A' ' 38' ' ' ASN . 80.1 mt -135.6 166.26 23.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.477 -0.764 . . . . 0.0 110.609 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -154.05 132.29 11.89 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.696 -0.627 . . . . 0.0 110.161 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.09 -129.82 5.07 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.485 ' N ' HD12 ' A' ' 8' ' ' ILE . 6.4 pt-20 -159.25 152.44 22.3 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.581 -0.953 . . . . 0.0 110.592 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.4 m -125.5 154.12 42.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.616 -0.677 . . . . 0.0 110.068 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.8 p -139.5 150.87 45.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.457 -0.777 . . . . 0.0 110.391 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.673 HG22 ' CE2' ' A' ' 31' ' ' PHE . 8.4 t -153.12 147.66 26.07 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.616 -0.677 . . . . 0.0 110.202 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -85.04 112.65 20.82 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.506 -0.746 . . . . 0.0 110.381 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.86 -171.15 2.55 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.498 -0.751 . . . . 0.0 110.032 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.5 p -109.46 -27.2 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.618 -0.676 . . . . 0.0 110.067 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -170.13 173.8 5.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.464 -0.772 . . . . 0.0 110.185 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -59.2 -26.25 64.67 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.571 -0.705 . . . . 0.0 110.715 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.37 -26.56 65.19 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.463 -0.773 . . . . 0.0 110.621 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.4 m -109.45 -32.54 7.11 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.5 -0.75 . . . . 0.0 110.31 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.708 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.15 -52.61 64.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.5 -0.75 . . . . 0.0 110.427 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -59.15 -43.17 92.03 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.518 -0.739 . . . . 0.0 110.302 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -57.52 -34.75 69.44 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.369 -0.832 . . . . 0.0 110.319 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 83.6 t -84.99 -48.44 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.585 -0.697 . . . . 0.0 109.84 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.673 ' CE2' HG22 ' A' ' 19' ' ' THR . 3.9 m-85 -65.39 -36.09 82.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.594 -0.691 . . . . 0.0 110.183 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -63.87 -46.59 84.26 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.477 -0.764 . . . . 0.0 109.341 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 52.6 tp60 -59.9 -30.71 69.2 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.541 0.686 . . . . 0.0 109.822 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -70.33 -52.69 20.85 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.687 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.18 -38.49 91.23 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.701 -0.624 . . . . 0.0 110.042 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -57.14 -45.89 83.17 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.45 -0.781 . . . . 0.0 110.563 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.83 -49.89 54.68 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.612 -0.68 . . . . 0.0 110.02 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.695 ' OD1' HD11 ' A' ' 13' ' ' LEU . 15.8 m-80 -62.5 -42.88 99.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.613 -0.679 . . . . 0.0 110.032 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.51 47.83 0.53 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.687 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 83.6 mt -119.07 74.58 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.53 -0.983 . . . . 0.0 110.409 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -97.78 39.69 1.2 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.67 -138.01 0.03 OUTLIER Glycine 0 N--CA 1.488 2.159 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -112.24 112.49 24.12 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.54 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 29.6 m95 -82.38 143.86 30.93 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.24 1.019 . . . . 0.0 112.499 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 44' ' ' TRP . 2.4 p -155.24 131.89 10.55 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 50.8 t80 -102.09 128.65 48.47 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.644 -0.66 . . . . 0.0 110.263 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -99.78 104.57 16.28 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.673 -0.642 . . . . 0.0 109.866 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -64.52 -21.45 66.68 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.594 -0.691 . . . . 0.0 110.881 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.428 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.29 -38.41 63.1 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.286 -0.884 . . . . 0.0 110.788 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.428 HG23 ' C ' ' A' ' 49' ' ' ALA . 74.3 p -147.65 21.12 1.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.607 -0.683 . . . . 0.0 110.617 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.449 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER 50.27 90.83 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.211 -0.931 . . . . 0.0 111.129 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 5' ' ' LYS . 88.4 m -155.29 103.59 2.36 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.523 -0.735 . . . . 0.0 110.717 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 86.8 m-85 -60.92 132.21 53.13 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.64 ' HA ' HG22 ' A' ' 7' ' ' ILE . 52.7 m -122.66 98.84 6.1 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.133 -1.027 . . . . 0.0 113.119 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.541 HG21 HG22 ' A' ' 40' ' ' ILE . 11.2 p -102.87 166.7 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.333 -0.854 . . . . 0.0 109.144 177.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.558 HG23 ' HB3' ' A' ' 9' ' ' ASN . 91.6 m -160.84 109.99 1.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.659 -0.65 . . . . 0.0 109.762 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.263 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 mmt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.125 0.488 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.516 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 90.5 m -61.38 159.32 12.79 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.534 -0.729 . . . . 0.0 110.007 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.5 m -139.92 107.44 5.58 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 121.582 -0.699 . . . . 0.0 110.436 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.797 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 97.4 m-85 -96.06 169.68 9.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.654 -0.654 . . . . 0.0 109.996 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -139.3 119.46 13.62 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.48 -0.763 . . . . 0.0 110.423 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.63 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 50.2 tp -98.75 121.99 41.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.486 -0.759 . . . . 0.0 110.243 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.604 HG22 ' HA ' ' A' ' 54' ' ' THR . 5.0 tp -70.26 171.78 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 82.8 mt -132.09 71.74 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.175 -0.953 . . . . 0.0 110.523 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.432 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.8 m-20 -96.17 46.81 1.08 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.478 -0.764 . . . . 0.0 109.085 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.54 158.27 17.3 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -73.39 -7.86 53.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.759 -0.847 . . . . 0.0 110.525 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.2 m -96.81 -32.77 11.94 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.208 -0.932 . . . . 0.0 110.273 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.9 mt -136.5 173.85 11.26 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.498 -0.751 . . . . 0.0 110.6 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -153.22 128.47 9.8 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.655 -0.653 . . . . 0.0 110.179 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.02 -142.6 14.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -148.01 -178.9 6.54 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.997 . . . . 0.0 110.347 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 6' ' ' LEU . 7.0 t -162.74 159.77 24.61 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.588 -0.695 . . . . 0.0 110.278 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.4 p -134.52 156.46 48.6 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.57 -0.706 . . . . 0.0 110.177 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.582 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.5 t -142.62 -173.17 3.8 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.538 -0.727 . . . . 0.0 110.305 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -122.45 101.93 7.79 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.611 -0.681 . . . . 0.0 110.2 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.446 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -127.36 170.31 12.65 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.592 -0.692 . . . . 0.0 110.087 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -87.01 -26.93 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.64 -0.662 . . . . 0.0 109.902 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -175.24 -179.03 1.25 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.41 -0.806 . . . . 0.0 109.772 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.435 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.39 -25.88 38.15 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.392 -0.817 . . . . 0.0 110.936 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.24 -25.66 65.82 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.573 -0.705 . . . . 0.0 110.552 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.446 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 7.3 m -112.74 -26.17 8.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.476 -0.765 . . . . 0.0 110.359 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.797 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.6 -58.74 7.22 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.441 -0.787 . . . . 0.0 110.422 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -60.08 -41.3 92.17 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.604 -0.685 . . . . 0.0 110.143 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.6 mtpt -56.74 -38.44 72.41 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.362 -0.836 . . . . 0.0 110.346 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 26' ' ' THR . 84.0 t -82.63 -48.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.622 -0.674 . . . . 0.0 109.975 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.582 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.3 m-85 -64.33 -32.81 74.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.531 -0.731 . . . . 0.0 110.19 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -64.75 -45.77 85.01 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.415 -0.803 . . . . 0.0 108.934 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -62.53 -33.12 74.28 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.659 0.743 . . . . 0.0 109.391 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -66.13 -51.48 57.52 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.788 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -67.61 -42.52 82.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.77 -0.581 . . . . 0.0 110.095 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -56.94 -36.14 69.91 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.47 -0.768 . . . . 0.0 110.537 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -62.98 -59.19 5.16 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.562 -0.711 . . . . 0.0 110.094 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -67.87 -47.25 69.42 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.656 -0.652 . . . . 0.0 110.017 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.33 60.0 0.19 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.788 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 85.2 mt -115.8 62.91 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.475 -1.015 . . . . 0.0 110.145 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -86.2 56.53 4.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.443 -0.786 . . . . 0.0 109.037 178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.68 -136.53 3.01 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -117.43 99.42 6.98 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.842 -0.799 . . . . 0.0 109.298 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.63 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 30.8 m95 -69.16 143.38 54.09 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.225 1.012 . . . . 0.0 112.541 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 44' ' ' TRP . 3.0 p -153.41 131.41 11.78 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -101.79 138.14 39.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.641 -0.662 . . . . 0.0 110.166 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -105.92 103.5 13.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.725 -0.61 . . . . 0.0 109.784 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.12 -21.96 66.54 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.672 -0.643 . . . . 0.0 110.657 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.434 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.95 -39.41 65.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.295 -0.878 . . . . 0.0 110.84 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.434 HG23 ' C ' ' A' ' 49' ' ' ALA . 73.8 p -148.14 22.75 1.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.483 -0.76 . . . . 0.0 110.7 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.443 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.3 91.32 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.21 -0.931 . . . . 0.0 110.816 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.4 m -153.99 102.71 2.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.484 -0.76 . . . . 0.0 111.119 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.431 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 75.3 m-85 -63.26 133.73 54.69 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.604 ' HA ' HG22 ' A' ' 7' ' ' ILE . 52.6 m -126.3 101.84 6.91 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.347 -0.941 . . . . 0.0 112.883 -178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.567 HG21 HG22 ' A' ' 40' ' ' ILE . 10.6 p -104.26 165.81 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.374 -0.829 . . . . 0.0 109.322 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.466 ' N ' HG22 ' A' ' 55' ' ' VAL . 76.0 m -162.24 119.37 2.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.753 -0.592 . . . . 0.0 110.074 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.173 179.588 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mtt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.071 0.463 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.599 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 47.9 m -89.41 112.23 23.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.545 -0.722 . . . . 0.0 110.271 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.2 m -88.87 93.97 9.77 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.591 -0.693 . . . . 0.0 110.76 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.684 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 94.0 m-85 -76.92 167.9 21.03 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.5 -0.75 . . . . 0.0 109.963 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -138.92 123.84 18.82 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.525 -0.735 . . . . 0.0 110.352 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.608 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 44.8 tp -100.0 124.26 45.16 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.476 -0.765 . . . . 0.0 110.317 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.657 HG22 ' HA ' ' A' ' 54' ' ' THR . 5.5 tp -74.6 168.2 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.431 HG22 ' O ' ' A' ' 13' ' ' LEU . 72.6 mt -127.84 73.63 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.41 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.501 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.3 m-20 -95.13 47.58 1.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.37 -0.831 . . . . 0.0 108.985 179.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.74 159.33 14.21 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -79.19 -1.53 36.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.759 -0.848 . . . . 0.0 110.364 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.8 m -99.87 -32.4 11.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.194 -0.941 . . . . 0.0 110.035 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.431 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -146.36 172.0 14.16 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.513 -0.742 . . . . 0.0 110.379 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.59 145.18 19.93 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.573 -0.705 . . . . 0.0 110.267 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.89 -132.11 6.01 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -154.23 163.19 40.52 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.59 -0.947 . . . . 0.0 110.349 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.1 m -149.58 145.48 26.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.566 -0.709 . . . . 0.0 110.141 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.3 p -132.68 167.2 20.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.585 -0.697 . . . . 0.0 110.24 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.692 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.1 t -162.94 170.15 18.57 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.617 -0.677 . . . . 0.0 110.305 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -101.68 123.38 45.58 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.626 -0.671 . . . . 0.0 110.143 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -151.89 146.41 25.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.568 -0.707 . . . . 0.0 110.264 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.446 HG13 ' OD1' ' A' ' 23' ' ' ASP . 10.4 p -61.39 -34.25 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.595 -0.691 . . . . 0.0 110.056 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.512 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 39.3 p30 -170.19 177.03 4.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.592 -0.692 . . . . 0.0 110.281 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.461 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.45 -26.86 21.93 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.518 -0.739 . . . . 0.0 111.021 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.512 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.48 -23.33 57.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.539 -0.725 . . . . 0.0 110.554 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.6 m -118.0 -14.14 10.0 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.499 -0.751 . . . . 0.0 111.088 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.684 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -72.14 -50.07 30.85 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.228 -0.92 . . . . 0.0 110.406 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.52 -30.68 68.76 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.482 -0.761 . . . . 0.0 110.412 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.8 mttp -58.9 -40.46 84.54 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.376 -0.827 . . . . 0.0 110.341 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.0 t -82.99 -42.21 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.517 -0.739 . . . . 0.0 109.867 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.692 ' CZ ' HG22 ' A' ' 19' ' ' THR . 13.1 m-85 -68.27 -35.37 77.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.573 -0.704 . . . . 0.0 110.119 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -63.77 -46.66 84.23 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.473 -0.767 . . . . 0.0 109.128 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -62.64 -30.95 71.75 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.611 0.72 . . . . 0.0 109.467 178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -69.7 -47.84 61.76 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.71 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -73.61 -33.76 64.73 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.68 -0.637 . . . . 0.0 110.001 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -60.68 -52.23 66.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.623 -0.673 . . . . 0.0 110.417 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.6 -35.54 78.14 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.633 -0.667 . . . . 0.0 110.52 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -79.29 -42.42 25.84 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.562 -0.711 . . . . 0.0 110.312 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.3 41.0 1.19 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.71 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 79.8 mt -99.64 59.52 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.549 -0.971 . . . . 0.0 110.166 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -80.84 61.48 4.49 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.36 -138.32 7.84 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -117.39 102.1 8.95 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.981 -0.717 . . . . 0.0 109.332 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.608 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 37.0 m95 -71.91 142.68 49.49 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.191 0.996 . . . . 0.0 112.516 -178.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -151.93 132.52 13.92 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.408 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 25.0 t80 -108.39 138.04 45.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.645 -0.659 . . . . 0.0 110.285 -178.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.06 123.4 49.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.69 -0.631 . . . . 0.0 109.602 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -78.01 -24.25 48.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.624 -0.672 . . . . 0.0 110.619 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -54.06 -39.43 66.25 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.382 -0.824 . . . . 0.0 110.834 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.5 p -141.77 12.86 2.08 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.599 -0.688 . . . . 0.0 111.102 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.46 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.95 94.41 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.133 -0.98 . . . . 0.0 111.205 179.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.2 m -157.9 105.33 1.97 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.549 -0.719 . . . . 0.0 110.761 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -60.67 132.96 55.53 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.461 -0.774 . . . . 0.0 109.169 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.657 ' HA ' HG22 ' A' ' 7' ' ' ILE . 58.7 m -125.82 99.9 6.16 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.207 -0.997 . . . . 0.0 112.666 -178.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.557 HG11 HG21 ' A' ' 40' ' ' ILE . 11.2 p -102.17 167.47 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.88 . . . . 0.0 109.271 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.501 HG23 ' HB3' ' A' ' 9' ' ' ASN . 98.9 m -160.28 109.2 1.71 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.593 -0.692 . . . . 0.0 109.894 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.274 -179.992 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.067 0.46 . . . . 0.0 110.316 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.555 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 63.0 m -145.32 111.86 5.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.517 -0.739 . . . . 0.0 110.201 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.623 HG23 ' O ' ' A' ' 3' ' ' THR . 7.5 t -87.82 95.15 9.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.66 -0.65 . . . . 0.0 110.819 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.764 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.5 m-85 -77.1 171.48 14.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.42 -0.8 . . . . 0.0 109.819 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -139.31 128.89 24.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.49 -0.756 . . . . 0.0 110.331 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.611 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 41.1 tp -103.41 122.62 45.25 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.385 -0.822 . . . . 0.0 110.432 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.65 HG21 HG23 ' A' ' 54' ' ' THR . 5.0 tp -70.74 171.13 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.43 HG21 ' HB3' ' A' ' 13' ' ' LEU . 73.9 mt -133.8 74.4 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.644 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.677 ' HB3' HG23 ' A' ' 56' ' ' THR . 27.7 m-20 -95.86 47.73 1.11 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.545 -0.722 . . . . 0.0 109.138 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.42 163.66 13.58 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -82.3 2.65 31.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.651 -0.911 . . . . 0.0 110.791 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 m -111.5 -28.87 7.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.19 -0.943 . . . . 0.0 110.138 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.43 ' HB3' HG21 ' A' ' 8' ' ' ILE . 6.3 mt -136.93 167.3 21.76 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.558 -0.714 . . . . 0.0 110.393 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.8 tttt -155.75 138.04 14.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.538 -0.726 . . . . 0.0 110.213 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 130.07 -133.23 7.32 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -163.75 163.02 24.21 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.533 -0.98 . . . . 0.0 110.262 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.9 m -144.56 150.32 37.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.551 -0.718 . . . . 0.0 110.281 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.2 p -126.91 161.27 28.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.592 -0.693 . . . . 0.0 110.247 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.4 t -153.08 -171.59 3.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.506 -0.746 . . . . 0.0 110.382 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -115.97 109.25 17.31 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.54 -0.725 . . . . 0.0 110.152 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.36 138.55 38.39 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.601 -0.687 . . . . 0.0 110.155 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.8 m -57.4 -30.51 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.571 -0.705 . . . . 0.0 110.515 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.631 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 23.2 p30 -172.47 -179.56 2.25 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.407 -0.808 . . . . 0.0 110.283 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.451 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.18 -25.2 31.09 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.502 -0.749 . . . . 0.0 110.876 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.631 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -60.27 -25.88 66.04 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.49 -0.756 . . . . 0.0 110.605 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.9 m -113.3 -25.86 8.65 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.435 -0.791 . . . . 0.0 110.64 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.764 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.14 -49.09 78.19 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.458 -0.776 . . . . 0.0 110.569 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -61.6 -36.47 80.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.607 -0.683 . . . . 0.0 110.447 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -56.72 -40.06 75.02 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.327 -0.858 . . . . 0.0 110.744 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.4 -45.52 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.483 -0.761 . . . . 0.0 110.065 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 12.7 m-85 -66.91 -35.87 80.99 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.622 -0.674 . . . . 0.0 110.3 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.5 tttm -63.61 -44.06 95.06 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.488 -0.758 . . . . 0.0 109.35 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 tp-100 -64.33 -30.68 71.72 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.61 0.719 . . . . 0.0 109.565 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -70.02 -44.24 69.7 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.627 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -76.47 -41.54 46.87 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.716 -0.615 . . . . 0.0 109.802 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -58.95 -37.77 77.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.624 -0.672 . . . . 0.0 110.4 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -69.68 -50.75 40.81 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.602 -0.686 . . . . 0.0 110.058 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -69.87 -50.0 46.76 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.531 -0.731 . . . . 0.0 110.018 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.92 50.99 0.17 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.627 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 77.9 mt -115.79 74.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.52 -0.988 . . . . 0.0 110.298 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -98.25 39.54 1.23 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.85 -137.25 0.02 OUTLIER Glycine 0 N--CA 1.488 2.127 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -111.89 109.61 19.5 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.888 -0.772 . . . . 0.0 108.973 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.611 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 35.1 m95 -79.81 143.78 34.11 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 122.042 0.925 . . . . 0.0 112.062 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 44' ' ' TRP . 1.8 p -155.29 132.8 11.14 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -101.92 137.41 40.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.726 -0.609 . . . . 0.0 110.109 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -108.28 114.32 28.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.766 -0.584 . . . . 0.0 109.829 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -69.8 -18.04 63.44 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.666 -0.646 . . . . 0.0 110.896 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.419 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.8 -42.58 72.0 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.234 -0.916 . . . . 0.0 110.788 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.419 HG23 ' C ' ' A' ' 49' ' ' ALA . 70.9 p -147.14 22.92 1.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.549 -0.719 . . . . 0.0 110.559 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.442 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.3 OUTLIER 51.67 94.69 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.322 -0.862 . . . . 0.0 110.859 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.4 m -156.94 107.5 2.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.456 -0.778 . . . . 0.0 111.269 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -63.65 132.57 51.54 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.65 HG23 HG21 ' A' ' 7' ' ' ILE . 61.0 m -124.08 99.52 6.28 Favored 'General case' 0 N--CA 1.5 2.025 0 C-N-CA 119.254 -0.979 . . . . 0.0 113.08 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.5 HG21 HG22 ' A' ' 40' ' ' ILE . 11.9 p -102.03 167.67 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 108.917 177.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.677 HG23 ' HB3' ' A' ' 9' ' ' ASN . 97.8 m -160.19 109.42 1.75 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.573 -0.705 . . . . 0.0 110.034 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.184 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.759 0 CA-C-O 121.064 0.459 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.571 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 46.1 m -151.59 112.66 4.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.552 -0.718 . . . . 0.0 110.217 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 16.5 m -85.34 95.94 9.39 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.656 -0.652 . . . . 0.0 110.697 -179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.645 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 89.8 m-85 -80.55 165.67 21.89 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.52 -0.738 . . . . 0.0 109.717 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 13.7 ttpp -139.62 118.61 12.57 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.426 -0.796 . . . . 0.0 110.521 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.624 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 46.9 tp -95.95 125.24 40.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.424 -0.797 . . . . 0.0 110.241 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.669 HG21 HG23 ' A' ' 54' ' ' THR . 4.3 tp -73.48 168.55 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 79.6 mt -128.93 73.18 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.195 -0.94 . . . . 0.0 110.45 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.498 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.8 m-20 -96.64 47.2 1.06 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.451 -0.781 . . . . 0.0 109.147 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.29 166.92 20.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.951 -1.259 . . . . 0.0 109.951 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -85.84 7.24 24.72 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.691 -0.888 . . . . 0.0 110.456 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.3 m -115.43 -33.35 5.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.142 -0.973 . . . . 0.0 110.086 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 mt -137.45 167.64 21.22 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.486 -0.759 . . . . 0.0 110.571 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.7 tttm -153.23 139.14 18.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.596 -0.69 . . . . 0.0 110.369 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.08 -144.6 16.23 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -142.68 168.14 20.43 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.573 -0.957 . . . . 0.0 110.255 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.6 m -157.67 133.38 9.18 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.564 -0.71 . . . . 0.0 110.181 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.2 p -112.86 167.5 10.45 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.54 -0.725 . . . . 0.0 110.25 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.632 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.7 t -159.35 167.68 28.26 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.499 -0.751 . . . . 0.0 110.29 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -98.51 112.19 24.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.618 -0.676 . . . . 0.0 110.219 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.88 137.9 31.71 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.586 -0.696 . . . . 0.0 110.052 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.64 HG23 ' OD1' ' A' ' 23' ' ' ASP . 33.9 m -60.46 -30.33 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.506 -0.746 . . . . 0.0 110.254 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.64 ' OD1' HG23 ' A' ' 22' ' ' VAL . 46.6 p-10 -170.67 -179.65 2.97 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.574 -0.703 . . . . 0.0 110.326 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.461 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -55.51 -24.39 31.43 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.584 -0.698 . . . . 0.0 110.87 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.43 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.67 -28.11 65.43 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.46 -0.775 . . . . 0.0 110.512 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 30' ' ' VAL . 46.5 m -109.43 -27.29 9.54 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.585 -0.697 . . . . 0.0 110.291 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.645 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -61.6 -61.32 2.61 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.537 -0.727 . . . . 0.0 110.062 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -58.85 -38.36 78.54 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.562 -0.711 . . . . 0.0 109.921 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -58.69 -40.13 82.69 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.575 -0.703 . . . . 0.0 109.735 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 26' ' ' THR . 97.9 t -82.6 -47.89 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.692 -0.63 . . . . 0.0 109.509 179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.632 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.1 m-85 -61.18 -32.71 72.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.629 -0.669 . . . . 0.0 109.998 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -65.5 -46.21 80.57 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -61.93 -30.94 71.24 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.65 0.738 . . . . 0.0 109.471 178.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -69.14 -54.29 15.73 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.715 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.3 -37.77 86.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.689 -0.632 . . . . 0.0 109.956 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -59.6 -33.34 71.35 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.512 -0.743 . . . . 0.0 110.428 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -70.68 -36.64 73.41 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.648 -0.657 . . . . 0.0 110.287 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -88.47 -27.9 21.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.581 -0.699 . . . . 0.0 110.161 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.82 39.73 3.3 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.715 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.8 mt -95.77 65.85 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.551 -0.97 . . . . 0.0 110.199 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -87.83 54.66 3.18 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -82.62 -137.01 2.64 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.71 105.29 11.84 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.939 -0.742 . . . . 0.0 109.202 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.624 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 31.7 m95 -74.13 143.38 45.34 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 122.138 0.97 . . . . 0.0 112.413 -177.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 44' ' ' TRP . 8.6 p -153.83 131.49 11.48 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -102.27 129.69 48.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.681 -0.637 . . . . 0.0 110.198 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.27 117.66 35.42 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.675 -0.64 . . . . 0.0 109.879 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.13 -13.16 61.13 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.648 -0.657 . . . . 0.0 111.005 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.425 ' C ' HG23 ' A' ' 50' ' ' THR . . . -56.66 -43.19 80.14 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.174 -0.954 . . . . 0.0 110.549 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.425 HG23 ' C ' ' A' ' 49' ' ' ALA . 73.7 p -147.49 24.33 1.11 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.609 -0.682 . . . . 0.0 110.435 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.439 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.69 93.45 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.305 -0.872 . . . . 0.0 110.853 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 71.4 m -156.48 105.11 2.24 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.803 -0.759 . . . . 0.0 110.903 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 91.6 m-85 -62.7 132.84 53.63 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.669 HG23 HG21 ' A' ' 7' ' ' ILE . 61.5 m -124.22 101.43 7.19 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.866 -178.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.551 HG11 HG21 ' A' ' 40' ' ' ILE . 11.2 p -102.51 166.59 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.349 -0.844 . . . . 0.0 109.167 177.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.498 HG23 ' HB3' ' A' ' 9' ' ' ASN . 98.9 m -160.52 110.12 1.74 Allowed 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.653 -0.654 . . . . 0.0 109.865 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.23 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 mtp . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.132 0.492 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.501 HG22 ' CE2' ' A' ' 4' ' ' PHE . 60.4 m -83.47 123.05 29.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.588 -0.695 . . . . 0.0 110.041 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 13.0 m -115.01 102.24 9.76 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 121.564 -0.71 . . . . 0.0 110.77 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.78 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 94.9 m-85 -82.77 -177.22 6.65 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.586 -0.696 . . . . 0.0 109.746 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.528 ' O ' HG23 ' A' ' 52' ' ' THR . 84.9 tttt -152.2 114.85 4.57 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.43 -0.794 . . . . 0.0 110.396 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.526 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 14.1 tp -93.51 140.03 30.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.269 -0.894 . . . . 0.0 110.277 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.7 tp -89.96 165.2 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 177.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.474 HG21 ' HB3' ' A' ' 13' ' ' LEU . 48.7 mm -126.44 77.02 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.255 -0.903 . . . . 0.0 110.514 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.732 ' HB3' HG23 ' A' ' 56' ' ' THR . 3.0 m-20 -98.83 48.93 0.97 Allowed 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.58 161.63 12.64 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.1 ttpt -76.96 -12.47 59.95 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.767 -0.843 . . . . 0.0 110.435 179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.8 m -91.1 -29.97 17.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.893 . . . . 0.0 110.158 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.474 ' HB3' HG21 ' A' ' 8' ' ' ILE . 24.6 mt -141.14 167.64 21.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 110.49 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -153.82 131.48 11.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.645 -0.659 . . . . 0.0 110.057 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.401 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 135.95 -124.67 3.33 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -165.91 172.54 11.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.521 -0.987 . . . . 0.0 110.43 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.1 m -152.87 161.37 42.63 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.55 -0.719 . . . . 0.0 110.241 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 p -137.96 171.26 14.69 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.614 -0.679 . . . . 0.0 110.207 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.552 HG22 ' CE2' ' A' ' 31' ' ' PHE . 7.7 t -161.77 164.03 29.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.588 -0.695 . . . . 0.0 110.341 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -102.34 93.69 5.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.574 -0.704 . . . . 0.0 110.159 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.406 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -117.36 -172.45 2.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.553 -0.717 . . . . 0.0 110.214 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.4 p -112.14 -25.82 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.656 -0.653 . . . . 0.0 110.154 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -166.84 177.96 6.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.521 -0.737 . . . . 0.0 110.023 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.25 -25.84 59.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.723 . . . . 0.0 110.812 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.13 -45.33 93.36 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.451 -0.78 . . . . 0.0 110.458 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 30' ' ' VAL . 6.7 m -87.61 -28.04 22.14 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.495 -0.753 . . . . 0.0 110.433 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.78 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -64.57 -63.47 1.12 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.533 -0.729 . . . . 0.0 110.402 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -57.9 -42.67 85.2 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.518 -0.739 . . . . 0.0 110.311 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -55.61 -39.3 70.59 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.382 -0.824 . . . . 0.0 110.248 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 26' ' ' THR . 88.3 t -82.31 -49.03 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.701 -0.624 . . . . 0.0 109.893 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.552 ' CE2' HG22 ' A' ' 19' ' ' THR . 5.6 m-85 -62.95 -33.62 75.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.65 -0.656 . . . . 0.0 110.337 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -65.21 -45.87 82.98 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.414 -0.804 . . . . 0.0 109.094 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 41.9 tp60 -61.71 -31.72 71.88 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.625 0.726 . . . . 0.0 109.552 179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 18.0 t80 -68.43 -53.4 23.92 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.616 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.14 -47.25 80.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.733 -0.605 . . . . 0.0 109.784 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -58.03 -28.11 64.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.603 -0.686 . . . . 0.0 110.43 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.88 -47.19 19.32 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.608 -0.683 . . . . 0.0 110.194 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -76.22 -43.12 43.7 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.562 -0.711 . . . . 0.0 110.063 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.23 51.09 0.18 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.616 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 83.9 mt -122.57 73.52 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.463 -1.022 . . . . 0.0 110.231 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.97 39.7 1.26 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 178.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.56 -137.79 0.02 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -111.94 111.91 23.18 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.526 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 28.4 m95 -80.59 142.82 33.69 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.233 1.016 . . . . 0.0 112.467 -177.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 44' ' ' TRP . 3.0 p -153.93 132.95 12.48 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -103.16 140.5 37.27 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.649 -0.657 . . . . 0.0 110.156 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -112.6 116.63 30.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.643 -0.661 . . . . 0.0 110.004 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -71.2 -15.14 62.45 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.646 -0.659 . . . . 0.0 111.147 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.426 ' C ' HG23 ' A' ' 50' ' ' THR . . . -55.99 -43.48 77.68 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.206 -0.934 . . . . 0.0 110.681 -179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.426 HG23 ' C ' ' A' ' 49' ' ' ALA . 68.8 p -147.47 23.02 1.15 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.566 -0.709 . . . . 0.0 110.569 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.448 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.51 88.99 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.246 -0.909 . . . . 0.0 110.764 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 5' ' ' LYS . 88.2 m -151.95 106.16 3.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.448 -0.782 . . . . 0.0 110.872 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.433 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 86.0 m-85 -62.98 137.11 58.17 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.419 -0.801 . . . . 0.0 108.842 178.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.628 ' HA ' HG22 ' A' ' 7' ' ' ILE . 55.8 m -126.81 95.09 4.22 Favored 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 119.124 -1.03 . . . . 0.0 113.231 -178.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.514 HG11 ' CG2' ' A' ' 40' ' ' ILE . 11.5 p -97.4 167.34 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.272 -0.893 . . . . 0.0 109.145 177.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.732 HG23 ' HB3' ' A' ' 9' ' ' ASN . 97.9 m -160.58 111.62 1.85 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.549 -0.719 . . . . 0.0 110.126 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.05 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.2 mtt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.107 0.479 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.631 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 8.7 m -87.32 114.24 23.76 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.546 -0.721 . . . . 0.0 110.194 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 3' ' ' THR . 8.8 t -95.13 79.97 3.58 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.533 -0.729 . . . . 0.0 110.892 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.803 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 98.1 m-85 -62.13 179.62 0.28 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.335 -0.853 . . . . 0.0 109.779 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.462 ' HB3' HG23 ' A' ' 52' ' ' THR . 26.6 tttt -153.9 126.46 8.1 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.524 -0.735 . . . . 0.0 110.353 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.582 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 46.3 tp -103.87 135.43 45.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.459 -0.776 . . . . 0.0 110.189 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.59 HG21 HG23 ' A' ' 54' ' ' THR . 2.6 tp -86.78 168.69 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 13' ' ' LEU . 83.8 mt -128.43 72.64 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.203 -0.936 . . . . 0.0 110.634 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.626 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.1 m-80 -95.6 48.47 1.14 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.367 -0.833 . . . . 0.0 108.969 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.95 154.56 16.53 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.3 ptmt -72.42 -6.99 47.43 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.665 -0.903 . . . . 0.0 110.942 179.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -96.99 -30.75 12.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.202 -0.936 . . . . 0.0 110.283 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.563 ' O ' HG22 ' A' ' 8' ' ' ILE . 2.5 tp -145.21 157.58 44.04 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.497 -0.752 . . . . 0.0 110.433 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 14.6 mttm -140.13 136.01 33.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.591 -0.693 . . . . 0.0 110.497 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.72 -140.57 10.87 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -151.72 168.55 24.69 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.541 -0.976 . . . . 0.0 110.434 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.2 m -150.54 148.49 28.75 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.588 -0.695 . . . . 0.0 110.265 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.455 HG23 ' HE3' ' A' ' 5' ' ' LYS . 9.1 p -131.13 168.38 17.54 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.578 -0.701 . . . . 0.0 110.155 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.791 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.6 t -164.32 179.09 7.02 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.588 -0.695 . . . . 0.0 110.378 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.96 128.25 54.47 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.714 . . . . 0.0 110.111 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.565 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -154.25 138.3 16.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.598 -0.689 . . . . 0.0 110.189 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.9 m -59.35 -26.7 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.505 -0.747 . . . . 0.0 110.45 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.562 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 30.3 p30 -173.12 -178.24 1.73 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.452 -0.78 . . . . 0.0 110.304 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.91 -25.29 56.88 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.54 -0.725 . . . . 0.0 110.869 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.562 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.04 -27.17 65.23 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.456 -0.778 . . . . 0.0 110.397 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.565 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 5.9 m -109.71 -27.84 9.14 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.518 -0.739 . . . . 0.0 110.305 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.803 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.02 -62.98 1.47 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.536 -0.727 . . . . 0.0 110.233 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -58.47 -32.48 68.8 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.521 -0.737 . . . . 0.0 110.166 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.8 tttt -56.61 -45.56 81.4 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.414 -0.804 . . . . 0.0 110.156 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.8 t -80.18 -45.05 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.653 -0.654 . . . . 0.0 109.697 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.791 ' CZ ' HG22 ' A' ' 19' ' ' THR . 12.6 m-85 -61.88 -33.56 74.42 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.597 -0.689 . . . . 0.0 110.04 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.1 mmtt -64.52 -46.65 82.0 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.457 -0.777 . . . . 0.0 109.058 179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -63.15 -33.5 75.6 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.608 0.718 . . . . 0.0 109.329 179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.426 ' CD2' HD23 ' A' ' 6' ' ' LEU . 18.8 t80 -65.2 -46.67 79.76 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.571 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -72.99 -38.2 66.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.718 -0.614 . . . . 0.0 109.651 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -60.27 -45.3 93.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.539 -0.726 . . . . 0.0 110.316 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -60.28 -53.35 58.73 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.585 -0.697 . . . . 0.0 110.358 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -69.18 -48.24 62.74 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.525 -0.735 . . . . 0.0 110.033 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.44 46.11 0.3 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.571 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.1 mt -108.79 77.03 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.501 -0.999 . . . . 0.0 110.454 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -98.99 39.28 1.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.74 -138.35 0.02 OUTLIER Glycine 0 N--CA 1.488 2.148 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -112.45 111.05 21.62 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.842 -0.799 . . . . 0.0 108.956 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.582 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 29.3 m95 -80.31 143.56 33.51 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.182 0.991 . . . . 0.0 112.483 -178.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 44' ' ' TRP . 1.6 p -152.91 132.28 12.86 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.402 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 14.5 t80 -104.81 120.87 42.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.678 -0.638 . . . . 0.0 110.111 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -90.77 111.39 22.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.649 -0.657 . . . . 0.0 110.087 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -66.72 -15.76 63.76 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.601 -0.687 . . . . 0.0 110.849 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.416 ' C ' HG23 ' A' ' 50' ' ' THR . . . -55.09 -42.69 73.18 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.168 -0.957 . . . . 0.0 110.812 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.416 HG23 ' C ' ' A' ' 49' ' ' ALA . 81.0 p -147.07 24.12 1.17 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.53 -0.731 . . . . 0.0 110.527 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.445 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 4.3 mptt 51.79 87.35 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.247 -0.908 . . . . 0.0 110.78 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.462 HG23 ' HB3' ' A' ' 5' ' ' LYS . 58.4 m -150.88 103.65 3.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.513 -0.742 . . . . 0.0 110.728 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -62.5 134.84 56.98 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.489 -0.757 . . . . 0.0 109.112 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.59 HG23 HG21 ' A' ' 7' ' ' ILE . 75.7 m -125.72 104.05 8.15 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 119.354 -0.938 . . . . 0.0 112.71 -178.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.519 HG21 HG22 ' A' ' 40' ' ' ILE . 11.1 p -104.73 167.24 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.279 177.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.626 HG23 ' HB3' ' A' ' 9' ' ' ASN . 93.2 m -159.79 109.59 1.85 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.586 -0.696 . . . . 0.0 109.801 -179.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.098 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mtt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.047 0.451 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.554 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 40.2 m -72.01 111.64 7.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.576 -0.702 . . . . 0.0 110.011 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 58.8 m -89.87 96.73 10.81 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 121.588 -0.695 . . . . 0.0 110.662 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.766 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 87.6 m-85 -79.34 170.03 17.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.528 -0.732 . . . . 0.0 109.77 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.735 ' HG3' HG22 ' A' ' 18' ' ' THR . 2.2 mtpp -140.09 124.57 18.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.456 -0.778 . . . . 0.0 110.474 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.607 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 53.3 tp -101.94 120.42 40.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.426 -0.796 . . . . 0.0 109.817 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.635 HG21 HG23 ' A' ' 54' ' ' THR . 2.5 tt -69.36 172.75 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 13' ' ' LEU . 76.8 mt -135.39 75.39 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 119.414 -0.915 . . . . 0.0 110.676 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -96.68 47.59 1.06 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.89 154.46 16.63 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.0 tttp -71.25 -9.78 58.67 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.688 -0.889 . . . . 0.0 110.611 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.0 m -91.44 -33.44 15.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.215 -0.928 . . . . 0.0 110.273 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.462 ' O ' HG22 ' A' ' 8' ' ' ILE . 23.8 mt -142.13 167.5 21.97 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.465 -0.772 . . . . 0.0 110.638 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -147.52 136.78 22.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.634 -0.666 . . . . 0.0 110.198 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.401 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 127.26 -137.41 9.87 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -155.96 152.2 27.9 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.591 -0.947 . . . . 0.0 110.356 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.8 m -122.94 160.67 25.72 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.626 -0.671 . . . . 0.0 110.223 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.735 HG22 ' HG3' ' A' ' 5' ' ' LYS . 20.4 p -128.67 174.87 9.04 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.538 -0.726 . . . . 0.0 110.296 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.484 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.5 t -167.14 -173.26 2.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.526 -0.734 . . . . 0.0 110.328 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -128.56 101.97 6.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 0.0 110.177 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.0 155.07 47.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.605 -0.684 . . . . 0.0 110.135 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.42 HG13 ' OD2' ' A' ' 23' ' ' ASP . 7.8 p -74.42 -23.84 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.59 -0.694 . . . . 0.0 110.287 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.721 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 3.9 p30 -171.62 176.04 3.84 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.311 -0.868 . . . . 0.0 110.385 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.451 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -57.12 -29.61 63.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.553 -0.717 . . . . 0.0 110.992 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.721 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -57.89 -24.4 57.52 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.458 -0.776 . . . . 0.0 110.614 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.9 m -110.94 -27.98 8.56 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.466 -0.771 . . . . 0.0 110.355 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.766 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.81 -52.75 63.73 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.506 -0.746 . . . . 0.0 110.278 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -57.66 -39.87 78.03 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.554 -0.716 . . . . 0.0 110.415 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -56.9 -39.11 73.8 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.332 -0.855 . . . . 0.0 110.288 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.3 t -80.91 -49.19 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.665 -0.647 . . . . 0.0 110.105 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.484 ' CZ ' HG22 ' A' ' 19' ' ' THR . 6.2 m-85 -65.01 -33.08 75.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.594 -0.691 . . . . 0.0 110.409 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 ttmt -64.1 -46.85 82.38 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.439 -0.788 . . . . 0.0 109.232 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -61.5 -31.97 71.98 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.619 0.724 . . . . 0.0 109.675 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.409 ' CD2' HD23 ' A' ' 6' ' ' LEU . 15.8 t80 -67.88 -42.96 80.44 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.63 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -78.45 -38.89 40.11 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.614 -0.678 . . . . 0.0 110.017 179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -58.29 -52.19 66.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.467 -0.77 . . . . 0.0 110.28 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.6 -47.22 86.45 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.647 -0.658 . . . . 0.0 110.108 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -65.37 -45.9 82.24 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.555 -0.716 . . . . 0.0 110.037 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.44 36.93 0.88 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.63 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.1 mt -104.21 69.05 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.43 -1.041 . . . . 0.0 110.29 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -92.23 49.35 1.5 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.54 -0.725 . . . . 0.0 109.324 179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -77.1 -137.09 0.84 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.17 112.24 22.21 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.893 -0.769 . . . . 0.0 109.11 179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.607 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 25.2 m95 -81.09 143.11 32.67 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.247 1.023 . . . . 0.0 112.445 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 p -150.98 131.82 14.13 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.416 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 31.1 t80 -105.05 128.81 53.5 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.669 -0.645 . . . . 0.0 110.031 -178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -102.47 111.26 23.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.676 -0.64 . . . . 0.0 109.953 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -66.69 -23.9 66.19 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.719 -0.613 . . . . 0.0 110.588 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.65 -38.78 64.46 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.404 -0.81 . . . . 0.0 110.851 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.2 p -143.26 14.71 1.84 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.541 -0.724 . . . . 0.0 110.911 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 4.4 mptt 50.92 87.12 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.074 -1.016 . . . . 0.0 110.712 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.5 m -149.64 105.59 3.46 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.118 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.439 ' O ' HD12 ' A' ' 6' ' ' LEU . 82.4 m-85 -62.25 123.72 18.94 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.635 HG23 HG21 ' A' ' 7' ' ' ILE . 63.3 m -117.39 104.15 10.83 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.175 -0.953 . . . . 0.0 112.854 -178.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.536 HG11 HG21 ' A' ' 40' ' ' ILE . 10.4 p -106.38 164.67 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.353 -0.842 . . . . 0.0 109.377 177.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.459 ' N ' HG22 ' A' ' 55' ' ' VAL . 64.0 m -163.91 116.11 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 . . . . . 0 N--CA 1.496 1.839 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.384 179.96 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mtp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.106 0.479 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.463 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 86.3 m -99.91 112.08 24.37 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.584 -0.698 . . . . 0.0 110.237 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 3' ' ' THR . 8.7 t -88.04 104.29 16.52 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.701 -0.624 . . . . 0.0 110.756 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.622 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 83.9 m-85 -86.79 176.45 7.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.387 -0.821 . . . . 0.0 109.87 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.528 ' O ' HG23 ' A' ' 52' ' ' THR . 25.0 ttmt -146.75 115.82 6.94 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.47 -0.769 . . . . 0.0 110.245 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.606 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 48.3 tp -93.66 122.39 36.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.545 -0.722 . . . . 0.0 110.157 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.652 HG21 HG23 ' A' ' 54' ' ' THR . 5.0 tp -70.44 171.64 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.537 HG21 ' HB3' ' A' ' 13' ' ' LEU . 84.9 mt -132.26 71.73 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.216 -0.928 . . . . 0.0 110.564 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.475 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.0 m-20 -95.43 48.07 1.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.499 -0.751 . . . . 0.0 109.062 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.5 159.79 14.05 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -75.66 -6.16 49.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.707 -0.878 . . . . 0.0 110.564 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.401 ' H ' HG22 ' A' ' 12' ' ' THR . 9.9 t -100.17 -27.09 13.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.201 -0.937 . . . . 0.0 110.666 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.537 ' HB3' HG21 ' A' ' 8' ' ' ILE . 17.4 mt -143.78 163.59 32.9 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.425 -0.797 . . . . 0.0 110.577 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -147.9 131.95 17.25 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.588 -0.695 . . . . 0.0 110.2 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.71 -132.63 6.25 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.482 ' N ' HD12 ' A' ' 8' ' ' ILE . 2.2 pt-20 -162.54 159.04 24.31 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.51 -0.994 . . . . 0.0 110.326 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 18' ' ' THR . 48.7 m -138.84 165.1 27.92 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.501 -0.749 . . . . 0.0 110.275 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.421 ' N ' HG22 ' A' ' 17' ' ' THR . 29.6 p -135.27 168.84 18.44 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.584 -0.697 . . . . 0.0 110.262 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.642 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.1 t -164.62 168.9 17.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.55 -0.719 . . . . 0.0 110.194 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -101.54 116.32 32.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.488 -0.757 . . . . 0.0 110.262 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -144.88 142.78 30.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.567 -0.708 . . . . 0.0 110.095 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.43 HG23 ' N ' ' A' ' 23' ' ' ASP . 33.7 m -57.35 -37.32 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.449 -0.782 . . . . 0.0 110.095 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.43 ' N ' HG23 ' A' ' 22' ' ' VAL . 1.5 t70 -172.34 -172.49 0.94 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.699 -0.626 . . . . 0.0 109.773 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.455 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.98 -23.14 12.22 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.461 -0.774 . . . . 0.0 111.174 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.28 -35.9 74.58 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.471 -0.768 . . . . 0.0 110.718 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.5 m -106.64 -25.39 11.8 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.445 -0.784 . . . . 0.0 110.811 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.622 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -57.83 -60.61 3.43 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.407 -0.808 . . . . 0.0 110.733 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -57.01 -40.09 75.98 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.521 -0.737 . . . . 0.0 110.568 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.4 mttt -57.65 -37.89 74.12 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.366 -0.834 . . . . 0.0 110.144 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 99.5 t -82.46 -48.7 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.64 -0.663 . . . . 0.0 109.851 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.642 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.1 m-85 -63.85 -33.17 75.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.551 -0.718 . . . . 0.0 110.212 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.3 tttt -64.76 -44.98 88.28 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.5 -0.75 . . . . 0.0 109.086 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -61.85 -27.63 68.92 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.505 0.669 . . . . 0.0 109.779 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -74.4 -53.08 10.31 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.728 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.94 -40.14 92.1 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.581 -0.7 . . . . 0.0 110.18 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -57.72 -49.73 75.55 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.537 -0.727 . . . . 0.0 110.693 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.88 -55.94 27.07 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.522 -0.736 . . . . 0.0 110.2 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -60.96 -47.68 85.34 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.563 -0.711 . . . . 0.0 110.082 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.71 64.58 0.3 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.728 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 82.4 mt -126.01 79.01 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.545 -0.974 . . . . 0.0 110.148 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -95.39 43.95 1.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -74.52 -140.48 0.64 Allowed Glycine 0 N--CA 1.487 2.093 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -118.78 111.33 18.32 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.606 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 26.0 m95 -77.13 143.9 38.81 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.178 0.99 . . . . 0.0 112.416 -177.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.6 p -151.27 132.77 14.72 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -104.41 113.71 27.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.621 -0.674 . . . . 0.0 110.122 -178.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -88.66 116.27 26.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.674 -0.641 . . . . 0.0 109.957 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.15 -15.78 61.98 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.625 -0.672 . . . . 0.0 110.845 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.437 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.97 -39.43 65.96 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.189 -0.944 . . . . 0.0 110.766 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.437 HG23 ' C ' ' A' ' 49' ' ' ALA . 69.1 p -148.47 20.11 1.06 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.561 -0.712 . . . . 0.0 110.702 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.52 85.89 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.194 -0.941 . . . . 0.0 110.837 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 5' ' ' LYS . 89.5 m -150.39 105.51 3.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.559 -0.713 . . . . 0.0 110.494 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.434 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 90.0 m-85 -60.02 126.98 29.62 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.652 HG23 HG21 ' A' ' 7' ' ' ILE . 48.7 m -119.96 100.03 6.97 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.984 -177.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.69 HG11 HG21 ' A' ' 40' ' ' ILE . 10.6 p -100.83 166.93 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.44 -0.788 . . . . 0.0 109.021 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.475 HG23 ' HB3' ' A' ' 9' ' ' ASN . 90.1 m -158.68 109.81 2.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.515 -0.74 . . . . 0.0 110.295 -179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.288 179.917 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.101 0.477 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.567 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 55.6 m -77.75 145.53 36.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.597 -0.689 . . . . 0.0 110.177 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 65.6 m -122.75 96.65 5.11 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.617 -0.677 . . . . 0.0 110.44 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.652 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 97.4 m-85 -81.41 175.34 10.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.585 -0.697 . . . . 0.0 110.081 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.498 ' HB3' HG23 ' A' ' 52' ' ' THR . 16.0 ttpt -151.33 127.78 10.7 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.523 -0.736 . . . . 0.0 110.185 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.618 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 48.0 tp -104.73 125.21 50.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.494 -0.754 . . . . 0.0 110.442 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.728 HG21 HG23 ' A' ' 54' ' ' THR . 2.1 tp -75.17 171.31 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.474 HD12 ' C ' ' A' ' 15' ' ' GLY . 78.0 mt -130.8 74.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.179 -0.951 . . . . 0.0 110.674 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.54 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.7 m-20 -97.3 46.91 1.03 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.31 -0.869 . . . . 0.0 108.796 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.93 165.17 17.36 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.94 4.58 29.0 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.726 -0.867 . . . . 0.0 110.643 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -114.87 -26.86 7.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.182 -0.949 . . . . 0.0 110.484 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.459 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.3 tp -143.39 166.8 23.77 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.37 -0.831 . . . . 0.0 110.769 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -153.53 143.23 21.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.559 -0.713 . . . . 0.0 110.27 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.474 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 134.05 -142.62 14.13 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -142.5 172.07 13.19 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.568 -0.96 . . . . 0.0 110.341 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.9 m -155.9 132.72 10.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.628 -0.67 . . . . 0.0 110.02 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.0 p -119.81 167.24 12.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.514 -0.741 . . . . 0.0 110.357 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.677 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.0 t -167.17 166.06 15.15 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.618 -0.677 . . . . 0.0 110.265 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -100.29 111.06 23.31 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.564 -0.71 . . . . 0.0 110.218 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.454 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -135.01 139.67 45.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.583 -0.698 . . . . 0.0 110.199 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.8 m -58.73 -28.8 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.543 -0.723 . . . . 0.0 110.408 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.598 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 27.5 p30 -173.87 -176.45 1.21 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.431 -0.793 . . . . 0.0 110.34 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -57.99 -23.94 56.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.613 -0.679 . . . . 0.0 110.809 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.598 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.65 -29.38 67.99 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.453 -0.779 . . . . 0.0 110.281 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.454 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 30.2 m -106.29 -28.17 10.57 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.55 -0.719 . . . . 0.0 110.154 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.652 ' HB2' ' CD1' ' A' ' 4' ' ' PHE . . . -61.3 -59.89 4.58 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.562 -0.711 . . . . 0.0 110.097 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -59.77 -43.79 94.17 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.601 -0.687 . . . . 0.0 110.215 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.6 tttt -54.64 -40.22 68.78 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.284 -0.885 . . . . 0.0 110.229 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 26' ' ' THR . 97.8 t -82.17 -48.52 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.697 -0.627 . . . . 0.0 109.918 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.677 ' CZ ' HG22 ' A' ' 19' ' ' THR . 13.5 m-85 -62.16 -32.73 73.38 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.653 -0.654 . . . . 0.0 110.304 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -66.31 -42.86 87.68 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.046 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -62.42 -30.11 70.99 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.505 0.669 . . . . 0.0 109.678 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -70.22 -50.68 37.47 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.673 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -67.24 -37.47 83.59 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.629 -0.67 . . . . 0.0 110.075 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -57.0 -36.47 70.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.479 -0.763 . . . . 0.0 110.65 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -69.83 -41.29 75.14 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.519 -0.738 . . . . 0.0 110.174 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -80.84 -27.98 36.29 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.596 -0.69 . . . . 0.0 110.269 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 95.82 38.35 4.68 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.673 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 76.8 mt -89.5 66.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.548 -0.972 . . . . 0.0 110.226 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -85.63 56.97 4.2 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.569 -0.707 . . . . 0.0 109.15 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.33 -138.21 4.98 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.47 102.19 8.72 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.868 -0.784 . . . . 0.0 109.161 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.618 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 32.6 m95 -69.88 143.13 52.88 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 122.153 0.977 . . . . 0.0 112.457 -177.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.405 HG23 ' O ' ' A' ' 44' ' ' TRP . 3.4 p -152.0 131.83 13.28 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -107.26 152.72 23.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.635 -0.666 . . . . 0.0 110.059 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -126.98 113.72 16.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.687 -0.633 . . . . 0.0 109.911 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -67.61 -23.05 65.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.703 -0.623 . . . . 0.0 110.833 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.75 -40.15 62.83 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.275 -0.891 . . . . 0.0 110.718 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.2 p -144.98 16.46 1.57 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.667 -0.645 . . . . 0.0 110.744 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.461 ' HG2' ' CE2' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.81 89.56 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.121 -0.987 . . . . 0.0 110.876 179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.498 HG23 ' HB3' ' A' ' 5' ' ' LYS . 63.6 m -152.78 102.46 2.69 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.494 -0.754 . . . . 0.0 110.949 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -63.0 136.75 58.0 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.728 HG23 HG21 ' A' ' 7' ' ' ILE . 86.4 m -129.37 103.04 6.69 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.37 -0.932 . . . . 0.0 112.322 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.598 HG11 HG21 ' A' ' 40' ' ' ILE . 10.7 p -102.54 167.04 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.374 -0.829 . . . . 0.0 109.265 177.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.54 HG23 ' HB3' ' A' ' 9' ' ' ASN . 92.0 m -160.71 112.65 1.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.595 -0.69 . . . . 0.0 110.273 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.086 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 tpp . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.06 0.457 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.477 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 93.9 m -134.93 112.97 11.07 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.63 -0.669 . . . . 0.0 110.124 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.2 m -88.58 104.27 16.68 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.606 -0.684 . . . . 0.0 110.707 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.663 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 88.8 m-85 -85.57 179.6 7.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.548 -0.72 . . . . 0.0 109.821 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 11.3 mtmm -144.44 117.24 8.74 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.438 -0.789 . . . . 0.0 110.575 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.583 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 34.7 tp -99.47 121.66 41.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.464 -0.772 . . . . 0.0 110.164 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.65 HG21 HG23 ' A' ' 54' ' ' THR . 4.8 tp -70.69 169.3 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.529 HD11 ' OG1' ' A' ' 17' ' ' THR . 81.2 mt -131.33 77.24 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.246 -0.909 . . . . 0.0 110.856 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.532 ' HB3' HG23 ' A' ' 56' ' ' THR . 71.5 m-20 -97.24 46.93 1.03 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.225 -0.922 . . . . 0.0 108.633 178.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.12 153.04 16.97 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.59 -8.09 53.5 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.756 -0.849 . . . . 0.0 110.716 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 m -94.14 -30.88 14.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.215 -0.928 . . . . 0.0 110.4 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -145.63 174.78 10.89 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.423 -0.798 . . . . 0.0 110.498 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -165.72 142.58 5.44 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.608 -0.682 . . . . 0.0 110.48 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.5 -121.74 2.75 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -157.07 153.05 27.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.973 . . . . 0.0 110.304 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.529 ' OG1' HD11 ' A' ' 8' ' ' ILE . 4.4 m -138.9 142.67 38.51 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.553 -0.717 . . . . 0.0 110.244 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.9 p -124.61 153.09 42.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.617 -0.677 . . . . 0.0 110.184 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.734 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.9 t -151.35 142.24 22.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.554 -0.716 . . . . 0.0 110.285 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -77.49 114.66 16.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.594 -0.691 . . . . 0.0 110.34 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -142.4 139.87 31.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.463 -0.773 . . . . 0.0 110.054 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 23' ' ' ASP . 33.2 m -56.46 -36.45 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.481 -0.762 . . . . 0.0 110.23 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' N ' HG23 ' A' ' 22' ' ' VAL . 3.6 t70 -172.66 -173.27 0.99 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.595 -0.691 . . . . 0.0 109.934 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.5 -22.36 12.71 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.403 -0.811 . . . . 0.0 111.269 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.71 66.77 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.355 -0.841 . . . . 0.0 110.505 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 8.5 m -116.44 -21.69 9.11 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.466 -0.771 . . . . 0.0 110.954 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.663 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -57.3 -62.97 1.39 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.318 -0.864 . . . . 0.0 110.667 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -59.98 -36.41 77.09 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.45 -0.781 . . . . 0.0 110.086 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.8 tttt -57.6 -43.68 84.86 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.486 -0.759 . . . . 0.0 109.962 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.6 t -78.77 -48.23 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.713 -0.617 . . . . 0.0 109.667 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.734 ' CZ ' HG22 ' A' ' 19' ' ' THR . 4.9 m-85 -61.33 -32.81 72.69 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.621 -0.675 . . . . 0.0 110.262 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -64.07 -42.94 96.8 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.433 -0.792 . . . . 0.0 108.9 179.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -64.56 -32.31 73.9 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.643 0.735 . . . . 0.0 109.341 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -68.04 -56.02 10.42 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -59.9 -41.38 91.5 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.716 -0.615 . . . . 0.0 110.287 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -56.77 -37.92 71.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.483 -0.76 . . . . 0.0 110.643 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -61.14 -37.87 84.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.596 -0.69 . . . . 0.0 110.284 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -91.21 -30.72 16.49 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.511 -0.743 . . . . 0.0 110.178 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.06 44.3 1.77 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.757 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 79.8 mt -95.08 62.39 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.486 -1.008 . . . . 0.0 110.159 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.85 59.16 5.05 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -88.66 -138.47 6.4 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -115.13 103.15 10.58 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.845 -0.797 . . . . 0.0 109.015 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.583 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 38.5 m95 -73.18 143.34 47.26 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 122.161 0.981 . . . . 0.0 112.195 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 44' ' ' TRP . 7.0 p -155.91 131.43 9.61 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -105.71 133.07 51.03 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.655 -0.653 . . . . 0.0 109.955 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -104.3 109.97 22.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.77 -0.581 . . . . 0.0 109.888 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.6 -20.99 66.59 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.656 -0.653 . . . . 0.0 110.588 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.433 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.87 -37.84 60.86 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.263 -0.898 . . . . 0.0 110.958 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.433 HG23 ' C ' ' A' ' 49' ' ' ALA . 73.6 p -147.68 19.89 1.16 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.573 -0.704 . . . . 0.0 110.826 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.442 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 50.63 85.38 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.154 -0.966 . . . . 0.0 110.875 179.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.3 m -151.43 105.81 3.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.467 -0.771 . . . . 0.0 111.035 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.468 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 84.1 m-85 -62.83 137.6 58.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.485 -0.76 . . . . 0.0 109.071 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.65 HG23 HG21 ' A' ' 7' ' ' ILE . 68.3 m -128.79 98.76 5.08 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.316 -0.954 . . . . 0.0 112.764 -178.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 40' ' ' ILE . 11.0 p -101.86 166.46 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -0.897 . . . . 0.0 109.254 177.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.532 HG23 ' HB3' ' A' ' 9' ' ' ASN . 82.8 m -161.67 111.06 1.55 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.725 -0.609 . . . . 0.0 109.657 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.24 -179.999 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.034 0.445 . . . . 0.0 110.038 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.499 HG22 ' CE2' ' A' ' 4' ' ' PHE . 87.1 m -82.56 112.41 19.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.538 -0.726 . . . . 0.0 110.16 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 19' ' ' THR . 4.6 m -110.58 92.23 3.97 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 121.603 -0.686 . . . . 0.0 110.506 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.591 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.9 m-85 -67.35 169.38 9.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.568 -0.707 . . . . 0.0 109.961 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.631 ' HG2' HG22 ' A' ' 18' ' ' THR . 64.0 mttt -140.41 120.16 13.41 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.576 -0.703 . . . . 0.0 110.491 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.597 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 28.7 tp -98.95 130.41 45.32 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.512 -0.743 . . . . 0.0 109.919 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.635 HG21 HG23 ' A' ' 54' ' ' THR . 2.4 tp -78.95 171.81 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.521 HG22 ' O ' ' A' ' 13' ' ' LEU . 83.2 mt -132.63 72.12 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.258 -0.901 . . . . 0.0 110.431 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.609 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.0 m-20 -93.94 50.55 1.43 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -114.43 156.07 15.9 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -71.64 -13.43 61.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.716 -0.873 . . . . 0.0 110.492 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.5 m -88.57 -33.44 17.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.272 -0.893 . . . . 0.0 110.38 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.521 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.4 mt -144.1 162.81 35.32 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.406 -0.809 . . . . 0.0 110.832 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -143.35 136.71 28.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.67 -0.644 . . . . 0.0 110.146 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.401 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 133.23 -145.41 17.44 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -144.57 166.8 24.13 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.537 -0.978 . . . . 0.0 110.275 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.0 m -139.33 168.84 18.93 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.533 -0.73 . . . . 0.0 110.211 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.631 HG22 ' HG2' ' A' ' 5' ' ' LYS . 10.0 p -137.55 165.43 26.32 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.526 -0.734 . . . . 0.0 110.354 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 3' ' ' THR . 7.9 t -146.78 163.03 37.32 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.507 -0.745 . . . . 0.0 110.262 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -111.97 87.63 2.61 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.499 -0.75 . . . . 0.0 110.24 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.654 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -126.29 -171.76 2.47 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.529 -0.732 . . . . 0.0 110.206 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.7 p -112.41 -25.84 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.563 -0.711 . . . . 0.0 110.224 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -164.91 174.4 10.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.469 -0.77 . . . . 0.0 110.0 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.591 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -54.08 -23.5 14.04 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.422 -0.799 . . . . 0.0 110.781 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -56.56 -42.84 79.26 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.392 -0.817 . . . . 0.0 109.996 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.654 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 85.6 m -87.93 -34.03 18.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.649 -0.657 . . . . 0.0 109.413 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.591 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -63.25 -178.8 0.27 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.673 -0.642 . . . . 0.0 109.595 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 66.36 -63.01 0.26 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.546 -0.721 . . . . 0.0 110.528 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.83 -34.72 60.13 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.999 -1.063 . . . . 0.0 110.246 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.3 t -82.17 -50.23 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.698 -0.626 . . . . 0.0 109.666 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.539 ' HB3' HD22 ' A' ' 6' ' ' LEU . 4.6 m-85 -62.86 -33.65 75.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.586 -0.696 . . . . 0.0 109.856 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.2 mtpt -63.7 -41.32 98.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.593 -0.692 . . . . 0.0 109.28 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -60.97 -31.78 71.35 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.642 0.734 . . . . 0.0 109.714 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -71.53 -55.73 7.28 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.776 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -65.51 -47.18 76.84 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.68 -0.638 . . . . 0.0 110.31 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -56.18 -28.36 57.91 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.491 -0.756 . . . . 0.0 110.519 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.41 -39.64 24.65 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.69 -0.631 . . . . 0.0 110.048 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -79.13 -46.89 17.08 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.65 -0.656 . . . . 0.0 110.003 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.79 60.06 0.18 Allowed Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.776 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 86.4 mt -124.04 67.89 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.549 -0.971 . . . . 0.0 110.173 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.26 53.29 2.6 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -81.93 -138.47 2.71 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -115.56 101.11 8.57 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.857 -0.79 . . . . 0.0 109.337 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.597 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 34.3 m95 -70.02 143.52 52.52 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 122.002 0.906 . . . . 0.0 112.098 -178.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 44' ' ' TRP . 12.2 p -155.01 130.51 9.81 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -103.08 146.14 28.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.665 -0.647 . . . . 0.0 109.783 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -118.31 116.89 27.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.72 -0.612 . . . . 0.0 109.857 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -71.42 -21.2 62.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.666 -0.646 . . . . 0.0 110.584 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.83 -40.52 66.5 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.269 -0.895 . . . . 0.0 110.806 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 74.8 p -144.83 17.19 1.61 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.605 -0.684 . . . . 0.0 110.789 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.456 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.27 91.61 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.187 -0.945 . . . . 0.0 111.043 179.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 5' ' ' LYS . 59.8 m -158.59 104.8 1.81 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.45 -0.781 . . . . 0.0 110.715 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.501 ' CE1' ' HB1' ' A' ' 27' ' ' ALA . 93.1 m-85 -62.16 139.49 58.47 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.635 HG23 HG21 ' A' ' 7' ' ' ILE . 25.2 m -131.51 102.7 6.04 Favored 'General case' 0 N--CA 1.5 2.071 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.954 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.549 HG21 HG22 ' A' ' 40' ' ' ILE . 11.3 p -102.97 166.95 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.347 -0.846 . . . . 0.0 109.17 177.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.609 HG23 ' HB3' ' A' ' 9' ' ' ASN . 99.8 m -160.92 115.09 2.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.666 -0.646 . . . . 0.0 109.964 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.127 179.807 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 mmt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.058 0.456 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.452 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 62.8 m -116.03 112.09 21.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.572 -0.705 . . . . 0.0 110.198 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.6 m -92.26 103.01 15.51 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.604 -0.685 . . . . 0.0 110.503 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.756 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 79.5 m-85 -84.68 170.05 13.69 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.586 -0.696 . . . . 0.0 110.068 179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -139.66 145.29 38.26 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.571 -0.705 . . . . 0.0 109.889 179.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 53' ' ' PHE . 18.3 tp -123.12 135.2 54.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.484 -0.76 . . . . 0.0 110.436 -179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.638 HG21 HG23 ' A' ' 54' ' ' THR . 3.8 tp -85.56 156.0 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 177.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.472 HG21 ' HB3' ' A' ' 13' ' ' LEU . 49.5 mm -120.51 74.78 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.368 -179.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.587 ' HB3' HG23 ' A' ' 56' ' ' THR . 5.9 m-20 -95.7 47.35 1.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 109.003 -0.739 . . . . 0.0 109.003 178.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.74 153.28 17.59 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -69.28 -10.91 60.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.627 -0.925 . . . . 0.0 110.452 179.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.2 m -87.66 -37.76 16.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 110.256 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.472 ' HB3' HG21 ' A' ' 8' ' ' ILE . 18.1 mt -138.62 172.44 12.88 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.45 -0.781 . . . . 0.0 110.778 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -151.9 135.93 16.53 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.602 -0.686 . . . . 0.0 110.094 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 126.12 -145.46 15.73 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -146.18 178.2 8.41 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.585 -0.95 . . . . 0.0 110.406 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 80.4 m -159.71 152.87 22.01 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 110.16 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.0 p -124.51 163.4 21.94 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.561 -0.712 . . . . 0.0 110.349 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.2 t -150.5 -171.54 3.95 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.633 -0.667 . . . . 0.0 110.211 179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.35 98.35 5.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.549 -0.719 . . . . 0.0 110.33 179.688 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.403 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -128.3 148.54 50.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.456 -0.777 . . . . 0.0 109.844 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.8 p -63.35 -36.43 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.041 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -169.75 -174.9 1.96 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.606 -0.683 . . . . 0.0 110.081 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -54.54 -26.02 29.4 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.504 -0.747 . . . . 0.0 111.074 -179.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.87 -28.64 69.02 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.506 -0.747 . . . . 0.0 110.3 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.403 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 4.5 m -113.03 -25.81 8.78 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.596 -0.69 . . . . 0.0 110.464 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.756 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.58 -61.74 2.37 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.471 -0.768 . . . . 0.0 110.496 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -57.7 -34.42 69.43 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.55 -0.719 . . . . 0.0 110.166 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -58.01 -36.86 73.28 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.37 -0.831 . . . . 0.0 109.996 179.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.2 t -84.59 -48.6 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.67 -0.644 . . . . 0.0 109.674 179.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -62.31 -37.01 83.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.623 -0.673 . . . . 0.0 110.008 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -62.76 -47.28 84.22 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.572 -0.705 . . . . 0.0 109.169 179.413 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -63.21 -34.19 77.1 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.708 0.766 . . . . 0.0 109.286 179.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -65.81 -53.31 41.83 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.62 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.89 -45.72 84.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.735 -0.603 . . . . 0.0 109.895 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -58.82 -37.03 75.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 110.349 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -65.46 -54.17 32.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.659 -0.651 . . . . 0.0 109.949 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -69.61 -49.24 55.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.566 -0.709 . . . . 0.0 109.852 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.69 54.17 0.11 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.62 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.1 mt -119.97 70.32 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.427 -1.043 . . . . 0.0 110.236 179.588 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -94.55 48.82 1.23 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.16 -138.24 0.6 Allowed Glycine 0 N--CA 1.487 2.083 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -110.31 111.7 23.18 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.474 ' O ' HG23 ' A' ' 45' ' ' THR . 35.9 m95 -83.83 143.27 30.04 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 122.213 1.006 . . . . 0.0 112.738 -177.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 44' ' ' TRP . 1.7 p -154.7 131.72 10.91 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -101.03 143.94 30.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.65 -0.656 . . . . 0.0 110.306 -178.454 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -115.75 109.58 17.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.726 -0.609 . . . . 0.0 109.775 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -67.13 -21.8 65.81 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.646 -0.659 . . . . 0.0 110.593 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.449 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.4 -40.26 64.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.318 -0.864 . . . . 0.0 110.805 -179.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.449 HG23 ' C ' ' A' ' 49' ' ' ALA . 80.1 p -148.82 21.04 1.01 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.549 -0.719 . . . . 0.0 110.676 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.439 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.54 92.74 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 O-C-N 121.168 -0.957 . . . . 0.0 110.744 179.874 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.1 m -152.57 101.64 2.66 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.355 -0.841 . . . . 0.0 111.515 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.403 ' O ' HD12 ' A' ' 6' ' ' LEU . 91.6 m-85 -63.49 124.21 20.74 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.272 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.638 HG23 HG21 ' A' ' 7' ' ' ILE . 63.0 m -115.23 96.66 5.78 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.263 -0.898 . . . . 0.0 113.14 -177.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.533 HG21 HG22 ' A' ' 40' ' ' ILE . 10.4 p -99.24 166.89 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.457 177.339 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.587 HG23 ' HB3' ' A' ' 9' ' ' ASN . 92.5 m -157.5 105.77 2.08 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.606 -0.684 . . . . 0.0 109.749 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.254 -179.723 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 121.092 0.472 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.568 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 44.1 m -99.14 111.31 23.73 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.546 -0.721 . . . . 0.0 110.362 -179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.2 m -85.53 90.83 8.08 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.589 -0.694 . . . . 0.0 110.623 -179.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.568 ' CZ ' HG21 ' A' ' 2' ' ' THR . 96.5 m-85 -73.28 170.34 15.23 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.478 -0.764 . . . . 0.0 109.81 179.692 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -141.44 139.71 33.45 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.467 -0.77 . . . . 0.0 110.583 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.528 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 38.9 tp -114.3 121.39 43.5 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.636 -0.665 . . . . 0.0 109.95 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.666 HG21 HG23 ' A' ' 54' ' ' THR . 3.8 tp -71.47 166.26 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.666 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 13' ' ' LEU . 71.5 mt -127.7 72.51 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.335 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.535 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.6 m-20 -93.62 49.17 1.34 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.456 -0.777 . . . . 0.0 109.107 179.117 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.4 149.7 18.81 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -66.71 -13.63 61.55 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.649 -0.913 . . . . 0.0 110.41 179.406 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.6 m -85.05 -37.59 20.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.243 -0.911 . . . . 0.0 110.446 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.463 ' O ' HG22 ' A' ' 8' ' ' ILE . 10.0 mt -141.38 170.06 16.43 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.444 -0.785 . . . . 0.0 110.769 -179.696 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -151.22 141.49 22.33 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.611 -0.681 . . . . 0.0 110.177 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.401 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 129.95 -149.73 18.89 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -144.4 160.3 41.29 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.535 -0.98 . . . . 0.0 110.351 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.7 m -147.89 147.84 30.18 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.585 -0.697 . . . . 0.0 110.207 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -119.27 171.23 8.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.529 -0.732 . . . . 0.0 110.225 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.449 ' CG2' ' CE2' ' A' ' 31' ' ' PHE . 7.9 t -142.97 -170.43 3.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.548 -0.72 . . . . 0.0 110.369 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -126.86 88.59 2.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.622 -0.674 . . . . 0.0 110.123 179.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.809 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -130.64 137.89 49.82 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.608 -0.682 . . . . 0.0 110.3 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 35.1 m -59.39 -25.45 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.527 -0.733 . . . . 0.0 110.574 179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.718 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 26.1 p30 -170.87 179.95 3.0 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.401 -0.812 . . . . 0.0 110.404 179.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.585 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -55.18 -22.84 18.94 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.478 -0.764 . . . . 0.0 110.89 179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.718 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -56.04 -45.14 79.28 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.307 -0.87 . . . . 0.0 110.173 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.809 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 62.7 m -85.83 -31.63 22.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.649 -0.657 . . . . 0.0 109.541 179.262 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 24' ' ' ALA . . . -62.26 -176.93 0.11 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.698 -0.626 . . . . 0.0 109.611 179.44 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 66.63 -61.73 0.3 Allowed 'General case' 0 N--CA 1.508 2.455 0 O-C-N 121.508 -0.745 . . . . 0.0 110.75 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -55.63 -34.22 64.73 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.064 -1.022 . . . . 0.0 110.268 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 90.0 t -83.49 -49.81 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.599 -0.688 . . . . 0.0 109.768 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.449 ' CE2' ' CG2' ' A' ' 19' ' ' THR . 7.7 m-85 -63.17 -34.19 77.09 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.578 -0.701 . . . . 0.0 109.668 179.837 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -63.56 -41.23 98.42 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -62.8 -33.83 76.01 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.701 0.763 . . . . 0.0 109.544 179.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -68.02 -51.47 46.58 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.015 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.728 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -68.53 -49.07 62.34 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.792 -0.567 . . . . 0.0 110.078 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -55.94 -29.78 60.67 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.468 -0.77 . . . . 0.0 110.356 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.36 -40.16 89.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.681 -0.637 . . . . 0.0 109.822 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.26 -44.15 10.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.624 -0.672 . . . . 0.0 109.983 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.52 38.62 0.51 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 179.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.728 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.9 mt -93.32 64.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.379 -1.071 . . . . 0.0 109.908 179.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.3 54.77 3.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.503 -0.748 . . . . 0.0 108.999 178.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.76 -136.55 1.8 Allowed Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -179.038 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -114.08 102.09 9.84 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.932 -0.746 . . . . 0.0 109.035 179.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.528 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 40.4 m95 -74.44 142.41 44.94 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 122.154 0.978 . . . . 0.0 112.226 -178.133 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 44' ' ' TRP . 4.5 p -153.22 131.3 11.85 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.657 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.429 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 13.7 t80 -107.5 113.56 26.97 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.877 -178.529 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.37 118.62 26.93 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.699 -0.626 . . . . 0.0 109.929 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -69.76 -23.41 63.36 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.72 -0.612 . . . . 0.0 110.36 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -52.38 -37.12 55.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.416 -0.803 . . . . 0.0 111.015 -179.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 77.3 p -144.34 14.51 1.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.482 -0.761 . . . . 0.0 111.12 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.429 ' HG3' ' CE2' ' A' ' 46' ' ' TYR . 1.0 OUTLIER 50.97 86.72 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.043 -1.036 . . . . 0.0 110.82 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 44.1 m -153.14 107.48 3.12 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.515 -0.741 . . . . 0.0 110.934 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -64.06 124.15 20.86 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.666 HG23 HG21 ' A' ' 7' ' ' ILE . 91.7 m -116.14 98.32 6.55 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.283 -0.886 . . . . 0.0 112.888 -177.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.569 HG21 HG22 ' A' ' 40' ' ' ILE . 10.3 p -98.13 166.75 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.887 . . . . 0.0 109.395 177.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.535 HG23 ' HB3' ' A' ' 9' ' ' ASN . 99.7 m -160.78 108.84 1.58 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.648 -0.657 . . . . 0.0 109.751 -179.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.13 -179.961 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 mtm . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.082 0.468 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.632 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 5.7 m -102.7 113.85 27.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.534 -0.729 . . . . 0.0 110.118 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 3' ' ' THR . 8.9 t -96.35 79.24 3.1 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.68 -0.637 . . . . 0.0 110.99 -179.502 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.789 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 97.4 m-85 -62.14 166.38 4.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.321 -0.862 . . . . 0.0 109.6 179.445 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.404 ' HB3' HG23 ' A' ' 52' ' ' THR . 37.4 ttpt -137.4 122.21 18.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.403 -0.811 . . . . 0.0 110.658 -179.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.65 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 47.0 tp -99.88 130.59 46.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.546 -0.721 . . . . 0.0 110.049 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.662 HG21 HG23 ' A' ' 54' ' ' THR . 3.4 tp -81.75 165.52 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.512 HG22 ' O ' ' A' ' 13' ' ' LEU . 70.1 mt -124.11 73.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.251 -0.906 . . . . 0.0 110.279 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.17 46.79 1.12 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.378 -0.826 . . . . 0.0 108.967 178.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -106.22 158.1 15.66 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 ttmt -76.31 -5.07 45.44 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.767 -0.843 . . . . 0.0 110.604 179.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.73 ' O ' HD22 ' A' ' 13' ' ' LEU . 5.2 m -99.15 -36.84 9.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.191 -0.943 . . . . 0.0 110.273 -179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.73 HD22 ' O ' ' A' ' 12' ' ' THR . 0.5 OUTLIER -137.33 164.29 28.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.444 -0.785 . . . . 0.0 110.53 -179.948 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.16 138.4 19.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.602 -0.686 . . . . 0.0 110.326 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.492 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 139.21 -141.94 12.34 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -145.71 157.94 43.9 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.546 -0.973 . . . . 0.0 110.396 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.9 m -146.39 137.91 24.63 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.613 -0.679 . . . . 0.0 110.123 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 47.3 p -119.48 164.16 16.2 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.538 -0.727 . . . . 0.0 110.264 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.593 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.5 t -152.8 -166.26 2.41 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.589 -0.694 . . . . 0.0 110.285 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -131.12 122.66 27.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.712 -0.617 . . . . 0.0 110.204 179.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.481 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -151.08 158.71 44.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.575 -0.703 . . . . 0.0 110.197 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.4 HG12 ' H ' ' A' ' 22' ' ' VAL . 8.4 p -77.3 -25.44 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.583 -0.698 . . . . 0.0 110.156 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.566 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 25.8 p30 -172.41 179.61 2.47 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.406 -0.809 . . . . 0.0 110.277 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.416 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.61 -25.66 53.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.541 -0.725 . . . . 0.0 110.807 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.566 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.99 -27.32 65.31 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.484 -0.76 . . . . 0.0 110.489 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.481 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 62.5 m -109.27 -27.87 9.3 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.505 -0.747 . . . . 0.0 110.313 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.789 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.64 -55.64 31.95 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.522 -0.736 . . . . 0.0 110.324 -179.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -59.22 -42.11 90.22 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.573 -0.704 . . . . 0.0 110.333 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -57.59 -35.77 70.85 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.336 -0.853 . . . . 0.0 110.177 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 26' ' ' THR . 87.9 t -83.42 -49.04 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.692 -0.63 . . . . 0.0 110.004 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.593 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.2 m-85 -65.44 -35.45 80.95 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.56 -0.713 . . . . 0.0 110.329 -179.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 10.2 tttt -64.06 -41.98 97.18 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.435 -0.791 . . . . 0.0 109.377 179.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.5 tp60 -60.6 -29.63 69.33 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.561 0.696 . . . . 0.0 109.957 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -73.22 -54.11 9.23 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.695 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -64.41 -44.14 92.18 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.665 -0.647 . . . . 0.0 110.073 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -56.38 -37.33 69.96 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.494 -0.754 . . . . 0.0 110.581 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -75.1 -50.38 16.56 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.652 -0.655 . . . . 0.0 110.146 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -65.8 -48.5 71.51 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.528 -0.732 . . . . 0.0 110.067 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.3 62.05 0.2 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.695 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 85.5 mt -129.56 77.22 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.472 -1.016 . . . . 0.0 110.458 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -97.76 40.7 1.15 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.15 -136.14 0.02 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -120.22 100.79 7.39 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.82 -0.812 . . . . 0.0 109.011 179.284 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.65 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 27.8 m95 -67.38 142.97 56.56 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 122.218 1.008 . . . . 0.0 112.478 -177.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.5 p -151.72 131.6 13.31 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.801 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -103.13 128.55 50.02 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.696 -0.628 . . . . 0.0 109.967 -178.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -97.59 108.2 20.87 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.686 -0.634 . . . . 0.0 110.019 179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -65.97 -20.08 66.08 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.645 -0.659 . . . . 0.0 110.633 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.442 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.71 -38.6 64.44 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.282 -0.886 . . . . 0.0 110.812 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.442 HG23 ' C ' ' A' ' 49' ' ' ALA . 71.6 p -148.61 22.18 1.02 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.522 -0.736 . . . . 0.0 110.752 -179.874 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.88 90.75 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.128 -0.982 . . . . 0.0 110.928 179.828 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 5' ' ' LYS . 60.1 m -156.67 106.37 2.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.477 -0.764 . . . . 0.0 110.857 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -62.27 136.58 57.99 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.535 -0.728 . . . . 0.0 109.095 178.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.662 HG23 HG21 ' A' ' 7' ' ' ILE . 70.4 m -129.77 101.57 5.94 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.558 -178.559 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.54 HG21 HG22 ' A' ' 40' ' ' ILE . 10.2 p -102.81 165.4 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.612 177.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.468 ' N ' HG22 ' A' ' 55' ' ' VAL . 59.4 m -163.49 115.34 1.45 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.875 -0.516 . . . . 0.0 109.751 -179.706 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.34 179.521 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ptp . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.108 0.48 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.736 HG22 ' O ' ' A' ' 21' ' ' ALA . 9.9 t -109.8 -171.39 1.83 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.533 -0.729 . . . . 0.0 110.234 -179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 25.7 m -129.49 96.11 4.18 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.539 -0.725 . . . . 0.0 110.739 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.759 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 84.9 m-85 -77.6 169.34 18.46 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.533 -0.729 . . . . 0.0 109.644 179.471 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -140.14 113.61 8.57 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.503 -0.748 . . . . 0.0 110.418 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.622 HD13 ' CZ3' ' A' ' 44' ' ' TRP . 42.8 tp -94.03 122.31 36.41 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.565 -0.709 . . . . 0.0 109.966 179.751 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.632 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.9 tp -72.92 166.83 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.498 HD12 ' C ' ' A' ' 15' ' ' GLY . 73.8 mt -128.67 73.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.527 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.651 ' HB3' HG23 ' A' ' 56' ' ' THR . 5.7 m-20 -94.37 49.55 1.3 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.416 -0.802 . . . . 0.0 109.124 178.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -115.31 151.79 18.32 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.615 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.6 -10.1 56.83 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.678 -0.895 . . . . 0.0 110.613 179.426 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.1 m -90.38 -32.49 16.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 110.373 -179.82 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 13' ' ' LEU . 28.3 mt -143.34 173.12 11.89 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.451 -0.781 . . . . 0.0 110.917 -179.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -156.69 140.68 16.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.618 -0.676 . . . . 0.0 110.129 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.498 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 128.11 -134.48 8.19 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.402 ' N ' HD12 ' A' ' 8' ' ' ILE . 6.8 pt-20 -162.1 164.98 27.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.518 -0.99 . . . . 0.0 110.286 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.411 HG22 ' N ' ' A' ' 18' ' ' THR . 76.2 m -138.69 164.06 30.53 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.542 -0.724 . . . . 0.0 110.339 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.411 ' N ' HG22 ' A' ' 17' ' ' THR . 25.6 p -136.98 161.06 37.09 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.57 -0.706 . . . . 0.0 110.204 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.598 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.6 t -169.78 148.43 3.58 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.543 -0.723 . . . . 0.0 110.192 179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 2' ' ' THR . 43.5 mt-10 -82.36 132.43 35.22 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.495 -0.753 . . . . 0.0 110.13 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.736 ' O ' HG22 ' A' ' 2' ' ' THR . . . -155.36 140.98 17.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.358 -0.839 . . . . 0.0 110.473 -179.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.6 m -58.8 -32.59 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.571 -0.706 . . . . 0.0 110.405 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.598 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 30.0 p30 -170.14 179.11 3.62 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.546 -0.721 . . . . 0.0 110.294 179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.98 -24.67 40.01 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.492 -0.755 . . . . 0.0 110.847 -179.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.598 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.67 -35.13 72.09 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.438 -0.789 . . . . 0.0 110.508 -179.889 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.5 m -97.4 -25.58 15.16 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.52 -0.737 . . . . 0.0 110.506 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.759 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -66.62 -58.51 5.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.436 -0.79 . . . . 0.0 110.467 -179.742 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -57.23 -42.12 80.79 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.573 -0.704 . . . . 0.0 110.597 -179.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -55.99 -40.65 73.63 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.298 -0.876 . . . . 0.0 110.196 179.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.4 t -80.18 -49.41 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.626 -0.671 . . . . 0.0 109.733 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.598 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.7 m-85 -61.77 -30.51 70.84 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.098 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -65.11 -43.76 90.97 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.168 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 59.4 tp60 -62.57 -30.86 71.63 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.606 0.717 . . . . 0.0 109.439 178.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -70.95 -50.28 36.36 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.171 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.686 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -69.93 -42.92 72.65 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.638 -0.664 . . . . 0.0 109.989 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -58.7 -38.29 77.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.563 -0.711 . . . . 0.0 110.517 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -71.3 -51.96 21.54 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.551 -0.718 . . . . 0.0 110.037 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -66.66 -48.85 68.07 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.544 -0.722 . . . . 0.0 109.931 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.14 61.45 0.19 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 179.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.686 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 83.1 mt -126.18 68.23 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.519 -0.989 . . . . 0.0 110.331 179.657 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.76 52.92 2.42 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -83.49 -140.28 4.08 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -178.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.2 110.52 21.06 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.904 -0.762 . . . . 0.0 109.471 179.53 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.622 ' CZ3' HD13 ' A' ' 6' ' ' LEU . 31.6 m95 -80.23 143.9 33.35 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.125 0.964 . . . . 0.0 112.318 -178.134 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 44' ' ' TRP . 2.7 p -157.48 131.65 8.29 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -107.43 146.03 32.23 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.704 -0.623 . . . . 0.0 109.894 -178.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.487 ' OD1' ' HB3' ' A' ' 49' ' ' ALA . 23.3 t0 -118.36 114.99 23.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.716 -0.615 . . . . 0.0 109.929 179.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -69.31 -24.05 63.88 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.666 -0.646 . . . . 0.0 110.542 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.487 ' HB3' ' OD1' ' A' ' 47' ' ' ASP . . . -52.48 -36.82 55.78 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.37 -0.831 . . . . 0.0 110.832 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.431 HG23 ' C ' ' A' ' 49' ' ' ALA . 77.1 p -147.81 17.71 1.13 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.574 -0.703 . . . . 0.0 110.88 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.46 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.26 93.06 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.221 -0.924 . . . . 0.0 111.01 179.793 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.4 m -157.72 105.27 2.01 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.233 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -64.67 136.56 57.09 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.632 ' HA ' HG22 ' A' ' 7' ' ' ILE . 51.1 m -127.59 100.02 5.82 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.887 -178.506 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.513 HG11 HG21 ' A' ' 40' ' ' ILE . 11.4 p -104.88 166.65 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 0.0 108.974 177.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.651 HG23 ' HB3' ' A' ' 9' ' ' ASN . 94.1 m -161.12 112.33 1.79 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.719 -0.613 . . . . 0.0 109.778 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.158 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ptt? . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.106 0.479 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.562 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 63.3 m -112.61 112.12 23.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.565 -0.71 . . . . 0.0 110.32 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 19' ' ' THR . 42.0 m -96.19 94.39 7.48 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.654 -0.654 . . . . 0.0 110.417 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.77 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.4 m-85 -72.14 167.49 20.17 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.528 -0.732 . . . . 0.0 109.966 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.553 ' HG2' HG22 ' A' ' 18' ' ' THR . 12.1 mtmt -132.77 115.82 15.8 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.544 -0.722 . . . . 0.0 110.317 -179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.671 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -94.09 111.84 23.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.518 -0.738 . . . . 0.0 110.263 -179.977 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.635 HG22 ' HA ' ' A' ' 54' ' ' THR . 3.8 tp -63.74 171.32 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.074 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.478 HD11 ' OG1' ' A' ' 17' ' ' THR . 74.0 mt -133.23 74.53 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.928 . . . . 0.0 110.678 -179.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.484 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.4 m-80 -95.56 48.0 1.13 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.18 156.81 15.36 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.347 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 mmtt -74.47 -6.57 49.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.766 -0.844 . . . . 0.0 110.346 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.9 m -92.64 -37.1 12.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 110.133 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.406 ' HB3' HG21 ' A' ' 8' ' ' ILE . 7.3 mt -139.78 176.06 9.06 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.536 -0.728 . . . . 0.0 110.527 -180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.15 138.9 11.75 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.574 -0.704 . . . . 0.0 110.225 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.26 -136.54 9.04 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -144.46 162.91 35.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.56 -0.965 . . . . 0.0 110.332 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.478 ' OG1' HD11 ' A' ' 8' ' ' ILE . 5.6 m -146.67 130.23 16.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.598 -0.689 . . . . 0.0 110.107 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.553 HG22 ' HG2' ' A' ' 5' ' ' LYS . 66.8 p -112.4 174.88 5.67 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.628 -0.67 . . . . 0.0 110.323 -179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.567 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.4 t -166.54 -170.55 1.66 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.573 -0.705 . . . . 0.0 110.246 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -120.95 105.72 10.93 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.545 -0.722 . . . . 0.0 110.222 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.519 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -136.43 140.81 43.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.557 -0.714 . . . . 0.0 110.138 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.609 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.1 p -61.85 -30.67 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.552 -0.718 . . . . 0.0 109.909 179.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.609 ' OD1' HG13 ' A' ' 22' ' ' VAL . 48.4 p-10 -168.89 179.11 4.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.67 -0.644 . . . . 0.0 110.142 179.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.421 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.56 -23.01 14.85 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.489 -0.757 . . . . 0.0 111.137 -179.575 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.426 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.86 -32.1 70.39 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.391 -0.818 . . . . 0.0 110.441 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.519 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 5.4 m -104.05 -26.99 12.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.529 -0.732 . . . . 0.0 110.47 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.77 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.67 -58.17 9.59 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.526 -0.734 . . . . 0.0 110.495 -179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -58.43 -45.09 89.19 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.483 -0.76 . . . . 0.0 110.521 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -54.4 -41.0 68.75 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.254 -0.903 . . . . 0.0 110.507 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.2 t -81.39 -47.89 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.649 -0.657 . . . . 0.0 110.091 179.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CZ ' HG22 ' A' ' 19' ' ' THR . 4.5 m-85 -63.84 -32.72 74.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.589 -0.694 . . . . 0.0 110.212 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt -64.93 -42.97 94.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -63.64 -33.54 75.84 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.712 0.767 . . . . 0.0 109.099 178.748 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -66.06 -57.01 8.68 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.805 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.65 -46.18 91.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.753 -0.592 . . . . 0.0 110.085 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -57.48 -34.85 69.45 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.578 -0.701 . . . . 0.0 110.566 -179.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.19 -48.47 67.83 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.537 -0.727 . . . . 0.0 110.135 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -76.49 -47.26 23.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.58 -0.7 . . . . 0.0 110.041 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.22 69.17 0.19 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.805 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 81.7 mt -127.44 60.82 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.505 -0.997 . . . . 0.0 110.343 179.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -82.46 60.72 5.26 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.8 -140.8 10.05 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -178.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -114.04 105.5 13.3 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.922 -0.752 . . . . 0.0 109.039 179.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.671 ' HH2' HD11 ' A' ' 6' ' ' LEU . 55.9 m95 -75.78 143.27 42.05 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 122.04 0.924 . . . . 0.0 112.209 -178.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 44' ' ' TRP . 4.1 p -153.16 132.08 12.49 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.783 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.412 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 48.7 t80 -99.82 131.62 45.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.744 -0.597 . . . . 0.0 110.18 -178.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -102.16 119.15 38.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.754 -0.591 . . . . 0.0 109.951 179.746 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.24 -21.32 56.51 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.591 -0.693 . . . . 0.0 110.719 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.424 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.07 -40.39 67.16 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.311 -0.868 . . . . 0.0 110.829 -179.691 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.424 HG23 ' C ' ' A' ' 49' ' ' ALA . 70.0 p -147.55 19.51 1.18 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.585 -0.697 . . . . 0.0 110.84 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.412 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 0.6 OUTLIER 51.68 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.195 -0.941 . . . . 0.0 111.004 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 5' ' ' LYS . 57.1 m -158.54 108.33 2.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.513 -0.742 . . . . 0.0 110.684 179.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.503 ' O ' HD23 ' A' ' 6' ' ' LEU . 64.9 m-85 -62.22 127.44 31.36 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.576 -0.703 . . . . 0.0 109.177 179.146 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.635 ' HA ' HG22 ' A' ' 7' ' ' ILE . 58.1 m -120.3 105.39 10.88 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.398 -0.921 . . . . 0.0 112.47 -178.465 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.598 HG11 HG21 ' A' ' 40' ' ' ILE . 11.9 p -109.57 168.14 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.468 -0.77 . . . . 0.0 108.954 177.478 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 9' ' ' ASN . 96.5 m -160.04 109.7 1.81 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.471 -0.768 . . . . 0.0 110.013 -179.511 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.242 -179.941 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.055 0.455 . . . . 0.0 110.049 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.525 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 71.4 m -97.66 111.96 24.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.619 -0.676 . . . . 0.0 110.136 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.5 m -93.54 91.4 7.08 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.623 -0.673 . . . . 0.0 110.576 -179.756 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.666 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.8 m-85 -69.15 173.49 5.55 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.542 -0.724 . . . . 0.0 109.934 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.47 ' O ' HG23 ' A' ' 52' ' ' THR . 5.3 mtpm? -139.56 110.54 6.85 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.454 -0.778 . . . . 0.0 110.416 -179.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.6 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -91.28 109.63 20.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.535 -0.728 . . . . 0.0 110.068 179.872 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.661 HG21 HG23 ' A' ' 54' ' ' THR . 2.7 tt -63.06 171.75 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.341 -0.849 . . . . 0.0 108.854 179.315 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.518 HG21 ' HB3' ' A' ' 13' ' ' LEU . 80.1 mt -133.64 71.94 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.438 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.477 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.7 m-20 -95.12 47.7 1.15 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.423 -0.798 . . . . 0.0 109.175 179.125 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.96 160.24 13.52 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.524 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.0 tttt -76.43 -7.36 54.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.653 -0.91 . . . . 0.0 110.461 179.202 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.2 t -98.34 -23.51 15.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.209 -0.932 . . . . 0.0 110.458 179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.518 ' HB3' HG21 ' A' ' 8' ' ' ILE . 35.8 mt -147.21 163.62 35.77 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.321 -0.862 . . . . 0.0 110.495 179.848 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.47 132.68 17.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.64 -0.663 . . . . 0.0 110.146 179.864 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.4 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 133.06 -142.07 13.54 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -145.84 171.59 14.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.537 -0.978 . . . . 0.0 110.239 -179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.9 m -147.53 156.6 42.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.632 -0.667 . . . . 0.0 110.158 179.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.5 p -138.59 155.56 48.24 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.563 -0.711 . . . . 0.0 110.256 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.723 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.3 t -154.8 160.38 41.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.584 -0.698 . . . . 0.0 110.283 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -90.02 106.72 18.66 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.599 -0.688 . . . . 0.0 110.211 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.05 139.28 45.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.622 -0.674 . . . . 0.0 110.216 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.494 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.2 p -59.21 -34.59 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.547 -0.721 . . . . 0.0 110.1 179.775 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.588 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 51.3 p30 -169.3 -178.77 3.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.586 -0.696 . . . . 0.0 110.271 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.416 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -54.98 -23.0 17.1 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.531 -0.73 . . . . 0.0 111.053 -179.828 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.588 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.06 -26.32 62.35 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.49 -0.756 . . . . 0.0 110.701 -179.672 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.1 m -114.76 -24.85 8.5 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.422 -0.799 . . . . 0.0 110.691 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.666 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.1 -60.03 4.52 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.402 -0.811 . . . . 0.0 110.415 -179.817 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -59.42 -37.2 77.43 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.542 -0.724 . . . . 0.0 110.401 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -56.72 -44.73 81.92 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.423 -0.798 . . . . 0.0 110.578 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.0 t -80.13 -43.34 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.52 -0.737 . . . . 0.0 109.96 179.732 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.723 ' CZ ' HG22 ' A' ' 19' ' ' THR . 10.3 m-85 -65.52 -35.2 80.17 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.554 -0.717 . . . . 0.0 110.329 -179.727 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -63.64 -45.48 90.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 108.991 179.286 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -63.43 -32.84 74.39 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.69 0.757 . . . . 0.0 109.136 178.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -66.48 -56.58 10.22 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.783 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -59.56 -45.87 90.58 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.695 -0.628 . . . . 0.0 110.15 179.927 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -58.51 -32.49 68.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.57 -0.706 . . . . 0.0 110.328 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -60.94 -59.93 4.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.599 -0.688 . . . . 0.0 109.968 179.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.428 ' ND2' HD11 ' A' ' 13' ' ' LEU . 72.3 m-80 -72.5 -45.98 56.88 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.624 -0.673 . . . . 0.0 109.828 179.66 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.36 72.89 0.23 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.924 -1.271 . . . . 0.0 109.924 179.725 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.783 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.4 mt -122.9 62.06 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.482 -1.011 . . . . 0.0 110.004 179.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.78 61.12 5.0 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.72 -140.76 9.98 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -178.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -116.62 104.53 11.48 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.877 -0.778 . . . . 0.0 109.038 179.563 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.6 ' HH2' HD11 ' A' ' 6' ' ' LEU . 53.6 m95 -73.98 143.94 45.41 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 122.084 0.945 . . . . 0.0 112.248 -178.112 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 44' ' ' TRP . 2.0 p -153.84 132.13 11.95 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.75 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.406 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 26.4 t80 -103.74 139.08 39.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.618 -0.676 . . . . 0.0 110.186 -178.721 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -113.34 122.05 46.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.718 -0.613 . . . . 0.0 109.843 179.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -75.89 -19.5 58.78 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.732 -0.605 . . . . 0.0 110.778 -179.875 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.444 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.37 -39.18 66.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.24 -0.913 . . . . 0.0 110.774 -179.718 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.444 HG23 ' C ' ' A' ' 49' ' ' ALA . 74.4 p -148.18 18.56 1.09 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.561 -0.712 . . . . 0.0 110.752 -179.985 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.3 94.97 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.23 -0.919 . . . . 0.0 110.927 179.977 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 5' ' ' LYS . 70.2 m -156.22 108.78 2.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.472 -0.767 . . . . 0.0 111.015 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.463 ' O ' HD23 ' A' ' 6' ' ' LEU . 77.1 m-85 -65.17 127.58 32.28 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.59 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.661 HG23 HG21 ' A' ' 7' ' ' ILE . 45.7 m -120.23 102.87 8.79 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.282 -0.967 . . . . 0.0 112.753 -178.214 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.587 HG11 HG21 ' A' ' 40' ' ' ILE . 10.6 p -105.72 167.33 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.374 -0.829 . . . . 0.0 108.99 177.372 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.477 HG23 ' HB3' ' A' ' 9' ' ' ASN . 99.4 m -160.35 111.07 1.85 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.555 -0.716 . . . . 0.0 110.097 -179.603 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 118.001 -1.0 . . . . 0.0 110.169 179.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.5 mmm . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.096 0.474 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.495 HG22 ' CE2' ' A' ' 4' ' ' PHE . 92.6 m -103.07 112.12 24.81 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.633 -0.667 . . . . 0.0 110.153 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 57.5 m -92.95 108.53 20.07 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.618 -0.676 . . . . 0.0 110.437 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.792 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 73.7 m-85 -88.47 174.12 8.3 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.587 -0.696 . . . . 0.0 110.098 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.443 ' HB3' HG23 ' A' ' 52' ' ' THR . 0.4 OUTLIER -142.68 112.97 7.18 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.524 -0.735 . . . . 0.0 110.406 179.937 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.591 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -96.09 112.62 24.3 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.496 -0.753 . . . . 0.0 109.941 179.731 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.657 HG21 HG23 ' A' ' 54' ' ' THR . 2.4 tt -65.37 172.58 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 119.632 -0.827 . . . . 0.0 108.977 179.338 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.479 HG21 ' HB3' ' A' ' 13' ' ' LEU . 77.6 mt -133.98 72.33 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.384 -0.822 . . . . 0.0 110.383 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -95.23 47.17 1.13 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.439 -0.788 . . . . 0.0 109.272 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.32 160.7 13.38 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -77.64 -2.72 37.34 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.734 -0.862 . . . . 0.0 110.495 179.309 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -101.45 -30.44 11.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.149 -0.969 . . . . 0.0 109.951 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.479 ' HB3' HG21 ' A' ' 8' ' ' ILE . 60.4 mt -140.01 165.9 26.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.482 -0.761 . . . . 0.0 110.508 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.5 ttmt -151.11 132.41 14.54 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.643 -0.661 . . . . 0.0 110.218 179.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 131.84 -133.44 7.17 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -162.52 160.36 25.97 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.547 -0.972 . . . . 0.0 110.428 -179.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.2 m -140.79 143.13 34.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.572 -0.705 . . . . 0.0 110.069 179.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 54.5 p -122.84 150.16 43.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.505 -0.747 . . . . 0.0 110.403 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.705 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.8 t -143.54 -172.09 3.65 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.647 -0.658 . . . . 0.0 110.247 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -114.34 107.73 15.97 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.59 -0.694 . . . . 0.0 110.146 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.589 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -132.63 147.8 52.35 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.586 -0.696 . . . . 0.0 110.096 -179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.6 p -65.7 -31.69 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.542 -0.724 . . . . 0.0 109.57 179.482 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -173.07 -174.94 1.12 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.587 -0.696 . . . . 0.0 109.952 179.574 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.457 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -53.27 -24.77 12.33 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.456 -0.777 . . . . 0.0 111.162 -179.458 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.31 -37.59 78.14 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.497 -0.752 . . . . 0.0 110.377 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.589 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 5.1 m -100.78 -28.18 12.95 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.56 -0.712 . . . . 0.0 110.431 -179.88 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.792 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -61.42 -61.89 2.21 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.476 -0.765 . . . . 0.0 110.294 -179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -60.52 -37.28 80.66 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.596 -0.69 . . . . 0.0 110.25 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -57.6 -43.62 84.84 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.424 -0.798 . . . . 0.0 110.391 179.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.9 t -80.26 -45.81 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.585 -0.697 . . . . 0.0 109.819 179.691 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.705 ' CZ ' HG22 ' A' ' 19' ' ' THR . 11.5 m-85 -64.01 -33.21 75.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.573 -0.704 . . . . 0.0 110.283 -179.782 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 6.2 tptm -64.57 -45.09 88.51 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.132 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -63.02 -33.61 75.8 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.697 0.761 . . . . 0.0 109.18 178.911 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -64.5 -54.98 23.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.751 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.806 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.27 -44.27 96.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.784 -0.573 . . . . 0.0 110.023 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -57.92 -35.79 71.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.556 -0.715 . . . . 0.0 110.484 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.47 -43.35 99.02 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.624 -0.672 . . . . 0.0 110.023 179.972 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.423 ' CG ' HD11 ' A' ' 13' ' ' LEU . 71.2 m-80 -84.31 -42.46 15.77 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.625 -0.672 . . . . 0.0 109.922 179.814 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.51 47.47 0.41 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.722 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.806 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 79.6 mt -96.91 63.63 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.463 -1.022 . . . . 0.0 110.168 179.798 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.4 59.56 4.64 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.89 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.53 -139.71 8.1 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 -179.046 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -118.59 103.09 9.39 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.307 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.591 ' CH2' HD11 ' A' ' 6' ' ' LEU . 53.1 m95 -71.62 142.73 49.95 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 122.065 0.936 . . . . 0.0 112.266 -177.854 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 p -150.26 131.62 14.64 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -108.97 123.56 49.3 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.719 -0.613 . . . . 0.0 110.099 -178.606 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -100.93 119.05 38.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.708 -0.62 . . . . 0.0 109.834 179.599 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -71.36 -19.41 62.29 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.672 -0.643 . . . . 0.0 110.812 -179.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.427 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.12 -37.69 55.02 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.214 -0.929 . . . . 0.0 110.877 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.427 HG23 ' C ' ' A' ' 49' ' ' ALA . 75.7 p -147.06 17.37 1.22 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.628 -0.67 . . . . 0.0 110.754 179.906 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.87 86.67 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.18 -0.95 . . . . 0.0 110.948 179.817 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.443 HG23 ' HB3' ' A' ' 5' ' ' LYS . 86.6 m -151.51 105.7 3.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.483 -0.761 . . . . 0.0 110.766 -179.875 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.442 ' O ' HD23 ' A' ' 6' ' ' LEU . 97.6 m-85 -62.06 129.14 39.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.462 -0.774 . . . . 0.0 108.971 178.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.657 HG23 HG21 ' A' ' 7' ' ' ILE . 57.5 m -121.92 102.13 7.99 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.336 -0.946 . . . . 0.0 112.451 -178.668 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.624 HG11 HG21 ' A' ' 40' ' ' ILE . 10.2 p -103.16 167.46 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.381 -0.824 . . . . 0.0 109.319 177.744 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.459 ' N ' HG22 ' A' ' 55' ' ' VAL . 99.7 m -159.99 110.33 1.87 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.598 -0.689 . . . . 0.0 110.159 -179.474 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.068 179.721 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.006 0.432 . . . . 0.0 110.232 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.564 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 67.5 m -91.27 111.16 22.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.619 -0.676 . . . . 0.0 110.259 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.5 m -80.87 101.97 9.75 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.611 -0.681 . . . . 0.0 110.573 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.705 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 74.9 m-85 -88.2 166.95 14.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.545 -0.722 . . . . 0.0 109.813 179.652 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -134.02 118.56 17.94 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.416 -0.803 . . . . 0.0 110.414 179.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.586 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -99.21 112.87 24.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.51 -0.744 . . . . 0.0 110.384 -179.926 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.609 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.5 tp -66.08 167.31 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.07 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.486 HD12 ' C ' ' A' ' 15' ' ' GLY . 73.6 mt -129.0 72.8 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.33 -0.856 . . . . 0.0 110.459 -179.849 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.548 ' HB3' HG23 ' A' ' 56' ' ' THR . 2.2 m-80 -95.87 47.82 1.11 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.264 -0.898 . . . . 0.0 108.999 179.014 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.67 166.43 16.92 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.373 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -86.04 6.89 26.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.75 -0.853 . . . . 0.0 110.375 179.066 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.8 m -113.95 -30.85 6.58 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.915 . . . . 0.0 110.067 179.891 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.3 169.67 17.15 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.435 -0.791 . . . . 0.0 110.507 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -153.1 143.41 22.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.608 -0.682 . . . . 0.0 110.258 179.9 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.486 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 132.64 -140.73 12.08 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -153.67 155.91 36.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.631 -0.923 . . . . 0.0 110.209 -179.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.474 ' C ' HG23 ' A' ' 18' ' ' THR . 7.9 m -134.94 169.5 17.31 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.6 -0.687 . . . . 0.0 110.281 -179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.474 HG23 ' C ' ' A' ' 17' ' ' THR . 41.5 p -151.66 150.17 29.95 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.613 -0.679 . . . . 0.0 110.133 179.929 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.893 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.3 t -156.36 142.86 18.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.593 -0.692 . . . . 0.0 110.236 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -67.07 124.18 22.33 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.585 -0.697 . . . . 0.0 110.24 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.01 140.58 25.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.524 -0.735 . . . . 0.0 110.208 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.454 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.2 p -58.54 -35.24 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.548 -0.72 . . . . 0.0 110.14 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.62 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 35.7 p30 -171.24 -170.79 0.87 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.564 -0.71 . . . . 0.0 110.159 179.546 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.436 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.68 -25.54 54.18 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.507 -0.746 . . . . 0.0 110.844 -179.812 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.62 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.64 -51.88 67.9 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.464 -0.773 . . . . 0.0 110.429 -179.778 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.8 m -84.56 -27.6 27.19 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.477 -0.764 . . . . 0.0 110.338 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.705 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -61.39 -59.34 5.42 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.592 -0.692 . . . . 0.0 110.245 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -61.81 -32.63 72.95 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.569 -0.707 . . . . 0.0 110.268 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 ttmt -57.87 -45.84 85.76 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.42 -0.8 . . . . 0.0 110.445 -179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.0 t -79.54 -42.57 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.61 -0.681 . . . . 0.0 109.879 179.716 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.893 ' CZ ' HG22 ' A' ' 19' ' ' THR . 12.5 m-85 -65.9 -33.85 76.78 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.631 -0.668 . . . . 0.0 110.182 -179.808 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -64.04 -47.39 80.38 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.305 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -63.64 -33.28 75.28 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.672 0.748 . . . . 0.0 109.081 178.789 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -64.32 -54.51 31.93 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.772 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.12 -40.17 95.0 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.825 -0.547 . . . . 0.0 110.014 179.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -58.95 -37.29 76.41 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.532 -0.73 . . . . 0.0 110.488 -179.849 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -64.19 -40.03 95.23 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.55 -0.719 . . . . 0.0 110.265 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -86.38 -29.03 23.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.543 -0.723 . . . . 0.0 110.15 179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.74 49.68 1.36 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.772 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.8 mt -103.4 62.7 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.603 -0.939 . . . . 0.0 110.286 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -85.12 58.57 5.11 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.795 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.99 -138.97 6.22 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.334 -1.107 . . . . 0.0 110.334 -178.848 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -116.74 102.94 9.85 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.497 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.586 ' CH2' HD11 ' A' ' 6' ' ' LEU . 53.0 m95 -72.79 141.39 48.07 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.101 0.953 . . . . 0.0 112.401 -177.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.4 132.45 19.27 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.299 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.412 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 53.9 t80 -105.53 113.24 26.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.635 -0.666 . . . . 0.0 110.128 -178.485 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.87 104.12 14.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.702 -0.624 . . . . 0.0 109.826 179.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -65.04 -24.83 67.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.676 -0.64 . . . . 0.0 110.553 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -53.95 -34.81 60.76 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.414 -0.804 . . . . 0.0 110.787 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.1 p -144.9 15.66 1.56 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.621 -0.674 . . . . 0.0 110.982 -179.939 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.438 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 50.3 90.34 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.129 -0.982 . . . . 0.0 111.097 179.81 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.7 m -154.89 107.15 2.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.538 -0.726 . . . . 0.0 110.853 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.456 ' O ' HD23 ' A' ' 6' ' ' LEU . 82.6 m-85 -62.08 125.4 23.75 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.483 -0.761 . . . . 0.0 109.041 178.858 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.609 ' HA ' HG22 ' A' ' 7' ' ' ILE . 60.5 m -120.27 100.01 6.92 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 119.251 -0.98 . . . . 0.0 112.54 -178.618 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.553 HG11 HG21 ' A' ' 40' ' ' ILE . 10.8 p -103.7 167.28 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.39 -0.819 . . . . 0.0 109.212 177.597 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.548 HG23 ' HB3' ' A' ' 9' ' ' ASN . 99.2 m -160.65 109.89 1.69 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.667 -0.646 . . . . 0.0 109.762 -179.785 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.249 -179.922 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.007 0.432 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.459 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 89.2 m -83.72 111.56 19.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.594 -0.691 . . . . 0.0 110.222 179.886 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 3' ' ' THR . 8.1 t -80.99 105.86 12.55 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.634 -0.666 . . . . 0.0 110.503 -179.854 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.708 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 60.4 m-85 -90.37 164.42 14.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.447 -0.783 . . . . 0.0 109.966 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.459 ' CB ' HG23 ' A' ' 52' ' ' THR . 18.1 mttm -130.38 122.29 27.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.461 -0.775 . . . . 0.0 110.569 179.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.561 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -105.5 110.55 22.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.527 -0.733 . . . . 0.0 109.939 179.81 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.606 HG22 ' HA ' ' A' ' 54' ' ' THR . 2.6 tp -62.74 166.9 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.353 -0.842 . . . . 0.0 109.007 179.482 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.46 HG21 ' HB3' ' A' ' 13' ' ' LEU . 79.8 mt -130.8 72.38 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.303 -0.873 . . . . 0.0 110.489 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.507 ' HB3' HG23 ' A' ' 56' ' ' THR . 34.6 m-20 -97.12 49.58 1.06 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.449 -0.782 . . . . 0.0 109.257 179.197 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.71 163.25 12.49 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 -179.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.8 pttt -78.18 -2.05 35.7 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.646 -0.914 . . . . 0.0 110.874 179.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.778 ' HB ' HD12 ' A' ' 13' ' ' LEU . 19.5 m -107.34 -28.03 10.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.232 -179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.778 HD12 ' HB ' ' A' ' 12' ' ' THR . 4.3 mp -135.13 164.8 26.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.521 -0.737 . . . . 0.0 110.303 179.749 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.3 ttmt -154.71 126.78 7.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.571 -0.706 . . . . 0.0 110.313 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.07 -140.01 11.33 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -144.85 171.77 13.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.637 -0.92 . . . . 0.0 110.376 -179.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.485 HG23 ' CE1' ' A' ' 31' ' ' PHE . 7.0 t -154.98 157.79 38.2 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.628 -0.67 . . . . 0.0 109.976 179.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.9 p -140.42 149.43 42.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.546 -0.721 . . . . 0.0 110.513 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.843 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.5 t -146.35 162.15 38.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.626 -0.671 . . . . 0.0 109.994 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -88.22 107.16 18.65 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.567 -0.708 . . . . 0.0 110.281 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -129.96 138.56 50.91 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.611 -0.681 . . . . 0.0 110.1 179.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.68 -31.81 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.614 -0.679 . . . . 0.0 110.248 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.515 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 14.7 p30 -171.32 179.99 2.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.504 -0.747 . . . . 0.0 110.377 179.856 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.45 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.79 -31.47 64.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.489 -0.757 . . . . 0.0 110.78 -179.573 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.515 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -60.27 -28.47 68.09 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.536 -0.727 . . . . 0.0 110.266 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.3 m -108.14 -27.99 9.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.58 -0.7 . . . . 0.0 110.304 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.708 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.2 -54.95 39.72 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.508 -0.745 . . . . 0.0 110.236 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -60.06 -31.82 70.36 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.573 -0.705 . . . . 0.0 110.239 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.8 ttmt -58.26 -40.62 82.29 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.342 -0.849 . . . . 0.0 110.35 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.0 t -82.19 -44.93 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.585 -0.697 . . . . 0.0 109.851 179.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.843 ' CZ ' HG22 ' A' ' 19' ' ' THR . 9.1 m-85 -65.85 -37.84 87.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.65 -0.656 . . . . 0.0 110.229 -179.808 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -62.07 -46.05 90.83 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.465 -0.772 . . . . 0.0 109.387 179.665 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 tp-100 -62.47 -34.24 76.44 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.782 0.801 . . . . 0.0 109.339 179.083 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.64 -49.36 68.96 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.749 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -73.25 -45.15 57.53 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.769 -0.582 . . . . 0.0 110.444 -179.758 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -56.26 -39.84 73.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.423 -0.798 . . . . 0.0 110.617 -179.715 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -75.13 -31.54 61.11 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.606 -0.684 . . . . 0.0 110.11 179.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -80.14 -40.89 26.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.546 -0.721 . . . . 0.0 110.006 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.43 37.15 0.94 Allowed Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.749 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.7 mt -103.64 62.43 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.528 -0.984 . . . . 0.0 110.174 179.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -85.67 57.35 4.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.51 -0.744 . . . . 0.0 109.008 178.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -86.47 -138.69 5.23 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 -178.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -116.3 105.14 12.21 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.43 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.561 ' HH2' HD11 ' A' ' 6' ' ' LEU . 52.8 m95 -74.63 142.22 44.59 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.182 0.992 . . . . 0.0 112.459 -177.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.05 132.59 17.72 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.452 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -106.48 111.74 24.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.646 -0.659 . . . . 0.0 110.262 -178.357 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.16 112.02 20.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.694 -0.629 . . . . 0.0 109.778 179.662 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -70.32 -21.78 62.88 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.639 -0.663 . . . . 0.0 110.663 -179.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.454 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.94 -35.24 58.41 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.311 -0.868 . . . . 0.0 110.955 -179.784 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.454 HG23 ' C ' ' A' ' 49' ' ' ALA . 70.9 p -148.16 18.41 1.09 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.537 -0.727 . . . . 0.0 110.932 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 50.72 93.14 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.182 -0.949 . . . . 0.0 110.989 179.713 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.459 HG23 ' CB ' ' A' ' 5' ' ' LYS . 62.4 m -158.66 104.68 1.79 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.454 -0.779 . . . . 0.0 110.886 -179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.485 ' O ' HD23 ' A' ' 6' ' ' LEU . 98.7 m-85 -61.05 128.52 36.82 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.423 -0.798 . . . . 0.0 109.149 179.014 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.606 ' HA ' HG22 ' A' ' 7' ' ' ILE . 85.0 m -120.7 101.21 7.58 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.522 -178.404 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.568 HG11 HG21 ' A' ' 40' ' ' ILE . 9.5 p -103.9 166.87 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.863 . . . . 0.0 109.309 177.599 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 9' ' ' ASN . 95.0 m -160.72 110.02 1.68 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.62 -0.675 . . . . 0.0 109.835 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 117.96 -1.019 . . . . 0.0 110.19 -179.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.042 0.449 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.513 HG22 ' CE2' ' A' ' 4' ' ' PHE . 55.0 m -92.71 111.89 23.65 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.551 -0.718 . . . . 0.0 110.149 179.877 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.609 HG23 ' O ' ' A' ' 19' ' ' THR . 6.6 m -106.66 96.1 6.21 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.585 -0.697 . . . . 0.0 110.624 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.737 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 92.1 m-85 -73.59 -178.85 3.26 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.538 -0.726 . . . . 0.0 109.838 179.606 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -146.74 110.75 5.02 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.49 -0.756 . . . . 0.0 110.289 179.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.66 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -92.27 110.67 22.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.502 -0.749 . . . . 0.0 110.364 -179.771 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.655 HG21 HG23 ' A' ' 54' ' ' THR . 3.4 tp -64.22 170.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.286 -0.884 . . . . 0.0 108.653 178.997 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.511 HD11 ' OG1' ' A' ' 17' ' ' THR . 78.0 mt -131.53 74.2 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.245 -0.909 . . . . 0.0 110.722 -179.655 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.429 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.5 m-20 -96.07 47.13 1.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.458 -0.776 . . . . 0.0 109.052 179.022 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.1 161.9 13.29 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 -179.602 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -79.74 -0.53 34.66 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.771 -0.84 . . . . 0.0 110.587 179.315 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -104.79 -30.82 9.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.981 . . . . 0.0 109.928 179.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.473 ' HB3' HG21 ' A' ' 8' ' ' ILE . 54.8 mt -138.54 166.02 25.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.635 -0.666 . . . . 0.0 110.363 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -154.63 132.81 11.75 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.573 -0.704 . . . . 0.0 110.202 179.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 138.89 -147.29 19.12 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -144.88 122.25 11.62 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.555 -0.967 . . . . 0.0 110.368 179.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.511 ' OG1' HD11 ' A' ' 8' ' ' ILE . 62.5 m -109.67 149.81 29.18 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.631 -0.668 . . . . 0.0 110.253 179.967 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.8 p -131.94 162.41 30.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.56 -0.712 . . . . 0.0 110.164 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.628 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.6 t -142.93 -172.55 3.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.561 -0.712 . . . . 0.0 110.328 179.956 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 -123.53 89.36 3.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.614 -0.679 . . . . 0.0 110.153 179.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -116.19 -177.25 3.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.585 -0.697 . . . . 0.0 109.982 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.17 -24.88 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.536 -0.728 . . . . 0.0 110.326 179.822 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -168.11 175.56 6.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.452 -0.78 . . . . 0.0 110.156 179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.407 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -57.88 -25.14 60.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.516 -0.74 . . . . 0.0 110.744 -179.772 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.7 -27.96 66.89 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.472 -0.767 . . . . 0.0 110.502 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 4.4 m -109.27 -27.23 9.64 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.551 -0.718 . . . . 0.0 110.417 -179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.737 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -62.0 -62.96 1.42 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.505 -0.747 . . . . 0.0 110.407 -179.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -58.17 -41.65 84.33 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.519 -0.738 . . . . 0.0 110.528 -179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.6 tttm -55.68 -42.49 75.24 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.362 -0.836 . . . . 0.0 110.314 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.2 t -80.27 -48.13 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.674 . . . . 0.0 109.934 179.545 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.628 ' CZ ' HG22 ' A' ' 19' ' ' THR . 5.4 m-85 -62.05 -33.75 74.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.585 -0.697 . . . . 0.0 110.22 -179.676 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -63.7 -43.84 95.41 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.425 -0.797 . . . . 0.0 108.924 179.19 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.4 tp60 -62.71 -33.5 75.23 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.728 0.775 . . . . 0.0 109.298 178.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -67.26 -56.48 9.63 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.758 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.56 -41.44 94.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.736 -0.602 . . . . 0.0 110.302 179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -58.11 -36.93 73.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.51 -0.744 . . . . 0.0 110.605 -179.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.38 -42.4 68.44 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.545 -0.722 . . . . 0.0 110.18 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -77.77 -28.93 50.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.573 -0.705 . . . . 0.0 110.215 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.88 55.06 0.95 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.876 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.758 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.0 mt -115.44 59.7 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.485 -1.009 . . . . 0.0 110.353 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.15 60.77 5.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.658 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.05 -138.93 7.97 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -178.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -115.4 103.57 10.91 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.948 -0.736 . . . . 0.0 109.28 179.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.66 ' HH2' HD11 ' A' ' 6' ' ' LEU . 55.6 m95 -73.92 143.38 45.77 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 122.146 0.974 . . . . 0.0 112.497 -177.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -151.22 133.31 15.21 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 178.656 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -104.0 139.17 39.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.593 -0.692 . . . . 0.0 110.313 -178.41 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -112.74 113.57 25.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.687 -0.633 . . . . 0.0 109.976 179.794 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -69.68 -21.37 63.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.701 -0.624 . . . . 0.0 110.847 -179.827 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.44 ' C ' HG23 ' A' ' 50' ' ' THR . . . -53.6 -40.48 65.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.293 -0.879 . . . . 0.0 110.814 -179.592 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.44 HG23 ' C ' ' A' ' 49' ' ' ALA . 66.5 p -148.84 20.28 1.01 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.555 -0.716 . . . . 0.0 110.597 -179.927 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.45 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER 52.1 93.46 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.174 -0.954 . . . . 0.0 110.63 179.948 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.6 m -151.41 103.17 2.96 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.497 -0.752 . . . . 0.0 111.112 -179.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.518 ' O ' HD23 ' A' ' 6' ' ' LEU . 78.2 m-85 -63.44 123.41 18.68 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.451 -0.781 . . . . 0.0 109.018 178.786 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.655 HG23 HG21 ' A' ' 7' ' ' ILE . 62.9 m -116.92 103.78 10.63 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.323 -0.951 . . . . 0.0 112.619 -178.349 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.567 HG11 HG21 ' A' ' 40' ' ' ILE . 11.4 p -106.02 168.27 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.409 -0.807 . . . . 0.0 109.002 177.396 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.461 ' N ' HG22 ' A' ' 55' ' ' VAL . 99.7 m -160.2 108.9 1.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.543 -0.723 . . . . 0.0 110.028 -179.558 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.168 179.884 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.157 0.503 . . . . 0.0 110.18 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.565 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 79.1 m -102.84 112.19 24.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.567 -0.708 . . . . 0.0 110.278 -179.943 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 3' ' ' THR . 8.1 t -89.44 99.39 12.4 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.65 -0.656 . . . . 0.0 110.585 -179.844 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.715 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 90.6 m-85 -80.68 176.56 9.69 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.364 -0.835 . . . . 0.0 110.005 179.885 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.52 ' HB3' HG23 ' A' ' 52' ' ' THR . 16.8 mttt -141.95 110.46 6.07 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.428 -0.795 . . . . 0.0 110.272 -179.972 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.607 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -93.62 111.54 23.24 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.489 -0.757 . . . . 0.0 110.467 -179.92 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.635 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.5 tp -64.18 170.29 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.948 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.498 HD11 ' OG1' ' A' ' 17' ' ' THR . 77.8 mt -132.43 74.72 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.772 -179.788 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.434 ' HB3' HG23 ' A' ' 56' ' ' THR . 1.5 m-20 -95.72 49.33 1.16 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.811 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.43 160.75 13.17 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.327 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -80.6 -0.16 36.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.769 -0.842 . . . . 0.0 110.47 179.015 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -102.14 -31.81 10.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.134 -0.979 . . . . 0.0 109.951 179.855 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -144.9 170.49 16.04 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.508 -0.745 . . . . 0.0 110.401 -179.978 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -154.12 142.77 20.85 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.618 -0.676 . . . . 0.0 110.374 -179.793 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.432 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 127.55 -164.34 21.02 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.963 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -119.88 145.31 46.8 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.551 -0.97 . . . . 0.0 110.315 -179.955 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.498 ' OG1' HD11 ' A' ' 8' ' ' ILE . 7.0 m -121.75 146.2 47.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.586 -0.696 . . . . 0.0 110.225 179.905 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.9 p -130.08 166.94 19.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.57 -0.706 . . . . 0.0 110.179 179.915 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.629 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.4 t -167.01 -179.5 4.69 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.568 -0.708 . . . . 0.0 110.3 -179.921 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -112.55 101.18 9.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.546 -0.721 . . . . 0.0 110.209 179.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.48 146.21 50.88 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.589 -0.694 . . . . 0.0 110.219 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.1 p -70.17 -26.28 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.546 -0.721 . . . . 0.0 110.186 -179.997 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.721 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 8.1 p30 -170.37 177.94 3.92 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.412 -0.805 . . . . 0.0 110.465 179.734 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.13 -25.84 47.71 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.578 -0.701 . . . . 0.0 111.139 -179.425 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.721 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.11 -39.26 81.72 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.372 -0.83 . . . . 0.0 110.334 -179.776 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.6 m -94.41 -29.63 14.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.594 -0.691 . . . . 0.0 110.087 179.914 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.715 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -61.02 -55.91 27.27 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.595 -0.69 . . . . 0.0 110.226 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -61.97 -37.32 84.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.568 -0.708 . . . . 0.0 110.3 -179.949 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.3 tttt -58.36 -41.9 85.72 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.379 -0.825 . . . . 0.0 110.387 -179.958 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.8 t -81.37 -44.21 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.558 -0.714 . . . . 0.0 109.813 179.666 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.629 ' CZ ' HG22 ' A' ' 19' ' ' THR . 11.2 m-85 -65.75 -36.46 83.63 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.602 -0.686 . . . . 0.0 110.192 -179.861 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.1 tptp -63.13 -45.17 93.23 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.469 -0.769 . . . . 0.0 109.15 179.366 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -63.25 -31.06 72.12 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.657 0.742 . . . . 0.0 109.27 178.713 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -69.67 -51.06 38.06 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.866 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.789 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -69.31 -41.27 76.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.627 -0.671 . . . . 0.0 110.002 179.9 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -58.49 -44.53 89.43 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.507 -0.746 . . . . 0.0 110.423 -179.977 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.74 -46.21 83.18 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.59 -0.694 . . . . 0.0 110.204 -179.952 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -70.84 -50.19 38.01 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.535 -0.728 . . . . 0.0 110.07 179.941 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.61 58.08 0.19 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.789 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 82.2 mt -116.05 59.82 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.548 -0.971 . . . . 0.0 110.234 179.826 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.97 62.89 3.51 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.872 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.18 -141.99 12.84 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -178.813 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -114.73 111.47 21.31 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 121.944 -0.739 . . . . 0.0 109.039 179.152 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.607 ' HH2' HD11 ' A' ' 6' ' ' LEU . 52.8 m95 -80.39 143.22 33.66 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.038 0.923 . . . . 0.0 112.264 -177.887 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 p -152.17 133.62 14.54 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 178.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -104.09 139.98 38.41 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.124 -0.63 . . . . 0.0 110.194 -178.636 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -109.54 108.9 19.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.65 -0.656 . . . . 0.0 109.938 179.724 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -67.62 -21.08 65.41 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.707 -0.621 . . . . 0.0 110.759 -179.866 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.422 ' C ' HG23 ' A' ' 50' ' ' THR . . . -55.15 -41.79 72.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.29 -0.881 . . . . 0.0 110.747 -179.726 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.422 HG23 ' C ' ' A' ' 49' ' ' ALA . 67.2 p -146.84 21.75 1.26 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.6 -0.688 . . . . 0.0 110.617 -179.932 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.451 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.31 95.32 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.235 -0.916 . . . . 0.0 110.753 179.804 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.52 HG23 ' HB3' ' A' ' 5' ' ' LYS . 26.8 m -154.81 102.75 2.38 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.793 -0.763 . . . . 0.0 111.213 -179.841 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.436 ' O ' HD23 ' A' ' 6' ' ' LEU . 71.4 m-85 -63.81 128.9 37.86 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.708 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.635 ' HA ' HG22 ' A' ' 7' ' ' ILE . 61.1 m -122.65 106.76 11.24 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 119.291 -0.964 . . . . 0.0 112.588 -178.583 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.611 HG11 HG21 ' A' ' 40' ' ' ILE . 11.0 p -110.69 167.35 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.436 -0.79 . . . . 0.0 109.143 177.481 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.467 ' N ' HG22 ' A' ' 55' ' ' VAL . 78.7 m -161.39 111.42 1.65 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.642 -0.661 . . . . 0.0 109.83 -179.791 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.495 1.78 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.137 179.903 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 121.08 0.467 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.566 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 68.5 m -143.29 112.27 6.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.638 -0.664 . . . . 0.0 110.137 179.971 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.4 m -84.43 94.31 8.49 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.606 -0.684 . . . . 0.0 110.698 -179.679 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.798 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.7 m-85 -77.47 177.86 7.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.521 -0.737 . . . . 0.0 109.736 179.518 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.479 ' HB3' HG23 ' A' ' 52' ' ' THR . 8.3 ttmm -142.93 112.11 6.62 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.417 -0.802 . . . . 0.0 110.608 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.656 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -94.14 116.84 29.3 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.523 -0.736 . . . . 0.0 110.378 179.95 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.696 HG21 HG23 ' A' ' 54' ' ' THR . 2.7 tt -70.79 173.38 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.457 -0.777 . . . . 0.0 109.023 179.287 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.413 ' HB ' ' N ' ' A' ' 15' ' ' GLY . 83.0 mt -132.63 75.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.835 . . . . 0.0 110.161 179.903 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.01 45.2 1.04 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.526 -0.734 . . . . 0.0 109.204 179.379 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.04 158.92 15.89 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.74 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.7 tttm -76.7 -3.61 38.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.705 -0.879 . . . . 0.0 110.598 179.358 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 m -101.84 -33.1 9.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.161 -0.962 . . . . 0.0 110.217 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.609 HD11 ' CG ' ' A' ' 38' ' ' ASN . 73.0 mt -132.7 175.29 9.46 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.497 -0.752 . . . . 0.0 110.483 179.932 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -159.69 133.46 7.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.651 -0.656 . . . . 0.0 110.125 -179.866 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.413 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 132.46 -145.9 17.71 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.826 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -135.97 175.52 9.53 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.529 -0.983 . . . . 0.0 110.321 -179.922 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.9 m -150.73 134.42 16.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.527 -0.733 . . . . 0.0 110.262 179.899 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.3 p -121.56 161.82 21.69 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.537 -0.727 . . . . 0.0 110.335 -179.968 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.752 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 9.1 t -165.66 -179.52 5.43 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.56 -0.712 . . . . 0.0 110.272 179.921 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -109.42 119.58 39.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.607 -0.683 . . . . 0.0 110.061 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.471 ' HB1' ' HB ' ' A' ' 26' ' ' THR . . . -147.07 139.03 24.4 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.585 -0.697 . . . . 0.0 110.142 -179.892 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.0 m -57.98 -33.71 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.474 -0.766 . . . . 0.0 110.598 -179.932 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.708 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 15.4 p30 -170.35 -174.21 1.64 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.519 -0.738 . . . . 0.0 110.33 179.84 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.46 -27.15 56.12 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.523 -0.735 . . . . 0.0 110.739 -179.755 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.708 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.74 -26.46 65.67 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.474 -0.766 . . . . 0.0 110.32 179.861 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.471 ' HB ' ' HB1' ' A' ' 21' ' ' ALA . 50.2 m -110.0 -27.38 9.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.539 -0.725 . . . . 0.0 110.249 179.908 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.798 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.55 -60.68 3.45 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.624 -0.672 . . . . 0.0 110.361 -179.917 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -59.93 -36.15 76.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.555 -0.716 . . . . 0.0 110.158 -179.985 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 tttt -57.66 -45.23 85.81 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.461 -0.774 . . . . 0.0 110.49 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.6 t -79.03 -43.91 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.561 -0.712 . . . . 0.0 110.134 -179.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.752 ' CZ ' HG22 ' A' ' 19' ' ' THR . 8.0 m-85 -66.77 -34.06 76.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.583 -0.698 . . . . 0.0 110.291 -179.679 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 11.6 tptt -63.95 -40.57 96.73 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.393 -0.817 . . . . 0.0 108.897 179.212 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 tp60 -63.35 -33.92 76.58 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.733 0.777 . . . . 0.0 109.239 179.003 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.68 -59.31 3.7 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 178.735 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.794 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -59.85 -46.78 88.2 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.752 -0.592 . . . . 0.0 110.275 179.894 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -55.95 -27.96 54.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.524 -0.735 . . . . 0.0 110.712 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.89 -52.56 49.1 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.577 -0.702 . . . . 0.0 109.973 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.609 ' CG ' HD11 ' A' ' 13' ' ' LEU . 43.0 m-80 -78.13 -45.0 24.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.596 -0.69 . . . . 0.0 109.994 179.856 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.47 53.16 0.18 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.769 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.794 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 84.1 mt -103.13 63.03 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.514 -0.992 . . . . 0.0 110.052 179.63 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.92 56.35 3.93 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.414 -0.804 . . . . 0.0 108.907 178.879 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.56 -137.31 3.66 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.123 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -116.03 101.16 8.5 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.403 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.656 ' CH2' HD11 ' A' ' 6' ' ' LEU . 49.9 m95 -71.77 142.52 49.71 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.998 0.904 . . . . 0.0 111.846 -178.197 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 p -151.24 132.19 14.24 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.939 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.401 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 13.3 t80 -103.17 139.35 38.77 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.679 -0.638 . . . . 0.0 110.108 -178.701 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.25 104.76 13.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.775 -0.578 . . . . 0.0 109.511 179.432 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -63.2 -20.87 65.81 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.676 -0.64 . . . . 0.0 110.798 -179.568 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.445 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.26 -40.05 67.44 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.287 -0.883 . . . . 0.0 110.703 -179.765 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.445 HG23 ' C ' ' A' ' 49' ' ' ALA . 68.0 p -148.14 21.84 1.09 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.621 -0.674 . . . . 0.0 110.516 179.998 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.445 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.56 91.36 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.198 -0.939 . . . . 0.0 110.743 179.976 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.479 HG23 ' HB3' ' A' ' 5' ' ' LYS . 20.4 m -150.23 98.54 2.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.462 -0.774 . . . . 0.0 111.23 -179.807 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.456 ' O ' HD23 ' A' ' 6' ' ' LEU . 66.3 m-85 -61.81 127.8 33.17 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.391 -0.818 . . . . 0.0 108.959 178.656 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.696 HG23 HG21 ' A' ' 7' ' ' ILE . 91.7 m -123.67 107.63 11.69 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.405 -0.918 . . . . 0.0 112.451 -178.499 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.545 HG21 HG22 ' A' ' 40' ' ' ILE . 11.6 p -107.96 167.4 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.358 -0.839 . . . . 0.0 108.917 177.401 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.462 ' N ' HG22 ' A' ' 55' ' ' VAL . 99.2 m -160.7 111.01 1.77 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.636 -0.665 . . . . 0.0 109.984 -179.703 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.102 179.811 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 mtt . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.099 0.476 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.552 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 86.6 m -97.62 112.72 24.48 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.547 -0.72 . . . . 0.0 110.155 -179.99 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 3' ' ' THR . 7.2 t -82.36 99.94 9.68 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.628 -0.67 . . . . 0.0 110.503 -179.95 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.647 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 89.6 m-85 -84.76 170.52 13.15 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.351 -0.843 . . . . 0.0 109.771 179.696 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.519 ' HB3' HG23 ' A' ' 52' ' ' THR . 7.5 tttt -139.96 115.31 9.89 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.417 -0.802 . . . . 0.0 110.466 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.627 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -96.95 113.16 24.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.5 -0.75 . . . . 0.0 110.479 -179.915 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.672 HG21 HG23 ' A' ' 54' ' ' THR . 2.7 tp -65.42 170.01 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.133 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 13' ' ' LEU . 83.8 mt -131.17 73.17 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 110.237 179.734 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.18 48.15 1.23 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.475 -0.766 . . . . 0.0 109.092 179.094 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.97 156.0 15.81 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -179.464 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.7 ttmt -74.18 -6.35 47.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.746 -0.855 . . . . 0.0 110.408 179.185 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.8 m -94.94 -31.52 13.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 110.167 179.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.537 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.8 OUTLIER -147.47 164.51 33.13 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.489 -0.757 . . . . 0.0 110.604 -179.869 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.5 mtmt -144.73 140.27 28.45 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.62 -0.675 . . . . 0.0 110.311 -179.877 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 132.6 -144.47 16.33 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.605 ' HG2' HD12 ' A' ' 7' ' ' ILE . 51.3 mt-10 -144.26 162.34 36.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.505 -0.997 . . . . 0.0 110.281 -179.979 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.4 m -137.8 143.44 41.06 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.598 -0.689 . . . . 0.0 109.951 179.788 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.2 p -127.21 153.67 45.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.592 -0.692 . . . . 0.0 110.297 -179.874 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.842 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 9.0 t -159.04 156.14 28.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.605 -0.685 . . . . 0.0 110.236 179.848 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -86.23 123.76 31.86 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.579 -0.701 . . . . 0.0 110.148 179.899 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.14 144.9 29.34 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.595 -0.691 . . . . 0.0 110.271 179.949 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.18 -36.06 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 121.565 -0.709 . . . . 0.0 110.195 -179.998 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.589 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 4.2 p30 -170.81 -168.38 0.67 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.561 -0.712 . . . . 0.0 110.389 179.787 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.421 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.88 -33.52 66.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.593 -0.692 . . . . 0.0 111.214 -179.287 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.589 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -55.02 -48.05 73.89 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.349 -0.845 . . . . 0.0 110.826 -179.51 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 21.9 m -85.87 -27.54 24.99 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.543 -0.723 . . . . 0.0 110.306 179.998 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.647 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.42 -61.21 2.76 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.537 -0.727 . . . . 0.0 110.303 -179.922 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -59.81 -38.79 82.95 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.554 -0.716 . . . . 0.0 110.382 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -55.95 -40.44 73.22 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.326 -0.859 . . . . 0.0 110.617 -179.893 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.5 t -82.05 -47.36 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.588 -0.695 . . . . 0.0 110.148 179.863 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.842 ' CZ ' HG22 ' A' ' 19' ' ' THR . 8.1 m-85 -64.68 -35.25 80.42 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.529 -0.732 . . . . 0.0 110.292 -179.771 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.59 -43.81 95.84 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.498 -0.751 . . . . 0.0 109.17 179.441 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.8 tp60 -60.77 -32.39 71.71 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 121.677 0.751 . . . . 0.0 109.539 179.07 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -68.86 -55.44 11.08 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 178.881 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.786 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -65.55 -44.18 87.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.746 -0.596 . . . . 0.0 110.209 -179.948 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -56.24 -32.13 64.19 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.491 -0.756 . . . . 0.0 110.439 -179.839 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -70.48 -52.77 19.65 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.649 -0.657 . . . . 0.0 109.883 179.692 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -68.54 -41.68 79.52 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.596 -0.69 . . . . 0.0 109.759 179.652 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.44 44.05 0.62 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.685 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.786 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 81.2 mt -96.51 63.1 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.522 -0.987 . . . . 0.0 110.204 179.762 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -83.73 58.52 4.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.578 -0.701 . . . . 0.0 109.292 179.163 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.47 -137.69 5.44 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.33 100.95 7.63 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.183 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.627 ' CH2' HD11 ' A' ' 6' ' ' LEU . 52.8 m95 -69.73 142.68 53.25 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.131 0.967 . . . . 0.0 112.489 -177.775 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -149.88 131.81 15.19 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.567 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.4 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 21.8 t80 -106.29 134.84 48.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.638 -0.663 . . . . 0.0 110.159 -178.454 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -106.61 110.5 22.71 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.661 -0.649 . . . . 0.0 109.848 179.57 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -67.3 -24.64 65.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.637 -0.664 . . . . 0.0 110.623 -179.672 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.405 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.42 -37.44 56.74 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.325 -0.859 . . . . 0.0 110.899 -179.655 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.405 HG23 ' C ' ' A' ' 49' ' ' ALA . 72.1 p -145.93 16.83 1.41 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.623 -0.673 . . . . 0.0 110.839 179.837 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.442 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 51.13 93.06 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.084 -1.01 . . . . 0.0 110.729 179.939 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.519 HG23 ' HB3' ' A' ' 5' ' ' LYS . 91.9 m -155.49 104.06 2.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.523 -0.736 . . . . 0.0 111.051 -179.697 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.437 ' O ' HD23 ' A' ' 6' ' ' LEU . 86.1 m-85 -62.44 132.17 51.64 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.498 -0.751 . . . . 0.0 109.037 178.88 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.672 HG23 HG21 ' A' ' 7' ' ' ILE . 77.1 m -126.9 105.17 8.45 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.396 -0.922 . . . . 0.0 112.426 -178.686 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.58 HG11 HG21 ' A' ' 40' ' ' ILE . 9.2 p -107.2 166.43 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.341 -0.85 . . . . 0.0 109.443 177.694 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.447 ' N ' HG22 ' A' ' 55' ' ' VAL . 86.9 m -162.33 117.02 1.85 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.673 -0.642 . . . . 0.0 110.107 -179.525 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.411 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 3.5 mt-10 . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.124 179.456 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.6 mtt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.108 0.48 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.554 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 62.2 m -120.65 112.57 19.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.558 -0.714 . . . . 0.0 110.383 -179.962 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.7 m -94.26 93.43 7.74 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.508 -0.745 . . . . 0.0 110.481 -179.835 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.707 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 97.5 m-85 -71.77 169.72 15.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.579 -0.701 . . . . 0.0 109.978 179.824 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.509 ' HG2' HG22 ' A' ' 18' ' ' THR . 2.7 mttt -136.22 114.15 11.28 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.532 -0.73 . . . . 0.0 110.413 -179.825 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.659 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -93.98 111.98 23.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.485 -0.759 . . . . 0.0 110.554 -179.969 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.637 HG21 HG23 ' A' ' 54' ' ' THR . 3.6 tp -63.51 171.06 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.061 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.479 HD11 ' OG1' ' A' ' 17' ' ' THR . 82.8 mt -133.05 74.03 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.559 -179.91 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -96.16 46.46 1.08 Allowed 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.854 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.05 156.83 16.72 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.692 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 ttpp -75.48 -5.83 47.08 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.766 -0.844 . . . . 0.0 110.383 179.117 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.47 HG22 HD12 ' A' ' 13' ' ' LEU . 7.5 m -93.88 -34.74 13.0 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.204 -0.935 . . . . 0.0 110.136 179.941 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.47 HD12 HG22 ' A' ' 12' ' ' THR . 0.6 OUTLIER -139.52 -176.34 4.51 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.536 -179.994 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -163.47 134.56 4.7 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.644 -0.66 . . . . 0.0 110.167 -179.953 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 136.89 -141.93 12.97 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.932 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -138.88 161.81 36.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.573 -0.957 . . . . 0.0 110.306 -179.796 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.479 ' OG1' HD11 ' A' ' 8' ' ' ILE . 6.1 m -136.87 140.34 42.29 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.581 -0.699 . . . . 0.0 110.175 -179.965 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.509 HG22 ' HG2' ' A' ' 5' ' ' LYS . 38.7 p -129.55 159.44 36.33 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.492 -0.755 . . . . 0.0 110.398 -179.794 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.746 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.9 t -162.14 171.31 17.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.566 -0.709 . . . . 0.0 110.231 179.657 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -101.13 105.45 16.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.552 -0.718 . . . . 0.0 110.155 179.982 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.17 139.03 49.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.542 -0.724 . . . . 0.0 110.232 179.89 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.1 p -59.4 -33.36 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.566 -0.709 . . . . 0.0 110.179 179.953 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.586 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 30.3 p30 -170.04 -179.36 3.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.554 -0.716 . . . . 0.0 110.344 179.887 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -56.2 -24.83 44.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.49 -0.756 . . . . 0.0 110.862 -179.831 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.586 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.68 -30.48 67.41 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.447 -0.783 . . . . 0.0 110.472 -179.776 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 30' ' ' VAL . 25.2 m -109.48 -27.13 9.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.525 -0.735 . . . . 0.0 110.313 179.936 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.707 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -60.35 -42.77 96.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.501 -0.749 . . . . 0.0 110.127 179.916 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -70.87 -45.76 63.84 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.66 -0.65 . . . . 0.0 110.251 179.84 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -56.04 -31.9 63.56 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.243 -0.911 . . . . 0.0 110.551 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 26' ' ' THR . 60.0 t -87.01 -48.44 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.652 -0.655 . . . . 0.0 110.104 -179.937 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.746 ' CZ ' HG22 ' A' ' 19' ' ' THR . 6.3 m-85 -67.56 -38.79 84.63 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.981 -179.731 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -62.63 -43.87 97.71 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.515 -0.741 . . . . 0.0 109.093 179.226 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.6 tp60 -64.04 -34.12 77.29 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.761 0.791 . . . . 0.0 109.123 178.792 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -64.91 -57.71 8.07 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.676 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.781 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -58.96 -40.76 85.7 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.777 -0.577 . . . . 0.0 110.292 -179.895 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -58.01 -36.74 73.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.539 -0.726 . . . . 0.0 110.467 -179.879 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.96 -44.47 89.29 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.556 -0.715 . . . . 0.0 109.825 179.773 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -77.57 -40.37 42.58 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.673 -0.642 . . . . 0.0 109.971 179.729 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.87 40.83 0.88 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.82 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.781 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 75.8 mt -97.52 63.73 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.52 -0.988 . . . . 0.0 110.239 179.799 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -85.64 57.38 4.43 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.492 -0.755 . . . . 0.0 109.09 178.895 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.64 -139.32 6.17 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -178.839 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.55 108.72 17.92 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.859 -0.789 . . . . 0.0 109.008 179.455 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.659 ' HH2' HD11 ' A' ' 6' ' ' LEU . 57.9 m95 -79.59 142.49 35.63 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.118 0.961 . . . . 0.0 112.349 -177.794 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.456 HG23 ' O ' ' A' ' 44' ' ' TRP . 6.2 p -153.7 131.9 11.89 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.786 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.41 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 21.8 t80 -97.04 125.48 41.51 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.701 -0.625 . . . . 0.0 110.202 -178.506 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -87.72 98.46 11.46 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.751 -0.593 . . . . 0.0 109.746 179.584 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -63.4 -19.19 64.47 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.589 -0.694 . . . . 0.0 110.767 -179.767 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.444 ' C ' HG23 ' A' ' 50' ' ' THR . . . -55.6 -42.54 74.97 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.269 -0.895 . . . . 0.0 110.661 -179.77 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.444 HG23 ' C ' ' A' ' 49' ' ' ALA . 75.2 p -148.45 27.82 0.9 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.627 -0.671 . . . . 0.0 110.356 -179.871 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.441 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 5.6 mptt 52.52 96.8 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.336 -0.853 . . . . 0.0 110.809 -179.964 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.0 m -158.19 104.25 1.86 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.45 -0.781 . . . . 0.0 110.829 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.451 ' O ' HD23 ' A' ' 6' ' ' LEU . 64.3 m-85 -63.05 131.86 50.02 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.522 -0.736 . . . . 0.0 109.026 178.969 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.637 HG23 HG21 ' A' ' 7' ' ' ILE . 80.7 m -125.77 110.11 13.33 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 119.432 -0.907 . . . . 0.0 112.421 -178.528 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.568 HG11 HG21 ' A' ' 40' ' ' ILE . 11.3 p -114.35 167.4 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.37 -0.831 . . . . 0.0 109.35 177.726 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.456 ' N ' HG22 ' A' ' 55' ' ' VAL . 85.3 m -161.65 112.34 1.66 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.623 -0.673 . . . . 0.0 110.084 -179.649 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.172 179.764 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtm . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.1 0.476 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.592 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 40.2 m -101.27 112.94 25.59 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.581 -0.7 . . . . 0.0 110.371 -179.861 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 m -89.23 91.91 8.96 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.604 -0.685 . . . . 0.0 110.615 -179.791 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.665 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 97.3 m-85 -74.08 170.07 16.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.45 -0.781 . . . . 0.0 109.834 179.661 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -134.23 114.55 13.16 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.419 -0.801 . . . . 0.0 110.323 179.901 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.579 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -94.87 110.69 22.54 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.687 . . . . 0.0 110.399 -179.948 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 54' ' ' THR . 2.1 tt -65.46 162.64 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.044 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.405 HG21 ' HB3' ' A' ' 13' ' ' LEU . 49.0 mm -125.37 76.97 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.397 -179.741 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -96.13 47.33 1.09 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.991 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -110.23 159.58 13.82 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.217 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.0 tptt -77.83 -3.24 40.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.787 -0.831 . . . . 0.0 110.394 179.163 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.5 m -99.79 -32.01 11.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.178 -0.951 . . . . 0.0 110.14 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.537 HD11 ' OD1' ' A' ' 38' ' ' ASN . 55.9 mt -140.49 173.98 10.97 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.508 -0.745 . . . . 0.0 110.559 -179.916 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -160.73 135.98 7.84 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.63 -0.669 . . . . 0.0 109.994 179.795 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.07 -144.49 16.46 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -137.47 151.65 48.7 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.564 -0.963 . . . . 0.0 110.446 -179.851 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.6 m -130.84 144.87 51.77 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.613 -0.679 . . . . 0.0 110.08 179.857 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.8 p -131.8 139.8 48.99 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.549 -0.719 . . . . 0.0 110.355 -179.837 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.895 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.9 t -146.04 134.01 21.4 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 110.353 179.942 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.91 129.1 39.36 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.592 -0.692 . . . . 0.0 110.455 -179.919 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.53 140.67 19.43 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.561 -0.712 . . . . 0.0 109.989 179.887 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.47 HG13 ' OD1' ' A' ' 23' ' ' ASP . 9.2 p -58.58 -36.36 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.479 -0.763 . . . . 0.0 110.225 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.549 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 39.4 p30 -169.92 -176.01 2.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.578 -0.701 . . . . 0.0 110.209 179.621 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.453 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.57 -26.36 54.96 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.535 -0.728 . . . . 0.0 110.786 -179.667 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.549 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -59.48 -29.6 67.94 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.467 -0.771 . . . . 0.0 110.319 -179.895 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.453 ' O ' HG23 ' A' ' 30' ' ' VAL . 11.7 m -106.26 -27.39 11.06 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.583 -0.698 . . . . 0.0 110.382 179.952 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.665 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.73 -50.04 75.4 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.481 -0.762 . . . . 0.0 110.32 -179.981 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -62.19 -46.22 89.89 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.591 -0.693 . . . . 0.0 110.078 179.862 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.6 mttt -55.73 -34.68 65.37 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.445 -0.784 . . . . 0.0 110.873 -179.801 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 26' ' ' THR . 65.2 t -84.66 -47.65 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.502 -0.749 . . . . 0.0 110.274 -179.829 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.895 ' CZ ' HG22 ' A' ' 19' ' ' THR . 7.5 m-85 -68.11 -37.88 81.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.547 -0.721 . . . . 0.0 110.188 -179.76 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 26.7 tttt -62.26 -45.78 91.75 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.533 -0.73 . . . . 0.0 109.367 179.661 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.1 tp60 -60.95 -29.91 69.92 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.608 0.718 . . . . 0.0 109.619 179.004 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -72.53 -59.16 2.86 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.832 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.805 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.68 -49.42 77.57 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.728 -0.608 . . . . 0.0 110.194 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -56.1 -33.0 64.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.547 -0.721 . . . . 0.0 110.666 -179.816 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.16 -31.23 49.57 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.58 -0.7 . . . . 0.0 110.025 179.886 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.537 ' OD1' HD11 ' A' ' 13' ' ' LEU . 3.7 m-80 -83.47 -47.26 11.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.602 -0.686 . . . . 0.0 110.028 179.908 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.93 48.88 0.15 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.93 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.805 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 79.1 mt -116.26 58.52 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.505 -0.997 . . . . 0.0 110.391 179.935 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -81.35 60.55 4.46 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.433 -0.792 . . . . 0.0 109.013 178.918 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.96 -139.68 8.88 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -178.87 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -114.43 110.25 19.57 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.397 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.579 ' HH2' HD11 ' A' ' 6' ' ' LEU . 55.5 m95 -80.31 142.93 34.04 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 122.131 0.967 . . . . 0.0 112.456 -177.852 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 44' ' ' TRP . 7.0 p -153.04 130.95 11.73 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.853 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.417 ' CE2' ' HG3' ' A' ' 51' ' ' LYS . 14.3 t80 -102.07 128.76 48.38 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.693 -0.629 . . . . 0.0 109.848 -178.742 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -95.6 110.67 22.74 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.712 -0.617 . . . . 0.0 109.887 179.726 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -69.69 -22.9 63.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.706 -0.621 . . . . 0.0 110.686 -179.913 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.41 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.92 -39.56 68.95 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.424 -0.798 . . . . 0.0 110.939 -179.769 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.41 HG23 ' C ' ' A' ' 49' ' ' ALA . 77.8 p -145.77 19.22 1.47 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.53 -0.731 . . . . 0.0 110.974 -179.873 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.417 ' HG3' ' CE2' ' A' ' 46' ' ' TYR . 0.3 OUTLIER 51.88 95.65 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.23 -0.918 . . . . 0.0 110.957 179.7 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 81.1 m -158.7 106.46 1.87 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.499 -0.75 . . . . 0.0 110.683 179.83 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.436 ' O ' HD23 ' A' ' 6' ' ' LEU . 69.3 m-85 -63.65 129.38 39.92 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 178.948 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.645 ' HA ' HG22 ' A' ' 7' ' ' ILE . 56.7 m -123.25 107.2 11.42 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.36 -178.472 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.604 HG11 HG21 ' A' ' 40' ' ' ILE . 10.6 p -110.82 167.16 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.845 . . . . 0.0 109.436 177.791 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.457 ' N ' HG22 ' A' ' 55' ' ' VAL . 83.7 m -161.61 116.37 2.0 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.652 -0.655 . . . . 0.0 110.06 -179.782 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 . . . . . 0 N--CA 1.498 1.951 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.387 179.746 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mmt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.175 0.512 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.545 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 32.7 m -119.1 112.39 19.48 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.58 -0.7 . . . . 0.0 110.222 179.922 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 51.3 m -95.08 91.31 6.28 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.622 -0.674 . . . . 0.0 110.492 -179.767 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.663 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 96.8 m-85 -69.89 172.43 7.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.548 -0.72 . . . . 0.0 109.836 179.713 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -140.59 116.31 10.25 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.476 -0.765 . . . . 0.0 110.555 -179.659 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.635 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -96.27 112.77 24.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.536 -0.727 . . . . 0.0 110.423 -179.9 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.614 HG22 ' HA ' ' A' ' 54' ' ' THR . 4.2 tp -63.01 172.67 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.005 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.734 HD11 ' OG1' ' A' ' 17' ' ' THR . 74.2 mt -135.61 70.24 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.209 -0.932 . . . . 0.0 110.974 -179.724 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -93.59 50.12 1.44 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.316 -0.865 . . . . 0.0 109.033 178.539 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.04 155.31 16.18 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.303 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -11.82 61.15 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.639 -0.918 . . . . 0.0 110.247 179.138 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -86.75 -36.11 18.8 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -0.903 . . . . 0.0 110.332 -179.849 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.504 ' HB3' HG21 ' A' ' 8' ' ' ILE . 17.8 mt -138.67 -173.26 3.51 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.449 -0.782 . . . . 0.0 110.655 -179.912 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.15 127.08 2.48 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.603 -0.685 . . . . 0.0 110.345 179.94 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 135.99 -137.85 9.45 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.858 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -143.92 173.38 11.76 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.553 -0.969 . . . . 0.0 110.396 -179.858 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.734 ' OG1' HD11 ' A' ' 8' ' ' ILE . 7.4 m -153.26 146.8 25.0 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.622 -0.674 . . . . 0.0 110.175 179.864 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.3 p -132.5 170.19 15.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.628 -0.67 . . . . 0.0 110.226 179.965 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.74 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.3 t -165.58 179.43 6.07 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.573 -0.705 . . . . 0.0 110.166 -179.938 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -104.58 102.04 11.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.564 -0.71 . . . . 0.0 110.255 179.988 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.42 135.4 49.45 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.58 -0.7 . . . . 0.0 110.187 179.972 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 34.8 m -60.48 -27.23 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.497 -0.752 . . . . 0.0 110.345 179.955 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.453 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 31.1 p30 -172.79 178.43 2.61 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.422 -0.798 . . . . 0.0 110.221 179.67 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.02 -27.54 45.17 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.504 -0.747 . . . . 0.0 110.763 -179.606 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.453 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -63.37 -24.09 67.69 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.6 -0.688 . . . . 0.0 110.49 179.934 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 m -108.11 -26.11 10.79 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.449 -0.782 . . . . 0.0 110.628 -179.738 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.663 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -69.38 -48.24 61.78 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.495 -0.753 . . . . 0.0 110.35 -179.813 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -60.18 -41.53 93.07 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.564 -0.71 . . . . 0.0 110.488 -179.867 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -58.55 -36.36 73.78 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.379 -0.826 . . . . 0.0 110.591 -179.874 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.88 -41.56 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.516 -0.74 . . . . 0.0 110.222 -179.922 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.74 ' CZ ' HG22 ' A' ' 19' ' ' THR . 11.0 m-85 -72.5 -39.04 67.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.519 -0.738 . . . . 0.0 110.32 -179.851 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.4 tttt -62.03 -45.49 93.37 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.387 -0.821 . . . . 0.0 109.173 179.335 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 29.4 tp60 -62.43 -33.06 74.05 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.721 0.772 . . . . 0.0 109.339 179.023 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -67.5 -56.71 8.45 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 178.847 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.789 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -61.07 -38.69 87.1 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.749 -0.595 . . . . 0.0 110.148 179.997 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.8 m-20 -58.11 -39.96 79.99 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.503 -0.748 . . . . 0.0 110.557 -179.843 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -69.66 -43.04 73.39 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.567 -0.708 . . . . 0.0 110.134 -179.946 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -75.34 -28.9 59.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.589 -0.695 . . . . 0.0 110.102 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.06 52.25 1.39 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.886 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.789 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 83.9 mt -109.22 61.24 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.501 -0.999 . . . . 0.0 110.256 179.94 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -84.05 57.89 4.43 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.439 -0.788 . . . . 0.0 108.993 178.791 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.46 -138.04 5.56 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -178.916 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -116.79 101.22 8.36 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.874 -0.78 . . . . 0.0 109.365 179.484 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.635 ' CH2' HD11 ' A' ' 6' ' ' LEU . 52.6 m95 -71.74 143.06 49.73 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 122.02 0.914 . . . . 0.0 112.176 -178.2 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.66 131.74 14.37 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.464 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.404 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 38.5 t80 -105.02 131.73 52.17 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.713 -0.617 . . . . 0.0 110.294 -178.365 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -106.74 119.22 38.75 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.662 -0.649 . . . . 0.0 109.819 179.546 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -73.22 -21.46 60.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.655 -0.653 . . . . 0.0 110.707 -179.762 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.429 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.67 -38.23 60.14 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.257 -0.902 . . . . 0.0 110.804 -179.781 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.429 HG23 ' C ' ' A' ' 49' ' ' ALA . 76.0 p -146.88 17.15 1.25 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.594 -0.691 . . . . 0.0 110.86 179.889 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.427 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.1 OUTLIER 50.88 93.33 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.122 -0.986 . . . . 0.0 110.697 179.953 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 91.0 m -154.86 106.87 2.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.464 -0.772 . . . . 0.0 110.94 -179.662 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.473 ' O ' HD23 ' A' ' 6' ' ' LEU . 79.1 m-85 -61.93 130.12 44.15 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.698 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.614 ' HA ' HG22 ' A' ' 7' ' ' ILE . 85.0 m -123.39 107.23 11.39 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.539 -178.598 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.564 HG11 HG21 ' A' ' 40' ' ' ILE . 11.1 p -111.64 166.94 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.452 -0.78 . . . . 0.0 109.15 177.536 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.451 ' N ' HG22 ' A' ' 55' ' ' VAL . 90.8 m -161.88 111.89 1.57 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.766 -0.584 . . . . 0.0 109.796 -179.857 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.163 179.86 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mtt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.1 0.476 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.617 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 12.0 m -151.16 112.14 4.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.578 -0.702 . . . . 0.0 110.23 -179.969 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 3' ' ' THR . 8.0 t -87.81 84.29 7.05 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.684 -0.635 . . . . 0.0 110.8 -179.616 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.634 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 92.9 m-85 -68.6 167.82 14.28 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.357 -0.84 . . . . 0.0 109.938 179.72 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.509 ' HG3' HG22 ' A' ' 18' ' ' THR . 22.8 mttt -131.21 114.75 15.46 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.524 -0.735 . . . . 0.0 110.308 179.974 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.628 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -95.12 109.63 21.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.498 -0.752 . . . . 0.0 110.256 179.916 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.601 HG21 HG23 ' A' ' 54' ' ' THR . 4.1 tp -63.24 169.56 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.166 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.526 HD12 ' C ' ' A' ' 15' ' ' GLY . 81.2 mt -130.84 71.52 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.589 -179.575 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -94.68 48.3 1.2 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.383 -0.823 . . . . 0.0 108.978 178.947 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.8 160.29 17.12 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.504 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.66 -1.62 35.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.776 -0.837 . . . . 0.0 110.583 179.205 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.806 ' O ' HD22 ' A' ' 13' ' ' LEU . 9.1 m -103.0 -37.58 7.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 0.0 110.318 -179.928 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.806 HD22 ' O ' ' A' ' 12' ' ' THR . 0.9 OUTLIER -134.65 176.54 8.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.486 -0.759 . . . . 0.0 110.589 -179.981 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -157.14 137.85 13.22 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.528 -0.732 . . . . 0.0 110.274 -179.962 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.526 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 134.02 -153.5 20.95 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.946 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -143.04 157.74 44.25 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.558 -0.966 . . . . 0.0 110.248 -179.961 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.7 t -144.16 164.49 30.54 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.556 -0.715 . . . . 0.0 110.304 179.993 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.509 HG22 ' HG3' ' A' ' 5' ' ' LYS . 11.9 p -135.84 174.21 10.86 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.573 -0.704 . . . . 0.0 110.189 179.941 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.623 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 7.6 t -161.98 -168.59 1.96 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.583 -0.698 . . . . 0.0 110.369 -179.951 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.26 103.23 8.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.637 -0.664 . . . . 0.0 110.387 179.9 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -133.56 143.18 48.54 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.485 -0.76 . . . . 0.0 110.238 -179.888 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.603 HG13 ' OD1' ' A' ' 23' ' ' ASP . 8.8 p -60.72 -31.6 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.584 -0.698 . . . . 0.0 109.927 179.789 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.603 ' OD1' HG13 ' A' ' 22' ' ' VAL . 50.9 p-10 -170.18 179.1 3.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.635 -0.666 . . . . 0.0 110.148 179.723 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.446 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.04 -25.56 45.4 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.508 -0.745 . . . . 0.0 110.855 -179.647 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -59.23 -26.51 64.95 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.52 -0.737 . . . . 0.0 110.533 -179.855 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.3 m -111.36 -26.98 8.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.521 -0.737 . . . . 0.0 110.46 -179.896 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.634 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.96 -53.51 56.99 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.498 -0.751 . . . . 0.0 110.317 -179.868 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -59.78 -37.72 79.84 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.578 -0.701 . . . . 0.0 110.315 179.94 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -56.32 -43.31 78.85 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.415 -0.803 . . . . 0.0 110.371 179.93 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.7 t -80.29 -46.09 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.611 -0.68 . . . . 0.0 109.852 179.633 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.623 ' CZ ' HG22 ' A' ' 19' ' ' THR . 9.2 m-85 -63.22 -35.52 80.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.607 -0.683 . . . . 0.0 110.355 -179.749 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -63.54 -42.71 98.4 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.411 -0.806 . . . . 0.0 109.138 179.438 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 42.6 tp60 -63.25 -33.97 76.65 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.735 0.779 . . . . 0.0 109.205 178.898 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -66.63 -58.67 4.67 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.745 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.809 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -60.6 -34.11 73.72 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.712 -0.618 . . . . 0.0 110.061 179.799 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -55.16 -54.13 47.17 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.613 -0.68 . . . . 0.0 110.741 -179.924 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.18 -44.35 96.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.573 -0.705 . . . . 0.0 110.13 179.923 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -67.5 -29.64 69.11 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.597 -0.689 . . . . 0.0 110.072 179.87 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.6 50.96 2.42 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.987 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.809 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 83.1 mt -107.52 61.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.569 -0.96 . . . . 0.0 110.208 179.936 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.07 61.62 4.71 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 178.612 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -93.23 -140.73 10.23 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -178.685 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -116.02 103.54 10.68 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.572 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.628 ' HH2' HD11 ' A' ' 6' ' ' LEU . 52.0 m95 -73.73 142.13 46.33 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 122.044 0.926 . . . . 0.0 112.129 -178.211 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.5 p -149.71 131.96 15.49 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.722 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.433 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 45.9 t80 -103.7 127.8 51.12 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.718 -0.614 . . . . 0.0 110.014 -178.452 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -98.02 120.61 38.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.706 -0.621 . . . . 0.0 110.075 179.902 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.48 -23.03 53.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.677 -0.639 . . . . 0.0 110.489 179.961 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.402 ' C ' HG23 ' A' ' 50' ' ' THR . . . -54.4 -40.66 68.46 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.39 -0.819 . . . . 0.0 110.894 -179.733 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.402 HG23 ' C ' ' A' ' 49' ' ' ALA . 73.8 p -145.76 18.0 1.46 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.564 -0.71 . . . . 0.0 111.011 -179.899 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' HG3' ' CE1' ' A' ' 46' ' ' TYR . 0.2 OUTLIER 52.15 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.115 -0.99 . . . . 0.0 110.962 179.715 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.0 m -156.2 104.68 2.26 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.431 -0.793 . . . . 0.0 110.996 -179.949 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.462 ' O ' HD23 ' A' ' 6' ' ' LEU . 63.7 m-85 -61.48 123.9 19.14 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.522 -0.736 . . . . 0.0 109.129 178.839 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.601 HG23 HG21 ' A' ' 7' ' ' ILE . 60.4 m -119.49 104.89 10.72 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.322 -0.951 . . . . 0.0 112.667 -178.453 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.59 HG11 HG21 ' A' ' 40' ' ' ILE . 10.6 p -107.32 167.02 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.241 177.554 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.459 ' N ' HG22 ' A' ' 55' ' ' VAL . 99.5 m -159.09 109.17 1.97 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.647 -0.658 . . . . 0.0 109.902 -179.766 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.122 -179.929 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mtm . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.103 0.478 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.72 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 33.1 m -77.79 165.22 24.44 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.565 -0.709 . . . . 0.0 110.217 -179.921 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.412 ' N ' HG22 ' A' ' 2' ' ' THR . 90.0 m -143.3 91.16 2.24 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 121.643 -0.661 . . . . 0.0 109.902 179.88 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.72 ' CZ ' HG21 ' A' ' 2' ' ' THR . 83.6 m-85 -80.95 175.88 10.3 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.555 -0.716 . . . . 0.0 110.253 -179.608 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.633 ' CB ' HG23 ' A' ' 52' ' ' THR . 26.7 mttt -137.49 142.16 41.49 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.673 -0.642 . . . . 0.0 109.96 179.728 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.536 ' C ' HD13 ' A' ' 6' ' ' LEU . 3.4 tm? -115.62 99.8 7.59 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.527 -0.733 . . . . 0.0 110.191 -179.614 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.748 HG21 HG23 ' A' ' 54' ' ' THR . 2.0 tp -63.16 124.68 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.465 -0.772 . . . . 0.0 108.96 179.625 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.589 HG21 ' HB3' ' A' ' 13' ' ' LEU . 10.0 mt -92.65 68.27 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.524 -0.735 . . . . 0.0 110.605 -178.907 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.478 ' HB3' HG23 ' A' ' 56' ' ' THR . 18.1 m-20 -89.19 53.0 2.52 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.199 -0.938 . . . . 0.0 109.221 178.966 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.3 169.0 17.0 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.483 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -83.72 5.48 24.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.749 -0.853 . . . . 0.0 110.499 179.088 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.5 m -114.29 -30.45 6.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.199 -0.938 . . . . 0.0 110.245 -179.931 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.589 ' HB3' HG21 ' A' ' 8' ' ' ILE . 13.2 mt -137.1 179.24 6.5 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.373 -0.829 . . . . 0.0 110.741 -179.903 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.03 134.45 4.26 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.625 -0.672 . . . . 0.0 110.084 -179.938 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 141.11 -150.1 21.54 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.921 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -139.06 155.32 48.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.624 -0.927 . . . . 0.0 110.298 -179.883 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.4 ' OG1' HD11 ' A' ' 8' ' ' ILE . 76.8 m -126.04 156.08 40.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.548 -0.72 . . . . 0.0 110.089 -179.99 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.5 p -145.38 144.98 30.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.587 -0.695 . . . . 0.0 110.323 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.499 HG22 ' CE1' ' A' ' 31' ' ' PHE . 9.7 t -156.17 144.78 20.13 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.57 -0.706 . . . . 0.0 110.202 179.775 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.23 112.6 12.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.567 -0.708 . . . . 0.0 109.778 179.712 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -131.91 144.42 50.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.605 -0.685 . . . . 0.0 110.027 -179.864 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 33.8 m -60.6 -33.48 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.522 -0.736 . . . . 0.0 110.239 -179.976 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.656 ' OD1' ' HB3' ' A' ' 25' ' ' ALA . 24.0 p30 -175.26 -175.35 0.82 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.462 -0.774 . . . . 0.0 110.254 179.422 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -56.8 -25.19 55.09 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.545 -0.722 . . . . 0.0 110.876 -179.725 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.656 ' HB3' ' OD1' ' A' ' 23' ' ' ASP . . . -58.24 -26.52 63.0 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.462 -0.774 . . . . 0.0 110.543 -179.83 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.5 m -111.49 -25.91 9.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.529 -0.732 . . . . 0.0 110.559 -179.882 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.704 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -59.66 -57.41 13.03 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.457 -0.777 . . . . 0.0 110.45 -179.825 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -59.18 -36.28 75.06 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.465 -0.772 . . . . 0.0 110.416 -179.986 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.1 mttm -61.06 -41.54 96.81 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.351 -0.843 . . . . 0.0 109.864 179.764 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.9 t -83.51 -39.34 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.578 -0.701 . . . . 0.0 109.337 179.278 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.499 ' CE1' HG22 ' A' ' 19' ' ' THR . 5.0 m-30 -66.45 -35.41 80.23 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.703 -0.623 . . . . 0.0 109.644 179.558 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -69.43 -45.45 69.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.663 -0.648 . . . . 0.0 109.624 179.712 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 8.8 tp60 -61.94 -32.18 72.58 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.625 0.726 . . . . 0.0 109.671 179.397 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -67.65 -48.48 66.55 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.063 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.696 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -75.19 -33.09 61.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.781 -0.574 . . . . 0.0 110.391 -179.679 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -58.69 -45.24 89.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.497 -0.752 . . . . 0.0 110.399 -179.814 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.03 -36.98 72.57 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.599 -0.688 . . . . 0.0 110.156 179.941 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -74.43 -34.8 63.3 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.617 -0.677 . . . . 0.0 110.049 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.59 35.5 3.53 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.965 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.696 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 81.6 mt -100.09 69.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.537 -0.978 . . . . 0.0 110.204 179.991 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -92.08 51.5 1.81 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.692 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.71 -136.81 0.75 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -178.711 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -113.95 102.95 10.68 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.641 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.463 ' CH2' HD21 ' A' ' 6' ' ' LEU . 35.2 m95 -74.02 142.0 45.78 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 122.113 0.959 . . . . 0.0 112.161 -178.101 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 44' ' ' TRP . 4.3 p -152.58 132.17 13.06 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.022 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.432 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 53.8 t80 -103.8 103.75 13.67 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.71 -0.618 . . . . 0.0 109.951 -178.846 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.78 109.32 15.22 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.686 -0.634 . . . . 0.0 109.839 179.781 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -64.62 -22.12 66.89 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.706 -0.621 . . . . 0.0 110.437 -179.965 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -51.79 -35.54 44.33 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.331 -0.855 . . . . 0.0 110.791 -179.855 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.0 p -145.4 15.48 1.46 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.545 -0.722 . . . . 0.0 110.95 179.862 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.44 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 51.01 82.24 0.06 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.092 -1.005 . . . . 0.0 110.716 179.818 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.633 HG23 ' CB ' ' A' ' 5' ' ' LYS . 26.6 m -150.11 110.71 4.25 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.38 -0.825 . . . . 0.0 111.429 -179.642 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -65.53 112.76 3.75 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.439 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.748 HG23 HG21 ' A' ' 7' ' ' ILE . 88.4 m -104.85 99.41 9.05 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.918 -177.545 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.516 HG21 HG22 ' A' ' 40' ' ' ILE . 10.7 p -100.38 164.92 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 0.0 108.972 177.044 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.478 HG23 ' HB3' ' A' ' 9' ' ' ASN . 90.0 m -160.62 110.53 1.75 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.722 -0.611 . . . . 0.0 110.135 -179.677 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.038 179.824 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 ptt? . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.128 0.489 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.643 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 4.1 m -103.85 114.75 29.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.624 -0.672 . . . . 0.0 110.048 179.991 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.8 m -89.08 86.68 6.95 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.585 -0.697 . . . . 0.0 110.627 -179.576 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.728 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 66.0 m-85 -76.05 169.73 17.62 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.458 -0.776 . . . . 0.0 109.788 179.684 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 52' ' ' THR . 11.0 mtmm -141.45 105.3 4.74 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.482 -0.761 . . . . 0.0 110.392 -179.928 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.524 HD11 ' HH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -90.61 107.34 19.1 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.495 -0.753 . . . . 0.0 110.041 179.817 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 54' ' ' THR . 2.8 tp -64.2 160.2 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 119.616 -0.834 . . . . 0.0 108.921 179.231 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 13' ' ' LEU . 49.0 mm -123.31 76.84 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.456 -179.735 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.9 48.3 1.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.784 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -113.9 153.16 17.76 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.234 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.39 -12.61 61.7 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.686 -0.89 . . . . 0.0 110.283 179.178 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.6 m -85.98 -35.75 20.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.264 -0.898 . . . . 0.0 110.336 -179.999 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.438 ' O ' HG22 ' A' ' 8' ' ' ILE . 38.9 mt -143.72 171.43 14.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.521 -0.737 . . . . 0.0 110.545 -179.902 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.96 137.54 13.13 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.611 -0.681 . . . . 0.0 110.105 179.89 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.28 -138.05 9.43 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 179.962 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -141.08 165.53 27.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.55 -0.971 . . . . 0.0 110.298 -179.917 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.1 m -151.75 128.47 10.86 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.582 -0.699 . . . . 0.0 110.1 179.977 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.428 HG22 ' HG2' ' A' ' 5' ' ' LYS . 26.4 p -126.32 149.4 49.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.525 -0.735 . . . . 0.0 110.374 -179.915 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.831 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 9.0 t -150.56 129.14 12.24 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.621 -0.675 . . . . 0.0 110.179 179.807 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -60.91 118.48 6.75 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.513 -0.742 . . . . 0.0 110.101 179.868 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.84 156.89 45.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.58 -0.7 . . . . 0.0 110.319 -179.786 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 13.8 p -65.0 -37.0 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.621 -0.674 . . . . 0.0 110.063 179.963 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -174.73 -173.67 0.74 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.517 -0.739 . . . . 0.0 109.964 179.8 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . . . -54.77 -24.15 21.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.43 -0.794 . . . . 0.0 111.018 -179.643 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -57.66 -43.79 85.24 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.402 -0.811 . . . . 0.0 110.504 -179.892 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.3 m -94.7 -29.97 14.53 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.572 -0.705 . . . . 0.0 110.254 179.907 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.728 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.76 -62.21 2.04 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.488 -0.758 . . . . 0.0 110.419 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -60.17 -35.26 74.95 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.652 -0.655 . . . . 0.0 110.308 179.988 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -60.35 -41.94 94.69 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.29 -0.881 . . . . 0.0 110.114 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 84.7 t -81.45 -41.28 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.605 -0.684 . . . . 0.0 109.648 179.562 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.831 ' CZ ' HG22 ' A' ' 19' ' ' THR . 14.7 m-85 -67.66 -38.37 83.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 0.0 110.155 -179.934 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -63.34 -47.89 80.28 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.535 -0.728 . . . . 0.0 109.654 179.723 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -59.82 -32.92 71.11 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.732 0.777 . . . . 0.0 109.452 179.241 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.402 ' OH ' HD12 ' A' ' 8' ' ' ILE . 2.3 t80 -66.99 -59.2 3.68 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.717 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.799 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -61.96 -44.66 96.28 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.729 -0.607 . . . . 0.0 109.995 179.703 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -56.0 -42.4 76.34 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.537 -0.727 . . . . 0.0 110.61 -179.777 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.22 -41.65 85.38 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.596 -0.69 . . . . 0.0 109.9 179.862 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -72.86 -51.66 17.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.577 -0.702 . . . . 0.0 109.856 179.779 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.8 43.72 0.23 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.686 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.799 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 80.3 mt -104.5 59.09 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.515 -0.991 . . . . 0.0 110.256 179.755 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -80.74 60.95 4.22 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.47 -0.769 . . . . 0.0 109.058 178.961 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -90.7 -138.34 7.5 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -178.906 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.79 102.78 9.39 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.891 -0.77 . . . . 0.0 109.07 179.281 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.524 ' HH2' HD11 ' A' ' 6' ' ' LEU . 53.3 m95 -73.03 142.62 47.68 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.207 1.004 . . . . 0.0 112.574 -177.705 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.3 p -150.46 131.49 14.33 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.411 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -106.58 128.86 54.47 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.637 -0.664 . . . . 0.0 110.329 -178.288 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -100.73 111.28 23.48 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.697 -0.627 . . . . 0.0 109.911 179.707 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -68.91 -24.69 64.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.689 -0.632 . . . . 0.0 110.525 -179.881 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.43 ' C ' HG23 ' A' ' 50' ' ' THR . . . -52.31 -36.33 52.93 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.353 -0.842 . . . . 0.0 110.969 -179.695 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.43 HG23 ' C ' ' A' ' 49' ' ' ALA . 77.3 p -147.2 16.86 1.19 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.514 -0.741 . . . . 0.0 110.94 179.99 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.459 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 0.0 OUTLIER 52.36 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.149 -0.969 . . . . 0.0 110.809 179.798 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 5' ' ' LYS . 74.9 m -159.64 104.27 1.58 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.423 -0.798 . . . . 0.0 111.209 -179.943 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.471 ' HE2' ' HB1' ' A' ' 27' ' ' ALA . 96.7 m-85 -65.0 128.12 34.43 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.557 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.672 ' HA ' HG22 ' A' ' 7' ' ' ILE . 61.8 m -120.39 103.11 8.93 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.301 -0.96 . . . . 0.0 112.34 -178.52 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.584 HG11 HG21 ' A' ' 40' ' ' ILE . 8.5 p -106.13 165.74 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.323 -0.861 . . . . 0.0 109.56 177.935 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.449 ' N ' HG22 ' A' ' 55' ' ' VAL . 84.4 m -162.54 117.08 1.79 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.785 -0.572 . . . . 0.0 109.88 -179.744 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.991 179.691 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mmt . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.104 0.478 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.465 HG21 ' CZ ' ' A' ' 4' ' ' PHE . 77.7 m -84.1 112.35 20.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.619 -0.675 . . . . 0.0 110.246 -179.929 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.4 m -93.47 103.8 15.98 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.631 -0.668 . . . . 0.0 110.446 -179.87 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.739 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 84.7 m-85 -84.11 179.54 7.47 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.515 -0.74 . . . . 0.0 110.178 179.938 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.547 ' HB3' HG23 ' A' ' 52' ' ' THR . 5.7 ttmt -145.69 111.94 5.74 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.527 -0.733 . . . . 0.0 110.502 179.966 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.515 HD11 ' CH2' ' A' ' 44' ' ' TRP . 0.0 OUTLIER -92.72 111.45 23.06 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.435 -0.79 . . . . 0.0 110.321 -179.959 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.643 HG21 HG23 ' A' ' 54' ' ' THR . 3.6 tt -65.03 174.01 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.357 -0.84 . . . . 0.0 108.801 179.205 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 13' ' ' LEU . 76.1 mt -135.0 74.51 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.296 -0.878 . . . . 0.0 110.658 -179.888 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -96.28 49.73 1.14 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.953 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -109.71 160.95 13.19 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.327 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm -78.15 -7.44 57.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.724 -0.868 . . . . 0.0 110.463 179.201 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 12' ' ' THR . 10.0 t -98.23 -25.56 14.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.164 -0.96 . . . . 0.0 110.701 -179.77 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.471 ' O ' HG22 ' A' ' 8' ' ' ILE . 3.6 tp -150.09 164.67 34.97 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.416 -0.802 . . . . 0.0 110.744 -179.875 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.16 140.11 23.99 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.61 -0.681 . . . . 0.0 110.412 -179.773 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.406 ' N ' ' HB ' ' A' ' 8' ' ' ILE . . . 132.79 -144.69 16.63 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.978 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -142.7 170.56 15.48 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.485 -1.009 . . . . 0.0 110.277 -179.942 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.7 m -144.06 161.39 38.92 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.64 -0.663 . . . . 0.0 110.188 179.991 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.8 p -144.54 151.09 38.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.543 -0.723 . . . . 0.0 110.41 -179.838 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.782 HG22 ' CZ ' ' A' ' 31' ' ' PHE . 8.6 t -155.99 164.56 38.31 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.584 -0.698 . . . . 0.0 110.064 179.795 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -94.87 109.72 21.68 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.526 -0.733 . . . . 0.0 110.292 -179.959 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -134.47 143.15 47.34 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.612 -0.68 . . . . 0.0 109.95 179.9 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.455 HG23 ' N ' ' A' ' 23' ' ' ASP . 33.5 m -57.4 -38.84 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.451 -0.781 . . . . 0.0 110.232 179.808 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.455 ' N ' HG23 ' A' ' 22' ' ' VAL . 1.3 t0 -172.93 -170.2 0.63 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.623 -0.673 . . . . 0.0 109.771 179.58 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.419 ' N ' ' CZ ' ' A' ' 4' ' ' PHE . . . -55.48 -22.57 21.44 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.474 -0.766 . . . . 0.0 111.096 -179.673 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.64 -27.9 69.54 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.461 -0.774 . . . . 0.0 110.55 -179.738 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 22.7 m -114.37 -25.65 8.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.468 -0.77 . . . . 0.0 110.684 -179.63 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.739 ' HB2' ' CD2' ' A' ' 4' ' ' PHE . . . -58.77 -62.28 1.99 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.453 -0.779 . . . . 0.0 110.628 -179.708 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -57.86 -45.04 86.87 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.446 -0.784 . . . . 0.0 110.446 179.934 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -53.29 -44.03 67.96 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.391 -0.818 . . . . 0.0 110.727 -179.956 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.1 t -78.25 -48.88 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.54 -0.725 . . . . 0.0 109.983 179.74 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.782 ' CZ ' HG22 ' A' ' 19' ' ' THR . 3.9 m-85 -62.11 -31.16 71.58 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 110.238 -179.55 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -64.88 -39.38 93.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.393 -0.817 . . . . 0.0 108.92 179.262 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -61.88 -30.04 70.6 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.56 0.695 . . . . 0.0 109.704 179.083 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -73.18 -54.86 7.41 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.196 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.738 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -63.65 -48.78 75.84 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.738 -0.601 . . . . 0.0 110.149 179.974 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -55.95 -28.71 58.22 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.516 -0.74 . . . . 0.0 110.515 -179.897 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.62 -38.39 29.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.658 -0.651 . . . . 0.0 110.056 179.909 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -80.59 -34.41 35.23 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.56 -0.713 . . . . 0.0 110.058 179.927 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.54 49.13 0.61 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.906 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.738 ' HB ' ' HB1' ' A' ' 35' ' ' ALA . 85.1 mt -115.15 67.92 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.52 -0.988 . . . . 0.0 110.329 179.852 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -90.83 51.88 2.06 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.771 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -80.49 -139.14 2.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -178.957 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -114.83 108.53 16.87 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.356 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.515 ' CH2' HD11 ' A' ' 6' ' ' LEU . 46.0 m95 -77.14 142.08 39.87 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.1 0.953 . . . . 0.0 112.321 -177.985 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.1 p -147.49 133.1 18.79 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.752 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.413 ' CE1' ' HG3' ' A' ' 51' ' ' LYS . 71.7 t80 -100.49 131.97 46.13 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.712 -0.618 . . . . 0.0 110.454 -178.357 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -100.79 125.29 47.26 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.678 -0.639 . . . . 0.0 109.946 179.81 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -82.04 -18.49 43.04 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.69 -0.631 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.43 ' C ' HG23 ' A' ' 50' ' ' THR . . . -57.01 -44.74 83.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.271 -0.893 . . . . 0.0 110.725 -179.7 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.43 HG23 ' C ' ' A' ' 49' ' ' ALA . 70.2 p -147.37 23.81 1.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.519 -0.738 . . . . 0.0 110.65 -179.588 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.43 ' HG2' ' CE1' ' A' ' 4' ' ' PHE . 1.3 mppt? 52.42 95.38 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.239 -0.913 . . . . 0.0 110.727 179.953 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.547 HG23 ' HB3' ' A' ' 5' ' ' LYS . 90.7 m -151.76 101.79 2.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.53 -0.731 . . . . 0.0 110.749 -179.964 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.469 ' O ' HD23 ' A' ' 6' ' ' LEU . 81.4 m-85 -61.08 124.16 19.73 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.811 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.643 HG23 HG21 ' A' ' 7' ' ' ILE . 62.3 m -117.98 105.47 11.93 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.387 -0.925 . . . . 0.0 112.611 -178.197 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.571 HG11 HG21 ' A' ' 40' ' ' ILE . 10.8 p -105.87 168.04 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.42 -0.8 . . . . 0.0 109.128 177.538 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.471 ' N ' HG22 ' A' ' 55' ' ' VAL . 95.1 m -158.28 108.14 2.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.564 -0.71 . . . . 0.0 109.948 -179.676 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.17 -179.928 . . . . . . . . 0 0 . 1 stop_ save_